data_2mzb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mzb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.605 ' O ' HG23 ' A' ' 42' ' ' VAL . 59.8 ttm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 1' ' ' MET . 52.6 m-20 -105.73 160.73 14.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.489 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -122.51 140.43 52.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.692 -177.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 98' ' ' VAL . 28.9 tp -112.42 123.73 50.93 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.362 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.564 ' HA ' HG22 ' A' ' 98' ' ' VAL . 55.1 mt -116.46 104.94 17.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.417 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 11.8 ptm -95.25 97.39 9.83 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.738 1.256 . . . . 0.0 112.465 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.436 ' CB ' HD11 ' A' ' 30' ' ' ILE . . . -115.94 96.98 5.84 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.094 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.582 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 N-CA-C 112.866 0.294 . . . . 0.0 112.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 56' ' ' THR . 43.4 mt -94.64 10.99 32.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.38 118.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -98.35 142.41 30.02 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.267 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.7 tp -137.21 115.87 12.1 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.106 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.1 m 56.06 24.14 7.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.57 2.22 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.01 -1.567 . . . . 0.0 115.436 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.688 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 69.5 mtt-85 -126.03 159.57 32.4 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 118.353 1.077 . . . . 0.0 111.059 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 72.7 m -83.85 157.99 21.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.7 -53.29 12.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD11 ' CB ' ' A' ' 7' ' ' ALA . 12.4 tt -62.07 -36.4 73.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.5 ' HA ' HG13 ' A' ' 34' ' ' VAL . 12.7 t70 -63.02 -40.51 97.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.688 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 25.1 m-85 -64.69 -37.17 86.68 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.573 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HA ' ' HZ3' ' A' ' 106' ' ' LYS . 72.1 t -66.37 -47.76 83.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.036 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.5 HG13 ' HA ' ' A' ' 31' ' ' ASP . 12.2 p -72.1 -35.15 52.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.524 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 35.1 t -53.9 -54.08 50.81 Favored Pre-proline 0 CA--C 1.562 1.438 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 46.0 Cg_exo -61.45 -39.34 56.67 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.002 1.801 . . . . 0.0 112.023 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 98' ' ' VAL . 81.2 mt -63.67 -42.08 98.1 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.459 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.474 ' HG ' HD22 ' A' ' 69' ' ' ASN . 8.9 tt -60.01 -45.79 91.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.0 -12.07 59.44 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.511 ' OG ' HG12 ' A' ' 42' ' ' VAL . 72.7 p -76.49 -175.86 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -51.48 -33.77 32.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.666 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 1' ' ' MET . 7.5 p -69.05 140.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 121.444 0.64 . . . . 0.0 111.616 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -83.6 -69.75 0.61 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.285 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -101.23 146.46 27.49 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.357 0.599 . . . . 0.0 111.156 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.7 mm -110.98 116.87 53.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.845 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 96.1 m-85 -103.39 114.96 29.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.516 HG23 HD11 ' A' ' 60' ' ' ILE . 88.0 mt -98.96 118.34 45.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.649 0.738 . . . . 0.0 110.482 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.443 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.33 124.36 33.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.374 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.424 ' OG1' ' HD2' ' A' ' 57' ' ' LYS . 55.1 p -132.2 168.63 17.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.213 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.1 m -129.89 155.01 81.21 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.506 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.63 -21.47 65.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.925 2.416 . . . . 0.0 111.044 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.16 -13.12 60.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.453 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -142.37 66.47 19.4 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 76.4 Cg_endo -107.99 87.0 0.02 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.591 0 CA-C-N 120.884 1.351 . . . . 0.0 111.363 170.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.5 mmtm -151.01 -44.58 0.12 Allowed 'General case' 1 C--N 1.221 -5.001 0 CA-C-N 109.599 -3.455 . . . . 0.0 102.649 176.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.42 ' HA ' HD13 ' A' ' 21' ' ' LEU . 74.9 m -62.68 -49.51 74.83 Favored 'General case' 0 N--CA 1.387 -3.615 0 CA-C-N 113.022 -1.899 . . . . 0.0 105.974 161.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.23 -50.26 70.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.628 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.5 pt-20 -62.14 -30.26 70.91 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 116.517 -2.073 . . . . 0.0 112.573 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.01 -50.31 66.81 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HD11 HG23 ' A' ' 47' ' ' ILE . 85.5 mt -60.62 -45.03 98.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.154 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -56.54 -45.53 81.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.634 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 70.1 m -71.1 -41.62 70.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.136 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.28 86.28 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 111.381 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' OH ' HG11 ' A' ' 34' ' ' VAL . 34.9 m-85 -115.99 39.79 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.952 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.2 mtmt -61.12 -29.04 69.53 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.131 0.491 . . . . 0.0 110.828 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.59 10.31 13.58 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 51.6 p90 -35.69 113.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.44 -48.61 5.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.474 HD22 ' HG ' ' A' ' 38' ' ' LEU . 20.1 p-10 -117.54 5.26 12.43 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 4.5 mp -95.11 122.58 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 75.8 t -124.01 128.49 74.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -105.82 129.13 59.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.363 0.601 . . . . 0.0 109.71 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.8 pt -121.88 156.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.293 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.89 128.58 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.405 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 11.7 t -158.72 -168.14 2.32 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-O 121.728 0.775 . . . . 0.0 112.916 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -69.06 1.48 3.5 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 126.184 1.794 . . . . 0.0 114.198 -176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.07 -20.35 0.0 OUTLIER Glycine 1 N--CA 1.521 4.365 0 C-N-CA 126.192 1.854 . . . . 0.0 116.903 -176.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -56.81 -38.05 72.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.51 127.81 8.5 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -60.9 -51.19 70.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 0.0 112.099 -172.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.3 pt -76.9 -27.43 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.485 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 50.7 mt-10 -63.36 -44.49 94.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.564 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 20.5 t0 -62.51 -50.69 70.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.278 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 88' ' ' ILE . 2.5 mm? -54.55 -46.28 73.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.631 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.1 m-80 -59.92 -42.99 95.15 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.385 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 28.9 mm-40 -65.18 -47.18 77.86 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.93 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.4 m -63.35 -42.56 98.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.329 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.537 HG21 ' O ' ' A' ' 84' ' ' LEU . 40.7 pt -65.87 -28.43 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.15 -10.65 85.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.775 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -109.17 -24.62 11.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 159' ' ' PRO . 76.9 m-85 -82.11 148.48 28.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.038 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 m -96.36 -12.28 24.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 111.153 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.02 158.77 66.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.588 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.71 141.84 33.72 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.384 2.723 . . . . 0.0 112.15 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.14 157.02 45.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.715 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.43 HD13 HD12 ' A' ' 154' ' ' ILE . 23.7 tp -87.83 143.2 27.26 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.733 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 72.6 t -113.11 129.64 68.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.564 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -132.26 160.57 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.136 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.447 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 51.2 m -100.38 137.11 39.25 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.5 p -77.05 -10.46 59.39 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 19.6 p-10 -99.19 9.61 43.09 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 175' ' ' ILE . 61.2 mt -91.52 115.9 28.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 85.4 mt -108.03 119.81 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 110.703 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 65.8 t30 170.04 153.15 0.05 OUTLIER 'General case' 0 C--O 1.247 0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.31 117.5 14.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HZ3' ' HA ' ' A' ' 33' ' ' VAL . 61.6 mttp -95.84 -1.37 49.65 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.462 -172.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -56.36 -38.87 72.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.74 -25.61 32.72 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.045 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.5 mm -71.32 -43.72 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.658 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.462 HD12 ' CB ' ' A' ' 40' ' ' SER . 60.2 mt -60.07 -48.48 87.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.126 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -64.64 -42.11 95.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.439 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -66.18 -43.0 88.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.526 HG13 ' CG1' ' A' ' 154' ' ' ILE . 38.7 mm -63.45 -48.62 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 120.907 0.384 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.485 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 66.3 t -61.29 -47.8 91.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.702 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -47.49 84.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.655 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.512 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.3 t80 -63.13 -44.26 96.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.375 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 58.4 t80 -58.39 -48.11 81.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.485 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 28.2 m-85 -63.1 -35.19 79.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.62 -40.35 96.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.121 0.486 . . . . 0.0 109.899 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 116' ' ' TYR . 80.0 mt -64.28 -45.73 95.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.688 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -62.68 -37.26 85.73 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.102 0.477 . . . . 0.0 110.672 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.98 88.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.288 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -83.84 -38.84 20.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.45 . . . . 0.0 111.314 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.3 m -130.07 94.1 31.82 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.184 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.05 -22.97 58.27 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.313 2.675 . . . . 0.0 113.126 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.49 -28.51 70.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.26 126.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' ' 160' ' ' LYS . 44.0 mt-10 -117.64 -13.18 10.23 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.224 -176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.67 157.04 46.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.4 . . . . 0.0 111.777 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 1.2 tm? -136.17 135.69 39.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.27 132.27 48.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 154' ' ' ILE . 14.1 p -114.66 126.56 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.92 160.99 41.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.5 pt -132.73 147.41 65.41 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.632 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 C--O 1.239 0.532 0 C-N-CA 122.413 2.075 . . . . 0.0 111.769 177.536 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.06 141.13 75.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.099 1.866 . . . . 0.0 110.567 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -90.36 -8.11 51.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.426 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.85 -86.58 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.637 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 132' ' ' VAL . 28.0 pt -123.75 160.17 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.217 0.532 . . . . 0.0 112.086 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.627 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.9 t-20 -128.61 151.99 48.85 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.469 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.6 t -123.43 131.04 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.522 0.201 . . . . 0.0 110.932 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.64 150.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.7 p -87.85 154.2 52.68 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.444 ' HB2' ' O ' ' A' ' 91' ' ' PHE . 67.2 Cg_endo -84.11 84.92 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.514 2.143 . . . . 0.0 113.307 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.433 ' HZ3' ' CD ' ' A' ' 128' ' ' GLU . 19.3 ptpt -130.81 -179.55 5.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.394 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -105.55 98.43 8.13 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.95 -170.29 21.32 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.845 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -96.62 150.01 21.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.776 0.322 . . . . 0.0 110.224 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.89 165.9 23.57 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.683 -171.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -64.03 124.71 22.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -120.62 132.9 55.36 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.114 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.28 161.3 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 121.559 0.695 . . . . 0.0 112.057 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.8 mm -118.36 129.04 75.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.566 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 58.4 ttp -132.06 136.63 47.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.35 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.84 130.26 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 49.4 pt -120.33 175.45 4.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.766 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -120.09 24.09 10.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.586 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -99.4 131.95 45.07 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.41 149.9 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.499 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.462 HD11 HD21 ' A' ' 102' ' ' LEU . 2.4 pt -119.59 148.89 22.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.644 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.51 118.24 33.2 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.443 HD22 HD23 ' A' ' 102' ' ' LEU . 1.9 m-20 -107.62 149.18 28.38 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.151 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.83 121.98 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.855 0.359 . . . . 0.0 111.507 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -130.12 -30.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.108 0.48 . . . . 0.0 110.406 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 t -140.92 -178.4 5.54 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.235 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -41.79 97.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.381 0.672 . . . . 0.0 112.623 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.4 -38.15 86.02 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.21 -40.6 94.58 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.273 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.81 -43.68 98.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 13.4 tmtt? -62.23 -44.23 97.04 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.534 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.66 -50.58 73.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.291 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.09 -39.91 90.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.458 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.2 pp20? -67.11 -28.69 68.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.336 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.6 mmm -63.26 -40.92 98.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.8 pp -71.3 -37.39 71.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.476 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.53 -39.73 94.3 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.804 0.812 . . . . 0.0 109.509 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.659 177.525 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.1 tpp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -110.49 166.6 10.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -113.09 139.93 48.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.242 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -119.51 114.55 22.45 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.553 ' HA ' HG23 ' A' ' 98' ' ' VAL . 69.0 mt -118.55 106.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.5 ptm -98.92 104.36 16.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.815 1.293 . . . . 0.0 112.621 -174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.57 6.14 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.165 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.491 178.641 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 N--CA 1.476 0.497 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.2 mt -89.15 13.04 14.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.489 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 94.8 mt -70.39 119.18 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 63.0 pttt -102.79 137.2 41.31 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-O 122.243 1.02 . . . . 0.0 113.123 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.32 131.68 50.39 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.174 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' HE3' ' A' ' 192' ' ' LYS . 83.7 m 53.48 32.36 13.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.77 -17.4 49.57 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.83 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 92.4 mtt180 -128.61 152.38 48.41 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 119.018 1.409 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 81.7 m -74.87 162.84 28.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.319 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HB3' ' O ' ' A' ' 100' ' ' SER . 84.0 mt -58.73 -40.89 85.11 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.144 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 60' ' ' ILE . 5.1 tp -58.08 -44.45 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.443 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.728 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 13.1 t70 -65.06 -43.57 91.82 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.97 0.414 . . . . 0.0 111.23 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.83 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 32.5 m-85 -67.33 -26.39 66.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.481 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 29' ' ' LEU . 69.7 t -73.7 -46.79 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.47 173.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.09 -47.72 88.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 66.1 m -54.61 -50.35 86.04 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.507 ' HG2' ' NZ ' ' A' ' 106' ' ' LYS . 78.3 Cg_exo -57.69 -42.59 58.44 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.75 1.634 . . . . 0.0 112.109 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 98' ' ' VAL . 90.0 mt -67.51 -39.48 85.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.8 tp -57.15 -43.68 82.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.44 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 35' ' ' SER . 19.0 ptpt -88.74 -6.15 57.62 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.521 ' OG ' HG12 ' A' ' 42' ' ' VAL . 57.6 p -81.55 -176.96 6.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.727 0.775 . . . . 0.0 112.212 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -63.63 -16.14 60.12 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.372 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' OG ' ' A' ' 40' ' ' SER . 13.3 p -75.28 147.69 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 122.189 -0.32 . . . . 0.0 111.691 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.03 -75.58 0.35 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -100.19 147.2 25.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.972 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.03 112.08 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.609 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -104.45 114.56 28.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.459 HG12 ' HB ' ' A' ' 5' ' ' ILE . 96.7 mt -97.26 116.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.674 0.749 . . . . 0.0 110.853 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.3 121.77 30.19 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.386 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 7' ' ' ALA . 53.2 p -132.69 162.38 31.54 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.414 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.6 m -117.87 154.75 51.33 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 29.1 Cg_endo -63.38 -18.86 66.58 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.028 2.485 . . . . 0.0 110.842 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -70.89 -20.72 62.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.084 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 p -137.59 66.69 50.59 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.741 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.661 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 63.2 Cg_endo -103.55 85.43 0.03 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.603 0 C-N-CA 116.974 -1.55 . . . . 0.0 110.162 170.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.1 ttpt -154.63 -47.24 0.09 Allowed 'General case' 1 C--N 1.211 -5.436 0 CA-C-N 109.393 -3.549 . . . . 0.0 102.27 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -63.42 -48.74 76.56 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 162.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.74 -50.4 71.24 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.834 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -63.6 -32.5 73.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 116.485 -2.086 . . . . 0.0 112.472 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.36 -51.21 64.44 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.192 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 30' ' ' ILE . 96.9 mt -64.91 -46.27 92.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.98 -175.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.4 -41.82 90.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 39.7 t -67.95 -42.87 80.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.508 0.671 . . . . 0.0 110.387 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.92 89.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.339 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 71.8 m-85 -112.0 18.26 18.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 62' ' ' SER . 64.6 pttt -65.03 -17.47 64.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.62 2.66 52.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -102.66 130.38 49.55 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.076 -0.39 . . . . 0.0 111.137 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.15 60.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.384 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -85.97 2.09 47.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.03 123.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.5 135.1 65.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.93 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.92 129.1 58.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 48' ' ' ALA . 42.9 pt -122.27 156.64 27.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.366 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.84 133.11 56.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.528 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.0 t -167.06 -167.29 0.91 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 52.6 m -64.08 1.17 0.74 Allowed 'General case' 0 C--O 1.197 -1.698 0 C-N-CA 126.826 2.05 . . . . 0.0 114.6 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.54 -28.21 0.01 OUTLIER Glycine 0 N--CA 1.515 3.922 0 C-N-CA 125.604 1.573 . . . . 0.0 116.713 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -56.12 -33.0 64.74 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.65 115.85 4.0 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -58.39 -50.72 72.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.2 -46.02 92.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.55 0.691 . . . . 0.0 110.742 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.48 -42.38 96.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.51 -50.1 74.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.901 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.4 mm? -57.06 -44.05 82.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.465 ' HA ' HG12 ' A' ' 88' ' ' ILE . 11.4 m120 -60.7 -42.3 96.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.41 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.19 -45.22 89.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.145 0.498 . . . . 0.0 110.572 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.613 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 95.5 m -64.65 -41.77 95.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.089 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.537 HG21 ' O ' ' A' ' 84' ' ' LEU . 39.2 pt -68.45 -31.02 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 121.98 -0.45 . . . . 0.0 110.952 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.86 95.55 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.158 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -101.94 9.78 40.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.613 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 62.8 m-85 -112.62 150.57 31.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.82 0.343 . . . . 0.0 111.823 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -102.41 -6.68 22.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.295 0.569 . . . . 0.0 109.951 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -125.49 156.76 69.98 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.432 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.89 153.6 42.49 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.622 2.215 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.92 152.55 43.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 0.0 112.657 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 155' ' ' ASN . 2.4 tm? -86.31 124.01 32.2 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.177 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 57.8 t -99.04 130.8 47.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 123.395 0.678 . . . . 0.0 109.805 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.553 HG23 ' HA ' ' A' ' 5' ' ' ILE . 13.3 m -129.37 166.38 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 121.871 0.843 . . . . 0.0 112.454 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.5 m -98.85 157.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.937 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 81.2 p -88.94 -6.25 57.4 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.309 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -117.59 9.96 13.3 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.96 122.32 31.43 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.073 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 103' ' ' ILE . 28.0 pt -122.47 101.51 10.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.663 0.744 . . . . 0.0 111.516 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -160.01 177.71 10.46 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.401 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.29 59.6 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.735 0.779 . . . . 0.0 109.93 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HA ' HD12 ' A' ' 109' ' ' ILE . 16.9 pttp -69.72 -3.69 16.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.79 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -59.17 -41.9 89.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HD3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -88.6 -23.16 23.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.812 0.815 . . . . 0.0 110.566 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.74 ' O ' HG12 ' A' ' 113' ' ' ILE . 74.2 mt -64.34 -38.79 83.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.882 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.1 mt -55.44 -47.85 77.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.769 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -63.69 -41.34 98.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.462 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.6 m -63.43 -39.8 95.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.2 mm -61.28 -47.69 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.041 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.505 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 67.9 t -60.43 -48.07 89.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.263 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.77 -47.64 84.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.607 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.585 ' CE2' HD13 ' A' ' 120' ' ' ILE . 75.0 t80 -61.43 -48.24 82.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.658 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -59.56 -47.59 84.95 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.246 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.505 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.8 m-85 -61.82 -37.94 86.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.331 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.7 t -61.12 -46.43 90.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.399 0.619 . . . . 0.0 109.908 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.585 HD13 ' CE2' ' A' ' 116' ' ' TYR . 80.0 mt -62.46 -45.98 97.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -62.85 -37.44 86.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.994 0.426 . . . . 0.0 110.833 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.49 91.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.398 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -81.27 -36.02 30.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.071 0.462 . . . . 0.0 111.206 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.7 m -139.89 100.1 7.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.169 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.03 -16.72 53.46 Favored 'Trans proline' 0 N--CA 1.481 0.775 0 C-N-CA 123.087 2.525 . . . . 0.0 113.241 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -69.48 -13.39 62.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.45 HG22 ' CG2' ' A' ' 120' ' ' ILE . 94.3 t -76.85 120.04 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.29 11.85 10.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.504 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.0 23.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.0 135.97 38.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.123 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.0 137.78 52.35 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.27 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 113' ' ' ILE . 57.6 t -112.29 116.91 53.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 4.3 ptm -145.46 155.55 43.19 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.956 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.472 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 24.0 pt -130.03 157.48 76.85 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.919 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 39.5 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 121.763 1.642 . . . . 0.0 111.772 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.91 147.5 55.63 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.198 1.932 . . . . 0.0 111.891 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.424 ' HB2' HG11 ' A' ' 132' ' ' VAL . . . -117.45 -6.64 11.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.226 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.05 -116.89 0.39 Allowed Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.48 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.413 HD12 HD12 ' A' ' 96' ' ' LEU . 22.2 pt -124.55 160.08 29.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 120.7 0.286 . . . . 0.0 111.02 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.551 ' O ' HD23 ' A' ' 96' ' ' LEU . 6.0 m-20 -117.65 159.27 23.21 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.91 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.67 133.46 69.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.88 148.45 31.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.479 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -92.43 149.29 38.02 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.13 75.2 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -104.11 -170.97 1.85 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.171 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -132.33 125.94 32.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.45 -105.99 3.34 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.207 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -147.03 140.5 25.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -133.3 166.96 21.28 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.424 ' HE3' HG21 ' A' ' 127' ' ' VAL . 63.6 tttp -58.47 125.7 24.45 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.828 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.14 128.31 49.08 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.143 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -93.9 163.49 13.48 Favored 'General case' 0 CA--C 1.477 -1.852 0 CA-C-O 121.687 0.756 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.33 130.12 69.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.537 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.419 ' HE1' HD13 ' A' ' 113' ' ' ILE . 51.3 ttm -112.45 129.85 56.19 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.376 175.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.54 126.32 66.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.2 pt -121.55 174.29 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 112.029 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -111.48 4.89 19.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.059 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.496 ' HB2' HD12 ' A' ' 171' ' ' ILE . 34.9 mt-10 -99.34 130.29 45.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 111.03 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.49 151.15 19.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.249 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.99 150.49 31.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.325 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.01 122.82 43.05 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.164 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.419 ' C ' HD12 ' A' ' 178' ' ' ILE . 23.7 p-10 -94.08 168.17 11.11 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.787 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.438 HG12 HD21 ' A' ' 184' ' ' LEU . 2.0 mp -120.32 121.05 64.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.873 0.368 . . . . 0.0 111.093 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -111.72 -32.34 6.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.422 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.1 t -138.39 176.6 8.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.022 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -64.24 -29.13 70.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.83 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.28 -39.11 91.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.414 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -61.42 -35.76 78.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.388 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.438 HD21 HG12 ' A' ' 178' ' ' ILE . 96.0 mt -60.68 -43.7 97.4 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.354 0.597 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.646 ' O ' ' HG3' ' A' ' 189' ' ' MET . 60.0 tptt -62.84 -43.61 98.35 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.707 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.56 -48.21 82.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.593 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.71 -43.14 99.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.306 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 192' ' ' LYS . 13.2 pt-20 -70.2 -29.59 66.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.932 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.646 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -61.44 -39.71 91.83 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -70.67 -33.41 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.96 -40.57 87.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.66 0.743 . . . . 0.0 110.558 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 188' ' ' GLU . 34.8 mmtp . . . . . 0 C--N 1.308 -1.203 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.368 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 64.2 m-20 -97.35 165.91 11.79 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.9 130.07 56.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.901 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.439 ' O ' HG21 ' A' ' 98' ' ' VAL . 36.1 tp -100.93 124.72 47.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.369 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HA ' HG21 ' A' ' 98' ' ' VAL . 68.5 mt -117.59 104.88 17.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.454 ' HE1' ' CG ' ' A' ' 83' ' ' ASP . 12.0 ptm -96.64 107.64 20.12 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.786 1.279 . . . . 0.0 112.505 -174.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.92 96.92 5.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.801 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.623 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.654 -179.032 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 44.1 Cg_exo . . . . . 0 N--CA 1.48 0.715 0 CA-C-O 121.348 0.478 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.538 HD23 ' CB ' ' A' ' 59' ' ' TYR . 9.6 mp -83.51 15.71 2.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -69.73 123.19 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -80.75 132.08 35.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.575 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 tp -137.83 125.33 22.06 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.152 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t 58.64 26.17 14.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.278 0.561 . . . . 0.0 110.74 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 -13.85 56.86 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -134.4 169.81 16.68 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 118.945 1.372 . . . . 0.0 111.434 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 75.6 m -85.73 163.79 18.01 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.672 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 82.3 mt -59.43 -39.69 84.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.268 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.3 tp -57.17 -45.17 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.201 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.43 -41.65 93.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.973 0.416 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -61.52 -33.89 74.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.409 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.491 ' HA ' ' HZ3' ' A' ' 106' ' ' LYS . 71.4 t -73.54 -42.95 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.774 0.321 . . . . 0.0 111.412 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.4 t -63.39 -44.81 99.13 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -52.87 -50.47 81.28 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 28.9 Cg_endo -64.13 -40.95 24.04 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.367 1.378 . . . . 0.0 112.489 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.463 HD11 HG11 ' A' ' 98' ' ' VAL . 88.6 mt -66.7 -37.71 85.26 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.498 0.666 . . . . 0.0 110.436 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.22 -44.12 88.05 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.284 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 36' ' ' PRO . 64.3 pttt -90.32 -3.23 57.89 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.206 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 59.5 p -81.43 -178.9 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.778 0.799 . . . . 0.0 112.997 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -59.94 -25.28 65.05 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.2 m -64.26 161.78 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.445 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.2 t30 -83.38 -76.31 0.29 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.218 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -115.16 157.44 23.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.074 0.464 . . . . 0.0 110.82 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.63 115.89 50.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -107.81 117.32 33.8 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -96.88 119.41 44.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.736 0.779 . . . . 0.0 110.583 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB1' HD12 ' A' ' 4' ' ' LEU . . . -91.05 121.0 32.48 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.758 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.1 p -132.07 165.81 23.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.44 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.9 p -128.45 157.57 74.36 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.081 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.2 -25.68 72.91 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.916 2.41 . . . . 0.0 110.963 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -75.46 -14.04 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.712 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -141.76 65.94 21.09 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.8 Cg_endo -106.26 86.72 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.113 0 C-N-CA 117.148 -1.435 . . . . 0.0 109.586 168.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.571 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 ttmt -147.83 -50.43 0.18 Allowed 'General case' 1 C--N 1.209 -5.534 0 CA-C-N 109.489 -3.505 . . . . 0.0 101.675 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 98.0 m -62.52 -48.41 79.65 Favored 'General case' 0 N--CA 1.382 -3.85 0 CA-C-N 111.712 -2.494 . . . . 0.0 106.047 164.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.629 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.23 -49.1 77.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.004 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 18.9 pt-20 -56.17 -35.96 67.8 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 117.589 -1.644 . . . . 0.0 110.988 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.538 ' CB ' HD23 ' A' ' 21' ' ' LEU . 57.7 t80 -70.76 -52.05 23.22 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.744 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.431 HG12 HG12 ' A' ' 30' ' ' ILE . 97.1 mt -63.92 -45.12 97.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.508 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.714 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 49.2 t30 -57.08 -47.33 81.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.907 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 t -71.47 -43.68 66.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.733 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.96 89.32 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.377 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 95.2 m-85 -104.52 20.16 19.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtpt -63.32 -23.14 67.28 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 174.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.03 10.02 15.43 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.22 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 45.1 p90 -50.51 148.55 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -103.55 -52.88 2.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.448 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -121.14 16.57 11.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.557 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 79.1 mt -103.87 127.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.54 0.686 . . . . 0.0 111.838 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 69.2 t -125.84 134.0 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.879 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.32 132.7 49.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.189 0.519 . . . . 0.0 109.973 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 pt -127.51 157.04 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.901 0.857 . . . . 0.0 111.672 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -106.6 133.79 50.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.981 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.8 t -159.75 -168.6 2.3 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 78' ' ' LYS . 65.7 m -77.37 3.28 13.58 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 126.001 1.72 . . . . 0.0 113.725 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.473 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.51 -14.56 0.0 OUTLIER Glycine 1 N--CA 1.522 4.372 0 C-N-CA 127.11 2.29 . . . . 0.0 117.992 -174.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.8 tmtt? -59.93 -37.11 78.55 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.68 130.35 8.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.48 -51.04 71.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.483 HD11 ' OH ' ' A' ' 163' ' ' TYR . 45.7 pt -71.32 -36.41 61.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.52 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.37 -40.01 92.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.124 0.488 . . . . 0.0 109.834 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.473 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 19.0 t0 -59.66 -51.03 71.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.962 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.2 mm? -56.34 -45.4 80.41 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.783 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.493 ' HA ' HG12 ' A' ' 88' ' ' ILE . 24.6 m-80 -60.32 -41.31 93.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.584 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 77.4 mm-40 -65.19 -46.06 82.32 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.538 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.4 m -63.02 -43.76 97.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.238 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 84' ' ' LEU . 34.7 pt -67.72 -29.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.822 0.344 . . . . 0.0 110.403 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.31 96.09 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.71 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.5 3.89 50.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.449 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 63.8 m-85 -108.74 143.26 38.1 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.581 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.3 p -102.78 -0.76 30.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.484 . . . . 0.0 111.11 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -133.24 156.75 79.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.864 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.76 146.34 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.409 2.072 . . . . 0.0 111.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.25 161.69 38.28 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.488 0.661 . . . . 0.0 112.362 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 97' ' ' VAL . 1.5 tm? -84.81 143.08 29.32 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.222 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.6 ' N ' HD12 ' A' ' 96' ' ' LEU . 99.8 t -119.59 130.15 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.86 0.864 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 5' ' ' ILE . 14.6 m -130.87 161.95 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.207 0.527 . . . . 0.0 112.136 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.8 t -99.37 140.74 33.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -72.24 -10.86 60.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -104.15 9.69 36.15 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.28 122.86 27.96 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 122.086 -0.384 . . . . 0.0 110.931 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 pt -62.98 166.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -89.56 72.53 7.84 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.17 -14.01 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 168.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.491 ' HZ3' ' HA ' ' A' ' 33' ' ' VAL . 25.0 pttm -67.66 -0.44 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.002 -1.908 . . . . 0.0 114.454 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.4 m -58.09 -40.67 81.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -82.49 -23.99 34.41 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.738 0.78 . . . . 0.0 110.303 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.762 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.6 mm -64.02 -40.22 88.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.112 -174.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.495 ' HA ' HD13 ' A' ' 154' ' ' ILE . 58.1 mt -57.89 -48.57 83.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.644 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -65.12 -39.75 93.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.58 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.6 m -61.33 -40.16 93.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.634 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.762 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -61.8 -49.18 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.695 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 71.4 t -62.85 -47.76 91.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.425 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.12 -45.83 93.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.731 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CE2' HD11 ' A' ' 120' ' ' ILE . 62.3 t80 -62.85 -48.38 79.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.813 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.53 -47.64 84.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.363 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.448 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 25.5 m-85 -61.8 -37.77 85.64 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.459 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -63.66 -39.75 95.11 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.277 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.622 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.6 mt -63.35 -46.36 95.69 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.078 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.409 ' HG2' HG13 ' A' ' 127' ' ' VAL . 52.5 mtmt -61.74 -38.66 88.77 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.908 0.385 . . . . 0.0 111.178 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.6 87.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.398 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -86.93 -35.25 19.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.017 0.437 . . . . 0.0 111.627 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.418 ' O ' HG11 ' A' ' 127' ' ' VAL . 34.4 m -136.88 94.53 12.81 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 122.806 0.443 . . . . 0.0 110.848 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.34 -15.8 31.43 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.388 2.725 . . . . 0.0 113.051 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.9 -32.92 72.37 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 12.0 p -65.54 132.14 31.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.215 0.531 . . . . 0.0 111.947 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -119.56 -15.79 8.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.167 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.82 160.23 43.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 23.1 tp -134.61 144.26 47.8 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.96 140.73 51.53 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.317 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' A' ' 113' ' ' ILE . 84.2 t -118.58 120.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 ptm -145.49 154.62 42.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.787 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.435 HG12 ' HB3' ' A' ' 152' ' ' ALA . 28.2 pt -129.87 156.29 79.22 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.382 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.209 1.939 . . . . 0.0 110.739 176.155 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.45 142.48 98.12 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.028 2.485 . . . . 0.0 111.166 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 175' ' ' ILE . . . -135.25 -30.19 1.05 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.239 0.543 . . . . 0.0 111.431 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.39 -141.91 11.66 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 119.715 -1.231 . . . . 0.0 112.49 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.521 ' CG1' HG13 ' A' ' 113' ' ' ILE . 17.6 pt -126.37 160.69 33.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.926 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.537 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.0 m-20 -109.53 159.74 16.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.33 132.39 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.34 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.96 152.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.108 0.48 . . . . 0.0 111.513 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.586 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.2 m -97.07 160.12 29.79 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.374 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.5 83.24 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.783 2.322 . . . . 0.0 111.615 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' A' ' 164' ' ' GLN . 30.8 mmmt -114.31 150.3 34.69 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.864 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.79 -42.45 90.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.788 0.328 . . . . 0.0 110.469 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.01 -148.29 7.28 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.594 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.483 ' OH ' HD11 ' A' ' 81' ' ' ILE . 97.7 m-85 -75.98 149.47 37.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.0 110.893 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.586 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 16.3 pt20 -134.23 167.61 20.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 1.9 tmtm? -60.71 131.4 50.57 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.999 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -134.56 130.58 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.727 0.299 . . . . 0.0 111.69 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -95.08 164.09 13.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.8 mm -119.13 131.69 71.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -135.8 140.66 44.43 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.312 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.9 t -108.38 129.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.398 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.79 170.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 112.01 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 3.05 56.31 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.975 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.51 ' CD ' HD13 ' A' ' 109' ' ' ILE . 12.1 pt-20 -130.09 142.37 50.61 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.815 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.43 ' O ' HD11 ' A' ' 174' ' ' LEU . 2.7 pp -97.23 149.66 21.79 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.625 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 175' ' ' ILE . 2.3 pp -131.41 145.35 35.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.398 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -131.01 149.68 52.5 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -98.39 178.94 4.88 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.97 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.15 119.72 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -125.49 -22.0 4.39 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.386 0.612 . . . . 0.0 109.731 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.1 p -130.03 164.21 24.82 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.521 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 mppt? -63.28 -35.79 81.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.92 -44.32 94.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.118 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.34 -41.43 96.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.177 0.513 . . . . 0.0 109.647 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.19 -47.73 84.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.522 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.618 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 86.6 tttt -68.11 -35.88 78.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.583 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.5 tp -58.5 -48.36 81.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.748 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.34 -42.45 98.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.274 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.618 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.3 -32.38 73.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.848 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -61.87 -44.8 96.09 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.687 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.84 -35.83 67.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.146 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 190' ' ' LEU . 95.1 mt -65.11 -41.08 95.26 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.845 0.831 . . . . 0.0 109.845 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 C--N 1.309 -1.154 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.346 178.521 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 68.9 m-20 -94.82 166.02 12.19 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.8 127.73 56.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.121 0.486 . . . . 0.0 110.519 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.88 121.97 45.15 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.614 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.539 ' HA ' HG23 ' A' ' 98' ' ' VAL . 65.9 mt -118.83 114.27 44.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.567 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 59.8 ttm -84.7 97.11 9.47 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-O 121.936 0.874 . . . . 0.0 111.302 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 49' ' ' THR . . . -114.42 100.82 8.6 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.038 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.467 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.974 -178.221 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 113.647 0.595 . . . . 0.0 113.647 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 56' ' ' THR . 72.7 mt -86.84 23.07 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.6 mt -70.4 116.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.5 pttm -96.24 131.82 42.34 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.205 1.003 . . . . 0.0 112.759 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -128.93 138.54 52.05 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 113.395 -1.729 . . . . 0.0 108.634 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 191' ' ' LEU . 81.0 m 63.33 -75.65 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.55 0.531 . . . . 0.0 112.263 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.18 0.58 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.669 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 7.7 ptm180 -150.6 170.1 19.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.402 1.101 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 96.3 m -78.07 156.96 29.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -53.01 -46.94 68.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.327 0.651 . . . . 0.0 110.929 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -63.95 -36.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.817 0.341 . . . . 0.0 110.762 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.56 -40.8 97.93 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.519 ' CE2' ' HG2' ' A' ' 27' ' ' ARG . 7.7 m-85 -61.63 -36.75 81.65 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 29' ' ' LEU . 78.9 t -65.77 -42.35 92.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.924 0.392 . . . . 0.0 110.881 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.01 -41.61 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 t -48.04 -56.5 13.49 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.91 -37.37 15.6 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 121.719 1.612 . . . . 0.0 112.435 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.471 HD12 HG11 ' A' ' 98' ' ' VAL . 82.0 mt -65.52 -42.59 91.86 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.48 ' HG ' HD22 ' A' ' 69' ' ' ASN . 6.6 tt -61.45 -46.92 88.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.283 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -76.34 -12.8 60.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.1 p -72.17 -178.41 2.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.925 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -70.04 -4.56 21.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.997 -1.002 . . . . 0.0 113.529 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.32 162.07 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.483 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.555 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.1 t30 -80.12 -75.44 0.26 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.201 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.0 161.04 21.6 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.039 0.447 . . . . 0.0 110.8 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.8 mm -108.99 116.49 52.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.301 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 88.6 m-85 -109.89 118.1 35.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.481 HG23 HD12 ' A' ' 60' ' ' ILE . 90.2 mt -101.57 118.77 48.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.567 0.699 . . . . 0.0 111.023 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -84.48 117.99 24.01 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.074 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 7' ' ' ALA . 71.5 p -125.26 164.32 20.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -126.53 156.14 73.52 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.491 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.07 -24.29 65.23 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.98 2.453 . . . . 0.0 111.154 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -70.1 -20.86 63.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.021 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -139.6 67.64 37.06 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.629 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 86.3 Cg_endo -100.76 84.9 0.04 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.618 0 C-N-CA 116.682 -1.745 . . . . 0.0 109.522 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -151.43 -45.78 0.11 Allowed 'General case' 1 C--N 1.213 -5.362 0 CA-C-N 110.311 -3.131 . . . . 0.0 102.938 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.457 ' HA ' HD21 ' A' ' 21' ' ' LEU . 87.4 m -63.6 -46.1 87.34 Favored 'General case' 0 N--CA 1.386 -3.628 0 CA-C-N 112.933 -1.939 . . . . 0.0 105.824 163.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.7 tmtt? -61.18 -50.28 73.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.239 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 57.9 mt-10 -59.79 -43.93 94.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 118.274 -1.371 . . . . 0.0 112.348 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.15 -50.87 71.41 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.481 HD12 HG23 ' A' ' 47' ' ' ILE . 97.5 mt -63.1 -42.52 96.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.333 0.587 . . . . 0.0 110.414 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.22 -44.84 84.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.054 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 68.5 m -70.39 -40.19 74.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.736 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.78 89.83 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.26 0.552 . . . . 0.0 110.956 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 62.0 m-85 -112.73 41.39 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.169 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 62' ' ' SER . 12.7 mmmm -59.7 -37.3 78.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.112 177.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.62 11.15 15.78 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.807 0.443 . . . . 0.0 111.024 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 47.7 p90 -39.51 132.96 1.49 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.0 -48.18 4.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.48 HD22 ' HG ' ' A' ' 38' ' ' LEU . 26.1 p-10 -118.81 9.7 12.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.843 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.5 mp -99.7 119.17 47.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.615 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.0 t -121.22 131.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.737 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.69 130.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.3 pt -125.4 156.63 34.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.127 0.489 . . . . 0.0 110.562 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -118.23 134.91 54.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.406 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 13.8 t -160.57 -169.22 2.36 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.6 m -64.32 2.35 0.61 Allowed 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 127.169 2.188 . . . . 0.0 114.674 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.43 -22.32 0.0 OUTLIER Glycine 0 N--CA 1.511 3.64 0 C-N-CA 126.358 1.932 . . . . 0.0 116.929 -174.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.7 OUTLIER -56.42 -36.82 69.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.04 125.74 7.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.59 -51.6 68.7 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.1 pt -75.49 -30.72 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.375 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 43.7 mt-10 -65.52 -41.86 92.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.825 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.567 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 6.9 t0 -60.21 -51.27 70.27 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.991 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -59.41 -44.36 92.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 88' ' ' ILE . 22.7 m-80 -61.2 -40.32 93.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.92 0.39 . . . . 0.0 111.774 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 63.4 mm-40 -62.79 -46.45 87.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 99.5 m -62.15 -43.15 99.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.085 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.0 pt -65.68 -27.72 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.032 0.444 . . . . 0.0 110.316 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.99 -20.28 74.51 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.713 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -105.3 -23.58 12.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 60.0 m-85 -75.2 149.57 38.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -97.11 -15.48 20.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -139.83 160.91 58.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.808 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -52.91 143.19 49.99 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 111.778 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -137.57 156.16 48.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.439 0.638 . . . . 0.0 111.687 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 154' ' ' ILE . 1.5 tm? -86.86 133.87 33.59 Favored 'General case' 0 C--O 1.189 -2.131 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.057 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.7 t -107.03 128.54 61.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.141 0.576 . . . . 0.0 109.756 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 5' ' ' ILE . 4.4 m -130.53 161.53 40.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.495 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.493 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 70.2 m -99.73 144.28 28.98 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.731 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.496 ' O ' HD23 ' A' ' 29' ' ' LEU . 63.6 m -88.03 -1.48 58.02 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -108.32 7.78 27.36 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 65.9 mt -81.44 114.91 20.5 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.176 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.35 112.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 173.58 176.95 0.12 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.0 tp -84.21 103.06 13.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -96.98 -3.84 40.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.686 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -59.77 -45.01 93.58 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.057 0.456 . . . . 0.0 111.778 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -79.15 -23.57 43.88 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.365 0.602 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 113' ' ' ILE . 35.1 mm -68.98 -41.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.395 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.07 -46.55 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.376 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.22 -42.42 99.29 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.256 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.4 m -64.76 -41.71 95.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.55 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.701 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.8 mm -64.21 -49.96 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.008 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.411 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 64.8 t -61.6 -47.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.769 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.41 -46.42 88.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.823 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.624 ' CE2' HD11 ' A' ' 120' ' ' ILE . 67.0 t80 -63.43 -46.51 86.01 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.795 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.62 -48.3 81.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.907 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.411 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.1 m-85 -63.21 -33.79 76.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.427 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.01 -46.92 87.09 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.286 0.565 . . . . 0.0 109.676 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.624 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.8 mt -64.18 -48.58 85.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.577 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -65.55 -26.53 67.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.413 -178.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.49 99.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.57 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 19.0 ptpt -82.24 -37.0 26.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.669 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.553 ' O ' HG13 ' A' ' 127' ' ' VAL . 85.9 m -132.65 91.72 29.2 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.15 -17.44 38.73 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 123.379 2.72 . . . . 0.0 112.921 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.75 -32.27 73.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 124' ' ' THR . 9.9 p -73.33 127.64 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.479 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 45.0 mt-10 -122.19 2.9 9.83 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.193 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.51 155.23 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.971 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.8 tp -137.58 146.1 43.63 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.93 137.12 53.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.338 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.471 HG22 ' CD1' ' A' ' 113' ' ' ILE . 98.9 t -114.24 115.77 50.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.379 0.609 . . . . 0.0 109.615 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.5 ptm -145.9 156.61 43.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.785 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 152' ' ' ALA . 22.2 pt -131.5 158.39 75.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.652 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--O 1.239 0.546 0 C-N-CA 122.411 2.074 . . . . 0.0 111.706 179.629 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.442 -0.85 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 141.65 48.54 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.039 1.826 . . . . 0.0 111.252 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.441 ' HB3' HG12 ' A' ' 134' ' ' ILE . . . -114.69 -5.11 12.7 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.295 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.25 -116.95 0.45 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.557 -1.306 . . . . 0.0 113.176 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.453 ' CG1' HG13 ' A' ' 113' ' ' ILE . 25.2 pt -119.05 161.15 18.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.991 0.424 . . . . 0.0 111.768 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.566 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.7 t-20 -120.18 156.02 31.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.118 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 81.3 t -124.25 130.27 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 122.253 0.221 . . . . 0.0 110.75 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.502 HG11 ' OD1' ' A' ' 155' ' ' ASN . 27.7 m -135.52 155.16 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.055 0.455 . . . . 0.0 111.346 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.544 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.6 m -97.06 157.45 34.97 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.187 174.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.34 69.22 7.26 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.873 2.382 . . . . 0.0 111.731 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.31 169.58 10.27 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.918 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -110.22 22.07 15.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.622 0.725 . . . . 0.0 109.606 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -170.27 -176.32 39.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.509 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -72.22 146.17 47.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.091 0.446 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.544 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 19.9 pt20 -133.37 166.6 22.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -173.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.47 127.62 33.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.763 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.13 132.15 53.15 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.65 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -93.49 163.05 13.72 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.641 0.734 . . . . 0.0 112.207 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.4 mm -116.16 127.77 73.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.442 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.8 ttp -131.19 132.86 45.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.911 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 133' ' ' MET . 78.8 t -107.87 131.78 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.163 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.638 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 39.2 pt -114.55 172.62 3.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -117.97 8.02 12.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.352 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.638 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.1 pm0 -104.32 134.67 47.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.708 0.766 . . . . 0.0 110.828 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.73 151.05 19.72 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.536 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.6 pt -110.37 146.16 15.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.436 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.34 111.8 24.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -110.12 153.02 25.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 183' ' ' ASP . 92.6 mt -110.73 119.59 59.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -114.4 -24.8 8.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.561 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.1 p -128.26 163.96 23.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.695 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -61.8 -32.46 72.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.18 -37.54 85.63 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.366 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 178' ' ' ILE . 57.3 m-20 -60.89 -35.28 76.24 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.007 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.502 HD23 HD13 ' A' ' 178' ' ' ILE . 96.0 mt -60.02 -46.2 90.27 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.87 0.843 . . . . 0.0 109.184 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 65.7 tttm -65.82 -40.05 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.505 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 189' ' ' MET . 10.5 tt -64.13 -44.36 92.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 0.0 110.187 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.06 -43.03 99.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.332 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -70.33 -29.74 66.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.064 0.459 . . . . 0.0 110.607 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.424 ' HB3' ' O ' ' A' ' 186' ' ' LEU . 60.0 ttm -61.87 -47.91 82.9 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.325 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -70.1 -31.38 68.91 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.768 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.457 HD13 ' SG ' ' A' ' 25' ' ' CYS . 83.5 mt -62.11 -45.02 95.34 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.339 0.59 . . . . 0.0 110.678 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.27 178.351 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 59.2 ttm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.474 ' HA ' HG12 ' A' ' 42' ' ' VAL . 63.6 m-20 -103.94 164.6 11.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.614 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.7 129.79 56.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.178 0.513 . . . . 0.0 111.168 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.402 ' O ' HG21 ' A' ' 98' ' ' VAL . 2.2 tm? -103.57 119.27 38.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.55 ' HA ' HG21 ' A' ' 98' ' ' VAL . 68.6 mt -116.6 115.69 49.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.138 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.567 ' CE ' HD23 ' A' ' 84' ' ' LEU . 47.2 mtt -89.66 97.47 11.21 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 122.48 1.133 . . . . 0.0 113.591 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' HG21 ' A' ' 49' ' ' THR . . . -115.86 110.62 19.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.07 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.78 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -178.481 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 N--CA 1.478 0.571 0 CA-C-O 121.064 0.36 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 59' ' ' TYR . 10.8 mp -79.69 6.31 11.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.47 125.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.513 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -109.54 146.09 35.23 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.647 0.737 . . . . 0.0 112.386 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 184' ' ' LEU . 96.4 mt -129.45 124.71 34.75 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.848 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.6 m 65.66 -74.32 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.732 0.645 . . . . 0.0 112.418 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.9 -68.96 0.55 Allowed Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.529 -0.843 . . . . 0.0 114.221 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 98.5 mtt180 -115.76 172.86 6.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 112.349 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 78.4 m -71.84 154.47 41.25 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.466 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -42.21 20.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.436 1.094 . . . . 0.0 111.219 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG21 ' A' ' 34' ' ' VAL . 5.1 tp -58.18 -48.2 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.504 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 19.0 t70 -63.74 -40.01 95.7 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.036 0.446 . . . . 0.0 110.584 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 7.0 m-30 -62.13 -37.4 85.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.865 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.45 -43.66 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.701 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 30' ' ' ILE . 78.4 t -64.62 -42.18 94.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.643 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -50.04 -54.99 27.35 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.12 -38.09 9.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.205 1.27 . . . . 0.0 112.583 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 98' ' ' VAL . 91.1 mt -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.967 0.413 . . . . 0.0 111.405 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.546 ' HG ' HD22 ' A' ' 69' ' ' ASN . 7.5 tt -63.09 -46.88 85.29 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.07 -12.93 60.03 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 p -74.62 -176.75 2.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.932 0.396 . . . . 0.0 110.803 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.28 -9.51 3.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.883 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 2' ' ' ASP . 69.0 t -64.51 133.11 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.171 0.51 . . . . 0.0 110.588 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -80.26 -68.3 0.69 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.988 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -111.12 148.38 32.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.405 0.621 . . . . 0.0 111.217 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.9 mm -108.47 117.12 53.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.765 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.24 113.83 27.23 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -95.23 116.3 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.427 0 CA-C-O 121.657 0.741 . . . . 0.0 110.042 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.6 120.6 29.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.826 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 7' ' ' ALA . 76.0 p -125.61 160.16 30.32 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.254 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.9 m -109.66 150.44 41.26 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.999 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.27 -27.6 75.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.103 2.536 . . . . 0.0 111.801 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -81.05 -6.62 59.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.476 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.8 66.34 40.58 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.9 Cg_endo -109.24 85.79 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.842 0 CA-C-N 120.713 1.29 . . . . 0.0 110.159 168.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.0 mttt -146.45 -45.63 0.19 Allowed 'General case' 1 C--N 1.217 -5.187 0 CA-C-N 109.852 -3.34 . . . . 0.0 102.327 177.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.422 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 77.1 m -62.03 -47.99 82.3 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 112.033 -2.349 . . . . 0.0 105.989 162.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.32 -50.1 72.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.061 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.594 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.2 pt-20 -59.33 -35.15 73.32 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.858 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CB ' HD21 ' A' ' 21' ' ' LEU . 56.4 t80 -67.25 -51.61 51.02 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.932 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' HG12 ' A' ' 30' ' ' ILE . 97.7 mt -63.47 -44.91 99.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.536 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -58.77 -42.65 89.42 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.475 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 35.2 t -70.33 -43.2 70.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.847 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.48 89.73 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.798 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.51 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 68.3 m-85 -108.11 34.69 3.47 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.185 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.8 mmmt -62.64 -20.23 64.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.564 0.697 . . . . 0.0 110.128 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.7 10.84 16.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.938 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.51 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 52.9 p90 -46.78 126.48 8.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -104.34 -49.37 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.546 HD22 ' HG ' ' A' ' 38' ' ' LEU . 24.9 p-10 -117.01 15.73 15.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.255 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 67' ' ' TYR . 78.8 mt -105.32 127.58 59.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.248 0.547 . . . . 0.0 110.851 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.03 132.98 68.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.83 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.61 130.96 60.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.4 155.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 122.038 0.923 . . . . 0.0 112.372 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -111.13 132.61 54.15 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.189 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 2.6 t -161.14 -172.05 3.28 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.8 m -66.69 2.08 1.51 Allowed 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 127.236 2.214 . . . . 0.0 114.68 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.11 -23.98 0.0 OUTLIER Glycine 0 N--CA 1.51 3.596 0 C-N-CA 126.237 1.875 . . . . 0.0 117.038 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -55.38 -35.3 65.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.18 121.77 5.51 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.29 -50.44 73.61 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.9 mt -65.99 -43.62 92.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.585 0.707 . . . . 0.0 110.172 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.1 -44.12 91.91 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.295 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.515 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 33.7 t0 -62.07 -48.15 81.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.282 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -53.76 -41.54 67.27 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.861 177.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.573 ' O ' HG12 ' A' ' 88' ' ' ILE . 28.0 m-80 -60.09 -43.99 95.12 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.365 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 53.3 mm-40 -65.67 -41.91 91.93 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.264 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 84' ' ' LEU . 26.1 pt -66.23 -25.12 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.335 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.18 92.28 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.121 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -80.75 -8.99 59.84 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -119.81 145.97 46.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.4 m -115.73 10.73 15.5 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -133.36 157.65 77.6 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.121 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.84 146.05 64.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.195 1.93 . . . . 0.0 111.557 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -139.2 158.26 44.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 155' ' ' ASN . 27.0 tp -86.27 140.62 29.93 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.928 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 60.3 t -115.17 131.34 67.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 5' ' ' ILE . 11.0 m -126.97 157.02 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.691 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.461 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 36.3 t -99.71 136.5 39.54 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.8 p -64.54 -34.03 77.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -88.79 1.95 54.37 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 70.3 mt -91.26 114.11 26.55 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.757 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -121.88 130.29 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -176.91 -178.08 0.82 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.97 71.7 1.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.491 ' HA ' HD11 ' A' ' 109' ' ' ILE . 58.6 mtpt -79.98 -8.05 59.13 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.546 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.8 t -59.75 -45.94 90.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -82.97 -24.26 33.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.797 0.808 . . . . 0.0 110.169 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.677 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.6 mt -65.63 -39.24 84.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.03 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 106' ' ' LYS . 60.3 mt -57.09 -46.47 84.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.279 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -61.66 -43.9 97.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.12 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -63.98 -40.77 97.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.738 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.01 -49.11 85.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.217 0.532 . . . . 0.0 110.373 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.51 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.7 t -62.48 -46.83 95.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.244 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.61 -43.81 98.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.113 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.428 ' CD2' ' HG3' ' A' ' 169' ' ' MET . 37.5 t80 -66.77 -42.75 85.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.147 0.498 . . . . 0.0 110.287 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.2 t80 -57.46 -47.3 82.2 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.333 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 39.8 m-85 -67.95 -30.75 70.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.39 -39.79 95.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -65.34 -42.33 93.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.409 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.922 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -38.5 74.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.67 177.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.48 91.17 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.561 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -88.59 -37.39 15.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 111.612 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.6 m -141.27 92.06 8.49 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.411 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.262 2.641 . . . . 0.0 112.295 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.39 -30.47 70.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.463 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.479 HG23 ' HE3' ' A' ' 165' ' ' LYS . 61.9 t -67.05 127.45 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.087 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 158' ' ' SER . 30.1 mt-10 -102.44 -34.11 9.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.234 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -131.45 165.6 23.17 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.44 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -140.22 134.25 30.85 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.807 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.51 135.93 51.03 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.533 HG21 ' CD1' ' A' ' 113' ' ' ILE . 78.3 t -117.24 118.61 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.68 41.92 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.747 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.577 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 34.8 pt -124.58 163.28 37.71 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 10.7 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 121.82 1.68 . . . . 0.0 110.772 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.444 -0.761 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.96 144.92 48.87 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.271 1.981 . . . . 0.0 110.977 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.453 ' HB1' HG12 ' A' ' 134' ' ' ILE . . . -128.79 16.65 6.34 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.785 0.326 . . . . 0.0 111.525 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.18 -114.86 0.33 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.89 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.512 ' CG1' HG13 ' A' ' 113' ' ' ILE . 13.0 pt -134.45 160.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.239 -0.481 . . . . 0.0 110.348 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.7 t30 -118.19 155.91 29.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.69 130.36 73.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 122.421 0.289 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.53 147.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.134 0.492 . . . . 0.0 111.13 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 8.4 t -99.28 158.45 32.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.462 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 28.7 Cg_exo -62.98 93.93 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.373 1.382 . . . . 0.0 110.669 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.497 ' HD2' ' HA ' ' A' ' 163' ' ' TYR . 20.6 pttp -78.01 174.83 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.843 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -124.08 -68.81 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.069 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -113.46 47.23 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.497 ' HA ' ' HD2' ' A' ' 160' ' ' LYS . 91.8 m-85 74.9 148.9 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.566 0.746 . . . . 0.0 110.542 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 158' ' ' SER . 26.7 pt20 -133.84 165.11 25.75 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.479 ' HE3' HG23 ' A' ' 127' ' ' VAL . 64.9 tttp -67.85 121.97 17.14 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.204 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -123.38 126.74 47.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.848 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -94.37 163.05 13.58 Favored 'General case' 0 CA--C 1.469 -2.172 0 CA-C-O 121.895 0.855 . . . . 0.0 113.218 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.0 129.51 69.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.006 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.487 ' SD ' HG23 ' A' ' 171' ' ' ILE . 15.0 tmm? -131.31 138.24 49.15 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.738 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.22 131.09 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.921 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.569 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 2.2 pp -114.63 178.52 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.889 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -115.81 3.36 13.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.569 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 1.8 pm0 -98.83 136.85 38.26 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.81 0.814 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.68 139.27 32.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.965 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.452 HD13 HD22 ' A' ' 102' ' ' LEU . 1.8 pp -101.93 155.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -98.99 107.31 19.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -92.3 124.92 36.72 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 183' ' ' ASP . 85.5 mt -108.86 110.01 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.725 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -124.4 -13.72 7.07 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 43.1 p -127.04 167.75 15.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.381 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -35.18 80.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.83 -42.45 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.054 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 178' ' ' ILE . 73.2 m-20 -62.28 -37.8 86.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.143 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.401 ' HB3' HD21 ' A' ' 24' ' ' LEU . 95.5 mt -60.26 -46.79 88.6 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.765 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 189' ' ' MET . 28.9 mtpp -64.93 -38.41 90.89 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.368 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.98 -50.5 73.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.154 0.502 . . . . 0.0 110.078 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.35 -41.92 88.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.435 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER -68.98 -30.8 69.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.549 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.4 mtp -64.61 -41.57 96.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.747 0.308 . . . . 0.0 111.684 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -77.84 -33.02 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.923 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 86.9 mt -61.28 -47.42 86.1 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm . . . . . 0 C--N 1.311 -1.107 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.988 -178.634 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.625 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 36.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -90.37 166.2 13.42 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.021 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -123.29 134.01 54.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.66 127.28 52.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.148 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.559 ' HA ' HG22 ' A' ' 98' ' ' VAL . 61.4 mt -118.11 106.83 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.619 ' HE1' ' CG ' ' A' ' 83' ' ' ASP . 60.3 ttm -80.5 101.53 9.15 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 121.898 0.856 . . . . 0.0 111.021 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 49' ' ' THR . . . -115.54 97.72 6.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.35 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.984 178.644 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 CA--C 1.538 0.678 0 N-CA-C 113.546 0.556 . . . . 0.0 113.546 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 49.7 mt -89.08 6.34 40.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.58 114.21 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 60.4 pttt -95.6 131.77 41.45 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.583 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 188' ' ' GLU . 61.9 tp -136.13 120.97 18.57 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.322 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.6 m 58.54 24.09 11.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.86 -31.36 4.57 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.223 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.71 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 95.8 mtt180 -126.39 157.54 38.25 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.787 1.294 . . . . 0.0 111.764 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 73.5 m -81.54 163.52 22.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.535 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 33' ' ' VAL . 84.9 mt -58.77 -39.7 81.79 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.592 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.589 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.7 tp -56.21 -47.47 80.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.245 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.671 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.1 t70 -65.02 -42.86 94.02 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.168 0.508 . . . . 0.0 110.634 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 30.8 m-85 -64.07 -36.94 85.66 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.427 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.506 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 79.1 t -70.07 -41.05 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 30' ' ' ILE . 59.8 t -61.47 -43.27 96.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.899 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.421 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 65.8 m -52.76 -52.46 64.31 Favored Pre-proline 0 CA--C 1.571 1.768 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 33' ' ' VAL . 51.9 Cg_exo -60.53 -42.46 40.24 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 121.758 1.639 . . . . 0.0 111.982 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 98' ' ' VAL . 96.1 mt -68.2 -37.23 80.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.722 0.772 . . . . 0.0 110.585 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 HD22 ' A' ' 69' ' ' ASN . 59.7 tp -58.33 -45.77 87.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.989 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.11 -1.61 58.17 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.414 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.554 ' HB2' HG22 ' A' ' 110' ' ' ILE . 60.3 p -75.69 175.4 8.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.9 ttmm -58.26 -27.01 63.62 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.493 0.717 . . . . 0.0 112.469 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.529 HG23 ' OG ' ' A' ' 40' ' ' SER . 30.7 m -59.94 154.51 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.16 -69.0 0.56 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.844 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.92 153.67 36.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.207 0.527 . . . . 0.0 111.16 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.8 mm -106.64 115.26 47.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 87.0 m-85 -104.91 116.09 31.39 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.507 HG21 HD12 ' A' ' 60' ' ' ILE . 96.6 mt -94.97 116.05 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-O 121.574 0.702 . . . . 0.0 110.319 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.66 120.74 28.29 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.439 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 7' ' ' ALA . 68.9 p -125.06 158.0 34.86 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.472 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -111.9 142.29 26.44 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.169 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.48 -25.89 51.29 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.457 2.771 . . . . 0.0 111.949 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -75.84 -9.0 58.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -140.35 67.12 31.41 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-O 119.244 -0.408 . . . . 0.0 112.011 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 67.0 Cg_endo -104.68 85.26 0.02 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.781 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.413 170.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.598 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 97.6 mttt -147.63 -46.78 0.17 Allowed 'General case' 1 C--N 1.214 -5.308 0 CA-C-N 109.932 -3.304 . . . . 0.0 103.721 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.417 ' HA ' HD12 ' A' ' 21' ' ' LEU . 87.9 m -61.93 -47.43 84.96 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 164.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -62.68 -49.62 74.39 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.016 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.1 pt-20 -59.19 -37.73 78.12 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.876 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.48 -50.25 70.4 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 47' ' ' ILE . 94.7 mt -63.47 -41.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.601 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.542 ' OD1' HG12 ' A' ' 72' ' ' VAL . 92.7 m-20 -57.06 -45.73 83.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.866 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.3 m -71.32 -41.96 69.22 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.262 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 -38.91 92.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.328 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.466 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 70.3 m-85 -113.55 37.86 3.1 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.71 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 10.8 mmmm -62.47 -23.38 66.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.316 0.579 . . . . 0.0 110.758 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -92.55 11.28 26.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.332 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 53.0 p90 -43.25 128.6 4.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -101.36 -52.03 3.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.023 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.474 HD22 HD11 ' A' ' 38' ' ' LEU . 6.8 p-10 -119.48 14.31 12.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.71 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.52 125.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 59.3 t -125.42 133.17 69.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG12 ' OD1' ' A' ' 61' ' ' ASN . 7.2 p -104.5 134.47 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.2 pt -129.25 157.1 42.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.585 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -116.07 136.13 53.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 12.7 t -160.2 -172.4 3.58 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -66.73 3.81 0.95 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 127.543 2.337 . . . . 0.0 114.592 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.98 -20.73 0.0 OUTLIER Glycine 1 N--CA 1.517 4.099 0 C-N-CA 126.51 2.005 . . . . 0.0 116.947 -173.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 76' ' ' SER . 55.8 tptt -56.55 -39.78 73.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.26 122.37 6.09 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.15 -50.44 73.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.219 0.533 . . . . 0.0 111.718 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.3 -45.65 95.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.71 0.766 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 48.3 mt-10 -60.07 -42.48 94.65 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.83 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.619 ' CG ' ' HE1' ' A' ' 6' ' ' MET . 6.2 t0 -58.79 -51.61 69.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.347 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.609 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.0 mm? -58.76 -43.56 90.35 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.614 ' O ' HG12 ' A' ' 88' ' ' ILE . 30.0 m-80 -61.61 -39.93 93.02 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.332 0.587 . . . . 0.0 112.4 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 54.6 mm-40 -65.91 -42.21 90.47 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.506 -0.746 . . . . 0.0 109.009 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.5 m -61.73 -43.21 99.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.961 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 85' ' ' ASN . 33.1 pt -63.64 -27.1 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.687 0.28 . . . . 0.0 110.344 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.73 -24.87 64.88 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.566 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -99.93 2.87 44.08 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.85 135.6 54.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 112.285 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -103.66 -2.35 26.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.1 mt-10 -131.55 160.83 65.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.1 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.625 ' O ' ' HG3' ' A' ' 1' ' ' MET . 48.7 Cg_endo -67.31 157.67 60.66 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.445 2.096 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -144.71 159.25 43.14 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.367 0.603 . . . . 0.0 111.699 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.544 ' HB3' ' HA ' ' A' ' 3' ' ' ALA . 21.9 tp -86.64 145.98 26.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.726 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 95.8 t -116.63 130.11 72.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 124.07 0.948 . . . . 0.0 108.601 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.4 m -131.77 163.97 35.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.26 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.9 t -99.8 139.71 35.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.4 p -89.6 -1.3 57.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.01 9.54 13.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 102' ' ' LEU . 2.8 pp -92.53 143.48 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.938 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 18.0 tt -140.26 132.41 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.074 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 18.9 t-20 173.28 167.61 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.163 0.985 . . . . 0.0 108.415 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tt -80.19 88.32 5.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.565 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -101.82 3.6 39.52 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.5 p -52.76 -36.04 57.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.419 ' CG ' HD11 ' A' ' 109' ' ' ILE . 21.5 pttp -73.15 -28.51 62.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.254 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.736 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.0 mp -61.4 -43.05 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.304 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.554 HG22 ' HB2' ' A' ' 40' ' ' SER . 5.2 mm -54.16 -49.82 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 121.821 0.819 . . . . 0.0 109.743 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.452 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 62.3 m-80 -61.98 -42.93 99.69 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.662 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -61.81 -38.35 87.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.726 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.736 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -60.83 -49.15 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.11 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.54 -47.76 91.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.863 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.08 -46.91 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.731 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.651 ' CE2' HD11 ' A' ' 120' ' ' ILE . 45.2 t80 -66.53 -46.05 77.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.637 0.256 . . . . 0.0 111.483 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -58.19 -47.58 83.01 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.073 0.464 . . . . 0.0 110.694 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -62.84 -37.36 86.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.204 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 91.7 m -63.75 -40.15 96.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.024 0.44 . . . . 0.0 110.568 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.651 HD11 ' CE2' ' A' ' 116' ' ' TYR . 81.2 mt -65.45 -46.02 91.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.138 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 52.8 mtmt -63.08 -37.52 87.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.218 0.533 . . . . 0.0 110.531 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.61 91.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.293 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -82.2 -35.0 28.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.024 0.44 . . . . 0.0 111.513 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 66.4 m -137.24 97.51 10.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.447 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.04 -20.52 54.13 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.412 2.742 . . . . 0.0 113.036 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.77 -30.39 71.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.787 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.425 HG21 ' HE3' ' A' ' 165' ' ' LYS . 67.5 t -73.77 125.38 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.82 2.58 7.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.995 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -143.0 156.08 44.78 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.962 0.41 . . . . 0.0 111.468 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.39 133.1 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -120.37 129.98 54.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.86 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.657 HG23 ' CD1' ' A' ' 113' ' ' ILE . 60.8 t -115.01 121.74 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 6.5 ptm -145.89 156.8 43.79 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.661 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.415 HG22 ' CB ' ' A' ' 152' ' ' ALA . 14.3 pt -128.54 156.52 77.09 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.633 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.219 1.946 . . . . 0.0 111.95 -179.669 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 120.823 0.344 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.26 153.61 56.46 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.843 2.362 . . . . 0.0 111.792 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB2' HG13 ' A' ' 132' ' ' VAL . . . -102.32 -7.69 21.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.117 0.484 . . . . 0.0 111.371 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.86 -88.9 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.749 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 113' ' ' ILE . 16.9 pt -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.237 0.541 . . . . 0.0 112.308 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.535 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 9.9 t-20 -120.65 153.82 36.35 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.928 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.91 131.18 72.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 O-C-N 122.368 -0.207 . . . . 0.0 111.141 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.32 155.07 36.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.192 0.52 . . . . 0.0 111.141 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.435 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 72.3 m -97.51 158.79 32.51 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 84.5 Cg_endo -75.61 59.39 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.108 1.872 . . . . 0.0 112.484 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -117.87 138.5 52.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.95 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -72.54 133.71 44.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.83 -130.35 9.75 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.936 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.99 141.68 46.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.353 0.597 . . . . 0.0 111.635 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.435 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 22.9 pt20 -134.91 162.72 31.63 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.664 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.425 ' HE3' HG21 ' A' ' 127' ' ' VAL . 63.9 tttp -60.68 128.13 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.4 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -124.76 131.55 53.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -97.35 163.15 13.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.52 131.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.256 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.6 ttp -133.42 132.67 41.41 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.967 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.6 t -112.49 131.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 173' ' ' GLU . 50.7 pt -115.63 176.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.742 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.52 -3.27 31.03 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.205 0.526 . . . . 0.0 110.861 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.471 ' HB2' HD13 ' A' ' 171' ' ' ILE . 56.7 mp0 -98.83 130.47 45.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.922 0.868 . . . . 0.0 112.775 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.474 HD22 ' H ' ' A' ' 174' ' ' LEU . 1.4 pt? -97.72 153.83 17.99 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.754 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.504 HG23 ' HZ1' ' A' ' 106' ' ' LYS . 3.6 pt -112.08 149.18 14.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.429 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.48 115.2 29.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.52 150.29 24.06 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.616 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 183' ' ' ASP . 88.1 mt -116.28 117.66 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.998 0.427 . . . . 0.0 111.28 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -120.73 -18.9 7.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.121 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.3 p -128.96 164.21 23.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.403 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -60.87 -29.5 69.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.262 0.553 . . . . 0.0 109.531 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.58 -41.35 98.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.335 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.452 ' HB2' HG23 ' A' ' 178' ' ' ILE . 72.6 m-20 -64.21 -28.4 69.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 96.4 mt -61.54 -45.25 94.96 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.514 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -62.09 -42.66 99.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.747 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.43 -49.84 76.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.456 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.76 -42.54 99.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 8.0 pt-20 -68.15 -33.98 75.48 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.9 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -63.67 -41.42 98.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 111.35 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -77.2 -31.17 55.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.131 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 69.3 tp -64.42 -45.08 89.1 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.483 0.658 . . . . 0.0 110.165 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 63.5 tttm . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.654 176.447 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' HG22 ' A' ' 42' ' ' VAL . 54.2 tpp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.639 0.257 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -113.93 166.19 11.83 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.6 130.86 56.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.261 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.9 tp -105.42 124.21 49.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -118.71 101.05 11.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.407 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 8.7 ptm -91.76 106.2 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.851 1.31 . . . . 0.0 111.984 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.05 103.75 11.21 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.865 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 N-CA-C 114.346 0.864 . . . . 0.0 114.346 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 56' ' ' THR . 44.4 mt -92.69 5.87 49.5 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.498 HG22 HD22 ' A' ' 184' ' ' LEU . 77.2 mt -76.73 118.55 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.93 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -76.75 130.62 37.96 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.056 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 188' ' ' GLU . 81.8 mt -127.75 125.43 39.91 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.522 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.8 m 54.31 28.88 9.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.21 35.32 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.764 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 98.8 mtt180 -129.77 153.35 48.3 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 118.181 0.99 . . . . 0.0 112.435 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 61.2 m -80.16 164.4 23.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.32 -39.24 82.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.793 0.33 . . . . 0.0 110.87 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -39.76 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.728 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 21.2 m-20 -62.29 -40.93 97.9 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.153 0.501 . . . . 0.0 110.497 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 10.1 m-85 -63.04 -37.14 86.02 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.693 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.67 -42.41 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 0.0 110.766 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.35 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.777 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.0 m -53.58 -51.94 71.57 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.37 -38.17 35.68 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 121.531 1.487 . . . . 0.0 112.082 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.5 HD11 HG11 ' A' ' 98' ' ' VAL . 93.1 mt -68.45 -40.04 81.23 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.401 0.619 . . . . 0.0 110.782 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.65 -44.04 89.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.398 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -84.03 -14.73 49.87 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.548 ' OG ' HG13 ' A' ' 42' ' ' VAL . 85.5 p -74.37 172.35 12.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.973 0.416 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -65.49 -7.06 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.7 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG13 ' OG ' ' A' ' 40' ' ' SER . 12.2 p -71.24 144.98 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 O-C-N 122.183 -0.323 . . . . 0.0 110.771 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -82.33 -72.37 0.44 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.57 147.08 28.01 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.528 0.68 . . . . 0.0 111.656 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.09 113.66 44.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.61 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -103.31 115.17 30.04 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.21 116.46 36.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.7 0.762 . . . . 0.0 110.368 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -89.9 118.8 29.75 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.245 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.4 p -129.63 158.15 40.13 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.3 m -105.63 148.84 37.11 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.376 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.07 -24.99 68.79 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.06 2.507 . . . . 0.0 111.085 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -77.92 -5.89 52.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.185 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -139.84 66.87 34.47 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 119.401 -0.333 . . . . 0.0 111.879 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 96.1 Cg_endo -105.8 86.57 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.813 0 CA-C-N 120.982 1.386 . . . . 0.0 109.653 168.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 mmtm -155.61 -46.18 0.08 Allowed 'General case' 1 C--N 1.212 -5.405 0 CA-C-N 109.709 -3.405 . . . . 0.0 102.443 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 21' ' ' LEU . 97.9 m -63.99 -49.31 72.99 Favored 'General case' 0 N--CA 1.381 -3.9 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 162.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.59 -51.28 66.0 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.11 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.3 pt-20 -63.66 -29.4 70.64 Favored 'General case' 0 C--N 1.37 1.469 0 C-N-CA 116.639 -2.024 . . . . 0.0 112.907 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.483 ' CD2' HD21 ' A' ' 21' ' ' LEU . 55.8 t80 -64.96 -50.37 66.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.434 0.635 . . . . 0.0 110.623 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.0 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -57.63 -45.97 84.75 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.902 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 42.3 t -67.04 -42.45 84.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.547 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.03 92.85 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.166 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.522 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 45.8 m-85 -115.84 37.98 3.46 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.059 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.6 mmmm -60.68 -24.21 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.162 0.506 . . . . 0.0 111.057 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.67 10.47 25.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.2 p90 -45.02 131.4 7.36 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -102.5 -48.92 4.0 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.597 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -118.28 16.35 13.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.786 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.9 mt -107.62 131.06 58.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.512 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.3 t -125.17 133.05 70.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.27 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.43 130.46 56.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.314 0.578 . . . . 0.0 110.313 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.88 156.53 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 CA-C-O 121.967 0.889 . . . . 0.0 111.37 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.01 130.76 55.49 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.435 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 11.2 t -158.06 -173.24 4.25 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.734 0.778 . . . . 0.0 112.891 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 49.2 m -71.53 2.09 5.57 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 126.472 1.909 . . . . 0.0 114.637 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.67 -23.73 0.0 OUTLIER Glycine 1 N--CA 1.521 4.331 0 C-N-CA 126.462 1.982 . . . . 0.0 117.393 -173.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 12.1 tmtt? -56.17 -36.48 68.37 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 172.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.73 122.4 6.2 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -60.27 -51.05 71.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 pt -77.68 -28.64 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.802 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.91 -41.68 99.53 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.561 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 14.0 t0 -60.2 -51.48 69.4 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.049 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.501 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.5 mm? -57.71 -43.71 85.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.509 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.5 m-80 -60.29 -41.33 93.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 70.3 mm-40 -63.95 -46.95 82.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.375 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.1 m -62.71 -42.99 99.93 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.351 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' A' ' 85' ' ' ASN . 37.2 pt -65.46 -30.6 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.962 0.41 . . . . 0.0 110.431 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.44 -39.29 95.65 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.245 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -82.01 -36.78 27.46 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 75.2 m-85 -71.31 146.53 48.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.19 0.519 . . . . 0.0 111.801 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -102.06 -10.61 19.55 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.369 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.46 160.32 64.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.667 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.77 142.45 41.53 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 123.27 2.647 . . . . 0.0 112.307 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -142.99 155.62 44.7 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.057 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 155' ' ' ASN . 42.4 tp -86.37 143.91 27.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.221 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 66.5 t -115.49 133.79 60.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 108.93 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 5' ' ' ILE . 11.1 m -129.98 164.82 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.371 0.605 . . . . 0.0 112.225 -178.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.568 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 50.6 m -99.21 152.79 19.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.0 p -73.61 -10.79 60.07 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 45.4 p-10 -117.23 16.55 14.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.568 ' CD1' ' HB2' ' A' ' 99' ' ' SER . 11.0 mp -61.54 153.13 28.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 111.798 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.89 174.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.686 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.68 162.59 12.9 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.013 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.5 tp 82.52 3.28 1.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.576 1.151 . . . . 0.0 110.213 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -94.02 -1.23 54.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.604 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -62.21 -24.73 67.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.155 0.502 . . . . 0.0 111.786 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.98 -20.91 61.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.15 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.422 ' O ' HG12 ' A' ' 113' ' ' ILE . 28.5 mm -68.57 -41.42 82.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.445 ' HA ' HG12 ' A' ' 113' ' ' ILE . 61.7 mt -60.99 -44.46 98.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.41 -46.84 86.77 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.03 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.3 m -64.15 -42.62 96.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.026 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.62 HG13 ' N ' ' A' ' 114' ' ' VAL . 36.0 pt -67.76 -43.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.62 ' N ' HG13 ' A' ' 113' ' ' ILE . 62.9 t -62.44 -49.15 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.824 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.55 -45.36 93.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.464 -0.494 . . . . 0.0 112.247 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.697 ' CE2' HD12 ' A' ' 120' ' ' ILE . 54.2 t80 -65.84 -46.12 79.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.623 0.249 . . . . 0.0 110.918 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -58.8 -47.9 83.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 15.8 m-85 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.081 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 93.2 m -63.72 -40.37 96.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.672 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.697 HD12 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -66.85 -47.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 124' ' ' THR . 54.6 pttt -65.15 -26.26 68.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.302 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.04 99.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.918 0.39 . . . . 0.0 110.455 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -83.24 -34.04 25.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 50.7 m -139.52 97.42 8.34 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.663 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.53 -11.77 31.87 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.933 2.422 . . . . 0.0 112.856 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.29 -32.7 73.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.454 HG12 ' CG2' ' A' ' 120' ' ' ILE . 7.6 p -87.29 122.41 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.975 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 41.6 mt-10 -127.38 19.15 6.89 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -142.19 148.75 38.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.0 tp -139.63 148.08 41.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.816 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.8 136.18 52.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.09 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 152' ' ' ALA . 99.2 t -111.12 115.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.244 0.545 . . . . 0.0 109.722 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -145.61 157.46 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.775 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 17.0 pt -134.97 155.51 79.14 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.24 0.584 0 C-N-CA 122.356 2.037 . . . . 0.0 110.797 176.402 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.34 143.92 60.07 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.183 1.922 . . . . 0.0 110.456 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 132' ' ' VAL . . . -112.27 4.98 18.09 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 164.54 -97.98 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 118.759 -1.686 . . . . 0.0 114.346 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 15.0 pt -130.17 160.85 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.706 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.0 m-20 -123.74 158.78 30.9 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.46 129.58 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.29 156.04 40.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.638 0.732 . . . . 0.0 112.06 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 33.3 t -98.28 146.48 31.61 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.528 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.01 66.99 4.1 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.691 2.261 . . . . 0.0 112.549 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.37 175.81 6.79 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -104.7 -11.63 16.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.268 0.556 . . . . 0.0 109.732 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -122.45 -156.28 9.61 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.838 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -106.7 134.34 49.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.342 0.591 . . . . 0.0 109.987 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -121.2 167.19 12.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -55.18 130.08 40.71 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.321 0.581 . . . . 0.0 112.151 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -123.52 132.55 53.94 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.259 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.424 ' HG2' HG22 ' A' ' 127' ' ' VAL . 25.5 mm-40 -96.75 162.6 13.36 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 121.603 0.716 . . . . 0.0 111.967 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.019 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.0 ttp -128.74 129.94 46.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.266 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 133' ' ' MET . 89.6 t -102.23 129.3 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 173' ' ' GLU . 50.0 pt -110.55 174.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.42 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.57 0.65 31.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.692 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.447 ' HB2' HD11 ' A' ' 171' ' ' ILE . 79.1 mm-40 -98.51 139.38 34.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.776 0.798 . . . . 0.0 112.641 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.29 143.89 26.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.628 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.6 155.6 41.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.88 111.04 19.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.876 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.583 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 26.5 t-20 -91.02 109.58 20.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.467 ' HA ' ' OD2' ' A' ' 183' ' ' ASP . 51.4 mm -66.26 123.84 20.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.431 0.634 . . . . 0.0 112.652 -172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.45 -36.43 8.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.5 p -137.72 165.74 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.599 0.237 . . . . 0.0 111.469 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 184' ' ' LEU . 15.1 mtmm -62.03 -37.37 84.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.641 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.44 -40.62 97.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.272 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.467 ' OD2' ' HA ' ' A' ' 178' ' ' ILE . 38.8 t70 -64.57 -38.92 92.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 22' ' ' ILE . 54.2 tp -59.3 -46.89 87.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.275 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.543 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.9 ttpt -62.5 -40.63 97.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.338 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.53 -49.03 79.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.294 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.79 -41.23 97.46 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.775 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 13.6 pt-20 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.855 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.61 -32.53 68.1 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.37 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.15 -28.66 63.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.761 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.62 -44.99 95.96 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.491 0.662 . . . . 0.0 109.802 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.758 177.327 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG22 ' A' ' 42' ' ' VAL . 58.8 ttm . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -113.42 164.41 13.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -114.25 140.47 48.56 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.097 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 28.4 tp -115.63 120.61 39.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' HA ' ' HB ' ' A' ' 98' ' ' VAL . 69.4 mt -111.71 108.72 26.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.562 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 60.4 ttm -80.25 104.8 11.05 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 121.643 0.735 . . . . 0.0 110.583 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 56' ' ' THR . . . -112.43 97.78 6.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.745 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.548 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.493 -179.691 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.476 0.492 0 CA-C-O 121.084 0.368 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 73.3 mt -92.3 14.05 17.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.09 125.71 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -95.28 133.64 38.95 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.819 -172.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' O ' ' HE2' ' A' ' 32' ' ' TYR . 56.6 tp -130.08 121.5 26.5 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 113.316 -1.766 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HB3' ' HH ' ' A' ' 32' ' ' TYR . 13.0 t 58.04 27.04 14.29 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.393 0.616 . . . . 0.0 110.73 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.31 -8.87 69.62 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.012 -0.614 . . . . 0.0 114.548 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 85.9 mtt180 -117.07 155.03 29.96 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 118.169 0.985 . . . . 0.0 110.717 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 72.2 m -82.08 163.15 22.24 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.834 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.475 HD23 ' CG1' ' A' ' 178' ' ' ILE . 83.7 mt -59.22 -44.48 92.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 110.256 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -62.75 -36.82 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.77 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.45 -45.23 91.82 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.337 0.589 . . . . 0.0 110.4 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.581 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 8.5 m-85 -65.72 -30.19 70.82 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 100' ' ' SER . 66.6 t -70.1 -43.23 79.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 120.649 0.261 . . . . 0.0 111.574 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.34 -43.58 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.501 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 67.5 m -50.59 -53.58 44.61 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 33.8 Cg_exo -62.4 -41.28 34.3 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.931 1.754 . . . . 0.0 112.286 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.87 -42.32 90.51 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.89 -45.37 94.87 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.757 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 35' ' ' SER . 64.1 pttt -80.98 -9.31 59.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.583 ' OG ' HG13 ' A' ' 42' ' ' VAL . 84.2 p -77.85 175.55 9.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 111.514 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.16 -22.12 60.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.141 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.583 HG13 ' OG ' ' A' ' 40' ' ' SER . 12.7 p -66.07 145.03 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.671 -177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -78.37 -79.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -102.6 152.48 21.13 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.451 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.4 mm -110.06 116.42 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.118 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 93.8 m-85 -106.93 117.09 33.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 60' ' ' ILE . 94.7 mt -98.74 118.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.527 0.68 . . . . 0.0 110.576 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.23 116.4 24.39 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.795 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.3 p -127.28 162.87 25.22 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.028 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.5 p -129.44 157.25 76.9 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.906 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.69 -19.09 67.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.834 2.356 . . . . 0.0 110.896 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.92 -24.95 62.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.744 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 67.33 26.3 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.6 Cg_endo -103.87 85.45 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.683 0 C-N-CA 117.172 -1.419 . . . . 0.0 109.906 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.621 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 36.0 mmtm -148.99 -44.98 0.14 Allowed 'General case' 1 C--N 1.215 -5.272 0 CA-C-N 109.605 -3.452 . . . . 0.0 102.638 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 7' ' ' ALA . 96.8 m -63.16 -47.77 81.26 Favored 'General case' 1 N--CA 1.379 -4.006 0 CA-C-N 112.307 -2.224 . . . . 0.0 105.773 163.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.08 -51.19 68.95 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.796 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.621 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 pt-20 -64.58 -30.73 71.75 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.341 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.91 -50.21 71.74 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.071 0.462 . . . . 0.0 111.18 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.5 HD11 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -62.68 -42.75 97.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.964 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -58.25 -41.38 84.08 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.574 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.666 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t -73.74 -43.31 59.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 111.233 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.53 90.8 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.337 0.589 . . . . 0.0 111.105 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.461 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 58.1 m-85 -114.44 42.59 2.07 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.002 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.666 ' HG3' ' O ' ' A' ' 62' ' ' SER . 38.1 mtmm -59.82 -26.79 66.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.028 0.442 . . . . 0.0 110.971 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.42 10.13 18.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.055 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.461 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 53.8 p90 -44.59 122.77 3.27 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.47 -49.44 3.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.36 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -110.26 7.74 23.26 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.095 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 4.8 mp -100.31 119.62 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.257 0.551 . . . . 0.0 110.028 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 78.3 t -120.55 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.312 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.9 pt -123.66 154.74 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.161 0.505 . . . . 0.0 109.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -117.08 127.82 54.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.445 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 14.3 t -155.96 -167.98 2.63 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -173.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -67.81 2.41 1.98 Allowed 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 126.633 1.973 . . . . 0.0 114.22 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.19 -16.62 0.0 OUTLIER Glycine 0 N--CA 1.516 3.971 0 C-N-CA 126.693 2.092 . . . . 0.0 117.376 -175.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 14.2 tmtt? -58.61 -38.45 78.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.6 127.48 7.73 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.459 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -59.97 -49.91 75.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.093 0.473 . . . . 0.0 111.987 -176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.83 -47.49 90.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.547 0.689 . . . . 0.0 110.294 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 53.6 mt-10 -60.91 -43.28 98.79 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.784 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.562 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 7.4 t0 -60.05 -50.77 72.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.116 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.5 mm? -59.62 -42.87 93.66 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.169 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 88' ' ' ILE . 10.1 m120 -60.56 -42.02 95.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.257 0.551 . . . . 0.0 111.053 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 66.0 mm-40 -65.58 -45.65 82.46 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.0 m -63.57 -41.82 98.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.497 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 84' ' ' LEU . 38.1 pt -65.92 -29.88 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.081 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.41 96.56 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.941 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -71.9 -40.12 69.06 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.1 m-85 -79.01 154.08 29.77 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.8 m -113.24 -4.52 13.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 159' ' ' PRO . 40.0 mt-10 -132.74 156.02 80.55 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.275 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.44 140.0 64.41 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.207 2.604 . . . . 0.0 111.649 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.55 156.7 45.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.34 0.591 . . . . 0.0 110.748 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.46 HD13 HD11 ' A' ' 154' ' ' ILE . 24.3 tp -87.53 144.4 26.72 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.029 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 93.7 t -107.14 125.89 63.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 60.8 t -130.47 141.11 47.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.5 m -96.09 142.49 28.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.782 174.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.484 ' HA ' HG23 ' A' ' 33' ' ' VAL . 67.9 m -89.45 0.78 56.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -104.93 -4.2 22.41 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.493 ' CD1' ' HA2' ' A' ' 153' ' ' GLY . 75.2 mt -82.6 136.63 34.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.278 0.49 . . . . 0.0 110.599 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.8 pt -75.67 -174.24 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.953 0.406 . . . . 0.0 111.35 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -78.53 71.18 4.98 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.39 -3.84 4.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.41 ' O ' HG13 ' A' ' 110' ' ' ILE . 11.7 ptmm? -88.38 -2.24 58.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.217 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 p -60.99 -41.57 96.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -80.43 -22.44 41.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.895 0.855 . . . . 0.0 109.725 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.535 ' O ' HG12 ' A' ' 113' ' ' ILE . 38.4 mm -67.7 -37.61 78.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.953 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 106' ' ' LYS . 64.4 mt -57.26 -50.0 78.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.064 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -70.74 -39.65 73.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.172 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.8 m -63.36 -42.95 98.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.07 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.2 mm -64.39 -44.78 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.8 t -60.44 -46.71 94.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.273 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.75 -46.1 91.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.657 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CE2' HD13 ' A' ' 120' ' ' ILE . 31.8 t80 -70.19 -41.82 73.2 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.2 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.5 t80 -59.18 -48.35 81.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.523 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 21.3 m-85 -62.88 -35.5 80.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.658 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.8 -47.5 86.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.966 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.594 HD13 ' CE2' ' A' ' 116' ' ' TYR . 70.5 mt -66.45 -49.37 75.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.484 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 124' ' ' THR . 16.0 ptmt -65.34 -25.85 67.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.965 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.56 98.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -85.69 -36.83 19.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.309 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 32.0 m -130.9 96.21 23.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.154 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.91 -14.2 40.6 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.918 2.412 . . . . 0.0 113.197 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.47 -32.94 74.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.889 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 124' ' ' THR . 10.7 p -75.79 120.53 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.606 0.717 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 45.8 mt-10 -123.04 15.0 9.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.872 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.71 150.07 33.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.931 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -140.86 135.04 30.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.034 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.33 140.84 51.65 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.727 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 169' ' ' MET . 14.8 p -123.22 135.95 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 75.1 mtm -134.47 158.02 44.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.747 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.486 HG21 ' O ' ' A' ' 171' ' ' ILE . 9.9 pt -130.12 154.55 81.33 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--O 1.237 0.453 0 C-N-CA 122.62 2.213 . . . . 0.0 113.253 -178.16 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 120.752 0.31 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.25 148.74 56.16 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.52 2.146 . . . . 0.0 111.517 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -91.75 -4.26 55.23 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 102' ' ' LEU . . . 152.5 -75.06 0.24 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.338 -1.411 . . . . 0.0 114.376 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.465 HG13 HG13 ' A' ' 113' ' ' ILE . 25.0 pt -128.32 161.49 36.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -173.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.585 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 11.5 t-20 -127.75 155.55 43.84 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.884 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -120.97 130.3 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 O-C-N 122.167 -0.333 . . . . 0.0 110.691 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.438 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.2 m -133.1 154.24 39.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.656 0.741 . . . . 0.0 111.967 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.604 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 45.0 t -98.52 144.27 27.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.115 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.433 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 72.2 Cg_endo -72.89 67.07 4.01 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.116 2.544 . . . . 0.0 113.35 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.413 ' HD2' ' HB3' ' A' ' 164' ' ' GLN . 69.0 mttm -99.99 -168.37 1.58 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -133.56 90.03 2.67 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.889 0.852 . . . . 0.0 109.221 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.41 -136.74 6.65 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.26 142.74 51.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.815 0.34 . . . . 0.0 110.347 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . 18.6 pm0 -134.02 166.1 23.5 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.924 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -60.08 127.81 33.72 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.109 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -128.04 133.57 49.11 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.86 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -93.5 160.93 14.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-O 121.609 0.719 . . . . 0.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.6 128.87 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.192 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 61.7 ttp -127.35 135.21 50.19 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.14 126.63 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.486 ' O ' HG21 ' A' ' 134' ' ' ILE . 50.4 pt -116.18 174.94 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.003 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -117.66 21.5 12.93 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.143 0.496 . . . . 0.0 110.544 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -98.33 133.17 43.11 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.3 150.69 19.98 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.401 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.0 pt -130.11 153.26 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.33 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -125.69 144.48 50.59 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.462 ' HB3' HD21 ' A' ' 102' ' ' LEU . 28.4 p-10 -137.29 156.76 47.88 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.475 ' CG1' HD23 ' A' ' 29' ' ' LEU . 31.9 mm -94.97 81.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.546 0.688 . . . . 0.0 111.171 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.488 ' HB2' ' OD2' ' A' ' 183' ' ' ASP . 66.9 m-80 -65.96 -40.1 90.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.515 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.5 t -149.36 177.41 9.71 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.051 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -57.89 -28.35 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.932 0.493 . . . . 0.0 111.418 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.13 -46.77 88.53 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 109.943 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 44.7 m-20 -64.78 -35.67 81.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.212 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.458 ' HA ' HD11 ' A' ' 178' ' ' ILE . 59.8 tp -59.36 -45.32 91.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.833 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.573 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 12.9 mmtt -64.08 -38.23 90.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.04 -49.76 74.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.268 0.556 . . . . 0.0 109.524 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.1 -43.3 98.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.751 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 4.3 pt-20 -67.72 -34.12 76.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.461 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.428 ' N ' ' HG3' ' A' ' 188' ' ' GLU . 57.8 ttm -62.13 -45.49 93.24 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.692 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.4 pp -70.38 -37.16 74.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.366 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.58 -44.44 90.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.347 0.594 . . . . 0.0 110.53 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.862 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.44 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 37.0 m-20 -111.59 164.73 12.68 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -113.8 132.03 56.01 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.881 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 48' ' ' ALA . 33.3 tp -106.32 125.66 51.27 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.024 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.546 ' HA ' HG21 ' A' ' 98' ' ' VAL . 69.4 mt -117.24 104.76 16.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.549 ' HE1' ' CG ' ' A' ' 83' ' ' ASP . 11.1 ptm -95.98 97.93 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.892 1.329 . . . . 0.0 112.042 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 49' ' ' THR . . . -115.66 97.15 5.97 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.765 178.836 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo . . . . . 0 CA--C 1.534 0.517 0 N-CA-C 113.474 0.528 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 56' ' ' THR . 41.5 mt -90.49 12.59 18.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -66.23 117.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -82.16 134.79 35.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.675 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 46.6 tp -136.29 112.47 9.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.257 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t 61.27 20.14 10.76 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.381 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.34 -23.2 5.8 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.837 -1.173 . . . . 0.0 115.422 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.749 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 90.5 mtt180 -131.06 158.75 39.52 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.579 1.19 . . . . 0.0 111.088 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 71.6 m -76.2 150.79 37.04 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.199 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD21 ' O ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -49.22 -45.6 44.72 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.832 0.453 . . . . 0.0 111.298 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.462 ' O ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.36 -38.0 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.233 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.677 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.7 t70 -64.03 -42.59 97.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.212 0.529 . . . . 0.0 109.867 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.749 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 28.2 m-85 -61.03 -38.08 84.83 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.738 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.45 -42.54 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 110.671 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 30' ' ' ILE . 77.5 t -62.31 -43.34 97.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.566 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.54 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 44.5 t -50.3 -57.94 11.32 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 37.2 Cg_exo -62.07 -41.09 38.11 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.803 1.669 . . . . 0.0 112.359 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 98' ' ' VAL . 90.5 mt -66.09 -42.11 89.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.184 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.37 -45.43 91.16 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.073 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.04 -15.92 61.5 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.6 p -70.57 172.51 8.44 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.246 0.546 . . . . 0.0 111.231 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -70.03 2.24 3.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.537 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 3' ' ' ALA . 9.7 p -72.67 152.89 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 122.182 -0.324 . . . . 0.0 111.137 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.42 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 59.5 t30 -68.17 -79.62 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.416 HD21 ' C ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -121.04 163.96 17.51 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.238 0.542 . . . . 0.0 111.074 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -107.89 115.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.997 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -106.52 117.16 33.31 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.496 HG22 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -97.58 118.09 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-O 121.774 0.797 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.4 122.92 33.08 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.853 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 7' ' ' ALA . 56.8 p -130.48 156.61 44.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.552 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 75' ' ' THR . 35.4 t -105.04 143.15 26.14 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.283 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -56.79 -25.22 59.85 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.074 2.516 . . . . 0.0 111.033 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.44 -2.85 47.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -141.77 66.43 21.97 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.597 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 95.3 Cg_endo -105.14 86.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.144 0 C-N-CA 116.759 -1.694 . . . . 0.0 109.854 170.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 39.1 ttmt -148.84 -50.83 0.16 Allowed 'General case' 1 C--N 1.212 -5.386 0 CA-C-N 109.89 -3.323 . . . . 0.0 103.044 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 21' ' ' LEU . 86.4 m -62.07 -47.53 84.28 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.918 -1.946 . . . . 0.0 105.906 163.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.653 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.71 -47.96 81.34 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.949 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.576 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.4 pt-20 -57.23 -38.02 73.14 Favored 'General case' 0 C--N 1.369 1.431 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -65.89 -51.62 57.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 120.912 0.387 . . . . 0.0 111.714 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 47' ' ' ILE . 97.0 mt -62.99 -46.26 96.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.505 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.578 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 65.1 t30 -59.25 -39.97 84.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.381 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 t -74.91 -47.43 29.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.31 87.95 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -108.82 14.83 24.01 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.635 -0.426 . . . . 0.0 112.015 -173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.0 pttt -62.9 -22.09 66.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -88.36 -1.19 57.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.81 128.54 49.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.943 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -70.23 -41.25 73.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.834 -178.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -80.17 -0.67 37.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.2 mt -108.06 122.67 62.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.515 0.674 . . . . 0.0 110.206 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.9 135.68 63.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.929 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -106.95 131.03 57.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.061 0.458 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.6 pt -125.56 157.57 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.339 0.59 . . . . 0.0 111.814 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -102.32 133.32 47.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.389 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.632 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.2 t -161.77 -177.94 6.19 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.113 0.959 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 57.4 m -75.09 5.21 5.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 126.943 2.097 . . . . 0.0 113.158 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.04 -19.62 0.0 OUTLIER Glycine 0 N--CA 1.513 3.793 0 C-N-CA 127.876 2.655 . . . . 0.0 118.134 -171.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 11.5 tmtt? -59.29 -38.85 81.2 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 171.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.12 8.56 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -62.2 -50.51 71.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.17 -45.35 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.872 0.844 . . . . 0.0 110.575 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.84 -43.57 94.55 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.378 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.595 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.2 t0 -58.4 -50.12 74.83 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.874 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.4 mm? -56.87 -41.86 78.74 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.041 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.0 m-80 -60.03 -43.72 95.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.632 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 62.7 mm-40 -66.74 -42.61 85.95 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.79 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.58 -42.52 99.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -67.95 -26.57 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -38.64 96.95 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.929 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -70.5 -40.06 73.79 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.01 150.66 27.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -111.75 -0.96 15.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.047 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 28.2 mt-10 -134.86 159.01 73.75 Favored Pre-proline 0 CA--C 1.508 -0.663 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.161 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 36.5 Cg_endo -65.02 147.85 89.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.157 1.904 . . . . 0.0 111.124 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.44 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 51.2 p90 -141.69 162.13 36.23 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.588 0.709 . . . . 0.0 111.707 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 3' ' ' ALA . 1.1 tm? -86.17 139.41 31.11 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.597 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 89.3 t -117.12 134.08 61.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.78 0.832 . . . . 0.0 108.857 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 5' ' ' ILE . 8.6 m -127.79 159.88 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.246 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -100.19 135.3 41.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.534 ' O ' HD21 ' A' ' 29' ' ' LEU . 81.0 p -74.95 -12.03 60.25 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -102.32 3.28 37.87 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 175' ' ' ILE . 70.0 mt -91.22 121.01 32.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.882 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.569 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 86.2 mt -118.33 118.67 58.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.193 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 60.8 t30 166.87 168.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.676 0.79 . . . . 0.0 110.386 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.18 93.48 3.95 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.546 0.689 . . . . 0.0 109.914 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HE3' HG13 ' A' ' 109' ' ' ILE . 31.8 mmmt -99.43 2.88 45.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.266 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.483 ' HA ' HD11 ' A' ' 110' ' ' ILE . 71.9 p -53.65 -32.56 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HG3' HD11 ' A' ' 109' ' ' ILE . 19.5 ptpt -70.7 -27.78 64.25 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.745 0.783 . . . . 0.0 110.008 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.444 HG13 ' HE3' ' A' ' 106' ' ' LYS . 28.1 mm -71.57 -40.57 71.46 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.304 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 107' ' ' SER . 70.0 mt -60.4 -45.79 96.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.933 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -64.64 -43.37 93.89 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.436 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.9 t -61.9 -45.54 93.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 114' ' ' VAL . 42.6 pt -65.04 -41.57 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.518 ' N ' HG13 ' A' ' 113' ' ' ILE . 57.6 t -62.16 -49.13 85.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.98 -43.18 93.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.852 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.506 ' CE2' HD12 ' A' ' 120' ' ' ILE . 71.7 t80 -63.7 -49.48 72.93 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 110.949 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -59.04 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.986 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.409 ' HD2' ' O ' ' A' ' 114' ' ' VAL . 28.1 m-85 -65.03 -31.83 73.25 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 50.3 t -62.02 -46.85 87.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.445 0.641 . . . . 0.0 109.421 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.506 HD12 ' CE2' ' A' ' 116' ' ' TYR . 71.6 mt -64.59 -43.54 96.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.352 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -60.48 -41.74 94.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.279 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.44 -44.33 95.92 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.648 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -77.85 -32.42 52.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.999 0.428 . . . . 0.0 111.33 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.512 ' O ' HG12 ' A' ' 127' ' ' VAL . 46.9 m -143.57 100.69 5.14 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.8 -13.75 39.55 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.8 2.333 . . . . 0.0 112.966 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.01 -32.73 74.15 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 124' ' ' THR . 10.7 p -71.37 129.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -128.45 4.6 5.66 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.637 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.05 153.41 39.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.939 0.4 . . . . 0.0 111.374 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 23.4 tp -137.64 146.34 43.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.52 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.88 129.41 46.85 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.943 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.51 HG12 ' HB3' ' A' ' 152' ' ' ALA . 63.9 t -105.06 115.11 46.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.3 ptm -145.82 157.53 43.91 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.19 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.5 pt -133.03 155.0 81.57 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.834 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 C--O 1.237 0.445 0 C-N-CA 122.361 2.04 . . . . 0.0 111.923 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.47 136.76 77.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.993 1.795 . . . . 0.0 110.352 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -93.47 0.78 56.88 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.386 0.613 . . . . 0.0 110.617 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.79 -91.26 0.08 OUTLIER Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.993 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.466 ' HB ' HD11 ' A' ' 96' ' ' LEU . 14.4 pt -139.66 162.12 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.171 0.51 . . . . 0.0 112.173 -176.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.604 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.4 m120 -112.45 156.6 22.29 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.45 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.6 t -125.4 129.47 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 122.788 0.435 . . . . 0.0 109.889 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.35 155.27 31.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.048 0.451 . . . . 0.0 111.56 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.526 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 61.3 m -98.17 155.06 37.39 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.954 173.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 72.4 Cg_endo -76.52 86.11 1.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.579 2.186 . . . . 0.0 111.519 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -108.54 -175.42 2.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -128.9 28.16 5.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.875 0.845 . . . . 0.0 109.627 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.72 38.26 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -77.4 143.15 38.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.43 0.615 . . . . 0.0 109.545 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.526 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 20.9 pt20 -130.06 161.31 31.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.754 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.38 125.95 26.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.835 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.69 127.33 52.78 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.758 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -93.76 162.79 13.79 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 121.528 0.68 . . . . 0.0 111.716 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -117.42 129.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.891 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.4 ttp -128.45 126.02 39.69 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.686 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.8 t -105.38 132.06 53.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 173' ' ' GLU . 43.3 pt -119.78 171.73 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.208 0.527 . . . . 0.0 111.211 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -109.02 13.94 24.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.501 ' HB2' HD13 ' A' ' 171' ' ' ILE . 26.8 mm-40 -97.95 135.77 39.19 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.871 0.843 . . . . 0.0 111.278 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.9 153.67 18.11 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.459 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.43 HD12 HD21 ' A' ' 102' ' ' LEU . 1.8 pt -132.78 151.02 33.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.386 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.12 116.94 27.86 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -116.13 175.78 5.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 184' ' ' LEU . 46.4 mm -116.3 120.13 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.975 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 -47.25 5.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.82 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.5 p -128.03 166.54 18.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.19 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.35 -42.11 95.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.557 0.694 . . . . 0.0 109.754 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.58 -39.39 94.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.679 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.472 ' HA ' HD11 ' A' ' 178' ' ' ILE . 57.8 tp -61.02 -42.36 98.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.486 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 61.4 tttp -61.56 -40.92 96.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.872 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.9 -45.57 94.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.74 98.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.947 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 192' ' ' LYS . 11.5 pt-20 -64.86 -37.75 88.69 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.526 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.8 mmm -63.54 -39.65 94.97 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.979 0.418 . . . . 0.0 110.349 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.1 tp -62.6 -44.86 95.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.908 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.14 -39.43 94.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.337 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 99.3 mttt . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 95' ' ' PHE . 59.8 tpp . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.258 0.551 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -122.04 166.3 14.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.2 127.14 56.08 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.942 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 98' ' ' VAL . 36.7 tp -101.48 126.21 48.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.56 ' HA ' HG23 ' A' ' 98' ' ' VAL . 65.5 mt -119.08 107.97 22.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.611 ' HE1' ' CG ' ' A' ' 83' ' ' ASP . 60.6 ttm -80.93 98.07 7.72 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.513 0.673 . . . . 0.0 111.47 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 49' ' ' THR . . . -117.22 98.04 6.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.364 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -0.99 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.347 177.874 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 27.4 Cg_endo . . . . . 0 C--O 1.226 -0.098 0 N-CA-C 114.639 0.976 . . . . 0.0 114.639 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.09 4.95 24.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 90.6 mt -71.68 126.11 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 62.9 pttt -115.11 143.18 45.6 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.44 ' O ' ' HE2' ' A' ' 32' ' ' TYR . 89.4 mt -127.47 140.25 52.27 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.735 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.7 m 48.42 35.43 5.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.74 -12.7 53.57 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.23 161.28 38.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 119.476 1.638 . . . . 0.0 112.124 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 80.8 m -77.82 164.91 24.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.505 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 92.6 mt -58.35 -39.73 80.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.151 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 60' ' ' ILE . 4.6 tp -58.32 -45.24 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.199 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.77 -42.41 97.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.12 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.44 ' HE2' ' O ' ' A' ' 24' ' ' LEU . 4.2 m-85 -62.65 -36.17 81.99 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.773 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 29' ' ' LEU . 74.7 t -72.17 -45.2 63.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 120.818 0.342 . . . . 0.0 111.04 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 30' ' ' ILE . 76.0 t -63.85 -44.98 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 74.7 m -53.0 -54.58 42.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -173.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 51.3 Cg_exo -60.67 -40.3 56.47 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.009 1.806 . . . . 0.0 112.299 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.502 HD12 HG11 ' A' ' 98' ' ' VAL . 81.7 mt -67.3 -43.2 82.31 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.919 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -61.9 -46.06 91.03 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -72.99 -15.57 61.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.485 ' OG ' HG13 ' A' ' 42' ' ' VAL . 79.9 p -75.41 173.71 10.57 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.195 0.521 . . . . 0.0 111.007 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -60.6 -18.39 52.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.746 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' OG ' ' A' ' 40' ' ' SER . 11.9 p -64.98 146.41 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.991 0.424 . . . . 0.0 111.108 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -79.79 -73.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.05 150.78 25.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.452 0.644 . . . . 0.0 111.799 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.06 116.12 51.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.553 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 84.4 m-85 -106.12 117.79 34.94 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -98.64 118.48 45.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.645 0.736 . . . . 0.0 110.301 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HB2' HD12 ' A' ' 4' ' ' LEU . . . -88.18 117.85 27.36 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.964 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 7' ' ' ALA . 70.0 p -125.94 157.85 36.69 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.6 p -109.27 155.65 40.72 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.326 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.29 -18.44 62.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.598 2.199 . . . . 0.0 111.002 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -83.38 -7.4 59.57 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.999 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.0 p -141.37 66.74 24.41 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.0 Cg_endo -102.09 84.22 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.699 0 C-N-CA 116.469 -1.888 . . . . 0.0 108.577 168.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 53.5 mtmt -150.68 -50.34 0.13 Allowed 'General case' 1 C--N 1.216 -5.198 0 CA-C-N 109.446 -3.524 . . . . 0.0 103.184 -176.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.3 m -62.82 -46.97 85.46 Favored 'General case' 0 N--CA 1.391 -3.41 0 CA-C-N 112.692 -2.049 . . . . 0.0 106.125 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -61.5 -49.27 77.42 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.383 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 14.3 pt-20 -58.71 -38.48 78.38 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.03 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.76 -50.26 69.74 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.704 0.287 . . . . 0.0 111.458 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 30' ' ' ILE . 96.7 mt -63.59 -43.65 98.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.879 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -58.23 -44.36 88.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.346 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.1 m -68.74 -40.16 79.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.348 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.16 90.57 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.424 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 60.0 m-85 -115.96 42.19 2.4 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.549 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.62 -21.39 62.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.143 0.497 . . . . 0.0 110.976 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -93.24 11.69 27.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.631 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 48.4 p90 -43.4 122.34 2.57 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.33 -50.0 3.58 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -111.05 10.96 22.07 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.531 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 85.9 mt -105.99 124.27 61.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.295 0.569 . . . . 0.0 110.35 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 60.3 t -125.28 133.7 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.687 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.41 132.46 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.091 0.472 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.9 pt -127.83 156.03 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-O 121.912 0.863 . . . . 0.0 111.325 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -110.35 133.14 53.55 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.496 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 10.1 t -162.22 -169.81 2.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 53.8 m -69.6 1.77 3.82 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 126.56 1.944 . . . . 0.0 114.438 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.46 -21.53 0.0 OUTLIER Glycine 1 N--CA 1.519 4.226 0 C-N-CA 126.209 1.862 . . . . 0.0 117.019 -174.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 76' ' ' SER . 2.5 tmmt? -56.57 -34.2 66.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.78 126.08 6.57 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -60.26 -51.69 68.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.48 -45.76 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 121.727 0.775 . . . . 0.0 110.795 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 69.5 mm-40 -60.99 -42.69 98.9 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.859 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.611 ' CG ' ' HE1' ' A' ' 6' ' ' MET . 8.7 t0 -58.94 -50.69 73.09 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.9 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.514 ' O ' HG21 ' A' ' 88' ' ' ILE . 2.3 mm? -57.5 -43.98 84.6 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.055 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' HA ' HG12 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -61.36 -40.1 93.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.968 178.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 70.7 mm-40 -67.17 -44.27 80.13 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.565 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 97.0 m -63.92 -41.63 97.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.619 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 84' ' ' LEU . 35.4 pt -66.73 -35.3 74.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.197 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.33 94.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.345 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.0 -49.19 77.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.958 . . . . 0.0 112.969 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.565 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 75.5 m-85 -74.2 148.23 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.176 0.512 . . . . 0.0 112.103 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.4 m -96.26 -8.41 32.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.549 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 15.5 pt-20 -151.55 173.47 4.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 93' ' ' GLU . 58.1 Cg_endo -69.35 148.48 67.82 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.072 1.848 . . . . 0.0 113.795 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 40.6 p90 -146.18 162.39 38.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.493 HD21 HG23 ' A' ' 156' ' ' VAL . 91.2 mt -84.44 150.13 25.51 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.542 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 87.3 t -121.84 129.57 75.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.434 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 5' ' ' ILE . 5.7 m -131.65 162.96 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.088 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.1 t -99.4 145.89 26.9 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.597 ' HB3' ' O ' ' A' ' 6' ' ' MET . 80.0 p -65.49 -20.5 66.37 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 177' ' ' ASN . 53.7 p-10 -105.14 12.41 32.06 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.21 115.37 11.37 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.929 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 29' ' ' LEU . 73.6 mt -122.45 117.02 50.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 33.6 t-20 173.88 169.62 0.2 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.62 73.71 5.16 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HA ' HD13 ' A' ' 109' ' ' ILE . 23.2 pttp -82.64 -1.84 52.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.185 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.582 ' HA ' HD13 ' A' ' 110' ' ' ILE . 71.2 m -58.95 -40.61 85.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.52 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -71.33 -40.35 70.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.558 1.17 . . . . 0.0 109.895 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.73 ' O ' HG12 ' A' ' 113' ' ' ILE . 66.7 mt -63.02 -39.56 85.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.127 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 107' ' ' SER . 59.8 mt -57.52 -47.61 84.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -63.9 -39.97 95.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.718 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.7 m -61.66 -37.44 84.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.184 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.73 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -60.05 -48.38 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.323 0.582 . . . . 0.0 109.622 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.84 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.162 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.55 -47.56 85.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.157 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.525 ' CE2' HD12 ' A' ' 120' ' ' ILE . 80.9 t80 -64.18 -49.52 71.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.239 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.408 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 82.8 t80 -59.44 -47.92 83.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.538 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 4.2 m-85 -61.5 -35.46 77.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.15 -46.71 85.9 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.23 0.538 . . . . 0.0 109.733 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.525 HD12 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -65.08 -49.92 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.481 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 124' ' ' THR . 20.4 ptmt -66.32 -27.31 67.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.3 96.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.566 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 20.5 pttp -83.45 -39.71 20.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.917 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 25.2 m -130.49 98.83 19.69 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.403 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -9.56 26.62 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 122.842 2.361 . . . . 0.0 112.55 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.17 -32.81 72.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.856 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.496 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 10.3 p -74.72 124.99 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 0.0 110.993 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 41.1 mt-10 -117.85 -2.61 11.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.702 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.78 41.73 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.859 0.361 . . . . 0.0 111.289 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.4 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -135.16 131.98 37.44 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.407 ' HB1' ' CD ' ' A' ' 166' ' ' GLU . . . -119.06 127.08 53.07 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.538 HG21 ' CD1' ' A' ' 113' ' ' ILE . 90.1 t -107.55 112.55 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 9.9 ptm -146.22 158.4 43.88 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.225 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.7 pt -134.22 157.0 78.55 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.147 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.239 0.536 0 C-N-CA 122.235 1.956 . . . . 0.0 111.878 178.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 121.056 0.455 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.58 147.89 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.395 2.063 . . . . 0.0 110.891 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -114.22 0.22 14.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 176.21 -123.72 0.93 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.268 -1.444 . . . . 0.0 113.648 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 113' ' ' ILE . 4.1 mp -101.17 137.09 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 121.679 0.752 . . . . 0.0 111.713 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.582 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.9 t-20 -109.6 156.7 19.87 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.48 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.493 HG23 HD21 ' A' ' 96' ' ' LEU . 94.7 t -123.62 130.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 C-N-CA 122.667 0.387 . . . . 0.0 110.243 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.419 HG11 ' OD1' ' A' ' 155' ' ' ASN . 28.9 m -133.96 150.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.379 0.609 . . . . 0.0 111.415 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 53.0 p -98.25 164.58 16.93 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.383 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 77.9 Cg_endo -75.72 76.1 3.79 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.55 2.167 . . . . 0.0 111.826 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.82 -172.08 2.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -127.46 131.78 50.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.583 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.91 -114.09 3.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.975 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.33 145.34 51.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.52 166.98 21.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 2.5 tmtm? -55.81 127.66 31.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.152 0.501 . . . . 0.0 110.615 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.407 ' CD ' ' HB1' ' A' ' 131' ' ' ALA . 44.1 tt0 -137.52 134.72 36.02 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.587 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -94.11 162.84 13.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.485 0.66 . . . . 0.0 111.646 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.01 130.08 73.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.081 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.477 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.7 ttp -129.6 130.99 46.37 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.691 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.9 t -111.42 131.51 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 173' ' ' GLU . 42.1 pt -117.66 169.69 7.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.777 0.799 . . . . 0.0 112.482 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -93.51 2.84 56.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.404 ' HB2' HD13 ' A' ' 171' ' ' ILE . 57.7 mm-40 -99.45 131.71 45.27 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 122.076 0.941 . . . . 0.0 113.149 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.08 149.47 21.91 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.886 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.2 pt -123.64 139.81 49.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.833 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -113.53 126.44 55.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 34.1 p-10 -119.13 19.33 12.93 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.555 0.693 . . . . 0.0 111.595 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 184' ' ' LEU . 23.2 mm 77.21 -93.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.515 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.91 -36.69 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.9 p -128.55 162.36 27.43 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.143 -0.348 . . . . 0.0 111.71 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.62 -39.12 83.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -48.66 80.81 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.52 -36.54 84.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.743 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.526 ' HA ' HD13 ' A' ' 178' ' ' ILE . 47.9 tp -59.98 -50.25 74.5 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.433 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.95 -40.5 91.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -60.61 -43.53 97.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.977 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.79 -43.51 98.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.698 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 24' ' ' LEU . 53.7 mm-40 -60.7 -45.48 94.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.24 0.543 . . . . 0.0 110.201 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 98.5 mtp -63.36 -42.28 98.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.698 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.4 -42.26 92.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 120.884 0.373 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -60.99 -43.25 99.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.354 0.597 . . . . 0.0 110.003 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.433 176.202 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 94' ' ' PRO . 59.2 ttm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 38.9 m-20 -115.8 166.1 12.33 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.81 127.4 55.99 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.09 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.38 124.8 49.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.444 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.539 ' HA ' HG23 ' A' ' 98' ' ' VAL . 64.0 mt -118.3 106.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.467 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 14.1 ptm -99.69 100.36 11.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.905 1.336 . . . . 0.0 113.736 -172.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.54 96.8 5.68 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.537 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.158 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.197 -176.946 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.958 0.316 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.526 HD22 ' CD2' ' A' ' 59' ' ' TYR . 35.0 mt -95.43 7.32 46.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.334 -0.393 . . . . 0.0 112.042 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.76 119.83 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 39.9 pttt -100.55 138.39 37.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.029 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.0 tp -136.47 115.9 12.75 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.197 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.2 m 60.53 19.66 9.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.85 -89.1 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.013 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 99.0 mtt180 -103.84 170.03 8.17 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.24 0.543 . . . . 0.0 111.954 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 69.7 m -76.71 163.72 26.56 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.462 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.78 -39.43 81.01 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.283 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.6 tp -56.73 -46.32 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.183 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 11.7 t70 -67.35 -40.76 85.84 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.044 0.45 . . . . 0.0 110.947 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 13.5 m-30 -62.29 -33.99 75.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.36 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -71.55 -42.91 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 30' ' ' ILE . 74.2 t -63.92 -43.79 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.2 m -52.42 -54.55 41.03 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.56 -39.51 16.0 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.565 1.51 . . . . 0.0 112.275 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.24 -42.82 92.99 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 120.801 0.334 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HG ' HD22 ' A' ' 69' ' ' ASN . 8.4 tt -61.3 -46.52 89.96 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.708 0.29 . . . . 0.0 111.19 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -76.3 -13.15 60.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -73.82 -178.49 3.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 112.126 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.448 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.5 ttmm -59.48 -24.95 64.01 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.941 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.56 156.02 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.176 0.513 . . . . 0.0 112.29 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -77.74 -86.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 10.0 m120 -107.72 156.85 18.64 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 111.454 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mm -107.85 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 89.7 m-85 -108.91 121.29 44.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -102.33 118.9 49.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.667 0.746 . . . . 0.0 110.715 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 6' ' ' MET . . . -87.77 126.43 34.99 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.752 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -133.85 170.78 15.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.4 m -127.34 150.88 73.73 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 -27.16 80.94 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.501 2.801 . . . . 0.0 111.986 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.15 5.01 40.02 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.996 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.5 p -140.77 66.08 26.08 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.43 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.651 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 88.4 Cg_endo -106.73 88.12 0.02 OUTLIER 'Trans proline' 1 N--CA 1.379 -5.212 0 C-N-CA 117.212 -1.392 . . . . 0.0 110.66 170.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 72.6 mmtt -151.39 -50.41 0.12 Allowed 'General case' 1 C--N 1.22 -5.04 0 CA-C-N 109.862 -3.335 . . . . 0.0 103.054 177.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.8 m -63.83 -48.34 77.2 Favored 'General case' 0 N--CA 1.384 -3.759 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.107 163.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.651 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 13.5 tmtt? -64.66 -52.37 57.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -60.13 -33.07 71.63 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 116.701 -1.999 . . . . 0.0 112.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.526 ' CD2' HD22 ' A' ' 21' ' ' LEU . 58.0 t80 -70.34 -52.73 20.51 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.483 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.447 HG12 HG12 ' A' ' 30' ' ' ILE . 97.1 mt -63.44 -45.91 96.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.57 -42.26 92.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.264 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.1 t -71.67 -41.72 68.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.491 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.19 90.05 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 77.5 m-85 -106.69 32.51 4.48 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.502 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.4 mtmt -63.34 -18.66 63.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.474 0.654 . . . . 0.0 110.08 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.31 10.4 24.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.641 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.1 p90 -45.84 128.1 8.58 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -102.48 -51.48 3.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.846 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.519 HD22 ' HG ' ' A' ' 38' ' ' LEU . 26.0 p-10 -118.74 15.74 13.55 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.885 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -106.45 129.8 59.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.854 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.7 t -127.86 131.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.52 129.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.413 HG13 ' HA ' ' A' ' 48' ' ' ALA . 44.0 pt -125.63 157.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.473 0.654 . . . . 0.0 111.818 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -108.05 134.3 51.13 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.844 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.6 t -161.18 -172.18 3.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.565 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 66.1 m -77.65 4.66 10.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 126.921 2.088 . . . . 0.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.556 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.6 -23.66 0.0 OUTLIER Glycine 0 N--CA 1.513 3.822 0 C-N-CA 127.167 2.317 . . . . 0.0 117.623 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 22.3 tptm -58.01 -37.11 73.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.19 122.95 6.7 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.89 -51.3 70.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.44 -43.98 87.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.677 0.751 . . . . 0.0 110.523 -177.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -59.89 -42.87 94.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.551 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.556 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 34.9 t0 -60.07 -50.27 74.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.952 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.564 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.6 mm? -56.64 -41.76 77.73 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.583 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.445 ' HA ' HG12 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -61.37 -42.1 98.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.849 178.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.56 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 64.4 mm-40 -66.16 -44.24 84.65 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.4 m -63.4 -41.52 98.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.324 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 160' ' ' LYS . 34.4 pt -64.42 -30.16 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.67 96.53 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.331 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.55 -38.18 71.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.41 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 92.2 m-85 -92.55 136.8 32.91 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 m -100.68 -4.53 28.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.441 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 41.3 mt-10 -134.46 160.58 67.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.5 Cg_endo -63.06 143.54 90.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.082 1.855 . . . . 0.0 111.843 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.49 162.04 37.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.719 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.458 HD21 HG23 ' A' ' 156' ' ' VAL . 92.8 mt -84.73 149.82 25.51 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.914 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 59.7 t -122.14 125.12 72.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.104 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 5' ' ' ILE . 1.3 m -136.37 158.13 37.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.302 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.463 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.2 t -100.9 143.49 30.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.241 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.9 m -76.73 -9.35 58.61 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -106.27 11.18 31.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 62.5 mt -91.63 114.67 27.26 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.85 135.06 65.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 112.009 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 178.61 -178.89 0.31 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.83 58.69 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -66.23 -8.1 22.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.9 -1.5 . . . . 0.0 113.519 -174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 110' ' ' ILE . 60.3 m -58.72 -41.44 86.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -72.82 -37.85 67.36 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.743 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.6 mm -60.78 -40.81 86.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.188 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 107' ' ' SER . 59.4 mt -58.33 -48.65 84.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.445 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 55.0 m-80 -65.65 -39.91 91.9 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.3 m -61.55 -37.23 83.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.743 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.7 mm -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.872 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.89 -44.66 99.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.687 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -60.03 -48.19 82.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.8 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.737 ' CE2' HD13 ' A' ' 120' ' ' ILE . 78.9 t80 -63.98 -47.21 81.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.4 -46.61 83.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.426 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 14.4 m-85 -62.13 -38.3 88.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.49 -41.51 98.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.339 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.737 HD13 ' CE2' ' A' ' 116' ' ' TYR . 74.7 mt -67.9 -48.63 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.204 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.17 -25.46 68.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.543 -177.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.72 98.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.819 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.99 -39.52 19.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.7 m -130.67 95.37 26.52 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.656 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.07 -13.14 35.85 Favored 'Trans proline' 0 N--CA 1.474 0.38 0 C-N-CA 122.738 2.292 . . . . 0.0 111.952 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.91 -31.01 71.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.069 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 124' ' ' THR . 13.4 p -65.53 133.1 31.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.061 0.458 . . . . 0.0 111.154 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.517 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 43.7 mt-10 -124.34 -3.28 7.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.899 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.26 156.8 43.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.801 0.334 . . . . 0.0 111.433 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.78 137.74 38.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.7 139.32 52.77 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.037 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 113' ' ' ILE . 67.8 t -113.97 117.06 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.9 ptm -145.72 152.81 40.19 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.872 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.4 pt -132.02 159.55 71.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.051 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.238 0.477 0 C-N-CA 122.003 1.802 . . . . 0.0 110.784 177.856 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.447 -0.585 0 CA-C-O 121.069 0.461 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 59.1 Cg_endo -71.0 144.29 47.03 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.709 2.273 . . . . 0.0 112.102 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.39 -6.03 10.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.34 -120.35 1.26 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.934 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.604 ' CG1' HG13 ' A' ' 113' ' ' ILE . 40.5 pt -121.21 158.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 120.903 0.382 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.1 t-20 -116.5 152.23 34.49 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.409 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.458 HG23 HD21 ' A' ' 96' ' ' LEU . 93.6 t -121.41 129.46 75.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 122.51 0.324 . . . . 0.0 110.409 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.456 HG13 ' OD1' ' A' ' 155' ' ' ASN . 31.6 m -135.3 149.01 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.143 0.497 . . . . 0.0 111.391 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.517 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 77.1 p -98.79 163.7 18.35 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.543 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 62.4 Cg_endo -73.4 74.65 3.1 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.258 1.972 . . . . 0.0 112.079 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.58 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.3 mmmt -115.33 137.68 51.78 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.748 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -93.18 107.05 18.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.336 0.589 . . . . 0.0 110.23 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.02 -128.95 6.37 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -136.29 129.27 31.19 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -117.53 166.5 12.29 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.607 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.0 120.37 9.53 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.301 0.572 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -121.02 130.1 53.65 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.801 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.415 ' HG3' HG23 ' A' ' 120' ' ' ILE . 42.8 mm-40 -92.8 161.9 14.33 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 121.731 0.777 . . . . 0.0 112.196 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.2 mm -117.89 127.05 75.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.652 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.554 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.3 ttp -124.77 128.71 49.17 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.92 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.3 t -107.97 128.75 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.492 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.544 ' HB ' ' OE1' ' A' ' 173' ' ' GLU . 48.6 pt -115.51 175.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.019 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -121.69 23.07 10.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.769 0.795 . . . . 0.0 109.889 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.544 ' OE1' ' HB ' ' A' ' 171' ' ' ILE . 20.0 mp0 -98.7 130.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.988 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.03 143.03 28.27 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.287 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.461 HD11 HD23 ' A' ' 102' ' ' LEU . 10.1 pt -121.6 154.06 25.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.409 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.38 106.1 13.91 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.672 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -68.05 -35.79 78.82 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.088 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 183' ' ' ASP . 98.7 mt 66.32 109.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.045 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -120.93 -15.26 8.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.217 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.8 p -127.54 166.34 18.19 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.414 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.8 mppt? -63.51 -36.91 85.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.04 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.54 -40.6 87.78 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.457 ' HB3' HG12 ' A' ' 178' ' ' ILE . 77.0 m-20 -61.27 -41.71 97.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.491 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 89.9 mt -61.94 -47.63 84.02 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.312 0.577 . . . . 0.0 109.949 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 88.0 tttt -61.92 -42.68 99.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.623 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.406 ' C ' HD21 ' A' ' 186' ' ' LEU . 8.6 tt -60.47 -47.97 83.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.937 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -64.91 -42.11 95.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.202 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 pt-20 -69.5 -31.65 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 96.5 mtp -62.73 -40.96 98.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.646 0.26 . . . . 0.0 111.537 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.6 -36.27 60.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.189 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.95 -45.77 90.89 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.443 0.64 . . . . 0.0 110.525 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 C--N 1.314 -0.965 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.994 178.944 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.432 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.4 ttm . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.514 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 33.5 m-20 -100.12 166.17 11.15 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 42' ' ' VAL . . . -115.58 130.77 56.99 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.924 0.392 . . . . 0.0 111.101 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.8 tp -106.06 125.07 50.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.181 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.595 ' HA ' HG21 ' A' ' 98' ' ' VAL . 71.9 mt -117.68 102.22 13.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 100' ' ' SER . 12.1 ptm -96.22 98.52 10.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.987 1.375 . . . . 0.0 112.093 -175.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.44 98.23 6.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.196 -1.82 . . . . 0.0 110.332 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.331 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.843 179.317 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 CA--C 1.534 0.493 0 CA-C-O 121.011 0.338 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 59' ' ' TYR . 57.8 mt -102.59 7.61 39.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.41 118.37 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.592 0.711 . . . . 0.0 109.129 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 48.8 pttt -87.68 125.92 34.67 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.999 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 184' ' ' LEU . 60.3 tp -131.71 119.69 21.69 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.003 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.1 m 57.29 28.72 15.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.25 -76.02 0.39 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.019 -1.086 . . . . 0.0 114.48 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.716 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 44.3 mtt180 -101.73 166.42 10.69 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 112.36 -172.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 75.7 m -76.15 151.79 36.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.674 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.1 tt -48.91 -47.93 42.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.26 0.624 . . . . 0.0 111.711 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 HG12 ' CD1' ' A' ' 60' ' ' ILE . 5.7 tp -57.61 -42.49 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 0.0 111.811 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.716 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 15.0 t70 -65.24 -39.73 93.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.142 0.496 . . . . 0.0 109.933 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -63.73 -37.34 86.99 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.969 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 29' ' ' LEU . 72.3 t -65.27 -43.43 95.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 110.239 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -63.61 -43.0 98.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.583 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -49.99 -57.01 13.85 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 40' ' ' SER . 41.8 Cg_endo -67.83 -37.99 14.52 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 121.57 1.514 . . . . 0.0 112.462 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.471 HD11 HG12 ' A' ' 98' ' ' VAL . 83.3 mt -65.09 -41.22 95.19 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.879 0.371 . . . . 0.0 111.67 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HG ' HD22 ' A' ' 69' ' ' ASN . 5.7 tt -59.97 -46.58 88.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.035 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -83.31 -5.87 59.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 57.4 p -75.79 -178.38 4.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.518 0.675 . . . . 0.0 111.585 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -57.44 -24.8 57.8 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.719 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.421 HG21 ' HB1' ' A' ' 3' ' ' ALA . 22.7 m -67.38 161.8 3.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.514 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 60.1 t30 -80.43 -76.83 0.21 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.544 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -117.56 159.77 22.34 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.909 0.385 . . . . 0.0 110.767 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.67 114.06 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.3 m-85 -107.88 116.75 32.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.492 HG12 ' HB ' ' A' ' 5' ' ' ILE . 96.1 mt -97.98 116.15 39.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.558 0.694 . . . . 0.0 110.543 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.81 125.35 34.4 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.705 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -129.34 158.94 37.7 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.413 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 38.0 m -103.93 149.76 37.53 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.575 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.9 -20.63 57.99 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.745 2.297 . . . . 0.0 111.309 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -89.04 1.66 55.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 20.3 p -138.08 67.51 48.07 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.653 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.646 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 90.8 Cg_endo -100.99 87.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.384 -4.939 0 C-N-CA 117.303 -1.331 . . . . 0.0 109.17 169.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.642 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.5 mmtm -156.94 -52.7 0.08 Allowed 'General case' 1 C--N 1.215 -5.268 0 CA-C-N 110.183 -3.19 . . . . 0.0 103.057 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.3 m -63.77 -50.03 70.62 Favored 'General case' 0 N--CA 1.379 -3.991 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -65.25 -49.25 70.35 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.7 pt-20 -60.83 -31.36 70.78 Favored 'General case' 0 C--N 1.374 1.664 0 C-N-CA 116.16 -2.216 . . . . 0.0 112.17 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' HD23 ' A' ' 21' ' ' LEU . 52.9 t80 -72.2 -51.22 22.1 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.582 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.472 ' CD1' HG12 ' A' ' 30' ' ' ILE . 97.8 mt -62.35 -44.92 99.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.689 -174.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.71 -44.01 90.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.499 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.1 m -68.8 -41.21 79.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.384 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.58 88.08 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.45 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.574 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 66.5 m-85 -110.54 31.82 5.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.409 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -61.77 -24.19 66.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.16 0.505 . . . . 0.0 110.739 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.27 10.97 25.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.017 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.5 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.4 p90 -45.44 134.26 6.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -175.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.06 -49.53 3.74 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.459 HD22 ' HG ' ' A' ' 38' ' ' LEU . 26.2 p-10 -119.25 11.65 12.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.563 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 80.8 mt -106.2 127.29 61.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.27 0.557 . . . . 0.0 110.697 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 76.9 t -126.45 132.23 70.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.732 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.85 130.58 52.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' A' ' 48' ' ' ALA . 37.7 pt -124.07 155.73 31.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.391 0.615 . . . . 0.0 110.396 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.72 132.35 56.49 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.865 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.549 ' OG1' ' HG2' ' A' ' 86' ' ' GLU . 14.2 t -163.66 -167.42 1.4 Allowed 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.5 m -66.04 1.0 1.61 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 127.017 2.127 . . . . 0.0 114.349 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.56 -22.39 0.0 OUTLIER Glycine 0 N--CA 1.514 3.875 0 C-N-CA 126.026 1.774 . . . . 0.0 116.67 -175.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 76' ' ' SER . 13.9 tmtt? -57.39 -36.6 71.49 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.38 122.84 6.23 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.58 -50.47 73.76 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 pt -71.49 -32.16 45.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.097 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.53 -43.46 89.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.467 0.651 . . . . 0.0 109.891 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.562 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.1 t0 -61.3 -50.5 72.74 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.859 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.55 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.4 mm? -57.44 -45.09 85.1 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.035 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.485 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.6 m-80 -60.69 -42.63 97.53 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.549 ' HG2' ' OG1' ' A' ' 75' ' ' THR . 16.8 tp10 -65.37 -46.43 80.15 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 99.0 m -63.78 -41.01 98.03 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.403 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.55 HG21 ' O ' ' A' ' 84' ' ' LEU . 33.2 pt -65.18 -36.82 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.393 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.63 -38.97 95.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.4 174.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.35 -49.22 74.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.64 0.776 . . . . 0.0 112.814 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.533 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 83.3 m-85 -75.76 149.83 37.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -103.06 -5.29 23.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.386 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.78 158.33 74.31 Favored Pre-proline 0 CA--C 1.505 -0.787 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.94 141.62 77.83 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.858 2.372 . . . . 0.0 110.534 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.432 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 45.5 p90 -141.84 156.81 45.53 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.543 0.687 . . . . 0.0 111.923 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.452 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.42 138.5 31.73 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.931 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 64.3 t -116.94 131.67 68.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 123.311 0.644 . . . . 0.0 109.291 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 5' ' ' ILE . 17.7 m -126.72 164.04 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 112.02 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.436 ' O ' HD22 ' A' ' 102' ' ' LEU . 47.6 t -82.54 159.95 22.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.009 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 6' ' ' MET . 81.1 p -86.1 -26.07 25.46 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.6 28.77 7.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 99' ' ' SER . 1.5 pt? -86.55 156.88 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.694 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.7 pt -96.74 174.09 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 96.2 m-20 -69.19 -170.29 0.25 Allowed 'General case' 0 C--O 1.247 0.932 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.041 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 104' ' ' ASN . 4.2 mm? 75.03 14.74 3.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.311 1.044 . . . . 0.0 109.97 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HA ' HG12 ' A' ' 109' ' ' ILE . 47.9 mmtm -99.52 -0.81 39.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.032 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.4 p -59.31 -37.1 76.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.97 -24.77 59.66 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.87 0.843 . . . . 0.0 109.747 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.762 ' O ' HG12 ' A' ' 113' ' ' ILE . 41.2 mm -67.17 -39.77 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.27 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 154' ' ' ILE . 66.3 mt -57.24 -49.07 81.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.13 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -66.12 -40.41 90.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.195 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -62.77 -41.09 99.08 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.97 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.762 HG12 ' O ' ' A' ' 109' ' ' ILE . 47.7 mm -62.12 -48.69 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.044 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.471 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.1 t -61.98 -48.77 87.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.428 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.57 -41.99 98.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.057 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.82 -41.65 78.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.927 0.394 . . . . 0.0 110.354 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.75 -46.68 86.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.93 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 17.2 m-85 -60.05 -37.01 78.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.492 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.05 -41.14 97.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 109.563 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.1 mt -68.55 -41.36 82.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.298 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 127' ' ' VAL . 17.7 mmmt -59.94 -43.11 95.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.478 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.56 93.51 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.724 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.29 -34.73 31.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.519 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.3 m -140.31 95.43 8.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.31 -25.12 77.24 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.207 2.605 . . . . 0.0 112.688 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.66 -31.75 72.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.511 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.425 ' O ' ' HD2' ' A' ' 121' ' ' LYS . 63.3 t -69.26 122.6 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.575 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 33.8 mt-10 -130.93 18.83 5.04 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 156' ' ' VAL . . . -151.0 151.55 32.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.043 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 18.7 tp -138.89 143.29 38.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.905 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.55 138.56 52.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 113' ' ' ILE . 60.0 t -117.5 117.03 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 4.3 ptm -146.01 161.77 39.37 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.53 -176.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.445 HG12 ' HB1' ' A' ' 152' ' ' ALA . 22.7 pt -132.66 154.58 81.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.558 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 121.971 1.78 . . . . 0.0 110.1 176.626 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.149 0.5 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.402 ' O ' HD11 ' A' ' 175' ' ' ILE . 61.1 Cg_endo -72.01 151.2 55.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.501 2.134 . . . . 0.0 110.432 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.445 ' HB1' HG12 ' A' ' 134' ' ' ILE . . . -131.98 -28.3 1.77 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.895 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.57 -136.63 6.75 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.977 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.452 HD12 HD11 ' A' ' 96' ' ' LEU . 20.6 pt -123.66 161.02 26.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.735 -177.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.563 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.7 t-20 -112.13 152.52 28.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.449 -174.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' ALA . 71.6 t -124.59 130.86 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.201 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.491 HG12 ' OD1' ' A' ' 155' ' ' ASN . 20.1 m -133.75 149.03 30.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.513 0.673 . . . . 0.0 111.396 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.575 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 23.3 t -97.83 151.66 37.7 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.412 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 43.2 Cg_endo -67.32 77.73 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.589 2.193 . . . . 0.0 111.61 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.71 -175.67 2.83 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.13 115.9 15.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.71 -123.78 7.12 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.275 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.91 140.7 50.91 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -134.12 164.14 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.649 0.261 . . . . 0.0 111.653 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.421 ' CG ' HG23 ' A' ' 127' ' ' VAL . 49.4 tptt -57.08 127.98 34.7 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.506 0.67 . . . . 0.0 112.22 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -128.63 137.26 51.57 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.538 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.1 163.19 12.67 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.53 130.97 69.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.597 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.7 ttm -122.63 141.76 51.38 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 133' ' ' MET . 57.9 t -117.06 131.41 69.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.4 pt -120.76 175.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.12 5.5 30.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.328 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.565 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.4 mp0 -96.84 130.24 44.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.195 0.998 . . . . 0.0 111.917 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.2 mt -97.05 152.22 18.96 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.115 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.402 HD11 ' O ' ' A' ' 151' ' ' PRO . 18.1 pt -130.61 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.833 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.1 119.34 28.34 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -82.26 118.91 23.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.84 105.68 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.107 0.479 . . . . 0.0 110.402 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -113.1 -19.18 11.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.163 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -147.64 165.92 28.96 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.12 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -58.26 -31.91 67.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.844 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.51 -43.01 99.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.1 -42.32 98.3 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.459 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.444 ' CD1' HD13 ' A' ' 24' ' ' LEU . 58.9 tp -62.08 -46.67 88.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 63.5 tttm -64.24 -42.13 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.989 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.15 -45.38 93.26 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.501 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.13 -40.89 98.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.996 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 8.7 pt-20 -67.42 -36.28 80.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.872 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.0 mtp -62.59 -39.08 92.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.33 -34.96 61.26 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.3 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -46.06 64.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.066 0.46 . . . . 0.0 112.157 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.214 -177.386 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 23.5 ptp . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.437 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 22.7 m-20 -95.33 163.36 13.29 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -121.09 128.51 52.66 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 40.9 tp -103.75 127.45 51.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HA ' HG23 ' A' ' 98' ' ' VAL . 63.6 mt -117.63 103.48 14.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.508 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 14.7 ptm -98.25 115.94 29.44 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-O 123.474 1.607 . . . . 0.0 112.07 -176.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.91 -173.22 2.24 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 111.226 -2.716 . . . . 0.0 109.819 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.267 -3.271 0 CA-C-N 114.12 -1.4 . . . . 0.0 111.283 -178.121 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 113.517 0.545 . . . . 0.0 113.517 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 64.3 mt -88.11 10.76 18.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.87 126.81 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 62.6 mttp -102.32 141.15 35.62 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 122.264 1.03 . . . . 0.0 113.705 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD23 HD12 ' A' ' 184' ' ' LEU . 86.4 mt -125.41 110.25 13.72 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.222 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.38 33.44 18.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.657 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -20.01 39.19 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.904 1.121 . . . . 0.0 115.904 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.659 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 89.6 mtt180 -117.71 152.31 35.5 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 119.235 1.518 . . . . 0.0 112.327 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 81.7 m -75.27 162.45 28.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.779 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 100' ' ' SER . 88.6 mt -59.86 -40.67 89.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.051 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.546 HG12 ' CD1' ' A' ' 60' ' ' ILE . 3.8 tp -59.77 -43.08 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.624 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 9.9 t70 -62.86 -44.08 97.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.292 0.568 . . . . 0.0 110.029 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 23.9 m-85 -65.11 -33.3 75.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.646 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.612 ' HA ' ' NZ ' ' A' ' 106' ' ' LYS . 69.7 t -71.9 -44.61 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.606 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 30' ' ' ILE . 72.2 t -64.57 -43.76 96.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 73.4 m -52.22 -54.61 39.71 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 42.4 Cg_exo -62.41 -41.91 30.66 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.11 1.874 . . . . 0.0 112.479 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 HD11 HG12 ' A' ' 98' ' ' VAL . 87.2 mt -67.11 -40.28 86.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.087 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.438 ' HG ' HD22 ' A' ' 69' ' ' ASN . 7.2 tt -62.28 -46.3 89.43 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.0 0.429 . . . . 0.0 109.891 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.61 -17.15 60.75 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.404 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.44 ' CB ' HG23 ' A' ' 110' ' ' ILE . 78.7 p -70.69 170.05 13.16 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.185 0.517 . . . . 0.0 111.757 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -71.85 24.77 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.1 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.92 162.38 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.828 -0.545 . . . . 0.0 110.767 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 64.5 t30 -72.27 -76.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.619 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -125.9 160.19 30.57 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.952 0.406 . . . . 0.0 110.438 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.0 mm -108.4 116.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.7 m-85 -109.72 116.97 32.69 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.479 HG22 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -98.15 119.85 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.562 0.696 . . . . 0.0 111.039 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -95.19 119.8 34.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.984 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.3 p -125.95 150.99 47.58 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.419 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 75' ' ' THR . 54.8 m -83.77 152.2 62.58 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.009 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.32 -18.43 63.16 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.152 2.568 . . . . 0.0 111.4 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -89.95 -0.63 57.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.6 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -141.32 68.17 26.3 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 97.5 Cg_endo -104.65 85.67 0.02 OUTLIER 'Trans proline' 1 N--CA 1.382 -5.056 0 C-N-CA 116.845 -1.637 . . . . 0.0 108.889 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 35.1 mmtp -144.94 -50.14 0.26 Allowed 'General case' 1 C--N 1.224 -4.857 0 CA-C-N 110.299 -3.137 . . . . 0.0 103.78 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.435 ' HA ' HD22 ' A' ' 21' ' ' LEU . 68.4 m -62.41 -45.8 91.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.632 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -61.95 -50.86 70.42 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.896 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.3 pt-20 -63.12 -32.19 73.51 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.039 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -62.59 -50.5 71.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.91 0.386 . . . . 0.0 111.466 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.546 ' CD1' HG12 ' A' ' 30' ' ' ILE . 92.1 mt -63.29 -43.75 98.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.104 -176.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -57.65 -43.71 85.12 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.5 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t -71.82 -43.07 66.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.48 93.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.347 0.594 . . . . 0.0 110.891 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.439 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 90.2 m-85 -111.6 41.65 1.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.006 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.5 mtmt -61.3 -21.79 64.28 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.261 0.553 . . . . 0.0 110.423 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -91.2 10.59 26.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.4 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.439 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 35.3 p90 -35.62 113.79 0.22 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.506 ' C ' ' HD3' ' A' ' 68' ' ' LYS . 4.6 tmtm? -93.16 -51.93 4.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.066 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.438 HD22 ' HG ' ' A' ' 38' ' ' LEU . 27.2 p-10 -118.74 13.92 13.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.767 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.19 126.48 56.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.403 0.62 . . . . 0.0 111.527 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.8 t -126.06 133.1 69.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.56 132.71 54.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.34 155.28 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.426 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -118.11 131.18 56.44 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.222 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 50' ' ' SER . 13.0 t -165.41 -173.66 2.89 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.137 0.97 . . . . 0.0 113.582 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 78' ' ' LYS . 48.9 m -64.67 3.48 0.51 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.404 2.282 . . . . 0.0 115.497 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.14 -29.36 0.01 OUTLIER Glycine 1 N--CA 1.519 4.186 0 C-N-CA 126.434 1.969 . . . . 0.0 117.602 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' SER . 53.6 tptt -58.08 -38.91 77.26 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -100.46 114.58 5.05 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.74 -47.77 84.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.63 -49.01 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.629 0.728 . . . . 0.0 109.797 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.7 -47.16 86.74 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.631 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.54 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.4 t0 -61.12 -51.9 67.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.733 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.518 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.5 mm? -58.29 -44.99 88.74 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.805 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -58.29 -46.49 85.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.083 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.91 -46.97 82.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.176 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.578 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 96.4 m -63.6 -43.47 96.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.194 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.518 HG21 ' O ' ' A' ' 84' ' ' LEU . 35.8 pt -65.73 -30.86 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 120.855 0.36 . . . . 0.0 110.27 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.94 -39.67 97.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.983 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -74.99 -34.75 62.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.578 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 74.6 m-85 -76.16 142.65 41.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -103.69 1.14 31.49 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.981 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 36.5 mt-10 -138.39 160.86 62.07 Favored Pre-proline 0 CA--C 1.503 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.464 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 1' ' ' MET . 42.9 Cg_endo -68.19 145.4 66.37 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.808 1.672 . . . . 0.0 109.792 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -145.21 161.91 38.38 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.201 0.524 . . . . 0.0 112.192 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 156' ' ' VAL . 93.3 mt -85.63 149.74 25.11 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.693 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.9 t -120.77 125.47 74.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 5' ' ' ILE . 6.1 m -131.44 162.4 39.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.325 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 49.0 m -99.45 143.3 29.86 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.16 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 78.2 p -73.15 -10.01 59.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.299 0.571 . . . . 0.0 111.605 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 99' ' ' SER . 4.7 p-10 -101.41 16.78 24.51 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.251 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.45 117.17 28.94 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 122.007 -0.433 . . . . 0.0 110.619 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 47.4 pt -69.93 -172.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.782 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.44 -175.42 2.79 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.1 tp 80.73 24.32 0.32 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 110.023 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.612 ' NZ ' ' HA ' ' A' ' 33' ' ' VAL . 50.0 mtmt -98.79 -1.86 39.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.829 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.0 m -58.07 -43.75 87.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -86.82 -20.64 27.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.722 ' O ' HG12 ' A' ' 113' ' ' ILE . 43.2 mm -63.73 -45.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.961 -175.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.44 HG23 ' CB ' ' A' ' 40' ' ' SER . 58.3 mt -59.52 -48.58 86.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.556 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -63.92 -39.67 94.71 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.084 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.2 m -62.45 -38.04 88.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.855 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.6 mm -59.61 -48.23 88.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.219 0.533 . . . . 0.0 109.932 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 78.7 t -62.71 -49.51 83.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.495 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.02 -41.97 99.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.287 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.499 ' CE2' HD13 ' A' ' 120' ' ' ILE . 46.0 t80 -63.92 -46.68 83.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.148 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.46 -47.69 84.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.989 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 27.2 m-85 -61.02 -36.88 80.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.169 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.8 t -62.21 -45.37 93.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.455 0.645 . . . . 0.0 109.71 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 ' CE2' ' A' ' 116' ' ' TYR . 84.7 mt -63.38 -49.22 83.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.497 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.64 -25.0 67.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.59 99.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.552 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.415 ' HZ3' ' HA ' ' A' ' 120' ' ' ILE . 24.3 pttm -83.83 -34.33 24.7 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.65 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 54.4 m -137.73 97.23 10.26 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.33 -13.4 39.27 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.049 2.499 . . . . 0.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.69 -29.64 70.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.425 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.5 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 85.7 t -67.21 126.48 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.214 0.531 . . . . 0.0 110.681 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.506 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 39.8 mt-10 -108.25 -25.22 11.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.798 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.7 38.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.115 0.483 . . . . 0.0 112.111 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.96 132.21 36.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.174 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -122.28 135.41 54.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 113' ' ' ILE . 59.0 t -113.72 119.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.22 157.88 43.85 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.563 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 152' ' ' ALA . 37.8 pt -134.07 157.83 76.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.595 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.24 0.623 0 C-N-CA 122.446 2.098 . . . . 0.0 112.054 178.636 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.65 144.18 53.81 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.496 2.13 . . . . 0.0 111.501 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -116.49 -2.67 11.96 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.71 -127.29 1.0 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.724 -1.703 . . . . 0.0 114.163 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' A' ' 113' ' ' ILE . 4.0 mp -101.63 140.43 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-O 121.591 0.71 . . . . 0.0 111.918 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.589 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.4 t-20 -109.13 155.49 20.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.397 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.513 HG23 HD21 ' A' ' 96' ' ' LEU . 87.9 t -124.58 135.74 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 122.905 0.482 . . . . 0.0 110.467 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.16 151.41 30.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 120.79 0.328 . . . . 0.0 110.566 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 82.9 p -90.8 163.18 31.01 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.037 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 71.9 Cg_endo -75.75 63.25 6.59 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.385 2.057 . . . . 0.0 112.426 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.409 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 33.6 mmtp -110.89 -172.77 2.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.674 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -143.03 120.23 11.49 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.35 -125.49 5.79 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.242 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -112.99 142.41 45.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.03 152.3 47.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.852 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.5 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 9.1 tmtm? -76.75 125.98 30.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.67 136.48 54.5 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.987 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.478 ' HG3' HG21 ' A' ' 120' ' ' ILE . 24.8 mm-40 -95.77 164.01 12.93 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.328 0.585 . . . . 0.0 112.058 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.71 131.04 68.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.427 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.446 ' HE1' ' CG ' ' A' ' 116' ' ' TYR . 44.1 ttm -116.75 135.49 53.72 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.645 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.31 126.45 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.533 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 42.7 pt -119.28 175.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.407 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.13 3.3 9.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.491 . . . . 0.0 111.496 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.533 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 1.8 pm0 -98.78 137.03 37.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.621 0.724 . . . . 0.0 111.262 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -95.86 150.59 20.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.831 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.0 pt -127.18 153.94 36.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.512 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.67 107.61 13.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -74.51 -35.3 63.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.606 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.501 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 86.1 mt 79.98 96.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.772 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -110.28 -19.38 13.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.697 175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.2 p -126.33 162.24 25.97 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.096 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.71 -35.07 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.956 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -62.07 -41.78 98.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 73.3 m-20 -63.96 -41.73 97.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 109.571 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.444 HD12 HD23 ' A' ' 24' ' ' LEU . 60.0 tp -61.51 -48.35 81.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.194 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 62.9 tttm -63.4 -44.33 94.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.138 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.66 -44.65 96.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 0.0 110.02 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.49 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.81 -42.47 99.06 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.705 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.3 pt-20 -70.97 -36.11 72.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 95.0 mtp -63.99 -42.37 97.21 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -65.19 -36.02 82.89 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.955 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.0 mt -63.48 -46.14 87.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--N 1.314 -0.958 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.71 -179.587 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 42.6 m-20 -96.52 165.91 11.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.81 137.87 51.75 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.7 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' HG21 ' A' ' 98' ' ' VAL . 8.5 mt -96.58 135.78 38.01 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.785 174.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HA ' HG21 ' A' ' 98' ' ' VAL . 75.7 mt -127.59 100.03 5.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.4 ptm -95.5 99.08 11.02 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 123.269 1.509 . . . . 0.0 112.248 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.0 110.53 20.2 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 112.378 -2.192 . . . . 0.0 109.615 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.966 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.722 -179.291 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 25.4 Cg_exo . . . . . 0 C--O 1.233 0.253 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 73.4 mt -95.93 18.27 13.64 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.471 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.83 118.81 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.883 0.849 . . . . 0.0 109.296 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -86.14 131.2 34.3 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.991 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -132.57 125.46 30.55 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.737 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 52.28 30.0 7.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.45 -9.19 58.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.509 -0.853 . . . . 0.0 115.063 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.697 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.7 mtt180 -127.01 153.84 45.4 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.826 1.313 . . . . 0.0 111.846 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 77.3 m -80.26 164.09 23.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 33' ' ' VAL . 77.6 mt -59.05 -43.99 91.75 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.075 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.484 ' O ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.58 -39.88 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.697 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.3 t70 -64.55 -43.61 93.4 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.276 0.56 . . . . 0.0 110.193 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 7.5 m-85 -63.24 -34.17 77.08 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.622 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 29' ' ' LEU . 69.8 t -69.34 -42.12 81.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.915 0.388 . . . . 0.0 110.543 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 30' ' ' ILE . 66.2 t -62.45 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.793 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.556 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 67.8 m -53.47 -52.29 68.05 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 53.2 Cg_exo -60.33 -43.1 36.57 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 121.789 1.66 . . . . 0.0 112.484 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.454 HD11 HG12 ' A' ' 98' ' ' VAL . 93.2 mt -66.68 -38.31 86.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 110.563 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.518 HD11 HD22 ' A' ' 69' ' ' ASN . 62.1 tp -59.33 -44.7 92.58 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.385 178.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 35' ' ' SER . 61.1 pttt -91.18 -4.39 56.14 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.452 ' OG ' HG21 ' A' ' 42' ' ' VAL . 80.8 p -82.46 -176.55 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 111.071 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -54.22 -22.45 11.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.642 1.177 . . . . 0.0 112.23 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.452 HG21 ' OG ' ' A' ' 40' ' ' SER . 58.5 t -54.49 137.59 15.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.507 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -72.0 -79.44 0.07 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.153 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.44 HD21 ' C ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -115.58 155.76 27.02 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.258 0.552 . . . . 0.0 110.567 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.9 mm -107.05 116.05 49.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.046 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 96.9 m-85 -107.84 116.54 32.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 60' ' ' ILE . 82.1 mt -98.96 116.69 42.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.38 123.99 32.92 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.17 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.5 p -129.26 161.9 29.14 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.664 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -117.12 151.4 47.62 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.895 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.82 -19.08 53.22 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.867 2.378 . . . . 0.0 111.245 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.15 -10.86 59.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.5 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -140.76 66.7 27.69 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.558 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 98.2 Cg_endo -102.64 88.8 0.03 OUTLIER 'Trans proline' 1 N--CA 1.376 -5.41 0 C-N-CA 117.197 -1.402 . . . . 0.0 110.345 171.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -150.9 -47.35 0.12 Allowed 'General case' 1 C--N 1.205 -5.699 0 CA-C-N 110.368 -3.106 . . . . 0.0 102.865 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.4 m -63.38 -48.27 78.58 Favored 'General case' 0 N--CA 1.386 -3.64 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.679 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.653 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -62.91 -45.12 94.02 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.522 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 54' ' ' PRO . 32.0 mm-40 -57.3 -43.52 83.3 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.182 -1.407 . . . . 0.0 110.975 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -60.98 -51.59 68.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.845 0.355 . . . . 0.0 111.89 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.537 HD12 HG22 ' A' ' 47' ' ' ILE . 87.2 mt -63.98 -45.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.736 -176.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.569 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 54.9 t-20 -58.8 -39.38 80.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -86.74 -31.1 21.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.831 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.17 -34.67 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -103.6 6.82 37.46 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.892 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.4 pttt -61.32 -23.7 65.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 110.835 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.46 -33.58 71.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.536 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -80.15 140.81 36.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.334 0.588 . . . . 0.0 112.38 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -86.9 -43.53 12.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.606 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.518 HD22 HD11 ' A' ' 38' ' ' LEU . 15.9 p-10 -82.14 -0.77 46.37 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.949 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -106.37 121.25 58.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.2 t -123.28 130.68 74.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.248 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.38 131.59 45.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.461 HG13 ' HA ' ' A' ' 48' ' ' ALA . 40.6 pt -126.89 156.71 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.267 0.556 . . . . 0.0 110.573 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.08 134.22 55.03 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 8.9 t -158.42 -171.16 3.35 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.1 m -66.69 1.86 1.61 Allowed 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 126.696 1.999 . . . . 0.0 114.774 -174.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.37 -24.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.056 0 C-N-CA 125.877 1.703 . . . . 0.0 116.841 -174.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.0 tmtt? -53.31 -33.83 54.94 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.06 120.23 4.66 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -59.22 -50.55 73.57 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.08 -44.8 97.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.94 0.876 . . . . 0.0 109.823 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.96 -42.02 97.47 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.71 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.549 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 8.0 t0 -58.68 -50.94 72.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.17 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.6 mm? -58.78 -42.59 89.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.998 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.505 ' HA ' HG12 ' A' ' 88' ' ' ILE . 17.8 m-80 -59.98 -41.27 91.66 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 67.0 mm-40 -64.52 -44.84 89.6 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.271 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.3 m -63.47 -44.75 93.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 160' ' ' LYS . 24.6 pt -65.06 -28.42 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 0.0 110.79 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.61 -37.77 94.75 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.455 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.56 -2.23 42.18 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -97.51 156.74 16.36 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.752 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -118.58 1.25 11.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.09 155.22 80.27 Favored Pre-proline 0 CA--C 1.502 -0.878 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -56.65 141.92 91.21 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.868 2.379 . . . . 0.0 110.509 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -141.83 158.4 43.84 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.372 0.606 . . . . 0.0 111.755 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 ' N ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -86.03 143.84 27.9 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.118 -175.025 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 75.6 t -120.32 130.73 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.935 0.894 . . . . 0.0 109.765 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 5' ' ' ILE . 18.7 m -131.34 159.64 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.514 0.674 . . . . 0.0 112.774 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.546 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 42.3 t -99.97 153.72 18.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.5 p -88.58 -0.19 57.0 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -173.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 24.7 p-10 -108.82 -3.59 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -174.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.546 ' CD2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER -87.98 115.28 25.34 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.181 177.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -96.27 8.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.72 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.535 ' CB ' HG21 ' A' ' 175' ' ' ILE . 21.9 t-20 -55.93 143.88 30.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.126 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.61 80.0 0.42 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.169 0.985 . . . . 0.0 109.257 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 110' ' ' ILE . 14.0 ptpt -74.38 -1.08 19.38 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.574 -1.648 . . . . 0.0 113.724 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.7 t -57.31 -45.34 84.31 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -76.95 -26.33 53.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.588 0.708 . . . . 0.0 109.841 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 113' ' ' ILE . 37.6 mm -69.73 -43.0 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.646 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.414 ' HA ' HD13 ' A' ' 154' ' ' ILE . 63.5 mt -58.62 -48.54 85.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.381 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -64.6 -41.23 96.37 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.252 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -62.9 -39.38 94.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.086 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.754 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.5 mm -61.01 -47.87 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.99 -47.57 92.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.433 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -61.91 -43.7 98.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.081 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.457 ' CE2' HD11 ' A' ' 120' ' ' ILE . 83.2 t80 -63.86 -49.02 74.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.9 0.381 . . . . 0.0 111.04 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.57 -47.8 84.14 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.89 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 31.8 m-85 -65.83 -31.4 72.33 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.028 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.93 -45.07 94.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.457 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.9 mt -63.22 -49.44 83.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.329 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 14.8 ptmt -63.64 -23.43 67.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.938 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.34 -41.86 97.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.53 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.11 -41.3 10.56 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 111.23 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 29.6 m -127.47 91.99 44.48 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.54 -12.0 32.35 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 122.595 2.197 . . . . 0.0 112.508 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 23.3 t70 -64.86 -28.84 69.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.123 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 124' ' ' THR . 7.7 p -54.13 130.06 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.19 0.519 . . . . 0.0 111.32 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.581 ' HB3' ' OE1' ' A' ' 164' ' ' GLN . 47.1 mt-10 -115.01 -12.52 11.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.057 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.2 163.34 40.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.939 0.4 . . . . 0.0 111.612 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 133.3 31.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.752 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -123.6 139.13 54.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.808 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 113' ' ' ILE . 58.4 t -118.22 122.67 70.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.115 0.484 . . . . 0.0 110.505 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -145.0 166.67 24.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.695 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 9.1 pt -124.39 158.53 61.11 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.645 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 32.3 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 C-N-CA 121.885 1.723 . . . . 0.0 112.119 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.351 0.596 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -61.09 142.03 95.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.595 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.91 -47.36 1.52 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.111 0.482 . . . . 0.0 111.29 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.33 -153.49 26.42 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.457 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 96' ' ' LEU . 20.2 pt -107.91 160.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.296 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.593 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.8 t-20 -109.9 151.83 26.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.864 -172.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.4 t -123.35 131.75 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 122.963 0.505 . . . . 0.0 110.097 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.45 HG11 ' OD1' ' A' ' 155' ' ' ASN . 23.5 m -131.83 150.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.186 0.517 . . . . 0.0 111.238 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.57 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 59.7 m -97.55 160.78 27.91 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.613 174.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.06 52.5 2.68 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.672 2.248 . . . . 0.0 111.963 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.63 ' O ' HD13 ' A' ' 88' ' ' ILE . 30.1 mmmt -112.61 109.41 18.93 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -61.99 146.37 50.29 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.281 0.363 . . . . 0.0 111.284 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.13 -146.05 19.49 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.58 141.59 36.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.917 0.389 . . . . 0.0 110.002 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.581 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 27.5 pt20 -133.84 160.8 36.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.82 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -59.37 118.69 6.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.019 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -120.9 126.28 49.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.134 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.52 164.14 13.11 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 121.773 0.797 . . . . 0.0 112.509 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 130.2 67.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 114.231 -1.349 . . . . 0.0 112.745 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.6 ttm -114.14 130.21 56.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.046 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.53 123.11 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.528 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 42.4 pt -112.45 173.22 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.768 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.96 1.72 9.86 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.605 0.717 . . . . 0.0 110.288 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.528 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.2 pm0 -98.73 134.18 42.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.049 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.77 149.61 21.06 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.561 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.535 HG21 ' CB ' ' A' ' 104' ' ' ASN . 1.9 pp -104.08 154.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.559 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.16 113.55 26.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 101' ' ' ASP . 97.6 m-20 -113.43 153.44 28.62 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.67 109.88 21.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . 0.429 ' HB2' ' OD2' ' A' ' 183' ' ' ASP . 45.1 m-80 -104.63 -34.63 8.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.492 0.663 . . . . 0.0 109.67 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -149.47 -178.5 6.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.54 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.417 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -62.58 -36.81 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.826 0.45 . . . . 0.0 111.973 -177.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 29.9 m-20 -60.37 -36.02 77.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 58.6 m-20 -61.69 -33.94 74.88 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.936 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 97.7 mt -61.29 -42.36 98.52 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.457 ' HA ' ' CG ' ' A' ' 188' ' ' GLU . 87.5 tttt -61.85 -41.85 98.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.831 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.08 -47.87 84.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.201 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.91 -46.19 91.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.914 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 9.0 pt-20 -68.9 -31.01 69.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.99 0.424 . . . . 0.0 110.998 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.9 ttm -61.58 -46.07 91.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.298 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.89 -30.64 64.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.335 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.508 0.671 . . . . 0.0 109.624 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 192' ' ' LYS . 7.8 tmtm? . . . . . 0 C--N 1.318 -0.776 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.104 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' HG21 ' A' ' 114' ' ' VAL . 8.8 ptm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.483 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 45.3 m-20 -104.83 165.71 10.88 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.614 0.245 . . . . 0.0 110.801 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.46 134.45 55.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.896 0.379 . . . . 0.0 111.181 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.37 126.25 51.9 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.603 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.568 ' HA ' HG22 ' A' ' 98' ' ' VAL . 70.4 mt -117.55 102.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.421 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 10.2 ptm -92.34 99.06 11.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.964 1.364 . . . . 0.0 111.3 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.87 96.7 5.84 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.895 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.799 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.164 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.519 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 60.3 Cg_endo . . . . . 0 CA--C 1.532 0.385 0 N-CA-C 113.583 0.57 . . . . 0.0 113.583 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.522 HD11 ' HA ' ' A' ' 56' ' ' THR . 35.8 mt -82.22 16.85 1.83 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.29 121.18 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -81.07 125.56 30.35 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.041 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.3 tp -144.92 117.18 8.43 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.283 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' HH ' ' A' ' 32' ' ' TYR . 85.4 m 54.17 39.66 30.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.19 -27.12 10.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.339 0.895 . . . . 0.0 115.339 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.717 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 25.8 ptt180 -146.18 171.8 14.39 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.835 1.318 . . . . 0.0 111.941 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.3 m -82.36 153.57 25.69 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.021 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.51 -38.9 64.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.092 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 14.0 tt -62.85 -39.67 85.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.68 -39.55 94.3 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.717 ' CE2' ' HG3' ' A' ' 27' ' ' ARG . 27.5 m-85 -61.08 -35.41 76.92 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.493 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.5 t -71.3 -45.89 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.799 0.333 . . . . 0.0 111.41 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.88 -42.55 96.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.534 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -51.36 -55.43 28.97 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.86 -37.05 16.53 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.314 1.343 . . . . 0.0 112.584 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD12 HG11 ' A' ' 98' ' ' VAL . 78.9 mt -65.49 -42.18 92.44 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.36 -45.03 93.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.987 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -79.04 -7.84 58.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.415 ' CB ' HG22 ' A' ' 110' ' ' ILE . 60.2 p -74.96 179.7 4.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.32 -22.7 61.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.615 0.766 . . . . 0.0 112.934 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.0 160.75 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.5 t30 -83.09 -73.24 0.41 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.578 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.69 156.71 26.65 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.037 0.446 . . . . 0.0 110.645 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.86 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -106.79 117.9 35.26 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.509 HG22 HD11 ' A' ' 60' ' ' ILE . 88.6 mt -100.05 118.92 47.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.609 0.718 . . . . 0.0 110.524 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.492 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.22 121.98 31.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.399 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.0 p -129.83 166.76 19.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.738 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -130.92 158.12 75.97 Favored Pre-proline 0 C--N 1.298 -1.634 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.884 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.17 -21.06 72.26 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.633 2.222 . . . . 0.0 110.902 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -70.45 -23.17 62.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.817 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -138.17 68.36 48.16 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.627 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 69.9 Cg_endo -99.35 84.08 0.05 OUTLIER 'Trans proline' 1 N--CA 1.392 -4.492 0 C-N-CA 116.659 -1.761 . . . . 0.0 108.688 169.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.629 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.7 mttt -146.1 -52.18 0.24 Allowed 'General case' 1 C--N 1.222 -4.945 0 CA-C-N 109.568 -3.469 . . . . 0.0 102.799 -177.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.522 ' HA ' HD11 ' A' ' 21' ' ' LEU . 96.0 m -63.71 -47.37 81.42 Favored 'General case' 0 N--CA 1.385 -3.708 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.493 164.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -62.39 -49.36 75.82 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.148 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 4.8 pt-20 -58.09 -36.58 73.07 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 117.564 -1.654 . . . . 0.0 111.526 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -63.68 -51.22 66.06 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.986 0.422 . . . . 0.0 111.63 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 47' ' ' ILE . 89.6 mt -61.85 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.192 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.717 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 54.6 t-20 -57.85 -45.3 86.47 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.694 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -73.49 -44.92 56.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.396 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.22 90.26 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.327 0.584 . . . . 0.0 111.349 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.455 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 68.2 m-85 -109.94 33.56 4.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.253 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 2.7 mmpt? -60.75 -25.49 66.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -90.95 11.53 22.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 55.0 p90 -43.71 133.96 4.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.02 -48.97 3.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -118.92 10.11 12.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.013 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 86.4 mt -100.66 122.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.606 0.717 . . . . 0.0 111.312 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.78 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.802 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.06 131.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.3 pt -125.78 155.81 35.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.65 131.3 56.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.196 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.45 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 11.7 t -160.12 -167.94 2.07 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 51.6 m -64.03 1.96 0.61 Allowed 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 127.126 2.17 . . . . 0.0 114.556 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.03 -18.76 0.0 OUTLIER Glycine 0 N--CA 1.514 3.851 0 C-N-CA 126.484 1.993 . . . . 0.0 117.265 -175.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -58.23 -38.24 76.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -112.33 129.76 9.21 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -61.34 -51.25 69.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -74.14 -30.32 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.746 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.07 -43.13 88.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.493 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.8 t0 -61.52 -50.83 71.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.947 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 88' ' ' ILE . 1.7 mm? -55.69 -47.83 76.12 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.925 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.493 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.0 m-80 -60.14 -42.86 95.77 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' HG1' ' A' ' 75' ' ' THR . 44.7 mm-40 -65.56 -44.42 86.83 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.362 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.91 -42.0 97.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.225 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 85' ' ' ASN . 22.3 pt -68.56 -23.67 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.374 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.02 -14.09 80.54 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.456 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -98.93 -0.52 42.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.514 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 99.3 m-85 -126.5 150.08 48.97 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.658 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -109.9 3.48 20.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.599 0.714 . . . . 0.0 109.626 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -128.92 153.34 80.1 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.498 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.92 148.75 76.95 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.679 2.253 . . . . 0.0 112.058 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -144.24 163.17 34.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.26 0.553 . . . . 0.0 111.79 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 154' ' ' ILE . 1.2 tm? -85.63 140.92 30.17 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.735 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 79.6 t -117.29 133.41 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.174 0.99 . . . . 0.0 108.824 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 5' ' ' ILE . 14.1 m -128.39 162.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.88 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.449 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 t -98.6 142.58 30.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.3 p -70.95 -13.26 61.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -110.84 12.32 22.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 70.4 mt -77.21 113.2 14.71 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.205 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 tt -129.49 122.04 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.719 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 63.4 t30 162.02 178.93 0.01 OUTLIER 'General case' 0 C--O 1.248 0.985 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.4 103.51 4.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HA ' HD11 ' A' ' 109' ' ' ILE . 37.6 mtmm -99.79 -1.11 38.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.404 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -56.64 -41.11 76.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -169.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -85.07 -25.83 27.35 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.984 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.513 ' O ' HG12 ' A' ' 113' ' ' ILE . 84.4 mt -65.62 -42.75 93.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.536 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.462 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . 58.5 mt -59.71 -49.54 83.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.066 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.21 -38.85 92.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -62.64 -42.39 99.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.55 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.0 mm -63.96 -48.31 86.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.097 0.475 . . . . 0.0 110.793 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.589 HG21 ' SD ' ' A' ' 1' ' ' MET . 79.2 t -60.75 -48.0 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.534 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -61.85 -47.5 84.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.301 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.512 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.7 t80 -64.42 -45.07 89.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 77.1 t80 -58.33 -48.62 79.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.229 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.428 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 20.0 m-85 -60.68 -37.05 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.437 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.65 -44.72 96.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.279 0.561 . . . . 0.0 109.55 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.558 ' CG2' HG23 ' A' ' 127' ' ' VAL . 74.8 mt -62.99 -43.5 99.11 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.801 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -60.1 -42.59 95.0 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.615 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.53 96.01 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.457 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -83.03 -36.85 24.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 0.0 111.797 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.7 m -133.66 89.36 31.07 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.28 -15.51 35.35 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.95 -31.96 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.206 0.603 . . . . 0.0 111.533 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.56 HG22 ' HE2' ' A' ' 165' ' ' LYS . 87.9 t -69.45 126.51 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -120.62 5.37 10.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.585 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.37 24.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.687 0.28 . . . . 0.0 111.205 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.515 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -137.46 129.5 29.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.05 142.08 51.02 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 169' ' ' MET . 18.9 m -121.24 144.75 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.439 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.452 ' C ' ' HB3' ' A' ' 152' ' ' ALA . 63.3 mtm -134.99 153.84 51.94 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 171' ' ' ILE . 9.3 pt -131.84 145.53 57.87 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.026 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 C--O 1.235 0.372 0 C-N-CA 122.425 2.083 . . . . 0.0 113.12 -178.018 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.681 0.277 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.45 146.76 56.82 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.264 1.976 . . . . 0.0 111.715 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.452 ' HB3' ' C ' ' A' ' 133' ' ' MET . . . -88.95 -10.22 48.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.782 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 161.48 -99.0 0.17 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.748 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.487 ' CG1' HG13 ' A' ' 113' ' ' ILE . 30.6 pt -118.79 161.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.237 0.541 . . . . 0.0 112.23 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.3 t-20 -119.54 156.59 30.0 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.476 -176.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 117' ' ' PHE . 94.0 t -124.84 133.54 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 122.334 0.253 . . . . 0.0 110.609 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.428 HG11 ' OD1' ' A' ' 155' ' ' ASN . 32.3 m -131.12 150.33 34.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.367 0.603 . . . . 0.0 111.988 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -98.92 159.13 31.03 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.095 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 17.3 Cg_exo -68.15 91.28 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.362 2.041 . . . . 0.0 112.037 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -125.19 -165.85 1.46 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.073 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.74 147.4 39.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.73 -116.82 5.84 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.261 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -129.87 145.27 51.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -134.36 163.89 28.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.56 ' HE2' HG22 ' A' ' 127' ' ' VAL . 1.6 tmtp? -61.03 128.01 34.34 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.09 139.28 52.6 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.095 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.68 160.78 14.83 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 121.727 0.775 . . . . 0.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.83 129.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 14.7 tmm? -137.27 136.04 37.7 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.15 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.7 129.93 63.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.062 0.458 . . . . 0.0 110.769 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.504 ' O ' HG22 ' A' ' 134' ' ' ILE . 49.4 pt -120.52 176.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.426 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.55 69.54 1.31 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.664 0.745 . . . . 0.0 109.128 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.456 ' HG3' HG12 ' A' ' 109' ' ' ILE . 77.5 mm-40 -128.59 143.59 50.99 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.205 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.95 140.63 31.2 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.985 0.898 . . . . 0.0 113.082 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.9 pt -139.55 151.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.435 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 103' ' ' ILE . 93.0 m-85 -120.55 107.93 13.44 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.176 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.448 ' OD1' HD22 ' A' ' 102' ' ' LEU . 98.0 m-20 -93.96 110.8 22.46 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 183' ' ' ASP . 98.2 mt -81.32 114.44 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.354 0.597 . . . . 0.0 111.337 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -113.75 -20.97 10.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.1 p -131.59 164.9 24.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.269 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.66 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -60.87 -27.63 68.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.104 176.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -68.58 -39.24 81.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.44 0.638 . . . . 0.0 109.95 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.496 ' HB2' HG21 ' A' ' 178' ' ' ILE . 71.9 m-20 -61.52 -33.57 74.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.514 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.438 HD23 HD13 ' A' ' 178' ' ' ILE . 96.1 mt -59.95 -44.77 94.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.224 0.535 . . . . 0.0 109.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 7.8 tmtm? -67.5 -42.46 82.84 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.759 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tt -62.09 -46.93 86.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.944 0.402 . . . . 0.0 110.102 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.5 -41.24 98.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.757 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.9 pp20? -68.02 -30.91 70.26 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.651 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.1 mmm -61.51 -43.8 98.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.4 pp -74.85 -39.74 61.41 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.127 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.3 -40.59 96.24 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.44 0.638 . . . . 0.0 110.275 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 C--N 1.302 -1.458 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.575 179.553 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.651 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.1 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -113.53 165.11 12.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.433 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HB2' HG22 ' A' ' 42' ' ' VAL . . . -117.29 142.69 46.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 30.2 tp -120.35 127.51 52.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.275 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.551 ' HA ' HG23 ' A' ' 98' ' ' VAL . 64.5 mt -117.69 108.27 24.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.016 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.594 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 60.4 ttm -82.31 92.71 7.01 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-O 121.84 0.829 . . . . 0.0 111.545 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.62 97.53 5.91 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.406 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.058 0 C-N-CA 119.968 -1.11 . . . . 0.0 113.129 177.85 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 24.4 Cg_exo . . . . . 0 N--CA 1.48 0.73 0 CA-C-O 120.998 0.333 . . . . 0.0 112.263 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.488 HD22 ' CB ' ' A' ' 59' ' ' TYR . 8.8 mp -77.23 26.87 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.6 119.44 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.81 136.65 32.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-O 122.011 0.91 . . . . 0.0 113.048 -174.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 184' ' ' LEU . 80.2 mt -136.83 124.69 22.62 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.291 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 191' ' ' LEU . 74.3 m 53.95 30.54 11.83 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.39 20.54 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.913 -1.136 . . . . 0.0 115.794 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 34.7 ptt180 -146.22 166.35 26.47 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.085 1.443 . . . . 0.0 112.434 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.3 m -73.29 156.58 38.31 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.222 -176.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 20' ' ' PRO . 5.1 tt -57.53 -44.69 85.31 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 124.395 1.078 . . . . 0.0 110.475 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -60.2 -39.94 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.434 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 13.8 t70 -63.95 -41.69 97.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.249 0.547 . . . . 0.0 109.569 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 27' ' ' ARG . 5.7 m-85 -61.06 -36.57 79.93 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.158 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 29' ' ' LEU . 69.1 t -66.87 -42.99 89.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 0.0 110.811 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.85 -45.02 99.91 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.576 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -50.91 -53.61 45.85 Favored Pre-proline 0 CA--C 1.57 1.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.94 -39.42 32.83 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.518 1.479 . . . . 0.0 112.387 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD13 HG12 ' A' ' 98' ' ' VAL . 83.3 mt -67.13 -39.68 86.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.609 0.719 . . . . 0.0 110.018 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.2 tp -59.31 -45.67 90.68 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.515 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -84.99 -8.71 58.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.507 ' OG ' HG13 ' A' ' 42' ' ' VAL . 77.9 p -74.58 174.74 8.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.213 0.53 . . . . 0.0 111.668 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -60.32 -18.51 50.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.056 0.942 . . . . 0.0 112.603 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.507 HG13 ' OG ' ' A' ' 40' ' ' SER . 11.4 p -63.64 150.76 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 120.909 0.385 . . . . 0.0 111.999 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -76.7 -75.91 0.18 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -110.43 152.13 26.67 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.057 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.47 110.99 33.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -104.16 117.86 35.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.505 HG23 HD12 ' A' ' 60' ' ' ILE . 95.6 mt -97.88 119.19 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.602 0.715 . . . . 0.0 110.568 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 4' ' ' LEU . . . -89.37 122.13 32.3 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.811 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 7' ' ' ALA . 41.9 p -126.59 155.0 43.17 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.494 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 50.1 m -98.79 145.1 29.35 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.871 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 75' ' ' THR . 51.8 Cg_exo -59.27 -28.78 88.58 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.197 2.598 . . . . 0.0 111.348 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 -6.89 58.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.963 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 7.7 p -134.63 66.47 69.59 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.414 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 83.0 Cg_endo -103.73 85.62 0.03 OUTLIER 'Trans proline' 1 N--CA 1.377 -5.332 0 C-N-CA 116.764 -1.691 . . . . 0.0 109.246 169.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.584 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 34.4 mmtp -145.45 -52.04 0.26 Allowed 'General case' 1 C--N 1.214 -5.318 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 99.0 m -63.48 -48.39 77.86 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 111.958 -2.383 . . . . 0.0 106.363 165.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.657 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -63.1 -48.18 79.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.913 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.584 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.8 pt-20 -58.64 -34.97 71.79 Favored 'General case' 0 C--N 1.365 1.266 0 C-N-CA 117.481 -1.687 . . . . 0.0 110.335 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CB ' HD22 ' A' ' 21' ' ' LEU . 48.8 t80 -67.57 -52.25 40.9 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 120.86 0.362 . . . . 0.0 111.828 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 47' ' ' ILE . 96.8 mt -63.62 -46.54 94.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.837 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.1 t30 -58.92 -44.0 91.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.5 t -69.72 -44.62 69.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.18 90.14 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.305 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.424 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 78.7 m-85 -105.83 25.69 10.55 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.194 -176.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 9.9 mmmm -62.22 -21.39 65.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.857 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.26 10.57 21.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.374 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.3 p90 -44.18 138.04 3.18 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -176.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.585 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -101.62 -52.55 3.18 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.913 0.863 . . . . 0.0 109.361 172.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -121.45 12.67 10.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.163 -1.381 . . . . 0.0 111.467 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.404 ' HB ' ' CB ' ' A' ' 67' ' ' TYR . 82.6 mt -99.1 128.44 50.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.291 0.567 . . . . 0.0 111.053 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 67.3 t -128.04 132.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.18 132.15 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 4' ' ' LEU . 40.1 pt -126.96 156.89 38.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.624 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.46 ' OD1' ' HG3' ' A' ' 51' ' ' PRO . 10.5 t70 -114.74 131.96 56.6 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.201 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 12.9 t -161.95 -171.87 3.04 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.95 0.881 . . . . 0.0 113.218 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.1 m -74.18 3.58 6.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.602 1.961 . . . . 0.0 114.605 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.94 -21.82 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 C-N-CA 126.638 2.066 . . . . 0.0 117.605 -173.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 76' ' ' SER . 58.4 tptt -58.53 -37.88 76.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.88 123.11 6.26 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.438 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.8 t80 -59.45 -50.4 74.07 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.14 -47.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 55.1 mt-10 -59.83 -44.94 93.8 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.798 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.594 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 5.5 t0 -59.29 -51.39 70.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.437 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.581 ' O ' HG21 ' A' ' 88' ' ' ILE . 4.2 mm? -59.98 -41.74 92.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.962 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.414 ' HA ' HG12 ' A' ' 88' ' ' ILE . 9.2 m120 -60.42 -43.19 97.0 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 72.4 mm-40 -65.72 -44.42 86.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.57 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.8 m -62.31 -43.16 99.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.114 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 84' ' ' LEU . 33.9 pt -66.08 -24.64 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.28 77.47 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.411 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -104.75 -21.47 13.36 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 82.2 m-85 -89.1 140.92 28.96 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.986 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -104.42 -6.32 20.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.417 0.627 . . . . 0.0 109.817 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -132.24 152.49 80.22 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.443 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.94 142.03 54.27 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 123.515 2.81 . . . . 0.0 112.223 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -139.64 154.12 47.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.503 0.668 . . . . 0.0 111.595 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.499 HD12 HD12 ' A' ' 154' ' ' ILE . 2.1 tm? -87.05 132.81 33.7 Favored 'General case' 0 C--O 1.193 -1.889 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.726 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 68.4 t -108.37 127.87 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.225 0.61 . . . . 0.0 109.559 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 5' ' ' ILE . 8.4 m -126.53 156.62 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.759 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.459 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 67.7 m -101.03 132.92 46.23 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 170.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.43 ' O ' HD23 ' A' ' 29' ' ' LEU . 69.3 m -67.46 -37.39 82.87 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.499 0.666 . . . . 0.0 111.532 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.37 -0.85 34.42 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.533 ' O ' HD11 ' A' ' 102' ' ' LEU . 1.4 pp -91.63 116.26 28.73 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.15 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.4 mt -103.1 119.6 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.036 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.403 HD22 ' HB2' ' A' ' 173' ' ' GLU . 64.9 t30 178.38 163.5 0.71 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.145 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.54 98.6 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.507 ' HA ' HD13 ' A' ' 109' ' ' ILE . 15.6 ptpt -97.8 -2.28 41.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.908 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.483 ' HA ' HD11 ' A' ' 110' ' ' ILE . 77.9 p -60.26 -38.94 85.03 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.61 -27.17 37.4 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.432 1.111 . . . . 0.0 109.36 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.71 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -70.08 -39.52 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.759 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 107' ' ' SER . 65.3 mt -56.92 -49.21 79.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.944 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -65.07 -40.86 95.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.195 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.7 m -63.32 -40.67 97.97 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.548 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.71 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.26 -48.33 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.209 0.528 . . . . 0.0 110.674 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.651 HG22 ' SD ' ' A' ' 1' ' ' MET . 69.4 t -61.43 -48.21 89.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.93 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.67 -43.79 97.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.966 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.726 ' CE2' HD12 ' A' ' 120' ' ' ILE . 73.1 t80 -63.83 -46.58 84.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -58.11 -48.19 80.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.891 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 30.0 m-85 -62.03 -36.19 80.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.299 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.9 t -61.53 -46.66 88.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.997 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.726 HD12 ' CE2' ' A' ' 116' ' ' TYR . 67.3 mt -66.03 -47.06 86.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.854 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -64.03 -25.09 67.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.997 -178.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.55 99.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.788 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -83.91 -39.05 20.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.038 0.447 . . . . 0.0 110.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.61 ' O ' HG11 ' A' ' 127' ' ' VAL . 90.2 m -132.65 92.51 26.89 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.31 -19.04 48.59 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.263 2.642 . . . . 0.0 113.069 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 39.0 t70 -62.01 -32.31 72.78 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 124' ' ' THR . 10.7 p -70.61 118.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.596 0.712 . . . . 0.0 109.829 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.3 mt-10 -122.43 13.11 10.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.402 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.3 155.01 37.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 133.25 27.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -122.79 139.61 53.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.373 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 113' ' ' ILE . 95.8 t -121.18 123.39 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.54 0.686 . . . . 0.0 111.179 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 3.1 ptm -145.48 162.5 37.22 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.551 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.6 pt -123.15 158.07 59.05 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.455 -0.752 0 C-N-CA 121.816 1.677 . . . . 0.0 110.675 177.135 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.426 ' O ' HG21 ' A' ' 150' ' ' VAL . 29.6 m . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.36 139.02 87.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.504 2.136 . . . . 0.0 110.676 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 175' ' ' ILE . . . -132.62 -36.84 1.07 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.264 0.554 . . . . 0.0 111.337 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.81 -149.55 25.8 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.521 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.605 ' CG1' HG13 ' A' ' 113' ' ' ILE . 17.2 pt -119.44 161.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.045 -0.577 . . . . 0.0 110.46 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.537 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.6 t-20 -110.27 152.12 26.53 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.475 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.87 131.6 72.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.321 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.485 HG11 ' OD1' ' A' ' 155' ' ' ASN . 28.7 m -134.45 149.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.399 0.619 . . . . 0.0 111.243 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.5 m -98.51 153.63 37.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 14.8 Cg_exo -69.79 89.81 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.951 1.768 . . . . 0.0 110.99 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -116.72 -160.14 0.75 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -136.97 149.47 47.56 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 62.93 -124.17 31.96 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.657 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.02 149.22 50.46 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -131.62 163.99 26.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.008 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -57.77 128.5 37.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.027 0.441 . . . . 0.0 111.873 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -125.53 129.4 49.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.67 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -94.56 161.96 14.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.593 0.711 . . . . 0.0 112.212 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.8 mm -115.69 130.84 69.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.303 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -131.17 138.75 49.58 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.681 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 133' ' ' MET . 76.0 t -108.12 129.64 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.79 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.528 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 36.7 pt -101.3 174.51 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.986 0.422 . . . . 0.0 111.321 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -99.77 -21.18 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.588 ' HG3' HD11 ' A' ' 109' ' ' ILE . 1.6 pm0 -99.08 138.32 36.36 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.811 0.815 . . . . 0.0 112.568 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.02 151.92 18.76 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.458 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 152' ' ' ALA . 23.6 pt -107.41 155.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -102.98 106.91 17.54 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.112 0.482 . . . . 0.0 110.824 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.85 121.47 37.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.19 85.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.339 0.59 . . . . 0.0 112.396 -173.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -70.65 -38.8 73.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.323 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 81.0 p -129.57 162.92 27.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.104 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.475 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.522 178.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.45 -36.29 79.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.108 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.43 -40.38 96.36 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.47 ' CD1' HD22 ' A' ' 24' ' ' LEU . 51.6 tp -62.64 -42.71 99.75 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.059 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.8 ttmt -61.0 -42.54 98.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.67 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.93 -43.21 99.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.01 99.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.022 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.7 pt-20 -71.05 -36.02 72.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.887 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 35.2 mmt -64.4 -39.99 94.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.28 -47.47 84.19 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.403 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.443 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 mt -63.9 -43.2 96.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.902 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.044 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.9 ttp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 61.8 m-20 -98.88 166.97 11.04 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.934 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.446 ' HB1' HG22 ' A' ' 42' ' ' VAL . . . -114.34 130.98 56.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.486 ' O ' HG21 ' A' ' 98' ' ' VAL . 38.4 tp -106.69 125.46 51.04 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.521 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.571 ' HA ' HG21 ' A' ' 98' ' ' VAL . 60.4 mt -116.65 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.509 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 12.7 ptm -95.92 92.11 6.34 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.941 1.353 . . . . 0.0 112.908 -173.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.574 ' CB ' HD11 ' A' ' 30' ' ' ILE . . . -116.82 97.79 6.16 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.936 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.149 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.797 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.476 0.452 0 N-CA-C 113.052 0.366 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 69.1 mt -88.83 11.34 18.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mt -69.87 115.73 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -82.11 140.88 33.56 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.663 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.8 tp -130.97 107.59 9.21 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.698 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m 58.25 20.94 7.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.218 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 -80.87 0.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.926 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.5 mtt180 -93.7 172.2 8.4 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.422 0.629 . . . . 0.0 112.107 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.1 m -79.25 162.75 25.47 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.37 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.5 mt -59.08 -45.52 90.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.218 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.574 HD11 ' CB ' ' A' ' 7' ' ' ALA . 11.8 tt -65.49 -37.91 81.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.168 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.531 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 6.9 t0 -60.59 -43.13 97.73 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-O 121.636 0.731 . . . . 0.0 109.075 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -65.86 -36.53 83.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.595 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 29' ' ' LEU . 58.6 t -66.11 -43.29 92.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 30' ' ' ILE . 73.8 t -63.49 -45.35 98.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.075 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -49.75 -52.59 49.94 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.06 -36.51 29.45 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.412 1.408 . . . . 0.0 112.44 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 98' ' ' VAL . 83.7 mt -68.48 -37.57 80.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.576 0.703 . . . . 0.0 110.553 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.1 tp -59.11 -43.93 91.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.38 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -89.3 -7.19 55.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.523 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.514 ' OG ' HG13 ' A' ' 42' ' ' VAL . 83.3 p -72.52 172.0 11.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.206 0.527 . . . . 0.0 111.605 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.82 5.08 2.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.783 -175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.514 HG13 ' OG ' ' A' ' 40' ' ' SER . 11.2 p -77.96 152.53 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.821 -0.549 . . . . 0.0 111.2 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.6 t30 -69.23 -77.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.32 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -117.69 156.46 28.18 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 111.021 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.3 114.61 47.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.86 119.79 40.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.506 HG23 HD13 ' A' ' 60' ' ' ILE . 95.9 mt -99.91 119.66 48.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.565 0.698 . . . . 0.0 110.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 6' ' ' MET . . . -89.42 121.82 32.03 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.293 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.3 p -131.7 169.53 16.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.031 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.3 p -131.29 158.83 74.13 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.412 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.21 -19.24 68.14 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.576 2.184 . . . . 0.0 110.782 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -70.3 -25.39 63.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.595 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -135.76 66.65 63.38 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.628 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.8 Cg_endo -101.26 85.32 0.04 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.814 0 C-N-CA 116.869 -1.62 . . . . 0.0 109.087 169.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.644 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 32.1 mmtm -155.29 -46.82 0.08 Allowed 'General case' 1 C--N 1.209 -5.511 0 CA-C-N 109.182 -3.644 . . . . 0.0 102.462 -179.072 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD22 ' A' ' 21' ' ' LEU . 97.8 m -64.05 -49.07 73.79 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 163.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.628 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -62.85 -50.36 71.24 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.1 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.644 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.6 pt-20 -64.35 -30.05 71.11 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 116.722 -1.991 . . . . 0.0 112.759 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.07 -50.94 66.38 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.327 0.584 . . . . 0.0 111.208 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.506 HD13 HG23 ' A' ' 47' ' ' ILE . 93.3 mt -63.13 -45.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.426 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -57.87 -44.04 86.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.576 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.501 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 27.7 t -69.64 -40.89 76.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.804 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.51 93.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.958 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.534 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 57.0 m-85 -116.41 42.31 2.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 62' ' ' SER . 56.4 mtmt -58.93 -35.46 73.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.218 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -88.47 12.37 14.54 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.15 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.534 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 53.6 p90 -39.64 131.87 1.7 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 -48.22 4.26 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -116.82 13.17 14.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.147 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -104.99 124.46 59.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.267 0.556 . . . . 0.0 110.426 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.29 133.51 68.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -103.57 130.68 53.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.276 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.1 pt -128.48 157.1 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.749 0.785 . . . . 0.0 111.347 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -107.82 136.52 47.41 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.703 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.647 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 7.8 t -159.96 -173.84 4.27 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -74.34 5.09 4.9 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 127.328 2.251 . . . . 0.0 114.19 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.21 -13.81 0.0 OUTLIER Glycine 1 N--CA 1.525 4.632 0 C-N-CA 127.184 2.326 . . . . 0.0 117.646 -174.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -57.39 -39.56 76.34 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.518 ' HA3' ' OE1' ' A' ' 82' ' ' GLU . . . -116.32 132.8 10.38 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.408 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.4 t80 -61.29 -52.81 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.6 -39.81 76.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 121.755 0.788 . . . . 0.0 110.071 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.518 ' OE1' ' HA3' ' A' ' 79' ' ' GLY . 48.7 mt-10 -57.93 -43.49 86.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.548 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.53 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.5 t0 -60.59 -49.89 75.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.671 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 mm? -57.14 -40.44 77.16 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.772 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.441 ' HA ' HG12 ' A' ' 88' ' ' ILE . 11.3 m120 -60.05 -42.96 95.6 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.626 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 46.0 mm-40 -66.86 -43.38 83.76 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.15 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.1 m -62.18 -45.01 95.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.277 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.698 HD11 ' O ' ' A' ' 160' ' ' LYS . 30.3 pt -64.92 -27.44 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 120.789 0.328 . . . . 0.0 110.911 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.45 -22.1 69.22 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.87 7.25 19.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.521 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 76.9 m-85 -109.86 143.17 40.14 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.05 -0.406 . . . . 0.0 111.274 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.6 m -100.67 -11.63 19.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.337 0.589 . . . . 0.0 110.382 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 38.6 mt-10 -133.19 162.46 57.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.327 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 1' ' ' MET . 38.1 Cg_endo -64.65 156.73 59.53 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.872 . . . . 0.0 111.466 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 46.6 p90 -143.94 156.6 44.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.526 0.679 . . . . 0.0 111.663 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.462 HD11 HD13 ' A' ' 154' ' ' ILE . 1.6 tm? -86.33 135.45 33.52 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.616 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 63.6 t -110.85 130.21 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 123.5 0.72 . . . . 0.0 109.146 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.571 HG21 ' HA ' ' A' ' 5' ' ' ILE . 4.9 m -128.34 163.35 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.272 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.401 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 69.8 m -98.7 141.92 30.92 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -88.21 -3.41 58.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 177' ' ' ASN . 10.9 p-10 -108.95 3.98 22.83 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 75.0 mt -91.11 132.98 35.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.29 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -68.3 171.24 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.123 0.487 . . . . 0.0 111.717 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -81.72 78.53 8.44 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -122.42 -6.27 8.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.507 ' O ' HG13 ' A' ' 110' ' ' ILE . 23.4 pttp -84.41 0.16 50.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.85 -1.523 . . . . 0.0 113.83 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -53.86 -42.9 69.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -86.59 -26.8 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.071 0.939 . . . . 0.0 109.852 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.68 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -64.57 -37.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.405 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.6 mt -54.77 -49.18 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.584 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -67.55 -39.04 84.98 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.507 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.9 m -60.63 -42.22 96.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.68 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -63.54 -47.77 89.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.165 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.467 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.4 t -61.56 -48.76 87.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.328 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.39 -42.57 98.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.988 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.587 ' CE2' HD12 ' A' ' 120' ' ' ILE . 58.0 t80 -64.55 -47.33 79.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.734 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.402 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 72.3 t80 -59.04 -48.26 82.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.015 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 25.1 m-85 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.521 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 47.7 t -61.69 -47.08 86.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.108 0.48 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.587 HD12 ' CE2' ' A' ' 116' ' ' TYR . 68.4 mt -65.04 -48.83 82.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.886 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 124' ' ' THR . 19.8 ptmt -66.03 -26.6 67.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.95 97.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.598 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.57 -38.05 26.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.874 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 45.7 m -132.1 96.49 19.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.694 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.2 -14.14 42.07 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 122.772 2.315 . . . . 0.0 113.273 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 35.4 t70 -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 124' ' ' THR . 9.1 p -71.33 120.59 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.376 0.607 . . . . 0.0 110.069 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 41.4 mt-10 -127.64 19.2 6.75 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.782 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.27 150.15 29.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.485 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.81 130.75 30.14 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.7 54.93 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.715 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 152' ' ' ALA . 47.4 t -116.95 122.46 70.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 ptm -144.69 158.26 43.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.6 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 171' ' ' ILE . 6.6 pt -130.77 165.6 33.51 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.107 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 C--N 1.348 0.552 0 C-N-CA 122.536 2.157 . . . . 0.0 112.378 178.315 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.444 -0.736 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 139.6 89.08 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.75 2.3 . . . . 0.0 110.931 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB2' HG12 ' A' ' 132' ' ' VAL . . . -103.13 2.88 35.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 166.87 -100.66 0.17 Allowed Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 118.937 -1.602 . . . . 0.0 113.503 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.497 ' CG1' HG13 ' A' ' 113' ' ' ILE . 28.2 pt -124.77 161.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.75 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.509 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 7.7 t-20 -120.17 155.11 33.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.861 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.72 130.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 122.383 0.273 . . . . 0.0 110.612 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.508 HG12 ' OD1' ' A' ' 155' ' ' ASN . 27.9 m -136.68 152.0 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.41 0.624 . . . . 0.0 112.001 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.1 t -97.33 145.11 29.08 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.85 74.66 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.267 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.698 ' O ' HD11 ' A' ' 88' ' ' ILE . 75.8 mmtt -105.0 132.0 51.8 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.582 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -81.87 74.0 8.88 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.05 -146.25 13.71 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -118.74 144.19 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.048 0.424 . . . . 0.0 109.992 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -134.28 166.38 22.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.29 129.8 43.84 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -125.07 126.89 46.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.57 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -93.96 162.36 13.92 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 121.558 0.694 . . . . 0.0 111.582 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -117.31 129.57 73.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.977 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 49.8 ttm -116.16 131.53 56.92 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.623 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 133' ' ' MET . 7.4 p -119.68 128.21 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 134' ' ' ILE . 33.6 pt -119.95 172.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.541 -176.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -109.33 -2.33 17.91 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.427 ' CG ' HD12 ' A' ' 171' ' ' ILE . 4.1 pt-20 -97.99 131.13 44.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.666 0.746 . . . . 0.0 110.401 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.19 149.38 21.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.937 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.7 pp -123.84 154.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.218 171.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.85 137.38 52.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.537 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 9.3 p30 -110.39 127.73 55.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.08 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.532 HD12 ' OD2' ' A' ' 183' ' ' ASP . 16.9 mm -88.59 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.77 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.3 -0.37 56.71 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.313 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.8 t -148.11 151.39 35.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.655 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.594 ' HD2' ' H ' ' A' ' 181' ' ' LYS . 0.2 OUTLIER -62.09 -37.14 83.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.302 -177.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -61.56 -41.72 97.79 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.417 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.532 ' OD2' HD12 ' A' ' 178' ' ' ILE . 11.6 t70 -63.6 -36.05 82.54 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 178' ' ' ILE . 59.4 tp -58.52 -43.44 89.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 60.7 tttm -62.21 -43.72 98.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.718 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.7 tt -61.39 -45.05 95.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.04 98.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.013 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 12.5 pt-20 -66.34 -33.43 75.72 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -64.89 -40.25 94.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.643 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 88.2 mt -64.83 -43.19 93.86 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.362 0.601 . . . . 0.0 110.09 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.26 -40.76 97.27 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.584 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.518 178.679 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 19.3 m-20 -97.93 165.9 11.7 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.69 130.48 56.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.279 0.562 . . . . 0.0 111.533 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.0 122.15 45.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -117.98 116.23 50.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.238 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.481 ' CE ' HD21 ' A' ' 84' ' ' LEU . 38.3 mtt -89.05 96.57 10.78 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 122.32 1.057 . . . . 0.0 113.638 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 49' ' ' THR . . . -116.11 97.43 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.284 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.479 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.446 -178.813 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 114.523 0.932 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 39.6 mt -97.75 4.69 49.85 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.31 123.78 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.93 139.38 31.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.818 -177.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.55 108.16 12.82 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.299 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.9 m 54.5 26.24 7.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.135 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.91 -101.58 0.2 Allowed Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.668 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 75.3 mtt-85 -88.03 168.36 12.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.105 0.479 . . . . 0.0 111.969 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.9 m -79.5 163.81 24.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 33' ' ' VAL . 67.1 mt -57.89 -45.28 86.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -39.5 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.785 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.569 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 18.8 t70 -65.74 -39.58 91.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 110.038 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -63.69 -34.62 78.26 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.605 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 29' ' ' LEU . 75.8 t -66.4 -45.36 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.3 -41.04 88.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.592 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -50.88 -54.52 36.07 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' SER . 56.5 Cg_endo -71.36 -36.47 6.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.585 1.523 . . . . 0.0 112.249 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.97 -41.8 95.12 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -59.95 -46.32 89.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -82.03 -9.07 59.67 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 59.3 p -74.28 -177.94 3.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.539 0.685 . . . . 0.0 112.202 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.8 ttmm -56.26 -26.32 51.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.253 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.69 161.91 2.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.677 0.751 . . . . 0.0 112.989 -174.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.498 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -81.07 -78.42 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.99 161.95 18.97 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.027 0.441 . . . . 0.0 111.128 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.34 116.53 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.488 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 89.9 m-85 -109.72 114.81 28.71 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 60' ' ' ILE . 94.3 mt -97.24 117.82 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.569 0.7 . . . . 0.0 110.66 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.503 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.85 119.29 28.04 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.381 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.521 HG21 ' O ' ' A' ' 7' ' ' ALA . 69.8 p -121.42 155.92 33.82 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.565 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 35.8 m -105.45 145.66 31.24 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.733 -177.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.96 -29.83 87.86 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.449 2.766 . . . . 0.0 112.01 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.16 -2.84 56.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 2.1 p -139.03 67.07 40.47 Favored Pre-proline 0 CA--C 1.498 -1.049 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.968 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.64 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.4 Cg_endo -106.99 86.59 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.11 0 C-N-CA 117.115 -1.456 . . . . 0.0 110.486 169.206 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 29.5 mtmm -144.06 -48.1 0.28 Allowed 'General case' 1 C--N 1.219 -5.081 0 CA-C-N 109.973 -3.285 . . . . 0.0 103.424 177.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.7 m -61.8 -48.9 78.53 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 112.549 -2.114 . . . . 0.0 106.054 164.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.13 -49.66 75.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.963 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.2 pt-20 -59.78 -34.52 73.11 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.698 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.14 -50.8 66.76 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.103 0.477 . . . . 0.0 111.088 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 47' ' ' ILE . 97.3 mt -64.0 -41.59 92.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.884 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.412 ' ND2' ' HG2' ' A' ' 57' ' ' LYS . 87.9 m-20 -57.74 -40.99 80.94 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.264 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.472 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 4.5 t -82.04 -39.12 23.96 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.895 0.378 . . . . 0.0 110.575 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.09 93.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.363 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 81.0 m-85 -110.19 34.59 3.81 Favored 'General case' 0 C--O 1.206 -1.191 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.757 -176.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 10.9 mmmm -61.51 -25.04 67.02 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.09 0.471 . . . . 0.0 111.035 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -89.38 11.08 20.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.299 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 53.8 p90 -43.32 127.4 4.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -103.0 -49.05 3.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.945 0.878 . . . . 0.0 109.661 172.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -117.97 11.87 13.54 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.935 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.96 125.21 57.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.27 0.557 . . . . 0.0 110.302 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 67.2 t -125.45 131.76 71.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.378 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.5 132.63 53.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.138 0.494 . . . . 0.0 109.67 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.503 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.6 pt -125.98 152.16 32.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.288 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -119.83 130.49 54.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.452 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.579 ' HG1' ' CD ' ' A' ' 86' ' ' GLU . 11.6 t -165.26 -167.42 1.17 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 78' ' ' LYS . 73.7 m -59.42 0.59 0.11 Allowed 'General case' 0 C--O 1.198 -1.61 0 C-N-CA 127.383 2.273 . . . . 0.0 116.082 -173.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' N ' ' HB2' ' A' ' 83' ' ' ASP . . . -31.61 -22.36 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 C-N-CA 125.805 1.669 . . . . 0.0 116.972 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.2 tmmt? -56.84 -35.51 68.91 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.83 113.62 3.81 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -59.31 -49.08 79.19 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.96 -48.21 89.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.713 0.768 . . . . 0.0 110.4 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.53 -45.91 92.18 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.271 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.474 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 28.6 t0 -63.09 -50.03 72.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.385 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.481 HD21 ' CE ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -53.61 -47.39 70.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.237 0.542 . . . . 0.0 109.61 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.2 m-80 -61.98 -40.44 95.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.032 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' CD ' ' HG1' ' A' ' 75' ' ' THR . 26.9 tt0 -66.84 -42.99 84.87 Favored 'General case' 1 N--CA 1.374 -4.235 0 O-C-N 122.092 -0.38 . . . . 0.0 110.632 177.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 91.3 m -62.98 -42.07 99.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.774 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 85' ' ' ASN . 26.3 pt -67.01 -28.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.29 -38.24 96.14 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.976 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -84.0 -12.09 55.78 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 81.2 m-85 -96.06 145.26 25.61 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.887 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.7 p -105.67 -2.74 23.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.806 0.813 . . . . 0.0 109.208 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -128.82 157.1 76.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.032 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.37 148.61 74.04 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.357 2.038 . . . . 0.0 111.626 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.44 ' CZ ' HG23 ' A' ' 88' ' ' ILE . 40.7 p90 -143.28 159.33 42.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.279 0.561 . . . . 0.0 111.394 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 155' ' ' ASN . 30.7 tp -86.41 143.05 28.0 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 92.2 t -115.2 126.32 72.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.6 m -130.85 157.22 43.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.355 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . 33.8 t -100.23 150.93 22.04 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 171.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.51 ' HA ' HG22 ' A' ' 33' ' ' VAL . 68.3 m -88.39 1.33 54.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.403 ' OD1' HD11 ' A' ' 102' ' ' LEU . 40.5 p-10 -104.14 4.18 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.466 ' CD1' ' HB3' ' A' ' 99' ' ' SER . 7.2 mp -88.57 140.53 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.099 -0.376 . . . . 0.0 111.106 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.526 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 41.7 pt -64.36 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.555 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.439 ' C ' ' H ' ' A' ' 106' ' ' LYS . 31.8 p-10 -82.24 4.31 24.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.03 11.84 1.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.689 0.757 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 103' ' ' ILE . 57.9 mtmt -83.86 -1.4 54.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.278 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.6 t -57.31 -46.39 83.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -78.59 -23.8 45.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.716 0.77 . . . . 0.0 109.463 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.725 ' O ' HG12 ' A' ' 113' ' ' ILE . 39.2 mm -67.12 -41.52 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.117 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 106' ' ' LYS . 59.6 mt -58.28 -48.89 83.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.83 -177.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.411 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 59.5 m-80 -65.9 -39.85 90.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.1 m -61.76 -40.2 94.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.849 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -62.84 -47.54 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.474 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 72.6 t -61.85 -48.83 86.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.556 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -62.03 -43.46 98.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.463 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.499 ' CE2' HD11 ' A' ' 120' ' ' ILE . 68.8 t80 -64.84 -49.86 68.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.1 t80 -59.37 -48.63 80.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.278 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.474 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 36.4 m-85 -65.85 -30.7 71.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.334 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.26 -45.51 92.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.499 HD11 ' CE2' ' A' ' 116' ' ' TYR . 75.0 mt -64.63 -42.97 96.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.584 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.465 ' HD2' HG12 ' A' ' 127' ' ' VAL . 17.1 mmmt -59.93 -42.38 93.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.269 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.07 85.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.064 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.41 -34.07 15.78 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.098 0.475 . . . . 0.0 111.076 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 26.0 m -133.23 98.39 15.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 123.184 0.594 . . . . 0.0 109.717 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.93 -15.32 36.42 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.394 2.063 . . . . 0.0 112.327 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -63.28 -31.23 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.465 HG12 ' HD2' ' A' ' 121' ' ' LYS . 9.8 p -66.31 127.23 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.711 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -119.52 6.27 11.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.606 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.31 159.25 25.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.859 0.361 . . . . 0.0 111.622 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -138.33 135.03 35.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.24 137.66 54.49 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.722 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 113' ' ' ILE . 72.1 t -115.39 117.02 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 121.257 0.551 . . . . 0.0 109.666 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -146.48 159.07 43.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.2 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.492 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 18.1 pt -132.6 158.37 75.88 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.792 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 30.9 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 121.451 1.434 . . . . 0.0 111.722 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.133 0.492 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.06 142.99 48.02 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.331 2.021 . . . . 0.0 111.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.471 ' HB3' HG12 ' A' ' 134' ' ' ILE . . . -109.09 -13.03 14.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.732 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.28 -117.74 0.44 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.309 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.468 ' CG1' HG13 ' A' ' 113' ' ' ILE . 17.8 pt -122.98 160.93 25.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 122.656 0.382 . . . . 0.0 111.443 -175.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.7 t-20 -116.61 153.71 31.79 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.9 t -123.51 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.423 0.289 . . . . 0.0 110.378 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.424 HG11 ' OD1' ' A' ' 155' ' ' ASN . 28.4 m -130.79 149.79 33.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.412 0.625 . . . . 0.0 112.1 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.419 ' OG ' ' HD2' ' A' ' 159' ' ' PRO . 23.1 t -98.19 151.62 37.61 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.419 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 29.1 Cg_endo -63.11 82.17 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.844 2.363 . . . . 0.0 112.582 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.96 -172.64 2.16 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.034 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -137.2 92.24 2.7 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.96 -137.09 10.95 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.96 139.87 41.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.136 0.494 . . . . 0.0 110.746 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.91 166.59 22.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -54.31 121.62 8.64 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -129.78 129.42 44.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.545 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -93.84 162.95 13.71 Favored 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 121.936 0.874 . . . . 0.0 112.716 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.12 128.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.579 -175.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 55.4 ttp -125.79 129.99 50.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.419 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 133' ' ' MET . 60.0 t -106.63 129.94 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.015 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.3 pt -115.87 175.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -176.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -113.4 11.44 18.51 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.528 ' HB2' HD12 ' A' ' 171' ' ' ILE . 29.2 mp0 -97.41 131.45 44.05 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.791 0.805 . . . . 0.0 110.882 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.7 139.63 32.49 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.667 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.84 148.85 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.946 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.48 117.34 30.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.892 0.377 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -105.26 13.99 29.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.257 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 184' ' ' LEU . 11.7 mm 55.46 71.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.62 -41.99 83.09 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.429 0.633 . . . . 0.0 110.277 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -145.88 -175.34 4.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.336 -173.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.478 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 1.3 mptp? -59.48 -36.49 76.12 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.222 0.609 . . . . 0.0 111.328 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -58.23 -43.3 87.66 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.459 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 63.9 m-20 -70.7 -39.52 73.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.303 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 178' ' ' ILE . 64.3 tp -59.45 -50.49 73.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.2 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -64.36 -43.26 95.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.93 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.8 tt -61.03 -49.01 79.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.737 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.04 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 pt-20 -66.26 -37.45 85.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.049 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -66.69 -37.56 84.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.715 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 89.5 mt -62.46 -44.39 96.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.452 0.644 . . . . 0.0 109.323 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.49 -42.97 98.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.467 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.306 -1.293 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.077 179.14 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.813 0.34 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.569 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 75.9 m-20 -105.38 166.27 10.54 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.46 127.39 56.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -103.26 119.68 39.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.782 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.553 ' HA ' HG21 ' A' ' 98' ' ' VAL . 65.6 mt -118.88 104.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.552 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.412 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.0 ptm -92.83 102.19 14.57 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.008 1.385 . . . . 0.0 112.047 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HB3' ' HG2' ' A' ' 20' ' ' PRO . . . -115.12 98.29 6.7 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.795 -2.002 . . . . 0.0 111.139 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.775 178.646 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 7' ' ' ALA . 20.7 Cg_exo . . . . . 0 CA--C 1.519 -0.271 0 CA-C-O 121.12 0.383 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 21.7 mt -87.05 6.07 34.38 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -74.13 110.56 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.7 pttm -81.67 131.39 35.27 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.685 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 HD13 ' CD1' ' A' ' 184' ' ' LEU . 57.6 tp -122.71 112.07 17.49 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.155 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m 58.2 17.95 4.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.87 -95.48 0.15 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.146 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HG2' ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -87.29 172.41 9.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 111.34 -176.144 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 76.6 m -76.07 163.42 27.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.61 -39.18 83.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG12 ' CD1' ' A' ' 60' ' ' ILE . 4.8 tp -57.68 -45.18 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.035 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB3' ' HG3' ' A' ' 27' ' ' ARG . 17.7 t70 -64.56 -40.34 95.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.493 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CD2' ' HG2' ' A' ' 27' ' ' ARG . 11.2 m-85 -61.26 -37.99 85.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.15 -44.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.409 . . . . 0.0 111.148 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.14 -41.97 94.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.3 m -51.67 -55.67 27.75 Favored Pre-proline 0 CA--C 1.562 1.436 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.23 -37.27 14.46 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.512 1.475 . . . . 0.0 112.409 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.503 HD13 HG11 ' A' ' 98' ' ' VAL . 82.1 mt -66.26 -41.53 89.78 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.845 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.33 -46.26 91.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.684 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.16 -9.29 59.52 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -72.08 -177.7 2.15 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.934 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -73.34 2.54 7.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.811 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -80.42 162.03 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.342 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.569 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.6 t30 -81.63 -71.78 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.947 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -120.52 160.14 23.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.256 0.55 . . . . 0.0 111.396 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.1 mm -109.8 117.54 54.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 83.7 m-85 -109.46 116.86 32.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.0 mt -97.39 116.22 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 121.715 0.769 . . . . 0.0 110.467 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.18 120.53 28.55 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.65 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 7' ' ' ALA . 45.1 p -127.93 154.72 45.23 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m -100.58 149.36 36.06 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.56 -17.58 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.714 2.276 . . . . 0.0 110.169 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.07 -11.1 59.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.599 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 p -140.17 67.55 33.07 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.117 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 77.3 Cg_endo -102.46 85.76 0.03 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.629 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.107 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.65 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.7 mmtm -149.8 -48.45 0.13 Allowed 'General case' 1 C--N 1.22 -5.049 0 CA-C-N 109.845 -3.343 . . . . 0.0 103.074 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.3 m -62.81 -48.63 78.26 Favored 'General case' 0 N--CA 1.386 -3.659 0 CA-C-N 113.104 -1.862 . . . . 0.0 105.987 163.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.632 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.32 -50.42 70.08 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.341 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 7.8 pt-20 -62.6 -34.14 76.42 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 117.159 -1.817 . . . . 0.0 112.138 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CD2' HD21 ' A' ' 21' ' ' LEU . 51.0 t80 -64.55 -51.09 64.63 Favored 'General case' 0 C--O 1.211 -0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 111.728 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.457 ' CD1' HG12 ' A' ' 30' ' ' ILE . 95.5 mt -62.59 -41.25 91.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.1 -46.02 79.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.065 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.689 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.2 t -73.06 -40.26 65.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.38 0.61 . . . . 0.0 110.848 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.78 86.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.436 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 89.5 m-85 -114.75 42.29 2.18 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.544 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 62' ' ' SER . 39.2 mtmm -60.55 -22.21 63.41 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.221 0.534 . . . . 0.0 110.25 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.98 10.64 18.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.235 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 55.4 p90 -44.33 117.27 1.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 3.9 mmpt? -103.06 -49.35 3.78 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.444 1.116 . . . . 0.0 109.088 171.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.42 9.92 18.21 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.577 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.48 123.87 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.083 0.468 . . . . 0.0 110.124 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 65.5 t -124.02 131.9 72.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.347 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.2 131.89 53.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.112 0.482 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.3 pt -125.89 156.53 35.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.307 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -117.36 129.59 55.97 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.414 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 7.5 t -158.74 -170.19 2.97 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.5 m -66.18 2.36 1.2 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 127.268 2.227 . . . . 0.0 115.011 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.17 -22.61 0.0 OUTLIER Glycine 1 N--CA 1.52 4.262 0 C-N-CA 126.187 1.851 . . . . 0.0 117.02 -174.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -55.65 -39.87 71.48 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.14 122.64 6.98 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -59.82 -50.56 73.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.218 0.509 . . . . 0.0 111.454 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.405 HD11 ' HH ' ' A' ' 163' ' ' TYR . 42.9 pt -72.88 -30.81 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.774 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.87 -43.34 93.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 109.353 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.568 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.5 t0 -61.45 -51.09 70.13 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.15 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.517 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.3 mm? -57.61 -43.2 84.56 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 88' ' ' ILE . 14.9 m-80 -60.39 -42.62 96.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB2' ' HG1' ' A' ' 75' ' ' THR . 55.9 mm-40 -63.84 -45.71 88.29 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.286 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.9 m -62.56 -41.95 99.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.158 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.517 HG21 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -66.0 -29.51 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.24 -39.59 96.14 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.637 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -71.38 -40.97 70.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.497 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.8 m-85 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.943 0.402 . . . . 0.0 111.916 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -105.16 -2.36 24.32 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.67 157.02 78.17 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.975 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.39 141.94 59.59 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 123.486 2.791 . . . . 0.0 112.237 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.66 156.4 45.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.354 0.597 . . . . 0.0 111.543 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.446 HD12 HD13 ' A' ' 154' ' ' ILE . 1.2 tm? -86.34 138.78 31.55 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.178 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 63.5 t -113.96 129.99 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 5' ' ' ILE . 7.3 m -129.47 160.17 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.484 0.659 . . . . 0.0 112.505 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.432 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 62.4 m -100.44 138.26 37.74 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.772 172.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -64.79 -21.46 66.78 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -112.27 22.76 14.39 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 95.9 mt -68.81 138.4 54.75 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.915 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -92.99 142.81 12.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 79.37 171.65 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.527 1.131 . . . . 0.0 112.799 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.75 134.33 47.34 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.212 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -101.81 -1.65 31.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.431 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.522 ' HA ' HD12 ' A' ' 110' ' ' ILE . 69.6 m -57.19 -40.73 77.97 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -170.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.486 ' HG3' HG13 ' A' ' 109' ' ' ILE . 17.2 ptmt -74.34 -38.22 63.31 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.065 0.936 . . . . 0.0 110.304 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 113' ' ' ILE . 58.8 mt -66.49 -40.43 86.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.23 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 107' ' ' SER . 62.6 mt -58.42 -45.8 89.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.913 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -60.95 -45.14 95.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.986 179.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -62.99 -39.85 96.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.624 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -61.69 -48.66 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.205 0.526 . . . . 0.0 110.331 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.04 -48.19 89.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.687 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -62.26 -45.68 92.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.677 ' CE2' HD12 ' A' ' 120' ' ' ILE . 80.1 t80 -64.08 -47.79 78.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 79.6 t80 -58.37 -46.02 87.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.453 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -60.4 -37.15 79.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.96 -42.72 99.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.913 0.387 . . . . 0.0 110.528 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.677 HD12 ' CE2' ' A' ' 116' ' ' TYR . 71.2 mt -68.26 -44.19 84.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.711 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -66.73 -37.0 83.78 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.585 -178.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.426 ' N ' ' HD3' ' A' ' 121' ' ' LYS . . . -62.01 -42.71 99.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 0.0 111.16 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -80.14 -39.42 29.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.073 0.464 . . . . 0.0 111.034 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 126' ' ' ASP . 35.8 m -132.36 99.97 15.61 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.12 -11.9 34.0 Favored 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 123.002 2.468 . . . . 0.0 112.231 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' HG23 ' A' ' 124' ' ' THR . 25.4 t70 -61.49 -32.63 72.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.208 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.4 t -81.3 119.24 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.282 0.563 . . . . 0.0 111.011 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.578 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 39.5 mt-10 -122.55 7.12 9.49 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.658 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.59 153.75 39.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -139.37 139.0 37.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.191 -177.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.14 139.0 52.73 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.191 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 113' ' ' ILE . 98.4 t -115.32 117.51 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 121.74 0.781 . . . . 0.0 110.683 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 5.2 ptm -146.5 161.87 39.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.113 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.401 HG12 ' HB3' ' A' ' 152' ' ' ALA . 24.9 pt -128.77 159.59 67.49 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.459 -0.526 0 C-N-CA 122.261 1.974 . . . . 0.0 111.298 178.462 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.15 0.5 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.473 ' O ' HD11 ' A' ' 175' ' ' ILE . 61.8 Cg_endo -71.73 149.94 55.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.483 2.122 . . . . 0.0 111.218 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 175' ' ' ILE . . . -132.4 -31.82 1.38 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.974 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -117.03 -134.16 5.21 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.993 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.472 ' CG1' HG13 ' A' ' 113' ' ' ILE . 22.6 pt -126.08 160.36 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.399 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.559 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.5 m-20 -111.78 158.03 19.85 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.1 132.31 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.785 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.9 153.72 38.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.379 0.609 . . . . 0.0 111.808 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.578 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 34.3 t -97.99 151.19 37.43 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.893 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.462 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 61.3 Cg_endo -70.28 59.18 1.87 Allowed 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.281 2.654 . . . . 0.0 112.684 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -88.72 -172.33 3.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.259 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -134.31 94.86 3.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.92 -119.99 4.1 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.689 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.405 ' HH ' HD11 ' A' ' 81' ' ' ILE . 92.9 m-85 -127.82 140.99 51.7 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -135.37 167.0 21.84 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.846 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -55.25 128.33 33.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.137 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -132.58 130.59 40.49 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.298 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -98.94 162.34 13.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 121.701 0.762 . . . . 0.0 112.996 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -118.09 130.16 73.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.696 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.6 ttp -127.9 137.97 52.5 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.6 t -110.1 130.39 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.073 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 48.5 pt -113.74 172.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.018 0.437 . . . . 0.0 110.503 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.7 9.98 31.05 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.311 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -101.65 129.04 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.804 0.811 . . . . 0.0 111.247 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.75 150.76 20.34 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.508 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 151' ' ' PRO . 23.3 pt -133.79 155.4 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.952 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.08 127.32 54.77 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.635 0.255 . . . . 0.0 110.483 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -84.41 109.36 17.81 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.463 HG21 ' HB2' ' A' ' 183' ' ' ASP . 94.5 mt -85.63 115.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.537 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -119.73 -18.72 8.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.319 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.6 p -128.38 167.21 17.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.33 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -59.72 -38.9 82.94 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.847 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.54 -39.96 92.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.463 ' HB2' HG21 ' A' ' 178' ' ' ILE . 71.7 m-20 -62.44 -42.0 99.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.296 0.569 . . . . 0.0 109.871 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.47 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.2 tp -62.12 -43.96 97.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.291 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 6.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.24 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 10.1 tt -62.46 -46.09 90.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.58 99.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.759 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.74 -31.88 72.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.533 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -64.32 -39.74 94.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.642 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 87.4 mt -63.77 -43.68 95.69 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 0.0 109.624 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.78 -39.28 93.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.418 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.316 177.496 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.856 0.36 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 35.5 m-20 -106.28 166.12 10.75 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.26 129.83 55.7 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.94 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.41 ' O ' HG21 ' A' ' 98' ' ' VAL . 25.5 tp -105.31 125.23 50.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.614 ' HA ' HG21 ' A' ' 98' ' ' VAL . 65.0 mt -117.1 103.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.579 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 58.2 ttm -83.04 96.84 8.48 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-O 121.711 0.767 . . . . 0.0 110.887 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.51 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.96 97.69 6.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.598 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.662 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 N--CA 1.473 0.293 0 N-CA-C 112.869 0.296 . . . . 0.0 112.869 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 42.8 mt -97.02 14.87 24.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.0 mt -75.3 114.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.6 ptmm? -85.45 125.04 32.71 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.82 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 62.4 tp -126.38 115.68 20.01 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.94 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.9 t 58.84 19.19 6.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.975 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.3 -62.92 0.54 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.253 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.685 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 96.2 mtt180 -104.85 167.47 9.69 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 117.508 0.654 . . . . 0.0 111.476 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 76.1 m -82.15 160.84 23.0 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.704 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 33' ' ' VAL . 90.1 mt -59.41 -39.65 84.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.949 0.155 . . . . 0.0 111.246 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.7 tp -57.04 -46.1 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.685 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 11.4 t70 -64.87 -41.64 95.49 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.138 0.494 . . . . 0.0 110.403 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 27' ' ' ARG . 18.8 m-85 -64.4 -34.34 77.95 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 29' ' ' LEU . 77.0 t -66.99 -43.87 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 121.327 0.584 . . . . 0.0 110.206 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 30' ' ' ILE . 79.0 t -63.35 -41.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.38 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -51.28 -55.93 24.57 Favored Pre-proline 0 CA--C 1.565 1.547 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.23 -36.1 12.88 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 121.573 1.516 . . . . 0.0 112.491 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.482 HD13 HG13 ' A' ' 98' ' ' VAL . 99.4 mt -67.46 -41.79 84.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.642 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.434 ' HG ' HD22 ' A' ' 69' ' ' ASN . 7.8 tt -63.0 -44.54 95.73 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.049 0.452 . . . . 0.0 110.886 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -75.26 -12.31 60.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.0 p -71.24 -178.9 2.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.144 0.497 . . . . 0.0 110.588 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -76.51 0.32 20.34 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.67 159.38 5.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -77.35 -73.18 0.31 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.755 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -121.17 159.46 25.8 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.171 0.51 . . . . 0.0 111.132 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.16 116.31 50.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.11 114.95 29.11 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 60' ' ' ILE . 96.5 mt -95.03 117.8 39.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.501 0.667 . . . . 0.0 110.182 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.1 119.68 28.72 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.219 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 7' ' ' ALA . 77.6 p -129.88 166.86 19.13 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.565 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.5 p -131.3 158.84 74.12 Favored Pre-proline 0 C--N 1.298 -1.65 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.856 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.23 -19.79 65.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.809 2.339 . . . . 0.0 111.435 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.63 -13.9 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.881 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -142.09 67.16 21.63 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.612 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 85.6 Cg_endo -104.29 86.58 0.03 OUTLIER 'Trans proline' 1 N--CA 1.385 -4.863 0 C-N-CA 116.827 -1.649 . . . . 0.0 110.108 169.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.61 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 73.6 mmtt -146.96 -47.51 0.18 Allowed 'General case' 1 C--N 1.222 -4.964 0 CA-C-N 110.08 -3.236 . . . . 0.0 103.405 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.8 m -61.93 -48.59 79.73 Favored 'General case' 0 N--CA 1.379 -3.996 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.16 -50.68 69.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.558 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.3 pt-20 -64.36 -26.39 68.45 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 117.098 -1.841 . . . . 0.0 112.879 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -70.52 -51.23 30.21 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.277 0.561 . . . . 0.0 111.483 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 ' CD1' HG12 ' A' ' 30' ' ' ILE . 94.5 mt -63.55 -43.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.493 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.73 -45.01 82.2 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.495 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.0 t -69.18 -42.28 76.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.631 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.05 93.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.199 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 70.9 m-85 -114.61 41.61 2.3 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.39 -176.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -58.93 -37.01 75.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.131 0.491 . . . . 0.0 110.951 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -83.52 11.9 6.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 49.8 p90 -44.46 130.65 6.63 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 68' ' ' LYS . 3.6 tmmm? -102.55 -48.28 4.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.21 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.434 HD22 ' HG ' ' A' ' 38' ' ' LEU . 24.1 p-10 -118.12 7.89 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.251 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.1 mp -100.09 116.34 43.21 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.1 t -117.7 130.74 72.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.77 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -104.09 127.69 58.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.1 pt -120.85 153.3 24.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.331 0.586 . . . . 0.0 110.959 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB2' ' HZ3' ' A' ' 57' ' ' LYS . 23.0 t70 -118.08 131.21 56.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.841 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 t -166.67 -166.22 0.83 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 67.5 m -57.58 1.5 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 126.965 2.106 . . . . 0.0 115.344 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -33.07 -12.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.069 0 C-N-CA 126.048 1.785 . . . . 0.0 116.587 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -58.13 -38.96 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.402 ' HA3' ' OE2' ' A' ' 82' ' ' GLU . . . -114.92 131.83 10.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.08 -51.33 69.58 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.067 0.433 . . . . 0.0 111.957 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.6 pt -79.45 -25.99 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.199 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 47.1 mt-10 -62.18 -44.73 95.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.579 ' CG ' ' HE2' ' A' ' 6' ' ' MET . 10.6 t0 -63.45 -48.57 77.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.18 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.462 ' O ' HG21 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -54.82 -46.96 74.62 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.792 178.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.448 ' O ' HG12 ' A' ' 88' ' ' ILE . 29.1 m-80 -61.43 -40.5 94.68 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.861 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 76.8 mm-40 -63.36 -45.66 90.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.135 0.493 . . . . 0.0 109.744 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . 0.571 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 98.0 m -63.07 -42.2 99.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.526 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 160' ' ' LYS . 36.4 pt -64.83 -28.73 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.37 -20.24 75.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.302 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -103.78 -28.25 11.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.563 0.682 . . . . 0.0 112.786 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.571 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 71.8 m-85 -77.24 141.28 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -105.87 -1.95 23.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.507 0.67 . . . . 0.0 109.868 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 40.4 mt-10 -132.99 160.0 70.44 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 41.6 Cg_endo -67.65 145.46 69.94 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.729 1.619 . . . . 0.0 110.761 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.1 157.98 44.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.61 0.719 . . . . 0.0 111.488 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.503 HD11 ' O ' ' A' ' 155' ' ' ASN . 26.6 tp -87.43 141.46 28.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.457 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 94.0 t -112.87 130.92 65.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -128.82 168.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.283 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.2 m -98.45 144.61 27.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.013 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 6' ' ' MET . 88.0 p -73.16 -12.51 60.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -174.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.427 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 7.9 p-10 -116.9 11.67 14.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.38 157.2 30.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.74 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -116.64 174.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.003 0.43 . . . . 0.0 111.911 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -62.31 178.42 0.4 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.829 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.3 mt 81.47 5.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.576 1.15 . . . . 0.0 109.893 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 48.5 mmtm -98.69 1.88 46.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.288 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.537 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.2 p -58.01 -35.29 71.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.92 -29.69 62.17 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.169 0.985 . . . . 0.0 108.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.594 ' O ' HG12 ' A' ' 113' ' ' ILE . 25.7 mm -64.59 -38.69 83.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 107' ' ' SER . 73.8 mt -59.31 -45.31 93.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.307 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -61.31 -43.62 98.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.96 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.0 m -64.73 -41.68 95.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.591 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.9 mm -62.86 -45.51 98.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.27 0.557 . . . . 0.0 109.873 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.436 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 53.8 t -60.44 -47.34 92.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.355 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.9 -47.61 85.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.03 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.599 ' CE2' HD13 ' A' ' 120' ' ' ILE . 54.3 t80 -64.56 -45.76 85.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.88 0.372 . . . . 0.0 110.554 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.27 -48.8 80.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.106 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.3 m-85 -62.81 -36.24 82.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.897 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.78 -41.59 97.92 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.599 HD13 ' CE2' ' A' ' 116' ' ' TYR . 76.3 mt -68.96 -46.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -68.22 -27.68 66.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.062 -177.575 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.23 99.34 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -83.92 -38.24 21.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.387 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.1 m -126.65 96.45 35.47 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.643 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.66 -15.61 48.03 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 122.804 2.336 . . . . 0.0 112.349 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.67 -32.08 73.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.814 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 116.45 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.835 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.543 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 38.7 mt-10 -126.72 14.07 7.49 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.113 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.91 31.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.404 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.5 tp -140.83 143.27 34.7 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.178 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.18 143.21 50.65 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.279 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 154' ' ' ILE . 12.1 p -123.24 133.27 69.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.159 0.504 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' MET . . . . . 0.469 ' C ' ' HB1' ' A' ' 152' ' ' ALA . 71.5 mtm -134.01 157.04 47.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.361 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.527 HG21 ' O ' ' A' ' 171' ' ' ILE . 7.7 pt -127.8 151.81 76.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.788 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo . . . . . 0 N--CA 1.458 -0.59 0 C-N-CA 122.55 2.167 . . . . 0.0 112.448 179.236 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.458 0.17 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.455 ' O ' HD12 ' A' ' 175' ' ' ILE . 52.6 Cg_exo -58.82 144.56 98.4 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.003 2.469 . . . . 0.0 111.725 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HB1' ' C ' ' A' ' 133' ' ' MET . . . -103.69 -15.42 15.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 170.11 -89.14 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.39 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ILE . . . . . 0.536 ' O ' HG13 ' A' ' 132' ' ' VAL . 22.3 pt -133.85 159.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.113 0.483 . . . . 0.0 111.722 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.4 m-20 -122.57 157.77 31.38 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.51 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.12 127.95 72.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 122.322 -0.236 . . . . 0.0 110.745 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.68 151.23 25.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.245 0.545 . . . . 0.0 111.795 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 88.8 p -97.29 169.78 8.16 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 37.4 Cg_endo -67.88 67.69 0.88 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.906 1.738 . . . . 0.0 110.978 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB3' ' NE2' ' A' ' 164' ' ' GLN . 61.0 pttt -67.15 123.42 20.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.016 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -62.44 -43.03 99.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.547 0.689 . . . . 0.0 109.197 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 160' ' ' LYS . . . -128.77 -177.31 14.81 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -72.31 128.46 35.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 118.066 0.933 . . . . 0.0 108.629 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.543 ' OE1' ' HB2' ' A' ' 128' ' ' GLU . 29.9 pt20 -117.8 168.09 10.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.586 -169.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -56.91 121.0 8.88 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 110.086 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.62 130.65 52.98 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.9 161.64 14.4 Favored 'General case' 0 CA--C 1.471 -2.07 0 CA-C-O 121.976 0.893 . . . . 0.0 112.954 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.6 mm -118.44 129.6 74.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 113.713 -1.585 . . . . 0.0 111.583 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 62.0 ttp -129.72 134.14 47.45 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.332 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 133' ' ' MET . 49.8 t -112.14 126.47 69.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.527 ' O ' HG21 ' A' ' 134' ' ' ILE . 47.8 pt -113.47 175.82 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.056 0.455 . . . . 0.0 111.052 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -111.18 16.07 21.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.32 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.45 ' HB2' HD12 ' A' ' 171' ' ' ILE . 75.0 mm-40 -98.76 133.28 43.3 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.672 0.749 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.0 mt -97.09 149.5 21.89 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.514 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 151' ' ' PRO . 12.9 pt -127.73 155.83 39.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.863 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.6 112.3 24.1 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.541 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASN . . . . . 0.427 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 7.8 t-20 -95.13 103.67 15.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.015 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.464 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 1.9 mp -81.92 113.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.521 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.91 -22.48 7.89 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 64.9 p -130.37 165.87 21.63 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.163 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.426 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.8 mppt? -65.98 -28.39 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 109.777 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.46 -42.35 98.64 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.227 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.464 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 49.3 m-20 -61.3 -41.03 96.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 109.535 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.62 -45.05 95.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 30.4 mmmt -62.47 -39.87 94.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.501 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.01 -45.99 89.76 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . 0.588 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.83 -42.78 97.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.472 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.9 OUTLIER -70.59 -34.68 72.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.757 0.313 . . . . 0.0 111.674 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.5 ttm -62.35 -43.38 98.96 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.301 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.1 pp -69.72 -37.94 76.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.87 -42.72 97.44 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.315 0.578 . . . . 0.0 110.385 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.763 178.186 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.605 ' O ' HG23 ' A' ' 42' ' ' VAL . 59.8 ttm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 1' ' ' MET . 52.6 m-20 -105.73 160.73 14.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.489 ' CB ' HG22 ' A' ' 42' ' ' VAL . . . -122.51 140.43 52.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.692 -177.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.411 ' O ' HG22 ' A' ' 98' ' ' VAL . 28.9 tp -112.42 123.73 50.93 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.362 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' HA ' HG22 ' A' ' 98' ' ' VAL . 55.1 mt -116.46 104.94 17.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.417 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 11.8 ptm -95.25 97.39 9.83 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.738 1.256 . . . . 0.0 112.465 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.436 ' CB ' HD11 ' A' ' 30' ' ' ILE . . . -115.94 96.98 5.84 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.094 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.66 0.57 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 17' ' ' VAL . . . 85.65 10.94 75.45 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.873 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.15 146.48 50.7 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.365 0.602 . . . . 0.0 111.959 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.49 -176.44 39.93 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -97.04 85.4 3.73 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.723 0.762 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.459 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -142.87 -80.0 0.21 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.771 -177.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.5 mtm -130.42 -53.47 1.09 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.057 0.456 . . . . 0.0 111.0 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.74 -169.09 26.18 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.48 -121.96 21.67 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.6 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 14.4 m -123.5 98.41 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -72.49 147.66 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.543 ' HB2' ' HZ2' ' A' ' 19' ' ' LYS . 4.7 ttmp? -106.37 104.97 52.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.939 0.4 . . . . 0.0 110.887 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.81 -5.0 13.75 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.208 2.605 . . . . 0.0 112.866 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 56' ' ' THR . 43.4 mt -94.64 10.99 32.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.38 118.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -98.35 142.41 30.02 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.267 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.7 tp -137.21 115.87 12.1 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.106 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.1 m 56.06 24.14 7.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.57 2.22 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.01 -1.567 . . . . 0.0 115.436 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.688 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 69.5 mtt-85 -126.03 159.57 32.4 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 118.353 1.077 . . . . 0.0 111.059 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 72.7 m -83.85 157.99 21.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -46.7 -53.29 12.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD11 ' CB ' ' A' ' 7' ' ' ALA . 12.4 tt -62.07 -36.4 73.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.5 ' HA ' HG13 ' A' ' 34' ' ' VAL . 12.7 t70 -63.02 -40.51 97.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.688 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 25.1 m-85 -64.69 -37.17 86.68 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.573 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HA ' ' HZ3' ' A' ' 106' ' ' LYS . 72.1 t -66.37 -47.76 83.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.036 177.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.5 HG13 ' HA ' ' A' ' 31' ' ' ASP . 12.2 p -72.1 -35.15 52.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.524 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 35.1 t -53.9 -54.08 50.81 Favored Pre-proline 0 CA--C 1.562 1.438 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 46.0 Cg_exo -61.45 -39.34 56.67 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.002 1.801 . . . . 0.0 112.023 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.411 HD11 HG11 ' A' ' 98' ' ' VAL . 81.2 mt -63.67 -42.08 98.1 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.459 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.474 ' HG ' HD22 ' A' ' 69' ' ' ASN . 8.9 tt -60.01 -45.79 91.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.0 -12.07 59.44 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.511 ' OG ' HG12 ' A' ' 42' ' ' VAL . 72.7 p -76.49 -175.86 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -51.48 -33.77 32.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.666 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 1' ' ' MET . 7.5 p -69.05 140.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 121.444 0.64 . . . . 0.0 111.616 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -83.6 -69.75 0.61 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.285 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -101.23 146.46 27.49 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.357 0.599 . . . . 0.0 111.156 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.7 mm -110.98 116.87 53.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.845 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 96.1 m-85 -103.39 114.96 29.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.516 HG23 HD11 ' A' ' 60' ' ' ILE . 88.0 mt -98.96 118.34 45.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.649 0.738 . . . . 0.0 110.482 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.443 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.33 124.36 33.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.374 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.424 ' OG1' ' HD2' ' A' ' 57' ' ' LYS . 55.1 p -132.2 168.63 17.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.213 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.1 m -129.89 155.01 81.21 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.506 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.63 -21.47 65.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.925 2.416 . . . . 0.0 111.044 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.16 -13.12 60.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.453 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -142.37 66.47 19.4 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 76.4 Cg_endo -107.99 87.0 0.02 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.591 0 CA-C-N 120.884 1.351 . . . . 0.0 111.363 170.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.5 mmtm -151.01 -44.58 0.12 Allowed 'General case' 1 C--N 1.221 -5.001 0 CA-C-N 109.599 -3.455 . . . . 0.0 102.649 176.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.42 ' HA ' HD13 ' A' ' 21' ' ' LEU . 74.9 m -62.68 -49.51 74.83 Favored 'General case' 0 N--CA 1.387 -3.615 0 CA-C-N 113.022 -1.899 . . . . 0.0 105.974 161.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.23 -50.26 70.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.628 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.5 pt-20 -62.14 -30.26 70.91 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 116.517 -2.073 . . . . 0.0 112.573 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.01 -50.31 66.81 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HD11 HG23 ' A' ' 47' ' ' ILE . 85.5 mt -60.62 -45.03 98.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.154 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -56.54 -45.53 81.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.634 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 70.1 m -71.1 -41.62 70.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.136 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.28 86.28 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 111.381 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' OH ' HG11 ' A' ' 34' ' ' VAL . 34.9 m-85 -115.99 39.79 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.952 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.2 mtmt -61.12 -29.04 69.53 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.131 0.491 . . . . 0.0 110.828 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.59 10.31 13.58 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 51.6 p90 -35.69 113.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.44 -48.61 5.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.474 HD22 ' HG ' ' A' ' 38' ' ' LEU . 20.1 p-10 -117.54 5.26 12.43 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 4.5 mp -95.11 122.58 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 75.8 t -124.01 128.49 74.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -105.82 129.13 59.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.363 0.601 . . . . 0.0 109.71 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.8 pt -121.88 156.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.293 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.89 128.58 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.405 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 11.7 t -158.72 -168.14 2.32 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-O 121.728 0.775 . . . . 0.0 112.916 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -69.06 1.48 3.5 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 126.184 1.794 . . . . 0.0 114.198 -176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.07 -20.35 0.0 OUTLIER Glycine 1 N--CA 1.521 4.365 0 C-N-CA 126.192 1.854 . . . . 0.0 116.903 -176.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -56.81 -38.05 72.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.51 127.81 8.5 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -60.9 -51.19 70.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 0.0 112.099 -172.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.3 pt -76.9 -27.43 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.485 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 50.7 mt-10 -63.36 -44.49 94.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.564 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 20.5 t0 -62.51 -50.69 70.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.278 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 88' ' ' ILE . 2.5 mm? -54.55 -46.28 73.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.631 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.1 m-80 -59.92 -42.99 95.15 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.385 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 28.9 mm-40 -65.18 -47.18 77.86 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.93 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.421 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.4 m -63.35 -42.56 98.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.329 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.537 HG21 ' O ' ' A' ' 84' ' ' LEU . 40.7 pt -65.87 -28.43 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.15 -10.65 85.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.775 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -109.17 -24.62 11.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 159' ' ' PRO . 76.9 m-85 -82.11 148.48 28.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.038 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 m -96.36 -12.28 24.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 111.153 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.02 158.77 66.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.588 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.71 141.84 33.72 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.384 2.723 . . . . 0.0 112.15 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.14 157.02 45.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.715 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.43 HD13 HD12 ' A' ' 154' ' ' ILE . 23.7 tp -87.83 143.2 27.26 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.733 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 72.6 t -113.11 129.64 68.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.564 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -132.26 160.57 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.136 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.447 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 51.2 m -100.38 137.11 39.25 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.5 p -77.05 -10.46 59.39 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 19.6 p-10 -99.19 9.61 43.09 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 175' ' ' ILE . 61.2 mt -91.52 115.9 28.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 85.4 mt -108.03 119.81 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 110.703 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 65.8 t30 170.04 153.15 0.05 OUTLIER 'General case' 0 C--O 1.247 0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.31 117.5 14.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HZ3' ' HA ' ' A' ' 33' ' ' VAL . 61.6 mttp -95.84 -1.37 49.65 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.462 -172.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -56.36 -38.87 72.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.74 -25.61 32.72 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.045 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.512 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.5 mm -71.32 -43.72 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.658 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.462 HD12 ' CB ' ' A' ' 40' ' ' SER . 60.2 mt -60.07 -48.48 87.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.126 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -64.64 -42.11 95.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.439 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -66.18 -43.0 88.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.526 HG13 ' CG1' ' A' ' 154' ' ' ILE . 38.7 mm -63.45 -48.62 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 120.907 0.384 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.485 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 66.3 t -61.29 -47.8 91.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.702 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -47.49 84.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.655 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.512 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.3 t80 -63.13 -44.26 96.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.375 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.57 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 58.4 t80 -58.39 -48.11 81.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.485 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 28.2 m-85 -63.1 -35.19 79.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.62 -40.35 96.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.121 0.486 . . . . 0.0 109.899 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 116' ' ' TYR . 80.0 mt -64.28 -45.73 95.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.688 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -62.68 -37.26 85.73 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.102 0.477 . . . . 0.0 110.672 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.98 88.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.288 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -83.84 -38.84 20.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.45 . . . . 0.0 111.314 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.3 m -130.07 94.1 31.82 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.184 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.05 -22.97 58.27 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.313 2.675 . . . . 0.0 113.126 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.49 -28.51 70.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 74.9 t -70.26 126.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.433 ' CD ' ' HZ3' ' A' ' 160' ' ' LYS . 44.0 mt-10 -117.64 -13.18 10.23 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.224 -176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -140.67 157.04 46.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.4 . . . . 0.0 111.777 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.57 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 1.2 tm? -136.17 135.69 39.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.27 132.27 48.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 154' ' ' ILE . 14.1 p -114.66 126.56 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.92 160.99 41.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 12.5 pt -132.73 147.41 65.41 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.632 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.522 ' HD2' ' HE2' ' A' ' 138' ' ' LYS . 77.4 Cg_exo -56.92 137.64 82.61 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.413 2.075 . . . . 0.0 111.769 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -61.94 -29.67 70.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.054 -178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 146' ' ' PHE . 37.8 tt0 -60.72 -39.88 90.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.522 ' HE2' ' HD2' ' A' ' 135' ' ' PRO . 63.2 pttt -91.62 -11.97 35.59 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.691 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -62.31 127.2 89.4 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.358 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.63 -21.24 65.58 Favored 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.267 2.645 . . . . 0.0 115.224 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -132.41 90.23 34.36 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.91 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.94 117.99 2.0 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.407 2.738 . . . . 0.0 111.076 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.3 t -66.04 -46.33 78.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 79.4 mt -123.53 -55.75 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.999 0.428 . . . . 0.0 111.402 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.78 166.58 30.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.912 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 137' ' ' GLU . 50.6 p90 -85.78 7.6 23.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.948 0.404 . . . . 0.0 111.932 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.75 127.46 32.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.6 179.9 19.06 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.883 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.83 153.45 41.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.93 148.74 68.23 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.06 141.13 75.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.099 1.866 . . . . 0.0 110.567 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -90.36 -8.11 51.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.426 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.85 -86.58 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.637 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.542 ' O ' HG12 ' A' ' 132' ' ' VAL . 28.0 pt -123.75 160.17 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.217 0.532 . . . . 0.0 112.086 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.627 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.9 t-20 -128.61 151.99 48.85 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.469 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.6 t -123.43 131.04 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.522 0.201 . . . . 0.0 110.932 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.64 150.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.7 p -87.85 154.2 52.68 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.444 ' HB2' ' O ' ' A' ' 91' ' ' PHE . 67.2 Cg_endo -84.11 84.92 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.514 2.143 . . . . 0.0 113.307 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.433 ' HZ3' ' CD ' ' A' ' 128' ' ' GLU . 19.3 ptpt -130.81 -179.55 5.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.394 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -105.55 98.43 8.13 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.95 -170.29 21.32 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.845 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -96.62 150.01 21.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.776 0.322 . . . . 0.0 110.224 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.89 165.9 23.57 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.683 -171.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -64.03 124.71 22.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -120.62 132.9 55.36 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.114 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.28 161.3 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 121.559 0.695 . . . . 0.0 112.057 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.8 mm -118.36 129.04 75.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.566 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 58.4 ttp -132.06 136.63 47.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.35 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.84 130.26 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 49.4 pt -120.33 175.45 4.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.766 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -120.09 24.09 10.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.586 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -99.4 131.95 45.07 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.41 149.9 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.499 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.462 HD11 HD21 ' A' ' 102' ' ' LEU . 2.4 pt -119.59 148.89 22.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.644 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.51 118.24 33.2 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.443 HD22 HD23 ' A' ' 102' ' ' LEU . 1.9 m-20 -107.62 149.18 28.38 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.151 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.83 121.98 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.855 0.359 . . . . 0.0 111.507 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -130.12 -30.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.108 0.48 . . . . 0.0 110.406 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 t -140.92 -178.4 5.54 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.235 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -41.79 97.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.381 0.672 . . . . 0.0 112.623 -175.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.4 -38.15 86.02 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.21 -40.6 94.58 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.273 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.81 -43.68 98.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 13.4 tmtt? -62.23 -44.23 97.04 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.534 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.66 -50.58 73.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.291 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.685 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.09 -39.91 90.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.458 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.2 pp20? -67.11 -28.69 68.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.336 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.6 mmm -63.26 -40.92 98.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.685 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.8 pp -71.3 -37.39 71.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.476 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.53 -39.73 94.3 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.804 0.812 . . . . 0.0 109.509 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -60.77 -43.13 98.43 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.659 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.48 -42.31 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.337 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.78 -27.61 66.05 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.262 0.553 . . . . 0.0 110.82 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.52 -21.68 79.37 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.188 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--O 1.261 1.696 0 CA-C-O 117.745 -1.122 . . . . 0.0 110.042 179.639 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.515 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.1 tpp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -110.49 166.6 10.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -113.09 139.93 48.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.242 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -119.51 114.55 22.45 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.553 ' HA ' HG23 ' A' ' 98' ' ' VAL . 69.0 mt -118.55 106.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.5 ptm -98.92 104.36 16.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.815 1.293 . . . . 0.0 112.621 -174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.57 6.14 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.73 90.15 0.08 OUTLIER Glycine 0 C--N 1.305 -1.165 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.491 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.13 41.5 60.18 Favored Glycine 0 C--O 1.221 -0.684 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.54 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -53.12 131.29 36.45 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.13 -154.66 16.61 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.549 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.1 t -149.83 153.31 36.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 14' ' ' MET . 73.7 ttp85 63.37 53.79 2.11 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 13' ' ' ARG . 66.5 mtt 76.03 168.85 0.26 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.678 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.86 124.33 6.98 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.309 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.78 96.71 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -99.83 130.77 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.28 -49.75 76.64 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 123.213 0.32 . . . . 0.0 110.921 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -164.92 145.01 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.563 0.22 . . . . 0.0 111.066 174.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 22.7 Cg_exo -70.03 -9.33 25.76 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.489 2.793 . . . . 0.0 113.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.2 mt -89.15 13.04 14.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.489 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 94.8 mt -70.39 119.18 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 63.0 pttt -102.79 137.2 41.31 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-O 122.243 1.02 . . . . 0.0 113.123 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.32 131.68 50.39 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.174 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' SG ' ' HE3' ' A' ' 192' ' ' LYS . 83.7 m 53.48 32.36 13.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.77 -17.4 49.57 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.83 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 92.4 mtt180 -128.61 152.38 48.41 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 119.018 1.409 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 81.7 m -74.87 162.84 28.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.319 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HB3' ' O ' ' A' ' 100' ' ' SER . 84.0 mt -58.73 -40.89 85.11 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.144 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 60' ' ' ILE . 5.1 tp -58.08 -44.45 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.443 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.728 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 13.1 t70 -65.06 -43.57 91.82 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.97 0.414 . . . . 0.0 111.23 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.83 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 32.5 m-85 -67.33 -26.39 66.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.481 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 29' ' ' LEU . 69.7 t -73.7 -46.79 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.47 173.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.09 -47.72 88.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 66.1 m -54.61 -50.35 86.04 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.507 ' HG2' ' NZ ' ' A' ' 106' ' ' LYS . 78.3 Cg_exo -57.69 -42.59 58.44 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.75 1.634 . . . . 0.0 112.109 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.492 HD13 HG12 ' A' ' 98' ' ' VAL . 90.0 mt -67.51 -39.48 85.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 61.8 tp -57.15 -43.68 82.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.44 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 35' ' ' SER . 19.0 ptpt -88.74 -6.15 57.62 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.521 ' OG ' HG12 ' A' ' 42' ' ' VAL . 57.6 p -81.55 -176.96 6.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.727 0.775 . . . . 0.0 112.212 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -63.63 -16.14 60.12 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.372 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' OG ' ' A' ' 40' ' ' SER . 13.3 p -75.28 147.69 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 122.189 -0.32 . . . . 0.0 111.691 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.03 -75.58 0.35 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -100.19 147.2 25.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.972 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.03 112.08 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.609 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -104.45 114.56 28.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.459 HG12 ' HB ' ' A' ' 5' ' ' ILE . 96.7 mt -97.26 116.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.674 0.749 . . . . 0.0 110.853 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.3 121.77 30.19 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.386 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 7' ' ' ALA . 53.2 p -132.69 162.38 31.54 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.414 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.6 m -117.87 154.75 51.33 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 29.1 Cg_endo -63.38 -18.86 66.58 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.028 2.485 . . . . 0.0 110.842 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -70.89 -20.72 62.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.084 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 p -137.59 66.69 50.59 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.741 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.661 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 63.2 Cg_endo -103.55 85.43 0.03 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.603 0 C-N-CA 116.974 -1.55 . . . . 0.0 110.162 170.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.1 ttpt -154.63 -47.24 0.09 Allowed 'General case' 1 C--N 1.211 -5.436 0 CA-C-N 109.393 -3.549 . . . . 0.0 102.27 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -63.42 -48.74 76.56 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 162.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.661 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.74 -50.4 71.24 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.834 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -63.6 -32.5 73.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 116.485 -2.086 . . . . 0.0 112.472 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.36 -51.21 64.44 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.192 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 30' ' ' ILE . 96.9 mt -64.91 -46.27 92.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.98 -175.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.4 -41.82 90.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.433 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 39.7 t -67.95 -42.87 80.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.508 0.671 . . . . 0.0 110.387 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.92 89.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.339 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.598 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 71.8 m-85 -112.0 18.26 18.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 62' ' ' SER . 64.6 pttt -65.03 -17.47 64.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.62 2.66 52.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -102.66 130.38 49.55 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.076 -0.39 . . . . 0.0 111.137 -178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.15 60.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.384 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -85.97 2.09 47.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.03 123.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.5 135.1 65.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.93 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.92 129.1 58.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.471 HG13 ' HA ' ' A' ' 48' ' ' ALA . 42.9 pt -122.27 156.64 27.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.366 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.84 133.11 56.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.528 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.0 t -167.06 -167.29 0.91 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 52.6 m -64.08 1.17 0.74 Allowed 'General case' 0 C--O 1.197 -1.698 0 C-N-CA 126.826 2.05 . . . . 0.0 114.6 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.54 -28.21 0.01 OUTLIER Glycine 0 N--CA 1.515 3.922 0 C-N-CA 125.604 1.573 . . . . 0.0 116.713 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -56.12 -33.0 64.74 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.65 115.85 4.0 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -58.39 -50.72 72.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.2 -46.02 92.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.55 0.691 . . . . 0.0 110.742 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.48 -42.38 96.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.51 -50.1 74.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.901 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.4 mm? -57.06 -44.05 82.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.465 ' HA ' HG12 ' A' ' 88' ' ' ILE . 11.4 m120 -60.7 -42.3 96.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.41 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.19 -45.22 89.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.145 0.498 . . . . 0.0 110.572 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.613 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 95.5 m -64.65 -41.77 95.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.089 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.537 HG21 ' O ' ' A' ' 84' ' ' LEU . 39.2 pt -68.45 -31.02 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 121.98 -0.45 . . . . 0.0 110.952 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.86 95.55 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.158 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -101.94 9.78 40.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.613 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 62.8 m-85 -112.62 150.57 31.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.82 0.343 . . . . 0.0 111.823 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -102.41 -6.68 22.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.295 0.569 . . . . 0.0 109.951 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -125.49 156.76 69.98 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.432 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.89 153.6 42.49 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.622 2.215 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.92 152.55 43.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 0.0 112.657 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 155' ' ' ASN . 2.4 tm? -86.31 124.01 32.2 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.177 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 57.8 t -99.04 130.8 47.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 123.395 0.678 . . . . 0.0 109.805 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.553 HG23 ' HA ' ' A' ' 5' ' ' ILE . 13.3 m -129.37 166.38 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 121.871 0.843 . . . . 0.0 112.454 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.5 m -98.85 157.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.937 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.521 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 81.2 p -88.94 -6.25 57.4 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.309 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -117.59 9.96 13.3 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.96 122.32 31.43 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.073 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.445 ' O ' HG13 ' A' ' 103' ' ' ILE . 28.0 pt -122.47 101.51 10.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.663 0.744 . . . . 0.0 111.516 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -160.01 177.71 10.46 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.401 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.29 59.6 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.735 0.779 . . . . 0.0 109.93 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HA ' HD12 ' A' ' 109' ' ' ILE . 16.9 pttp -69.72 -3.69 16.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.79 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -59.17 -41.9 89.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.49 ' HD3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -88.6 -23.16 23.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.812 0.815 . . . . 0.0 110.566 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.74 ' O ' HG12 ' A' ' 113' ' ' ILE . 74.2 mt -64.34 -38.79 83.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.882 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.1 mt -55.44 -47.85 77.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.769 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -63.69 -41.34 98.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.462 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.6 m -63.43 -39.8 95.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.2 mm -61.28 -47.69 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.041 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.505 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 67.9 t -60.43 -48.07 89.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.263 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.77 -47.64 84.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.607 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.585 ' CE2' HD13 ' A' ' 120' ' ' ILE . 75.0 t80 -61.43 -48.24 82.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.658 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -59.56 -47.59 84.95 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.246 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.505 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.8 m-85 -61.82 -37.94 86.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.331 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.7 t -61.12 -46.43 90.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.399 0.619 . . . . 0.0 109.908 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.585 HD13 ' CE2' ' A' ' 116' ' ' TYR . 80.0 mt -62.46 -45.98 97.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -62.85 -37.44 86.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.994 0.426 . . . . 0.0 110.833 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.49 91.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.398 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -81.27 -36.02 30.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.071 0.462 . . . . 0.0 111.206 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.7 m -139.89 100.1 7.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.169 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.03 -16.72 53.46 Favored 'Trans proline' 0 N--CA 1.481 0.775 0 C-N-CA 123.087 2.525 . . . . 0.0 113.241 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -69.48 -13.39 62.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.45 HG22 ' CG2' ' A' ' 120' ' ' ILE . 94.3 t -76.85 120.04 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.29 11.85 10.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.504 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.0 23.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -137.0 135.97 38.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.123 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.0 137.78 52.35 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.27 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 113' ' ' ILE . 57.6 t -112.29 116.91 53.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 4.3 ptm -145.46 155.55 43.19 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.956 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.472 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 24.0 pt -130.03 157.48 76.85 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.919 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.472 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 39.5 Cg_endo -67.2 140.81 54.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.763 1.642 . . . . 0.0 111.772 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -16.93 62.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.014 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.34 -38.73 92.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.068 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.15 -16.83 16.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.192 0.52 . . . . 0.0 111.348 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -59.6 131.48 88.42 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.063 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.71 -32.13 92.76 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.939 2.426 . . . . 0.0 114.702 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -142.63 78.15 16.32 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.532 0.682 . . . . 0.0 111.3 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.58 -5.73 11.68 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 123.735 2.956 . . . . 0.0 112.027 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.6 m 63.3 -161.19 0.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.2 pt -104.59 149.15 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 146' ' ' PHE . 21.3 t70 56.2 -134.66 1.33 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.435 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 38.5 t80 53.73 61.75 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.342 0.592 . . . . 0.0 111.047 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.37 110.4 17.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.158 0.504 . . . . 0.0 110.032 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.23 -154.63 11.86 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 149' ' ' LEU . 2.4 pt? -108.54 149.68 28.51 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.914 0.357 . . . . 0.0 110.243 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.62 146.0 59.34 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.91 147.5 55.63 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.198 1.932 . . . . 0.0 111.891 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.424 ' HB2' HG11 ' A' ' 132' ' ' VAL . . . -117.45 -6.64 11.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.226 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.05 -116.89 0.39 Allowed Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.48 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.413 HD12 HD12 ' A' ' 96' ' ' LEU . 22.2 pt -124.55 160.08 29.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 120.7 0.286 . . . . 0.0 111.02 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.551 ' O ' HD23 ' A' ' 96' ' ' LEU . 6.0 m-20 -117.65 159.27 23.21 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.91 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.67 133.46 69.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.88 148.45 31.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.479 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -92.43 149.29 38.02 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.13 75.2 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -104.11 -170.97 1.85 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.171 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -132.33 125.94 32.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.45 -105.99 3.34 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.207 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -147.03 140.5 25.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -133.3 166.96 21.28 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.424 ' HE3' HG21 ' A' ' 127' ' ' VAL . 63.6 tttp -58.47 125.7 24.45 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.828 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.14 128.31 49.08 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.143 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -93.9 163.49 13.48 Favored 'General case' 0 CA--C 1.477 -1.852 0 CA-C-O 121.687 0.756 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.33 130.12 69.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.537 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.419 ' HE1' HD13 ' A' ' 113' ' ' ILE . 51.3 ttm -112.45 129.85 56.19 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.376 175.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.54 126.32 66.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.2 pt -121.55 174.29 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 112.029 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -111.48 4.89 19.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.059 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.496 ' HB2' HD12 ' A' ' 171' ' ' ILE . 34.9 mt-10 -99.34 130.29 45.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 111.03 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.49 151.15 19.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.249 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.99 150.49 31.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.325 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.01 122.82 43.05 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.164 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.419 ' C ' HD12 ' A' ' 178' ' ' ILE . 23.7 p-10 -94.08 168.17 11.11 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.787 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.438 HG12 HD21 ' A' ' 184' ' ' LEU . 2.0 mp -120.32 121.05 64.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.873 0.368 . . . . 0.0 111.093 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -111.72 -32.34 6.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.422 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.1 t -138.39 176.6 8.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.022 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -64.24 -29.13 70.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.83 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.28 -39.11 91.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.414 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -61.42 -35.76 78.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.388 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.438 HD21 HG12 ' A' ' 178' ' ' ILE . 96.0 mt -60.68 -43.7 97.4 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.354 0.597 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.646 ' O ' ' HG3' ' A' ' 189' ' ' MET . 60.0 tptt -62.84 -43.61 98.35 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.707 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.56 -48.21 82.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.593 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.71 -43.14 99.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.306 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 192' ' ' LYS . 13.2 pt-20 -70.2 -29.59 66.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.932 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.646 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -61.44 -39.71 91.83 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -70.67 -33.41 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.96 -40.57 87.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.66 0.743 . . . . 0.0 110.558 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 188' ' ' GLU . 34.8 mmtp -65.66 -37.58 86.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.442 ' O ' ' HD3' ' A' ' 193' ' ' LYS . 9.2 tmtt? -60.65 -42.21 96.53 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.501 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.73 2.85 54.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.496 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.35 97.66 0.45 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.1 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.2 tp . . . . . 0 C--O 1.266 1.954 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.029 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 64.2 m-20 -97.35 165.91 11.79 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.9 130.07 56.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.901 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.439 ' O ' HG21 ' A' ' 98' ' ' VAL . 36.1 tp -100.93 124.72 47.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.369 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HA ' HG21 ' A' ' 98' ' ' VAL . 68.5 mt -117.59 104.88 17.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.454 ' HE1' ' CG ' ' A' ' 83' ' ' ASP . 12.0 ptm -96.64 107.64 20.12 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.786 1.279 . . . . 0.0 112.505 -174.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.92 96.92 5.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.801 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.78 -105.99 0.51 Allowed Glycine 0 C--N 1.297 -1.623 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.654 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.14 178.63 24.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.988 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' H ' ' HG2' ' A' ' 14' ' ' MET . 60.1 mtpt -127.51 -176.54 3.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.012 0.525 . . . . 0.0 110.084 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.54 49.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m 63.57 26.68 14.78 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.973 0.892 . . . . 0.0 110.212 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 64.22 27.57 13.93 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.519 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.433 ' HG2' ' H ' ' A' ' 10' ' ' LYS . 98.7 mtp 70.08 133.81 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 144.96 17.66 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.68 -43.87 98.35 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.535 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -70.1 -39.8 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.491 0.662 . . . . 0.0 110.72 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.65 102.52 0.93 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.103 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.473 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.3 ptmt -148.02 148.34 29.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.485 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 44.1 Cg_exo -61.39 -17.82 55.63 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.235 2.624 . . . . 0.0 112.402 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.538 HD23 ' CB ' ' A' ' 59' ' ' TYR . 9.6 mp -83.51 15.71 2.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 19' ' ' LYS . 88.1 mt -69.73 123.19 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -80.75 132.08 35.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.575 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 tp -137.83 125.33 22.06 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.152 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t 58.64 26.17 14.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.278 0.561 . . . . 0.0 110.74 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 -13.85 56.86 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -134.4 169.81 16.68 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 118.945 1.372 . . . . 0.0 111.434 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 75.6 m -85.73 163.79 18.01 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.672 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 82.3 mt -59.43 -39.69 84.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.268 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.3 tp -57.17 -45.17 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.201 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.43 -41.65 93.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.973 0.416 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -61.52 -33.89 74.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.409 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.491 ' HA ' ' HZ3' ' A' ' 106' ' ' LYS . 71.4 t -73.54 -42.95 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.774 0.321 . . . . 0.0 111.412 175.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.4 t -63.39 -44.81 99.13 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -52.87 -50.47 81.28 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.448 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 28.9 Cg_endo -64.13 -40.95 24.04 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.367 1.378 . . . . 0.0 112.489 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.463 HD11 HG11 ' A' ' 98' ' ' VAL . 88.6 mt -66.7 -37.71 85.26 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.498 0.666 . . . . 0.0 110.436 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.22 -44.12 88.05 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.284 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 36' ' ' PRO . 64.3 pttt -90.32 -3.23 57.89 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.206 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 59.5 p -81.43 -178.9 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.778 0.799 . . . . 0.0 112.997 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -59.94 -25.28 65.05 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.2 m -64.26 161.78 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.445 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.2 t30 -83.38 -76.31 0.29 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.218 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -115.16 157.44 23.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.074 0.464 . . . . 0.0 110.82 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.63 115.89 50.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -107.81 117.32 33.8 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -96.88 119.41 44.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.736 0.779 . . . . 0.0 110.583 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB1' HD12 ' A' ' 4' ' ' LEU . . . -91.05 121.0 32.48 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.758 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.1 p -132.07 165.81 23.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.44 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.9 p -128.45 157.57 74.36 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.081 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.2 -25.68 72.91 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.916 2.41 . . . . 0.0 110.963 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -75.46 -14.04 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.712 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -141.76 65.94 21.09 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.629 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.8 Cg_endo -106.26 86.72 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.113 0 C-N-CA 117.148 -1.435 . . . . 0.0 109.586 168.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.571 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 ttmt -147.83 -50.43 0.18 Allowed 'General case' 1 C--N 1.209 -5.534 0 CA-C-N 109.489 -3.505 . . . . 0.0 101.675 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 98.0 m -62.52 -48.41 79.65 Favored 'General case' 0 N--CA 1.382 -3.85 0 CA-C-N 111.712 -2.494 . . . . 0.0 106.047 164.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.629 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.23 -49.1 77.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.004 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.571 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 18.9 pt-20 -56.17 -35.96 67.8 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 117.589 -1.644 . . . . 0.0 110.988 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.538 ' CB ' HD23 ' A' ' 21' ' ' LEU . 57.7 t80 -70.76 -52.05 23.22 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.744 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.431 HG12 HG12 ' A' ' 30' ' ' ILE . 97.1 mt -63.92 -45.12 97.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.508 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.714 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 49.2 t30 -57.08 -47.33 81.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.907 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 t -71.47 -43.68 66.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.733 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.96 89.32 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.377 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 95.2 m-85 -104.52 20.16 19.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtpt -63.32 -23.14 67.28 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 174.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.03 10.02 15.43 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.22 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 45.1 p90 -50.51 148.55 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -103.55 -52.88 2.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.448 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -121.14 16.57 11.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.557 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 79.1 mt -103.87 127.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.54 0.686 . . . . 0.0 111.838 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 69.2 t -125.84 134.0 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.879 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.32 132.7 49.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.189 0.519 . . . . 0.0 109.973 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 41.5 pt -127.51 157.04 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.901 0.857 . . . . 0.0 111.672 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -106.6 133.79 50.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.981 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.8 t -159.75 -168.6 2.3 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 78' ' ' LYS . 65.7 m -77.37 3.28 13.58 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 126.001 1.72 . . . . 0.0 113.725 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.473 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.51 -14.56 0.0 OUTLIER Glycine 1 N--CA 1.522 4.372 0 C-N-CA 127.11 2.29 . . . . 0.0 117.992 -174.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.8 tmtt? -59.93 -37.11 78.55 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.68 130.35 8.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.48 -51.04 71.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.483 HD11 ' OH ' ' A' ' 163' ' ' TYR . 45.7 pt -71.32 -36.41 61.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.52 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.37 -40.01 92.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.124 0.488 . . . . 0.0 109.834 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.473 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 19.0 t0 -59.66 -51.03 71.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.962 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.514 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.2 mm? -56.34 -45.4 80.41 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.783 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.493 ' HA ' HG12 ' A' ' 88' ' ' ILE . 24.6 m-80 -60.32 -41.31 93.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.584 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 77.4 mm-40 -65.19 -46.06 82.32 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.538 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.4 m -63.02 -43.76 97.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.238 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 84' ' ' LEU . 34.7 pt -67.72 -29.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.822 0.344 . . . . 0.0 110.403 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.31 96.09 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.71 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.5 3.89 50.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.449 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 63.8 m-85 -108.74 143.26 38.1 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.581 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.3 p -102.78 -0.76 30.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.484 . . . . 0.0 111.11 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -133.24 156.75 79.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.864 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.76 146.34 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.409 2.072 . . . . 0.0 111.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.25 161.69 38.28 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.488 0.661 . . . . 0.0 112.362 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 97' ' ' VAL . 1.5 tm? -84.81 143.08 29.32 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.222 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.6 ' N ' HD12 ' A' ' 96' ' ' LEU . 99.8 t -119.59 130.15 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.86 0.864 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 5' ' ' ILE . 14.6 m -130.87 161.95 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.207 0.527 . . . . 0.0 112.136 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.8 t -99.37 140.74 33.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -72.24 -10.86 60.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -104.15 9.69 36.15 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.28 122.86 27.96 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 122.086 -0.384 . . . . 0.0 110.931 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 pt -62.98 166.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -89.56 72.53 7.84 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.17 -14.01 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 168.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.491 ' HZ3' ' HA ' ' A' ' 33' ' ' VAL . 25.0 pttm -67.66 -0.44 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.002 -1.908 . . . . 0.0 114.454 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.4 m -58.09 -40.67 81.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -82.49 -23.99 34.41 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.738 0.78 . . . . 0.0 110.303 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.762 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.6 mm -64.02 -40.22 88.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.112 -174.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.495 ' HA ' HD13 ' A' ' 154' ' ' ILE . 58.1 mt -57.89 -48.57 83.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.644 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -65.12 -39.75 93.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.58 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.6 m -61.33 -40.16 93.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.634 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.762 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -61.8 -49.18 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.695 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 71.4 t -62.85 -47.76 91.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.425 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.12 -45.83 93.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.731 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CE2' HD11 ' A' ' 120' ' ' ILE . 62.3 t80 -62.85 -48.38 79.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.813 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.53 -47.64 84.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.363 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.448 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 25.5 m-85 -61.8 -37.77 85.64 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.459 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -63.66 -39.75 95.11 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.277 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.622 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.6 mt -63.35 -46.36 95.69 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.078 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.409 ' HG2' HG13 ' A' ' 127' ' ' VAL . 52.5 mtmt -61.74 -38.66 88.77 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.908 0.385 . . . . 0.0 111.178 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.6 87.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.398 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -86.93 -35.25 19.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.017 0.437 . . . . 0.0 111.627 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.418 ' O ' HG11 ' A' ' 127' ' ' VAL . 34.4 m -136.88 94.53 12.81 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 122.806 0.443 . . . . 0.0 110.848 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.34 -15.8 31.43 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.388 2.725 . . . . 0.0 113.051 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.9 -32.92 72.37 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.483 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 12.0 p -65.54 132.14 31.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.215 0.531 . . . . 0.0 111.947 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -119.56 -15.79 8.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.167 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.82 160.23 43.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 23.1 tp -134.61 144.26 47.8 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.96 140.73 51.53 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.317 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' A' ' 113' ' ' ILE . 84.2 t -118.58 120.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 ptm -145.49 154.62 42.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.787 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.435 HG12 ' HB3' ' A' ' 152' ' ' ALA . 28.2 pt -129.87 156.29 79.22 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.382 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.4 142.05 97.12 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.209 1.939 . . . . 0.0 110.739 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -62.03 -19.05 62.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.35 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.27 -39.54 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.072 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -90.19 -21.47 22.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.752 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -67.29 126.09 92.03 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 174' ' ' LEU . 37.0 Cg_endo -65.79 -67.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.732 2.288 . . . . 0.0 113.876 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -132.24 145.47 57.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.527 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.04 -33.15 82.34 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 124.136 3.224 . . . . 0.0 114.785 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m 59.81 27.13 16.4 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.6 mt 71.72 148.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.032 0.533 . . . . 0.0 111.504 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 62.88 29.79 16.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.134 0.492 . . . . 0.0 111.057 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.82 134.68 55.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.604 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -124.85 172.22 9.53 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.21 94.77 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.99 139.84 40.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.42 118.86 21.65 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -60.45 142.48 98.12 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.028 2.485 . . . . 0.0 111.166 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 175' ' ' ILE . . . -135.25 -30.19 1.05 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.239 0.543 . . . . 0.0 111.431 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.39 -141.91 11.66 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 119.715 -1.231 . . . . 0.0 112.49 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.521 ' CG1' HG13 ' A' ' 113' ' ' ILE . 17.6 pt -126.37 160.69 33.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.926 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.537 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.0 m-20 -109.53 159.74 16.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.33 132.39 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.34 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.96 152.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.108 0.48 . . . . 0.0 111.513 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.586 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.2 m -97.07 160.12 29.79 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.374 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.5 83.24 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.783 2.322 . . . . 0.0 111.615 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.509 ' HG3' ' HB3' ' A' ' 164' ' ' GLN . 30.8 mmmt -114.31 150.3 34.69 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.864 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.79 -42.45 90.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.788 0.328 . . . . 0.0 110.469 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.01 -148.29 7.28 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.594 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.483 ' OH ' HD11 ' A' ' 81' ' ' ILE . 97.7 m-85 -75.98 149.47 37.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.0 110.893 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.586 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 16.3 pt20 -134.23 167.61 20.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.483 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 1.9 tmtm? -60.71 131.4 50.57 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.999 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -134.56 130.58 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.727 0.299 . . . . 0.0 111.69 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -95.08 164.09 13.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.8 mm -119.13 131.69 71.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -135.8 140.66 44.43 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.312 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.9 t -108.38 129.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.398 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.79 170.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 112.01 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 3.05 56.31 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.975 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.51 ' CD ' HD13 ' A' ' 109' ' ' ILE . 12.1 pt-20 -130.09 142.37 50.61 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.815 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.43 ' O ' HD11 ' A' ' 174' ' ' LEU . 2.7 pp -97.23 149.66 21.79 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.625 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 175' ' ' ILE . 2.3 pp -131.41 145.35 35.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.398 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -131.01 149.68 52.5 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -98.39 178.94 4.88 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.97 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.15 119.72 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -125.49 -22.0 4.39 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.386 0.612 . . . . 0.0 109.731 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.1 p -130.03 164.21 24.82 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.521 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 mppt? -63.28 -35.79 81.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.92 -44.32 94.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.118 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.34 -41.43 96.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.177 0.513 . . . . 0.0 109.647 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 53.0 tp -61.19 -47.73 84.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.522 -176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.618 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 86.6 tttt -68.11 -35.88 78.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.583 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.5 tp -58.5 -48.36 81.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.748 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.34 -42.45 98.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.274 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.618 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.3 -32.38 73.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.848 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -61.87 -44.8 96.09 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.687 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.84 -35.83 67.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.146 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 190' ' ' LEU . 95.1 mt -65.11 -41.08 95.26 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.845 0.831 . . . . 0.0 109.845 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -61.54 -46.5 89.67 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.346 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -66.79 -31.56 72.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.63 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.04 -23.91 67.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.957 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.94 -90.42 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.271 2.228 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.85 179.41 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 68.9 m-20 -94.82 166.02 12.19 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.8 127.73 56.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.121 0.486 . . . . 0.0 110.519 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.88 121.97 45.15 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.614 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.539 ' HA ' HG23 ' A' ' 98' ' ' VAL . 65.9 mt -118.83 114.27 44.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.567 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 59.8 ttm -84.7 97.11 9.47 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-O 121.936 0.874 . . . . 0.0 111.302 -178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 49' ' ' THR . . . -114.42 100.82 8.6 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.038 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.96 -1.18 7.84 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.974 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.24 164.12 28.17 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -136.65 -9.51 1.87 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 71.83 -154.1 50.76 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.663 177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 p -97.62 11.84 35.62 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.953 0.501 . . . . 0.0 111.999 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' C ' ' H ' ' A' ' 15' ' ' GLY . 89.9 mmt-85 -114.27 20.7 15.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.837 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt 71.71 -37.4 0.39 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.507 0.723 . . . . 0.0 112.297 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 13' ' ' ARG . . . 98.39 61.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.483 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.5 55.43 4.09 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.953 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.42 150.54 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 158.88 19.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.928 0.394 . . . . 0.0 111.111 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.1 pttm -63.73 154.73 79.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.334 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 28.5 Cg_endo -62.58 -5.73 7.61 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.659 2.906 . . . . 0.0 113.647 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.457 HD21 ' HA ' ' A' ' 56' ' ' THR . 72.7 mt -86.84 23.07 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 19' ' ' LYS . 95.6 mt -70.4 116.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.5 pttm -96.24 131.82 42.34 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.205 1.003 . . . . 0.0 112.759 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -128.93 138.54 52.05 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 113.395 -1.729 . . . . 0.0 108.634 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 191' ' ' LEU . 81.0 m 63.33 -75.65 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.55 0.531 . . . . 0.0 112.263 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.18 0.58 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.669 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 7.7 ptm180 -150.6 170.1 19.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.402 1.101 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 96.3 m -78.07 156.96 29.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -53.01 -46.94 68.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.327 0.651 . . . . 0.0 110.929 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -63.95 -36.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.817 0.341 . . . . 0.0 110.762 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.56 -40.8 97.93 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.519 ' CE2' ' HG2' ' A' ' 27' ' ' ARG . 7.7 m-85 -61.63 -36.75 81.65 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 29' ' ' LEU . 78.9 t -65.77 -42.35 92.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.924 0.392 . . . . 0.0 110.881 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.0 t -64.01 -41.61 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 t -48.04 -56.5 13.49 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -67.91 -37.37 15.6 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 121.719 1.612 . . . . 0.0 112.435 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.471 HD12 HG11 ' A' ' 98' ' ' VAL . 82.0 mt -65.52 -42.59 91.86 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.48 ' HG ' HD22 ' A' ' 69' ' ' ASN . 6.6 tt -61.45 -46.92 88.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.283 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -76.34 -12.8 60.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.1 p -72.17 -178.41 2.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.925 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -70.04 -4.56 21.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.997 -1.002 . . . . 0.0 113.529 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.32 162.07 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.483 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.555 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.1 t30 -80.12 -75.44 0.26 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.201 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.0 161.04 21.6 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.039 0.447 . . . . 0.0 110.8 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.8 mm -108.99 116.49 52.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.301 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 88.6 m-85 -109.89 118.1 35.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.481 HG23 HD12 ' A' ' 60' ' ' ILE . 90.2 mt -101.57 118.77 48.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.567 0.699 . . . . 0.0 111.023 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.476 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -84.48 117.99 24.01 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.074 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 7' ' ' ALA . 71.5 p -125.26 164.32 20.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -126.53 156.14 73.52 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.491 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -58.07 -24.29 65.23 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.98 2.453 . . . . 0.0 111.154 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -70.1 -20.86 63.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.021 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -139.6 67.64 37.06 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.629 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 86.3 Cg_endo -100.76 84.9 0.04 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.618 0 C-N-CA 116.682 -1.745 . . . . 0.0 109.522 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -151.43 -45.78 0.11 Allowed 'General case' 1 C--N 1.213 -5.362 0 CA-C-N 110.311 -3.131 . . . . 0.0 102.938 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.457 ' HA ' HD21 ' A' ' 21' ' ' LEU . 87.4 m -63.6 -46.1 87.34 Favored 'General case' 0 N--CA 1.386 -3.628 0 CA-C-N 112.933 -1.939 . . . . 0.0 105.824 163.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.6 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.7 tmtt? -61.18 -50.28 73.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.239 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 57.9 mt-10 -59.79 -43.93 94.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 118.274 -1.371 . . . . 0.0 112.348 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.15 -50.87 71.41 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.481 HD12 HG23 ' A' ' 47' ' ' ILE . 97.5 mt -63.1 -42.52 96.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.333 0.587 . . . . 0.0 110.414 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.22 -44.84 84.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.054 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 68.5 m -70.39 -40.19 74.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.736 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.78 89.83 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.26 0.552 . . . . 0.0 110.956 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 62.0 m-85 -112.73 41.39 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.169 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 62' ' ' SER . 12.7 mmmm -59.7 -37.3 78.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.112 177.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.62 11.15 15.78 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.807 0.443 . . . . 0.0 111.024 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.499 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 47.7 p90 -39.51 132.96 1.49 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.0 -48.18 4.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.48 HD22 ' HG ' ' A' ' 38' ' ' LEU . 26.1 p-10 -118.81 9.7 12.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.843 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.5 mp -99.7 119.17 47.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.615 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.0 t -121.22 131.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.737 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.69 130.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.476 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.3 pt -125.4 156.63 34.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.127 0.489 . . . . 0.0 110.562 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -118.23 134.91 54.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.406 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 13.8 t -160.57 -169.22 2.36 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.6 m -64.32 2.35 0.61 Allowed 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 127.169 2.188 . . . . 0.0 114.674 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.43 -22.32 0.0 OUTLIER Glycine 0 N--CA 1.511 3.64 0 C-N-CA 126.358 1.932 . . . . 0.0 116.929 -174.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.7 OUTLIER -56.42 -36.82 69.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.337 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.04 125.74 7.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.59 -51.6 68.7 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.1 pt -75.49 -30.72 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.375 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 43.7 mt-10 -65.52 -41.86 92.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.825 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.567 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 6.9 t0 -60.21 -51.27 70.27 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.991 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -59.41 -44.36 92.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 88' ' ' ILE . 22.7 m-80 -61.2 -40.32 93.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.92 0.39 . . . . 0.0 111.774 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 63.4 mm-40 -62.79 -46.45 87.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 99.5 m -62.15 -43.15 99.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.085 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.0 pt -65.68 -27.72 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.032 0.444 . . . . 0.0 110.316 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.99 -20.28 74.51 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.713 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -105.3 -23.58 12.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 60.0 m-85 -75.2 149.57 38.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -97.11 -15.48 20.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -139.83 160.91 58.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.808 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -52.91 143.19 49.99 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 111.778 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -137.57 156.16 48.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.439 0.638 . . . . 0.0 111.687 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 154' ' ' ILE . 1.5 tm? -86.86 133.87 33.59 Favored 'General case' 0 C--O 1.189 -2.131 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.057 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.7 t -107.03 128.54 61.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.141 0.576 . . . . 0.0 109.756 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 5' ' ' ILE . 4.4 m -130.53 161.53 40.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.495 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.493 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 70.2 m -99.73 144.28 28.98 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.731 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.496 ' O ' HD23 ' A' ' 29' ' ' LEU . 63.6 m -88.03 -1.48 58.02 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -108.32 7.78 27.36 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 65.9 mt -81.44 114.91 20.5 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.176 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.35 112.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 173.58 176.95 0.12 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.0 tp -84.21 103.06 13.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -96.98 -3.84 40.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.686 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -59.77 -45.01 93.58 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.057 0.456 . . . . 0.0 111.778 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -79.15 -23.57 43.88 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.365 0.602 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 113' ' ' ILE . 35.1 mm -68.98 -41.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.395 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.07 -46.55 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.376 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.22 -42.42 99.29 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.256 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.4 m -64.76 -41.71 95.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.55 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.701 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.8 mm -64.21 -49.96 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.008 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.411 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 64.8 t -61.6 -47.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.769 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.41 -46.42 88.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.823 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.624 ' CE2' HD11 ' A' ' 120' ' ' ILE . 67.0 t80 -63.43 -46.51 86.01 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.795 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.62 -48.3 81.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.907 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.411 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.1 m-85 -63.21 -33.79 76.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.427 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.01 -46.92 87.09 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.286 0.565 . . . . 0.0 109.676 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.624 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.8 mt -64.18 -48.58 85.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.577 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -65.55 -26.53 67.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.413 -178.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.49 99.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.57 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 19.0 ptpt -82.24 -37.0 26.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.669 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.553 ' O ' HG13 ' A' ' 127' ' ' VAL . 85.9 m -132.65 91.72 29.2 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.15 -17.44 38.73 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 123.379 2.72 . . . . 0.0 112.921 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.75 -32.27 73.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.553 HG13 ' O ' ' A' ' 124' ' ' THR . 9.9 p -73.33 127.64 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.479 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 45.0 mt-10 -122.19 2.9 9.83 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.193 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.51 155.23 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.971 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.8 tp -137.58 146.1 43.63 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.93 137.12 53.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.338 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.471 HG22 ' CD1' ' A' ' 113' ' ' ILE . 98.9 t -114.24 115.77 50.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.379 0.609 . . . . 0.0 109.615 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.5 ptm -145.9 156.61 43.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.785 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.441 HG12 ' HB3' ' A' ' 152' ' ' ALA . 22.2 pt -131.5 158.39 75.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.652 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.51 142.21 95.34 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.411 2.074 . . . . 0.0 111.706 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.06 -24.83 68.09 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.362 0.601 . . . . 0.0 109.696 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.32 -36.1 82.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.461 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.07 -24.25 19.22 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.426 0.632 . . . . 0.0 110.996 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.409 ' HD1' HD11 ' A' ' 134' ' ' ILE . 59.7 t80 -92.0 118.17 68.08 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.773 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.84 -76.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.515 2.143 . . . . 0.0 114.555 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -129.56 127.41 22.99 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.4 ' N ' ' HE2' ' A' ' 139' ' ' TYR . 23.0 Cg_exo -67.07 169.73 14.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.465 2.777 . . . . 0.0 111.961 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.1 m -59.96 -39.64 86.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.09 -68.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -176.52 148.25 0.71 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.084 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -145.98 129.9 17.29 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -88.33 125.64 34.79 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.31 -44.58 2.62 Favored Glycine 0 CA--C 1.506 -0.494 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.148 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 159.71 41.65 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.92 135.87 28.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 141.65 48.54 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.039 1.826 . . . . 0.0 111.252 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.441 ' HB3' HG12 ' A' ' 134' ' ' ILE . . . -114.69 -5.11 12.7 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.295 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.25 -116.95 0.45 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.557 -1.306 . . . . 0.0 113.176 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.453 ' CG1' HG13 ' A' ' 113' ' ' ILE . 25.2 pt -119.05 161.15 18.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.991 0.424 . . . . 0.0 111.768 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.566 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.7 t-20 -120.18 156.02 31.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.118 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 81.3 t -124.25 130.27 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 122.253 0.221 . . . . 0.0 110.75 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.502 HG11 ' OD1' ' A' ' 155' ' ' ASN . 27.7 m -135.52 155.16 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.055 0.455 . . . . 0.0 111.346 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.544 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.6 m -97.06 157.45 34.97 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.187 174.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.34 69.22 7.26 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.873 2.382 . . . . 0.0 111.731 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.31 169.58 10.27 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.918 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -110.22 22.07 15.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.622 0.725 . . . . 0.0 109.606 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -170.27 -176.32 39.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.509 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -72.22 146.17 47.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.091 0.446 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.544 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 19.9 pt20 -133.37 166.6 22.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -173.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.47 127.62 33.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.763 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.13 132.15 53.15 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.65 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -93.49 163.05 13.72 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.641 0.734 . . . . 0.0 112.207 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.4 mm -116.16 127.77 73.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.442 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.8 ttp -131.19 132.86 45.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.911 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 133' ' ' MET . 78.8 t -107.87 131.78 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.163 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.638 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 39.2 pt -114.55 172.62 3.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -117.97 8.02 12.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.352 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.638 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.1 pm0 -104.32 134.67 47.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.708 0.766 . . . . 0.0 110.828 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.73 151.05 19.72 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.536 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.6 pt -110.37 146.16 15.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.436 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.34 111.8 24.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -110.12 153.02 25.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.509 HG23 ' HB2' ' A' ' 183' ' ' ASP . 92.6 mt -110.73 119.59 59.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -114.4 -24.8 8.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.561 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.1 p -128.26 163.96 23.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.695 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -61.8 -32.46 72.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.18 -37.54 85.63 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.366 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.509 ' HB2' HG23 ' A' ' 178' ' ' ILE . 57.3 m-20 -60.89 -35.28 76.24 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.007 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.502 HD23 HD13 ' A' ' 178' ' ' ILE . 96.0 mt -60.02 -46.2 90.27 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.87 0.843 . . . . 0.0 109.184 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 65.7 tttm -65.82 -40.05 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.505 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 189' ' ' MET . 10.5 tt -64.13 -44.36 92.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 0.0 110.187 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.06 -43.03 99.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.332 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -70.33 -29.74 66.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.064 0.459 . . . . 0.0 110.607 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.424 ' HB3' ' O ' ' A' ' 186' ' ' LEU . 60.0 ttm -61.87 -47.91 82.9 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.325 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -70.1 -31.38 68.91 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.768 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.457 HD13 ' SG ' ' A' ' 25' ' ' CYS . 83.5 mt -62.11 -45.02 95.34 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.339 0.59 . . . . 0.0 110.678 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -70.75 -47.56 59.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.27 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -66.55 -42.81 86.54 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -104.57 5.9 34.17 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.38 99.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.247 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.268 2.056 0 CA-C-O 117.478 -1.248 . . . . 0.0 109.862 178.16 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 59.2 ttm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.474 ' HA ' HG12 ' A' ' 42' ' ' VAL . 63.6 m-20 -103.94 164.6 11.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.614 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.7 129.79 56.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.178 0.513 . . . . 0.0 111.168 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.402 ' O ' HG21 ' A' ' 98' ' ' VAL . 2.2 tm? -103.57 119.27 38.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.55 ' HA ' HG21 ' A' ' 98' ' ' VAL . 68.6 mt -116.6 115.69 49.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.138 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.567 ' CE ' HD23 ' A' ' 84' ' ' LEU . 47.2 mtt -89.66 97.47 11.21 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 122.48 1.133 . . . . 0.0 113.591 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' HG21 ' A' ' 49' ' ' THR . . . -115.86 110.62 19.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.07 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.86 -14.35 49.31 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.13 170.61 49.51 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.11 153.93 48.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.962 0.411 . . . . 0.0 110.907 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 1.81 72.63 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.284 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m 70.75 102.39 0.06 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.025 0.441 . . . . 0.0 109.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 70.13 10.34 7.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.281 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 98.3 mtp -136.0 137.16 40.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.354 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.43 -158.97 9.7 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -10.4 72.05 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.791 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.404 ' HB ' ' OG ' ' A' ' 100' ' ' SER . 35.9 m -104.25 3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.454 0.645 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 0.1 OUTLIER -90.42 168.02 12.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.15 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 tppp? 62.91 59.36 2.21 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.611 0.764 . . . . 0.0 110.972 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 36.6 Cg_exo -64.96 -9.4 21.32 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.445 2.764 . . . . 0.0 112.402 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 59' ' ' TYR . 10.8 mp -79.69 6.31 11.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.47 125.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.513 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -109.54 146.09 35.23 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.647 0.737 . . . . 0.0 112.386 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 184' ' ' LEU . 96.4 mt -129.45 124.71 34.75 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.848 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.6 m 65.66 -74.32 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.732 0.645 . . . . 0.0 112.418 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.9 -68.96 0.55 Allowed Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.529 -0.843 . . . . 0.0 114.221 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 98.5 mtt180 -115.76 172.86 6.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 112.349 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 78.4 m -71.84 154.47 41.25 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.466 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -42.21 20.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.436 1.094 . . . . 0.0 111.219 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' O ' HG21 ' A' ' 34' ' ' VAL . 5.1 tp -58.18 -48.2 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.504 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 19.0 t70 -63.74 -40.01 95.7 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.036 0.446 . . . . 0.0 110.584 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 7.0 m-30 -62.13 -37.4 85.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.865 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.45 -43.66 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.701 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 30' ' ' ILE . 78.4 t -64.62 -42.18 94.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.643 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -50.04 -54.99 27.35 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.12 -38.09 9.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.205 1.27 . . . . 0.0 112.583 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.423 HD13 HG13 ' A' ' 98' ' ' VAL . 91.1 mt -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.967 0.413 . . . . 0.0 111.405 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.546 ' HG ' HD22 ' A' ' 69' ' ' ASN . 7.5 tt -63.09 -46.88 85.29 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.07 -12.93 60.03 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 p -74.62 -176.75 2.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.932 0.396 . . . . 0.0 110.803 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.28 -9.51 3.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.883 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.474 HG12 ' HA ' ' A' ' 2' ' ' ASP . 69.0 t -64.51 133.11 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.171 0.51 . . . . 0.0 110.588 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -80.26 -68.3 0.69 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.988 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -111.12 148.38 32.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.405 0.621 . . . . 0.0 111.217 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.9 mm -108.47 117.12 53.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.765 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.24 113.83 27.23 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -95.23 116.3 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.427 0 CA-C-O 121.657 0.741 . . . . 0.0 110.042 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.6 120.6 29.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.826 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 7' ' ' ALA . 76.0 p -125.61 160.16 30.32 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.254 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.9 m -109.66 150.44 41.26 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.999 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.27 -27.6 75.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.103 2.536 . . . . 0.0 111.801 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -81.05 -6.62 59.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.476 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.8 66.34 40.58 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.588 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.9 Cg_endo -109.24 85.79 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.842 0 CA-C-N 120.713 1.29 . . . . 0.0 110.159 168.092 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.594 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.0 mttt -146.45 -45.63 0.19 Allowed 'General case' 1 C--N 1.217 -5.187 0 CA-C-N 109.852 -3.34 . . . . 0.0 102.327 177.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.422 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 77.1 m -62.03 -47.99 82.3 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 112.033 -2.349 . . . . 0.0 105.989 162.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.32 -50.1 72.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.061 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.594 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.2 pt-20 -59.33 -35.15 73.32 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.858 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.459 ' CB ' HD21 ' A' ' 21' ' ' LEU . 56.4 t80 -67.25 -51.61 51.02 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.932 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.412 ' CD1' HG12 ' A' ' 30' ' ' ILE . 97.7 mt -63.47 -44.91 99.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.536 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -58.77 -42.65 89.42 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.475 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 35.2 t -70.33 -43.2 70.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.847 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.48 89.73 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.798 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.51 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 68.3 m-85 -108.11 34.69 3.47 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.185 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.8 mmmt -62.64 -20.23 64.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.564 0.697 . . . . 0.0 110.128 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.7 10.84 16.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.938 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.51 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 52.9 p90 -46.78 126.48 8.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -104.34 -49.37 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.546 HD22 ' HG ' ' A' ' 38' ' ' LEU . 24.9 p-10 -117.01 15.73 15.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.255 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 67' ' ' TYR . 78.8 mt -105.32 127.58 59.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.248 0.547 . . . . 0.0 110.851 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.03 132.98 68.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.83 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.61 130.96 60.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.4 155.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 122.038 0.923 . . . . 0.0 112.372 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -111.13 132.61 54.15 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.189 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 2.6 t -161.14 -172.05 3.28 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.8 m -66.69 2.08 1.51 Allowed 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 127.236 2.214 . . . . 0.0 114.68 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.11 -23.98 0.0 OUTLIER Glycine 0 N--CA 1.51 3.596 0 C-N-CA 126.237 1.875 . . . . 0.0 117.038 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -55.38 -35.3 65.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.18 121.77 5.51 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.29 -50.44 73.61 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.9 mt -65.99 -43.62 92.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.585 0.707 . . . . 0.0 110.172 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.1 -44.12 91.91 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.295 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.515 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 33.7 t0 -62.07 -48.15 81.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.282 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -53.76 -41.54 67.27 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.861 177.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.573 ' O ' HG12 ' A' ' 88' ' ' ILE . 28.0 m-80 -60.09 -43.99 95.12 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.365 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 53.3 mm-40 -65.67 -41.91 91.93 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.264 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 84' ' ' LEU . 26.1 pt -66.23 -25.12 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.335 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.18 92.28 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.121 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -80.75 -8.99 59.84 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -119.81 145.97 46.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.4 m -115.73 10.73 15.5 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -133.36 157.65 77.6 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.121 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.84 146.05 64.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.195 1.93 . . . . 0.0 111.557 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -139.2 158.26 44.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 155' ' ' ASN . 27.0 tp -86.27 140.62 29.93 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.928 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 60.3 t -115.17 131.34 67.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 5' ' ' ILE . 11.0 m -126.97 157.02 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.691 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.461 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 36.3 t -99.71 136.5 39.54 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.404 ' OG ' ' HB ' ' A' ' 17' ' ' VAL . 74.8 p -64.54 -34.03 77.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -174.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -88.79 1.95 54.37 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.461 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 70.3 mt -91.26 114.11 26.55 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.757 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -121.88 130.29 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -176.91 -178.08 0.82 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.97 71.7 1.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.491 ' HA ' HD11 ' A' ' 109' ' ' ILE . 58.6 mtpt -79.98 -8.05 59.13 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.546 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.8 t -59.75 -45.94 90.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -82.97 -24.26 33.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.797 0.808 . . . . 0.0 110.169 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.677 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.6 mt -65.63 -39.24 84.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.03 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 106' ' ' LYS . 60.3 mt -57.09 -46.47 84.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.279 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -61.66 -43.9 97.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.12 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -63.98 -40.77 97.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.738 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.01 -49.11 85.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.217 0.532 . . . . 0.0 110.373 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.51 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.7 t -62.48 -46.83 95.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.244 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.61 -43.81 98.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.113 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.428 ' CD2' ' HG3' ' A' ' 169' ' ' MET . 37.5 t80 -66.77 -42.75 85.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.147 0.498 . . . . 0.0 110.287 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.44 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.2 t80 -57.46 -47.3 82.2 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.333 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.51 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 39.8 m-85 -67.95 -30.75 70.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.39 -39.79 95.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -65.34 -42.33 93.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.409 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.922 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.33 -38.5 74.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.67 177.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.48 91.17 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.561 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -88.59 -37.39 15.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 111.612 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.6 m -141.27 92.06 8.49 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.411 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.262 2.641 . . . . 0.0 112.295 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.39 -30.47 70.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.463 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.479 HG23 ' HE3' ' A' ' 165' ' ' LYS . 61.9 t -67.05 127.45 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.087 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 158' ' ' SER . 30.1 mt-10 -102.44 -34.11 9.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.234 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -131.45 165.6 23.17 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.44 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -140.22 134.25 30.85 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.807 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.51 135.93 51.03 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.533 HG21 ' CD1' ' A' ' 113' ' ' ILE . 78.3 t -117.24 118.61 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.68 41.92 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.747 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.577 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 34.8 pt -124.58 163.28 37.71 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 10.7 Cg_endo -57.1 124.83 17.15 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.82 1.68 . . . . 0.0 110.772 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -60.76 -24.34 65.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.059 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.41 -39.2 88.83 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -82.94 -22.23 33.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.431 0.634 . . . . 0.0 110.432 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.424 ' HE2' ' O ' ' A' ' 141' ' ' ASN . 43.9 t80 -71.54 138.12 83.47 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.357 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.59 -73.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.363 2.042 . . . . 0.0 112.271 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.424 ' O ' ' HE2' ' A' ' 139' ' ' TYR . 31.6 p30 -158.16 143.18 11.99 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.702 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.436 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 35.2 Cg_exo -62.72 145.35 94.96 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.541 2.161 . . . . 0.0 111.682 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 53.7 m -73.99 101.87 3.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.4 mm 71.86 -38.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.593 0.757 . . . . 0.0 112.864 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 142' ' ' PRO . 8.9 t0 -61.41 133.23 55.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -70.86 -42.05 70.62 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -171.81 132.07 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.755 0.312 . . . . 0.0 111.325 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.86 -148.2 13.84 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.7 mp -88.35 140.92 28.98 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m -117.53 118.67 35.08 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.529 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.96 144.92 48.87 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.271 1.981 . . . . 0.0 110.977 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.453 ' HB1' HG12 ' A' ' 134' ' ' ILE . . . -128.79 16.65 6.34 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.785 0.326 . . . . 0.0 111.525 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.18 -114.86 0.33 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.89 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.512 ' CG1' HG13 ' A' ' 113' ' ' ILE . 13.0 pt -134.45 160.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.239 -0.481 . . . . 0.0 110.348 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.435 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.7 t30 -118.19 155.91 29.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.69 130.36 73.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 122.421 0.289 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.53 147.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.134 0.492 . . . . 0.0 111.13 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 8.4 t -99.28 158.45 32.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.462 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 28.7 Cg_exo -62.98 93.93 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.373 1.382 . . . . 0.0 110.669 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.497 ' HD2' ' HA ' ' A' ' 163' ' ' TYR . 20.6 pttp -78.01 174.83 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.843 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -124.08 -68.81 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.069 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -113.46 47.23 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.497 ' HA ' ' HD2' ' A' ' 160' ' ' LYS . 91.8 m-85 74.9 148.9 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.566 0.746 . . . . 0.0 110.542 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 158' ' ' SER . 26.7 pt20 -133.84 165.11 25.75 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.479 ' HE3' HG23 ' A' ' 127' ' ' VAL . 64.9 tttp -67.85 121.97 17.14 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.204 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -123.38 126.74 47.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.848 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -94.37 163.05 13.58 Favored 'General case' 0 CA--C 1.469 -2.172 0 CA-C-O 121.895 0.855 . . . . 0.0 113.218 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.0 129.51 69.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.006 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.487 ' SD ' HG23 ' A' ' 171' ' ' ILE . 15.0 tmm? -131.31 138.24 49.15 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.738 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.22 131.09 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.921 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.569 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 2.2 pp -114.63 178.52 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.889 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -115.81 3.36 13.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.569 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 1.8 pm0 -98.83 136.85 38.26 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.81 0.814 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.68 139.27 32.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.965 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.452 HD13 HD22 ' A' ' 102' ' ' LEU . 1.8 pp -101.93 155.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -98.99 107.31 19.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -92.3 124.92 36.72 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 183' ' ' ASP . 85.5 mt -108.86 110.01 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.725 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -124.4 -13.72 7.07 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 43.1 p -127.04 167.75 15.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.381 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -35.18 80.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.83 -42.45 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.054 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 178' ' ' ILE . 73.2 m-20 -62.28 -37.8 86.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.143 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.401 ' HB3' HD21 ' A' ' 24' ' ' LEU . 95.5 mt -60.26 -46.79 88.6 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.765 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 189' ' ' MET . 28.9 mtpp -64.93 -38.41 90.89 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.368 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.98 -50.5 73.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.154 0.502 . . . . 0.0 110.078 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.35 -41.92 88.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.435 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER -68.98 -30.8 69.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.549 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.4 mtp -64.61 -41.57 96.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.747 0.308 . . . . 0.0 111.684 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -77.84 -33.02 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.923 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 86.9 mt -61.28 -47.42 86.1 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -70.56 -40.93 73.07 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.988 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -68.06 -43.14 79.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.824 0.345 . . . . 0.0 111.648 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -71.76 -26.23 62.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.912 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -60.61 -40.56 98.07 Favored Glycine 0 C--N 1.321 -0.265 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.146 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.272 2.256 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.12 179.258 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.625 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 36.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -90.37 166.2 13.42 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.021 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.544 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -123.29 134.01 54.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.66 127.28 52.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.148 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.559 ' HA ' HG22 ' A' ' 98' ' ' VAL . 61.4 mt -118.11 106.83 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.619 ' HE1' ' CG ' ' A' ' 83' ' ' ASP . 60.3 ttm -80.5 101.53 9.15 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 121.898 0.856 . . . . 0.0 111.021 -178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 49' ' ' THR . . . -115.54 97.72 6.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.35 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.33 106.26 0.55 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.984 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.41 -163.13 35.94 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.087 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.74 105.33 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.35 154.28 19.73 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.268 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.4 p -92.15 -16.43 26.3 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.151 0.5 . . . . 0.0 110.132 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -130.5 149.77 52.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.047 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -95.77 116.44 28.89 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.73 134.21 11.35 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.85 -129.58 46.79 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.17 -68.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 116.999 0.399 . . . . 0.0 109.973 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' HA ' HD13 ' A' ' 22' ' ' ILE . 46.7 mt-10 49.69 -162.45 0.05 OUTLIER 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.215 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' HB3' ' CD ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER 67.26 176.25 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.051 175.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' CD ' ' HB3' ' A' ' 19' ' ' LYS . 51.1 Cg_exo -59.16 -8.96 7.2 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.607 2.205 . . . . 0.0 113.546 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.509 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 49.7 mt -89.08 6.34 40.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 18' ' ' GLU . 97.3 mt -63.58 114.21 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 60.4 pttt -95.6 131.77 41.45 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.583 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 188' ' ' GLU . 61.9 tp -136.13 120.97 18.57 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.322 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.6 m 58.54 24.09 11.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.86 -31.36 4.57 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.223 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.71 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 95.8 mtt180 -126.39 157.54 38.25 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.787 1.294 . . . . 0.0 111.764 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 73.5 m -81.54 163.52 22.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.535 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 33' ' ' VAL . 84.9 mt -58.77 -39.7 81.79 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.592 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.589 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.7 tp -56.21 -47.47 80.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.245 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.671 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.1 t70 -65.02 -42.86 94.02 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.168 0.508 . . . . 0.0 110.634 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 30.8 m-85 -64.07 -36.94 85.66 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.427 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.506 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 79.1 t -70.07 -41.05 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 30' ' ' ILE . 59.8 t -61.47 -43.27 96.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.899 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.421 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 65.8 m -52.76 -52.46 64.31 Favored Pre-proline 0 CA--C 1.571 1.768 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 33' ' ' VAL . 51.9 Cg_exo -60.53 -42.46 40.24 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 121.758 1.639 . . . . 0.0 111.982 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.468 HD12 HG12 ' A' ' 98' ' ' VAL . 96.1 mt -68.2 -37.23 80.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.722 0.772 . . . . 0.0 110.585 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 HD22 ' A' ' 69' ' ' ASN . 59.7 tp -58.33 -45.77 87.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.989 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.11 -1.61 58.17 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.414 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.554 ' HB2' HG22 ' A' ' 110' ' ' ILE . 60.3 p -75.69 175.4 8.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.452 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.9 ttmm -58.26 -27.01 63.62 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.493 0.717 . . . . 0.0 112.469 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.529 HG23 ' OG ' ' A' ' 40' ' ' SER . 30.7 m -59.94 154.51 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.16 -69.0 0.56 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.844 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.92 153.67 36.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.207 0.527 . . . . 0.0 111.16 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.8 mm -106.64 115.26 47.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 87.0 m-85 -104.91 116.09 31.39 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.507 HG21 HD12 ' A' ' 60' ' ' ILE . 96.6 mt -94.97 116.05 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-O 121.574 0.702 . . . . 0.0 110.319 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.474 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.66 120.74 28.29 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.439 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.438 HG21 ' O ' ' A' ' 7' ' ' ALA . 68.9 p -125.06 158.0 34.86 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.472 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.9 t -111.9 142.29 26.44 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.169 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -55.48 -25.89 51.29 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.457 2.771 . . . . 0.0 111.949 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -75.84 -9.0 58.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -140.35 67.12 31.41 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-O 119.244 -0.408 . . . . 0.0 112.011 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.613 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 67.0 Cg_endo -104.68 85.26 0.02 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.781 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.413 170.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.598 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 97.6 mttt -147.63 -46.78 0.17 Allowed 'General case' 1 C--N 1.214 -5.308 0 CA-C-N 109.932 -3.304 . . . . 0.0 103.721 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.417 ' HA ' HD12 ' A' ' 21' ' ' LEU . 87.9 m -61.93 -47.43 84.96 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 164.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -62.68 -49.62 74.39 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.016 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.598 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.1 pt-20 -59.19 -37.73 78.12 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.876 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.48 -50.25 70.4 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 47' ' ' ILE . 94.7 mt -63.47 -41.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.601 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.542 ' OD1' HG12 ' A' ' 72' ' ' VAL . 92.7 m-20 -57.06 -45.73 83.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.866 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 58.3 m -71.32 -41.96 69.22 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.262 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 -38.91 92.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.328 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.466 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 70.3 m-85 -113.55 37.86 3.1 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.71 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 10.8 mmmm -62.47 -23.38 66.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.316 0.579 . . . . 0.0 110.758 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -92.55 11.28 26.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.332 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.466 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 53.0 p90 -43.25 128.6 4.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -101.36 -52.03 3.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.023 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.474 HD22 HD11 ' A' ' 38' ' ' LEU . 6.8 p-10 -119.48 14.31 12.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.71 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.52 125.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 59.3 t -125.42 133.17 69.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG12 ' OD1' ' A' ' 61' ' ' ASN . 7.2 p -104.5 134.47 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.2 pt -129.25 157.1 42.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.585 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -116.07 136.13 53.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 12.7 t -160.2 -172.4 3.58 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -66.73 3.81 0.95 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 127.543 2.337 . . . . 0.0 114.592 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.98 -20.73 0.0 OUTLIER Glycine 1 N--CA 1.517 4.099 0 C-N-CA 126.51 2.005 . . . . 0.0 116.947 -173.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 76' ' ' SER . 55.8 tptt -56.55 -39.78 73.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.26 122.37 6.09 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.15 -50.44 73.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.219 0.533 . . . . 0.0 111.718 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.3 -45.65 95.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.71 0.766 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 48.3 mt-10 -60.07 -42.48 94.65 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.83 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.619 ' CG ' ' HE1' ' A' ' 6' ' ' MET . 6.2 t0 -58.79 -51.61 69.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.347 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.609 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.0 mm? -58.76 -43.56 90.35 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.614 ' O ' HG12 ' A' ' 88' ' ' ILE . 30.0 m-80 -61.61 -39.93 93.02 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.332 0.587 . . . . 0.0 112.4 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 54.6 mm-40 -65.91 -42.21 90.47 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.506 -0.746 . . . . 0.0 109.009 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.5 m -61.73 -43.21 99.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.961 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 85' ' ' ASN . 33.1 pt -63.64 -27.1 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.687 0.28 . . . . 0.0 110.344 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.73 -24.87 64.88 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.566 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -99.93 2.87 44.08 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.85 135.6 54.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 112.285 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -103.66 -2.35 26.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.1 mt-10 -131.55 160.83 65.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.1 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.625 ' O ' ' HG3' ' A' ' 1' ' ' MET . 48.7 Cg_endo -67.31 157.67 60.66 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.445 2.096 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -144.71 159.25 43.14 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.367 0.603 . . . . 0.0 111.699 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.544 ' HB3' ' HA ' ' A' ' 3' ' ' ALA . 21.9 tp -86.64 145.98 26.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.726 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 95.8 t -116.63 130.11 72.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 124.07 0.948 . . . . 0.0 108.601 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.4 m -131.77 163.97 35.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.26 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.9 t -99.8 139.71 35.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.4 p -89.6 -1.3 57.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.01 9.54 13.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 102' ' ' LEU . 2.8 pp -92.53 143.48 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.938 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.436 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 18.0 tt -140.26 132.41 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.074 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 18.9 t-20 173.28 167.61 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.163 0.985 . . . . 0.0 108.415 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tt -80.19 88.32 5.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.565 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -101.82 3.6 39.52 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.5 p -52.76 -36.04 57.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.419 ' CG ' HD11 ' A' ' 109' ' ' ILE . 21.5 pttp -73.15 -28.51 62.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.254 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.736 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.0 mp -61.4 -43.05 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.304 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.554 HG22 ' HB2' ' A' ' 40' ' ' SER . 5.2 mm -54.16 -49.82 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 121.821 0.819 . . . . 0.0 109.743 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.452 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 62.3 m-80 -61.98 -42.93 99.69 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.662 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -61.81 -38.35 87.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.726 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.736 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -60.83 -49.15 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.11 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.54 -47.76 91.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.863 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.08 -46.91 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.731 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.651 ' CE2' HD11 ' A' ' 120' ' ' ILE . 45.2 t80 -66.53 -46.05 77.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.637 0.256 . . . . 0.0 111.483 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -58.19 -47.58 83.01 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.073 0.464 . . . . 0.0 110.694 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -62.84 -37.36 86.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.204 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 91.7 m -63.75 -40.15 96.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.024 0.44 . . . . 0.0 110.568 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.651 HD11 ' CE2' ' A' ' 116' ' ' TYR . 81.2 mt -65.45 -46.02 91.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.138 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 52.8 mtmt -63.08 -37.52 87.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.218 0.533 . . . . 0.0 110.531 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.61 91.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.293 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -82.2 -35.0 28.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.024 0.44 . . . . 0.0 111.513 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 66.4 m -137.24 97.51 10.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.447 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.04 -20.52 54.13 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.412 2.742 . . . . 0.0 113.036 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.77 -30.39 71.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.787 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.425 HG21 ' HE3' ' A' ' 165' ' ' LYS . 67.5 t -73.77 125.38 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.82 2.58 7.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.995 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -143.0 156.08 44.78 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.962 0.41 . . . . 0.0 111.468 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.39 133.1 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 -177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -120.37 129.98 54.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.86 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.657 HG23 ' CD1' ' A' ' 113' ' ' ILE . 60.8 t -115.01 121.74 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 6.5 ptm -145.89 156.8 43.79 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.661 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.415 HG22 ' CB ' ' A' ' 152' ' ' ALA . 14.3 pt -128.54 156.52 77.09 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.633 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.9 131.78 48.07 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.219 1.946 . . . . 0.0 111.95 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.89 -19.7 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.521 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.09 -37.01 86.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.42 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -93.99 -23.6 17.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 110.207 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -64.55 135.35 96.33 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.652 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -49.96 -66.97 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.883 2.389 . . . . 0.0 112.952 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -156.57 133.86 6.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 143' ' ' SER . 50.2 Cg_exo -59.37 -41.52 57.62 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.553 2.169 . . . . 0.0 112.207 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.555 ' HG ' ' ND2' ' A' ' 179' ' ' ASN . 23.3 t 171.2 -63.34 0.01 OUTLIER 'General case' 0 CA--C 1.524 -0.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.285 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.2 tt -155.6 -39.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.042 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -107.81 149.46 28.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.761 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -88.22 -179.66 6.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.3 t30 75.7 161.64 0.24 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.996 0.918 . . . . 0.0 111.567 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.98 179.44 35.86 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.522 ' H ' HD22 ' A' ' 149' ' ' LEU . 2.5 pt? -106.98 149.97 26.97 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.358 0.579 . . . . 0.0 110.434 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.31 135.49 26.94 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.086 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.26 153.61 56.46 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.843 2.362 . . . . 0.0 111.792 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB2' HG13 ' A' ' 132' ' ' VAL . . . -102.32 -7.69 21.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.117 0.484 . . . . 0.0 111.371 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.86 -88.9 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.749 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.466 HD11 HG13 ' A' ' 113' ' ' ILE . 16.9 pt -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.237 0.541 . . . . 0.0 112.308 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.535 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 9.9 t-20 -120.65 153.82 36.35 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.928 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.91 131.18 72.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 O-C-N 122.368 -0.207 . . . . 0.0 111.141 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.32 155.07 36.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.192 0.52 . . . . 0.0 111.141 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.435 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 72.3 m -97.51 158.79 32.51 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 84.5 Cg_endo -75.61 59.39 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.108 1.872 . . . . 0.0 112.484 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -117.87 138.5 52.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.95 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -72.54 133.71 44.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.83 -130.35 9.75 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.936 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.99 141.68 46.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.353 0.597 . . . . 0.0 111.635 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.435 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 22.9 pt20 -134.91 162.72 31.63 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.664 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.425 ' HE3' HG21 ' A' ' 127' ' ' VAL . 63.9 tttp -60.68 128.13 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.4 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -124.76 131.55 53.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -97.35 163.15 13.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.52 131.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.256 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.6 ttp -133.42 132.67 41.41 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.967 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.6 t -112.49 131.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 173' ' ' GLU . 50.7 pt -115.63 176.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.742 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.52 -3.27 31.03 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.205 0.526 . . . . 0.0 110.861 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.471 ' HB2' HD13 ' A' ' 171' ' ' ILE . 56.7 mp0 -98.83 130.47 45.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.922 0.868 . . . . 0.0 112.775 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.474 HD22 ' H ' ' A' ' 174' ' ' LEU . 1.4 pt? -97.72 153.83 17.99 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.754 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.504 HG23 ' HZ1' ' A' ' 106' ' ' LYS . 3.6 pt -112.08 149.18 14.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.429 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.48 115.2 29.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.52 150.29 24.06 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.616 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.452 HG23 ' HB2' ' A' ' 183' ' ' ASP . 88.1 mt -116.28 117.66 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.998 0.427 . . . . 0.0 111.28 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.555 ' ND2' ' HG ' ' A' ' 143' ' ' SER . 18.5 m120 -120.73 -18.9 7.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.121 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.3 p -128.96 164.21 23.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.403 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -60.87 -29.5 69.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.262 0.553 . . . . 0.0 109.531 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.58 -41.35 98.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.335 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.452 ' HB2' HG23 ' A' ' 178' ' ' ILE . 72.6 m-20 -64.21 -28.4 69.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.496 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 96.4 mt -61.54 -45.25 94.96 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.514 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -62.09 -42.66 99.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.747 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.43 -49.84 76.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.456 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.76 -42.54 99.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 8.0 pt-20 -68.15 -33.98 75.48 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.9 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -63.67 -41.42 98.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 111.35 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -77.2 -31.17 55.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.131 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 69.3 tp -64.42 -45.08 89.1 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.483 0.658 . . . . 0.0 110.165 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.1 -37.71 86.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.654 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -58.1 -41.68 84.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.19 -3.59 30.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.382 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -63.16 -39.32 97.81 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.27 2.15 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.871 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' HG22 ' A' ' 42' ' ' VAL . 54.2 tpp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.639 0.257 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -113.93 166.19 11.83 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.6 130.86 56.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.261 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.429 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.9 tp -105.42 124.21 49.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -118.71 101.05 11.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.407 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 8.7 ptm -91.76 106.2 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.851 1.31 . . . . 0.0 111.984 -176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.05 103.75 11.21 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.59 -166.9 21.21 Favored Glycine 0 C--N 1.292 -1.865 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.65 139.01 29.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -85.6 80.57 8.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.811 0.339 . . . . 0.0 111.261 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.14 -62.61 3.34 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.905 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -101.1 125.23 47.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -80.73 -11.5 59.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtt -123.96 145.73 48.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.655 0.265 . . . . 0.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.39 173.99 18.99 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.34 16.77 57.7 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.34 165.11 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' OE2' ' HG3' ' A' ' 181' ' ' LYS . 24.5 mp0 -70.34 144.43 51.65 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.274 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 97.7 mttt -123.04 157.27 61.05 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.451 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 19' ' ' LYS . 27.5 Cg_endo -61.13 -15.72 41.42 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.174 2.583 . . . . 0.0 114.346 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 56' ' ' THR . 44.4 mt -92.69 5.87 49.5 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.498 HG22 HD22 ' A' ' 184' ' ' LEU . 77.2 mt -76.73 118.55 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.93 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -76.75 130.62 37.96 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.056 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 HD21 ' HB3' ' A' ' 188' ' ' GLU . 81.8 mt -127.75 125.43 39.91 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.522 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.8 m 54.31 28.88 9.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.21 35.32 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.764 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 98.8 mtt180 -129.77 153.35 48.3 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 118.181 0.99 . . . . 0.0 112.435 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 61.2 m -80.16 164.4 23.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.32 -39.24 82.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.793 0.33 . . . . 0.0 110.87 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -39.76 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.728 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 21.2 m-20 -62.29 -40.93 97.9 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.153 0.501 . . . . 0.0 110.497 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 10.1 m-85 -63.04 -37.14 86.02 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.693 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.67 -42.41 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 0.0 110.766 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.35 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.777 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.0 m -53.58 -51.94 71.57 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.37 -38.17 35.68 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 121.531 1.487 . . . . 0.0 112.082 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.5 HD11 HG11 ' A' ' 98' ' ' VAL . 93.1 mt -68.45 -40.04 81.23 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.401 0.619 . . . . 0.0 110.782 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.65 -44.04 89.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.398 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -84.03 -14.73 49.87 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.548 ' OG ' HG13 ' A' ' 42' ' ' VAL . 85.5 p -74.37 172.35 12.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.973 0.416 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -65.49 -7.06 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.7 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG13 ' OG ' ' A' ' 40' ' ' SER . 12.2 p -71.24 144.98 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 O-C-N 122.183 -0.323 . . . . 0.0 110.771 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -82.33 -72.37 0.44 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.57 147.08 28.01 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.528 0.68 . . . . 0.0 111.656 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.09 113.66 44.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.61 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -103.31 115.17 30.04 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -95.21 116.46 36.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.7 0.762 . . . . 0.0 110.368 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.422 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -89.9 118.8 29.75 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.245 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.4 p -129.63 158.15 40.13 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.3 m -105.63 148.84 37.11 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.376 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -58.07 -24.99 68.79 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.06 2.507 . . . . 0.0 111.085 177.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -77.92 -5.89 52.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.185 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -139.84 66.87 34.47 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 119.401 -0.333 . . . . 0.0 111.879 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 96.1 Cg_endo -105.8 86.57 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.813 0 CA-C-N 120.982 1.386 . . . . 0.0 109.653 168.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 mmtm -155.61 -46.18 0.08 Allowed 'General case' 1 C--N 1.212 -5.405 0 CA-C-N 109.709 -3.405 . . . . 0.0 102.443 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.492 ' HA ' HD12 ' A' ' 21' ' ' LEU . 97.9 m -63.99 -49.31 72.99 Favored 'General case' 0 N--CA 1.381 -3.9 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 162.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.59 -51.28 66.0 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.11 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.3 pt-20 -63.66 -29.4 70.64 Favored 'General case' 0 C--N 1.37 1.469 0 C-N-CA 116.639 -2.024 . . . . 0.0 112.907 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.483 ' CD2' HD21 ' A' ' 21' ' ' LEU . 55.8 t80 -64.96 -50.37 66.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.434 0.635 . . . . 0.0 110.623 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.0 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -57.63 -45.97 84.75 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.902 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 42.3 t -67.04 -42.45 84.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.547 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.03 92.85 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.166 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.522 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 45.8 m-85 -115.84 37.98 3.46 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.059 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.6 mmmm -60.68 -24.21 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.162 0.506 . . . . 0.0 111.057 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.67 10.47 25.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.2 p90 -45.02 131.4 7.36 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -102.5 -48.92 4.0 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.597 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -118.28 16.35 13.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.786 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.9 mt -107.62 131.06 58.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.512 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.3 t -125.17 133.05 70.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.27 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.43 130.46 56.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.314 0.578 . . . . 0.0 110.313 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.422 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.88 156.53 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 CA-C-O 121.967 0.889 . . . . 0.0 111.37 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.01 130.76 55.49 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.435 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 11.2 t -158.06 -173.24 4.25 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.734 0.778 . . . . 0.0 112.891 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 49.2 m -71.53 2.09 5.57 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 126.472 1.909 . . . . 0.0 114.637 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.67 -23.73 0.0 OUTLIER Glycine 1 N--CA 1.521 4.331 0 C-N-CA 126.462 1.982 . . . . 0.0 117.393 -173.664 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 12.1 tmtt? -56.17 -36.48 68.37 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 172.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.73 122.4 6.2 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -60.27 -51.05 71.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 pt -77.68 -28.64 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.802 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.91 -41.68 99.53 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.561 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 14.0 t0 -60.2 -51.48 69.4 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.049 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.501 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.5 mm? -57.71 -43.71 85.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.509 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.5 m-80 -60.29 -41.33 93.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 70.3 mm-40 -63.95 -46.95 82.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.375 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.1 m -62.71 -42.99 99.93 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.351 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.509 HG12 ' HA ' ' A' ' 85' ' ' ASN . 37.2 pt -65.46 -30.6 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.962 0.41 . . . . 0.0 110.431 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.44 -39.29 95.65 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.245 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -82.01 -36.78 27.46 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 75.2 m-85 -71.31 146.53 48.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.19 0.519 . . . . 0.0 111.801 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -102.06 -10.61 19.55 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.369 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.46 160.32 64.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.667 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.77 142.45 41.53 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 123.27 2.647 . . . . 0.0 112.307 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -142.99 155.62 44.7 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.057 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.706 HD12 ' O ' ' A' ' 155' ' ' ASN . 42.4 tp -86.37 143.91 27.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.221 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.549 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 66.5 t -115.49 133.79 60.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 108.93 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 5' ' ' ILE . 11.1 m -129.98 164.82 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.371 0.605 . . . . 0.0 112.225 -178.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.568 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 50.6 m -99.21 152.79 19.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.0 p -73.61 -10.79 60.07 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 45.4 p-10 -117.23 16.55 14.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.568 ' CD1' ' HB2' ' A' ' 99' ' ' SER . 11.0 mp -61.54 153.13 28.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 111.798 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.89 174.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.686 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.68 162.59 12.9 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.013 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.5 tp 82.52 3.28 1.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.576 1.151 . . . . 0.0 110.213 -177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HE3' ' HA ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -94.02 -1.23 54.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.604 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -62.21 -24.73 67.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.155 0.502 . . . . 0.0 111.786 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.98 -20.91 61.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.15 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.422 ' O ' HG12 ' A' ' 113' ' ' ILE . 28.5 mm -68.57 -41.42 82.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.445 ' HA ' HG12 ' A' ' 113' ' ' ILE . 61.7 mt -60.99 -44.46 98.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.41 -46.84 86.77 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.03 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.3 m -64.15 -42.62 96.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.026 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.62 HG13 ' N ' ' A' ' 114' ' ' VAL . 36.0 pt -67.76 -43.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.62 ' N ' HG13 ' A' ' 113' ' ' ILE . 62.9 t -62.44 -49.15 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.824 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.55 -45.36 93.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.464 -0.494 . . . . 0.0 112.247 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.697 ' CE2' HD12 ' A' ' 120' ' ' ILE . 54.2 t80 -65.84 -46.12 79.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.623 0.249 . . . . 0.0 110.918 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -58.8 -47.9 83.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 15.8 m-85 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.081 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 93.2 m -63.72 -40.37 96.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.672 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.697 HD12 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -66.85 -47.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 124' ' ' THR . 54.6 pttt -65.15 -26.26 68.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.302 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.04 99.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.918 0.39 . . . . 0.0 110.455 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -83.24 -34.04 25.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 50.7 m -139.52 97.42 8.34 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.663 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.53 -11.77 31.87 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.933 2.422 . . . . 0.0 112.856 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.29 -32.7 73.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.454 HG12 ' CG2' ' A' ' 120' ' ' ILE . 7.6 p -87.29 122.41 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.975 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 41.6 mt-10 -127.38 19.15 6.89 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -142.19 148.75 38.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.0 tp -139.63 148.08 41.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.816 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.8 136.18 52.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.09 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 152' ' ' ALA . 99.2 t -111.12 115.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.244 0.545 . . . . 0.0 109.722 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -145.61 157.46 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.775 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 17.0 pt -134.97 155.51 79.14 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.11 137.05 73.02 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.356 2.037 . . . . 0.0 110.797 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 139' ' ' TYR . 14.6 ptmm? -69.93 -16.35 63.2 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.1 -38.93 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -89.91 -15.03 32.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.476 0.655 . . . . 0.0 110.434 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.419 ' HB3' ' HA ' ' A' ' 136' ' ' LYS . 50.7 t80 -82.77 112.94 41.58 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.986 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.42 -27.77 22.92 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.083 2.522 . . . . 0.0 115.905 -172.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -130.54 78.94 73.18 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.61 148.26 41.81 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.301 2.668 . . . . 0.0 112.825 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.7 m -131.31 150.95 51.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.066 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 54.2 mt 69.94 114.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.831 0.852 . . . . 0.0 111.282 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.27 135.68 47.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 46.3 t80 83.31 -7.94 1.13 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.08 -37.84 88.81 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.546 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.76 -41.8 2.75 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.429 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.75 154.29 21.72 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.409 HG23 ' CG ' ' A' ' 139' ' ' TYR . 30.5 m -130.0 149.21 72.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.414 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.34 143.92 60.07 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.183 1.922 . . . . 0.0 110.456 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 132' ' ' VAL . . . -112.27 4.98 18.09 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 164.54 -97.98 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 118.759 -1.686 . . . . 0.0 114.346 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 15.0 pt -130.17 160.85 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.706 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.0 m-20 -123.74 158.78 30.9 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.46 129.58 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.29 156.04 40.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.638 0.732 . . . . 0.0 112.06 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.567 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 33.3 t -98.28 146.48 31.61 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.528 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.01 66.99 4.1 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.691 2.261 . . . . 0.0 112.549 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.37 175.81 6.79 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -104.7 -11.63 16.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.268 0.556 . . . . 0.0 109.732 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -122.45 -156.28 9.61 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.838 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -106.7 134.34 49.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.342 0.591 . . . . 0.0 109.987 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.1 pm0 -121.2 167.19 12.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 -173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -55.18 130.08 40.71 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.321 0.581 . . . . 0.0 112.151 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -123.52 132.55 53.94 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.259 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.424 ' HG2' HG22 ' A' ' 127' ' ' VAL . 25.5 mm-40 -96.75 162.6 13.36 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 121.603 0.716 . . . . 0.0 111.967 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.019 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.0 ttp -128.74 129.94 46.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.266 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 133' ' ' MET . 89.6 t -102.23 129.3 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 173' ' ' GLU . 50.0 pt -110.55 174.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.42 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.57 0.65 31.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.692 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.447 ' HB2' HD11 ' A' ' 171' ' ' ILE . 79.1 mm-40 -98.51 139.38 34.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.776 0.798 . . . . 0.0 112.641 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.29 143.89 26.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.628 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.6 155.6 41.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.88 111.04 19.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.876 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.583 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 26.5 t-20 -91.02 109.58 20.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.467 ' HA ' ' OD2' ' A' ' 183' ' ' ASP . 51.4 mm -66.26 123.84 20.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.431 0.634 . . . . 0.0 112.652 -172.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.45 -36.43 8.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.5 p -137.72 165.74 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.599 0.237 . . . . 0.0 111.469 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.505 ' HG3' ' OE2' ' A' ' 18' ' ' GLU . 15.1 mtmm -62.03 -37.37 84.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.641 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.44 -40.62 97.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.272 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.467 ' OD2' ' HA ' ' A' ' 178' ' ' ILE . 38.8 t70 -64.57 -38.92 92.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.498 HD22 HG22 ' A' ' 22' ' ' ILE . 54.2 tp -59.3 -46.89 87.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.275 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.543 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.9 ttpt -62.5 -40.63 97.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.338 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.53 -49.03 79.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.294 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.489 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.79 -41.23 97.46 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.775 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 13.6 pt-20 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.855 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.61 -32.53 68.1 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.37 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.15 -28.66 63.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.761 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.62 -44.99 95.96 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.491 0.662 . . . . 0.0 109.802 176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -68.07 -45.3 74.21 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.758 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.15 -44.59 96.27 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.774 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -88.98 -4.86 58.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.91 0.386 . . . . 0.0 111.689 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -90.23 -7.04 68.13 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.742 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.2 tt . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.347 -178.491 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG22 ' A' ' 42' ' ' VAL . 58.8 ttm . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -113.42 164.41 13.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -114.25 140.47 48.56 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.097 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 28.4 tp -115.63 120.61 39.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' HA ' ' HB ' ' A' ' 98' ' ' VAL . 69.4 mt -111.71 108.72 26.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.562 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 60.4 ttm -80.25 104.8 11.05 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 121.643 0.735 . . . . 0.0 110.583 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HB2' HG23 ' A' ' 56' ' ' THR . . . -112.43 97.78 6.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.745 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.16 174.85 43.64 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.493 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 53' ' ' THR . . . -82.27 147.59 25.96 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.297 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 60.47 39.22 18.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.79 0.436 . . . . 0.0 112.165 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.29 -143.84 13.01 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER 55.99 -144.32 0.68 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.808 0.304 . . . . 0.0 110.65 177.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' H ' HG23 ' A' ' 12' ' ' THR . 67.6 ttt180 -136.86 142.66 42.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.1 mmt 73.41 -74.64 0.08 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.881 0.872 . . . . 0.0 111.282 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.08 86.42 0.31 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.494 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -69.19 151.64 51.36 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.127 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.22 127.45 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.865 0.364 . . . . 0.0 110.489 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -66.13 -40.89 91.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.792 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' HG12 ' A' ' 22' ' ' ILE . 17.0 tppt? -113.09 98.54 46.16 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.832 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -68.54 -12.78 35.73 Favored 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 123.301 2.667 . . . . 0.0 111.664 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.448 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 73.3 mt -92.3 14.05 17.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 19' ' ' LYS . 46.4 mm -63.09 125.71 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -95.28 133.64 38.95 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.819 -172.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' O ' ' HE2' ' A' ' 32' ' ' TYR . 56.6 tp -130.08 121.5 26.5 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 113.316 -1.766 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.476 ' HB3' ' HH ' ' A' ' 32' ' ' TYR . 13.0 t 58.04 27.04 14.29 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.393 0.616 . . . . 0.0 110.73 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.31 -8.87 69.62 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.012 -0.614 . . . . 0.0 114.548 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 85.9 mtt180 -117.07 155.03 29.96 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 118.169 0.985 . . . . 0.0 110.717 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 72.2 m -82.08 163.15 22.24 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.834 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.475 HD23 ' CG1' ' A' ' 178' ' ' ILE . 83.7 mt -59.22 -44.48 92.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 110.256 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -62.75 -36.82 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.77 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.45 -45.23 91.82 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.337 0.589 . . . . 0.0 110.4 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.581 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 8.5 m-85 -65.72 -30.19 70.82 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG23 ' HA ' ' A' ' 100' ' ' SER . 66.6 t -70.1 -43.23 79.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 120.649 0.261 . . . . 0.0 111.574 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.34 -43.58 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.501 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 67.5 m -50.59 -53.58 44.61 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 33.8 Cg_exo -62.4 -41.28 34.3 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.931 1.754 . . . . 0.0 112.286 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.87 -42.32 90.51 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.89 -45.37 94.87 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.757 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 35' ' ' SER . 64.1 pttt -80.98 -9.31 59.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.583 ' OG ' HG13 ' A' ' 42' ' ' VAL . 84.2 p -77.85 175.55 9.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 111.514 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.16 -22.12 60.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.141 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.583 HG13 ' OG ' ' A' ' 40' ' ' SER . 12.7 p -66.07 145.03 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.671 -177.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -78.37 -79.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -102.6 152.48 21.13 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.451 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.4 mm -110.06 116.42 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.118 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 93.8 m-85 -106.93 117.09 33.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.5 HG21 HD11 ' A' ' 60' ' ' ILE . 94.7 mt -98.74 118.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.527 0.68 . . . . 0.0 110.576 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.23 116.4 24.39 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.795 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.3 p -127.28 162.87 25.22 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.028 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.5 p -129.44 157.25 76.9 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.906 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.69 -19.09 67.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.834 2.356 . . . . 0.0 110.896 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.92 -24.95 62.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.744 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -141.16 67.33 26.3 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.6 Cg_endo -103.87 85.45 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.683 0 C-N-CA 117.172 -1.419 . . . . 0.0 109.906 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.621 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 36.0 mmtm -148.99 -44.98 0.14 Allowed 'General case' 1 C--N 1.215 -5.272 0 CA-C-N 109.605 -3.452 . . . . 0.0 102.638 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.443 HG23 ' HB2' ' A' ' 7' ' ' ALA . 96.8 m -63.16 -47.77 81.26 Favored 'General case' 1 N--CA 1.379 -4.006 0 CA-C-N 112.307 -2.224 . . . . 0.0 105.773 163.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.08 -51.19 68.95 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.796 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.621 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 pt-20 -64.58 -30.73 71.75 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.341 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.91 -50.21 71.74 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.071 0.462 . . . . 0.0 111.18 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.5 HD11 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -62.68 -42.75 97.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.964 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -58.25 -41.38 84.08 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.574 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.666 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t -73.74 -43.31 59.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 111.233 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.53 90.8 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.337 0.589 . . . . 0.0 111.105 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.461 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 58.1 m-85 -114.44 42.59 2.07 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.002 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.666 ' HG3' ' O ' ' A' ' 62' ' ' SER . 38.1 mtmm -59.82 -26.79 66.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.028 0.442 . . . . 0.0 110.971 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.42 10.13 18.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.055 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.461 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 53.8 p90 -44.59 122.77 3.27 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.47 -49.44 3.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.36 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -110.26 7.74 23.26 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.095 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 4.8 mp -100.31 119.62 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.257 0.551 . . . . 0.0 110.028 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 78.3 t -120.55 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.312 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.9 pt -123.66 154.74 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.161 0.505 . . . . 0.0 109.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -117.08 127.82 54.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.445 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 14.3 t -155.96 -167.98 2.63 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -173.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -67.81 2.41 1.98 Allowed 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 126.633 1.973 . . . . 0.0 114.22 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.478 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.19 -16.62 0.0 OUTLIER Glycine 0 N--CA 1.516 3.971 0 C-N-CA 126.693 2.092 . . . . 0.0 117.376 -175.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 14.2 tmtt? -58.61 -38.45 78.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.6 127.48 7.73 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.459 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -59.97 -49.91 75.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.093 0.473 . . . . 0.0 111.987 -176.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.83 -47.49 90.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.547 0.689 . . . . 0.0 110.294 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 53.6 mt-10 -60.91 -43.28 98.79 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.784 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.562 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 7.4 t0 -60.05 -50.77 72.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.116 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.481 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.5 mm? -59.62 -42.87 93.66 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.169 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 88' ' ' ILE . 10.1 m120 -60.56 -42.02 95.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.257 0.551 . . . . 0.0 111.053 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 66.0 mm-40 -65.58 -45.65 82.46 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.0 m -63.57 -41.82 98.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.497 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 84' ' ' LEU . 38.1 pt -65.92 -29.88 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.081 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.41 96.56 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.941 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -71.9 -40.12 69.06 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.1 m-85 -79.01 154.08 29.77 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.8 m -113.24 -4.52 13.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.433 ' N ' ' HG3' ' A' ' 159' ' ' PRO . 40.0 mt-10 -132.74 156.02 80.55 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.275 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.44 140.0 64.41 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.207 2.604 . . . . 0.0 111.649 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.55 156.7 45.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.34 0.591 . . . . 0.0 110.748 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.46 HD13 HD11 ' A' ' 154' ' ' ILE . 24.3 tp -87.53 144.4 26.72 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.029 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 93.7 t -107.14 125.89 63.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 60.8 t -130.47 141.11 47.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.5 m -96.09 142.49 28.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.782 174.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.484 ' HA ' HG23 ' A' ' 33' ' ' VAL . 67.9 m -89.45 0.78 56.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -104.93 -4.2 22.41 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.493 ' CD1' ' HA2' ' A' ' 153' ' ' GLY . 75.2 mt -82.6 136.63 34.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.278 0.49 . . . . 0.0 110.599 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.8 pt -75.67 -174.24 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.953 0.406 . . . . 0.0 111.35 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -78.53 71.18 4.98 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.39 -3.84 4.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.41 ' O ' HG13 ' A' ' 110' ' ' ILE . 11.7 ptmm? -88.38 -2.24 58.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.217 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 p -60.99 -41.57 96.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -80.43 -22.44 41.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.895 0.855 . . . . 0.0 109.725 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.535 ' O ' HG12 ' A' ' 113' ' ' ILE . 38.4 mm -67.7 -37.61 78.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.953 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 106' ' ' LYS . 64.4 mt -57.26 -50.0 78.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.064 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -70.74 -39.65 73.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.172 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.8 m -63.36 -42.95 98.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.07 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.2 mm -64.39 -44.78 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.8 t -60.44 -46.71 94.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.273 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.75 -46.1 91.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.657 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CE2' HD13 ' A' ' 120' ' ' ILE . 31.8 t80 -70.19 -41.82 73.2 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.2 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.5 t80 -59.18 -48.35 81.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.523 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 21.3 m-85 -62.88 -35.5 80.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.658 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.8 -47.5 86.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.966 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.594 HD13 ' CE2' ' A' ' 116' ' ' TYR . 70.5 mt -66.45 -49.37 75.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.484 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 124' ' ' THR . 16.0 ptmt -65.34 -25.85 67.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.965 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.56 98.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -85.69 -36.83 19.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.309 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 32.0 m -130.9 96.21 23.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.154 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.91 -14.2 40.6 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.918 2.412 . . . . 0.0 113.197 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.47 -32.94 74.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.889 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 124' ' ' THR . 10.7 p -75.79 120.53 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.606 0.717 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 45.8 mt-10 -123.04 15.0 9.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.872 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.71 150.07 33.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.931 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -140.86 135.04 30.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.034 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.33 140.84 51.65 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.727 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 169' ' ' MET . 14.8 p -123.22 135.95 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 75.1 mtm -134.47 158.02 44.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.747 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.486 HG21 ' O ' ' A' ' 171' ' ' ILE . 9.9 pt -130.12 154.55 81.33 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.21 134.91 64.84 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.62 2.213 . . . . 0.0 113.253 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -60.83 -37.57 82.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.813 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -59.67 -37.03 77.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.005 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 172' ' ' ASP . 19.7 ptmt -99.82 -16.45 18.06 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.091 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.509 ' CG ' HG22 ' A' ' 150' ' ' VAL . 55.6 t80 -64.77 137.23 97.08 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.5 -70.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.249 . . . . 0.0 112.651 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -167.33 141.0 2.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.21 -21.15 27.37 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.85 2.367 . . . . 0.0 112.494 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.515 ' HA ' ' OD1' ' A' ' 179' ' ' ASN . 13.9 p -176.73 -66.85 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.6 mt -142.59 -66.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -150.87 86.52 1.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 111.794 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.28 152.53 47.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.43 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -111.81 130.93 55.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.999 0.428 . . . . 0.0 111.13 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 165.55 -174.79 41.33 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.72 144.68 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.223 0.512 . . . . 0.0 110.334 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.509 HG22 ' CG ' ' A' ' 139' ' ' TYR . 35.9 m -115.64 148.94 42.17 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.289 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.25 148.74 56.16 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.52 2.146 . . . . 0.0 111.517 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -91.75 -4.26 55.23 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 102' ' ' LEU . . . 152.5 -75.06 0.24 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.338 -1.411 . . . . 0.0 114.376 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.465 HG13 HG13 ' A' ' 113' ' ' ILE . 25.0 pt -128.32 161.49 36.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -173.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.585 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 11.5 t-20 -127.75 155.55 43.84 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.884 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -120.97 130.3 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 O-C-N 122.167 -0.333 . . . . 0.0 110.691 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.438 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.2 m -133.1 154.24 39.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.656 0.741 . . . . 0.0 111.967 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.604 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 45.0 t -98.52 144.27 27.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.115 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.433 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 72.2 Cg_endo -72.89 67.07 4.01 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.116 2.544 . . . . 0.0 113.35 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.413 ' HD2' ' HB3' ' A' ' 164' ' ' GLN . 69.0 mttm -99.99 -168.37 1.58 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -133.56 90.03 2.67 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.889 0.852 . . . . 0.0 109.221 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.41 -136.74 6.65 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.26 142.74 51.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.815 0.34 . . . . 0.0 110.347 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . 18.6 pm0 -134.02 166.1 23.5 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.924 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -60.08 127.81 33.72 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.109 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -128.04 133.57 49.11 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.86 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -93.5 160.93 14.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-O 121.609 0.719 . . . . 0.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.6 128.87 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.192 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 61.7 ttp -127.35 135.21 50.19 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.14 126.63 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.486 ' O ' HG21 ' A' ' 134' ' ' ILE . 50.4 pt -116.18 174.94 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.003 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 138' ' ' LYS . 22.4 t70 -117.66 21.5 12.93 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.143 0.496 . . . . 0.0 110.544 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -98.33 133.17 43.11 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.3 150.69 19.98 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.401 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.0 pt -130.11 153.26 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.33 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -125.69 144.48 50.59 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.462 ' HB3' HD21 ' A' ' 102' ' ' LEU . 28.4 p-10 -137.29 156.76 47.88 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.475 ' CG1' HD23 ' A' ' 29' ' ' LEU . 31.9 mm -94.97 81.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.546 0.688 . . . . 0.0 111.171 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 143' ' ' SER . 66.9 m-80 -65.96 -40.1 90.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.515 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.5 t -149.36 177.41 9.71 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.051 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -57.89 -28.35 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.932 0.493 . . . . 0.0 111.418 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -60.13 -46.77 88.53 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 109.943 177.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.488 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 44.7 m-20 -64.78 -35.67 81.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.212 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.458 ' HA ' HD11 ' A' ' 178' ' ' ILE . 59.8 tp -59.36 -45.32 91.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.833 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.573 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 12.9 mmtt -64.08 -38.23 90.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.04 -49.76 74.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.268 0.556 . . . . 0.0 109.524 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.524 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.1 -43.3 98.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.751 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 4.3 pt-20 -67.72 -34.12 76.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.461 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.428 ' N ' ' HG3' ' A' ' 188' ' ' GLU . 57.8 ttm -62.13 -45.49 93.24 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.692 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.4 pp -70.38 -37.16 74.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.366 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.58 -44.44 90.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.347 0.594 . . . . 0.0 110.53 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -64.86 -42.77 94.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.862 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.38 -39.9 94.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.766 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.77 -28.36 68.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.256 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.512 ' C ' HD13 ' A' ' 196' ' ' LEU . . . -94.13 7.56 72.77 Favored Glycine 0 C--N 1.311 -0.85 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.872 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . 0.512 HD13 ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.265 1.881 0 CA-C-O 117.274 -1.345 . . . . 0.0 113.935 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 37.0 m-20 -111.59 164.73 12.68 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.521 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -113.8 132.03 56.01 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.881 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 48' ' ' ALA . 33.3 tp -106.32 125.66 51.27 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.024 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.546 ' HA ' HG21 ' A' ' 98' ' ' VAL . 69.4 mt -117.24 104.76 16.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.549 ' HE1' ' CG ' ' A' ' 83' ' ' ASP . 11.1 ptm -95.98 97.93 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.892 1.329 . . . . 0.0 112.042 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 49' ' ' THR . . . -115.66 97.15 5.97 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.23 32.47 0.03 OUTLIER Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.765 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.6 142.95 16.43 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.442 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -133.79 147.47 51.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.2 -174.25 46.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.431 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.3 p -67.75 -33.25 74.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.552 0.692 . . . . 0.0 109.999 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.8 tpm_? -137.18 129.12 29.11 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.01 137.89 56.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 0.0 111.308 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.52 5.96 2.78 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.602 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.87 -143.41 12.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.472 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.99 86.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.803 0.811 . . . . 0.0 110.017 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 19' ' ' LYS . 13.2 pt-20 -161.59 -164.64 1.15 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.731 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 29.4 mtpp 61.4 72.02 0.72 Allowed Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 121.162 0.506 . . . . 0.0 111.127 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.33 -17.75 41.74 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.469 2.78 . . . . 0.0 113.474 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 56' ' ' THR . 41.5 mt -90.49 12.59 18.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 19' ' ' LYS . 93.5 mt -66.23 117.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -82.16 134.79 35.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.675 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 46.6 tp -136.29 112.47 9.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.257 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t 61.27 20.14 10.76 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.381 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.34 -23.2 5.8 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.837 -1.173 . . . . 0.0 115.422 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.749 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 90.5 mtt180 -131.06 158.75 39.52 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.579 1.19 . . . . 0.0 111.088 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 71.6 m -76.2 150.79 37.04 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.199 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD21 ' O ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -49.22 -45.6 44.72 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.832 0.453 . . . . 0.0 111.298 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.462 ' O ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.36 -38.0 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.233 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.677 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.7 t70 -64.03 -42.59 97.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.212 0.529 . . . . 0.0 109.867 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.749 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 28.2 m-85 -61.03 -38.08 84.83 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.738 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.45 -42.54 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 110.671 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 30' ' ' ILE . 77.5 t -62.31 -43.34 97.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.566 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.54 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 44.5 t -50.3 -57.94 11.32 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 37.2 Cg_exo -62.07 -41.09 38.11 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.803 1.669 . . . . 0.0 112.359 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD11 HG12 ' A' ' 98' ' ' VAL . 90.5 mt -66.09 -42.11 89.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.184 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.7 tt -63.37 -45.43 91.16 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.073 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.04 -15.92 61.5 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 71.6 p -70.57 172.51 8.44 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.246 0.546 . . . . 0.0 111.231 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -70.03 2.24 3.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.537 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 3' ' ' ALA . 9.7 p -72.67 152.89 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 122.182 -0.324 . . . . 0.0 111.137 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.42 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 59.5 t30 -68.17 -79.62 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.416 HD21 ' C ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -121.04 163.96 17.51 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.238 0.542 . . . . 0.0 111.074 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -107.89 115.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.997 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -106.52 117.16 33.31 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.496 HG22 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -97.58 118.09 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-O 121.774 0.797 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.4 122.92 33.08 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.853 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 7' ' ' ALA . 56.8 p -130.48 156.61 44.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.552 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 75' ' ' THR . 35.4 t -105.04 143.15 26.14 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.283 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -56.79 -25.22 59.85 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.074 2.516 . . . . 0.0 111.033 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.44 -2.85 47.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -141.77 66.43 21.97 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.597 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 95.3 Cg_endo -105.14 86.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.144 0 C-N-CA 116.759 -1.694 . . . . 0.0 109.854 170.24 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 39.1 ttmt -148.84 -50.83 0.16 Allowed 'General case' 1 C--N 1.212 -5.386 0 CA-C-N 109.89 -3.323 . . . . 0.0 103.044 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 21' ' ' LEU . 86.4 m -62.07 -47.53 84.28 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.918 -1.946 . . . . 0.0 105.906 163.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.653 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.71 -47.96 81.34 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.949 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.576 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.4 pt-20 -57.23 -38.02 73.14 Favored 'General case' 0 C--N 1.369 1.431 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -65.89 -51.62 57.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 120.912 0.387 . . . . 0.0 111.714 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.496 HD13 HG22 ' A' ' 47' ' ' ILE . 97.0 mt -62.99 -46.26 96.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.505 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.578 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 65.1 t30 -59.25 -39.97 84.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.381 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 t -74.91 -47.43 29.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.31 87.95 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -108.82 14.83 24.01 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.635 -0.426 . . . . 0.0 112.015 -173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.0 pttt -62.9 -22.09 66.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -88.36 -1.19 57.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.81 128.54 49.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.943 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.477 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -70.23 -41.25 73.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.834 -178.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -80.17 -0.67 37.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.2 mt -108.06 122.67 62.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.515 0.674 . . . . 0.0 110.206 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.9 135.68 63.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.929 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -106.95 131.03 57.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.061 0.458 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.6 pt -125.56 157.57 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.339 0.59 . . . . 0.0 111.814 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -102.32 133.32 47.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.389 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.632 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.2 t -161.77 -177.94 6.19 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.113 0.959 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 57.4 m -75.09 5.21 5.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 126.943 2.097 . . . . 0.0 113.158 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.04 -19.62 0.0 OUTLIER Glycine 0 N--CA 1.513 3.793 0 C-N-CA 127.876 2.655 . . . . 0.0 118.134 -171.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 11.5 tmtt? -59.29 -38.85 81.2 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 171.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.12 8.56 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -62.2 -50.51 71.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.17 -45.35 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.872 0.844 . . . . 0.0 110.575 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.84 -43.57 94.55 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.378 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.595 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.2 t0 -58.4 -50.12 74.83 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.874 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.4 mm? -56.87 -41.86 78.74 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.041 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.0 m-80 -60.03 -43.72 95.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.632 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 62.7 mm-40 -66.74 -42.61 85.95 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.79 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.58 -42.52 99.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -67.95 -26.57 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -38.64 96.95 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.929 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -70.5 -40.06 73.79 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.01 150.66 27.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -111.75 -0.96 15.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.047 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 28.2 mt-10 -134.86 159.01 73.75 Favored Pre-proline 0 CA--C 1.508 -0.663 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.161 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 36.5 Cg_endo -65.02 147.85 89.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.157 1.904 . . . . 0.0 111.124 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.44 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 51.2 p90 -141.69 162.13 36.23 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.588 0.709 . . . . 0.0 111.707 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 3' ' ' ALA . 1.1 tm? -86.17 139.41 31.11 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.597 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.604 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 89.3 t -117.12 134.08 61.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.78 0.832 . . . . 0.0 108.857 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.546 HG21 ' HA ' ' A' ' 5' ' ' ILE . 8.6 m -127.79 159.88 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.246 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -100.19 135.3 41.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.534 ' O ' HD21 ' A' ' 29' ' ' LEU . 81.0 p -74.95 -12.03 60.25 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -102.32 3.28 37.87 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.43 HD21 HD12 ' A' ' 175' ' ' ILE . 70.0 mt -91.22 121.01 32.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.882 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.569 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 86.2 mt -118.33 118.67 58.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.193 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 60.8 t30 166.87 168.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.676 0.79 . . . . 0.0 110.386 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.18 93.48 3.95 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.546 0.689 . . . . 0.0 109.914 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' HE3' HG13 ' A' ' 109' ' ' ILE . 31.8 mmmt -99.43 2.88 45.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.266 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.483 ' HA ' HD11 ' A' ' 110' ' ' ILE . 71.9 p -53.65 -32.56 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.439 ' HG3' HD11 ' A' ' 109' ' ' ILE . 19.5 ptpt -70.7 -27.78 64.25 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.745 0.783 . . . . 0.0 110.008 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.444 HG13 ' HE3' ' A' ' 106' ' ' LYS . 28.1 mm -71.57 -40.57 71.46 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.304 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 107' ' ' SER . 70.0 mt -60.4 -45.79 96.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.933 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -64.64 -43.37 93.89 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.436 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.9 t -61.9 -45.54 93.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.518 HG13 ' N ' ' A' ' 114' ' ' VAL . 42.6 pt -65.04 -41.57 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.518 ' N ' HG13 ' A' ' 113' ' ' ILE . 57.6 t -62.16 -49.13 85.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.98 -43.18 93.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.852 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.506 ' CE2' HD12 ' A' ' 120' ' ' ILE . 71.7 t80 -63.7 -49.48 72.93 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 110.949 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -59.04 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.986 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.409 ' HD2' ' O ' ' A' ' 114' ' ' VAL . 28.1 m-85 -65.03 -31.83 73.25 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 50.3 t -62.02 -46.85 87.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.445 0.641 . . . . 0.0 109.421 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.506 HD12 ' CE2' ' A' ' 116' ' ' TYR . 71.6 mt -64.59 -43.54 96.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.352 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -60.48 -41.74 94.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.279 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.44 -44.33 95.92 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.648 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -77.85 -32.42 52.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.999 0.428 . . . . 0.0 111.33 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.512 ' O ' HG12 ' A' ' 127' ' ' VAL . 46.9 m -143.57 100.69 5.14 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.8 -13.75 39.55 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.8 2.333 . . . . 0.0 112.966 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.01 -32.73 74.15 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 124' ' ' THR . 10.7 p -71.37 129.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -128.45 4.6 5.66 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.637 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.05 153.41 39.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.939 0.4 . . . . 0.0 111.374 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 23.4 tp -137.64 146.34 43.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.52 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.88 129.41 46.85 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.943 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.51 HG12 ' HB3' ' A' ' 152' ' ' ALA . 63.9 t -105.06 115.11 46.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.448 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.3 ptm -145.82 157.53 43.91 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.19 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 14.5 pt -133.03 155.0 81.57 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.834 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.36 128.09 28.99 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.361 2.04 . . . . 0.0 111.923 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.571 ' O ' ' HB3' ' A' ' 142' ' ' PRO . 1.5 pptp? -69.38 -21.97 63.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.56 -36.46 83.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -87.26 -22.8 24.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.577 0.703 . . . . 0.0 109.92 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -63.45 133.61 95.56 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.662 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.83 -36.65 83.5 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.569 2.846 . . . . 0.0 113.54 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -126.03 84.11 61.95 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-O 121.852 0.834 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.571 ' HB3' ' O ' ' A' ' 136' ' ' LYS . 74.2 Cg_endo -74.47 148.89 38.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.57 2.847 . . . . 0.0 113.508 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.1 t -89.37 70.41 8.11 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.09 -38.47 82.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.607 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -56.54 -40.96 76.0 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.424 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -108.69 -13.05 14.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.711 0.291 . . . . 0.0 111.033 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.9 t30 55.73 39.28 30.81 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.928 0.87 . . . . 0.0 109.467 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.4 28.87 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.073 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.58 152.96 21.12 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 124.14 29.05 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.809 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.47 136.76 77.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.993 1.795 . . . . 0.0 110.352 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -93.47 0.78 56.88 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.386 0.613 . . . . 0.0 110.617 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.79 -91.26 0.08 OUTLIER Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.993 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.466 ' HB ' HD11 ' A' ' 96' ' ' LEU . 14.4 pt -139.66 162.12 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.171 0.51 . . . . 0.0 112.173 -176.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.604 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.4 m120 -112.45 156.6 22.29 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.45 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.6 t -125.4 129.47 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 122.788 0.435 . . . . 0.0 109.889 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.35 155.27 31.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.048 0.451 . . . . 0.0 111.56 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.526 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 61.3 m -98.17 155.06 37.39 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.954 173.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.404 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 72.4 Cg_endo -76.52 86.11 1.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.579 2.186 . . . . 0.0 111.519 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -108.54 -175.42 2.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -128.9 28.16 5.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.875 0.845 . . . . 0.0 109.627 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.72 38.26 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -77.4 143.15 38.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.43 0.615 . . . . 0.0 109.545 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.526 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 20.9 pt20 -130.06 161.31 31.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.754 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.38 125.95 26.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.835 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.69 127.33 52.78 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.758 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -93.76 162.79 13.79 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 121.528 0.68 . . . . 0.0 111.716 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -117.42 129.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.891 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.4 ttp -128.45 126.02 39.69 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.686 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.8 t -105.38 132.06 53.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 173' ' ' GLU . 43.3 pt -119.78 171.73 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.208 0.527 . . . . 0.0 111.211 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -109.02 13.94 24.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.501 ' HB2' HD13 ' A' ' 171' ' ' ILE . 26.8 mm-40 -97.95 135.77 39.19 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.871 0.843 . . . . 0.0 111.278 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.9 153.67 18.11 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.459 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.43 HD12 HD21 ' A' ' 102' ' ' LEU . 1.8 pt -132.78 151.02 33.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.386 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.12 116.94 27.86 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -116.13 175.78 5.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.472 HD11 ' HA ' ' A' ' 184' ' ' LEU . 46.4 mm -116.3 120.13 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.975 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 -47.25 5.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.82 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.5 p -128.03 166.54 18.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.19 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.35 -42.11 95.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.557 0.694 . . . . 0.0 109.754 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.58 -39.39 94.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.679 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.472 ' HA ' HD11 ' A' ' 178' ' ' ILE . 57.8 tp -61.02 -42.36 98.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.486 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.599 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 61.4 tttp -61.56 -40.92 96.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.872 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.9 -45.57 94.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.74 98.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.947 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.606 ' O ' ' HG3' ' A' ' 192' ' ' LYS . 11.5 pt-20 -64.86 -37.75 88.69 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.526 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.41 ' O ' ' HG3' ' A' ' 193' ' ' LYS . 94.8 mmm -63.54 -39.65 94.97 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.979 0.418 . . . . 0.0 110.349 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.1 tp -62.6 -44.86 95.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.908 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.3 mt -64.14 -39.43 94.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.337 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 99.3 mttt -61.89 -17.29 56.06 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.345 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' A' ' 189' ' ' MET . 68.7 mttm -75.06 -8.01 55.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.01 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 -19.73 64.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.322 0.582 . . . . 0.0 109.804 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.82 -154.77 26.02 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.8 tp . . . . . 0 C--O 1.26 1.643 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.338 178.628 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 95' ' ' PHE . 59.8 tpp . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.258 0.551 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -122.04 166.3 14.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.2 127.14 56.08 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.942 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 98' ' ' VAL . 36.7 tp -101.48 126.21 48.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.56 ' HA ' HG23 ' A' ' 98' ' ' VAL . 65.5 mt -119.08 107.97 22.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.611 ' HE1' ' CG ' ' A' ' 83' ' ' ASP . 60.6 ttm -80.93 98.07 7.72 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.513 0.673 . . . . 0.0 111.47 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 49' ' ' THR . . . -117.22 98.04 6.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.364 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.86 81.3 0.23 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.347 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.27 -154.24 11.46 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.171 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.63 -11.44 19.2 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.17 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.05 -98.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.904 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.9 m -64.39 139.82 58.8 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -60.51 -37.38 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.736 0.303 . . . . 0.0 111.368 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 24.3 mmt -79.49 -5.08 54.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.974 0.416 . . . . 0.0 111.05 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.61 179.47 42.11 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.131 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.417 ' HA3' ' OG ' ' A' ' 143' ' ' SER . . . 123.91 -122.97 5.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.786 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.6 HG12 ' ND2' ' A' ' 177' ' ' ASN . 12.7 p -65.41 142.45 16.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 2.3 tm-20 169.49 -153.14 0.01 OUTLIER 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.561 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 55.9 mmtt 61.19 77.98 0.34 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.488 0.661 . . . . 0.0 110.349 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.496 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 27.4 Cg_endo -62.12 -4.75 5.43 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.905 3.07 . . . . 0.0 114.639 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.09 4.95 24.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.55 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 90.6 mt -71.68 126.11 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 62.9 pttt -115.11 143.18 45.6 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.44 ' O ' ' HE2' ' A' ' 32' ' ' TYR . 89.4 mt -127.47 140.25 52.27 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.735 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.7 m 48.42 35.43 5.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.74 -12.7 53.57 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.23 161.28 38.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 119.476 1.638 . . . . 0.0 112.124 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 80.8 m -77.82 164.91 24.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.505 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 92.6 mt -58.35 -39.73 80.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.151 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 60' ' ' ILE . 4.6 tp -58.32 -45.24 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.199 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.77 -42.41 97.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.12 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.44 ' HE2' ' O ' ' A' ' 24' ' ' LEU . 4.2 m-85 -62.65 -36.17 81.99 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.773 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 29' ' ' LEU . 74.7 t -72.17 -45.2 63.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 120.818 0.342 . . . . 0.0 111.04 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 30' ' ' ILE . 76.0 t -63.85 -44.98 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 74.7 m -53.0 -54.58 42.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -173.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 51.3 Cg_exo -60.67 -40.3 56.47 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.009 1.806 . . . . 0.0 112.299 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.502 HD12 HG11 ' A' ' 98' ' ' VAL . 81.7 mt -67.3 -43.2 82.31 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.919 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -61.9 -46.06 91.03 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -72.99 -15.57 61.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.485 ' OG ' HG13 ' A' ' 42' ' ' VAL . 79.9 p -75.41 173.71 10.57 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.195 0.521 . . . . 0.0 111.007 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -60.6 -18.39 52.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.746 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG13 ' OG ' ' A' ' 40' ' ' SER . 11.9 p -64.98 146.41 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.991 0.424 . . . . 0.0 111.108 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -79.79 -73.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.05 150.78 25.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.452 0.644 . . . . 0.0 111.799 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.06 116.12 51.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.553 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 84.4 m-85 -106.12 117.79 34.94 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -98.64 118.48 45.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.645 0.736 . . . . 0.0 110.301 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.434 ' HB2' HD12 ' A' ' 4' ' ' LEU . . . -88.18 117.85 27.36 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.964 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 7' ' ' ALA . 70.0 p -125.94 157.85 36.69 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.6 p -109.27 155.65 40.72 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.326 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.29 -18.44 62.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.598 2.199 . . . . 0.0 111.002 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -83.38 -7.4 59.57 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.999 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.0 p -141.37 66.74 24.41 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.0 Cg_endo -102.09 84.22 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.699 0 C-N-CA 116.469 -1.888 . . . . 0.0 108.577 168.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 53.5 mtmt -150.68 -50.34 0.13 Allowed 'General case' 1 C--N 1.216 -5.198 0 CA-C-N 109.446 -3.524 . . . . 0.0 103.184 -176.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.3 m -62.82 -46.97 85.46 Favored 'General case' 0 N--CA 1.391 -3.41 0 CA-C-N 112.692 -2.049 . . . . 0.0 106.125 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -61.5 -49.27 77.42 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.383 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 14.3 pt-20 -58.71 -38.48 78.38 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.03 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.76 -50.26 69.74 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.704 0.287 . . . . 0.0 111.458 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 30' ' ' ILE . 96.7 mt -63.59 -43.65 98.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.879 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -58.23 -44.36 88.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.346 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.1 m -68.74 -40.16 79.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.348 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.16 90.57 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.424 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 60.0 m-85 -115.96 42.19 2.4 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.549 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.62 -21.39 62.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.143 0.497 . . . . 0.0 110.976 177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -93.24 11.69 27.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.631 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 48.4 p90 -43.4 122.34 2.57 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.33 -50.0 3.58 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -111.05 10.96 22.07 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.531 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 85.9 mt -105.99 124.27 61.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.295 0.569 . . . . 0.0 110.35 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 60.3 t -125.28 133.7 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.687 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.41 132.46 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.091 0.472 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 39.9 pt -127.83 156.03 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-O 121.912 0.863 . . . . 0.0 111.325 -177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -110.35 133.14 53.55 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.496 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.41 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 10.1 t -162.22 -169.81 2.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 53.8 m -69.6 1.77 3.82 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 126.56 1.944 . . . . 0.0 114.438 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.46 -21.53 0.0 OUTLIER Glycine 1 N--CA 1.519 4.226 0 C-N-CA 126.209 1.862 . . . . 0.0 117.019 -174.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 76' ' ' SER . 2.5 tmmt? -56.57 -34.2 66.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.78 126.08 6.57 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -60.26 -51.69 68.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.48 -45.76 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 121.727 0.775 . . . . 0.0 110.795 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 69.5 mm-40 -60.99 -42.69 98.9 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.859 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.611 ' CG ' ' HE1' ' A' ' 6' ' ' MET . 8.7 t0 -58.94 -50.69 73.09 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.9 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.514 ' O ' HG21 ' A' ' 88' ' ' ILE . 2.3 mm? -57.5 -43.98 84.6 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.055 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' HA ' HG12 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -61.36 -40.1 93.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.968 178.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 70.7 mm-40 -67.17 -44.27 80.13 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.565 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 97.0 m -63.92 -41.63 97.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.619 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.514 HG21 ' O ' ' A' ' 84' ' ' LEU . 35.4 pt -66.73 -35.3 74.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.197 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.33 94.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.345 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.0 -49.19 77.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.958 . . . . 0.0 112.969 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.565 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 75.5 m-85 -74.2 148.23 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.176 0.512 . . . . 0.0 112.103 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.4 m -96.26 -8.41 32.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.549 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 15.5 pt-20 -151.55 173.47 4.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 93' ' ' GLU . 58.1 Cg_endo -69.35 148.48 67.82 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.072 1.848 . . . . 0.0 113.795 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 40.6 p90 -146.18 162.39 38.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.493 HD21 HG23 ' A' ' 156' ' ' VAL . 91.2 mt -84.44 150.13 25.51 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.542 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 87.3 t -121.84 129.57 75.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.434 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.56 HG23 ' HA ' ' A' ' 5' ' ' ILE . 5.7 m -131.65 162.96 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.088 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.1 t -99.4 145.89 26.9 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.597 ' HB3' ' O ' ' A' ' 6' ' ' MET . 80.0 p -65.49 -20.5 66.37 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 177' ' ' ASN . 53.7 p-10 -105.14 12.41 32.06 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.21 115.37 11.37 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.929 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.426 HD11 ' CD2' ' A' ' 29' ' ' LEU . 73.6 mt -122.45 117.02 50.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 33.6 t-20 173.88 169.62 0.2 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.62 73.71 5.16 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HA ' HD13 ' A' ' 109' ' ' ILE . 23.2 pttp -82.64 -1.84 52.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.185 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.582 ' HA ' HD13 ' A' ' 110' ' ' ILE . 71.2 m -58.95 -40.61 85.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.52 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -71.33 -40.35 70.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.558 1.17 . . . . 0.0 109.895 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.73 ' O ' HG12 ' A' ' 113' ' ' ILE . 66.7 mt -63.02 -39.56 85.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.127 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' A' ' 107' ' ' SER . 59.8 mt -57.52 -47.61 84.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -63.9 -39.97 95.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.718 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.7 m -61.66 -37.44 84.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.184 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.73 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -60.05 -48.38 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.323 0.582 . . . . 0.0 109.622 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.84 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.162 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.55 -47.56 85.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.157 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.525 ' CE2' HD12 ' A' ' 120' ' ' ILE . 80.9 t80 -64.18 -49.52 71.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.239 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.408 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 82.8 t80 -59.44 -47.92 83.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.538 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 4.2 m-85 -61.5 -35.46 77.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.15 -46.71 85.9 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.23 0.538 . . . . 0.0 109.733 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.525 HD12 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -65.08 -49.92 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.481 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 124' ' ' THR . 20.4 ptmt -66.32 -27.31 67.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.3 96.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.566 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 20.5 pttp -83.45 -39.71 20.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.917 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 25.2 m -130.49 98.83 19.69 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.403 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -9.56 26.62 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 122.842 2.361 . . . . 0.0 112.55 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.17 -32.81 72.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.856 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.496 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 10.3 p -74.72 124.99 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 0.0 110.993 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 41.1 mt-10 -117.85 -2.61 11.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.702 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.78 41.73 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.859 0.361 . . . . 0.0 111.289 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.4 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -135.16 131.98 37.44 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.407 ' HB1' ' CD ' ' A' ' 166' ' ' GLU . . . -119.06 127.08 53.07 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.538 HG21 ' CD1' ' A' ' 113' ' ' ILE . 90.1 t -107.55 112.55 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 9.9 ptm -146.22 158.4 43.88 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.225 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 25.7 pt -134.22 157.0 78.55 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.147 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.96 139.86 91.87 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.235 1.956 . . . . 0.0 111.878 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.532 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 14.0 tmtt? -59.92 -25.91 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.939 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.27 -38.05 79.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.201 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -93.86 -21.96 18.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.59 128.63 83.56 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.72 51.94 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.918 2.412 . . . . 0.0 114.002 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 59.69 107.56 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.485 ' HG3' ' CG1' ' A' ' 150' ' ' VAL . 72.2 Cg_endo -74.6 -20.42 17.88 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 123.128 2.552 . . . . 0.0 112.507 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.417 ' OG ' ' HA3' ' A' ' 16' ' ' GLY . 22.9 t -164.68 -175.65 3.92 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.1 -44.52 99.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.53 149.0 38.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.096 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -84.7 158.63 20.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 111.528 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -99.39 24.47 8.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.74 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.25 -57.48 3.93 Favored Glycine 0 C--N 1.32 -0.353 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 pp -131.3 159.0 39.14 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.485 ' CG1' ' HG3' ' A' ' 142' ' ' PRO . 32.7 m -121.85 124.85 26.91 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.907 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.58 147.89 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.395 2.063 . . . . 0.0 110.891 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -114.22 0.22 14.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 176.21 -123.72 0.93 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.268 -1.444 . . . . 0.0 113.648 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.515 ' HB ' HG13 ' A' ' 113' ' ' ILE . 4.1 mp -101.17 137.09 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 121.679 0.752 . . . . 0.0 111.713 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.582 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.9 t-20 -109.6 156.7 19.87 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.48 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.493 HG23 HD21 ' A' ' 96' ' ' LEU . 94.7 t -123.62 130.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 C-N-CA 122.667 0.387 . . . . 0.0 110.243 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.419 HG11 ' OD1' ' A' ' 155' ' ' ASN . 28.9 m -133.96 150.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.379 0.609 . . . . 0.0 111.415 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 53.0 p -98.25 164.58 16.93 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.383 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 77.9 Cg_endo -75.72 76.1 3.79 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.55 2.167 . . . . 0.0 111.826 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.82 -172.08 2.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -127.46 131.78 50.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.583 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.91 -114.09 3.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.975 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.33 145.34 51.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.52 166.98 21.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 2.5 tmtm? -55.81 127.66 31.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.152 0.501 . . . . 0.0 110.615 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.407 ' CD ' ' HB1' ' A' ' 131' ' ' ALA . 44.1 tt0 -137.52 134.72 36.02 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.587 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -94.11 162.84 13.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.485 0.66 . . . . 0.0 111.646 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.01 130.08 73.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.081 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.477 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.7 ttp -129.6 130.99 46.37 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.691 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.9 t -111.42 131.51 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.404 HD13 ' HB2' ' A' ' 173' ' ' GLU . 42.1 pt -117.66 169.69 7.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.777 0.799 . . . . 0.0 112.482 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -93.51 2.84 56.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.404 ' HB2' HD13 ' A' ' 171' ' ' ILE . 57.7 mm-40 -99.45 131.71 45.27 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 122.076 0.941 . . . . 0.0 113.149 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.08 149.47 21.91 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.886 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.2 pt -123.64 139.81 49.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.833 176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -113.53 126.44 55.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.6 ' ND2' HG12 ' A' ' 17' ' ' VAL . 34.1 p-10 -119.13 19.33 12.93 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.555 0.693 . . . . 0.0 111.595 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 184' ' ' LEU . 23.2 mm 77.21 -93.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.515 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.91 -36.69 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.9 p -128.55 162.36 27.43 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.143 -0.348 . . . . 0.0 111.71 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.62 -39.12 83.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -48.66 80.81 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.52 -36.54 84.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.743 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.526 ' HA ' HD13 ' A' ' 178' ' ' ILE . 47.9 tp -59.98 -50.25 74.5 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.433 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.95 -40.5 91.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -60.61 -43.53 97.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.977 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.463 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.79 -43.51 98.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.698 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 24' ' ' LEU . 53.7 mm-40 -60.7 -45.48 94.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.24 0.543 . . . . 0.0 110.201 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 98.5 mtp -63.36 -42.28 98.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.698 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.4 -42.26 92.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 120.884 0.373 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -60.99 -43.25 99.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.354 0.597 . . . . 0.0 110.003 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -64.22 -43.21 95.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.433 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -62.13 -43.69 98.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.736 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -93.35 -25.77 17.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.863 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -90.21 -13.0 60.9 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.178 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.5 tp . . . . . 0 C--O 1.267 1.987 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.362 -179.116 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 94' ' ' PRO . 59.2 ttm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 38.9 m-20 -115.8 166.1 12.33 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.81 127.4 55.99 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.09 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.38 124.8 49.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.444 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.539 ' HA ' HG23 ' A' ' 98' ' ' VAL . 64.0 mt -118.3 106.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.467 ' HA ' ' HB2' ' A' ' 48' ' ' ALA . 14.1 ptm -99.69 100.36 11.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.905 1.336 . . . . 0.0 113.736 -172.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.54 96.8 5.68 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.537 176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.03 54.14 0.52 Allowed Glycine 0 C--N 1.305 -1.158 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.197 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.71 42.87 53.09 Favored Glycine 0 C--O 1.235 0.212 0 C-N-CA 120.508 -0.853 . . . . 0.0 114.559 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.66 106.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.72 19.13 78.24 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.383 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -116.18 133.82 55.6 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.9 -78.84 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.627 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.8 tpt -70.36 -38.36 74.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.578 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 172.59 42.0 Favored Glycine 0 C--N 1.319 -0.369 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.825 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.67 19.94 44.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.444 HG11 ' HD2' ' A' ' 20' ' ' PRO . 4.8 t 70.4 58.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.7 0.8 . . . . 0.0 110.561 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -80.49 65.99 5.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.558 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' O ' HD11 ' A' ' 29' ' ' LEU . 24.9 ttmm -140.0 -63.53 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.009 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD2' HG11 ' A' ' 17' ' ' VAL . 56.5 Cg_endo -68.53 -19.8 42.13 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 121.752 1.635 . . . . 0.0 111.712 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.526 HD22 ' CD2' ' A' ' 59' ' ' TYR . 35.0 mt -95.43 7.32 46.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.334 -0.393 . . . . 0.0 112.042 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.76 119.83 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 39.9 pttt -100.55 138.39 37.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.029 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.0 tp -136.47 115.9 12.75 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.197 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.2 m 60.53 19.66 9.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.85 -89.1 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.013 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 99.0 mtt180 -103.84 170.03 8.17 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.24 0.543 . . . . 0.0 111.954 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 69.7 m -76.71 163.72 26.56 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.462 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.612 HD11 ' O ' ' A' ' 19' ' ' LYS . 77.0 mt -58.78 -39.43 81.01 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.283 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.6 tp -56.73 -46.32 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.183 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 11.7 t70 -67.35 -40.76 85.84 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.044 0.45 . . . . 0.0 110.947 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 13.5 m-30 -62.29 -33.99 75.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.36 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -71.55 -42.91 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 30' ' ' ILE . 74.2 t -63.92 -43.79 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.2 m -52.42 -54.55 41.03 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.56 -39.51 16.0 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.565 1.51 . . . . 0.0 112.275 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.24 -42.82 92.99 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 120.801 0.334 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HG ' HD22 ' A' ' 69' ' ' ASN . 8.4 tt -61.3 -46.52 89.96 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.708 0.29 . . . . 0.0 111.19 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -76.3 -13.15 60.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -73.82 -178.49 3.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 112.126 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.448 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.5 ttmm -59.48 -24.95 64.01 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.941 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.56 156.02 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.176 0.513 . . . . 0.0 112.29 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -77.74 -86.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 10.0 m120 -107.72 156.85 18.64 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 111.454 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mm -107.85 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 89.7 m-85 -108.91 121.29 44.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -102.33 118.9 49.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.667 0.746 . . . . 0.0 110.715 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' HA ' ' A' ' 6' ' ' MET . . . -87.77 126.43 34.99 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.752 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -133.85 170.78 15.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.4 m -127.34 150.88 73.73 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 -27.16 80.94 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.501 2.801 . . . . 0.0 111.986 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.15 5.01 40.02 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.996 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.5 p -140.77 66.08 26.08 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.43 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.651 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 88.4 Cg_endo -106.73 88.12 0.02 OUTLIER 'Trans proline' 1 N--CA 1.379 -5.212 0 C-N-CA 117.212 -1.392 . . . . 0.0 110.66 170.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.623 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 72.6 mmtt -151.39 -50.41 0.12 Allowed 'General case' 1 C--N 1.22 -5.04 0 CA-C-N 109.862 -3.335 . . . . 0.0 103.054 177.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.8 m -63.83 -48.34 77.2 Favored 'General case' 0 N--CA 1.384 -3.759 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.107 163.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.651 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 13.5 tmtt? -64.66 -52.37 57.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.623 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -60.13 -33.07 71.63 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 116.701 -1.999 . . . . 0.0 112.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.526 ' CD2' HD22 ' A' ' 21' ' ' LEU . 58.0 t80 -70.34 -52.73 20.51 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.483 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.447 HG12 HG12 ' A' ' 30' ' ' ILE . 97.1 mt -63.44 -45.91 96.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.57 -42.26 92.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.264 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.471 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.1 t -71.67 -41.72 68.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.491 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.19 90.05 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 77.5 m-85 -106.69 32.51 4.48 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.502 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.4 mtmt -63.34 -18.66 63.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.474 0.654 . . . . 0.0 110.08 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.31 10.4 24.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.641 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.1 p90 -45.84 128.1 8.58 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -102.48 -51.48 3.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.846 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.519 HD22 ' HG ' ' A' ' 38' ' ' LEU . 26.0 p-10 -118.74 15.74 13.55 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.885 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -106.45 129.8 59.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.854 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.7 t -127.86 131.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.52 129.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG13 ' HA ' ' A' ' 48' ' ' ALA . 44.0 pt -125.63 157.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.473 0.654 . . . . 0.0 111.818 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -108.05 134.3 51.13 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.844 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.6 t -161.18 -172.18 3.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.565 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 66.1 m -77.65 4.66 10.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 126.921 2.088 . . . . 0.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.6 -23.66 0.0 OUTLIER Glycine 0 N--CA 1.513 3.822 0 C-N-CA 127.167 2.317 . . . . 0.0 117.623 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 22.3 tptm -58.01 -37.11 73.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.19 122.95 6.7 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -59.89 -51.3 70.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.44 -43.98 87.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.677 0.751 . . . . 0.0 110.523 -177.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -59.89 -42.87 94.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.551 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.556 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 34.9 t0 -60.07 -50.27 74.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.952 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.564 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.6 mm? -56.64 -41.76 77.73 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.583 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.445 ' HA ' HG12 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -61.37 -42.1 98.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.849 178.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.56 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 64.4 mm-40 -66.16 -44.24 84.65 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.4 m -63.4 -41.52 98.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.324 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 160' ' ' LYS . 34.4 pt -64.42 -30.16 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.67 96.53 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.331 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.55 -38.18 71.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.41 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 92.2 m-85 -92.55 136.8 32.91 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 m -100.68 -4.53 28.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.441 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 41.3 mt-10 -134.46 160.58 67.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.553 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.5 Cg_endo -63.06 143.54 90.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.082 1.855 . . . . 0.0 111.843 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.49 162.04 37.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.719 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.458 HD21 HG23 ' A' ' 156' ' ' VAL . 92.8 mt -84.73 149.82 25.51 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.914 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.637 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 59.7 t -122.14 125.12 72.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.104 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 5' ' ' ILE . 1.3 m -136.37 158.13 37.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.302 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.463 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.2 t -100.9 143.49 30.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.241 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.9 m -76.73 -9.35 58.61 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -106.27 11.18 31.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 62.5 mt -91.63 114.67 27.26 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.85 135.06 65.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 112.009 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 178.61 -178.89 0.31 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.83 58.69 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -66.23 -8.1 22.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.9 -1.5 . . . . 0.0 113.519 -174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 110' ' ' ILE . 60.3 m -58.72 -41.44 86.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -72.82 -37.85 67.36 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.743 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.6 mm -60.78 -40.81 86.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.188 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.443 HD11 ' HA ' ' A' ' 107' ' ' SER . 59.4 mt -58.33 -48.65 84.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.445 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 55.0 m-80 -65.65 -39.91 91.9 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.3 m -61.55 -37.23 83.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.743 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.7 mm -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.872 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.89 -44.66 99.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.687 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -60.03 -48.19 82.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.8 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.737 ' CE2' HD13 ' A' ' 120' ' ' ILE . 78.9 t80 -63.98 -47.21 81.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.4 -46.61 83.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.426 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 14.4 m-85 -62.13 -38.3 88.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.49 -41.51 98.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.339 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.737 HD13 ' CE2' ' A' ' 116' ' ' TYR . 74.7 mt -67.9 -48.63 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.204 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.17 -25.46 68.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.543 -177.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.72 98.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.819 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.99 -39.52 19.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.7 m -130.67 95.37 26.52 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.656 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.07 -13.14 35.85 Favored 'Trans proline' 0 N--CA 1.474 0.38 0 C-N-CA 122.738 2.292 . . . . 0.0 111.952 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.91 -31.01 71.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.069 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 124' ' ' THR . 13.4 p -65.53 133.1 31.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.061 0.458 . . . . 0.0 111.154 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.517 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 43.7 mt-10 -124.34 -3.28 7.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.899 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.26 156.8 43.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.801 0.334 . . . . 0.0 111.433 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.78 137.74 38.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.7 139.32 52.77 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.037 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.495 HG23 ' CD1' ' A' ' 113' ' ' ILE . 67.8 t -113.97 117.06 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.9 ptm -145.72 152.81 40.19 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.872 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 36.4 pt -132.02 159.55 71.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.051 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.35 134.04 61.11 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.003 1.802 . . . . 0.0 110.784 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.36 -16.34 63.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.977 0.418 . . . . 0.0 111.157 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -63.21 -39.57 95.0 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.64 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -93.27 -15.76 25.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.272 0.558 . . . . 0.0 110.78 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.44 128.37 93.74 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.81 -44.37 21.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.231 1.954 . . . . 0.0 113.928 -174.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -172.84 129.16 0.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.529 0.204 . . . . 0.0 111.104 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -60.97 137.17 70.37 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.41 2.073 . . . . 0.0 111.226 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.1 t -64.23 -48.14 76.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 109.785 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.4 pt -140.17 148.14 22.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.583 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 146' ' ' PHE . 13.6 t70 54.3 -156.81 0.21 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.593 0.558 . . . . 0.0 110.161 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.502 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 98.9 m-85 -110.64 -30.37 7.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.1 m120 64.2 138.48 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.927 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.64 97.95 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 pp -139.3 149.8 44.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.37 121.31 31.22 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-O 121.069 0.461 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 59.1 Cg_endo -71.0 144.29 47.03 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.709 2.273 . . . . 0.0 112.102 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -118.39 -6.03 10.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.34 -120.35 1.26 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.934 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.604 ' CG1' HG13 ' A' ' 113' ' ' ILE . 40.5 pt -121.21 158.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 120.903 0.382 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.637 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.1 t-20 -116.5 152.23 34.49 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.409 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.458 HG23 HD21 ' A' ' 96' ' ' LEU . 93.6 t -121.41 129.46 75.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 122.51 0.324 . . . . 0.0 110.409 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.456 HG13 ' OD1' ' A' ' 155' ' ' ASN . 31.6 m -135.3 149.01 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.143 0.497 . . . . 0.0 111.391 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.517 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 77.1 p -98.79 163.7 18.35 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.543 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.408 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 62.4 Cg_endo -73.4 74.65 3.1 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.258 1.972 . . . . 0.0 112.079 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.58 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.3 mmmt -115.33 137.68 51.78 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.748 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -93.18 107.05 18.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.336 0.589 . . . . 0.0 110.23 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.02 -128.95 6.37 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -136.29 129.27 31.19 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -117.53 166.5 12.29 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.607 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.0 120.37 9.53 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.301 0.572 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -121.02 130.1 53.65 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.801 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.415 ' HG3' HG23 ' A' ' 120' ' ' ILE . 42.8 mm-40 -92.8 161.9 14.33 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 121.731 0.777 . . . . 0.0 112.196 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.2 mm -117.89 127.05 75.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.652 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.554 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.3 ttp -124.77 128.71 49.17 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.92 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.3 t -107.97 128.75 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.492 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.544 ' HB ' ' OE1' ' A' ' 173' ' ' GLU . 48.6 pt -115.51 175.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.019 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -121.69 23.07 10.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.769 0.795 . . . . 0.0 109.889 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.544 ' OE1' ' HB ' ' A' ' 171' ' ' ILE . 20.0 mp0 -98.7 130.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.988 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.03 143.03 28.27 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.287 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.461 HD11 HD23 ' A' ' 102' ' ' LEU . 10.1 pt -121.6 154.06 25.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.409 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.38 106.1 13.91 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.672 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -68.05 -35.79 78.82 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.088 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.457 HG12 ' HB3' ' A' ' 183' ' ' ASP . 98.7 mt 66.32 109.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.045 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -120.93 -15.26 8.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.217 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.8 p -127.54 166.34 18.19 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.414 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.8 mppt? -63.51 -36.91 85.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.04 177.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.54 -40.6 87.78 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.457 ' HB3' HG12 ' A' ' 178' ' ' ILE . 77.0 m-20 -61.27 -41.71 97.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.491 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 89.9 mt -61.94 -47.63 84.02 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.312 0.577 . . . . 0.0 109.949 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 88.0 tttt -61.92 -42.68 99.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.623 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.406 ' C ' HD21 ' A' ' 186' ' ' LEU . 8.6 tt -60.47 -47.97 83.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.937 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -64.91 -42.11 95.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.202 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 pt-20 -69.5 -31.65 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 96.5 mtp -62.73 -40.96 98.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.646 0.26 . . . . 0.0 111.537 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.6 -36.27 60.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.189 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 92.3 mt -62.95 -45.77 90.89 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.443 0.64 . . . . 0.0 110.525 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.96 -46.03 86.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.994 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.5 -42.5 98.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.617 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.89 -29.48 66.68 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.07 -40.65 95.2 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.084 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.263 1.764 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.811 -178.822 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.4 ttm . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.514 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 33.5 m-20 -100.12 166.17 11.15 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB1' HG21 ' A' ' 42' ' ' VAL . . . -115.58 130.77 56.99 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.924 0.392 . . . . 0.0 111.101 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.8 tp -106.06 125.07 50.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.181 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.595 ' HA ' HG21 ' A' ' 98' ' ' VAL . 71.9 mt -117.68 102.22 13.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 100' ' ' SER . 12.1 ptm -96.22 98.52 10.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.987 1.375 . . . . 0.0 112.093 -175.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.44 98.23 6.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.196 -1.82 . . . . 0.0 110.332 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.24 14.58 0.02 OUTLIER Glycine 0 C--N 1.302 -1.331 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.843 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.68 100.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.179 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -146.73 22.83 1.26 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.99 32.04 66.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.3 p -96.66 141.67 29.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -121.49 -27.62 4.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 60.1 mtt -103.37 -57.03 2.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.4 143.8 14.4 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.513 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.66 145.2 36.64 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.76 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -84.83 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.6 mp0 -75.3 22.18 0.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 97.3 mttt -56.82 -48.5 97.21 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 118.298 0.499 . . . . 0.0 112.064 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 42.9 Cg_endo -68.15 -14.51 40.86 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.767 1.645 . . . . 0.0 111.77 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.481 HD23 ' CD2' ' A' ' 59' ' ' TYR . 57.8 mt -102.59 7.61 39.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 18' ' ' GLU . 95.7 mt -69.41 118.37 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.592 0.711 . . . . 0.0 109.129 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 48.8 pttt -87.68 125.92 34.67 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.999 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 184' ' ' LEU . 60.3 tp -131.71 119.69 21.69 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.003 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.1 m 57.29 28.72 15.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.25 -76.02 0.39 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.019 -1.086 . . . . 0.0 114.48 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.716 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 44.3 mtt180 -101.73 166.42 10.69 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 112.36 -172.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 75.7 m -76.15 151.79 36.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.674 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.1 tt -48.91 -47.93 42.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.26 0.624 . . . . 0.0 111.711 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 HG12 ' CD1' ' A' ' 60' ' ' ILE . 5.7 tp -57.61 -42.49 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 0.0 111.811 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.716 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 15.0 t70 -65.24 -39.73 93.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.142 0.496 . . . . 0.0 109.933 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -63.73 -37.34 86.99 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.969 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 29' ' ' LEU . 72.3 t -65.27 -43.43 95.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 110.239 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -63.61 -43.0 98.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.583 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -49.99 -57.01 13.85 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' O ' ' HB3' ' A' ' 40' ' ' SER . 41.8 Cg_endo -67.83 -37.99 14.52 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 121.57 1.514 . . . . 0.0 112.462 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.471 HD11 HG12 ' A' ' 98' ' ' VAL . 83.3 mt -65.09 -41.22 95.19 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.879 0.371 . . . . 0.0 111.67 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 ' HG ' HD22 ' A' ' 69' ' ' ASN . 5.7 tt -59.97 -46.58 88.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.035 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -83.31 -5.87 59.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 57.4 p -75.79 -178.38 4.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.518 0.675 . . . . 0.0 111.585 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -57.44 -24.8 57.8 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.719 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.421 HG21 ' HB1' ' A' ' 3' ' ' ALA . 22.7 m -67.38 161.8 3.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.514 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 60.1 t30 -80.43 -76.83 0.21 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.544 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -117.56 159.77 22.34 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.909 0.385 . . . . 0.0 110.767 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.67 114.06 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.3 m-85 -107.88 116.75 32.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.492 HG12 ' HB ' ' A' ' 5' ' ' ILE . 96.1 mt -97.98 116.15 39.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.558 0.694 . . . . 0.0 110.543 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.81 125.35 34.4 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.705 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -129.34 158.94 37.7 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.413 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 38.0 m -103.93 149.76 37.53 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.575 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.9 -20.63 57.99 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.745 2.297 . . . . 0.0 111.309 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -89.04 1.66 55.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 20.3 p -138.08 67.51 48.07 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.653 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.646 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 90.8 Cg_endo -100.99 87.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.384 -4.939 0 C-N-CA 117.303 -1.331 . . . . 0.0 109.17 169.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.642 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.5 mmtm -156.94 -52.7 0.08 Allowed 'General case' 1 C--N 1.215 -5.268 0 CA-C-N 110.183 -3.19 . . . . 0.0 103.057 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.3 m -63.77 -50.03 70.62 Favored 'General case' 0 N--CA 1.379 -3.991 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 165.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.646 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -65.25 -49.25 70.35 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.7 pt-20 -60.83 -31.36 70.78 Favored 'General case' 0 C--N 1.374 1.664 0 C-N-CA 116.16 -2.216 . . . . 0.0 112.17 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' CD2' HD23 ' A' ' 21' ' ' LEU . 52.9 t80 -72.2 -51.22 22.1 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.582 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.472 ' CD1' HG12 ' A' ' 30' ' ' ILE . 97.8 mt -62.35 -44.92 99.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.689 -174.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.71 -44.01 90.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.499 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 73.1 m -68.8 -41.21 79.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.384 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.58 88.08 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.45 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.574 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 66.5 m-85 -110.54 31.82 5.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.409 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -61.77 -24.19 66.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.16 0.505 . . . . 0.0 110.739 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.27 10.97 25.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.017 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.5 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.4 p90 -45.44 134.26 6.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -175.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.06 -49.53 3.74 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.459 HD22 ' HG ' ' A' ' 38' ' ' LEU . 26.2 p-10 -119.25 11.65 12.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.563 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 80.8 mt -106.2 127.29 61.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.27 0.557 . . . . 0.0 110.697 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 76.9 t -126.45 132.23 70.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.732 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.85 130.58 52.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' A' ' 48' ' ' ALA . 37.7 pt -124.07 155.73 31.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.391 0.615 . . . . 0.0 110.396 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.72 132.35 56.49 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.865 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.549 ' OG1' ' HG2' ' A' ' 86' ' ' GLU . 14.2 t -163.66 -167.42 1.4 Allowed 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.5 m -66.04 1.0 1.61 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 127.017 2.127 . . . . 0.0 114.349 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.56 -22.39 0.0 OUTLIER Glycine 0 N--CA 1.514 3.875 0 C-N-CA 126.026 1.774 . . . . 0.0 116.67 -175.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 76' ' ' SER . 13.9 tmtt? -57.39 -36.6 71.49 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.38 122.84 6.23 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.58 -50.47 73.76 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 pt -71.49 -32.16 45.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.097 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.53 -43.46 89.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.467 0.651 . . . . 0.0 109.891 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.562 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.1 t0 -61.3 -50.5 72.74 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.859 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.55 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.4 mm? -57.44 -45.09 85.1 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.035 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.485 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.6 m-80 -60.69 -42.63 97.53 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.549 ' HG2' ' OG1' ' A' ' 75' ' ' THR . 16.8 tp10 -65.37 -46.43 80.15 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.533 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 99.0 m -63.78 -41.01 98.03 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.403 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.55 HG21 ' O ' ' A' ' 84' ' ' LEU . 33.2 pt -65.18 -36.82 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.393 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.63 -38.97 95.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.4 174.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.35 -49.22 74.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.64 0.776 . . . . 0.0 112.814 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.533 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 83.3 m-85 -75.76 149.83 37.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -103.06 -5.29 23.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.386 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.78 158.33 74.31 Favored Pre-proline 0 CA--C 1.505 -0.787 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.94 141.62 77.83 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.858 2.372 . . . . 0.0 110.534 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 45.5 p90 -141.84 156.81 45.53 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.543 0.687 . . . . 0.0 111.923 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.452 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.42 138.5 31.73 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.931 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 64.3 t -116.94 131.67 68.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 123.311 0.644 . . . . 0.0 109.291 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 5' ' ' ILE . 17.7 m -126.72 164.04 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 112.02 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.436 ' O ' HD22 ' A' ' 102' ' ' LEU . 47.6 t -82.54 159.95 22.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.009 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 6' ' ' MET . 81.1 p -86.1 -26.07 25.46 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.6 28.77 7.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 99' ' ' SER . 1.5 pt? -86.55 156.88 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.694 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.7 pt -96.74 174.09 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 96.2 m-20 -69.19 -170.29 0.25 Allowed 'General case' 0 C--O 1.247 0.932 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.041 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 104' ' ' ASN . 4.2 mm? 75.03 14.74 3.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.311 1.044 . . . . 0.0 109.97 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.441 ' HA ' HG12 ' A' ' 109' ' ' ILE . 47.9 mmtm -99.52 -0.81 39.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.032 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.4 p -59.31 -37.1 76.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.97 -24.77 59.66 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.87 0.843 . . . . 0.0 109.747 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.762 ' O ' HG12 ' A' ' 113' ' ' ILE . 41.2 mm -67.17 -39.77 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.27 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 154' ' ' ILE . 66.3 mt -57.24 -49.07 81.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.13 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -66.12 -40.41 90.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.195 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -62.77 -41.09 99.08 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.97 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.762 HG12 ' O ' ' A' ' 109' ' ' ILE . 47.7 mm -62.12 -48.69 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.044 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.471 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.1 t -61.98 -48.77 87.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.428 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.57 -41.99 98.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.057 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.82 -41.65 78.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.927 0.394 . . . . 0.0 110.354 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.75 -46.68 86.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.93 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 17.2 m-85 -60.05 -37.01 78.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.492 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.05 -41.14 97.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 109.563 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.1 mt -68.55 -41.36 82.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.298 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 127' ' ' VAL . 17.7 mmmt -59.94 -43.11 95.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.478 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.56 93.51 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.724 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.29 -34.73 31.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.519 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.3 m -140.31 95.43 8.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.31 -25.12 77.24 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.207 2.605 . . . . 0.0 112.688 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.66 -31.75 72.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.511 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.425 ' O ' ' HD2' ' A' ' 121' ' ' LYS . 63.3 t -69.26 122.6 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.575 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 33.8 mt-10 -130.93 18.83 5.04 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 156' ' ' VAL . . . -151.0 151.55 32.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.043 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 18.7 tp -138.89 143.29 38.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.905 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.55 138.56 52.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.444 HG23 ' CD1' ' A' ' 113' ' ' ILE . 60.0 t -117.5 117.03 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 4.3 ptm -146.01 161.77 39.37 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.53 -176.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.445 HG12 ' HB1' ' A' ' 152' ' ' ALA . 22.7 pt -132.66 154.58 81.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.558 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.506 ' O ' ' HG2' ' A' ' 138' ' ' LYS . 65.1 Cg_exo -56.77 131.29 44.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.971 1.78 . . . . 0.0 110.1 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 142' ' ' PRO . 65.6 pttt -64.42 -21.98 66.81 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.863 0.363 . . . . 0.0 111.532 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.49 -37.57 88.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.474 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 135' ' ' PRO . 13.7 ptmm? -83.35 -21.52 33.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.226 0.536 . . . . 0.0 110.829 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -78.03 120.55 81.68 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.472 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.0 126.75 18.67 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.409 2.072 . . . . 0.0 111.937 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.99 59.77 7.59 Favored Pre-proline 0 N--CA 1.483 1.195 0 CA-C-O 121.598 0.713 . . . . 0.0 111.421 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 63.5 Cg_endo -72.89 -27.03 14.9 Favored 'Trans proline' 0 C--N 1.327 -0.586 0 C-N-CA 123.533 2.822 . . . . 0.0 113.747 -177.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.0 m 65.21 178.94 0.19 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.522 0.513 . . . . 0.0 110.464 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm 51.2 85.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.427 0.632 . . . . 0.0 111.787 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -63.26 -40.55 97.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.328 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -102.3 119.1 38.24 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.483 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 148' ' ' GLY . 65.5 t30 62.0 -174.26 0.14 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.127 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.413 ' H ' ' CG ' ' A' ' 147' ' ' ASN . . . 92.04 157.96 34.09 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.068 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 pp -140.53 158.98 43.18 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.74 121.94 28.03 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-O 121.149 0.5 . . . . 0.0 111.912 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.402 ' O ' HD11 ' A' ' 175' ' ' ILE . 61.1 Cg_endo -72.01 151.2 55.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.501 2.134 . . . . 0.0 110.432 176.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.445 ' HB1' HG12 ' A' ' 134' ' ' ILE . . . -131.98 -28.3 1.77 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.895 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.57 -136.63 6.75 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.977 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.452 HD12 HD11 ' A' ' 96' ' ' LEU . 20.6 pt -123.66 161.02 26.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.735 -177.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.563 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.7 t-20 -112.13 152.52 28.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.449 -174.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 129' ' ' ALA . 71.6 t -124.59 130.86 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.201 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.491 HG12 ' OD1' ' A' ' 155' ' ' ASN . 20.1 m -133.75 149.03 30.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.513 0.673 . . . . 0.0 111.396 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.575 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 23.3 t -97.83 151.66 37.7 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.412 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 43.2 Cg_endo -67.32 77.73 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.589 2.193 . . . . 0.0 111.61 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.71 -175.67 2.83 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.13 115.9 15.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.71 -123.78 7.12 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.275 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.91 140.7 50.91 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -134.12 164.14 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.649 0.261 . . . . 0.0 111.653 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.421 ' CG ' HG23 ' A' ' 127' ' ' VAL . 49.4 tptt -57.08 127.98 34.7 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.506 0.67 . . . . 0.0 112.22 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -128.63 137.26 51.57 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.538 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.1 163.19 12.67 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.53 130.97 69.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.597 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.7 ttm -122.63 141.76 51.38 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 133' ' ' MET . 57.9 t -117.06 131.41 69.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.4 pt -120.76 175.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.12 5.5 30.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.328 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.565 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.4 mp0 -96.84 130.24 44.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.195 0.998 . . . . 0.0 111.917 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.2 mt -97.05 152.22 18.96 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.115 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.402 HD11 ' O ' ' A' ' 151' ' ' PRO . 18.1 pt -130.61 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.833 175.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.1 119.34 28.34 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -82.26 118.91 23.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.84 105.68 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.107 0.479 . . . . 0.0 110.402 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -113.1 -19.18 11.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.163 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -147.64 165.92 28.96 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.12 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -58.26 -31.91 67.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.844 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.51 -43.01 99.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 176.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.1 -42.32 98.3 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.459 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.444 ' CD1' HD13 ' A' ' 24' ' ' LEU . 58.9 tp -62.08 -46.67 88.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.568 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 63.5 tttm -64.24 -42.13 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.989 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.15 -45.38 93.26 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.501 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.13 -40.89 98.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.996 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 8.7 pt-20 -67.42 -36.28 80.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.872 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.468 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.0 mtp -62.59 -39.08 92.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.33 -34.96 61.26 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.3 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -46.06 64.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.066 0.46 . . . . 0.0 112.157 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -67.89 -28.44 67.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.214 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -64.85 -41.4 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.092 0.472 . . . . 0.0 110.238 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.36 -28.01 66.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.847 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -81.06 -60.53 2.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.978 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.8 tp . . . . . 0 C--O 1.263 1.803 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.109 179.75 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 23.5 ptp . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.437 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 22.7 m-20 -95.33 163.36 13.29 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -121.09 128.51 52.66 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 40.9 tp -103.75 127.45 51.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.547 ' HA ' HG23 ' A' ' 98' ' ' VAL . 63.6 mt -117.63 103.48 14.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.508 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 14.7 ptm -98.25 115.94 29.44 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-O 123.474 1.607 . . . . 0.0 112.07 -176.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.91 -173.22 2.24 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 111.226 -2.716 . . . . 0.0 109.819 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.03 -73.48 0.2 Allowed Glycine 0 C--N 1.267 -3.271 0 CA-C-N 114.12 -1.4 . . . . 0.0 111.283 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.62 167.95 39.85 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.587 ' O ' ' HA3' ' A' ' 15' ' ' GLY . 75.1 mmtt -122.4 143.41 49.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.07 0.435 . . . . 0.0 110.169 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 137.02 5.16 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.655 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 p -80.95 -77.44 0.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.014 0.435 . . . . 0.0 111.031 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 -65.29 -41.94 93.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.298 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -139.7 148.9 43.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.953 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 10' ' ' LYS . . . -161.5 131.26 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.195 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.81 -0.42 68.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.052 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.8 t -122.33 123.2 68.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -163.41 178.53 8.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.97 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.4 tptp 60.34 67.8 1.54 Allowed Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 123.568 0.542 . . . . 0.0 110.147 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.75 -7.54 7.66 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 123.76 2.973 . . . . 0.0 113.517 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 64.3 mt -88.11 10.76 18.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 19' ' ' LYS . 97.8 mt -63.87 126.81 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 173.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 62.6 mttp -102.32 141.15 35.62 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 122.264 1.03 . . . . 0.0 113.705 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD23 HD12 ' A' ' 184' ' ' LEU . 86.4 mt -125.41 110.25 13.72 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.222 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.38 33.44 18.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.657 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -20.01 39.19 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.904 1.121 . . . . 0.0 115.904 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.659 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 89.6 mtt180 -117.71 152.31 35.5 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 119.235 1.518 . . . . 0.0 112.327 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 81.7 m -75.27 162.45 28.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.779 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 100' ' ' SER . 88.6 mt -59.86 -40.67 89.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.051 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.546 HG12 ' CD1' ' A' ' 60' ' ' ILE . 3.8 tp -59.77 -43.08 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.624 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 9.9 t70 -62.86 -44.08 97.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.292 0.568 . . . . 0.0 110.029 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.659 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 23.9 m-85 -65.11 -33.3 75.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.646 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.612 ' HA ' ' NZ ' ' A' ' 106' ' ' LYS . 69.7 t -71.9 -44.61 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.606 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 30' ' ' ILE . 72.2 t -64.57 -43.76 96.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.514 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 73.4 m -52.22 -54.61 39.71 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 42.4 Cg_exo -62.41 -41.91 30.66 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.11 1.874 . . . . 0.0 112.479 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 HD11 HG12 ' A' ' 98' ' ' VAL . 87.2 mt -67.11 -40.28 86.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.087 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.438 ' HG ' HD22 ' A' ' 69' ' ' ASN . 7.2 tt -62.28 -46.3 89.43 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.0 0.429 . . . . 0.0 109.891 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.61 -17.15 60.75 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.404 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.44 ' CB ' HG23 ' A' ' 110' ' ' ILE . 78.7 p -70.69 170.05 13.16 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.185 0.517 . . . . 0.0 111.757 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -71.85 24.77 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.1 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.92 162.38 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.828 -0.545 . . . . 0.0 110.767 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 64.5 t30 -72.27 -76.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.619 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -125.9 160.19 30.57 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.952 0.406 . . . . 0.0 110.438 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.0 mm -108.4 116.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.7 m-85 -109.72 116.97 32.69 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.479 HG22 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -98.15 119.85 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.562 0.696 . . . . 0.0 111.039 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -95.19 119.8 34.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.984 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.3 p -125.95 150.99 47.58 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.419 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 75' ' ' THR . 54.8 m -83.77 152.2 62.58 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.009 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.32 -18.43 63.16 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.152 2.568 . . . . 0.0 111.4 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -89.95 -0.63 57.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.6 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -141.32 68.17 26.3 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 97.5 Cg_endo -104.65 85.67 0.02 OUTLIER 'Trans proline' 1 N--CA 1.382 -5.056 0 C-N-CA 116.845 -1.637 . . . . 0.0 108.889 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 35.1 mmtp -144.94 -50.14 0.26 Allowed 'General case' 1 C--N 1.224 -4.857 0 CA-C-N 110.299 -3.137 . . . . 0.0 103.78 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.435 ' HA ' HD22 ' A' ' 21' ' ' LEU . 68.4 m -62.41 -45.8 91.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.632 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -61.95 -50.86 70.42 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.896 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.648 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.3 pt-20 -63.12 -32.19 73.51 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.039 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -62.59 -50.5 71.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.91 0.386 . . . . 0.0 111.466 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.546 ' CD1' HG12 ' A' ' 30' ' ' ILE . 92.1 mt -63.29 -43.75 98.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.104 -176.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -57.65 -43.71 85.12 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.5 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t -71.82 -43.07 66.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.48 93.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.347 0.594 . . . . 0.0 110.891 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.439 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 90.2 m-85 -111.6 41.65 1.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.006 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.5 mtmt -61.3 -21.79 64.28 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.261 0.553 . . . . 0.0 110.423 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -91.2 10.59 26.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.4 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.439 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 35.3 p90 -35.62 113.79 0.22 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.506 ' C ' ' HD3' ' A' ' 68' ' ' LYS . 4.6 tmtm? -93.16 -51.93 4.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.066 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.438 HD22 ' HG ' ' A' ' 38' ' ' LEU . 27.2 p-10 -118.74 13.92 13.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.767 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.19 126.48 56.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.403 0.62 . . . . 0.0 111.527 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.8 t -126.06 133.1 69.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.56 132.71 54.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.34 155.28 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.426 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -118.11 131.18 56.44 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.222 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 50' ' ' SER . 13.0 t -165.41 -173.66 2.89 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.137 0.97 . . . . 0.0 113.582 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 78' ' ' LYS . 48.9 m -64.67 3.48 0.51 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.404 2.282 . . . . 0.0 115.497 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.54 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.14 -29.36 0.01 OUTLIER Glycine 1 N--CA 1.519 4.186 0 C-N-CA 126.434 1.969 . . . . 0.0 117.602 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' SER . 53.6 tptt -58.08 -38.91 77.26 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -100.46 114.58 5.05 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.74 -47.77 84.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.63 -49.01 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.629 0.728 . . . . 0.0 109.797 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.7 -47.16 86.74 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.631 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.54 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.4 t0 -61.12 -51.9 67.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.733 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.518 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.5 mm? -58.29 -44.99 88.74 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.805 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -58.29 -46.49 85.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.083 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.91 -46.97 82.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.176 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.578 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 96.4 m -63.6 -43.47 96.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.194 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.518 HG21 ' O ' ' A' ' 84' ' ' LEU . 35.8 pt -65.73 -30.86 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 120.855 0.36 . . . . 0.0 110.27 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.94 -39.67 97.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.983 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -74.99 -34.75 62.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.578 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 74.6 m-85 -76.16 142.65 41.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -103.69 1.14 31.49 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.981 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 36.5 mt-10 -138.39 160.86 62.07 Favored Pre-proline 0 CA--C 1.503 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.464 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 1' ' ' MET . 42.9 Cg_endo -68.19 145.4 66.37 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.808 1.672 . . . . 0.0 109.792 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -145.21 161.91 38.38 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.201 0.524 . . . . 0.0 112.192 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.513 HD21 HG23 ' A' ' 156' ' ' VAL . 93.3 mt -85.63 149.74 25.11 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.693 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.9 t -120.77 125.47 74.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 5' ' ' ILE . 6.1 m -131.44 162.4 39.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.325 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.5 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 49.0 m -99.45 143.3 29.86 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.16 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.478 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 78.2 p -73.15 -10.01 59.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.299 0.571 . . . . 0.0 111.605 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 99' ' ' SER . 4.7 p-10 -101.41 16.78 24.51 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.251 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.45 117.17 28.94 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 122.007 -0.433 . . . . 0.0 110.619 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 47.4 pt -69.93 -172.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.782 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.44 -175.42 2.79 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.1 tp 80.73 24.32 0.32 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 110.023 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.612 ' NZ ' ' HA ' ' A' ' 33' ' ' VAL . 50.0 mtmt -98.79 -1.86 39.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.829 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.0 m -58.07 -43.75 87.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -86.82 -20.64 27.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.722 ' O ' HG12 ' A' ' 113' ' ' ILE . 43.2 mm -63.73 -45.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.961 -175.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.44 HG23 ' CB ' ' A' ' 40' ' ' SER . 58.3 mt -59.52 -48.58 86.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.556 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -63.92 -39.67 94.71 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.084 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.2 m -62.45 -38.04 88.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.855 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.722 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.6 mm -59.61 -48.23 88.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.219 0.533 . . . . 0.0 109.932 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 78.7 t -62.71 -49.51 83.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.495 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.02 -41.97 99.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.287 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.499 ' CE2' HD13 ' A' ' 120' ' ' ILE . 46.0 t80 -63.92 -46.68 83.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.148 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.46 -47.69 84.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.989 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 27.2 m-85 -61.02 -36.88 80.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.169 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.8 t -62.21 -45.37 93.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.455 0.645 . . . . 0.0 109.71 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.499 HD13 ' CE2' ' A' ' 116' ' ' TYR . 84.7 mt -63.38 -49.22 83.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.497 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.64 -25.0 67.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.59 99.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.552 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.415 ' HZ3' ' HA ' ' A' ' 120' ' ' ILE . 24.3 pttm -83.83 -34.33 24.7 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.65 177.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 54.4 m -137.73 97.23 10.26 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.33 -13.4 39.27 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.049 2.499 . . . . 0.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.69 -29.64 70.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.425 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.5 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 85.7 t -67.21 126.48 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.214 0.531 . . . . 0.0 110.681 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.506 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 39.8 mt-10 -108.25 -25.22 11.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.798 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.7 38.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.115 0.483 . . . . 0.0 112.111 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.96 132.21 36.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.174 -178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -122.28 135.41 54.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.487 HG21 ' CD1' ' A' ' 113' ' ' ILE . 59.0 t -113.72 119.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.22 157.88 43.85 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.563 -177.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 152' ' ' ALA . 37.8 pt -134.07 157.83 76.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.595 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.97 139.08 89.13 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.446 2.098 . . . . 0.0 112.054 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.639 ' O ' ' HD2' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -62.66 -21.15 65.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.83 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.33 -38.76 81.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.589 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -99.12 -20.26 16.76 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -63.23 133.18 95.36 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.35 -63.14 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.684 2.256 . . . . 0.0 112.883 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -161.61 154.52 17.35 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.2 71.28 2.29 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.699 2.266 . . . . 0.0 111.481 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' A' ' 179' ' ' ASN . 70.1 m -60.02 -36.52 77.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 50.7 mm -58.7 -27.82 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.134 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 73.14 26.77 2.09 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 110.188 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.72 124.51 44.42 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.848 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -82.59 177.31 8.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.097 0.475 . . . . 0.0 112.14 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.39 -134.33 11.88 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 mp -89.88 146.5 24.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.843 0.354 . . . . 0.0 110.097 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 27.6 m -118.32 138.54 25.77 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.348 -176.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.65 144.18 53.81 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.496 2.13 . . . . 0.0 111.501 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.443 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -116.49 -2.67 11.96 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.71 -127.29 1.0 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.724 -1.703 . . . . 0.0 114.163 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.49 ' HB ' HG13 ' A' ' 113' ' ' ILE . 4.0 mp -101.63 140.43 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-O 121.591 0.71 . . . . 0.0 111.918 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.589 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.4 t-20 -109.13 155.49 20.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.397 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.513 HG23 HD21 ' A' ' 96' ' ' LEU . 87.9 t -124.58 135.74 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 122.905 0.482 . . . . 0.0 110.467 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.16 151.41 30.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 120.79 0.328 . . . . 0.0 110.566 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.506 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 82.9 p -90.8 163.18 31.01 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.037 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 71.9 Cg_endo -75.75 63.25 6.59 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.385 2.057 . . . . 0.0 112.426 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.409 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 33.6 mmtp -110.89 -172.77 2.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.674 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -143.03 120.23 11.49 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.35 -125.49 5.79 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.242 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -112.99 142.41 45.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.03 152.3 47.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.852 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.5 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 9.1 tmtm? -76.75 125.98 30.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.67 136.48 54.5 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.987 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.478 ' HG3' HG21 ' A' ' 120' ' ' ILE . 24.8 mm-40 -95.77 164.01 12.93 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.328 0.585 . . . . 0.0 112.058 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.71 131.04 68.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.427 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.446 ' HE1' ' CG ' ' A' ' 116' ' ' TYR . 44.1 ttm -116.75 135.49 53.72 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.645 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.31 126.45 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.533 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 42.7 pt -119.28 175.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.407 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.13 3.3 9.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.491 . . . . 0.0 111.496 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.533 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 1.8 pm0 -98.78 137.03 37.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.621 0.724 . . . . 0.0 111.262 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -95.86 150.59 20.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.831 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.0 pt -127.18 153.94 36.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.512 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.67 107.61 13.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 143' ' ' SER . 7.3 m120 -74.51 -35.3 63.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.606 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.501 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 86.1 mt 79.98 96.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.772 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 143' ' ' SER . 27.3 t-20 -110.28 -19.38 13.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.697 175.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.2 p -126.33 162.24 25.97 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.096 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.71 -35.07 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.956 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -62.07 -41.78 98.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.501 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 73.3 m-20 -63.96 -41.73 97.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 109.571 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.444 HD12 HD23 ' A' ' 24' ' ' LEU . 60.0 tp -61.51 -48.35 81.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.194 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.494 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 62.9 tttm -63.4 -44.33 94.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.138 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.66 -44.65 96.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 0.0 110.02 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.49 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.81 -42.47 99.06 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.705 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.3 pt-20 -70.97 -36.11 72.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.465 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 95.0 mtp -63.99 -42.37 97.21 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -65.19 -36.02 82.89 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.955 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.0 mt -63.48 -46.14 87.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.71 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -63.89 -39.51 94.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.28 -26.55 66.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.166 0.508 . . . . 0.0 111.096 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.43 -11.94 70.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.921 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.7 pp . . . . . 0 C--O 1.271 2.21 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.601 -179.241 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.507 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 42.6 m-20 -96.52 165.91 11.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.81 137.87 51.75 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.7 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.442 ' O ' HG21 ' A' ' 98' ' ' VAL . 8.5 mt -96.58 135.78 38.01 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.785 174.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' HA ' HG21 ' A' ' 98' ' ' VAL . 75.7 mt -127.59 100.03 5.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.4 ptm -95.5 99.08 11.02 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 123.269 1.509 . . . . 0.0 112.248 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.0 110.53 20.2 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 112.378 -2.192 . . . . 0.0 109.615 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.23 -2.36 5.44 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.722 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.66 73.26 1.67 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.134 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -139.95 123.12 16.85 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.15 -13.94 59.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.175 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -83.9 169.87 14.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.695 0.283 . . . . 0.0 111.196 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -86.39 -148.35 0.13 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 0.0 111.081 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 9.7 tpt -69.25 76.47 0.36 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.606 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.94 176.26 42.57 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.22 -121.7 27.49 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.5 93.94 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 172.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.444 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 36.8 tt0 -60.42 -50.14 74.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.983 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.0 mttt -143.42 129.8 10.35 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 25.4 Cg_exo -68.71 -11.22 31.3 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.406 2.071 . . . . 0.0 109.08 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 73.4 mt -95.93 18.27 13.64 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.471 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 19' ' ' LYS . 95.1 mt -62.83 118.81 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.883 0.849 . . . . 0.0 109.296 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -86.14 131.2 34.3 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.991 -175.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -132.57 125.46 30.55 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.737 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 52.28 30.0 7.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.45 -9.19 58.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.509 -0.853 . . . . 0.0 115.063 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.697 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.7 mtt180 -127.01 153.84 45.4 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.826 1.313 . . . . 0.0 111.846 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.56 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 77.3 m -80.26 164.09 23.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 33' ' ' VAL . 77.6 mt -59.05 -43.99 91.75 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.075 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.484 ' O ' HG21 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.58 -39.88 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.697 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.3 t70 -64.55 -43.61 93.4 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.276 0.56 . . . . 0.0 110.193 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 7.5 m-85 -63.24 -34.17 77.08 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.622 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 29' ' ' LEU . 69.8 t -69.34 -42.12 81.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.915 0.388 . . . . 0.0 110.543 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 30' ' ' ILE . 66.2 t -62.45 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.793 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.556 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 67.8 m -53.47 -52.29 68.05 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 53.2 Cg_exo -60.33 -43.1 36.57 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 121.789 1.66 . . . . 0.0 112.484 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.454 HD11 HG12 ' A' ' 98' ' ' VAL . 93.2 mt -66.68 -38.31 86.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 110.563 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.518 HD11 HD22 ' A' ' 69' ' ' ASN . 62.1 tp -59.33 -44.7 92.58 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.385 178.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 35' ' ' SER . 61.1 pttt -91.18 -4.39 56.14 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.452 ' OG ' HG21 ' A' ' 42' ' ' VAL . 80.8 p -82.46 -176.55 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 111.071 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -54.22 -22.45 11.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.642 1.177 . . . . 0.0 112.23 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.452 HG21 ' OG ' ' A' ' 40' ' ' SER . 58.5 t -54.49 137.59 15.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.507 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -72.0 -79.44 0.07 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.153 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.44 HD21 ' C ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -115.58 155.76 27.02 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.258 0.552 . . . . 0.0 110.567 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.9 mm -107.05 116.05 49.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.046 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 96.9 m-85 -107.84 116.54 32.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 60' ' ' ILE . 82.1 mt -98.96 116.69 42.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.461 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.38 123.99 32.92 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.17 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.5 p -129.26 161.9 29.14 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.664 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -117.12 151.4 47.62 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.895 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.82 -19.08 53.22 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.867 2.378 . . . . 0.0 111.245 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.15 -10.86 59.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.5 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -140.76 66.7 27.69 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.558 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 98.2 Cg_endo -102.64 88.8 0.03 OUTLIER 'Trans proline' 1 N--CA 1.376 -5.41 0 C-N-CA 117.197 -1.402 . . . . 0.0 110.345 171.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -150.9 -47.35 0.12 Allowed 'General case' 1 C--N 1.205 -5.699 0 CA-C-N 110.368 -3.106 . . . . 0.0 102.865 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.4 m -63.38 -48.27 78.58 Favored 'General case' 0 N--CA 1.386 -3.64 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.679 164.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.653 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -62.91 -45.12 94.02 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.522 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 54' ' ' PRO . 32.0 mm-40 -57.3 -43.52 83.3 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.182 -1.407 . . . . 0.0 110.975 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -60.98 -51.59 68.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.845 0.355 . . . . 0.0 111.89 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.537 HD12 HG22 ' A' ' 47' ' ' ILE . 87.2 mt -63.98 -45.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.736 -176.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.569 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 54.9 t-20 -58.8 -39.38 80.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -86.74 -31.1 21.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.831 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.17 -34.67 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -103.6 6.82 37.46 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.892 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.4 pttt -61.32 -23.7 65.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 110.835 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.46 -33.58 71.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.536 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -80.15 140.81 36.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.334 0.588 . . . . 0.0 112.38 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -86.9 -43.53 12.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.606 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.518 HD22 HD11 ' A' ' 38' ' ' LEU . 15.9 p-10 -82.14 -0.77 46.37 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.949 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -106.37 121.25 58.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.2 t -123.28 130.68 74.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.248 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.38 131.59 45.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.461 HG13 ' HA ' ' A' ' 48' ' ' ALA . 40.6 pt -126.89 156.71 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.267 0.556 . . . . 0.0 110.573 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.08 134.22 55.03 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 8.9 t -158.42 -171.16 3.35 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.1 m -66.69 1.86 1.61 Allowed 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 126.696 1.999 . . . . 0.0 114.774 -174.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.37 -24.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.056 0 C-N-CA 125.877 1.703 . . . . 0.0 116.841 -174.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.0 tmtt? -53.31 -33.83 54.94 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.06 120.23 4.66 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -59.22 -50.55 73.57 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.08 -44.8 97.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.94 0.876 . . . . 0.0 109.823 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.96 -42.02 97.47 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.71 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.549 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 8.0 t0 -58.68 -50.94 72.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.17 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.503 ' O ' HG22 ' A' ' 88' ' ' ILE . 3.6 mm? -58.78 -42.59 89.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.998 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.505 ' HA ' HG12 ' A' ' 88' ' ' ILE . 17.8 m-80 -59.98 -41.27 91.66 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 67.0 mm-40 -64.52 -44.84 89.6 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.271 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.3 m -63.47 -44.75 93.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.63 HD13 ' O ' ' A' ' 160' ' ' LYS . 24.6 pt -65.06 -28.42 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 0.0 110.79 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.61 -37.77 94.75 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.455 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.56 -2.23 42.18 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -97.51 156.74 16.36 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.752 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -118.58 1.25 11.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.09 155.22 80.27 Favored Pre-proline 0 CA--C 1.502 -0.878 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -56.65 141.92 91.21 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.868 2.379 . . . . 0.0 110.509 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -141.83 158.4 43.84 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.372 0.606 . . . . 0.0 111.755 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.482 HD11 ' N ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -86.03 143.84 27.9 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.118 -175.025 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 75.6 t -120.32 130.73 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.935 0.894 . . . . 0.0 109.765 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 5' ' ' ILE . 18.7 m -131.34 159.64 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.514 0.674 . . . . 0.0 112.774 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.546 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 42.3 t -99.97 153.72 18.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.5 p -88.58 -0.19 57.0 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -173.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 24.7 p-10 -108.82 -3.59 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -174.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.546 ' CD2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER -87.98 115.28 25.34 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.181 177.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -96.27 8.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.72 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.535 ' CB ' HG21 ' A' ' 175' ' ' ILE . 21.9 t-20 -55.93 143.88 30.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.126 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.61 80.0 0.42 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.169 0.985 . . . . 0.0 109.257 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.412 ' O ' HG13 ' A' ' 110' ' ' ILE . 14.0 ptpt -74.38 -1.08 19.38 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.574 -1.648 . . . . 0.0 113.724 -175.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.7 t -57.31 -45.34 84.31 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -76.95 -26.33 53.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.588 0.708 . . . . 0.0 109.841 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 113' ' ' ILE . 37.6 mm -69.73 -43.0 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.646 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.414 ' HA ' HD13 ' A' ' 154' ' ' ILE . 63.5 mt -58.62 -48.54 85.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.381 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -64.6 -41.23 96.37 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.252 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -62.9 -39.38 94.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.086 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.754 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.5 mm -61.01 -47.87 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.99 -47.57 92.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.433 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -61.91 -43.7 98.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.081 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.457 ' CE2' HD11 ' A' ' 120' ' ' ILE . 83.2 t80 -63.86 -49.02 74.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.9 0.381 . . . . 0.0 111.04 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.57 -47.8 84.14 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.89 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.603 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 31.8 m-85 -65.83 -31.4 72.33 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.028 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.93 -45.07 94.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.457 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.9 mt -63.22 -49.44 83.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.329 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.603 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 14.8 ptmt -63.64 -23.43 67.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.938 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.34 -41.86 97.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.53 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.11 -41.3 10.56 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 111.23 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 29.6 m -127.47 91.99 44.48 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.54 -12.0 32.35 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 122.595 2.197 . . . . 0.0 112.508 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 23.3 t70 -64.86 -28.84 69.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.123 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 124' ' ' THR . 7.7 p -54.13 130.06 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.19 0.519 . . . . 0.0 111.32 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.581 ' HB3' ' OE1' ' A' ' 164' ' ' GLN . 47.1 mt-10 -115.01 -12.52 11.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.057 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.2 163.34 40.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.939 0.4 . . . . 0.0 111.612 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 133.3 31.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.752 -178.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -123.6 139.13 54.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.808 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.497 HG21 ' CD1' ' A' ' 113' ' ' ILE . 58.4 t -118.22 122.67 70.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.115 0.484 . . . . 0.0 110.505 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -145.0 166.67 24.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.695 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.441 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 9.1 pt -124.39 158.53 61.11 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.645 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 32.3 Cg_endo -64.97 129.47 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.885 1.723 . . . . 0.0 112.119 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.09 -35.74 77.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.453 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -59.75 -37.37 78.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.839 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -88.57 -22.65 23.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.217 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -79.71 118.86 74.63 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.518 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.98 53.28 4.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.81 2.34 . . . . 0.0 113.418 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 64.93 140.85 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.253 0.621 . . . . 0.0 112.103 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.81 -78.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.735 1.624 . . . . 0.0 113.282 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 179' ' ' ASN . 57.1 p -131.8 20.75 4.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.276 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.7 mt 67.53 82.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.15 -166.11 2.42 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -63.91 137.33 57.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.513 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -92.56 134.21 35.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.204 0.526 . . . . 0.0 111.444 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.4 -131.16 1.29 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.01 143.04 27.13 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.319 0.559 . . . . 0.0 109.577 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.33 98.42 50.43 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-O 121.351 0.596 . . . . 0.0 112.475 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -61.09 142.03 95.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.595 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.91 -47.36 1.52 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.111 0.482 . . . . 0.0 111.29 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.33 -153.49 26.42 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.457 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 96' ' ' LEU . 20.2 pt -107.91 160.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.296 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.593 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.8 t-20 -109.9 151.83 26.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.864 -172.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.4 t -123.35 131.75 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 122.963 0.505 . . . . 0.0 110.097 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.45 HG11 ' OD1' ' A' ' 155' ' ' ASN . 23.5 m -131.83 150.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.186 0.517 . . . . 0.0 111.238 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.57 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 59.7 m -97.55 160.78 27.91 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.613 174.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.06 52.5 2.68 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.672 2.248 . . . . 0.0 111.963 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.63 ' O ' HD13 ' A' ' 88' ' ' ILE . 30.1 mmmt -112.61 109.41 18.93 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -61.99 146.37 50.29 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.281 0.363 . . . . 0.0 111.284 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.13 -146.05 19.49 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.58 141.59 36.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.917 0.389 . . . . 0.0 110.002 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.581 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 27.5 pt20 -133.84 160.8 36.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.82 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -59.37 118.69 6.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.019 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -120.9 126.28 49.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.134 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.52 164.14 13.11 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 121.773 0.797 . . . . 0.0 112.509 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 130.2 67.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 114.231 -1.349 . . . . 0.0 112.745 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.6 ttm -114.14 130.21 56.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.046 174.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.53 123.11 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.528 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 42.4 pt -112.45 173.22 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.768 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.96 1.72 9.86 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.605 0.717 . . . . 0.0 110.288 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.528 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.2 pm0 -98.73 134.18 42.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.049 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.77 149.61 21.06 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.561 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.535 HG21 ' CB ' ' A' ' 104' ' ' ASN . 1.9 pp -104.08 154.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.559 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.16 113.55 26.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 101' ' ' ASP . 97.6 m-20 -113.43 153.44 28.62 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.67 109.88 21.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . 0.463 ' OD1' ' HB3' ' A' ' 143' ' ' SER . 45.1 m-80 -104.63 -34.63 8.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.492 0.663 . . . . 0.0 109.67 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -149.47 -178.5 6.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.54 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.417 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -62.58 -36.81 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.826 0.45 . . . . 0.0 111.973 -177.401 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 29.9 m-20 -60.37 -36.02 77.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 58.6 m-20 -61.69 -33.94 74.88 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.936 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 97.7 mt -61.29 -42.36 98.52 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.457 ' HA ' ' CG ' ' A' ' 188' ' ' GLU . 87.5 tttt -61.85 -41.85 98.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.831 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.08 -47.87 84.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.201 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.409 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.91 -46.19 91.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.914 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 9.0 pt-20 -68.9 -31.01 69.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.99 0.424 . . . . 0.0 110.998 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.9 ttm -61.58 -46.07 91.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.298 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.89 -30.64 64.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.335 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.508 0.671 . . . . 0.0 109.624 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . 0.427 ' C ' ' HD3' ' A' ' 192' ' ' LYS . 7.8 tmtm? -63.82 -39.6 94.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -35.11 74.38 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.47 -26.94 68.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.4 0.619 . . . . 0.0 109.778 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -96.08 57.13 1.51 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.713 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' HG21 ' A' ' 114' ' ' VAL . 8.8 ptm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.483 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 45.3 m-20 -104.83 165.71 10.88 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.614 0.245 . . . . 0.0 110.801 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.46 134.45 55.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.896 0.379 . . . . 0.0 111.181 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.37 126.25 51.9 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.603 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.568 ' HA ' HG22 ' A' ' 98' ' ' VAL . 70.4 mt -117.55 102.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.421 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 10.2 ptm -92.34 99.06 11.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.964 1.364 . . . . 0.0 111.3 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.87 96.7 5.84 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.895 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.57 33.15 0.63 Allowed Glycine 0 C--N 1.294 -1.799 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.6 173.04 45.66 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.41 86.88 7.28 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.359 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.37 -8.74 59.85 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.045 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 t -60.46 -18.02 48.67 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -138.72 -76.11 0.37 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.15 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.4 mmt -113.84 -55.39 2.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.42 168.96 44.63 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.435 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.27 -63.5 4.13 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.437 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.53 -39.72 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.12 123.33 48.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -139.94 155.9 70.78 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.681 -175.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.519 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 60.3 Cg_endo -72.23 -4.18 14.72 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.224 2.616 . . . . 0.0 113.583 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.522 HD11 ' HA ' ' A' ' 56' ' ' THR . 35.8 mt -82.22 16.85 1.83 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.29 121.18 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -81.07 125.56 30.35 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.041 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 31.3 tp -144.92 117.18 8.43 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.283 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' HB2' ' HH ' ' A' ' 32' ' ' TYR . 85.4 m 54.17 39.66 30.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.19 -27.12 10.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.339 0.895 . . . . 0.0 115.339 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.717 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 25.8 ptt180 -146.18 171.8 14.39 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.835 1.318 . . . . 0.0 111.941 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.3 m -82.36 153.57 25.69 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.021 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.51 -38.9 64.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.092 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.519 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 14.0 tt -62.85 -39.67 85.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.68 -39.55 94.3 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.717 ' CE2' ' HG3' ' A' ' 27' ' ' ARG . 27.5 m-85 -61.08 -35.41 76.92 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.493 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 76.5 t -71.3 -45.89 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.799 0.333 . . . . 0.0 111.41 176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.88 -42.55 96.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.534 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -51.36 -55.43 28.97 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.86 -37.05 16.53 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.314 1.343 . . . . 0.0 112.584 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD12 HG11 ' A' ' 98' ' ' VAL . 78.9 mt -65.49 -42.18 92.44 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.36 -45.03 93.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.987 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -79.04 -7.84 58.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.415 ' CB ' HG22 ' A' ' 110' ' ' ILE . 60.2 p -74.96 179.7 4.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.32 -22.7 61.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.615 0.766 . . . . 0.0 112.934 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.0 160.75 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.5 t30 -83.09 -73.24 0.41 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.578 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.69 156.71 26.65 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.037 0.446 . . . . 0.0 110.645 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.86 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -106.79 117.9 35.26 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.509 HG22 HD11 ' A' ' 60' ' ' ILE . 88.6 mt -100.05 118.92 47.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.609 0.718 . . . . 0.0 110.524 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.492 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.22 121.98 31.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.399 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.0 p -129.83 166.76 19.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.738 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -130.92 158.12 75.97 Favored Pre-proline 0 C--N 1.298 -1.634 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.884 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.17 -21.06 72.26 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.633 2.222 . . . . 0.0 110.902 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -70.45 -23.17 62.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.817 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -138.17 68.36 48.16 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.627 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 69.9 Cg_endo -99.35 84.08 0.05 OUTLIER 'Trans proline' 1 N--CA 1.392 -4.492 0 C-N-CA 116.659 -1.761 . . . . 0.0 108.688 169.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.629 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.7 mttt -146.1 -52.18 0.24 Allowed 'General case' 1 C--N 1.222 -4.945 0 CA-C-N 109.568 -3.469 . . . . 0.0 102.799 -177.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.522 ' HA ' HD11 ' A' ' 21' ' ' LEU . 96.0 m -63.71 -47.37 81.42 Favored 'General case' 0 N--CA 1.385 -3.708 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.493 164.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -62.39 -49.36 75.82 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.148 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.629 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 4.8 pt-20 -58.09 -36.58 73.07 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 117.564 -1.654 . . . . 0.0 111.526 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -63.68 -51.22 66.06 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.986 0.422 . . . . 0.0 111.63 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.509 HD11 HG22 ' A' ' 47' ' ' ILE . 89.6 mt -61.85 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.192 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.717 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 54.6 t-20 -57.85 -45.3 86.47 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.694 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -73.49 -44.92 56.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.396 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.22 90.26 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.327 0.584 . . . . 0.0 111.349 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.455 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 68.2 m-85 -109.94 33.56 4.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.253 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 2.7 mmpt? -60.75 -25.49 66.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -90.95 11.53 22.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.455 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 55.0 p90 -43.71 133.96 4.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.02 -48.97 3.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -118.92 10.11 12.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.013 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 86.4 mt -100.66 122.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.606 0.717 . . . . 0.0 111.312 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.78 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.802 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.06 131.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.3 pt -125.78 155.81 35.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.65 131.3 56.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.196 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.45 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 11.7 t -160.12 -167.94 2.07 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 51.6 m -64.03 1.96 0.61 Allowed 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 127.126 2.17 . . . . 0.0 114.556 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.03 -18.76 0.0 OUTLIER Glycine 0 N--CA 1.514 3.851 0 C-N-CA 126.484 1.993 . . . . 0.0 117.265 -175.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -58.23 -38.24 76.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -112.33 129.76 9.21 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -61.34 -51.25 69.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -74.14 -30.32 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.746 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.07 -43.13 88.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.493 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.8 t0 -61.52 -50.83 71.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.947 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 88' ' ' ILE . 1.7 mm? -55.69 -47.83 76.12 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.925 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.493 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.0 m-80 -60.14 -42.86 95.77 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HB2' ' HG1' ' A' ' 75' ' ' THR . 44.7 mm-40 -65.56 -44.42 86.83 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.362 177.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.91 -42.0 97.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.225 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' A' ' 85' ' ' ASN . 22.3 pt -68.56 -23.67 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.374 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.02 -14.09 80.54 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.456 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -98.93 -0.52 42.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.514 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 99.3 m-85 -126.5 150.08 48.97 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.658 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -109.9 3.48 20.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.599 0.714 . . . . 0.0 109.626 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -128.92 153.34 80.1 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.498 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.92 148.75 76.95 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.679 2.253 . . . . 0.0 112.058 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -144.24 163.17 34.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.26 0.553 . . . . 0.0 111.79 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 154' ' ' ILE . 1.2 tm? -85.63 140.92 30.17 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.735 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 79.6 t -117.29 133.41 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.174 0.99 . . . . 0.0 108.824 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.568 HG22 ' HA ' ' A' ' 5' ' ' ILE . 14.1 m -128.39 162.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.88 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.449 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 t -98.6 142.58 30.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.3 p -70.95 -13.26 61.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -110.84 12.32 22.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.449 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 70.4 mt -77.21 113.2 14.71 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.205 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.502 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 tt -129.49 122.04 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.719 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 63.4 t30 162.02 178.93 0.01 OUTLIER 'General case' 0 C--O 1.248 0.985 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.4 103.51 4.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HA ' HD11 ' A' ' 109' ' ' ILE . 37.6 mtmm -99.79 -1.11 38.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.404 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -56.64 -41.11 76.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -169.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -85.07 -25.83 27.35 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.984 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.513 ' O ' HG12 ' A' ' 113' ' ' ILE . 84.4 mt -65.62 -42.75 93.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.536 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.462 ' HA ' ' CD1' ' A' ' 154' ' ' ILE . 58.5 mt -59.71 -49.54 83.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.066 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.21 -38.85 92.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -62.64 -42.39 99.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.55 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.0 mm -63.96 -48.31 86.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.097 0.475 . . . . 0.0 110.793 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.589 HG21 ' SD ' ' A' ' 1' ' ' MET . 79.2 t -60.75 -48.0 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.534 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -61.85 -47.5 84.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.301 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.512 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.7 t80 -64.42 -45.07 89.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 77.1 t80 -58.33 -48.62 79.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.229 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.428 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 20.0 m-85 -60.68 -37.05 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.437 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.65 -44.72 96.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.279 0.561 . . . . 0.0 109.55 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.558 ' CG2' HG23 ' A' ' 127' ' ' VAL . 74.8 mt -62.99 -43.5 99.11 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.801 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -60.1 -42.59 95.0 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.615 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.53 96.01 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.457 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -83.03 -36.85 24.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 0.0 111.797 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.7 m -133.66 89.36 31.07 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.28 -15.51 35.35 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.95 -31.96 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.206 0.603 . . . . 0.0 111.533 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.56 HG22 ' HE2' ' A' ' 165' ' ' LYS . 87.9 t -69.45 126.51 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -120.62 5.37 10.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.585 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.37 24.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.687 0.28 . . . . 0.0 111.205 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.515 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -137.46 129.5 29.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.05 142.08 51.02 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 169' ' ' MET . 18.9 m -121.24 144.75 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.439 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.452 ' C ' ' HB3' ' A' ' 152' ' ' ALA . 63.3 mtm -134.99 153.84 51.94 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.504 HG22 ' O ' ' A' ' 171' ' ' ILE . 9.3 pt -131.84 145.53 57.87 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.026 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.7 137.67 82.35 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.425 2.083 . . . . 0.0 113.12 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HE3' ' OD1' ' A' ' 145' ' ' ASP . 25.0 ttmm -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.794 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -62.27 -37.54 85.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -84.83 -23.09 29.23 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.311 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.09 125.03 91.81 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.82 126.44 13.94 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.971 1.781 . . . . 0.0 110.471 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 66.48 77.06 0.27 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 122.174 0.988 . . . . 0.0 109.829 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.88 -1.69 11.86 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 123.736 2.958 . . . . 0.0 112.336 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.8 t 60.1 40.79 18.01 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.1 mt 65.26 -84.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.721 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.448 ' OD1' ' HE3' ' A' ' 136' ' ' LYS . 29.8 t70 -171.63 -77.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.011 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 58.65 26.16 14.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 0.0 111.933 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 61.89 19.27 10.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.194 0.598 . . . . 0.0 111.236 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.81 143.89 16.31 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.102 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.54 160.1 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.7 137.36 20.01 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.5 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.45 146.76 56.82 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.264 1.976 . . . . 0.0 111.715 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.452 ' HB3' ' C ' ' A' ' 133' ' ' MET . . . -88.95 -10.22 48.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.782 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 161.48 -99.0 0.17 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.748 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.487 ' CG1' HG13 ' A' ' 113' ' ' ILE . 30.6 pt -118.79 161.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.237 0.541 . . . . 0.0 112.23 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.3 t-20 -119.54 156.59 30.0 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.476 -176.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 117' ' ' PHE . 94.0 t -124.84 133.54 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 122.334 0.253 . . . . 0.0 110.609 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.428 HG11 ' OD1' ' A' ' 155' ' ' ASN . 32.3 m -131.12 150.33 34.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.367 0.603 . . . . 0.0 111.988 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -98.92 159.13 31.03 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.095 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 17.3 Cg_exo -68.15 91.28 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.362 2.041 . . . . 0.0 112.037 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -125.19 -165.85 1.46 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.073 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.74 147.4 39.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.73 -116.82 5.84 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.261 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -129.87 145.27 51.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -134.36 163.89 28.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.56 ' HE2' HG22 ' A' ' 127' ' ' VAL . 1.6 tmtp? -61.03 128.01 34.34 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.09 139.28 52.6 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.095 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.68 160.78 14.83 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 121.727 0.775 . . . . 0.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.83 129.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.475 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 14.7 tmm? -137.27 136.04 37.7 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.15 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.7 129.93 63.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.062 0.458 . . . . 0.0 110.769 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.504 ' O ' HG22 ' A' ' 134' ' ' ILE . 49.4 pt -120.52 176.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.426 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.55 69.54 1.31 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.664 0.745 . . . . 0.0 109.128 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.456 ' HG3' HG12 ' A' ' 109' ' ' ILE . 77.5 mm-40 -128.59 143.59 50.99 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.205 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.95 140.63 31.2 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.985 0.898 . . . . 0.0 113.082 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.9 pt -139.55 151.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.435 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 103' ' ' ILE . 93.0 m-85 -120.55 107.93 13.44 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.176 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.448 ' OD1' HD22 ' A' ' 102' ' ' LEU . 98.0 m-20 -93.96 110.8 22.46 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 183' ' ' ASP . 98.2 mt -81.32 114.44 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.354 0.597 . . . . 0.0 111.337 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -113.75 -20.97 10.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.1 p -131.59 164.9 24.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.269 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.66 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -60.87 -27.63 68.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.104 176.311 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -68.58 -39.24 81.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.44 0.638 . . . . 0.0 109.95 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.496 ' HB2' HG21 ' A' ' 178' ' ' ILE . 71.9 m-20 -61.52 -33.57 74.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.514 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.438 HD23 HD13 ' A' ' 178' ' ' ILE . 96.1 mt -59.95 -44.77 94.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.224 0.535 . . . . 0.0 109.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.601 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 7.8 tmtm? -67.5 -42.46 82.84 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.759 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tt -62.09 -46.93 86.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.944 0.402 . . . . 0.0 110.102 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.52 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.5 -41.24 98.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.757 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.601 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.9 pp20? -68.02 -30.91 70.26 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.651 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.1 mmm -61.51 -43.8 98.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.4 pp -74.85 -39.74 61.41 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.127 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.3 -40.59 96.24 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.44 0.638 . . . . 0.0 110.275 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.575 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 189' ' ' MET . 35.2 mmtp -66.18 -41.4 90.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 111.181 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -83.67 -26.21 30.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.196 0.522 . . . . 0.0 112.052 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -92.3 -1.82 68.89 Favored Glycine 0 C--N 1.31 -0.894 0 CA-C-N 115.886 -0.597 . . . . 0.0 114.307 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 61.3 tp . . . . . 0 C--O 1.269 2.084 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.786 -179.658 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.651 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.1 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -113.53 165.11 12.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.433 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.459 ' HB2' HG22 ' A' ' 42' ' ' VAL . . . -117.29 142.69 46.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 30.2 tp -120.35 127.51 52.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.275 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.551 ' HA ' HG23 ' A' ' 98' ' ' VAL . 64.5 mt -117.69 108.27 24.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.016 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.594 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 60.4 ttm -82.31 92.71 7.01 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-O 121.84 0.829 . . . . 0.0 111.545 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.62 97.53 5.91 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.406 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.21 89.96 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.968 -1.11 . . . . 0.0 113.129 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.37 18.95 67.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.177 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -114.2 126.74 55.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.787 0.327 . . . . 0.0 111.203 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.4 119.51 0.92 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m 65.92 91.1 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 66.46 -93.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 79.3 mtm -132.39 153.5 50.74 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 -161.76 44.56 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.14 149.35 7.82 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.421 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.15 -7.01 11.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.54 143.65 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.694 . . . . 0.0 112.423 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.471 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.18 154.68 86.35 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.655 -176.293 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 24.4 Cg_exo -69.97 -5.7 16.95 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.119 3.213 . . . . 0.0 112.263 174.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.488 HD22 ' CB ' ' A' ' 59' ' ' TYR . 8.8 mp -77.23 26.87 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.6 119.44 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.81 136.65 32.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-O 122.011 0.91 . . . . 0.0 113.048 -174.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 184' ' ' LEU . 80.2 mt -136.83 124.69 22.62 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.291 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 191' ' ' LEU . 74.3 m 53.95 30.54 11.83 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.39 20.54 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.913 -1.136 . . . . 0.0 115.794 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 34.7 ptt180 -146.22 166.35 26.47 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.085 1.443 . . . . 0.0 112.434 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.3 m -73.29 156.58 38.31 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.222 -176.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 20' ' ' PRO . 5.1 tt -57.53 -44.69 85.31 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 124.395 1.078 . . . . 0.0 110.475 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -60.2 -39.94 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.434 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 13.8 t70 -63.95 -41.69 97.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.249 0.547 . . . . 0.0 109.569 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.462 ' CD2' ' HG3' ' A' ' 27' ' ' ARG . 5.7 m-85 -61.06 -36.57 79.93 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.158 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 29' ' ' LEU . 69.1 t -66.87 -42.99 89.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 0.0 110.811 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.6 t -62.85 -45.02 99.91 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.576 -178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -50.91 -53.61 45.85 Favored Pre-proline 0 CA--C 1.57 1.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.94 -39.42 32.83 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.518 1.479 . . . . 0.0 112.387 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD13 HG12 ' A' ' 98' ' ' VAL . 83.3 mt -67.13 -39.68 86.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.609 0.719 . . . . 0.0 110.018 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.2 tp -59.31 -45.67 90.68 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.515 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -84.99 -8.71 58.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.507 ' OG ' HG13 ' A' ' 42' ' ' VAL . 77.9 p -74.58 174.74 8.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.213 0.53 . . . . 0.0 111.668 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -60.32 -18.51 50.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.056 0.942 . . . . 0.0 112.603 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.507 HG13 ' OG ' ' A' ' 40' ' ' SER . 11.4 p -63.64 150.76 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 120.909 0.385 . . . . 0.0 111.999 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -76.7 -75.91 0.18 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -110.43 152.13 26.67 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.057 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.47 110.99 33.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -104.16 117.86 35.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.505 HG23 HD12 ' A' ' 60' ' ' ILE . 95.6 mt -97.88 119.19 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.602 0.715 . . . . 0.0 110.568 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 4' ' ' LEU . . . -89.37 122.13 32.3 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.811 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.475 HG22 ' O ' ' A' ' 7' ' ' ALA . 41.9 p -126.59 155.0 43.17 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.494 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 50.1 m -98.79 145.1 29.35 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.871 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 75' ' ' THR . 51.8 Cg_exo -59.27 -28.78 88.58 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.197 2.598 . . . . 0.0 111.348 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 -6.89 58.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.963 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 7.7 p -134.63 66.47 69.59 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.414 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.657 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 83.0 Cg_endo -103.73 85.62 0.03 OUTLIER 'Trans proline' 1 N--CA 1.377 -5.332 0 C-N-CA 116.764 -1.691 . . . . 0.0 109.246 169.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.584 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 34.4 mmtp -145.45 -52.04 0.26 Allowed 'General case' 1 C--N 1.214 -5.318 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.425 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 99.0 m -63.48 -48.39 77.86 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 111.958 -2.383 . . . . 0.0 106.363 165.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.657 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -63.1 -48.18 79.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.913 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.584 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.8 pt-20 -58.64 -34.97 71.79 Favored 'General case' 0 C--N 1.365 1.266 0 C-N-CA 117.481 -1.687 . . . . 0.0 110.335 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.488 ' CB ' HD22 ' A' ' 21' ' ' LEU . 48.8 t80 -67.57 -52.25 40.9 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 120.86 0.362 . . . . 0.0 111.828 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 47' ' ' ILE . 96.8 mt -63.62 -46.54 94.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.837 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.1 t30 -58.92 -44.0 91.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.5 t -69.72 -44.62 69.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.856 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.18 90.14 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.305 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.424 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 78.7 m-85 -105.83 25.69 10.55 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.194 -176.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 9.9 mmmm -62.22 -21.39 65.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.857 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.26 10.57 21.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.374 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.3 p90 -44.18 138.04 3.18 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -176.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.585 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -101.62 -52.55 3.18 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.913 0.863 . . . . 0.0 109.361 172.59 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -121.45 12.67 10.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.163 -1.381 . . . . 0.0 111.467 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.404 ' HB ' ' CB ' ' A' ' 67' ' ' TYR . 82.6 mt -99.1 128.44 50.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.291 0.567 . . . . 0.0 111.053 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 67.3 t -128.04 132.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.18 132.15 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 4' ' ' LEU . 40.1 pt -126.96 156.89 38.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.624 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.46 ' OD1' ' HG3' ' A' ' 51' ' ' PRO . 10.5 t70 -114.74 131.96 56.6 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.201 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 12.9 t -161.95 -171.87 3.04 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.95 0.881 . . . . 0.0 113.218 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.1 m -74.18 3.58 6.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.602 1.961 . . . . 0.0 114.605 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.561 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.94 -21.82 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 C-N-CA 126.638 2.066 . . . . 0.0 117.605 -173.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 76' ' ' SER . 58.4 tptt -58.53 -37.88 76.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.88 123.11 6.26 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.438 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.8 t80 -59.45 -50.4 74.07 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.14 -47.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 55.1 mt-10 -59.83 -44.94 93.8 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.798 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.594 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 5.5 t0 -59.29 -51.39 70.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.437 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.581 ' O ' HG21 ' A' ' 88' ' ' ILE . 4.2 mm? -59.98 -41.74 92.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.962 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.414 ' HA ' HG12 ' A' ' 88' ' ' ILE . 9.2 m120 -60.42 -43.19 97.0 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.471 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 72.4 mm-40 -65.72 -44.42 86.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.57 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.8 m -62.31 -43.16 99.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.114 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 84' ' ' LEU . 33.9 pt -66.08 -24.64 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.28 77.47 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.411 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -104.75 -21.47 13.36 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 82.2 m-85 -89.1 140.92 28.96 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.986 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -104.42 -6.32 20.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.417 0.627 . . . . 0.0 109.817 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -132.24 152.49 80.22 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.443 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.94 142.03 54.27 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 123.515 2.81 . . . . 0.0 112.223 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -139.64 154.12 47.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.503 0.668 . . . . 0.0 111.595 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.499 HD12 HD12 ' A' ' 154' ' ' ILE . 2.1 tm? -87.05 132.81 33.7 Favored 'General case' 0 C--O 1.193 -1.889 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.726 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 68.4 t -108.37 127.87 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.225 0.61 . . . . 0.0 109.559 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 5' ' ' ILE . 8.4 m -126.53 156.62 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.759 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.459 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 67.7 m -101.03 132.92 46.23 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 170.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.43 ' O ' HD23 ' A' ' 29' ' ' LEU . 69.3 m -67.46 -37.39 82.87 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.499 0.666 . . . . 0.0 111.532 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.37 -0.85 34.42 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.533 ' O ' HD11 ' A' ' 102' ' ' LEU . 1.4 pp -91.63 116.26 28.73 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.15 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.4 mt -103.1 119.6 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.036 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.403 HD22 ' HB2' ' A' ' 173' ' ' GLU . 64.9 t30 178.38 163.5 0.71 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.145 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.54 98.6 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.507 ' HA ' HD13 ' A' ' 109' ' ' ILE . 15.6 ptpt -97.8 -2.28 41.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.908 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.483 ' HA ' HD11 ' A' ' 110' ' ' ILE . 77.9 p -60.26 -38.94 85.03 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.61 -27.17 37.4 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.432 1.111 . . . . 0.0 109.36 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.71 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -70.08 -39.52 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.759 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 107' ' ' SER . 65.3 mt -56.92 -49.21 79.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.944 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -65.07 -40.86 95.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.195 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.7 m -63.32 -40.67 97.97 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.548 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.71 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.26 -48.33 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.209 0.528 . . . . 0.0 110.674 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.651 HG22 ' SD ' ' A' ' 1' ' ' MET . 69.4 t -61.43 -48.21 89.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.93 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.67 -43.79 97.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.966 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.726 ' CE2' HD12 ' A' ' 120' ' ' ILE . 73.1 t80 -63.83 -46.58 84.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -58.11 -48.19 80.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.891 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.496 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 30.0 m-85 -62.03 -36.19 80.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.299 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.9 t -61.53 -46.66 88.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.997 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.726 HD12 ' CE2' ' A' ' 116' ' ' TYR . 67.3 mt -66.03 -47.06 86.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.854 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -64.03 -25.09 67.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.997 -178.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.55 99.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.788 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -83.91 -39.05 20.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.038 0.447 . . . . 0.0 110.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.61 ' O ' HG11 ' A' ' 127' ' ' VAL . 90.2 m -132.65 92.51 26.89 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.31 -19.04 48.59 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.263 2.642 . . . . 0.0 113.069 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 39.0 t70 -62.01 -32.31 72.78 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 124' ' ' THR . 10.7 p -70.61 118.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.596 0.712 . . . . 0.0 109.829 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.3 mt-10 -122.43 13.11 10.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.402 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.3 155.01 37.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 133.25 27.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -122.79 139.61 53.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.373 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.589 HG21 ' CD1' ' A' ' 113' ' ' ILE . 95.8 t -121.18 123.39 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.54 0.686 . . . . 0.0 111.179 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 3.1 ptm -145.48 162.5 37.22 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.551 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 22.6 pt -123.15 158.07 59.05 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.31 132.5 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.816 1.677 . . . . 0.0 110.675 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.7 -21.8 66.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.105 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -65.52 -37.55 87.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.354 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.22 -25.27 42.68 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 121.482 0.658 . . . . 0.0 110.649 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -75.37 132.51 75.85 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.257 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.96 -62.35 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.883 2.389 . . . . 0.0 113.607 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -129.09 96.67 28.15 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.19 -30.98 15.24 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 123.233 2.622 . . . . 0.0 113.546 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 147' ' ' ASN . 36.5 t -177.18 152.54 0.89 Allowed 'General case' 0 C--O 1.24 0.571 0 CA-C-O 120.784 0.325 . . . . 0.0 110.532 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.8 tt -71.92 -28.95 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.345 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -127.78 -73.48 0.6 Allowed 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.46 133.4 32.69 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 143' ' ' SER . 64.2 t30 -162.65 104.27 1.06 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.809 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.25 98.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.86 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.49 150.96 49.93 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.426 ' O ' HG21 ' A' ' 150' ' ' VAL . 29.6 m -119.5 98.91 50.14 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.086 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.36 139.02 87.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.504 2.136 . . . . 0.0 110.676 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 175' ' ' ILE . . . -132.62 -36.84 1.07 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.264 0.554 . . . . 0.0 111.337 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.81 -149.55 25.8 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.521 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.605 ' CG1' HG13 ' A' ' 113' ' ' ILE . 17.2 pt -119.44 161.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.045 -0.577 . . . . 0.0 110.46 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.537 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.6 t-20 -110.27 152.12 26.53 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.475 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.87 131.6 72.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.321 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.485 HG11 ' OD1' ' A' ' 155' ' ' ASN . 28.7 m -134.45 149.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.399 0.619 . . . . 0.0 111.243 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.5 m -98.51 153.63 37.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 14.8 Cg_exo -69.79 89.81 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.951 1.768 . . . . 0.0 110.99 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -116.72 -160.14 0.75 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -136.97 149.47 47.56 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 62.93 -124.17 31.96 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.657 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.02 149.22 50.46 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -131.62 163.99 26.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.008 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -57.77 128.5 37.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.027 0.441 . . . . 0.0 111.873 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -125.53 129.4 49.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.67 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -94.56 161.96 14.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.593 0.711 . . . . 0.0 112.212 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 46.8 mm -115.69 130.84 69.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.303 -175.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -131.17 138.75 49.58 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.681 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 133' ' ' MET . 76.0 t -108.12 129.64 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.79 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.528 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 36.7 pt -101.3 174.51 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.986 0.422 . . . . 0.0 111.321 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -99.77 -21.18 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.588 ' HG3' HD11 ' A' ' 109' ' ' ILE . 1.6 pm0 -99.08 138.32 36.36 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.811 0.815 . . . . 0.0 112.568 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.02 151.92 18.76 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.458 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 152' ' ' ALA . 23.6 pt -107.41 155.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -102.98 106.91 17.54 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.112 0.482 . . . . 0.0 110.824 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.85 121.47 37.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 40.9 mm -71.19 85.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.339 0.59 . . . . 0.0 112.396 -173.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -70.65 -38.8 73.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.323 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 81.0 p -129.57 162.92 27.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.104 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.475 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.522 178.124 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.45 -36.29 79.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.108 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.43 -40.38 96.36 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.47 ' CD1' HD22 ' A' ' 24' ' ' LEU . 51.6 tp -62.64 -42.71 99.75 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.059 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.5 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.8 ttmt -61.0 -42.54 98.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.67 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.93 -43.21 99.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.01 99.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.022 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.7 pt-20 -71.05 -36.02 72.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.887 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 35.2 mmt -64.4 -39.99 94.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.28 -47.47 84.19 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.403 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.443 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 mt -63.9 -43.2 96.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.902 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.74 -49.49 76.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.044 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -71.78 -42.67 66.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.92 -25.02 18.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.24 -43.37 99.19 Favored Glycine 0 C--N 1.314 -0.651 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.733 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.263 1.776 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.146 179.658 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.9 ttp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 61.8 m-20 -98.88 166.97 11.04 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.934 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.446 ' HB1' HG22 ' A' ' 42' ' ' VAL . . . -114.34 130.98 56.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.486 ' O ' HG21 ' A' ' 98' ' ' VAL . 38.4 tp -106.69 125.46 51.04 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.521 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.571 ' HA ' HG21 ' A' ' 98' ' ' VAL . 60.4 mt -116.65 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.509 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 12.7 ptm -95.92 92.11 6.34 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.941 1.353 . . . . 0.0 112.908 -173.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.574 ' CB ' HD11 ' A' ' 30' ' ' ILE . . . -116.82 97.79 6.16 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.936 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.84 32.61 0.03 OUTLIER Glycine 0 C--N 1.287 -2.149 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.76 177.16 29.08 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.331 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -150.57 147.77 27.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.55 152.69 23.03 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -168.51 150.22 4.98 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.515 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 tpm_? -118.38 74.09 0.94 Allowed 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.5 tpt 71.86 -49.99 0.69 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.459 -175.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.56 165.85 21.29 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.0 162.55 38.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.634 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -136.81 145.01 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.846 0.355 . . . . 0.0 110.583 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.07 124.06 43.88 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.964 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.67 148.18 16.0 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 120.753 0.311 . . . . 0.0 111.411 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.03 -5.75 16.64 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.486 2.791 . . . . 0.0 113.052 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 69.1 mt -88.83 11.34 18.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mt -69.87 115.73 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -82.11 140.88 33.56 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.663 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.8 tp -130.97 107.59 9.21 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.698 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m 58.25 20.94 7.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.218 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 -80.87 0.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.926 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.531 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.5 mtt180 -93.7 172.2 8.4 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.422 0.629 . . . . 0.0 112.107 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.1 m -79.25 162.75 25.47 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.37 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.5 mt -59.08 -45.52 90.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.218 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.574 HD11 ' CB ' ' A' ' 7' ' ' ALA . 11.8 tt -65.49 -37.91 81.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.168 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.531 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 6.9 t0 -60.59 -43.13 97.73 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-O 121.636 0.731 . . . . 0.0 109.075 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -65.86 -36.53 83.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.595 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 29' ' ' LEU . 58.6 t -66.11 -43.29 92.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 30' ' ' ILE . 73.8 t -63.49 -45.35 98.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.075 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -49.75 -52.59 49.94 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.06 -36.51 29.45 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.412 1.408 . . . . 0.0 112.44 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.442 HD11 HG13 ' A' ' 98' ' ' VAL . 83.7 mt -68.48 -37.57 80.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.576 0.703 . . . . 0.0 110.553 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.1 tp -59.11 -43.93 91.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.38 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -89.3 -7.19 55.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.523 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.514 ' OG ' HG13 ' A' ' 42' ' ' VAL . 83.3 p -72.52 172.0 11.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.206 0.527 . . . . 0.0 111.605 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.82 5.08 2.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.783 -175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.514 HG13 ' OG ' ' A' ' 40' ' ' SER . 11.2 p -77.96 152.53 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.821 -0.549 . . . . 0.0 111.2 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.6 t30 -69.23 -77.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.32 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -117.69 156.46 28.18 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 111.021 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.3 114.61 47.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.86 119.79 40.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.506 HG23 HD13 ' A' ' 60' ' ' ILE . 95.9 mt -99.91 119.66 48.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.565 0.698 . . . . 0.0 110.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 6' ' ' MET . . . -89.42 121.82 32.03 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.293 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.3 p -131.7 169.53 16.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.031 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.3 p -131.29 158.83 74.13 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.412 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.21 -19.24 68.14 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.576 2.184 . . . . 0.0 110.782 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -70.3 -25.39 63.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.595 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -135.76 66.65 63.38 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.628 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.8 Cg_endo -101.26 85.32 0.04 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.814 0 C-N-CA 116.869 -1.62 . . . . 0.0 109.087 169.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.644 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 32.1 mmtm -155.29 -46.82 0.08 Allowed 'General case' 1 C--N 1.209 -5.511 0 CA-C-N 109.182 -3.644 . . . . 0.0 102.462 -179.072 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD22 ' A' ' 21' ' ' LEU . 97.8 m -64.05 -49.07 73.79 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 163.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.628 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -62.85 -50.36 71.24 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.1 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.644 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.6 pt-20 -64.35 -30.05 71.11 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 116.722 -1.991 . . . . 0.0 112.759 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.07 -50.94 66.38 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.327 0.584 . . . . 0.0 111.208 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.506 HD13 HG23 ' A' ' 47' ' ' ILE . 93.3 mt -63.13 -45.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.426 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -57.87 -44.04 86.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.576 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.501 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 27.7 t -69.64 -40.89 76.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.804 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.51 93.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.958 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.534 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 57.0 m-85 -116.41 42.31 2.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 62' ' ' SER . 56.4 mtmt -58.93 -35.46 73.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.218 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -88.47 12.37 14.54 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.15 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.534 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 53.6 p90 -39.64 131.87 1.7 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 -48.22 4.26 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -116.82 13.17 14.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.147 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -104.99 124.46 59.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.267 0.556 . . . . 0.0 110.426 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.29 133.51 68.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -103.57 130.68 53.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.276 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 43.1 pt -128.48 157.1 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.749 0.785 . . . . 0.0 111.347 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -107.82 136.52 47.41 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.703 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.647 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 7.8 t -159.96 -173.84 4.27 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -74.34 5.09 4.9 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 127.328 2.251 . . . . 0.0 114.19 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.21 -13.81 0.0 OUTLIER Glycine 1 N--CA 1.525 4.632 0 C-N-CA 127.184 2.326 . . . . 0.0 117.646 -174.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -57.39 -39.56 76.34 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.518 ' HA3' ' OE1' ' A' ' 82' ' ' GLU . . . -116.32 132.8 10.38 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.408 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.4 t80 -61.29 -52.81 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.6 -39.81 76.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 121.755 0.788 . . . . 0.0 110.071 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.518 ' OE1' ' HA3' ' A' ' 79' ' ' GLY . 48.7 mt-10 -57.93 -43.49 86.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.548 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.53 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.5 t0 -60.59 -49.89 75.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.671 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 mm? -57.14 -40.44 77.16 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.772 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.441 ' HA ' HG12 ' A' ' 88' ' ' ILE . 11.3 m120 -60.05 -42.96 95.6 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.626 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 46.0 mm-40 -66.86 -43.38 83.76 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.15 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.1 m -62.18 -45.01 95.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.277 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.698 HD11 ' O ' ' A' ' 160' ' ' LYS . 30.3 pt -64.92 -27.44 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 120.789 0.328 . . . . 0.0 110.911 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.45 -22.1 69.22 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.87 7.25 19.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.521 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 76.9 m-85 -109.86 143.17 40.14 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.05 -0.406 . . . . 0.0 111.274 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.6 m -100.67 -11.63 19.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.337 0.589 . . . . 0.0 110.382 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 38.6 mt-10 -133.19 162.46 57.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.327 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 1' ' ' MET . 38.1 Cg_endo -64.65 156.73 59.53 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.872 . . . . 0.0 111.466 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.46 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 46.6 p90 -143.94 156.6 44.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.526 0.679 . . . . 0.0 111.663 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.462 HD11 HD13 ' A' ' 154' ' ' ILE . 1.6 tm? -86.33 135.45 33.52 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.616 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 63.6 t -110.85 130.21 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 123.5 0.72 . . . . 0.0 109.146 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.571 HG21 ' HA ' ' A' ' 5' ' ' ILE . 4.9 m -128.34 163.35 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.272 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.401 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 69.8 m -98.7 141.92 30.92 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -88.21 -3.41 58.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 177' ' ' ASN . 10.9 p-10 -108.95 3.98 22.83 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.401 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 75.0 mt -91.11 132.98 35.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.29 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -68.3 171.24 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.123 0.487 . . . . 0.0 111.717 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -81.72 78.53 8.44 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -122.42 -6.27 8.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.507 ' O ' HG13 ' A' ' 110' ' ' ILE . 23.4 pttp -84.41 0.16 50.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.85 -1.523 . . . . 0.0 113.83 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -53.86 -42.9 69.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -86.59 -26.8 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.071 0.939 . . . . 0.0 109.852 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.68 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -64.57 -37.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.405 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.6 mt -54.77 -49.18 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.584 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -67.55 -39.04 84.98 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.507 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.9 m -60.63 -42.22 96.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.68 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -63.54 -47.77 89.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.165 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.467 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.4 t -61.56 -48.76 87.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.328 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.39 -42.57 98.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.988 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.587 ' CE2' HD12 ' A' ' 120' ' ' ILE . 58.0 t80 -64.55 -47.33 79.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.734 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.402 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 72.3 t80 -59.04 -48.26 82.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.015 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 25.1 m-85 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.521 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 47.7 t -61.69 -47.08 86.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.108 0.48 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.587 HD12 ' CE2' ' A' ' 116' ' ' TYR . 68.4 mt -65.04 -48.83 82.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.886 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 124' ' ' THR . 19.8 ptmt -66.03 -26.6 67.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.95 97.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.598 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.57 -38.05 26.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.874 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 45.7 m -132.1 96.49 19.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.694 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.2 -14.14 42.07 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 122.772 2.315 . . . . 0.0 113.273 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 35.4 t70 -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.512 HG12 ' O ' ' A' ' 124' ' ' THR . 9.1 p -71.33 120.59 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.376 0.607 . . . . 0.0 110.069 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 41.4 mt-10 -127.64 19.2 6.75 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.782 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.27 150.15 29.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.485 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.81 130.75 30.14 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.7 54.93 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.715 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.534 HG12 ' HB2' ' A' ' 152' ' ' ALA . 47.4 t -116.95 122.46 70.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.488 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 ptm -144.69 158.26 43.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.6 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.503 HG23 ' O ' ' A' ' 171' ' ' ILE . 6.6 pt -130.77 165.6 33.51 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.107 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.99 136.25 73.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.536 2.157 . . . . 0.0 112.378 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' HE2' ' O ' ' A' ' 148' ' ' GLY . 99.5 mttt -61.16 -39.93 91.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.213 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.06 -37.14 86.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -82.35 -13.43 56.9 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 121.395 0.617 . . . . 0.0 110.832 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -84.92 114.62 56.81 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.24 -36.24 47.4 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 122.569 2.179 . . . . 0.0 114.866 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -160.82 95.15 1.45 Allowed Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.419 ' HB3' HG11 ' A' ' 150' ' ' VAL . 32.0 Cg_endo -81.67 -67.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.781 1.654 . . . . 0.0 110.228 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.9 p -160.88 153.41 20.65 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.4 mp -111.83 80.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 t70 173.04 -86.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.417 -177.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -64.15 -47.37 80.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.398 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.7 m120 63.12 -104.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.681 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.543 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . 71.31 -152.49 49.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.983 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.2 151.47 22.14 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' A' ' 142' ' ' PRO . 31.7 m -106.23 118.97 53.51 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 139.6 89.08 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.75 2.3 . . . . 0.0 110.931 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB2' HG12 ' A' ' 132' ' ' VAL . . . -103.13 2.88 35.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 166.87 -100.66 0.17 Allowed Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 118.937 -1.602 . . . . 0.0 113.503 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.497 ' CG1' HG13 ' A' ' 113' ' ' ILE . 28.2 pt -124.77 161.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.75 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.509 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 7.7 t-20 -120.17 155.11 33.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.861 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.72 130.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 122.383 0.273 . . . . 0.0 110.612 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.508 HG12 ' OD1' ' A' ' 155' ' ' ASN . 27.9 m -136.68 152.0 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.41 0.624 . . . . 0.0 112.001 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.1 t -97.33 145.11 29.08 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.85 74.66 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.267 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.698 ' O ' HD11 ' A' ' 88' ' ' ILE . 75.8 mmtt -105.0 132.0 51.8 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.582 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -81.87 74.0 8.88 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.05 -146.25 13.71 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -118.74 144.19 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.048 0.424 . . . . 0.0 109.992 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -134.28 166.38 22.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.29 129.8 43.84 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -125.07 126.89 46.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.57 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -93.96 162.36 13.92 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 121.558 0.694 . . . . 0.0 111.582 176.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -117.31 129.57 73.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.977 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 49.8 ttm -116.16 131.53 56.92 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.623 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 133' ' ' MET . 7.4 p -119.68 128.21 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 134' ' ' ILE . 33.6 pt -119.95 172.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.541 -176.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -109.33 -2.33 17.91 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.427 ' CG ' HD12 ' A' ' 171' ' ' ILE . 4.1 pt-20 -97.99 131.13 44.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.666 0.746 . . . . 0.0 110.401 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.19 149.38 21.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.937 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.7 pp -123.84 154.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.218 171.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.85 137.38 52.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.537 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 9.3 p30 -110.39 127.73 55.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.08 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.532 HD12 ' OD2' ' A' ' 183' ' ' ASP . 16.9 mm -88.59 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.77 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.3 -0.37 56.71 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.313 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.8 t -148.11 151.39 35.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.655 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.594 ' HD2' ' H ' ' A' ' 181' ' ' LYS . 0.2 OUTLIER -62.09 -37.14 83.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.302 -177.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -61.56 -41.72 97.79 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.417 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.532 ' OD2' HD12 ' A' ' 178' ' ' ILE . 11.6 t70 -63.6 -36.05 82.54 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.418 ' HA ' HD13 ' A' ' 178' ' ' ILE . 59.4 tp -58.52 -43.44 89.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.607 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 60.7 tttm -62.21 -43.72 98.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.718 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.7 tt -61.39 -45.05 95.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.04 98.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.013 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.607 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 12.5 pt-20 -66.34 -33.43 75.72 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -64.89 -40.25 94.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.643 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 88.2 mt -64.83 -43.19 93.86 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.362 0.601 . . . . 0.0 110.09 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.26 -40.76 97.27 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.584 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.0 -44.42 96.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.518 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 189' ' ' MET . 31.4 mmmt -85.07 -42.33 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -88.65 -25.82 22.2 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -95.1 -50.95 1.98 Allowed Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.603 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.5 tp . . . . . 0 C--O 1.269 2.132 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.233 -178.754 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 ttm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.498 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 19.3 m-20 -97.93 165.9 11.7 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -114.69 130.48 56.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.279 0.562 . . . . 0.0 111.533 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.0 122.15 45.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -117.98 116.23 50.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.238 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.481 ' CE ' HD21 ' A' ' 84' ' ' LEU . 38.3 mtt -89.05 96.57 10.78 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 122.32 1.057 . . . . 0.0 113.638 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' HG21 ' A' ' 49' ' ' THR . . . -116.11 97.43 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.284 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.64 -118.94 0.79 Allowed Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.446 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.15 140.33 32.39 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.89 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -108.85 14.29 24.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.388 0.613 . . . . 0.0 109.757 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.54 -150.28 18.6 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.175 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.8 p -88.57 -3.08 58.88 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.189 0.519 . . . . 0.0 110.948 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -92.3 113.7 26.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.293 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.2 mtt -119.66 112.65 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.946 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.05 -158.5 28.65 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.839 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 -179.26 47.39 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.971 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.85 -0.32 10.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.149 0.5 . . . . 0.0 110.295 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -97.42 119.66 36.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.663 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.53 ' O ' HD12 ' A' ' 29' ' ' LEU . 61.5 mtpt -136.84 142.03 37.22 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.13 -20.24 66.94 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.973 2.449 . . . . 0.0 114.523 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 39.6 mt -97.75 4.69 49.85 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.31 123.78 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.542 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.93 139.38 31.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.818 -177.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.55 108.16 12.82 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.299 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.9 m 54.5 26.24 7.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.135 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.91 -101.58 0.2 Allowed Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.668 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 75.3 mtt-85 -88.03 168.36 12.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.105 0.479 . . . . 0.0 111.969 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.452 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.9 m -79.5 163.81 24.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 19' ' ' LYS . 67.1 mt -57.89 -45.28 86.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -39.5 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.785 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.569 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 18.8 t70 -65.74 -39.58 91.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 110.038 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -63.69 -34.62 78.26 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.605 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 29' ' ' LEU . 75.8 t -66.4 -45.36 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.3 -41.04 88.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.592 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -50.88 -54.52 36.07 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' SER . 56.5 Cg_endo -71.36 -36.47 6.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.585 1.523 . . . . 0.0 112.249 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 84.8 mt -64.97 -41.8 95.12 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -59.95 -46.32 89.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -82.03 -9.07 59.67 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 59.3 p -74.28 -177.94 3.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.539 0.685 . . . . 0.0 112.202 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.411 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.8 ttmm -56.26 -26.32 51.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.253 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.69 161.91 2.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.677 0.751 . . . . 0.0 112.989 -174.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -81.07 -78.42 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.99 161.95 18.97 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.027 0.441 . . . . 0.0 111.128 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.34 116.53 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.488 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 89.9 m-85 -109.72 114.81 28.71 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.474 HG21 HD12 ' A' ' 60' ' ' ILE . 94.3 mt -97.24 117.82 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.569 0.7 . . . . 0.0 110.66 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.503 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.85 119.29 28.04 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.381 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.521 HG21 ' O ' ' A' ' 7' ' ' ALA . 69.8 p -121.42 155.92 33.82 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.565 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 35.8 m -105.45 145.66 31.24 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.733 -177.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -57.96 -29.83 87.86 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.449 2.766 . . . . 0.0 112.01 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.16 -2.84 56.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 2.1 p -139.03 67.07 40.47 Favored Pre-proline 0 CA--C 1.498 -1.049 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.968 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.64 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.4 Cg_endo -106.99 86.59 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.11 0 C-N-CA 117.115 -1.456 . . . . 0.0 110.486 169.206 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.59 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 29.5 mtmm -144.06 -48.1 0.28 Allowed 'General case' 1 C--N 1.219 -5.081 0 CA-C-N 109.973 -3.285 . . . . 0.0 103.424 177.743 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.7 m -61.8 -48.9 78.53 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 112.549 -2.114 . . . . 0.0 106.054 164.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.13 -49.66 75.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.963 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.59 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.2 pt-20 -59.78 -34.52 73.11 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.698 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.14 -50.8 66.76 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.103 0.477 . . . . 0.0 111.088 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 47' ' ' ILE . 97.3 mt -64.0 -41.59 92.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.884 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.412 ' ND2' ' HG2' ' A' ' 57' ' ' LYS . 87.9 m-20 -57.74 -40.99 80.94 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.264 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.472 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 4.5 t -82.04 -39.12 23.96 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.895 0.378 . . . . 0.0 110.575 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.09 93.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.363 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.484 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 81.0 m-85 -110.19 34.59 3.81 Favored 'General case' 0 C--O 1.206 -1.191 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.757 -176.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 10.9 mmmm -61.51 -25.04 67.02 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.09 0.471 . . . . 0.0 111.035 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -89.38 11.08 20.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.299 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 53.8 p90 -43.32 127.4 4.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.598 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -103.0 -49.05 3.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.945 0.878 . . . . 0.0 109.661 172.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -117.97 11.87 13.54 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.935 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.96 125.21 57.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.27 0.557 . . . . 0.0 110.302 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 67.2 t -125.45 131.76 71.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.378 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.5 132.63 53.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.138 0.494 . . . . 0.0 109.67 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.503 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.6 pt -125.98 152.16 32.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.288 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -119.83 130.49 54.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.452 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.579 ' HG1' ' CD ' ' A' ' 86' ' ' GLU . 11.6 t -165.26 -167.42 1.17 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 78' ' ' LYS . 73.7 m -59.42 0.59 0.11 Allowed 'General case' 0 C--O 1.198 -1.61 0 C-N-CA 127.383 2.273 . . . . 0.0 116.082 -173.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' N ' ' HB2' ' A' ' 83' ' ' ASP . . . -31.61 -22.36 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 C-N-CA 125.805 1.669 . . . . 0.0 116.972 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.2 tmmt? -56.84 -35.51 68.91 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.83 113.62 3.81 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -59.31 -49.08 79.19 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.96 -48.21 89.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.713 0.768 . . . . 0.0 110.4 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.53 -45.91 92.18 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.271 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.474 ' CG ' ' HE3' ' A' ' 6' ' ' MET . 28.6 t0 -63.09 -50.03 72.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.385 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.481 HD21 ' CE ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -53.61 -47.39 70.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.237 0.542 . . . . 0.0 109.61 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.2 m-80 -61.98 -40.44 95.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.032 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' CD ' ' HG1' ' A' ' 75' ' ' THR . 26.9 tt0 -66.84 -42.99 84.87 Favored 'General case' 1 N--CA 1.374 -4.235 0 O-C-N 122.092 -0.38 . . . . 0.0 110.632 177.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 91.3 m -62.98 -42.07 99.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.774 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.519 HG12 ' HA ' ' A' ' 85' ' ' ASN . 26.3 pt -67.01 -28.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.29 -38.24 96.14 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.976 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -84.0 -12.09 55.78 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.481 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 81.2 m-85 -96.06 145.26 25.61 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.887 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.7 p -105.67 -2.74 23.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.806 0.813 . . . . 0.0 109.208 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -128.82 157.1 76.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.032 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.37 148.61 74.04 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.357 2.038 . . . . 0.0 111.626 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.44 ' CZ ' HG23 ' A' ' 88' ' ' ILE . 40.7 p90 -143.28 159.33 42.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.279 0.561 . . . . 0.0 111.394 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 155' ' ' ASN . 30.7 tp -86.41 143.05 28.0 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 92.2 t -115.2 126.32 72.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.6 m -130.85 157.22 43.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.355 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . 33.8 t -100.23 150.93 22.04 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 171.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.51 ' HA ' HG22 ' A' ' 33' ' ' VAL . 68.3 m -88.39 1.33 54.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.403 ' OD1' HD11 ' A' ' 102' ' ' LEU . 40.5 p-10 -104.14 4.18 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.466 ' CD1' ' HB3' ' A' ' 99' ' ' SER . 7.2 mp -88.57 140.53 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.099 -0.376 . . . . 0.0 111.106 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.526 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 41.7 pt -64.36 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.555 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.439 ' C ' ' H ' ' A' ' 106' ' ' LYS . 31.8 p-10 -82.24 4.31 24.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.03 11.84 1.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.689 0.757 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 103' ' ' ILE . 57.9 mtmt -83.86 -1.4 54.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.278 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.6 t -57.31 -46.39 83.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -78.59 -23.8 45.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.716 0.77 . . . . 0.0 109.463 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.725 ' O ' HG12 ' A' ' 113' ' ' ILE . 39.2 mm -67.12 -41.52 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.117 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 106' ' ' LYS . 59.6 mt -58.28 -48.89 83.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.83 -177.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.411 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 59.5 m-80 -65.9 -39.85 90.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.1 m -61.76 -40.2 94.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.849 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.725 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -62.84 -47.54 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.474 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 72.6 t -61.85 -48.83 86.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.556 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -62.03 -43.46 98.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.463 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.499 ' CE2' HD11 ' A' ' 120' ' ' ILE . 68.8 t80 -64.84 -49.86 68.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.411 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.1 t80 -59.37 -48.63 80.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.278 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.474 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 36.4 m-85 -65.85 -30.7 71.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.334 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.26 -45.51 92.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.499 HD11 ' CE2' ' A' ' 116' ' ' TYR . 75.0 mt -64.63 -42.97 96.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.584 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.465 ' HD2' HG12 ' A' ' 127' ' ' VAL . 17.1 mmmt -59.93 -42.38 93.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.269 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.07 85.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.064 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.41 -34.07 15.78 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.098 0.475 . . . . 0.0 111.076 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 26.0 m -133.23 98.39 15.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 123.184 0.594 . . . . 0.0 109.717 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.93 -15.32 36.42 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.394 2.063 . . . . 0.0 112.327 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -63.28 -31.23 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.465 HG12 ' HD2' ' A' ' 121' ' ' LYS . 9.8 p -66.31 127.23 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.711 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -119.52 6.27 11.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.606 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.31 159.25 25.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.859 0.361 . . . . 0.0 111.622 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -138.33 135.03 35.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.24 137.66 54.49 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.722 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 113' ' ' ILE . 72.1 t -115.39 117.02 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 121.257 0.551 . . . . 0.0 109.666 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -146.48 159.07 43.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.2 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.492 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 18.1 pt -132.6 158.37 75.88 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.792 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 30.9 Cg_endo -64.58 130.91 27.83 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.451 1.434 . . . . 0.0 111.722 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 139' ' ' TYR . 65.6 pttt -62.65 -16.42 56.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.554 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.43 -37.55 87.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.106 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.71 -21.93 17.29 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.495 0.664 . . . . 0.0 110.022 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.41 ' HB3' ' HA ' ' A' ' 136' ' ' LYS . 31.4 t80 -67.53 124.43 89.18 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.716 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.1 -72.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.236 1.958 . . . . 0.0 113.128 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.506 ' OD1' ' HD2' ' A' ' 142' ' ' PRO . 60.0 t30 -163.62 127.6 1.86 Allowed Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.506 ' HD2' ' OD1' ' A' ' 141' ' ' ASN . 72.5 Cg_endo -75.9 148.41 31.88 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.654 2.236 . . . . 0.0 112.654 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.6 p -63.91 -38.92 92.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.241 0.543 . . . . 0.0 110.765 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.5 pt -80.89 138.29 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.708 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.22 85.5 7.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.234 0.54 . . . . 0.0 110.455 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.38 126.52 4.12 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.318 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.63 108.55 21.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.316 0.579 . . . . 0.0 110.663 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.93 -108.41 0.21 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.5 mt -109.52 140.96 42.65 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.351 0.596 . . . . 0.0 110.385 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.88 120.88 43.56 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.875 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.06 142.99 48.02 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.331 2.021 . . . . 0.0 111.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.471 ' HB3' HG12 ' A' ' 134' ' ' ILE . . . -109.09 -13.03 14.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.732 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.28 -117.74 0.44 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.309 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.468 ' CG1' HG13 ' A' ' 113' ' ' ILE . 17.8 pt -122.98 160.93 25.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 122.656 0.382 . . . . 0.0 111.443 -175.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.559 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.7 t-20 -116.61 153.71 31.79 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.9 t -123.51 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.423 0.289 . . . . 0.0 110.378 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.424 HG11 ' OD1' ' A' ' 155' ' ' ASN . 28.4 m -130.79 149.79 33.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.412 0.625 . . . . 0.0 112.1 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.419 ' OG ' ' HD2' ' A' ' 159' ' ' PRO . 23.1 t -98.19 151.62 37.61 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.419 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 29.1 Cg_endo -63.11 82.17 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.844 2.363 . . . . 0.0 112.582 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.96 -172.64 2.16 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.034 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -137.2 92.24 2.7 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.96 -137.09 10.95 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.96 139.87 41.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.136 0.494 . . . . 0.0 110.746 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.91 166.59 22.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -54.31 121.62 8.64 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -129.78 129.42 44.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.545 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -93.84 162.95 13.71 Favored 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 121.936 0.874 . . . . 0.0 112.716 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.6 mm -116.12 128.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.579 -175.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 55.4 ttp -125.79 129.99 50.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.419 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 133' ' ' MET . 60.0 t -106.63 129.94 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.015 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.3 pt -115.87 175.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -176.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -113.4 11.44 18.51 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.528 ' HB2' HD12 ' A' ' 171' ' ' ILE . 29.2 mp0 -97.41 131.45 44.05 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.791 0.805 . . . . 0.0 110.882 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.7 139.63 32.49 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.667 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.84 148.85 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.946 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.48 117.34 30.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.892 0.377 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -105.26 13.99 29.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.257 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 184' ' ' LEU . 11.7 mm 55.46 71.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.62 -41.99 83.09 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.429 0.633 . . . . 0.0 110.277 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -145.88 -175.34 4.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.336 -173.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.478 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 1.3 mptp? -59.48 -36.49 76.12 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.222 0.609 . . . . 0.0 111.328 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -58.23 -43.3 87.66 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.459 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 63.9 m-20 -70.7 -39.52 73.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.303 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 178' ' ' ILE . 64.3 tp -59.45 -50.49 73.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.2 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -64.36 -43.26 95.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.93 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.8 tt -61.03 -49.01 79.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.737 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.04 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 pt-20 -66.26 -37.45 85.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.049 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -66.69 -37.56 84.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.715 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 89.5 mt -62.46 -44.39 96.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.452 0.644 . . . . 0.0 109.323 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.49 -42.97 98.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.467 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.35 -45.7 92.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.077 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -68.39 -41.43 80.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.155 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.87 -27.15 66.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.302 0.572 . . . . 0.0 110.722 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -96.84 29.96 9.7 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.784 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--O 1.267 1.983 0 C-N-CA 124.72 1.208 . . . . 0.0 111.323 -179.481 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.813 0.34 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.569 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 75.9 m-20 -105.38 166.27 10.54 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.46 127.39 56.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -103.26 119.68 39.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.782 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.553 ' HA ' HG21 ' A' ' 98' ' ' VAL . 65.6 mt -118.88 104.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.552 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.412 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.0 ptm -92.83 102.19 14.57 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.008 1.385 . . . . 0.0 112.047 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HB3' ' HG2' ' A' ' 20' ' ' PRO . . . -115.12 98.29 6.7 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.795 -2.002 . . . . 0.0 111.139 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.75 107.36 1.11 Allowed Glycine 0 C--N 1.302 -1.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.775 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.1 -13.38 67.16 Favored Glycine 0 N--CA 1.465 0.611 0 C-N-CA 121.602 -0.332 . . . . 0.0 112.57 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 3.9 tmtt? -77.71 148.06 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.76 0.314 . . . . 0.0 111.034 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.43 150.18 21.92 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -68.69 -38.91 80.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.287 0.543 . . . . 0.0 111.01 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 7.0 ptm180 -71.73 -31.82 67.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 27.4 ptm 169.81 -36.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.8 0.84 . . . . 0.0 110.114 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.11 -177.49 47.65 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.61 -163.26 27.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.798 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -82.29 107.34 14.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 38.7 tp10 -101.38 127.29 48.08 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.525 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -125.93 85.01 60.08 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 121.362 0.601 . . . . 0.0 110.29 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 7' ' ' ALA . 20.7 Cg_exo -69.34 -5.26 15.51 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.608 2.872 . . . . 0.0 111.579 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 21.7 mt -87.05 6.07 34.38 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -74.13 110.56 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.7 pttm -81.67 131.39 35.27 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.685 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 HD13 ' CD1' ' A' ' 184' ' ' LEU . 57.6 tp -122.71 112.07 17.49 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.155 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m 58.2 17.95 4.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.87 -95.48 0.15 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.146 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.51 ' HG2' ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -87.29 172.41 9.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 111.34 -176.144 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 76.6 m -76.07 163.42 27.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.61 -39.18 83.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG12 ' CD1' ' A' ' 60' ' ' ILE . 4.8 tp -57.68 -45.18 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.035 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB3' ' HG3' ' A' ' 27' ' ' ARG . 17.7 t70 -64.56 -40.34 95.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.493 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CD2' ' HG2' ' A' ' 27' ' ' ARG . 11.2 m-85 -61.26 -37.99 85.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.15 -44.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.409 . . . . 0.0 111.148 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.14 -41.97 94.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.3 m -51.67 -55.67 27.75 Favored Pre-proline 0 CA--C 1.562 1.436 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.23 -37.27 14.46 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.512 1.475 . . . . 0.0 112.409 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.503 HD13 HG11 ' A' ' 98' ' ' VAL . 82.1 mt -66.26 -41.53 89.78 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.845 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.33 -46.26 91.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.684 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.16 -9.29 59.52 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -72.08 -177.7 2.15 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.934 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -73.34 2.54 7.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.811 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.2 m -80.42 162.03 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.342 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.569 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.6 t30 -81.63 -71.78 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.947 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -120.52 160.14 23.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.256 0.55 . . . . 0.0 111.396 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.1 mm -109.8 117.54 54.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 83.7 m-85 -109.46 116.86 32.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.0 mt -97.39 116.22 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 121.715 0.769 . . . . 0.0 110.467 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.18 120.53 28.55 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.65 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 7' ' ' ALA . 45.1 p -127.93 154.72 45.23 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m -100.58 149.36 36.06 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.56 -17.58 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.714 2.276 . . . . 0.0 110.169 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.07 -11.1 59.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.599 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 p -140.17 67.55 33.07 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.117 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 77.3 Cg_endo -102.46 85.76 0.03 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.629 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.107 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.65 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.7 mmtm -149.8 -48.45 0.13 Allowed 'General case' 1 C--N 1.22 -5.049 0 CA-C-N 109.845 -3.343 . . . . 0.0 103.074 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.3 m -62.81 -48.63 78.26 Favored 'General case' 0 N--CA 1.386 -3.659 0 CA-C-N 113.104 -1.862 . . . . 0.0 105.987 163.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.632 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.32 -50.42 70.08 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.341 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.65 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 7.8 pt-20 -62.6 -34.14 76.42 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 117.159 -1.817 . . . . 0.0 112.138 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.434 ' CD2' HD21 ' A' ' 21' ' ' LEU . 51.0 t80 -64.55 -51.09 64.63 Favored 'General case' 0 C--O 1.211 -0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 111.728 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.457 ' CD1' HG12 ' A' ' 30' ' ' ILE . 95.5 mt -62.59 -41.25 91.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.1 -46.02 79.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.065 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.689 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.2 t -73.06 -40.26 65.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.38 0.61 . . . . 0.0 110.848 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.78 86.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.436 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 89.5 m-85 -114.75 42.29 2.18 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.544 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.689 ' HG3' ' O ' ' A' ' 62' ' ' SER . 39.2 mtmm -60.55 -22.21 63.41 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.221 0.534 . . . . 0.0 110.25 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.98 10.64 18.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.235 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 55.4 p90 -44.33 117.27 1.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.521 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 3.9 mmpt? -103.06 -49.35 3.78 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.444 1.116 . . . . 0.0 109.088 171.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.42 9.92 18.21 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.577 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.48 123.87 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.083 0.468 . . . . 0.0 110.124 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 65.5 t -124.02 131.9 72.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.347 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.2 131.89 53.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.112 0.482 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.3 pt -125.89 156.53 35.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.307 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -117.36 129.59 55.97 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.414 ' HG1' ' HB2' ' A' ' 86' ' ' GLU . 7.5 t -158.74 -170.19 2.97 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.5 m -66.18 2.36 1.2 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 127.268 2.227 . . . . 0.0 115.011 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.17 -22.61 0.0 OUTLIER Glycine 1 N--CA 1.52 4.262 0 C-N-CA 126.187 1.851 . . . . 0.0 117.02 -174.46 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -55.65 -39.87 71.48 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.482 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.14 122.64 6.98 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -59.82 -50.56 73.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.218 0.509 . . . . 0.0 111.454 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.405 HD11 ' HH ' ' A' ' 163' ' ' TYR . 42.9 pt -72.88 -30.81 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.774 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.87 -43.34 93.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 109.353 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.568 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.5 t0 -61.45 -51.09 70.13 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.15 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.517 ' O ' HG21 ' A' ' 88' ' ' ILE . 3.3 mm? -57.61 -43.2 84.56 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 88' ' ' ILE . 14.9 m-80 -60.39 -42.62 96.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB2' ' HG1' ' A' ' 75' ' ' THR . 55.9 mm-40 -63.84 -45.71 88.29 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.286 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.9 m -62.56 -41.95 99.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.158 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.517 HG21 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -66.0 -29.51 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.24 -39.59 96.14 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.637 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -71.38 -40.97 70.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.497 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.8 m-85 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.943 0.402 . . . . 0.0 111.916 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -105.16 -2.36 24.32 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.67 157.02 78.17 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.975 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.39 141.94 59.59 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 123.486 2.791 . . . . 0.0 112.237 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -141.66 156.4 45.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.354 0.597 . . . . 0.0 111.543 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.446 HD12 HD13 ' A' ' 154' ' ' ILE . 1.2 tm? -86.34 138.78 31.55 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.178 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 63.5 t -113.96 129.99 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 5' ' ' ILE . 7.3 m -129.47 160.17 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.484 0.659 . . . . 0.0 112.505 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.432 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 62.4 m -100.44 138.26 37.74 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.772 172.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -64.79 -21.46 66.78 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.556 ' CG ' ' HZ1' ' A' ' 10' ' ' LYS . 39.9 p-10 -112.27 22.76 14.39 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 95.9 mt -68.81 138.4 54.75 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.915 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -92.99 142.81 12.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 79.37 171.65 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.527 1.131 . . . . 0.0 112.799 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.75 134.33 47.34 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.212 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -101.81 -1.65 31.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.431 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.522 ' HA ' HD12 ' A' ' 110' ' ' ILE . 69.6 m -57.19 -40.73 77.97 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -170.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.486 ' HG3' HG13 ' A' ' 109' ' ' ILE . 17.2 ptmt -74.34 -38.22 63.31 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.065 0.936 . . . . 0.0 110.304 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 113' ' ' ILE . 58.8 mt -66.49 -40.43 86.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.23 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 107' ' ' SER . 62.6 mt -58.42 -45.8 89.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.913 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -60.95 -45.14 95.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.986 179.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -62.99 -39.85 96.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.624 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -61.69 -48.66 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.205 0.526 . . . . 0.0 110.331 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.04 -48.19 89.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.687 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -62.26 -45.68 92.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.677 ' CE2' HD12 ' A' ' 120' ' ' ILE . 80.1 t80 -64.08 -47.79 78.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.416 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 79.6 t80 -58.37 -46.02 87.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.453 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -60.4 -37.15 79.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.96 -42.72 99.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.913 0.387 . . . . 0.0 110.528 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.677 HD12 ' CE2' ' A' ' 116' ' ' TYR . 71.2 mt -68.26 -44.19 84.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.711 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.426 ' HD3' ' N ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -66.73 -37.0 83.78 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.585 -178.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.426 ' N ' ' HD3' ' A' ' 121' ' ' LYS . . . -62.01 -42.71 99.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 0.0 111.16 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -80.14 -39.42 29.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.073 0.464 . . . . 0.0 111.034 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 126' ' ' ASP . 35.8 m -132.36 99.97 15.61 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.12 -11.9 34.0 Favored 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 123.002 2.468 . . . . 0.0 112.231 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' HG23 ' A' ' 124' ' ' THR . 25.4 t70 -61.49 -32.63 72.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.208 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.4 t -81.3 119.24 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.282 0.563 . . . . 0.0 111.011 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.578 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 39.5 mt-10 -122.55 7.12 9.49 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.658 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.59 153.75 39.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -139.37 139.0 37.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.191 -177.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.14 139.0 52.73 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.191 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 113' ' ' ILE . 98.4 t -115.32 117.51 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 121.74 0.781 . . . . 0.0 110.683 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.453 ' SD ' HD23 ' A' ' 149' ' ' LEU . 5.2 ptm -146.5 161.87 39.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.113 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.401 HG12 ' HB3' ' A' ' 152' ' ' ALA . 24.9 pt -128.77 159.59 67.49 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.96 144.65 99.06 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.261 1.974 . . . . 0.0 111.298 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -57.76 -39.89 78.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.805 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -64.83 -37.13 86.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.115 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.31 -27.27 56.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.534 0.683 . . . . 0.0 110.075 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -68.31 139.2 92.09 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.268 176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.44 55.85 2.08 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.669 2.246 . . . . 0.0 112.813 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 18.0 m120 67.3 119.55 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.061 0.944 . . . . 0.0 112.556 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.64 140.18 92.64 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.695 2.263 . . . . 0.0 110.395 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.0 m -113.49 88.5 2.85 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 144' ' ' ILE . 26.4 mm 66.38 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.093 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.451 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 29.9 m-20 -63.58 -51.15 66.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.598 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 46.88 29.09 0.94 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -98.27 -1.23 42.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.288 0.566 . . . . 0.0 111.236 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.49 -59.1 4.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.142 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.453 HD23 ' SD ' ' A' ' 133' ' ' MET . 4.0 mp -90.4 148.07 23.04 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.0 m -126.72 116.06 22.58 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.242 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.473 ' O ' HD11 ' A' ' 175' ' ' ILE . 61.8 Cg_endo -71.73 149.94 55.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.483 2.122 . . . . 0.0 111.218 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 175' ' ' ILE . . . -132.4 -31.82 1.38 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.974 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -117.03 -134.16 5.21 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.993 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.472 ' CG1' HG13 ' A' ' 113' ' ' ILE . 22.6 pt -126.08 160.36 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.399 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.559 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.5 m-20 -111.78 158.03 19.85 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.1 132.31 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.785 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.9 153.72 38.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.379 0.609 . . . . 0.0 111.808 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.578 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 34.3 t -97.99 151.19 37.43 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.893 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.462 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 61.3 Cg_endo -70.28 59.18 1.87 Allowed 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.281 2.654 . . . . 0.0 112.684 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -88.72 -172.33 3.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.259 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -134.31 94.86 3.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.92 -119.99 4.1 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.689 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.405 ' HH ' HD11 ' A' ' 81' ' ' ILE . 92.9 m-85 -127.82 140.99 51.7 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -135.37 167.0 21.84 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.846 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -55.25 128.33 33.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.137 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -132.58 130.59 40.49 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.298 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -98.94 162.34 13.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 121.701 0.762 . . . . 0.0 112.996 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -118.09 130.16 73.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.696 -176.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.6 ttp -127.9 137.97 52.5 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.6 t -110.1 130.39 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.073 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 48.5 pt -113.74 172.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.018 0.437 . . . . 0.0 110.503 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.7 9.98 31.05 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.311 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -101.65 129.04 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.804 0.811 . . . . 0.0 111.247 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.75 150.76 20.34 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.508 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 151' ' ' PRO . 23.3 pt -133.79 155.4 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.952 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.08 127.32 54.77 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.635 0.255 . . . . 0.0 110.483 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -84.41 109.36 17.81 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.463 HG21 ' HB2' ' A' ' 183' ' ' ASP . 94.5 mt -85.63 115.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.537 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -119.73 -18.72 8.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.319 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.6 p -128.38 167.21 17.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.33 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -59.72 -38.9 82.94 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.847 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.54 -39.96 92.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.463 ' HB2' HG21 ' A' ' 178' ' ' ILE . 71.7 m-20 -62.44 -42.0 99.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.296 0.569 . . . . 0.0 109.871 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.47 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.2 tp -62.12 -43.96 97.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.291 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 6.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.24 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 10.1 tt -62.46 -46.09 90.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.58 99.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.759 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.74 -31.88 72.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.533 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -64.32 -39.74 94.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.642 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 87.4 mt -63.77 -43.68 95.69 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 0.0 109.624 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.78 -39.28 93.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.418 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.82 -45.66 93.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.316 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -62.41 -41.84 98.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.824 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.28 11.52 18.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.273 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.87 8.38 79.93 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 68.7 tp . . . . . 0 C--O 1.265 1.914 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.896 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.856 0.36 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 35.5 m-20 -106.28 166.12 10.75 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.26 129.83 55.7 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.94 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.41 ' O ' HG21 ' A' ' 98' ' ' VAL . 25.5 tp -105.31 125.23 50.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.614 ' HA ' HG21 ' A' ' 98' ' ' VAL . 65.0 mt -117.1 103.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.579 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 58.2 ttm -83.04 96.84 8.48 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-O 121.711 0.767 . . . . 0.0 110.887 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.51 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.96 97.69 6.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -98.41 0.12 Allowed Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.662 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.08 168.25 51.86 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.703 -176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -168.32 -36.07 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.52 179.73 51.5 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p -90.58 130.54 36.6 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.394 0.597 . . . . 0.0 112.415 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 58.68 -91.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.7 mtp -108.72 151.79 25.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.106 0.479 . . . . 0.0 112.032 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.65 89.85 1.5 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.03 61.18 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.961 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 39.2 t 56.32 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.732 0.813 . . . . 0.0 112.51 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.01 93.3 3.25 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.86 -0.525 . . . . 0.0 111.864 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 2.5 mppt? -105.81 -60.11 0.05 OUTLIER Pre-proline 0 C--O 1.219 -0.518 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.284 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 19' ' ' LYS . 24.2 Cg_exo -65.4 -24.12 57.57 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.318 2.012 . . . . 0.0 112.869 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 42.8 mt -97.02 14.87 24.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.0 mt -75.3 114.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.6 ptmm? -85.45 125.04 32.71 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.82 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 62.4 tp -126.38 115.68 20.01 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.94 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.9 t 58.84 19.19 6.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.975 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.3 -62.92 0.54 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.253 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.685 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 96.2 mtt180 -104.85 167.47 9.69 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 117.508 0.654 . . . . 0.0 111.476 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 76.1 m -82.15 160.84 23.0 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.704 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.579 HD13 ' O ' ' A' ' 19' ' ' LYS . 90.1 mt -59.41 -39.65 84.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.949 0.155 . . . . 0.0 111.246 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.7 tp -57.04 -46.1 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.685 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 11.4 t70 -64.87 -41.64 95.49 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.138 0.494 . . . . 0.0 110.403 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 27' ' ' ARG . 18.8 m-85 -64.4 -34.34 77.95 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 29' ' ' LEU . 77.0 t -66.99 -43.87 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 121.327 0.584 . . . . 0.0 110.206 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 30' ' ' ILE . 79.0 t -63.35 -41.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.38 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -51.28 -55.93 24.57 Favored Pre-proline 0 CA--C 1.565 1.547 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -69.23 -36.1 12.88 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 121.573 1.516 . . . . 0.0 112.491 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.482 HD13 HG13 ' A' ' 98' ' ' VAL . 99.4 mt -67.46 -41.79 84.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.642 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.434 ' HG ' HD22 ' A' ' 69' ' ' ASN . 7.8 tt -63.0 -44.54 95.73 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.049 0.452 . . . . 0.0 110.886 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -75.26 -12.31 60.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.0 p -71.24 -178.9 2.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.144 0.497 . . . . 0.0 110.588 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -76.51 0.32 20.34 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.67 159.38 5.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -77.35 -73.18 0.31 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.755 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -121.17 159.46 25.8 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.171 0.51 . . . . 0.0 111.132 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.16 116.31 50.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.11 114.95 29.11 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HD11 ' A' ' 60' ' ' ILE . 96.5 mt -95.03 117.8 39.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.501 0.667 . . . . 0.0 110.182 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.1 119.68 28.72 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.219 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 7' ' ' ALA . 77.6 p -129.88 166.86 19.13 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.565 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.5 p -131.3 158.84 74.12 Favored Pre-proline 0 C--N 1.298 -1.65 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.856 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.23 -19.79 65.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.809 2.339 . . . . 0.0 111.435 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.63 -13.9 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.881 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -142.09 67.16 21.63 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.612 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 85.6 Cg_endo -104.29 86.58 0.03 OUTLIER 'Trans proline' 1 N--CA 1.385 -4.863 0 C-N-CA 116.827 -1.649 . . . . 0.0 110.108 169.512 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.61 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 73.6 mmtt -146.96 -47.51 0.18 Allowed 'General case' 1 C--N 1.222 -4.964 0 CA-C-N 110.08 -3.236 . . . . 0.0 103.405 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.8 m -61.93 -48.59 79.73 Favored 'General case' 0 N--CA 1.379 -3.996 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.612 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.16 -50.68 69.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.558 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.3 pt-20 -64.36 -26.39 68.45 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 117.098 -1.841 . . . . 0.0 112.879 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -70.52 -51.23 30.21 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.277 0.561 . . . . 0.0 111.483 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 ' CD1' HG12 ' A' ' 30' ' ' ILE . 94.5 mt -63.55 -43.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.493 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.73 -45.01 82.2 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.495 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 33.0 t -69.18 -42.28 76.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.631 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.05 93.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.199 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 70.9 m-85 -114.61 41.61 2.3 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.39 -176.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -58.93 -37.01 75.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.131 0.491 . . . . 0.0 110.951 177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -83.52 11.9 6.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 49.8 p90 -44.46 130.65 6.63 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HD2' ' C ' ' A' ' 68' ' ' LYS . 3.6 tmmm? -102.55 -48.28 4.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.21 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.434 HD22 ' HG ' ' A' ' 38' ' ' LEU . 24.1 p-10 -118.12 7.89 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.251 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.1 mp -100.09 116.34 43.21 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.1 t -117.7 130.74 72.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.77 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -104.09 127.69 58.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.1 pt -120.85 153.3 24.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.331 0.586 . . . . 0.0 110.959 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.415 ' HB2' ' HZ3' ' A' ' 57' ' ' LYS . 23.0 t70 -118.08 131.21 56.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.841 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 t -166.67 -166.22 0.83 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 67.5 m -57.58 1.5 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 126.965 2.106 . . . . 0.0 115.344 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -33.07 -12.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.069 0 C-N-CA 126.048 1.785 . . . . 0.0 116.587 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -58.13 -38.96 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.402 ' HA3' ' OE2' ' A' ' 82' ' ' GLU . . . -114.92 131.83 10.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.08 -51.33 69.58 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.067 0.433 . . . . 0.0 111.957 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.6 pt -79.45 -25.99 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.199 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 47.1 mt-10 -62.18 -44.73 95.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.579 ' CG ' ' HE2' ' A' ' 6' ' ' MET . 10.6 t0 -63.45 -48.57 77.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.18 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.462 ' O ' HG21 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -54.82 -46.96 74.62 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.792 178.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.448 ' O ' HG12 ' A' ' 88' ' ' ILE . 29.1 m-80 -61.43 -40.5 94.68 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.861 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 76.8 mm-40 -63.36 -45.66 90.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.135 0.493 . . . . 0.0 109.744 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . 0.571 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 98.0 m -63.07 -42.2 99.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.526 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.482 HD12 ' O ' ' A' ' 160' ' ' LYS . 36.4 pt -64.83 -28.73 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.37 -20.24 75.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.302 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -103.78 -28.25 11.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.563 0.682 . . . . 0.0 112.786 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.571 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 71.8 m-85 -77.24 141.28 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -105.87 -1.95 23.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.507 0.67 . . . . 0.0 109.868 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 40.4 mt-10 -132.99 160.0 70.44 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 41.6 Cg_endo -67.65 145.46 69.94 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.729 1.619 . . . . 0.0 110.761 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.1 157.98 44.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.61 0.719 . . . . 0.0 111.488 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.503 HD11 ' O ' ' A' ' 155' ' ' ASN . 26.6 tp -87.43 141.46 28.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.457 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.582 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 94.0 t -112.87 130.92 65.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.614 HG21 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -128.82 168.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.283 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.2 m -98.45 144.61 27.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.013 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 6' ' ' MET . 88.0 p -73.16 -12.51 60.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -174.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.427 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 7.9 p-10 -116.9 11.67 14.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.38 157.2 30.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.74 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -116.64 174.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.003 0.43 . . . . 0.0 111.911 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -62.31 178.42 0.4 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.829 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.3 mt 81.47 5.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.576 1.15 . . . . 0.0 109.893 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 48.5 mmtm -98.69 1.88 46.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.288 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.537 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.2 p -58.01 -35.29 71.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.92 -29.69 62.17 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.169 0.985 . . . . 0.0 108.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.594 ' O ' HG12 ' A' ' 113' ' ' ILE . 25.7 mm -64.59 -38.69 83.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.537 HD12 ' HA ' ' A' ' 107' ' ' SER . 73.8 mt -59.31 -45.31 93.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.307 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -61.31 -43.62 98.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.96 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.0 m -64.73 -41.68 95.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.591 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.9 mm -62.86 -45.51 98.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.27 0.557 . . . . 0.0 109.873 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.436 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 53.8 t -60.44 -47.34 92.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.355 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.9 -47.61 85.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.03 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.599 ' CE2' HD13 ' A' ' 120' ' ' ILE . 54.3 t80 -64.56 -45.76 85.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.88 0.372 . . . . 0.0 110.554 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.27 -48.8 80.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.106 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.3 m-85 -62.81 -36.24 82.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.897 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.78 -41.59 97.92 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.599 HD13 ' CE2' ' A' ' 116' ' ' TYR . 76.3 mt -68.96 -46.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -68.22 -27.68 66.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.062 -177.575 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.23 99.34 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -83.92 -38.24 21.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.387 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.1 m -126.65 96.45 35.47 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.643 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.66 -15.61 48.03 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 122.804 2.336 . . . . 0.0 112.349 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.67 -32.08 73.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.814 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 116.45 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.835 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.543 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 38.7 mt-10 -126.72 14.07 7.49 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.113 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.91 31.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.404 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.5 tp -140.83 143.27 34.7 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.178 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.18 143.21 50.65 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.279 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 154' ' ' ILE . 12.1 p -123.24 133.27 69.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.159 0.504 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' MET . . . . . 0.469 ' C ' ' HB1' ' A' ' 152' ' ' ALA . 71.5 mtm -134.01 157.04 47.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.361 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.527 HG21 ' O ' ' A' ' 171' ' ' ILE . 7.7 pt -127.8 151.81 76.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.788 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.64 141.54 95.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.55 2.167 . . . . 0.0 112.448 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.06 -38.76 80.16 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.02 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.03 -37.63 85.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.726 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.05 -22.63 33.46 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.414 0.626 . . . . 0.0 111.322 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -59.57 134.66 89.02 Favored Pre-proline 0 C--N 1.291 -1.977 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.607 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.01 -32.7 98.05 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.871 2.381 . . . . 0.0 113.001 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -144.54 90.44 6.51 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.37 144.18 45.07 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.23 2.62 . . . . 0.0 112.608 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.2 m -82.79 90.53 6.92 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.003 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 pt -81.37 87.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.887 0.851 . . . . 0.0 110.307 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -153.65 -58.26 0.12 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.929 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.95 6.5 6.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.878 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 55.69 -115.49 0.94 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.784 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.86 -152.96 52.78 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.021 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.4 147.72 45.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.85 150.94 42.03 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.26 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.455 ' O ' HD12 ' A' ' 175' ' ' ILE . 52.6 Cg_exo -58.82 144.56 98.4 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.003 2.469 . . . . 0.0 111.725 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HB1' ' C ' ' A' ' 133' ' ' MET . . . -103.69 -15.42 15.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 170.11 -89.14 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.39 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.536 ' O ' HG13 ' A' ' 132' ' ' VAL . 22.3 pt -133.85 159.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.113 0.483 . . . . 0.0 111.722 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.582 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.4 m-20 -122.57 157.77 31.38 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.51 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.12 127.95 72.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 122.322 -0.236 . . . . 0.0 110.745 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.68 151.23 25.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.245 0.545 . . . . 0.0 111.795 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 94' ' ' PRO . 88.8 p -97.29 169.78 8.16 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 37.4 Cg_endo -67.88 67.69 0.88 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.906 1.738 . . . . 0.0 110.978 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.53 ' HB3' ' NE2' ' A' ' 164' ' ' GLN . 61.0 pttt -67.15 123.42 20.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.016 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -62.44 -43.03 99.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.547 0.689 . . . . 0.0 109.197 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 160' ' ' LYS . . . -128.77 -177.31 14.81 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -72.31 128.46 35.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 118.066 0.933 . . . . 0.0 108.629 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.543 ' OE1' ' HB2' ' A' ' 128' ' ' GLU . 29.9 pt20 -117.8 168.09 10.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.586 -169.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -56.91 121.0 8.88 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 110.086 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.62 130.65 52.98 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.9 161.64 14.4 Favored 'General case' 0 CA--C 1.471 -2.07 0 CA-C-O 121.976 0.893 . . . . 0.0 112.954 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.6 mm -118.44 129.6 74.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 113.713 -1.585 . . . . 0.0 111.583 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 62.0 ttp -129.72 134.14 47.45 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.332 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 133' ' ' MET . 49.8 t -112.14 126.47 69.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.527 ' O ' HG21 ' A' ' 134' ' ' ILE . 47.8 pt -113.47 175.82 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.056 0.455 . . . . 0.0 111.052 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -111.18 16.07 21.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.32 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.45 ' HB2' HD12 ' A' ' 171' ' ' ILE . 75.0 mm-40 -98.76 133.28 43.3 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.672 0.749 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.0 mt -97.09 149.5 21.89 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.514 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 151' ' ' PRO . 12.9 pt -127.73 155.83 39.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.863 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.6 112.3 24.1 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.541 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.427 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 7.8 t-20 -95.13 103.67 15.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.015 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.464 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 1.9 mp -81.92 113.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.521 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.91 -22.48 7.89 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 64.9 p -130.37 165.87 21.63 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.163 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.426 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.8 mppt? -65.98 -28.39 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 109.777 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.46 -42.35 98.64 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.227 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.464 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 49.3 m-20 -61.3 -41.03 96.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 109.535 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 59.2 tp -61.62 -45.05 95.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 30.4 mmmt -62.47 -39.87 94.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.501 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.01 -45.99 89.76 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.588 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.83 -42.78 97.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.472 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.9 OUTLIER -70.59 -34.68 72.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.757 0.313 . . . . 0.0 111.674 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.5 ttm -62.35 -43.38 98.96 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.301 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.1 pp -69.72 -37.94 76.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.87 -42.72 97.44 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.315 0.578 . . . . 0.0 110.385 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.74 -40.98 98.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.763 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.6 -42.02 91.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.614 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -84.63 -9.59 58.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.071 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.33 -39.79 97.73 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.359 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.269 2.11 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.445 179.2 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.612 ' O ' HG23 ' A' ' 42' ' ' VAL . 59.8 ttm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 1' ' ' MET . 52.6 m-20 -105.73 160.73 14.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.523 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -122.51 140.43 52.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.692 -177.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 98' ' ' VAL . 28.9 tp -112.42 123.73 50.93 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.362 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.721 ' HA ' HG22 ' A' ' 98' ' ' VAL . 55.1 mt -116.46 104.94 17.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.439 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 11.8 ptm -95.25 97.39 9.83 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.738 1.256 . . . . 0.0 112.465 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -115.94 96.98 5.84 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.094 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.582 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 N-CA-C 112.866 0.294 . . . . 0.0 112.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 56' ' ' THR . 43.4 mt -94.64 10.99 32.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.38 118.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -98.35 142.41 30.02 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.267 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.7 tp -137.21 115.87 12.1 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.106 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.1 m 56.06 24.14 7.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.57 2.22 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.01 -1.567 . . . . 0.0 115.436 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.703 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 69.5 mtt-85 -126.03 159.57 32.4 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 118.353 1.077 . . . . 0.0 111.059 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 72.7 m -83.85 157.99 21.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 101' ' ' ASP . 0.6 OUTLIER -46.7 -53.29 12.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.287 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 7' ' ' ALA . 12.4 tt -62.07 -36.4 73.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HA ' HG12 ' A' ' 34' ' ' VAL . 12.7 t70 -63.02 -40.51 97.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.703 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 25.1 m-85 -64.69 -37.17 86.68 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.573 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.37 -47.76 83.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.036 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 31' ' ' ASP . 12.2 p -72.1 -35.15 52.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.551 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 35.1 t -53.9 -54.08 50.81 Favored Pre-proline 0 CA--C 1.562 1.438 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 46.0 Cg_exo -61.45 -39.34 56.67 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.002 1.801 . . . . 0.0 112.023 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.45 HD12 HD11 ' A' ' 5' ' ' ILE . 81.2 mt -63.67 -42.08 98.1 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.459 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.487 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.9 tt -60.01 -45.79 91.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.0 -12.07 59.44 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.523 ' OG ' HG12 ' A' ' 42' ' ' VAL . 72.7 p -76.49 -175.86 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -51.48 -33.77 32.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.666 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 1' ' ' MET . 7.5 p -69.05 140.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 121.444 0.64 . . . . 0.0 111.616 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -83.6 -69.75 0.61 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.285 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -101.23 146.46 27.49 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.357 0.599 . . . . 0.0 111.156 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.429 HG21 HG23 ' A' ' 34' ' ' VAL . 47.7 mm -110.98 116.87 53.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.845 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 96.1 m-85 -103.39 114.96 29.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.759 HG21 HD13 ' A' ' 60' ' ' ILE . 88.0 mt -98.96 118.34 45.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.649 0.738 . . . . 0.0 110.482 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.33 124.36 33.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.374 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.1 p -132.2 168.63 17.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.213 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.1 m -129.89 155.01 81.21 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.506 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.63 -21.47 65.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.925 2.416 . . . . 0.0 111.044 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.16 -13.12 60.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.453 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -142.37 66.47 19.4 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.63 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 76.4 Cg_endo -107.99 87.0 0.02 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.591 0 CA-C-N 120.884 1.351 . . . . 0.0 111.363 170.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.5 mmtm -151.01 -44.58 0.12 Allowed 'General case' 1 C--N 1.221 -5.001 0 CA-C-N 109.599 -3.455 . . . . 0.0 102.649 176.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' HD11 ' A' ' 21' ' ' LEU . 74.9 m -62.68 -49.51 74.83 Favored 'General case' 0 N--CA 1.387 -3.615 0 CA-C-N 113.022 -1.899 . . . . 0.0 105.974 161.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.23 -50.26 70.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.628 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.668 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.5 pt-20 -62.14 -30.26 70.91 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 116.517 -2.073 . . . . 0.0 112.573 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.01 -50.31 66.81 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.759 HD13 HG21 ' A' ' 47' ' ' ILE . 85.5 mt -60.62 -45.03 98.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.154 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -56.54 -45.53 81.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.634 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 70.1 m -71.1 -41.62 70.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.136 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.28 86.28 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 111.381 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' OH ' HG11 ' A' ' 34' ' ' VAL . 34.9 m-85 -115.99 39.79 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.952 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.2 mtmt -61.12 -29.04 69.53 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.131 0.491 . . . . 0.0 110.828 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.59 10.31 13.58 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 51.6 p90 -35.69 113.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.44 -48.61 5.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.487 HD21 ' HG ' ' A' ' 38' ' ' LEU . 20.1 p-10 -117.54 5.26 12.43 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 4.5 mp -95.11 122.58 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 75.8 t -124.01 128.49 74.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -105.82 129.13 59.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.363 0.601 . . . . 0.0 109.71 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.8 pt -121.88 156.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.293 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.89 128.58 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -158.72 -168.14 2.32 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-O 121.728 0.775 . . . . 0.0 112.916 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -69.06 1.48 3.5 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 126.184 1.794 . . . . 0.0 114.198 -176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.07 -20.35 0.0 OUTLIER Glycine 1 N--CA 1.521 4.365 0 C-N-CA 126.192 1.854 . . . . 0.0 116.903 -176.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -56.81 -38.05 72.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.51 127.81 8.5 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -60.9 -51.19 70.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 0.0 112.099 -172.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.3 pt -76.9 -27.43 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.485 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 50.7 mt-10 -63.36 -44.49 94.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.615 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 20.5 t0 -62.51 -50.69 70.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.278 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.5 mm? -54.55 -46.28 73.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.631 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.498 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.1 m-80 -59.92 -42.99 95.15 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.385 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 28.9 mm-40 -65.18 -47.18 77.86 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.93 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.4 m -63.35 -42.56 98.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.329 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 84' ' ' LEU . 40.7 pt -65.87 -28.43 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.15 -10.65 85.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.775 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -109.17 -24.62 11.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 159' ' ' PRO . 76.9 m-85 -82.11 148.48 28.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.038 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 m -96.36 -12.28 24.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 111.153 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.02 158.77 66.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.588 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.71 141.84 33.72 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.384 2.723 . . . . 0.0 112.15 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.14 157.02 45.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.715 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 154' ' ' ILE . 23.7 tp -87.83 143.2 27.26 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.733 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 72.6 t -113.11 129.64 68.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -132.26 160.57 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.136 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 51.2 m -100.38 137.11 39.25 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.5 p -77.05 -10.46 59.39 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.499 ' HA ' HD22 ' A' ' 29' ' ' LEU . 19.6 p-10 -99.19 9.61 43.09 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 175' ' ' ILE . 61.2 mt -91.52 115.9 28.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 85.4 mt -108.03 119.81 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 110.703 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 65.8 t30 170.04 153.15 0.05 OUTLIER 'General case' 0 C--O 1.247 0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.31 117.5 14.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -95.84 -1.37 49.65 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.462 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -56.36 -38.87 72.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.74 -25.61 32.72 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.045 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.531 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.5 mm -71.32 -43.72 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.658 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 40' ' ' SER . 60.2 mt -60.07 -48.48 87.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.126 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -64.64 -42.11 95.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.439 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -66.18 -43.0 88.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.538 HG13 ' CG1' ' A' ' 154' ' ' ILE . 38.7 mm -63.45 -48.62 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 120.907 0.384 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.483 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 66.3 t -61.29 -47.8 91.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.702 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -47.49 84.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.655 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.508 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.3 t80 -63.13 -44.26 96.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.375 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 58.4 t80 -58.39 -48.11 81.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 28.2 m-85 -63.1 -35.19 79.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.62 -40.35 96.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.121 0.486 . . . . 0.0 109.899 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 116' ' ' TYR . 80.0 mt -64.28 -45.73 95.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.688 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -62.68 -37.26 85.73 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.102 0.477 . . . . 0.0 110.672 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.98 88.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.288 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -83.84 -38.84 20.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.45 . . . . 0.0 111.314 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.3 m -130.07 94.1 31.82 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.184 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.05 -22.97 58.27 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.313 2.675 . . . . 0.0 113.126 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.49 -28.51 70.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.407 HG22 ' HE3' ' A' ' 165' ' ' LYS . 74.9 t -70.26 126.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.64 -13.18 10.23 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.224 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 166' ' ' GLU . . . -140.67 157.04 46.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.4 . . . . 0.0 111.777 -177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 1.2 tm? -136.17 135.69 39.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.27 132.27 48.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 154' ' ' ILE . 14.1 p -114.66 126.56 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.92 160.99 41.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 152' ' ' ALA . 12.5 pt -132.73 147.41 65.41 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.632 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 C--O 1.239 0.532 0 C-N-CA 122.413 2.075 . . . . 0.0 111.769 177.536 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.06 141.13 75.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.099 1.866 . . . . 0.0 110.567 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' A' ' 171' ' ' ILE . . . -90.36 -8.11 51.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.426 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.85 -86.58 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.637 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.618 HG22 HG12 ' A' ' 98' ' ' VAL . 28.0 pt -123.75 160.17 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.217 0.532 . . . . 0.0 112.086 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.679 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.9 t-20 -128.61 151.99 48.85 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.469 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.6 t -123.43 131.04 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.522 0.201 . . . . 0.0 110.932 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.64 150.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.7 p -87.85 154.2 52.68 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' PHE . 67.2 Cg_endo -84.11 84.92 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.514 2.143 . . . . 0.0 113.307 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -130.81 -179.55 5.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.394 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -105.55 98.43 8.13 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.95 -170.29 21.32 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.845 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -96.62 150.01 21.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.776 0.322 . . . . 0.0 110.224 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.89 165.9 23.57 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.683 -171.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HE3' HG22 ' A' ' 127' ' ' VAL . 65.0 tttp -64.03 124.71 22.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 44.2 tt0 -120.62 132.9 55.36 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.114 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.28 161.3 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 121.559 0.695 . . . . 0.0 112.057 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.8 mm -118.36 129.04 75.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.566 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.4 ' CE ' HD13 ' A' ' 113' ' ' ILE . 58.4 ttp -132.06 136.63 47.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.35 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.84 130.26 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.649 HD11 ' HB1' ' A' ' 152' ' ' ALA . 49.4 pt -120.33 175.45 4.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.766 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -120.09 24.09 10.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.586 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HB2' HD12 ' A' ' 171' ' ' ILE . 2.3 mp0 -99.4 131.95 45.07 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.41 149.9 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.499 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.724 HD12 HD22 ' A' ' 102' ' ' LEU . 2.4 pt -119.59 148.89 22.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.644 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.51 118.24 33.2 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.469 HD21 HD23 ' A' ' 102' ' ' LEU . 1.9 m-20 -107.62 149.18 28.38 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.151 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.83 121.98 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.855 0.359 . . . . 0.0 111.507 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -130.12 -30.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.108 0.48 . . . . 0.0 110.406 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 t -140.92 -178.4 5.54 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.235 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -61.52 -41.79 97.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.381 0.672 . . . . 0.0 112.623 -175.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.4 -38.15 86.02 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.21 -40.6 94.58 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.273 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.81 -43.68 98.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 13.4 tmtt? -62.23 -44.23 97.04 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.534 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.66 -50.58 73.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.291 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.09 -39.91 90.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.458 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.2 pp20? -67.11 -28.69 68.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.336 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.6 mmm -63.26 -40.92 98.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.8 pp -71.3 -37.39 71.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.476 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.53 -39.73 94.3 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.804 0.812 . . . . 0.0 109.509 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.659 177.525 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.1 tpp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -110.49 166.6 10.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.528 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -113.09 139.93 48.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.242 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -119.51 114.55 22.45 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.655 ' HA ' HG22 ' A' ' 98' ' ' VAL . 69.0 mt -118.55 106.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.427 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.5 ptm -98.92 104.36 16.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.815 1.293 . . . . 0.0 112.621 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.57 6.14 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.165 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.491 178.641 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 N--CA 1.476 0.497 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.2 mt -89.15 13.04 14.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 94.8 mt -70.39 119.18 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 63.0 pttt -102.79 137.2 41.31 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-O 122.243 1.02 . . . . 0.0 113.123 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.32 131.68 50.39 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.174 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' ' HE3' ' A' ' 192' ' ' LYS . 83.7 m 53.48 32.36 13.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.77 -17.4 49.57 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.843 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 92.4 mtt180 -128.61 152.38 48.41 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 119.018 1.409 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 81.7 m -74.87 162.84 28.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.319 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 100' ' ' SER . 84.0 mt -58.73 -40.89 85.11 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.144 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 60' ' ' ILE . 5.1 tp -58.08 -44.45 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.443 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.741 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 13.1 t70 -65.06 -43.57 91.82 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.97 0.414 . . . . 0.0 111.23 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.843 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 32.5 m-85 -67.33 -26.39 66.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.481 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.7 t -73.7 -46.79 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.47 173.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.09 -47.72 88.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 66.1 m -54.61 -50.35 86.04 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HG2' ' NZ ' ' A' ' 106' ' ' LYS . 78.3 Cg_exo -57.69 -42.59 58.44 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.75 1.634 . . . . 0.0 112.109 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.658 HD11 HG11 ' A' ' 98' ' ' VAL . 90.0 mt -67.51 -39.48 85.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD12 HD21 ' A' ' 69' ' ' ASN . 61.8 tp -57.15 -43.68 82.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.44 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 35' ' ' SER . 19.0 ptpt -88.74 -6.15 57.62 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.525 ' OG ' HG12 ' A' ' 42' ' ' VAL . 57.6 p -81.55 -176.96 6.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.727 0.775 . . . . 0.0 112.212 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -63.63 -16.14 60.12 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.372 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 3' ' ' ALA . 13.3 p -75.28 147.69 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 122.189 -0.32 . . . . 0.0 111.691 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.03 -75.58 0.35 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -100.19 147.2 25.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.972 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.03 112.08 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.609 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -104.45 114.56 28.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 5' ' ' ILE . 96.7 mt -97.26 116.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.674 0.749 . . . . 0.0 110.853 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.3 121.77 30.19 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.386 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 7' ' ' ALA . 53.2 p -132.69 162.38 31.54 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.414 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.6 m -117.87 154.75 51.33 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 29.1 Cg_endo -63.38 -18.86 66.58 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.028 2.485 . . . . 0.0 110.842 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -70.89 -20.72 62.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.084 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 p -137.59 66.69 50.59 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.741 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.708 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 63.2 Cg_endo -103.55 85.43 0.03 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.603 0 C-N-CA 116.974 -1.55 . . . . 0.0 110.162 170.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.641 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.1 ttpt -154.63 -47.24 0.09 Allowed 'General case' 1 C--N 1.211 -5.436 0 CA-C-N 109.393 -3.549 . . . . 0.0 102.27 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -63.42 -48.74 76.56 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 162.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.708 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.74 -50.4 71.24 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.834 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -63.6 -32.5 73.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 116.485 -2.086 . . . . 0.0 112.472 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.36 -51.21 64.44 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.192 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 30' ' ' ILE . 96.9 mt -64.91 -46.27 92.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.98 -175.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.4 -41.82 90.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 39.7 t -67.95 -42.87 80.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.508 0.671 . . . . 0.0 110.387 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.92 89.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.339 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.61 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 71.8 m-85 -112.0 18.26 18.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 62' ' ' SER . 64.6 pttt -65.03 -17.47 64.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.62 2.66 52.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' HA ' ' A' ' 64' ' ' TYR . 74.5 m-85 -102.66 130.38 49.55 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.076 -0.39 . . . . 0.0 111.137 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.15 60.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.384 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.453 HD21 HD12 ' A' ' 38' ' ' LEU . 21.6 p-10 -85.97 2.09 47.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.03 123.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.5 135.1 65.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.93 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.92 129.1 58.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 48' ' ' ALA . 42.9 pt -122.27 156.64 27.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.366 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.84 133.11 56.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.528 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.0 t -167.06 -167.29 0.91 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 52.6 m -64.08 1.17 0.74 Allowed 'General case' 0 C--O 1.197 -1.698 0 C-N-CA 126.826 2.05 . . . . 0.0 114.6 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.54 -28.21 0.01 OUTLIER Glycine 0 N--CA 1.515 3.922 0 C-N-CA 125.604 1.573 . . . . 0.0 116.713 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -56.12 -33.0 64.74 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.65 115.85 4.0 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -58.39 -50.72 72.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.2 -46.02 92.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.55 0.691 . . . . 0.0 110.742 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.48 -42.38 96.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.595 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.51 -50.1 74.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.901 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -57.06 -44.05 82.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' HG12 ' A' ' 88' ' ' ILE . 93.9 m-20 -60.7 -42.3 96.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.41 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.19 -45.22 89.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.145 0.498 . . . . 0.0 110.572 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.615 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 95.5 m -64.65 -41.77 95.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.089 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 84' ' ' LEU . 39.2 pt -68.45 -31.02 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 121.98 -0.45 . . . . 0.0 110.952 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.86 95.55 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.158 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -101.94 9.78 40.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.615 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 62.8 m-85 -112.62 150.57 31.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.82 0.343 . . . . 0.0 111.823 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -102.41 -6.68 22.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.295 0.569 . . . . 0.0 109.951 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -125.49 156.76 69.98 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.432 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.89 153.6 42.49 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.622 2.215 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.92 152.55 43.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 0.0 112.657 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 155' ' ' ASN . 2.4 tm? -86.31 124.01 32.2 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.177 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 57.8 t -99.04 130.8 47.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 123.395 0.678 . . . . 0.0 109.805 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.658 HG11 HD11 ' A' ' 37' ' ' LEU . 13.3 m -129.37 166.38 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 121.871 0.843 . . . . 0.0 112.454 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.5 m -98.85 157.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.937 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 81.2 p -88.94 -6.25 57.4 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.309 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -117.59 9.96 13.3 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.96 122.32 31.43 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.073 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 103' ' ' ILE . 28.0 pt -122.47 101.51 10.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.663 0.744 . . . . 0.0 111.516 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -160.01 177.71 10.46 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.401 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.29 59.6 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.735 0.779 . . . . 0.0 109.93 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.777 ' HA ' HD12 ' A' ' 109' ' ' ILE . 16.9 pttp -69.72 -3.69 16.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.79 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -59.17 -41.9 89.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.544 ' HD3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -88.6 -23.16 23.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.812 0.815 . . . . 0.0 110.566 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.777 HD12 ' HA ' ' A' ' 106' ' ' LYS . 74.2 mt -64.34 -38.79 83.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.882 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.1 mt -55.44 -47.85 77.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.769 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -63.69 -41.34 98.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.462 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.6 m -63.43 -39.8 95.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.749 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.2 mm -61.28 -47.69 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.041 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.502 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 67.9 t -60.43 -48.07 89.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.263 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.77 -47.64 84.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.607 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CE2' HD11 ' A' ' 120' ' ' ILE . 75.0 t80 -61.43 -48.24 82.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.658 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -59.56 -47.59 84.95 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.246 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.8 m-85 -61.82 -37.94 86.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.331 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.7 t -61.12 -46.43 90.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.399 0.619 . . . . 0.0 109.908 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.593 HD11 ' CE2' ' A' ' 116' ' ' TYR . 80.0 mt -62.46 -45.98 97.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -62.85 -37.44 86.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.994 0.426 . . . . 0.0 110.833 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.49 91.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.398 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -81.27 -36.02 30.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.071 0.462 . . . . 0.0 111.206 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.7 m -139.89 100.1 7.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.169 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.03 -16.72 53.46 Favored 'Trans proline' 0 N--CA 1.481 0.775 0 C-N-CA 123.087 2.525 . . . . 0.0 113.241 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -69.48 -13.39 62.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.489 HG21 ' CG2' ' A' ' 120' ' ' ILE . 94.3 t -76.85 120.04 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.29 11.85 10.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.504 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.0 23.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -137.0 135.97 38.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.123 -178.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.0 137.78 52.35 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.27 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 113' ' ' ILE . 57.6 t -112.29 116.91 53.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 4.3 ptm -145.46 155.55 43.19 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.956 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 152' ' ' ALA . 24.0 pt -130.03 157.48 76.85 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.919 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 39.5 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 121.763 1.642 . . . . 0.0 111.772 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.91 147.5 55.63 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.198 1.932 . . . . 0.0 111.891 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.657 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -117.45 -6.64 11.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.226 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.05 -116.89 0.39 Allowed Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.48 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 96' ' ' LEU . 22.2 pt -124.55 160.08 29.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 120.7 0.286 . . . . 0.0 111.02 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.608 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.0 m-20 -117.65 159.27 23.21 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.91 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.67 133.46 69.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.88 148.45 31.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.479 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -92.43 149.29 38.02 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.13 75.2 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -104.11 -170.97 1.85 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.171 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -132.33 125.94 32.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.45 -105.99 3.34 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.207 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -147.03 140.5 25.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -133.3 166.96 21.28 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.451 ' HE3' HG22 ' A' ' 127' ' ' VAL . 63.6 tttp -58.47 125.7 24.45 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.828 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.14 128.31 49.08 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.143 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -93.9 163.49 13.48 Favored 'General case' 0 CA--C 1.477 -1.852 0 CA-C-O 121.687 0.756 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.33 130.12 69.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.537 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.558 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 51.3 ttm -112.45 129.85 56.19 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.376 175.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.54 126.32 66.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.2 pt -121.55 174.29 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 112.029 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -111.48 4.89 19.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.059 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 171' ' ' ILE . 34.9 mt-10 -99.34 130.29 45.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 111.03 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.49 151.15 19.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.249 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.99 150.49 31.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.325 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.01 122.82 43.05 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.164 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.415 ' C ' HD12 ' A' ' 178' ' ' ILE . 23.7 p-10 -94.08 168.17 11.11 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.787 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 184' ' ' LEU . 2.0 mp -120.32 121.05 64.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.873 0.368 . . . . 0.0 111.093 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -111.72 -32.34 6.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.422 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.1 t -138.39 176.6 8.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.022 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -64.24 -29.13 70.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.83 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.28 -39.11 91.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.414 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -61.42 -35.76 78.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.388 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 178' ' ' ILE . 96.0 mt -60.68 -43.7 97.4 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.354 0.597 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.644 ' O ' ' HG3' ' A' ' 189' ' ' MET . 60.0 tptt -62.84 -43.61 98.35 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.707 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.56 -48.21 82.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.71 -43.14 99.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.306 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 192' ' ' LYS . 13.2 pt-20 -70.2 -29.59 66.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.932 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -61.44 -39.71 91.83 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -70.67 -33.41 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.96 -40.57 87.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.66 0.743 . . . . 0.0 110.558 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 188' ' ' GLU . 34.8 mmtp . . . . . 0 C--N 1.308 -1.203 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.368 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 64.2 m-20 -97.35 165.91 11.79 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -117.9 130.07 56.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.901 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 48' ' ' ALA . 36.1 tp -100.93 124.72 47.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.369 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.662 ' HA ' HG22 ' A' ' 98' ' ' VAL . 68.5 mt -117.59 104.88 17.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.0 ptm -96.64 107.64 20.12 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.786 1.279 . . . . 0.0 112.505 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -114.92 96.92 5.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.801 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.623 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.654 -179.032 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 44.1 Cg_exo . . . . . 0 N--CA 1.48 0.715 0 CA-C-O 121.348 0.478 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.607 HD21 ' CB ' ' A' ' 59' ' ' TYR . 9.6 mp -83.51 15.71 2.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -69.73 123.19 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -80.75 132.08 35.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.575 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 HD13 HD12 ' A' ' 184' ' ' LEU . 59.8 tp -137.83 125.33 22.06 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.152 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t 58.64 26.17 14.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.278 0.561 . . . . 0.0 110.74 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 -13.85 56.86 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -134.4 169.81 16.68 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 118.945 1.372 . . . . 0.0 111.434 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 75.6 m -85.73 163.79 18.01 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.672 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 82.3 mt -59.43 -39.69 84.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.268 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.3 tp -57.17 -45.17 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.201 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.43 -41.65 93.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.973 0.416 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -61.52 -33.89 74.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.409 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.54 -42.95 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.774 0.321 . . . . 0.0 111.412 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.4 t -63.39 -44.81 99.13 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -52.87 -50.47 81.28 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 28.9 Cg_endo -64.13 -40.95 24.04 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.367 1.378 . . . . 0.0 112.489 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD11 HG11 ' A' ' 98' ' ' VAL . 88.6 mt -66.7 -37.71 85.26 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.498 0.666 . . . . 0.0 110.436 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.22 -44.12 88.05 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.284 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 36' ' ' PRO . 64.3 pttt -90.32 -3.23 57.89 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.206 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.422 ' CB ' HG21 ' A' ' 110' ' ' ILE . 59.5 p -81.43 -178.9 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.778 0.799 . . . . 0.0 112.997 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -59.94 -25.28 65.05 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 3' ' ' ALA . 30.2 m -64.26 161.78 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.2 t30 -83.38 -76.31 0.29 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.218 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -115.16 157.44 23.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.074 0.464 . . . . 0.0 110.82 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.63 115.89 50.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -107.81 117.32 33.8 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -96.88 119.41 44.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.736 0.779 . . . . 0.0 110.583 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -91.05 121.0 32.48 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.758 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.1 p -132.07 165.81 23.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.44 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.9 p -128.45 157.57 74.36 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.081 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 51.8 Cg_exo -58.2 -25.68 72.91 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.916 2.41 . . . . 0.0 110.963 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -75.46 -14.04 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.712 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -141.76 65.94 21.09 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.8 Cg_endo -106.26 86.72 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.113 0 C-N-CA 117.148 -1.435 . . . . 0.0 109.586 168.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 ttmt -147.83 -50.43 0.18 Allowed 'General case' 1 C--N 1.209 -5.534 0 CA-C-N 109.489 -3.505 . . . . 0.0 101.675 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.514 HG22 HD12 ' A' ' 60' ' ' ILE . 98.0 m -62.52 -48.41 79.65 Favored 'General case' 0 N--CA 1.382 -3.85 0 CA-C-N 111.712 -2.494 . . . . 0.0 106.047 164.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.23 -49.1 77.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.004 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 18.9 pt-20 -56.17 -35.96 67.8 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 117.589 -1.644 . . . . 0.0 110.988 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' HD21 ' A' ' 21' ' ' LEU . 57.7 t80 -70.76 -52.05 23.22 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.744 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 HD12 HG22 ' A' ' 56' ' ' THR . 97.1 mt -63.92 -45.12 97.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.508 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.734 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 49.2 t30 -57.08 -47.33 81.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.907 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 t -71.47 -43.68 66.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.733 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.96 89.32 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.377 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 95.2 m-85 -104.52 20.16 19.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.734 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtpt -63.32 -23.14 67.28 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 174.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.03 10.02 15.43 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.22 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 45.1 p90 -50.51 148.55 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -103.55 -52.88 2.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.448 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -121.14 16.57 11.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.557 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 79.1 mt -103.87 127.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.54 0.686 . . . . 0.0 111.838 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 69.2 t -125.84 134.0 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.879 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.32 132.7 49.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.189 0.519 . . . . 0.0 109.973 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.51 157.04 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.901 0.857 . . . . 0.0 111.672 -176.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -106.6 133.79 50.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.981 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.8 t -159.75 -168.6 2.3 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 78' ' ' LYS . 65.7 m -77.37 3.28 13.58 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 126.001 1.72 . . . . 0.0 113.725 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.51 -14.56 0.0 OUTLIER Glycine 1 N--CA 1.522 4.372 0 C-N-CA 127.11 2.29 . . . . 0.0 117.992 -174.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.8 tmtt? -59.93 -37.11 78.55 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.68 130.35 8.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.48 -51.04 71.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.484 HD12 ' OH ' ' A' ' 163' ' ' TYR . 45.7 pt -71.32 -36.41 61.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.52 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.37 -40.01 92.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.124 0.488 . . . . 0.0 109.834 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.501 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 19.0 t0 -59.66 -51.03 71.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.962 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.2 mm? -56.34 -45.4 80.41 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.783 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.521 ' HA ' HG12 ' A' ' 88' ' ' ILE . 24.6 m-80 -60.32 -41.31 93.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.597 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 77.4 mm-40 -65.19 -46.06 82.32 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.538 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.4 m -63.02 -43.76 97.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.238 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 84' ' ' LEU . 34.7 pt -67.72 -29.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.822 0.344 . . . . 0.0 110.403 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.31 96.09 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.71 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.5 3.89 50.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.45 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 63.8 m-85 -108.74 143.26 38.1 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.581 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.3 p -102.78 -0.76 30.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.484 . . . . 0.0 111.11 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -133.24 156.75 79.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.864 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.76 146.34 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.409 2.072 . . . . 0.0 111.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.25 161.69 38.28 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.488 0.661 . . . . 0.0 112.362 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.773 HD11 HD12 ' A' ' 154' ' ' ILE . 1.5 tm? -84.81 143.08 29.32 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.222 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.613 ' N ' HD13 ' A' ' 96' ' ' LEU . 99.8 t -119.59 130.15 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.86 0.864 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 37' ' ' LEU . 14.6 m -130.87 161.95 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.207 0.527 . . . . 0.0 112.136 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.8 t -99.37 140.74 33.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -72.24 -10.86 60.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -104.15 9.69 36.15 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.28 122.86 27.96 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 122.086 -0.384 . . . . 0.0 110.931 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 pt -62.98 166.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -89.56 72.53 7.84 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.17 -14.01 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 168.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 25.0 pttm -67.66 -0.44 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.002 -1.908 . . . . 0.0 114.454 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.4 m -58.09 -40.67 81.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -82.49 -23.99 34.41 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.738 0.78 . . . . 0.0 110.303 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.6 mm -64.02 -40.22 88.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.112 -174.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.57 ' HA ' HD11 ' A' ' 154' ' ' ILE . 58.1 mt -57.89 -48.57 83.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.644 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -65.12 -39.75 93.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.58 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.6 m -61.33 -40.16 93.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.634 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -61.8 -49.18 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.695 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 71.4 t -62.85 -47.76 91.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.425 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.12 -45.83 93.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.731 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.628 ' CE2' HD11 ' A' ' 120' ' ' ILE . 62.3 t80 -62.85 -48.38 79.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.813 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.53 -47.64 84.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.363 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.448 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 25.5 m-85 -61.8 -37.77 85.64 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.459 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -63.66 -39.75 95.11 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.277 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.628 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.6 mt -63.35 -46.36 95.69 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.078 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HG2' HG13 ' A' ' 127' ' ' VAL . 52.5 mtmt -61.74 -38.66 88.77 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.908 0.385 . . . . 0.0 111.178 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.6 87.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.398 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -86.93 -35.25 19.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.017 0.437 . . . . 0.0 111.627 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 127' ' ' VAL . 34.4 m -136.88 94.53 12.81 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 122.806 0.443 . . . . 0.0 110.848 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.34 -15.8 31.43 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.388 2.725 . . . . 0.0 113.051 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.9 -32.92 72.37 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.495 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 12.0 p -65.54 132.14 31.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.215 0.531 . . . . 0.0 111.947 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -119.56 -15.79 8.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.167 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.82 160.23 43.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 23.1 tp -134.61 144.26 47.8 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.96 140.73 51.53 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.317 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.557 HG21 ' CD1' ' A' ' 113' ' ' ILE . 84.2 t -118.58 120.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 ptm -145.49 154.62 42.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.787 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 152' ' ' ALA . 28.2 pt -129.87 156.29 79.22 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.382 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.209 1.939 . . . . 0.0 110.739 176.155 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 15.1 m . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 150' ' ' VAL . 48.2 Cg_exo -60.45 142.48 98.12 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.028 2.485 . . . . 0.0 111.166 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HA ' HD11 ' A' ' 175' ' ' ILE . . . -135.25 -30.19 1.05 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.239 0.543 . . . . 0.0 111.431 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.39 -141.91 11.66 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 119.715 -1.231 . . . . 0.0 112.49 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 96' ' ' LEU . 17.6 pt -126.37 160.69 33.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.926 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.0 m-20 -109.53 159.74 16.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.33 132.39 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.34 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.96 152.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.108 0.48 . . . . 0.0 111.513 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.568 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.2 m -97.07 160.12 29.79 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.374 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.5 83.24 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.783 2.322 . . . . 0.0 111.615 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.542 ' HG3' ' HB3' ' A' ' 164' ' ' GLN . 30.8 mmmt -114.31 150.3 34.69 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.864 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.79 -42.45 90.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.788 0.328 . . . . 0.0 110.469 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.01 -148.29 7.28 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.594 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.484 ' OH ' HD12 ' A' ' 81' ' ' ILE . 97.7 m-85 -75.98 149.47 37.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.0 110.893 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.568 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 16.3 pt20 -134.23 167.61 20.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 1.9 tmtm? -60.71 131.4 50.57 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.999 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -134.56 130.58 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.727 0.299 . . . . 0.0 111.69 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -95.08 164.09 13.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.8 mm -119.13 131.69 71.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -135.8 140.66 44.43 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.312 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.9 t -108.38 129.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.398 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.79 170.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 112.01 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 3.05 56.31 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.975 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.487 ' CD ' HD11 ' A' ' 109' ' ' ILE . 12.1 pt-20 -130.09 142.37 50.61 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.815 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.428 ' O ' HD12 ' A' ' 174' ' ' LEU . 2.7 pp -97.23 149.66 21.79 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.625 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 175' ' ' ILE . 2.3 pp -131.41 145.35 35.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.398 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -131.01 149.68 52.5 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -98.39 178.94 4.88 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.97 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.15 119.72 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -125.49 -22.0 4.39 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.386 0.612 . . . . 0.0 109.731 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.1 p -130.03 164.21 24.82 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.521 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.412 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 mppt? -63.28 -35.79 81.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.92 -44.32 94.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.118 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.34 -41.43 96.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.177 0.513 . . . . 0.0 109.647 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 24' ' ' LEU . 53.0 tp -61.19 -47.73 84.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.522 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.629 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 86.6 tttt -68.11 -35.88 78.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.583 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.5 tp -58.5 -48.36 81.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.748 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.474 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.34 -42.45 98.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.274 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.3 -32.38 73.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.848 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -61.87 -44.8 96.09 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.687 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.84 -35.83 67.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.146 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.1 mt -65.11 -41.08 95.26 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.845 0.831 . . . . 0.0 109.845 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 192' ' ' LYS . 41.0 ttmt . . . . . 0 C--N 1.309 -1.154 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.346 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 68.9 m-20 -94.82 166.02 12.19 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -113.8 127.73 56.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.121 0.486 . . . . 0.0 110.519 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.88 121.97 45.15 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.614 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.702 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.9 mt -118.83 114.27 44.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.8 ttm -84.7 97.11 9.47 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-O 121.936 0.874 . . . . 0.0 111.302 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -114.42 100.82 8.6 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.038 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.467 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.974 -178.221 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.482 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 113.647 0.595 . . . . 0.0 113.647 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' A' ' 56' ' ' THR . 72.7 mt -86.84 23.07 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.6 mt -70.4 116.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.5 pttm -96.24 131.82 42.34 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.205 1.003 . . . . 0.0 112.759 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -128.93 138.54 52.05 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 113.395 -1.729 . . . . 0.0 108.634 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.492 ' SG ' HD13 ' A' ' 191' ' ' LEU . 81.0 m 63.33 -75.65 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.55 0.531 . . . . 0.0 112.263 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.18 0.58 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.669 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 7.7 ptm180 -150.6 170.1 19.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.402 1.101 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 96.3 m -78.07 156.96 29.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -53.01 -46.94 68.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.327 0.651 . . . . 0.0 110.929 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -63.95 -36.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.817 0.341 . . . . 0.0 110.762 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.56 -40.8 97.93 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.539 ' CE2' ' HG2' ' A' ' 27' ' ' ARG . 7.7 m-85 -61.63 -36.75 81.65 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 29' ' ' LEU . 78.9 t -65.77 -42.35 92.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.924 0.392 . . . . 0.0 110.881 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.421 HG23 HD13 ' A' ' 30' ' ' ILE . 74.0 t -64.01 -41.61 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 t -48.04 -56.5 13.49 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 42.4 Cg_endo -67.91 -37.37 15.6 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 121.719 1.612 . . . . 0.0 112.435 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.57 HD11 HG11 ' A' ' 98' ' ' VAL . 82.0 mt -65.52 -42.59 91.86 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' A' ' 69' ' ' ASN . 6.6 tt -61.45 -46.92 88.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.283 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 19.0 ptpt -76.34 -12.8 60.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.1 p -72.17 -178.41 2.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.925 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -70.04 -4.56 21.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.997 -1.002 . . . . 0.0 113.529 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.32 162.07 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.483 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.555 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.1 t30 -80.12 -75.44 0.26 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.201 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -120.0 161.04 21.6 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.039 0.447 . . . . 0.0 110.8 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 3' ' ' ALA . 46.8 mm -108.99 116.49 52.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.301 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 88.6 m-85 -109.89 118.1 35.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 60' ' ' ILE . 90.2 mt -101.57 118.77 48.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.567 0.699 . . . . 0.0 111.023 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -84.48 117.99 24.01 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.074 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 7' ' ' ALA . 71.5 p -125.26 164.32 20.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -126.53 156.14 73.52 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.491 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 54.4 Cg_exo -58.07 -24.29 65.23 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.98 2.453 . . . . 0.0 111.154 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -70.1 -20.86 63.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.021 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -139.6 67.64 37.06 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.654 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 86.3 Cg_endo -100.76 84.9 0.04 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.618 0 C-N-CA 116.682 -1.745 . . . . 0.0 109.522 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -151.43 -45.78 0.11 Allowed 'General case' 1 C--N 1.213 -5.362 0 CA-C-N 110.311 -3.131 . . . . 0.0 102.938 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.491 ' HA ' HD21 ' A' ' 21' ' ' LEU . 87.4 m -63.6 -46.1 87.34 Favored 'General case' 0 N--CA 1.386 -3.628 0 CA-C-N 112.933 -1.939 . . . . 0.0 105.824 163.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.7 tmtt? -61.18 -50.28 73.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.239 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 57.9 mt-10 -59.79 -43.93 94.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 118.274 -1.371 . . . . 0.0 112.348 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.15 -50.87 71.41 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -63.1 -42.52 96.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.333 0.587 . . . . 0.0 110.414 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.22 -44.84 84.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.054 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 68.5 m -70.39 -40.19 74.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.736 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.78 89.83 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.26 0.552 . . . . 0.0 110.956 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 62.0 m-85 -112.73 41.39 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.169 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 62' ' ' SER . 12.7 mmmm -59.7 -37.3 78.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.112 177.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.62 11.15 15.78 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.807 0.443 . . . . 0.0 111.024 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 47.7 p90 -39.51 132.96 1.49 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.0 -48.18 4.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.515 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.1 p-10 -118.81 9.7 12.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.843 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.5 mp -99.7 119.17 47.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.615 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.0 t -121.22 131.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.737 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.69 130.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.513 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.3 pt -125.4 156.63 34.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.127 0.489 . . . . 0.0 110.562 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -118.23 134.91 54.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -160.57 -169.22 2.36 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.6 m -64.32 2.35 0.61 Allowed 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 127.169 2.188 . . . . 0.0 114.674 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.43 -22.32 0.0 OUTLIER Glycine 0 N--CA 1.511 3.64 0 C-N-CA 126.358 1.932 . . . . 0.0 116.929 -174.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.7 OUTLIER -56.42 -36.82 69.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.337 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.04 125.74 7.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.59 -51.6 68.7 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.1 pt -75.49 -30.72 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.375 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 43.7 mt-10 -65.52 -41.86 92.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.825 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.576 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.9 t0 -60.21 -51.27 70.27 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.991 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -59.41 -44.36 92.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 88' ' ' ILE . 22.7 m-80 -61.2 -40.32 93.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.92 0.39 . . . . 0.0 111.774 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 63.4 mm-40 -62.79 -46.45 87.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 99.5 m -62.15 -43.15 99.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.085 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.0 pt -65.68 -27.72 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.032 0.444 . . . . 0.0 110.316 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.99 -20.28 74.51 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.713 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -105.3 -23.58 12.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 60.0 m-85 -75.2 149.57 38.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -97.11 -15.48 20.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -139.83 160.91 58.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.808 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -52.91 143.19 49.99 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 111.778 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 42.7 p90 -137.57 156.16 48.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.439 0.638 . . . . 0.0 111.687 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 154' ' ' ILE . 1.5 tm? -86.86 133.87 33.59 Favored 'General case' 0 C--O 1.189 -2.131 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.057 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.7 t -107.03 128.54 61.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.141 0.576 . . . . 0.0 109.756 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 5' ' ' ILE . 4.4 m -130.53 161.53 40.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.495 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 70.2 m -99.73 144.28 28.98 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.731 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.514 ' O ' HD22 ' A' ' 29' ' ' LEU . 63.6 m -88.03 -1.48 58.02 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -108.32 7.78 27.36 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 65.9 mt -81.44 114.91 20.5 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.176 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.35 112.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 173.58 176.95 0.12 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.0 tp -84.21 103.06 13.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -96.98 -3.84 40.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.686 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -59.77 -45.01 93.58 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.057 0.456 . . . . 0.0 111.778 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -79.15 -23.57 43.88 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.365 0.602 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.716 ' O ' HG12 ' A' ' 113' ' ' ILE . 35.1 mm -68.98 -41.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.395 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.07 -46.55 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.376 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.22 -42.42 99.29 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.256 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.4 m -64.76 -41.71 95.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.55 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.8 mm -64.21 -49.96 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.008 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.41 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 64.8 t -61.6 -47.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.769 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.41 -46.42 88.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.823 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CE2' HD11 ' A' ' 120' ' ' ILE . 67.0 t80 -63.43 -46.51 86.01 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.795 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.62 -48.3 81.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.907 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.418 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 23.1 m-85 -63.21 -33.79 76.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.427 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.01 -46.92 87.09 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.286 0.565 . . . . 0.0 109.676 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.8 mt -64.18 -48.58 85.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.577 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -65.55 -26.53 67.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.413 -178.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.49 99.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.57 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 19.0 ptpt -82.24 -37.0 26.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.669 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 127' ' ' VAL . 85.9 m -132.65 91.72 29.2 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.15 -17.44 38.73 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 123.379 2.72 . . . . 0.0 112.921 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.75 -32.27 73.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 124' ' ' THR . 9.9 p -73.33 127.64 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 45.0 mt-10 -122.19 2.9 9.83 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.193 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.51 155.23 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.971 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.8 tp -137.58 146.1 43.63 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.93 137.12 53.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.338 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 113' ' ' ILE . 98.9 t -114.24 115.77 50.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.379 0.609 . . . . 0.0 109.615 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.5 ptm -145.9 156.61 43.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.785 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.637 HG12 ' HB2' ' A' ' 152' ' ' ALA . 22.2 pt -131.5 158.39 75.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.652 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--O 1.239 0.546 0 C-N-CA 122.411 2.074 . . . . 0.0 111.706 179.629 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.442 -0.85 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 141.65 48.54 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.039 1.826 . . . . 0.0 111.252 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.637 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -114.69 -5.11 12.7 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.295 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.25 -116.95 0.45 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.557 -1.306 . . . . 0.0 113.176 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.628 HD12 HD11 ' A' ' 96' ' ' LEU . 25.2 pt -119.05 161.15 18.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.991 0.424 . . . . 0.0 111.768 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.609 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.7 t-20 -120.18 156.02 31.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.118 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 81.3 t -124.25 130.27 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 122.253 0.221 . . . . 0.0 110.75 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.517 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.7 m -135.52 155.16 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.055 0.455 . . . . 0.0 111.346 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.536 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.6 m -97.06 157.45 34.97 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.187 174.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.34 69.22 7.26 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.873 2.382 . . . . 0.0 111.731 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.31 169.58 10.27 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.918 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -110.22 22.07 15.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.622 0.725 . . . . 0.0 109.606 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -170.27 -176.32 39.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.509 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -72.22 146.17 47.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.091 0.446 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.536 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 19.9 pt20 -133.37 166.6 22.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -173.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.47 127.62 33.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.763 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.13 132.15 53.15 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.65 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.431 ' HG3' HG21 ' A' ' 120' ' ' ILE . 45.8 mm-40 -93.49 163.05 13.72 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.641 0.734 . . . . 0.0 112.207 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.4 mm -116.16 127.77 73.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.442 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.8 ttp -131.19 132.86 45.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.911 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 133' ' ' MET . 78.8 t -107.87 131.78 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.163 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.648 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 39.2 pt -114.55 172.62 3.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -117.97 8.02 12.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.352 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.648 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.1 pm0 -104.32 134.67 47.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.708 0.766 . . . . 0.0 110.828 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.73 151.05 19.72 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.536 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 102' ' ' LEU . 7.6 pt -110.37 146.16 15.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.436 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.34 111.8 24.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -110.12 153.02 25.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.747 HG23 ' HB2' ' A' ' 183' ' ' ASP . 92.6 mt -110.73 119.59 59.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -176.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -114.4 -24.8 8.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.561 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.1 p -128.26 163.96 23.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.695 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -61.8 -32.46 72.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.18 -37.54 85.63 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.366 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.747 ' HB2' HG23 ' A' ' 178' ' ' ILE . 57.3 m-20 -60.89 -35.28 76.24 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.007 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 178' ' ' ILE . 96.0 mt -60.02 -46.2 90.27 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.87 0.843 . . . . 0.0 109.184 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.625 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 65.7 tttm -65.82 -40.05 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.505 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 189' ' ' MET . 10.5 tt -64.13 -44.36 92.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 0.0 110.187 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.06 -43.03 99.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.332 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -70.33 -29.74 66.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.064 0.459 . . . . 0.0 110.607 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 186' ' ' LEU . 60.0 ttm -61.87 -47.91 82.9 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.325 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -70.1 -31.38 68.91 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.768 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.492 HD13 ' SG ' ' A' ' 25' ' ' CYS . 83.5 mt -62.11 -45.02 95.34 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.339 0.59 . . . . 0.0 110.678 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.27 178.351 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 59.2 ttm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.517 ' HA ' HG13 ' A' ' 42' ' ' VAL . 63.6 m-20 -103.94 164.6 11.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.614 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -114.7 129.79 56.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.178 0.513 . . . . 0.0 111.168 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.2 tm? -103.57 119.27 38.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 98' ' ' VAL . 68.6 mt -116.6 115.69 49.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.138 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.568 ' CE ' HD22 ' A' ' 84' ' ' LEU . 47.2 mtt -89.66 97.47 11.21 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 122.48 1.133 . . . . 0.0 113.591 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.86 110.62 19.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.07 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.78 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -178.481 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 N--CA 1.478 0.571 0 CA-C-O 121.064 0.36 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.519 HD21 ' CB ' ' A' ' 59' ' ' TYR . 10.8 mp -79.69 6.31 11.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.47 125.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.608 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -109.54 146.09 35.23 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.647 0.737 . . . . 0.0 112.386 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 184' ' ' LEU . 96.4 mt -129.45 124.71 34.75 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.848 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 192' ' ' LYS . 79.6 m 65.66 -74.32 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.732 0.645 . . . . 0.0 112.418 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.9 -68.96 0.55 Allowed Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.529 -0.843 . . . . 0.0 114.221 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 98.5 mtt180 -115.76 172.86 6.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 112.349 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.4 m -71.84 154.47 41.25 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.466 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -42.21 20.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.436 1.094 . . . . 0.0 111.219 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.1 tp -58.18 -48.2 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 19.0 t70 -63.74 -40.01 95.7 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.036 0.446 . . . . 0.0 110.584 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 7.0 m-30 -62.13 -37.4 85.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.865 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.45 -43.66 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.701 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.4 t -64.62 -42.18 94.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.643 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -50.04 -54.99 27.35 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.12 -38.09 9.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.205 1.27 . . . . 0.0 112.583 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 HG11 ' A' ' 98' ' ' VAL . 91.1 mt -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.967 0.413 . . . . 0.0 111.405 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.604 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.5 tt -63.09 -46.88 85.29 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.07 -12.93 60.03 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 p -74.62 -176.75 2.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.932 0.396 . . . . 0.0 110.803 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.28 -9.51 3.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.883 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 2' ' ' ASP . 69.0 t -64.51 133.11 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.171 0.51 . . . . 0.0 110.588 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -80.26 -68.3 0.69 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.988 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -111.12 148.38 32.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.405 0.621 . . . . 0.0 111.217 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.9 mm -108.47 117.12 53.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.765 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.24 113.83 27.23 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -95.23 116.3 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.427 0 CA-C-O 121.657 0.741 . . . . 0.0 110.042 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.6 120.6 29.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.826 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 7' ' ' ALA . 76.0 p -125.61 160.16 30.32 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.254 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.9 m -109.66 150.44 41.26 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.999 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.27 -27.6 75.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.103 2.536 . . . . 0.0 111.801 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -81.05 -6.62 59.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.476 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.8 66.34 40.58 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.9 Cg_endo -109.24 85.79 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.842 0 CA-C-N 120.713 1.29 . . . . 0.0 110.159 168.092 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.0 mttt -146.45 -45.63 0.19 Allowed 'General case' 1 C--N 1.217 -5.187 0 CA-C-N 109.852 -3.34 . . . . 0.0 102.327 177.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 77.1 m -62.03 -47.99 82.3 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 112.033 -2.349 . . . . 0.0 105.989 162.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.32 -50.1 72.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.061 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.2 pt-20 -59.33 -35.15 73.32 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.858 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CB ' HD21 ' A' ' 21' ' ' LEU . 56.4 t80 -67.25 -51.61 51.02 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.932 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.454 HG23 ' CD2' ' A' ' 64' ' ' TYR . 97.7 mt -63.47 -44.91 99.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.536 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -58.77 -42.65 89.42 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.516 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 35.2 t -70.33 -43.2 70.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.847 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.48 89.73 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.798 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 68.3 m-85 -108.11 34.69 3.47 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.185 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.8 mmmt -62.64 -20.23 64.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.564 0.697 . . . . 0.0 110.128 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.7 10.84 16.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.938 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 52.9 p90 -46.78 126.48 8.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -104.34 -49.37 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.604 HD21 ' HG ' ' A' ' 38' ' ' LEU . 24.9 p-10 -117.01 15.73 15.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.255 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 78.8 mt -105.32 127.58 59.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.248 0.547 . . . . 0.0 110.851 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.03 132.98 68.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.83 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.61 130.96 60.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.484 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.4 155.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 122.038 0.923 . . . . 0.0 112.372 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -111.13 132.61 54.15 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.189 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 2.6 t -161.14 -172.05 3.28 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.8 m -66.69 2.08 1.51 Allowed 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 127.236 2.214 . . . . 0.0 114.68 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.11 -23.98 0.0 OUTLIER Glycine 0 N--CA 1.51 3.596 0 C-N-CA 126.237 1.875 . . . . 0.0 117.038 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -55.38 -35.3 65.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.18 121.77 5.51 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.29 -50.44 73.61 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.9 mt -65.99 -43.62 92.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.585 0.707 . . . . 0.0 110.172 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.1 -44.12 91.91 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.295 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 33.7 t0 -62.07 -48.15 81.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.282 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -53.76 -41.54 67.27 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.861 177.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.586 ' O ' HG12 ' A' ' 88' ' ' ILE . 28.0 m-80 -60.09 -43.99 95.12 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.365 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 53.3 mm-40 -65.67 -41.91 91.93 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.264 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 84' ' ' LEU . 26.1 pt -66.23 -25.12 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.335 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.18 92.28 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.121 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -80.75 -8.99 59.84 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -119.81 145.97 46.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.4 m -115.73 10.73 15.5 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -133.36 157.65 77.6 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.121 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.84 146.05 64.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.195 1.93 . . . . 0.0 111.557 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -139.2 158.26 44.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.686 HD21 HD12 ' A' ' 154' ' ' ILE . 27.0 tp -86.27 140.62 29.93 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.928 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 60.3 t -115.17 131.34 67.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' A' ' 5' ' ' ILE . 11.0 m -126.97 157.02 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.691 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 36.3 t -99.71 136.5 39.54 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.8 p -64.54 -34.03 77.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -88.79 1.95 54.37 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.629 HD22 HD13 ' A' ' 175' ' ' ILE . 70.3 mt -91.26 114.11 26.55 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.757 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -121.88 130.29 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -176.91 -178.08 0.82 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.97 71.7 1.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.694 ' HA ' HD12 ' A' ' 109' ' ' ILE . 58.6 mtpt -79.98 -8.05 59.13 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.546 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.8 t -59.75 -45.94 90.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -82.97 -24.26 33.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.797 0.808 . . . . 0.0 110.169 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 106' ' ' LYS . 78.6 mt -65.63 -39.24 84.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.03 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 106' ' ' LYS . 60.3 mt -57.09 -46.47 84.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.279 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -61.66 -43.9 97.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.12 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -63.98 -40.77 97.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.738 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.693 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.01 -49.11 85.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.217 0.532 . . . . 0.0 110.373 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.507 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.7 t -62.48 -46.83 95.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.244 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.61 -43.81 98.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.113 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD2' ' HG3' ' A' ' 169' ' ' MET . 37.5 t80 -66.77 -42.75 85.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.147 0.498 . . . . 0.0 110.287 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.2 t80 -57.46 -47.3 82.2 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.333 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.507 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 39.8 m-85 -67.95 -30.75 70.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.39 -39.79 95.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -65.34 -42.33 93.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.409 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.922 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.418 ' N ' ' HE3' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -57.33 -38.5 74.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.67 177.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.48 91.17 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.561 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -88.59 -37.39 15.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 111.612 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.6 m -141.27 92.06 8.49 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.411 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.262 2.641 . . . . 0.0 112.295 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.39 -30.47 70.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.463 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.544 HG22 ' HE3' ' A' ' 165' ' ' LYS . 61.9 t -67.05 127.45 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.087 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 158' ' ' SER . 30.1 mt-10 -102.44 -34.11 9.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.234 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -131.45 165.6 23.17 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -140.22 134.25 30.85 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.807 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.51 135.93 51.03 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.671 HG21 HD12 ' A' ' 113' ' ' ILE . 78.3 t -117.24 118.61 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.68 41.92 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.747 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.577 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 34.8 pt -124.58 163.28 37.71 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 10.7 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 121.82 1.68 . . . . 0.0 110.772 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.444 -0.761 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.96 144.92 48.87 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.271 1.981 . . . . 0.0 110.977 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -128.79 16.65 6.34 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.785 0.326 . . . . 0.0 111.525 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.18 -114.86 0.33 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.89 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.686 HD12 HD21 ' A' ' 96' ' ' LEU . 13.0 pt -134.45 160.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.239 -0.481 . . . . 0.0 110.348 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.482 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.7 t30 -118.19 155.91 29.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.69 130.36 73.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 122.421 0.289 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.53 147.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.134 0.492 . . . . 0.0 111.13 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 8.4 t -99.28 158.45 32.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 28.7 Cg_exo -62.98 93.93 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.373 1.382 . . . . 0.0 110.669 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 163' ' ' TYR . 20.6 pttp -78.01 174.83 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.843 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -124.08 -68.81 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.069 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -113.46 47.23 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.502 ' HA ' ' HD2' ' A' ' 160' ' ' LYS . 91.8 m-85 74.9 148.9 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.566 0.746 . . . . 0.0 110.542 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 158' ' ' SER . 26.7 pt20 -133.84 165.11 25.75 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.544 ' HE3' HG22 ' A' ' 127' ' ' VAL . 64.9 tttp -67.85 121.97 17.14 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.204 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -123.38 126.74 47.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.848 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -94.37 163.05 13.58 Favored 'General case' 0 CA--C 1.469 -2.172 0 CA-C-O 121.895 0.855 . . . . 0.0 113.218 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.0 129.51 69.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.006 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.496 ' SD ' HG23 ' A' ' 171' ' ' ILE . 15.0 tmm? -131.31 138.24 49.15 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.738 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.22 131.09 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.921 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.572 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 2.2 pp -114.63 178.52 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.889 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -115.81 3.36 13.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.572 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 1.8 pm0 -98.83 136.85 38.26 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.81 0.814 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.68 139.27 32.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.965 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.629 HD13 HD22 ' A' ' 102' ' ' LEU . 1.8 pp -101.93 155.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -98.99 107.31 19.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -92.3 124.92 36.72 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.634 HG21 HD23 ' A' ' 184' ' ' LEU . 85.5 mt -108.86 110.01 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.725 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -124.4 -13.72 7.07 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 43.1 p -127.04 167.75 15.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.381 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -65.09 -35.18 80.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.83 -42.45 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.054 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.568 ' HB2' HG23 ' A' ' 178' ' ' ILE . 73.2 m-20 -62.28 -37.8 86.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.143 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.634 HD23 HG21 ' A' ' 178' ' ' ILE . 95.5 mt -60.26 -46.79 88.6 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.765 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 189' ' ' MET . 28.9 mtpp -64.93 -38.41 90.89 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.368 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.98 -50.5 73.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.154 0.502 . . . . 0.0 110.078 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.35 -41.92 88.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.435 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.503 ' CG ' ' HA ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER -68.98 -30.8 69.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.4 mtp -64.61 -41.57 96.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.747 0.308 . . . . 0.0 111.684 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -77.84 -33.02 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.923 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 190' ' ' LEU . 86.9 mt -61.28 -47.42 86.1 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.414 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mtmm . . . . . 0 C--N 1.311 -1.107 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.988 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.637 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 36.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -90.37 166.2 13.42 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.021 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -123.29 134.01 54.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.66 127.28 52.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.148 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.619 ' HA ' HG22 ' A' ' 98' ' ' VAL . 61.4 mt -118.11 106.83 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttm -80.5 101.53 9.15 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 121.898 0.856 . . . . 0.0 111.021 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -115.54 97.72 6.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.35 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.984 178.644 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 CA--C 1.538 0.678 0 N-CA-C 113.546 0.556 . . . . 0.0 113.546 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 49.7 mt -89.08 6.34 40.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.58 114.21 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 60.4 pttt -95.6 131.77 41.45 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.583 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 188' ' ' GLU . 61.9 tp -136.13 120.97 18.57 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.322 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.6 m 58.54 24.09 11.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.86 -31.36 4.57 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.223 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.722 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 95.8 mtt180 -126.39 157.54 38.25 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.787 1.294 . . . . 0.0 111.764 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.5 m -81.54 163.52 22.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.535 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 33' ' ' VAL . 84.9 mt -58.77 -39.7 81.79 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.592 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.7 tp -56.21 -47.47 80.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.245 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.683 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.1 t70 -65.02 -42.86 94.02 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.168 0.508 . . . . 0.0 110.634 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.722 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 30.8 m-85 -64.07 -36.94 85.66 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.427 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.513 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 79.1 t -70.07 -41.05 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 30' ' ' ILE . 59.8 t -61.47 -43.27 96.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.899 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 65.8 m -52.76 -52.46 64.31 Favored Pre-proline 0 CA--C 1.571 1.768 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 33' ' ' VAL . 51.9 Cg_exo -60.53 -42.46 40.24 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 121.758 1.639 . . . . 0.0 111.982 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.566 HD11 HG11 ' A' ' 98' ' ' VAL . 96.1 mt -68.2 -37.23 80.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.722 0.772 . . . . 0.0 110.585 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 69' ' ' ASN . 59.7 tp -58.33 -45.77 87.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.989 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.11 -1.61 58.17 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.414 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.627 ' HB2' HG21 ' A' ' 110' ' ' ILE . 60.3 p -75.69 175.4 8.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.9 ttmm -58.26 -27.01 63.62 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.493 0.717 . . . . 0.0 112.469 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG22 ' OG ' ' A' ' 40' ' ' SER . 30.7 m -59.94 154.51 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.16 -69.0 0.56 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.844 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -120.92 153.67 36.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.207 0.527 . . . . 0.0 111.16 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.8 mm -106.64 115.26 47.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 87.0 m-85 -104.91 116.09 31.39 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.719 HG21 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -94.97 116.05 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-O 121.574 0.702 . . . . 0.0 110.319 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.66 120.74 28.29 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.439 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.9 p -125.06 158.0 34.86 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.472 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 28.9 t -111.9 142.29 26.44 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.169 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 75.6 Cg_exo -55.48 -25.89 51.29 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.457 2.771 . . . . 0.0 111.949 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -75.84 -9.0 58.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -140.35 67.12 31.41 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-O 119.244 -0.408 . . . . 0.0 112.011 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 67.0 Cg_endo -104.68 85.26 0.02 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.781 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.413 170.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 97.6 mttt -147.63 -46.78 0.17 Allowed 'General case' 1 C--N 1.214 -5.308 0 CA-C-N 109.932 -3.304 . . . . 0.0 103.721 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.472 HG21 ' HB1' ' A' ' 7' ' ' ALA . 87.9 m -61.93 -47.43 84.96 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 164.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -62.68 -49.62 74.39 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.016 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.1 pt-20 -59.19 -37.73 78.12 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.876 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.48 -50.25 70.4 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 47' ' ' ILE . 94.7 mt -63.47 -41.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.601 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.546 ' OD1' HG11 ' A' ' 72' ' ' VAL . 92.7 m-20 -57.06 -45.73 83.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.866 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 58.3 m -71.32 -41.96 69.22 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.262 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 -38.91 92.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.328 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 70.3 m-85 -113.55 37.86 3.1 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.71 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 10.8 mmmm -62.47 -23.38 66.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.316 0.579 . . . . 0.0 110.758 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -92.55 11.28 26.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.332 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 53.0 p90 -43.25 128.6 4.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -101.36 -52.03 3.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.023 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.513 HD21 HD12 ' A' ' 38' ' ' LEU . 6.8 p-10 -119.48 14.31 12.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.71 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.52 125.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 59.3 t -125.42 133.17 69.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' A' ' 61' ' ' ASN . 7.2 p -104.5 134.47 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.2 pt -129.25 157.1 42.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.585 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -116.07 136.13 53.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 12.7 t -160.2 -172.4 3.58 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -66.73 3.81 0.95 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 127.543 2.337 . . . . 0.0 114.592 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.98 -20.73 0.0 OUTLIER Glycine 1 N--CA 1.517 4.099 0 C-N-CA 126.51 2.005 . . . . 0.0 116.947 -173.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 76' ' ' SER . 55.8 tptt -56.55 -39.78 73.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.26 122.37 6.09 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.15 -50.44 73.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.219 0.533 . . . . 0.0 111.718 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.3 -45.65 95.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.71 0.766 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 48.3 mt-10 -60.07 -42.48 94.65 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.83 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.79 -51.61 69.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.347 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.628 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.0 mm? -58.76 -43.56 90.35 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.629 ' O ' HG12 ' A' ' 88' ' ' ILE . 30.0 m-80 -61.61 -39.93 93.02 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.332 0.587 . . . . 0.0 112.4 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 54.6 mm-40 -65.91 -42.21 90.47 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.506 -0.746 . . . . 0.0 109.009 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.5 m -61.73 -43.21 99.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.961 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.629 HG12 ' O ' ' A' ' 85' ' ' ASN . 33.1 pt -63.64 -27.1 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.687 0.28 . . . . 0.0 110.344 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.73 -24.87 64.88 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.566 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -99.93 2.87 44.08 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.85 135.6 54.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 112.285 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -103.66 -2.35 26.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.1 mt-10 -131.55 160.83 65.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.1 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.637 ' O ' ' HG3' ' A' ' 1' ' ' MET . 48.7 Cg_endo -67.31 157.67 60.66 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.445 2.096 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -144.71 159.25 43.14 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.367 0.603 . . . . 0.0 111.699 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 3' ' ' ALA . 21.9 tp -86.64 145.98 26.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.726 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 95.8 t -116.63 130.11 72.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 124.07 0.948 . . . . 0.0 108.601 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.4 m -131.77 163.97 35.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.26 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 46.9 t -99.8 139.71 35.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.4 p -89.6 -1.3 57.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.01 9.54 13.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.517 ' O ' HD12 ' A' ' 102' ' ' LEU . 2.8 pp -92.53 143.48 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.938 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 18.0 tt -140.26 132.41 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.074 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 18.9 t-20 173.28 167.61 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.163 0.985 . . . . 0.0 108.415 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tt -80.19 88.32 5.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.581 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -101.82 3.6 39.52 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.5 p -52.76 -36.04 57.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.429 ' CG ' HD12 ' A' ' 109' ' ' ILE . 21.5 pttp -73.15 -28.51 62.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.254 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.751 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.0 mp -61.4 -43.05 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.304 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.627 HG21 ' HB2' ' A' ' 40' ' ' SER . 5.2 mm -54.16 -49.82 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 121.821 0.819 . . . . 0.0 109.743 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 62.3 m-80 -61.98 -42.93 99.69 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.662 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -61.81 -38.35 87.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.726 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -60.83 -49.15 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.11 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.54 -47.76 91.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.863 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.08 -46.91 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.731 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.662 ' CE2' HD11 ' A' ' 120' ' ' ILE . 45.2 t80 -66.53 -46.05 77.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.637 0.256 . . . . 0.0 111.483 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 62.9 t80 -58.19 -47.58 83.01 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.073 0.464 . . . . 0.0 110.694 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -62.84 -37.36 86.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.204 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 91.7 m -63.75 -40.15 96.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.024 0.44 . . . . 0.0 110.568 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.662 HD11 ' CE2' ' A' ' 116' ' ' TYR . 81.2 mt -65.45 -46.02 91.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.138 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 52.8 mtmt -63.08 -37.52 87.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.218 0.533 . . . . 0.0 110.531 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.61 91.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.293 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -82.2 -35.0 28.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.024 0.44 . . . . 0.0 111.513 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 66.4 m -137.24 97.51 10.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.447 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.04 -20.52 54.13 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.412 2.742 . . . . 0.0 113.036 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.77 -30.39 71.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.787 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.447 HG22 ' HE3' ' A' ' 165' ' ' LYS . 67.5 t -73.77 125.38 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.82 2.58 7.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.995 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -143.0 156.08 44.78 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.962 0.41 . . . . 0.0 111.468 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -140.39 133.1 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.404 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -120.37 129.98 54.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.86 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.722 HG21 ' CD1' ' A' ' 113' ' ' ILE . 60.8 t -115.01 121.74 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 6.5 ptm -145.89 156.8 43.79 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.661 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 152' ' ' ALA . 14.3 pt -128.54 156.52 77.09 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.633 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.219 1.946 . . . . 0.0 111.95 -179.669 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 120.823 0.344 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.26 153.61 56.46 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.843 2.362 . . . . 0.0 111.792 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.694 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -102.32 -7.69 21.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.117 0.484 . . . . 0.0 111.371 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.86 -88.9 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.749 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.668 HD11 HG13 ' A' ' 113' ' ' ILE . 16.9 pt -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.237 0.541 . . . . 0.0 112.308 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.563 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 9.9 t-20 -120.65 153.82 36.35 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.928 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.91 131.18 72.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 O-C-N 122.368 -0.207 . . . . 0.0 111.141 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.32 155.07 36.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.192 0.52 . . . . 0.0 111.141 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.445 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 72.3 m -97.51 158.79 32.51 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 84.5 Cg_endo -75.61 59.39 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.108 1.872 . . . . 0.0 112.484 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -117.87 138.5 52.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.95 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -72.54 133.71 44.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.83 -130.35 9.75 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.936 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.99 141.68 46.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.353 0.597 . . . . 0.0 111.635 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.445 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 22.9 pt20 -134.91 162.72 31.63 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.664 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.447 ' HE3' HG22 ' A' ' 127' ' ' VAL . 63.9 tttp -60.68 128.13 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.4 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -124.76 131.55 53.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 120' ' ' ILE . 28.8 mm-40 -97.35 163.15 13.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 131' ' ' ALA . 50.0 mm -115.52 131.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.256 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.6 ttp -133.42 132.67 41.41 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.967 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.6 t -112.49 131.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 173' ' ' GLU . 50.7 pt -115.63 176.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.742 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.52 -3.27 31.03 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.205 0.526 . . . . 0.0 110.861 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.569 ' HB2' HD12 ' A' ' 171' ' ' ILE . 56.7 mp0 -98.83 130.47 45.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.922 0.868 . . . . 0.0 112.775 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 174' ' ' LEU . 1.4 pt? -97.72 153.83 17.99 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.754 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.08 149.18 14.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.429 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.48 115.2 29.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.52 150.29 24.06 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.616 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.652 HG23 ' HB2' ' A' ' 183' ' ' ASP . 88.1 mt -116.28 117.66 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.998 0.427 . . . . 0.0 111.28 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -120.73 -18.9 7.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.121 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.3 p -128.96 164.21 23.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.403 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -60.87 -29.5 69.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.262 0.553 . . . . 0.0 109.531 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.58 -41.35 98.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.335 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.652 ' HB2' HG23 ' A' ' 178' ' ' ILE . 72.6 m-20 -64.21 -28.4 69.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 96.4 mt -61.54 -45.25 94.96 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.546 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -62.09 -42.66 99.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.747 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.43 -49.84 76.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.456 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.76 -42.54 99.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 8.0 pt-20 -68.15 -33.98 75.48 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.9 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -63.67 -41.42 98.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 111.35 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -77.2 -31.17 55.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.131 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 69.3 tp -64.42 -45.08 89.1 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.483 0.658 . . . . 0.0 110.165 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 63.5 tttm . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.654 176.447 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' HG23 ' A' ' 42' ' ' VAL . 54.2 tpp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.639 0.257 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -113.93 166.19 11.83 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.533 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -114.6 130.86 56.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.261 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.9 tp -105.42 124.21 49.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.614 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -118.71 101.05 11.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.7 ptm -91.76 106.2 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.851 1.31 . . . . 0.0 111.984 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.05 103.75 11.21 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.865 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 N-CA-C 114.346 0.864 . . . . 0.0 114.346 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 59' ' ' TYR . 44.4 mt -92.69 5.87 49.5 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.723 HG21 HD21 ' A' ' 184' ' ' LEU . 77.2 mt -76.73 118.55 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.93 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -76.75 130.62 37.96 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.056 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 188' ' ' GLU . 81.8 mt -127.75 125.43 39.91 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.522 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.8 m 54.31 28.88 9.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.21 35.32 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.764 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 98.8 mtt180 -129.77 153.35 48.3 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 118.181 0.99 . . . . 0.0 112.435 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 61.2 m -80.16 164.4 23.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.32 -39.24 82.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.793 0.33 . . . . 0.0 110.87 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.453 HG13 HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -62.75 -39.76 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.728 178.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 21.2 m-20 -62.29 -40.93 97.9 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.153 0.501 . . . . 0.0 110.497 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 10.1 m-85 -63.04 -37.14 86.02 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.693 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.67 -42.41 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 0.0 110.766 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 30' ' ' ILE . 67.7 t -63.35 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.777 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.0 m -53.58 -51.94 71.57 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.37 -38.17 35.68 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 121.531 1.487 . . . . 0.0 112.082 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD11 HG11 ' A' ' 98' ' ' VAL . 93.1 mt -68.45 -40.04 81.23 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.401 0.619 . . . . 0.0 110.782 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.65 -44.04 89.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.398 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -84.03 -14.73 49.87 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.538 ' OG ' HG12 ' A' ' 42' ' ' VAL . 85.5 p -74.37 172.35 12.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.973 0.416 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -65.49 -7.06 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.7 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG12 ' OG ' ' A' ' 40' ' ' SER . 12.2 p -71.24 144.98 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 O-C-N 122.183 -0.323 . . . . 0.0 110.771 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -82.33 -72.37 0.44 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -104.57 147.08 28.01 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.528 0.68 . . . . 0.0 111.656 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.09 113.66 44.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.61 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -103.31 115.17 30.04 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -95.21 116.46 36.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.7 0.762 . . . . 0.0 110.368 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -89.9 118.8 29.75 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.245 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.4 p -129.63 158.15 40.13 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 63.3 m -105.63 148.84 37.11 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.376 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 52.6 Cg_exo -58.07 -24.99 68.79 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.06 2.507 . . . . 0.0 111.085 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -77.92 -5.89 52.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.185 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -139.84 66.87 34.47 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 119.401 -0.333 . . . . 0.0 111.879 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 96.1 Cg_endo -105.8 86.57 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.813 0 CA-C-N 120.982 1.386 . . . . 0.0 109.653 168.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 mmtm -155.61 -46.18 0.08 Allowed 'General case' 1 C--N 1.212 -5.405 0 CA-C-N 109.709 -3.405 . . . . 0.0 102.443 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 21' ' ' LEU . 97.9 m -63.99 -49.31 72.99 Favored 'General case' 0 N--CA 1.381 -3.9 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 162.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.666 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.59 -51.28 66.0 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.11 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.3 pt-20 -63.66 -29.4 70.64 Favored 'General case' 0 C--N 1.37 1.469 0 C-N-CA 116.639 -2.024 . . . . 0.0 112.907 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CD2' HD22 ' A' ' 21' ' ' LEU . 55.8 t80 -64.96 -50.37 66.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.434 0.635 . . . . 0.0 110.623 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 30' ' ' ILE . 98.0 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.0 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -57.63 -45.97 84.75 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.902 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 42.3 t -67.04 -42.45 84.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.547 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.03 92.85 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.166 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 45.8 m-85 -115.84 37.98 3.46 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.059 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.6 mmmm -60.68 -24.21 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.162 0.506 . . . . 0.0 111.057 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.67 10.47 25.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.609 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.2 p90 -45.02 131.4 7.36 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -102.5 -48.92 4.0 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.597 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -118.28 16.35 13.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.786 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.9 mt -107.62 131.06 58.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.512 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.3 t -125.17 133.05 70.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.27 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.43 130.46 56.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.314 0.578 . . . . 0.0 110.313 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.88 156.53 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 CA-C-O 121.967 0.889 . . . . 0.0 111.37 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.01 130.76 55.49 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.435 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 11.2 t -158.06 -173.24 4.25 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.734 0.778 . . . . 0.0 112.891 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 49.2 m -71.53 2.09 5.57 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 126.472 1.909 . . . . 0.0 114.637 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.67 -23.73 0.0 OUTLIER Glycine 1 N--CA 1.521 4.331 0 C-N-CA 126.462 1.982 . . . . 0.0 117.393 -173.664 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 12.1 tmtt? -56.17 -36.48 68.37 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 172.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.73 122.4 6.2 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -60.27 -51.05 71.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 pt -77.68 -28.64 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.802 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.91 -41.68 99.53 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.607 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 14.0 t0 -60.2 -51.48 69.4 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.049 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -57.71 -43.71 85.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.538 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.5 m-80 -60.29 -41.33 93.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 70.3 mm-40 -63.95 -46.95 82.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.375 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.1 m -62.71 -42.99 99.93 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.351 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 85' ' ' ASN . 37.2 pt -65.46 -30.6 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.962 0.41 . . . . 0.0 110.431 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.44 -39.29 95.65 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.245 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -82.01 -36.78 27.46 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 75.2 m-85 -71.31 146.53 48.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.19 0.519 . . . . 0.0 111.801 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -102.06 -10.61 19.55 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.369 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.46 160.32 64.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.667 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.77 142.45 41.53 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 123.27 2.647 . . . . 0.0 112.307 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -142.99 155.62 44.7 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.057 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 155' ' ' ASN . 42.4 tp -86.37 143.91 27.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.221 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 66.5 t -115.49 133.79 60.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 108.93 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 37' ' ' LEU . 11.1 m -129.98 164.82 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.371 0.605 . . . . 0.0 112.225 -178.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 50.6 m -99.21 152.79 19.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.0 p -73.61 -10.79 60.07 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.605 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 45.4 p-10 -117.23 16.55 14.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.58 ' CD1' ' HB2' ' A' ' 99' ' ' SER . 11.0 mp -61.54 153.13 28.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 111.798 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.89 174.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.686 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 105' ' ' LEU . 65.6 t30 -63.68 162.59 12.9 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.013 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 104' ' ' ASN . 51.5 tp 82.52 3.28 1.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.576 1.151 . . . . 0.0 110.213 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -94.02 -1.23 54.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.604 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.501 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -62.21 -24.73 67.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.155 0.502 . . . . 0.0 111.786 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.98 -20.91 61.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.15 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.455 HD11 ' HG3' ' A' ' 173' ' ' GLU . 28.5 mm -68.57 -41.42 82.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 107' ' ' SER . 61.7 mt -60.99 -44.46 98.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.41 -46.84 86.77 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.03 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.3 m -64.15 -42.62 96.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.026 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.637 HG13 ' N ' ' A' ' 114' ' ' VAL . 36.0 pt -67.76 -43.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.637 ' N ' HG13 ' A' ' 113' ' ' ILE . 62.9 t -62.44 -49.15 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.824 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.55 -45.36 93.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.464 -0.494 . . . . 0.0 112.247 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.709 ' CE2' HD11 ' A' ' 120' ' ' ILE . 54.2 t80 -65.84 -46.12 79.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.623 0.249 . . . . 0.0 110.918 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -58.8 -47.9 83.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.408 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 15.8 m-85 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.081 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 93.2 m -63.72 -40.37 96.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.672 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -66.85 -47.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 124' ' ' THR . 54.6 pttt -65.15 -26.26 68.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.302 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.04 99.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.918 0.39 . . . . 0.0 110.455 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 65.3 pttt -83.24 -34.04 25.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 50.7 m -139.52 97.42 8.34 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.663 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.53 -11.77 31.87 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.933 2.422 . . . . 0.0 112.856 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.29 -32.7 73.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.547 HG21 ' HG2' ' A' ' 167' ' ' GLU . 7.6 p -87.29 122.41 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.975 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 41.6 mt-10 -127.38 19.15 6.89 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -142.19 148.75 38.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.0 tp -139.63 148.08 41.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.816 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.8 136.18 52.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.09 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' A' ' 152' ' ' ALA . 99.2 t -111.12 115.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.244 0.545 . . . . 0.0 109.722 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -145.61 157.46 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.775 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 152' ' ' ALA . 17.0 pt -134.97 155.51 79.14 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.24 0.584 0 C-N-CA 122.356 2.037 . . . . 0.0 110.797 176.402 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.34 143.92 60.07 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.183 1.922 . . . . 0.0 110.456 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.554 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -112.27 4.98 18.09 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 164.54 -97.98 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 118.759 -1.686 . . . . 0.0 114.346 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 96' ' ' LEU . 15.0 pt -130.17 160.85 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.695 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.0 m-20 -123.74 158.78 30.9 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.46 129.58 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.29 156.04 40.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.638 0.732 . . . . 0.0 112.06 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 33.3 t -98.28 146.48 31.61 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.528 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.01 66.99 4.1 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.691 2.261 . . . . 0.0 112.549 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.37 175.81 6.79 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -104.7 -11.63 16.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.268 0.556 . . . . 0.0 109.732 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -122.45 -156.28 9.61 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.838 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -106.7 134.34 49.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.342 0.591 . . . . 0.0 109.987 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.431 HE21 ' H ' ' A' ' 158' ' ' SER . 20.1 pm0 -121.2 167.19 12.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -55.18 130.08 40.71 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.321 0.581 . . . . 0.0 112.151 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -123.52 132.55 53.94 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.259 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.547 ' HG2' HG21 ' A' ' 127' ' ' VAL . 25.5 mm-40 -96.75 162.6 13.36 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 121.603 0.716 . . . . 0.0 111.967 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.019 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.0 ttp -128.74 129.94 46.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.266 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 133' ' ' MET . 89.6 t -102.23 129.3 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' A' ' 173' ' ' GLU . 50.0 pt -110.55 174.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.42 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.57 0.65 31.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.692 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 171' ' ' ILE . 79.1 mm-40 -98.51 139.38 34.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.776 0.798 . . . . 0.0 112.641 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.29 143.89 26.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.628 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.6 155.6 41.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.88 111.04 19.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.876 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.605 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 26.5 t-20 -91.02 109.58 20.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.474 ' HA ' ' OD2' ' A' ' 183' ' ' ASP . 51.4 mm -66.26 123.84 20.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.431 0.634 . . . . 0.0 112.652 -172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.45 -36.43 8.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.466 ' H ' ' HB3' ' A' ' 183' ' ' ASP . 61.5 p -137.72 165.74 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.599 0.237 . . . . 0.0 111.469 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 184' ' ' LEU . 15.1 mtmm -62.03 -37.37 84.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.641 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.44 -40.62 97.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.272 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 178' ' ' ILE . 38.8 t70 -64.57 -38.92 92.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.723 HD21 HG21 ' A' ' 22' ' ' ILE . 54.2 tp -59.3 -46.89 87.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.275 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.9 ttpt -62.5 -40.63 97.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.338 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.53 -49.03 79.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.294 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.499 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.79 -41.23 97.46 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.775 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.675 ' HB3' HD22 ' A' ' 24' ' ' LEU . 13.6 pt-20 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.855 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.61 -32.53 68.1 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.37 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.15 -28.66 63.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.761 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 85.6 mt -61.62 -44.99 95.96 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.491 0.662 . . . . 0.0 109.802 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.758 177.327 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' HG23 ' A' ' 42' ' ' VAL . 58.8 ttm . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -113.42 164.41 13.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -114.25 140.47 48.56 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.097 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 28.4 tp -115.63 120.61 39.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HA ' ' HB ' ' A' ' 98' ' ' VAL . 69.4 mt -111.71 108.72 26.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.528 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 60.4 ttm -80.25 104.8 11.05 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 121.643 0.735 . . . . 0.0 110.583 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -112.43 97.78 6.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.745 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.548 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.493 -179.691 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.476 0.492 0 CA-C-O 121.084 0.368 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 56' ' ' THR . 73.3 mt -92.3 14.05 17.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.09 125.71 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 61.3 mttp -95.28 133.64 38.95 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.819 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' O ' ' HE2' ' A' ' 32' ' ' TYR . 56.6 tp -130.08 121.5 26.5 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 113.316 -1.766 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.0 t 58.04 27.04 14.29 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.393 0.616 . . . . 0.0 110.73 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.31 -8.87 69.62 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.012 -0.614 . . . . 0.0 114.548 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.592 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 85.9 mtt180 -117.07 155.03 29.96 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 118.169 0.985 . . . . 0.0 110.717 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 72.2 m -82.08 163.15 22.24 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.834 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.503 HD21 ' CG1' ' A' ' 178' ' ' ILE . 83.7 mt -59.22 -44.48 92.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 110.256 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -62.75 -36.82 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.77 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.45 -45.23 91.82 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.337 0.589 . . . . 0.0 110.4 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 8.5 m-85 -65.72 -30.19 70.82 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 100' ' ' SER . 66.6 t -70.1 -43.23 79.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 120.649 0.261 . . . . 0.0 111.574 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.507 HG23 HD13 ' A' ' 30' ' ' ILE . 79.8 t -65.34 -43.58 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.541 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 67.5 m -50.59 -53.58 44.61 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 33.8 Cg_exo -62.4 -41.28 34.3 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.931 1.754 . . . . 0.0 112.286 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.87 -42.32 90.51 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.89 -45.37 94.87 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.757 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 35' ' ' SER . 64.1 pttt -80.98 -9.31 59.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.58 ' OG ' HG12 ' A' ' 42' ' ' VAL . 84.2 p -77.85 175.55 9.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 111.514 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.16 -22.12 60.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.141 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' OG ' ' A' ' 40' ' ' SER . 12.7 p -66.07 145.03 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.671 -177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -78.37 -79.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -102.6 152.48 21.13 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.451 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.4 mm -110.06 116.42 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.118 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 93.8 m-85 -106.93 117.09 33.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.639 HG21 HD13 ' A' ' 60' ' ' ILE . 94.7 mt -98.74 118.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.527 0.68 . . . . 0.0 110.576 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.23 116.4 24.39 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.795 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.483 HG23 HG22 ' A' ' 47' ' ' ILE . 66.3 p -127.28 162.87 25.22 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.028 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.5 p -129.44 157.25 76.9 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.906 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.69 -19.09 67.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.834 2.356 . . . . 0.0 110.896 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.92 -24.95 62.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.744 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 67.33 26.3 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.624 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.6 Cg_endo -103.87 85.45 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.683 0 C-N-CA 117.172 -1.419 . . . . 0.0 109.906 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.632 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 36.0 mmtm -148.99 -44.98 0.14 Allowed 'General case' 1 C--N 1.215 -5.272 0 CA-C-N 109.605 -3.452 . . . . 0.0 102.638 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.624 HG21 ' HB1' ' A' ' 7' ' ' ALA . 96.8 m -63.16 -47.77 81.26 Favored 'General case' 1 N--CA 1.379 -4.006 0 CA-C-N 112.307 -2.224 . . . . 0.0 105.773 163.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.08 -51.19 68.95 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.796 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.632 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 pt-20 -64.58 -30.73 71.75 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.341 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.91 -50.21 71.74 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.071 0.462 . . . . 0.0 111.18 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.639 HD13 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -62.68 -42.75 97.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.964 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -58.25 -41.38 84.08 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.574 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.671 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t -73.74 -43.31 59.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 111.233 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.53 90.8 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.337 0.589 . . . . 0.0 111.105 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.459 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 58.1 m-85 -114.44 42.59 2.07 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.002 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HG3' ' O ' ' A' ' 62' ' ' SER . 38.1 mtmm -59.82 -26.79 66.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.028 0.442 . . . . 0.0 110.971 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.42 10.13 18.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.055 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.479 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 53.8 p90 -44.59 122.77 3.27 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.47 -49.44 3.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.36 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -110.26 7.74 23.26 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.095 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 4.8 mp -100.31 119.62 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.257 0.551 . . . . 0.0 110.028 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 78.3 t -120.55 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.312 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.487 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.9 pt -123.66 154.74 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.161 0.505 . . . . 0.0 109.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -117.08 127.82 54.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 t -155.96 -167.98 2.63 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -67.81 2.41 1.98 Allowed 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 126.633 1.973 . . . . 0.0 114.22 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.19 -16.62 0.0 OUTLIER Glycine 0 N--CA 1.516 3.971 0 C-N-CA 126.693 2.092 . . . . 0.0 117.376 -175.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 14.2 tmtt? -58.61 -38.45 78.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.6 127.48 7.73 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.459 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -59.97 -49.91 75.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.093 0.473 . . . . 0.0 111.987 -176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.83 -47.49 90.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.547 0.689 . . . . 0.0 110.294 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 53.6 mt-10 -60.91 -43.28 98.79 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.784 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.528 ' CG ' ' HE2' ' A' ' 6' ' ' MET . 7.4 t0 -60.05 -50.77 72.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.116 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -59.62 -42.87 93.66 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.169 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 88' ' ' ILE . 96.4 m-20 -60.56 -42.02 95.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.257 0.551 . . . . 0.0 111.053 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 66.0 mm-40 -65.58 -45.65 82.46 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.0 m -63.57 -41.82 98.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.497 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 84' ' ' LEU . 38.1 pt -65.92 -29.88 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.081 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.41 96.56 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.941 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -71.9 -40.12 69.06 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.1 m-85 -79.01 154.08 29.77 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.8 m -113.24 -4.52 13.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 159' ' ' PRO . 40.0 mt-10 -132.74 156.02 80.55 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.275 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.44 140.0 64.41 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.207 2.604 . . . . 0.0 111.649 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.55 156.7 45.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.34 0.591 . . . . 0.0 110.748 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 154' ' ' ILE . 24.3 tp -87.53 144.4 26.72 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.029 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 93.7 t -107.14 125.89 63.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 60.8 t -130.47 141.11 47.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.5 m -96.09 142.49 28.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.782 174.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.549 ' HA ' HG21 ' A' ' 33' ' ' VAL . 67.9 m -89.45 0.78 56.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -104.93 -4.2 22.41 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 177' ' ' ASN . 75.2 mt -82.6 136.63 34.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.278 0.49 . . . . 0.0 110.599 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.8 pt -75.67 -174.24 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.953 0.406 . . . . 0.0 111.35 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -78.53 71.18 4.98 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.39 -3.84 4.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 11.7 ptmm? -88.38 -2.24 58.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.217 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 p -60.99 -41.57 96.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -80.43 -22.44 41.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.895 0.855 . . . . 0.0 109.725 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 113' ' ' ILE . 38.4 mm -67.7 -37.61 78.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.953 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 106' ' ' LYS . 64.4 mt -57.26 -50.0 78.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.064 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -70.74 -39.65 73.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.172 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.8 m -63.36 -42.95 98.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.07 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.2 mm -64.39 -44.78 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.8 t -60.44 -46.71 94.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.273 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.75 -46.1 91.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.657 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CE2' HD11 ' A' ' 120' ' ' ILE . 31.8 t80 -70.19 -41.82 73.2 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.2 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.5 t80 -59.18 -48.35 81.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 21.3 m-85 -62.88 -35.5 80.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.658 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.8 -47.5 86.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.966 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' A' ' 116' ' ' TYR . 70.5 mt -66.45 -49.37 75.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.484 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 16.0 ptmt -65.34 -25.85 67.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.965 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.56 98.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 120' ' ' ILE . 63.6 pttt -85.69 -36.83 19.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.309 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 127' ' ' VAL . 32.0 m -130.9 96.21 23.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.154 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.91 -14.2 40.6 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.918 2.412 . . . . 0.0 113.197 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.47 -32.94 74.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.889 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.587 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -75.79 120.53 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.606 0.717 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 45.8 mt-10 -123.04 15.0 9.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.872 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.71 150.07 33.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.931 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -140.86 135.04 30.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.034 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.33 140.84 51.65 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.727 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 152' ' ' ALA . 14.8 p -123.22 135.95 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 75.1 mtm -134.47 158.02 44.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.747 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 152' ' ' ALA . 9.9 pt -130.12 154.55 81.33 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--O 1.237 0.453 0 C-N-CA 122.62 2.213 . . . . 0.0 113.253 -178.16 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 120.752 0.31 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.25 148.74 56.16 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.52 2.146 . . . . 0.0 111.517 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.62 ' HB3' HG13 ' A' ' 132' ' ' VAL . . . -91.75 -4.26 55.23 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 102' ' ' LEU . . . 152.5 -75.06 0.24 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.338 -1.411 . . . . 0.0 114.376 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 96' ' ' LEU . 25.0 pt -128.32 161.49 36.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -173.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.629 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 11.5 t-20 -127.75 155.55 43.84 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.884 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -120.97 130.3 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 O-C-N 122.167 -0.333 . . . . 0.0 110.691 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.45 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.2 m -133.1 154.24 39.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.656 0.741 . . . . 0.0 111.967 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.684 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 45.0 t -98.52 144.27 27.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.115 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 72.2 Cg_endo -72.89 67.07 4.01 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.116 2.544 . . . . 0.0 113.35 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 164' ' ' GLN . 69.0 mttm -99.99 -168.37 1.58 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -133.56 90.03 2.67 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.889 0.852 . . . . 0.0 109.221 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.41 -136.74 6.65 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.26 142.74 51.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.815 0.34 . . . . 0.0 110.347 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.449 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . 18.6 pm0 -134.02 166.1 23.5 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.924 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -60.08 127.81 33.72 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.109 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -128.04 133.57 49.11 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.86 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -93.5 160.93 14.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-O 121.609 0.719 . . . . 0.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.6 128.87 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.192 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 61.7 ttp -127.35 135.21 50.19 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.14 126.63 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 152' ' ' ALA . 50.4 pt -116.18 174.94 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.003 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -117.66 21.5 12.93 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.143 0.496 . . . . 0.0 110.544 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' HB3' HD12 ' A' ' 171' ' ' ILE . 35.7 tp10 -98.33 133.17 43.11 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.3 150.69 19.98 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.401 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 102' ' ' LEU . 5.0 pt -130.11 153.26 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.33 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -125.69 144.48 50.59 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.552 ' HB3' HD23 ' A' ' 102' ' ' LEU . 28.4 p-10 -137.29 156.76 47.88 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 184' ' ' LEU . 31.9 mm -94.97 81.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.546 0.688 . . . . 0.0 111.171 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.491 ' HB2' ' OD2' ' A' ' 183' ' ' ASP . 66.9 m-80 -65.96 -40.1 90.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.515 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 182' ' ' ASP . 13.5 t -149.36 177.41 9.71 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.051 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -57.89 -28.35 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.932 0.493 . . . . 0.0 111.418 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 180' ' ' THR . 27.3 t70 -60.13 -46.77 88.53 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 109.943 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 44.7 m-20 -64.78 -35.67 81.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.212 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.641 ' HA ' HD12 ' A' ' 178' ' ' ILE . 59.8 tp -59.36 -45.32 91.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.833 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 12.9 mmtt -64.08 -38.23 90.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.04 -49.76 74.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.268 0.556 . . . . 0.0 109.524 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.534 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.1 -43.3 98.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.751 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 4.3 pt-20 -67.72 -34.12 76.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.461 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.431 ' N ' ' HG3' ' A' ' 188' ' ' GLU . 57.8 ttm -62.13 -45.49 93.24 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.692 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.4 pp -70.38 -37.16 74.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.366 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.58 -44.44 90.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.347 0.594 . . . . 0.0 110.53 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.862 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.485 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 37.0 m-20 -111.59 164.73 12.68 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -113.8 132.03 56.01 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.881 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 48' ' ' ALA . 33.3 tp -106.32 125.66 51.27 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.024 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.625 ' HA ' HG22 ' A' ' 98' ' ' VAL . 69.4 mt -117.24 104.76 16.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.403 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 11.1 ptm -95.98 97.93 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.892 1.329 . . . . 0.0 112.042 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.66 97.15 5.97 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.765 178.836 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo . . . . . 0 CA--C 1.534 0.517 0 N-CA-C 113.474 0.528 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 56' ' ' THR . 41.5 mt -90.49 12.59 18.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -66.23 117.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -82.16 134.79 35.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.675 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 188' ' ' GLU . 46.6 tp -136.29 112.47 9.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.257 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t 61.27 20.14 10.76 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.381 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.34 -23.2 5.8 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.837 -1.173 . . . . 0.0 115.422 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.762 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 90.5 mtt180 -131.06 158.75 39.52 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.579 1.19 . . . . 0.0 111.088 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 71.6 m -76.2 150.79 37.04 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.199 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -49.22 -45.6 44.72 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.832 0.453 . . . . 0.0 111.298 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.36 -38.0 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.233 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.685 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.7 t70 -64.03 -42.59 97.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.212 0.529 . . . . 0.0 109.867 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.762 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 28.2 m-85 -61.03 -38.08 84.83 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.738 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.45 -42.54 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 110.671 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 30' ' ' ILE . 77.5 t -62.31 -43.34 97.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.566 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.576 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 44.5 t -50.3 -57.94 11.32 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 37.2 Cg_exo -62.07 -41.09 38.11 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.803 1.669 . . . . 0.0 112.359 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.697 HD11 HG11 ' A' ' 98' ' ' VAL . 90.5 mt -66.09 -42.11 89.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.184 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.411 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.7 tt -63.37 -45.43 91.16 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.073 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.04 -15.92 61.5 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.406 ' CB ' HD13 ' A' ' 110' ' ' ILE . 71.6 p -70.57 172.51 8.44 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.246 0.546 . . . . 0.0 111.231 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -70.03 2.24 3.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.537 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 3' ' ' ALA . 9.7 p -72.67 152.89 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 122.182 -0.324 . . . . 0.0 111.137 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 59.5 t30 -68.17 -79.62 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -121.04 163.96 17.51 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.238 0.542 . . . . 0.0 111.074 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -107.89 115.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.997 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -106.52 117.16 33.31 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.746 HG21 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -97.58 118.09 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-O 121.774 0.797 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.4 122.92 33.08 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.853 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 7' ' ' ALA . 56.8 p -130.48 156.61 44.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.552 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 75' ' ' THR . 35.4 t -105.04 143.15 26.14 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.283 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -56.79 -25.22 59.85 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.074 2.516 . . . . 0.0 111.033 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.44 -2.85 47.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -141.77 66.43 21.97 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.597 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.717 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 95.3 Cg_endo -105.14 86.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.144 0 C-N-CA 116.759 -1.694 . . . . 0.0 109.854 170.24 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 39.1 ttmt -148.84 -50.83 0.16 Allowed 'General case' 1 C--N 1.212 -5.386 0 CA-C-N 109.89 -3.323 . . . . 0.0 103.044 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 21' ' ' LEU . 86.4 m -62.07 -47.53 84.28 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.918 -1.946 . . . . 0.0 105.906 163.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.717 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.71 -47.96 81.34 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.949 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.583 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.4 pt-20 -57.23 -38.02 73.14 Favored 'General case' 0 C--N 1.369 1.431 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -65.89 -51.62 57.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 120.912 0.387 . . . . 0.0 111.714 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.746 HD13 HG21 ' A' ' 47' ' ' ILE . 97.0 mt -62.99 -46.26 96.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.505 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.589 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 65.1 t30 -59.25 -39.97 84.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.381 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 t -74.91 -47.43 29.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.31 87.95 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -108.82 14.83 24.01 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.635 -0.426 . . . . 0.0 112.015 -173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.0 pttt -62.9 -22.09 66.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -88.36 -1.19 57.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.81 128.54 49.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.943 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -70.23 -41.25 73.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.834 -178.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.411 HD21 ' HG ' ' A' ' 38' ' ' LEU . 10.1 p-10 -80.17 -0.67 37.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.2 mt -108.06 122.67 62.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.515 0.674 . . . . 0.0 110.206 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.9 135.68 63.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.929 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -106.95 131.03 57.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.061 0.458 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.6 pt -125.56 157.57 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.339 0.59 . . . . 0.0 111.814 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -102.32 133.32 47.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.389 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.2 t -161.77 -177.94 6.19 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.113 0.959 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 57.4 m -75.09 5.21 5.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 126.943 2.097 . . . . 0.0 113.158 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.04 -19.62 0.0 OUTLIER Glycine 0 N--CA 1.513 3.793 0 C-N-CA 127.876 2.655 . . . . 0.0 118.134 -171.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 11.5 tmtt? -59.29 -38.85 81.2 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 171.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.12 8.56 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -62.2 -50.51 71.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.17 -45.35 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.872 0.844 . . . . 0.0 110.575 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.84 -43.57 94.55 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.378 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.2 t0 -58.4 -50.12 74.83 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.874 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -56.87 -41.86 78.74 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.041 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.496 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.0 m-80 -60.03 -43.72 95.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 62.7 mm-40 -66.74 -42.61 85.95 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.79 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.58 -42.52 99.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -67.95 -26.57 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -38.64 96.95 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.929 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -70.5 -40.06 73.79 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.01 150.66 27.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -111.75 -0.96 15.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.047 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 28.2 mt-10 -134.86 159.01 73.75 Favored Pre-proline 0 CA--C 1.508 -0.663 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.161 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 36.5 Cg_endo -65.02 147.85 89.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.157 1.904 . . . . 0.0 111.124 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 51.2 p90 -141.69 162.13 36.23 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.588 0.709 . . . . 0.0 111.707 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.645 HD11 ' HB ' ' A' ' 154' ' ' ILE . 1.1 tm? -86.17 139.41 31.11 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.597 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.704 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 89.3 t -117.12 134.08 61.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.78 0.832 . . . . 0.0 108.857 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 37' ' ' LEU . 8.6 m -127.79 159.88 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.246 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -100.19 135.3 41.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.546 ' O ' HD22 ' A' ' 29' ' ' LEU . 81.0 p -74.95 -12.03 60.25 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -102.32 3.28 37.87 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 175' ' ' ILE . 70.0 mt -91.22 121.01 32.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.882 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.577 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 86.2 mt -118.33 118.67 58.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.193 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 60.8 t30 166.87 168.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.676 0.79 . . . . 0.0 110.386 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.18 93.48 3.95 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.546 0.689 . . . . 0.0 109.914 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HE3' HG13 ' A' ' 109' ' ' ILE . 31.8 mmmt -99.43 2.88 45.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.266 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.618 ' HA ' HD12 ' A' ' 110' ' ' ILE . 71.9 p -53.65 -32.56 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -70.7 -27.78 64.25 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.745 0.783 . . . . 0.0 110.008 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.486 HG13 ' HE3' ' A' ' 106' ' ' LYS . 28.1 mm -71.57 -40.57 71.46 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.304 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 107' ' ' SER . 70.0 mt -60.4 -45.79 96.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.933 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -64.64 -43.37 93.89 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.436 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.9 t -61.9 -45.54 93.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.533 HG13 ' N ' ' A' ' 114' ' ' VAL . 42.6 pt -65.04 -41.57 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.533 ' N ' HG13 ' A' ' 113' ' ' ILE . 57.6 t -62.16 -49.13 85.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.98 -43.18 93.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.852 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.518 ' CE2' HD11 ' A' ' 120' ' ' ILE . 71.7 t80 -63.7 -49.48 72.93 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 110.949 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.433 ' HB2' HD22 ' A' ' 130' ' ' LEU . 70.4 t80 -59.04 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.986 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 114' ' ' VAL . 28.1 m-85 -65.03 -31.83 73.25 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 50.3 t -62.02 -46.85 87.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.445 0.641 . . . . 0.0 109.421 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.659 HG22 HG11 ' A' ' 127' ' ' VAL . 71.6 mt -64.59 -43.54 96.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.352 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -60.48 -41.74 94.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.279 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.44 -44.33 95.92 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.648 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -77.85 -32.42 52.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.999 0.428 . . . . 0.0 111.33 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 127' ' ' VAL . 46.9 m -143.57 100.69 5.14 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.8 -13.75 39.55 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.8 2.333 . . . . 0.0 112.966 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.01 -32.73 74.15 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -71.37 129.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -128.45 4.6 5.66 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.637 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.05 153.41 39.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.939 0.4 . . . . 0.0 111.374 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 117' ' ' PHE . 23.4 tp -137.64 146.34 43.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.52 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.88 129.41 46.85 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.943 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 152' ' ' ALA . 63.9 t -105.06 115.11 46.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.3 ptm -145.82 157.53 43.91 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.19 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 152' ' ' ALA . 14.5 pt -133.03 155.0 81.57 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.834 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 C--O 1.237 0.445 0 C-N-CA 122.361 2.04 . . . . 0.0 111.923 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.47 136.76 77.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.993 1.795 . . . . 0.0 110.352 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -93.47 0.78 56.88 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.386 0.613 . . . . 0.0 110.617 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.79 -91.26 0.08 OUTLIER Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.993 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.645 ' HB ' HD11 ' A' ' 96' ' ' LEU . 14.4 pt -139.66 162.12 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.171 0.51 . . . . 0.0 112.173 -176.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.704 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.4 m120 -112.45 156.6 22.29 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.45 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 91.6 t -125.4 129.47 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 122.788 0.435 . . . . 0.0 109.889 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.35 155.27 31.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.048 0.451 . . . . 0.0 111.56 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.518 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 61.3 m -98.17 155.06 37.39 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.954 173.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 72.4 Cg_endo -76.52 86.11 1.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.579 2.186 . . . . 0.0 111.519 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -108.54 -175.42 2.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -128.9 28.16 5.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.875 0.845 . . . . 0.0 109.627 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.72 38.26 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -77.4 143.15 38.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.43 0.615 . . . . 0.0 109.545 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.518 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 20.9 pt20 -130.06 161.31 31.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.754 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.38 125.95 26.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.835 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.69 127.33 52.78 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.758 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -93.76 162.79 13.79 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 121.528 0.68 . . . . 0.0 111.716 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -117.42 129.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.891 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.4 ttp -128.45 126.02 39.69 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.686 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.8 t -105.38 132.06 53.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 173' ' ' GLU . 43.3 pt -119.78 171.73 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.208 0.527 . . . . 0.0 111.211 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -109.02 13.94 24.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.657 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.8 mm-40 -97.95 135.77 39.19 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.871 0.843 . . . . 0.0 111.278 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.9 153.67 18.11 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.459 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 102' ' ' LEU . 1.8 pt -132.78 151.02 33.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.386 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.12 116.94 27.86 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.474 ' HB3' HD23 ' A' ' 102' ' ' LEU . 31.0 p-10 -116.13 175.78 5.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 184' ' ' LEU . 46.4 mm -116.3 120.13 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.975 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 -47.25 5.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.82 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.5 p -128.03 166.54 18.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.19 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.35 -42.11 95.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.557 0.694 . . . . 0.0 109.754 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.58 -39.39 94.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.679 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.688 ' HA ' HD12 ' A' ' 178' ' ' ILE . 57.8 tp -61.02 -42.36 98.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.486 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 61.4 tttp -61.56 -40.92 96.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.872 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.9 -45.57 94.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.74 98.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.947 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 11.5 pt-20 -64.86 -37.75 88.69 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.526 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.8 mmm -63.54 -39.65 94.97 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.979 0.418 . . . . 0.0 110.349 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.1 tp -62.6 -44.86 95.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.908 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.432 HD12 ' HG ' ' A' ' 24' ' ' LEU . 94.3 mt -64.14 -39.43 94.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.337 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 99.3 mttt . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 95' ' ' PHE . 59.8 tpp . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.258 0.551 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -122.04 166.3 14.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.2 127.14 56.08 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.942 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.517 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.7 tp -101.48 126.21 48.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.677 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -119.08 107.97 22.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.598 ' O ' ' HB3' ' A' ' 100' ' ' SER . 60.6 ttm -80.93 98.07 7.72 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.513 0.673 . . . . 0.0 111.47 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.533 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.22 98.04 6.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.364 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -0.99 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.347 177.874 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 27.4 Cg_endo . . . . . 0 C--O 1.226 -0.098 0 N-CA-C 114.639 0.976 . . . . 0.0 114.639 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.09 4.95 24.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 90.6 mt -71.68 126.11 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 62.9 pttt -115.11 143.18 45.6 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 184' ' ' LEU . 89.4 mt -127.47 140.25 52.27 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.735 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.7 m 48.42 35.43 5.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.74 -12.7 53.57 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.23 161.28 38.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 119.476 1.638 . . . . 0.0 112.124 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 80.8 m -77.82 164.91 24.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.505 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 92.6 mt -58.35 -39.73 80.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.151 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.523 HG12 HG12 ' A' ' 60' ' ' ILE . 4.6 tp -58.32 -45.24 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.199 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.77 -42.41 97.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.12 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HE2' ' O ' ' A' ' 24' ' ' LEU . 4.2 m-85 -62.65 -36.17 81.99 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.773 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 29' ' ' LEU . 74.7 t -72.17 -45.2 63.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 120.818 0.342 . . . . 0.0 111.04 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 30' ' ' ILE . 76.0 t -63.85 -44.98 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.581 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 74.7 m -53.0 -54.58 42.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -173.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 51.3 Cg_exo -60.67 -40.3 56.47 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.009 1.806 . . . . 0.0 112.299 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.561 HD11 HG11 ' A' ' 98' ' ' VAL . 81.7 mt -67.3 -43.2 82.31 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.919 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -61.9 -46.06 91.03 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 21.6 ptmt -72.99 -15.57 61.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.485 ' OG ' HG12 ' A' ' 42' ' ' VAL . 79.9 p -75.41 173.71 10.57 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.195 0.521 . . . . 0.0 111.007 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -60.6 -18.39 52.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.746 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG12 ' OG ' ' A' ' 40' ' ' SER . 11.9 p -64.98 146.41 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.991 0.424 . . . . 0.0 111.108 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -79.79 -73.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -106.05 150.78 25.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.452 0.644 . . . . 0.0 111.799 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.06 116.12 51.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.553 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 84.4 m-85 -106.12 117.79 34.94 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -98.64 118.48 45.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.645 0.736 . . . . 0.0 110.301 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -88.18 117.85 27.36 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.964 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 7' ' ' ALA . 70.0 p -125.94 157.85 36.69 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.6 p -109.27 155.65 40.72 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.326 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.29 -18.44 62.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.598 2.199 . . . . 0.0 111.002 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -83.38 -7.4 59.57 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.999 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.0 p -141.37 66.74 24.41 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.749 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.0 Cg_endo -102.09 84.22 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.699 0 C-N-CA 116.469 -1.888 . . . . 0.0 108.577 168.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 53.5 mtmt -150.68 -50.34 0.13 Allowed 'General case' 1 C--N 1.216 -5.198 0 CA-C-N 109.446 -3.524 . . . . 0.0 103.184 -176.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.3 m -62.82 -46.97 85.46 Favored 'General case' 0 N--CA 1.391 -3.41 0 CA-C-N 112.692 -2.049 . . . . 0.0 106.125 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.749 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -61.5 -49.27 77.42 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.383 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.566 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 14.3 pt-20 -58.71 -38.48 78.38 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.03 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.76 -50.26 69.74 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.704 0.287 . . . . 0.0 111.458 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 47' ' ' ILE . 96.7 mt -63.59 -43.65 98.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.879 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -58.23 -44.36 88.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.346 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 75.1 m -68.74 -40.16 79.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.348 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.16 90.57 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.42 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 60.0 m-85 -115.96 42.19 2.4 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.549 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.2 mmmt -60.62 -21.39 62.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.143 0.497 . . . . 0.0 110.976 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -93.24 11.69 27.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.631 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.4 p90 -43.4 122.34 2.57 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.33 -50.0 3.58 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -111.05 10.96 22.07 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.531 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 85.9 mt -105.99 124.27 61.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.295 0.569 . . . . 0.0 110.35 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 60.3 t -125.28 133.7 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.687 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.41 132.46 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.091 0.472 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.9 pt -127.83 156.03 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-O 121.912 0.863 . . . . 0.0 111.325 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -110.35 133.14 53.55 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.496 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 10.1 t -162.22 -169.81 2.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 53.8 m -69.6 1.77 3.82 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 126.56 1.944 . . . . 0.0 114.438 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.46 -21.53 0.0 OUTLIER Glycine 1 N--CA 1.519 4.226 0 C-N-CA 126.209 1.862 . . . . 0.0 117.019 -174.158 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 76' ' ' SER . 2.5 tmmt? -56.57 -34.2 66.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.78 126.08 6.57 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -60.26 -51.69 68.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.48 -45.76 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 121.727 0.775 . . . . 0.0 110.795 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 69.5 mm-40 -60.99 -42.69 98.9 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.859 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.503 ' HB3' ' HE1' ' A' ' 6' ' ' MET . 8.7 t0 -58.94 -50.69 73.09 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.9 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.3 mm? -57.5 -43.98 84.6 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.055 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.523 ' HA ' HG12 ' A' ' 88' ' ' ILE . 7.3 m-20 -61.36 -40.1 93.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.968 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 70.7 mm-40 -67.17 -44.27 80.13 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.565 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 97.0 m -63.92 -41.63 97.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.619 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 84' ' ' LEU . 35.4 pt -66.73 -35.3 74.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.197 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.33 94.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.345 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.0 -49.19 77.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.958 . . . . 0.0 112.969 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.565 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 75.5 m-85 -74.2 148.23 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.176 0.512 . . . . 0.0 112.103 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.4 m -96.26 -8.41 32.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 15.5 pt-20 -151.55 173.47 4.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 93' ' ' GLU . 58.1 Cg_endo -69.35 148.48 67.82 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.072 1.848 . . . . 0.0 113.795 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 40.6 p90 -146.18 162.39 38.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 154' ' ' ILE . 91.2 mt -84.44 150.13 25.51 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.542 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 87.3 t -121.84 129.57 75.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.434 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.7 m -131.65 162.96 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.088 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.1 t -99.4 145.89 26.9 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 6' ' ' MET . 80.0 p -65.49 -20.5 66.37 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 177' ' ' ASN . 53.7 p-10 -105.14 12.41 32.06 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.21 115.37 11.37 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.929 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 29' ' ' LEU . 73.6 mt -122.45 117.02 50.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 33.6 t-20 173.88 169.62 0.2 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.62 73.71 5.16 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.76 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.2 pttp -82.64 -1.84 52.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.185 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.623 ' HA ' HD12 ' A' ' 110' ' ' ILE . 71.2 m -58.95 -40.61 85.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.52 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -71.33 -40.35 70.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.558 1.17 . . . . 0.0 109.895 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 106' ' ' LYS . 66.7 mt -63.02 -39.56 85.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.127 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 107' ' ' SER . 59.8 mt -57.52 -47.61 84.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -63.9 -39.97 95.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.718 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.7 m -61.66 -37.44 84.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.184 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -60.05 -48.38 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.323 0.582 . . . . 0.0 109.622 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.84 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.162 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.55 -47.56 85.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.157 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.528 ' CE2' HD11 ' A' ' 120' ' ' ILE . 80.9 t80 -64.18 -49.52 71.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.239 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.8 t80 -59.44 -47.92 83.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 4.2 m-85 -61.5 -35.46 77.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.15 -46.71 85.9 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.23 0.538 . . . . 0.0 109.733 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.528 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -65.08 -49.92 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.481 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.588 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 20.4 ptmt -66.32 -27.31 67.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.3 96.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.566 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 20.5 pttp -83.45 -39.71 20.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.917 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 25.2 m -130.49 98.83 19.69 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.403 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -9.56 26.62 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 122.842 2.361 . . . . 0.0 112.55 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.17 -32.81 72.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.856 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 10.3 p -74.72 124.99 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 0.0 110.993 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 41.1 mt-10 -117.85 -2.61 11.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.702 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.78 41.73 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.859 0.361 . . . . 0.0 111.289 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.428 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -135.16 131.98 37.44 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' HB2' ' CD ' ' A' ' 166' ' ' GLU . . . -119.06 127.08 53.07 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.575 HG21 ' CD1' ' A' ' 113' ' ' ILE . 90.1 t -107.55 112.55 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 9.9 ptm -146.22 158.4 43.88 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.225 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 152' ' ' ALA . 25.7 pt -134.22 157.0 78.55 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.147 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.239 0.536 0 C-N-CA 122.235 1.956 . . . . 0.0 111.878 178.789 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 121.056 0.455 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.408 ' O ' HD11 ' A' ' 175' ' ' ILE . 58.9 Cg_endo -70.58 147.89 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.395 2.063 . . . . 0.0 110.891 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -114.22 0.22 14.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 176.21 -123.72 0.93 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.268 -1.444 . . . . 0.0 113.648 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 113' ' ' ILE . 4.1 mp -101.17 137.09 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 121.679 0.752 . . . . 0.0 111.713 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.626 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.9 t-20 -109.6 156.7 19.87 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.48 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.531 HG22 HD23 ' A' ' 96' ' ' LEU . 94.7 t -123.62 130.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 C-N-CA 122.667 0.387 . . . . 0.0 110.243 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.429 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.9 m -133.96 150.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.379 0.609 . . . . 0.0 111.415 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.472 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 53.0 p -98.25 164.58 16.93 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.383 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 77.9 Cg_endo -75.72 76.1 3.79 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.55 2.167 . . . . 0.0 111.826 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.82 -172.08 2.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -127.46 131.78 50.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.583 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.91 -114.09 3.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.975 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.33 145.34 51.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.52 166.98 21.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 2.5 tmtm? -55.81 127.66 31.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.152 0.501 . . . . 0.0 110.615 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' CD ' ' HB2' ' A' ' 131' ' ' ALA . 44.1 tt0 -137.52 134.72 36.02 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.587 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.428 ' HG3' HG21 ' A' ' 120' ' ' ILE . 34.5 mm-40 -94.11 162.84 13.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.485 0.66 . . . . 0.0 111.646 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.01 130.08 73.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.081 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.484 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.7 ttp -129.6 130.99 46.37 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.691 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.9 t -111.42 131.51 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 173' ' ' GLU . 42.1 pt -117.66 169.69 7.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.777 0.799 . . . . 0.0 112.482 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -93.51 2.84 56.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' A' ' 171' ' ' ILE . 57.7 mm-40 -99.45 131.71 45.27 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 122.076 0.941 . . . . 0.0 113.149 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.08 149.47 21.91 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.886 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.408 HD11 ' O ' ' A' ' 151' ' ' PRO . 2.2 pt -123.64 139.81 49.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.833 176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -113.53 126.44 55.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 34.1 p-10 -119.13 19.33 12.93 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.555 0.693 . . . . 0.0 111.595 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 184' ' ' LEU . 23.2 mm 77.21 -93.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.515 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.91 -36.69 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.9 p -128.55 162.36 27.43 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.143 -0.348 . . . . 0.0 111.71 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.62 -39.12 83.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -48.66 80.81 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.52 -36.54 84.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.743 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.655 ' HA ' HD12 ' A' ' 178' ' ' ILE . 47.9 tp -59.98 -50.25 74.5 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.433 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.95 -40.5 91.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -60.61 -43.53 97.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.977 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.79 -43.51 98.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.698 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 24' ' ' LEU . 53.7 mm-40 -60.7 -45.48 94.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.24 0.543 . . . . 0.0 110.201 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 98.5 mtp -63.36 -42.28 98.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.698 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.4 -42.26 92.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 120.884 0.373 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -60.99 -43.25 99.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.354 0.597 . . . . 0.0 110.003 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.433 176.202 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 94' ' ' PRO . 59.2 ttm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.524 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 38.9 m-20 -115.8 166.1 12.33 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.81 127.4 55.99 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.09 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.38 124.8 49.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.444 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.693 ' HA ' HG22 ' A' ' 98' ' ' VAL . 64.0 mt -118.3 106.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.484 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 14.1 ptm -99.69 100.36 11.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.905 1.336 . . . . 0.0 113.736 -172.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -116.54 96.8 5.68 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.537 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.158 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.197 -176.946 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.958 0.316 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 59' ' ' TYR . 35.0 mt -95.43 7.32 46.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.334 -0.393 . . . . 0.0 112.042 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.76 119.83 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 39.9 pttt -100.55 138.39 37.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.029 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 188' ' ' GLU . 27.0 tp -136.47 115.9 12.75 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.197 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.2 m 60.53 19.66 9.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.85 -89.1 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.013 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 99.0 mtt180 -103.84 170.03 8.17 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.24 0.543 . . . . 0.0 111.954 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 69.7 m -76.71 163.72 26.56 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.462 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.78 -39.43 81.01 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.283 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.6 tp -56.73 -46.32 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.183 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.538 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 11.7 t70 -67.35 -40.76 85.84 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.044 0.45 . . . . 0.0 110.947 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 13.5 m-30 -62.29 -33.99 75.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.36 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -71.55 -42.91 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 30' ' ' ILE . 74.2 t -63.92 -43.79 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.2 m -52.42 -54.55 41.03 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.56 -39.51 16.0 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.565 1.51 . . . . 0.0 112.275 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.24 -42.82 92.99 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 120.801 0.334 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.4 tt -61.3 -46.52 89.96 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.708 0.29 . . . . 0.0 111.19 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -76.3 -13.15 60.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -73.82 -178.49 3.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 112.126 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.5 ttmm -59.48 -24.95 64.01 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.941 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.56 156.02 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.176 0.513 . . . . 0.0 112.29 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.524 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -77.74 -86.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 59.3 m-20 -107.72 156.85 18.64 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 111.454 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mm -107.85 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 89.7 m-85 -108.91 121.29 44.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -102.33 118.9 49.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.667 0.746 . . . . 0.0 110.715 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 6' ' ' MET . . . -87.77 126.43 34.99 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.752 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -133.85 170.78 15.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.4 m -127.34 150.88 73.73 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 -27.16 80.94 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.501 2.801 . . . . 0.0 111.986 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.15 5.01 40.02 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.996 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.5 p -140.77 66.08 26.08 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.43 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 88.4 Cg_endo -106.73 88.12 0.02 OUTLIER 'Trans proline' 1 N--CA 1.379 -5.212 0 C-N-CA 117.212 -1.392 . . . . 0.0 110.66 170.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.665 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 72.6 mmtt -151.39 -50.41 0.12 Allowed 'General case' 1 C--N 1.22 -5.04 0 CA-C-N 109.862 -3.335 . . . . 0.0 103.054 177.078 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.497 HG22 HD12 ' A' ' 60' ' ' ILE . 86.8 m -63.83 -48.34 77.2 Favored 'General case' 0 N--CA 1.384 -3.759 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.107 163.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.685 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 13.5 tmtt? -64.66 -52.37 57.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -60.13 -33.07 71.63 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 116.701 -1.999 . . . . 0.0 112.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.569 ' CD2' HD22 ' A' ' 21' ' ' LEU . 58.0 t80 -70.34 -52.73 20.51 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.483 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 47' ' ' ILE . 97.1 mt -63.44 -45.91 96.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.57 -42.26 92.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.264 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.1 t -71.67 -41.72 68.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.491 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.19 90.05 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.538 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 77.5 m-85 -106.69 32.51 4.48 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.502 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.4 mtmt -63.34 -18.66 63.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.474 0.654 . . . . 0.0 110.08 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.31 10.4 24.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.641 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.1 p90 -45.84 128.1 8.58 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -102.48 -51.48 3.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.846 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.547 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.0 p-10 -118.74 15.74 13.55 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.885 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -106.45 129.8 59.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.854 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.7 t -127.86 131.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.52 129.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 48' ' ' ALA . 44.0 pt -125.63 157.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.473 0.654 . . . . 0.0 111.818 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -108.05 134.3 51.13 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.844 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.6 t -161.18 -172.18 3.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.565 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 66.1 m -77.65 4.66 10.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 126.921 2.088 . . . . 0.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.6 -23.66 0.0 OUTLIER Glycine 0 N--CA 1.513 3.822 0 C-N-CA 127.167 2.317 . . . . 0.0 117.623 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 22.3 tptm -58.01 -37.11 73.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.19 122.95 6.7 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' HD23 ' A' ' 84' ' ' LEU . 87.5 t80 -59.89 -51.3 70.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.44 -43.98 87.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.677 0.751 . . . . 0.0 110.523 -177.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -59.89 -42.87 94.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.551 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.601 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 34.9 t0 -60.07 -50.27 74.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.952 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.6 mm? -56.64 -41.76 77.73 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.583 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' O ' HG12 ' A' ' 88' ' ' ILE . 6.7 m-20 -61.37 -42.1 98.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.849 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 64.4 mm-40 -66.16 -44.24 84.65 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.4 m -63.4 -41.52 98.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.324 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 160' ' ' LYS . 34.4 pt -64.42 -30.16 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.67 96.53 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.331 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.55 -38.18 71.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.41 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 92.2 m-85 -92.55 136.8 32.91 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 m -100.68 -4.53 28.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.441 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 41.3 mt-10 -134.46 160.58 67.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.559 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.5 Cg_endo -63.06 143.54 90.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.082 1.855 . . . . 0.0 111.843 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.49 162.04 37.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.719 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.582 HD23 HG22 ' A' ' 156' ' ' VAL . 92.8 mt -84.73 149.82 25.51 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.914 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 59.7 t -122.14 125.12 72.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.104 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.3 m -136.37 158.13 37.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.302 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.465 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.2 t -100.9 143.49 30.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.241 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 7' ' ' ALA . 49.9 m -76.73 -9.35 58.61 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -106.27 11.18 31.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.57 HD22 HD12 ' A' ' 175' ' ' ILE . 62.5 mt -91.63 114.67 27.26 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.85 135.06 65.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 112.009 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 178.61 -178.89 0.31 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.83 58.69 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 109' ' ' ILE . 16.6 ptmt -66.23 -8.1 22.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.9 -1.5 . . . . 0.0 113.519 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 110' ' ' ILE . 60.3 m -58.72 -41.44 86.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -72.82 -37.85 67.36 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.6 mm -60.78 -40.81 86.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.188 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 107' ' ' SER . 59.4 mt -58.33 -48.65 84.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.445 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 55.0 m-80 -65.65 -39.91 91.9 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.3 m -61.55 -37.23 83.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.754 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.7 mm -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.872 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.89 -44.66 99.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.687 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -60.03 -48.19 82.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.8 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.75 ' CE2' HD11 ' A' ' 120' ' ' ILE . 78.9 t80 -63.98 -47.21 81.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.4 -46.61 83.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 14.4 m-85 -62.13 -38.3 88.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.49 -41.51 98.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.339 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.75 HD11 ' CE2' ' A' ' 116' ' ' TYR . 74.7 mt -67.9 -48.63 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.204 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.17 -25.46 68.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.543 -177.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.72 98.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.819 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.99 -39.52 19.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.7 m -130.67 95.37 26.52 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.656 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.07 -13.14 35.85 Favored 'Trans proline' 0 N--CA 1.474 0.38 0 C-N-CA 122.738 2.292 . . . . 0.0 111.952 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.91 -31.01 71.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.069 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 124' ' ' THR . 13.4 p -65.53 133.1 31.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.061 0.458 . . . . 0.0 111.154 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.535 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 43.7 mt-10 -124.34 -3.28 7.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.899 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.26 156.8 43.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.801 0.334 . . . . 0.0 111.433 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.78 137.74 38.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.7 139.32 52.77 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.037 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 113' ' ' ILE . 67.8 t -113.97 117.06 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.9 ptm -145.72 152.81 40.19 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.872 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 152' ' ' ALA . 36.4 pt -132.02 159.55 71.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.051 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.238 0.477 0 C-N-CA 122.003 1.802 . . . . 0.0 110.784 177.856 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.447 -0.585 0 CA-C-O 121.069 0.461 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 59.1 Cg_endo -71.0 144.29 47.03 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.709 2.273 . . . . 0.0 112.102 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -118.39 -6.03 10.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.34 -120.35 1.26 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.934 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.619 ' CG1' HG13 ' A' ' 113' ' ' ILE . 40.5 pt -121.21 158.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 120.903 0.382 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.682 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.1 t-20 -116.5 152.23 34.49 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.409 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 96' ' ' LEU . 93.6 t -121.41 129.46 75.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 122.51 0.324 . . . . 0.0 110.409 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 155' ' ' ASN . 31.6 m -135.3 149.01 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.143 0.497 . . . . 0.0 111.391 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 77.1 p -98.79 163.7 18.35 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.543 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 62.4 Cg_endo -73.4 74.65 3.1 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.258 1.972 . . . . 0.0 112.079 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.593 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.3 mmmt -115.33 137.68 51.78 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.748 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -93.18 107.05 18.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.336 0.589 . . . . 0.0 110.23 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.02 -128.95 6.37 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -136.29 129.27 31.19 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -117.53 166.5 12.29 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.607 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.0 120.37 9.53 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.301 0.572 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -121.02 130.1 53.65 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.801 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.482 ' HG3' HG21 ' A' ' 120' ' ' ILE . 42.8 mm-40 -92.8 161.9 14.33 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 121.731 0.777 . . . . 0.0 112.196 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.2 mm -117.89 127.05 75.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.652 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.56 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.3 ttp -124.77 128.71 49.17 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.92 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.3 t -107.97 128.75 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.492 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.671 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.6 pt -115.51 175.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.019 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -121.69 23.07 10.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.769 0.795 . . . . 0.0 109.889 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.671 ' HB2' HD12 ' A' ' 171' ' ' ILE . 20.0 mp0 -98.7 130.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.988 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.03 143.03 28.27 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.287 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.57 HD12 HD22 ' A' ' 102' ' ' LEU . 10.1 pt -121.6 154.06 25.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.409 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.38 106.1 13.91 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.672 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -68.05 -35.79 78.82 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.088 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 183' ' ' ASP . 98.7 mt 66.32 109.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.045 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -120.93 -15.26 8.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.217 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.8 p -127.54 166.34 18.19 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.414 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.51 -36.91 85.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.04 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.54 -40.6 87.78 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 178' ' ' ILE . 77.0 m-20 -61.27 -41.71 97.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.491 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 178' ' ' ILE . 89.9 mt -61.94 -47.63 84.02 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.312 0.577 . . . . 0.0 109.949 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 88.0 tttt -61.92 -42.68 99.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.623 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 186' ' ' LEU . 8.6 tt -60.47 -47.97 83.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.937 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -64.91 -42.11 95.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.202 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 pt-20 -69.5 -31.65 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 96.5 mtp -62.73 -40.96 98.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.646 0.26 . . . . 0.0 111.537 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.6 -36.27 60.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.189 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 190' ' ' LEU . 92.3 mt -62.95 -45.77 90.89 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.443 0.64 . . . . 0.0 110.525 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 C--N 1.314 -0.965 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.994 178.944 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.471 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.4 ttm . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 33.5 m-20 -100.12 166.17 11.15 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -115.58 130.77 56.99 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.924 0.392 . . . . 0.0 111.101 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.8 tp -106.06 125.07 50.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.181 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.693 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -117.68 102.22 13.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.438 ' O ' ' HB3' ' A' ' 100' ' ' SER . 12.1 ptm -96.22 98.52 10.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.987 1.375 . . . . 0.0 112.093 -175.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.44 98.23 6.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.196 -1.82 . . . . 0.0 110.332 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.331 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.843 179.317 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 CA--C 1.534 0.493 0 CA-C-O 121.011 0.338 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 59' ' ' TYR . 57.8 mt -102.59 7.61 39.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.41 118.37 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.592 0.711 . . . . 0.0 109.129 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 48.8 pttt -87.68 125.92 34.67 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.999 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 188' ' ' GLU . 60.3 tp -131.71 119.69 21.69 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.003 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.1 m 57.29 28.72 15.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.25 -76.02 0.39 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.019 -1.086 . . . . 0.0 114.48 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.713 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 44.3 mtt180 -101.73 166.42 10.69 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 112.36 -172.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 75.7 m -76.15 151.79 36.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.674 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.1 tt -48.91 -47.93 42.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.26 0.624 . . . . 0.0 111.711 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 60' ' ' ILE . 5.7 tp -57.61 -42.49 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 0.0 111.811 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.713 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 15.0 t70 -65.24 -39.73 93.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.142 0.496 . . . . 0.0 109.933 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -63.73 -37.34 86.99 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.969 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 29' ' ' LEU . 72.3 t -65.27 -43.43 95.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 110.239 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -63.61 -43.0 98.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.583 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -49.99 -57.01 13.85 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 40' ' ' SER . 41.8 Cg_endo -67.83 -37.99 14.52 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 121.57 1.514 . . . . 0.0 112.462 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.528 HD11 HG11 ' A' ' 98' ' ' VAL . 83.3 mt -65.09 -41.22 95.19 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.879 0.371 . . . . 0.0 111.67 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.488 ' HG ' HD21 ' A' ' 69' ' ' ASN . 5.7 tt -59.97 -46.58 88.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.035 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -83.31 -5.87 59.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 57.4 p -75.79 -178.38 4.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.518 0.675 . . . . 0.0 111.585 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 24.5 ttmm -57.44 -24.8 57.8 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.719 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 3' ' ' ALA . 22.7 m -67.38 161.8 3.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.517 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 60.1 t30 -80.43 -76.83 0.21 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.544 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -117.56 159.77 22.34 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.909 0.385 . . . . 0.0 110.767 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.67 114.06 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.3 m-85 -107.88 116.75 32.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.567 HG21 HD13 ' A' ' 60' ' ' ILE . 96.1 mt -97.98 116.15 39.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.558 0.694 . . . . 0.0 110.543 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.51 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.81 125.35 34.4 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.705 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -129.34 158.94 37.7 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 38.0 m -103.93 149.76 37.53 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.575 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.9 -20.63 57.99 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.745 2.297 . . . . 0.0 111.309 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -89.04 1.66 55.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 20.3 p -138.08 67.51 48.07 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.653 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 90.8 Cg_endo -100.99 87.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.384 -4.939 0 C-N-CA 117.303 -1.331 . . . . 0.0 109.17 169.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.7 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.5 mmtm -156.94 -52.7 0.08 Allowed 'General case' 1 C--N 1.215 -5.268 0 CA-C-N 110.183 -3.19 . . . . 0.0 103.057 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.518 HG22 HD12 ' A' ' 60' ' ' ILE . 93.3 m -63.77 -50.03 70.62 Favored 'General case' 0 N--CA 1.379 -3.991 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 165.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -65.25 -49.25 70.35 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.7 pt-20 -60.83 -31.36 70.78 Favored 'General case' 0 C--N 1.374 1.664 0 C-N-CA 116.16 -2.216 . . . . 0.0 112.17 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.518 ' CD2' HD22 ' A' ' 21' ' ' LEU . 52.9 t80 -72.2 -51.22 22.1 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.582 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.567 HD13 HG21 ' A' ' 47' ' ' ILE . 97.8 mt -62.35 -44.92 99.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.689 -174.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.71 -44.01 90.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.499 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 73.1 m -68.8 -41.21 79.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.384 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.58 88.08 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.45 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.59 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 66.5 m-85 -110.54 31.82 5.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.409 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.3 mmmm -61.77 -24.19 66.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.16 0.505 . . . . 0.0 110.739 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.27 10.97 25.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.017 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.4 p90 -45.44 134.26 6.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -175.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.06 -49.53 3.74 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.488 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.2 p-10 -119.25 11.65 12.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.563 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 80.8 mt -106.2 127.29 61.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.27 0.557 . . . . 0.0 110.697 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 76.9 t -126.45 132.23 70.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.732 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.85 130.58 52.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 48' ' ' ALA . 37.7 pt -124.07 155.73 31.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.391 0.615 . . . . 0.0 110.396 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.72 132.35 56.49 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.865 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 86' ' ' GLU . 14.2 t -163.66 -167.42 1.4 Allowed 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.5 m -66.04 1.0 1.61 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 127.017 2.127 . . . . 0.0 114.349 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.56 -22.39 0.0 OUTLIER Glycine 0 N--CA 1.514 3.875 0 C-N-CA 126.026 1.774 . . . . 0.0 116.67 -175.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 76' ' ' SER . 13.9 tmtt? -57.39 -36.6 71.49 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.38 122.84 6.23 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.58 -50.47 73.76 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 pt -71.49 -32.16 45.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.097 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.53 -43.46 89.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.467 0.651 . . . . 0.0 109.891 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.608 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.1 t0 -61.3 -50.5 72.74 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.859 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -57.44 -45.09 85.1 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.035 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.6 m-80 -60.69 -42.63 97.53 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.535 ' HG2' ' OG1' ' A' ' 75' ' ' THR . 16.8 tp10 -65.37 -46.43 80.15 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.534 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 99.0 m -63.78 -41.01 98.03 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.403 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.2 pt -65.18 -36.82 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.393 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.63 -38.97 95.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.4 174.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.35 -49.22 74.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.64 0.776 . . . . 0.0 112.814 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.534 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 83.3 m-85 -75.76 149.83 37.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -103.06 -5.29 23.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.386 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.78 158.33 74.31 Favored Pre-proline 0 CA--C 1.505 -0.787 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.94 141.62 77.83 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.858 2.372 . . . . 0.0 110.534 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 45.5 p90 -141.84 156.81 45.53 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.543 0.687 . . . . 0.0 111.923 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.534 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.42 138.5 31.73 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.931 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 64.3 t -116.94 131.67 68.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 123.311 0.644 . . . . 0.0 109.291 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 5' ' ' ILE . 17.7 m -126.72 164.04 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 112.02 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.443 ' O ' HD22 ' A' ' 102' ' ' LEU . 47.6 t -82.54 159.95 22.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.009 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 6' ' ' MET . 81.1 p -86.1 -26.07 25.46 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.6 28.77 7.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.443 HD22 ' O ' ' A' ' 99' ' ' SER . 1.5 pt? -86.55 156.88 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.694 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.7 pt -96.74 174.09 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 96.2 m-20 -69.19 -170.29 0.25 Allowed 'General case' 0 C--O 1.247 0.932 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.041 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 104' ' ' ASN . 4.2 mm? 75.03 14.74 3.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.311 1.044 . . . . 0.0 109.97 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HA ' HG12 ' A' ' 109' ' ' ILE . 47.9 mmtm -99.52 -0.81 39.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.032 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' HD12 ' A' ' 110' ' ' ILE . 75.4 p -59.31 -37.1 76.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.97 -24.77 59.66 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.87 0.843 . . . . 0.0 109.747 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 113' ' ' ILE . 41.2 mm -67.17 -39.77 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.27 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 107' ' ' SER . 66.3 mt -57.24 -49.07 81.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.13 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.401 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 52.7 m-80 -66.12 -40.41 90.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.195 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -62.77 -41.09 99.08 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.97 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 109' ' ' ILE . 47.7 mm -62.12 -48.69 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.044 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.47 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.1 t -61.98 -48.77 87.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.428 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.57 -41.99 98.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.057 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.82 -41.65 78.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.927 0.394 . . . . 0.0 110.354 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.75 -46.68 86.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.93 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 17.2 m-85 -60.05 -37.01 78.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.492 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.05 -41.14 97.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 109.563 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.1 mt -68.55 -41.36 82.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.298 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 127' ' ' VAL . 17.7 mmmt -59.94 -43.11 95.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.478 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.56 93.51 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.724 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.29 -34.73 31.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.519 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.3 m -140.31 95.43 8.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.31 -25.12 77.24 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.207 2.605 . . . . 0.0 112.688 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.66 -31.75 72.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.511 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 121' ' ' LYS . 63.3 t -69.26 122.6 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 33.8 mt-10 -130.93 18.83 5.04 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 156' ' ' VAL . . . -151.0 151.55 32.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.043 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 113' ' ' ILE . 18.7 tp -138.89 143.29 38.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.905 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.55 138.56 52.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.472 HG21 ' CD1' ' A' ' 113' ' ' ILE . 60.0 t -117.5 117.03 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 4.3 ptm -146.01 161.77 39.37 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.53 -176.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 152' ' ' ALA . 22.7 pt -132.66 154.58 81.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.558 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 121.971 1.78 . . . . 0.0 110.1 176.626 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.149 0.5 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.01 151.2 55.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.501 2.134 . . . . 0.0 110.432 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -131.98 -28.3 1.77 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.895 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.57 -136.63 6.75 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.977 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 96' ' ' LEU . 20.6 pt -123.66 161.02 26.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.735 -177.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.605 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.7 t-20 -112.13 152.52 28.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.449 -174.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' ALA . 71.6 t -124.59 130.86 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.201 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' A' ' 155' ' ' ASN . 20.1 m -133.75 149.03 30.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.513 0.673 . . . . 0.0 111.396 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.594 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 23.3 t -97.83 151.66 37.7 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.411 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 43.2 Cg_endo -67.32 77.73 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.589 2.193 . . . . 0.0 111.61 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.71 -175.67 2.83 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.13 115.9 15.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.71 -123.78 7.12 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.275 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.91 140.7 50.91 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -134.12 164.14 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.649 0.261 . . . . 0.0 111.653 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.435 ' CG ' HG22 ' A' ' 127' ' ' VAL . 49.4 tptt -57.08 127.98 34.7 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.506 0.67 . . . . 0.0 112.22 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -128.63 137.26 51.57 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.538 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.1 163.19 12.67 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.53 130.97 69.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.597 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.7 ttm -122.63 141.76 51.38 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 133' ' ' MET . 57.9 t -117.06 131.41 69.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.4 pt -120.76 175.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.12 5.5 30.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.328 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.693 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.4 mp0 -96.84 130.24 44.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.195 0.998 . . . . 0.0 111.917 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.2 mt -97.05 152.22 18.96 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.115 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.61 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.833 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.1 119.34 28.34 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -82.26 118.91 23.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.84 105.68 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.107 0.479 . . . . 0.0 110.402 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -113.1 -19.18 11.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.163 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -147.64 165.92 28.96 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.12 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -58.26 -31.91 67.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.844 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.51 -43.01 99.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.1 -42.32 98.3 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.459 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.446 ' CD1' HD13 ' A' ' 24' ' ' LEU . 58.9 tp -62.08 -46.67 88.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 63.5 tttm -64.24 -42.13 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.989 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.15 -45.38 93.26 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.13 -40.89 98.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.996 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 8.7 pt-20 -67.42 -36.28 80.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.872 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.0 mtp -62.59 -39.08 92.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.33 -34.96 61.26 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.3 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -46.06 64.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.066 0.46 . . . . 0.0 112.157 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.214 -177.386 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 23.5 ptp . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 22.7 m-20 -95.33 163.36 13.29 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.428 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -121.09 128.51 52.66 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 40.9 tp -103.75 127.45 51.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 98' ' ' VAL . 63.6 mt -117.63 103.48 14.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.51 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 14.7 ptm -98.25 115.94 29.44 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-O 123.474 1.607 . . . . 0.0 112.07 -176.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.91 -173.22 2.24 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 111.226 -2.716 . . . . 0.0 109.819 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.267 -3.271 0 CA-C-N 114.12 -1.4 . . . . 0.0 111.283 -178.121 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 113.517 0.545 . . . . 0.0 113.517 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 64.3 mt -88.11 10.76 18.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.87 126.81 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 62.6 mttp -102.32 141.15 35.62 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 122.264 1.03 . . . . 0.0 113.705 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.612 HD21 HD12 ' A' ' 184' ' ' LEU . 86.4 mt -125.41 110.25 13.72 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.222 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.38 33.44 18.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.657 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -20.01 39.19 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.904 1.121 . . . . 0.0 115.904 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.678 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 89.6 mtt180 -117.71 152.31 35.5 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 119.235 1.518 . . . . 0.0 112.327 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 81.7 m -75.27 162.45 28.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.779 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 100' ' ' SER . 88.6 mt -59.86 -40.67 89.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.051 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.668 HG12 HD11 ' A' ' 60' ' ' ILE . 3.8 tp -59.77 -43.08 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.638 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 9.9 t70 -62.86 -44.08 97.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.292 0.568 . . . . 0.0 110.029 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 23.9 m-85 -65.11 -33.3 75.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.646 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.627 ' HA ' ' NZ ' ' A' ' 106' ' ' LYS . 69.7 t -71.9 -44.61 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.606 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 30' ' ' ILE . 72.2 t -64.57 -43.76 96.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.549 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 73.4 m -52.22 -54.61 39.71 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 42.4 Cg_exo -62.41 -41.91 30.66 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.11 1.874 . . . . 0.0 112.479 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.565 HD11 HG11 ' A' ' 98' ' ' VAL . 87.2 mt -67.11 -40.28 86.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.087 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.473 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.2 tt -62.28 -46.3 89.43 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.0 0.429 . . . . 0.0 109.891 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.61 -17.15 60.75 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.404 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.429 ' CB ' HG21 ' A' ' 110' ' ' ILE . 78.7 p -70.69 170.05 13.16 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.185 0.517 . . . . 0.0 111.757 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -71.85 24.77 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.1 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.92 162.38 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.828 -0.545 . . . . 0.0 110.767 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 64.5 t30 -72.27 -76.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.619 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -125.9 160.19 30.57 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.952 0.406 . . . . 0.0 110.438 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 3' ' ' ALA . 49.0 mm -108.4 116.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.7 m-85 -109.72 116.97 32.69 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.581 HG21 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -98.15 119.85 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.562 0.696 . . . . 0.0 111.039 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.479 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -95.19 119.8 34.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.984 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.3 p -125.95 150.99 47.58 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.419 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 75' ' ' THR . 54.8 m -83.77 152.2 62.58 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.009 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.32 -18.43 63.16 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.152 2.568 . . . . 0.0 111.4 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -89.95 -0.63 57.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.6 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -141.32 68.17 26.3 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 97.5 Cg_endo -104.65 85.67 0.02 OUTLIER 'Trans proline' 1 N--CA 1.382 -5.056 0 C-N-CA 116.845 -1.637 . . . . 0.0 108.889 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.685 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 35.1 mmtp -144.94 -50.14 0.26 Allowed 'General case' 1 C--N 1.224 -4.857 0 CA-C-N 110.299 -3.137 . . . . 0.0 103.78 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.517 ' HA ' HD21 ' A' ' 21' ' ' LEU . 68.4 m -62.41 -45.8 91.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -61.95 -50.86 70.42 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.896 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.685 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.3 pt-20 -63.12 -32.19 73.51 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.039 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -62.59 -50.5 71.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.91 0.386 . . . . 0.0 111.466 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 30' ' ' ILE . 92.1 mt -63.29 -43.75 98.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.104 -176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -57.65 -43.71 85.12 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.5 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t -71.82 -43.07 66.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.48 93.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.347 0.594 . . . . 0.0 110.891 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 90.2 m-85 -111.6 41.65 1.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.006 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.5 mtmt -61.3 -21.79 64.28 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.261 0.553 . . . . 0.0 110.423 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -91.2 10.59 26.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.4 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 35.3 p90 -35.62 113.79 0.22 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' C ' ' HD3' ' A' ' 68' ' ' LYS . 4.6 tmtm? -93.16 -51.93 4.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.066 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.473 HD21 ' HG ' ' A' ' 38' ' ' LEU . 27.2 p-10 -118.74 13.92 13.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.767 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.19 126.48 56.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.403 0.62 . . . . 0.0 111.527 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.8 t -126.06 133.1 69.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.56 132.71 54.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.34 155.28 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.426 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -118.11 131.18 56.44 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.222 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 50' ' ' SER . 13.0 t -165.41 -173.66 2.89 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.137 0.97 . . . . 0.0 113.582 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 78' ' ' LYS . 48.9 m -64.67 3.48 0.51 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.404 2.282 . . . . 0.0 115.497 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.14 -29.36 0.01 OUTLIER Glycine 1 N--CA 1.519 4.186 0 C-N-CA 126.434 1.969 . . . . 0.0 117.602 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' SER . 53.6 tptt -58.08 -38.91 77.26 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -100.46 114.58 5.05 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.74 -47.77 84.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.63 -49.01 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.629 0.728 . . . . 0.0 109.797 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.7 -47.16 86.74 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.631 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.591 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.4 t0 -61.12 -51.9 67.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.733 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -58.29 -44.99 88.74 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.805 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.415 ' HA ' HG12 ' A' ' 88' ' ' ILE . 5.4 m-80 -58.29 -46.49 85.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.083 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.91 -46.97 82.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.176 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 96.4 m -63.6 -43.47 96.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.194 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 84' ' ' LEU . 35.8 pt -65.73 -30.86 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 120.855 0.36 . . . . 0.0 110.27 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.94 -39.67 97.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.983 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -74.99 -34.75 62.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 74.6 m-85 -76.16 142.65 41.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -103.69 1.14 31.49 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.981 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 36.5 mt-10 -138.39 160.86 62.07 Favored Pre-proline 0 CA--C 1.503 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.464 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.608 ' O ' ' HB2' ' A' ' 1' ' ' MET . 42.9 Cg_endo -68.19 145.4 66.37 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.808 1.672 . . . . 0.0 109.792 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -145.21 161.91 38.38 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.201 0.524 . . . . 0.0 112.192 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.599 HD23 HG22 ' A' ' 156' ' ' VAL . 93.3 mt -85.63 149.74 25.11 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.693 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.9 t -120.77 125.47 74.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 5' ' ' ILE . 6.1 m -131.44 162.4 39.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.325 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.517 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 49.0 m -99.45 143.3 29.86 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.16 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 78.2 p -73.15 -10.01 59.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.299 0.571 . . . . 0.0 111.605 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 99' ' ' SER . 4.7 p-10 -101.41 16.78 24.51 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.251 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.45 117.17 28.94 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 122.007 -0.433 . . . . 0.0 110.619 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 47.4 pt -69.93 -172.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.782 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.44 -175.42 2.79 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.1 tp 80.73 24.32 0.32 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 110.023 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.627 ' NZ ' ' HA ' ' A' ' 33' ' ' VAL . 50.0 mtmt -98.79 -1.86 39.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.829 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.0 m -58.07 -43.75 87.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -86.82 -20.64 27.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG12 ' A' ' 113' ' ' ILE . 43.2 mm -63.73 -45.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.961 -175.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 40' ' ' SER . 58.3 mt -59.52 -48.58 86.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.556 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -63.92 -39.67 94.71 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.084 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.2 m -62.45 -38.04 88.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.855 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.6 mm -59.61 -48.23 88.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.219 0.533 . . . . 0.0 109.932 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 78.7 t -62.71 -49.51 83.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.495 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.02 -41.97 99.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.287 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.518 ' CE2' HD11 ' A' ' 120' ' ' ILE . 46.0 t80 -63.92 -46.68 83.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.148 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.46 -47.69 84.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.989 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 27.2 m-85 -61.02 -36.88 80.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.169 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.8 t -62.21 -45.37 93.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.455 0.645 . . . . 0.0 109.71 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.576 HG21 ' HG3' ' A' ' 167' ' ' GLU . 84.7 mt -63.38 -49.22 83.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.497 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.64 -25.0 67.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.59 99.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.552 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -83.83 -34.33 24.7 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 54.4 m -137.73 97.23 10.26 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.33 -13.4 39.27 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.049 2.499 . . . . 0.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.69 -29.64 70.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.425 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.553 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 85.7 t -67.21 126.48 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.214 0.531 . . . . 0.0 110.681 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.509 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 39.8 mt-10 -108.25 -25.22 11.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.798 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.7 38.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.115 0.483 . . . . 0.0 112.111 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -135.96 132.21 36.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.174 -178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -122.28 135.41 54.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 113' ' ' ILE . 59.0 t -113.72 119.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -146.22 157.88 43.85 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.563 -177.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.649 HG12 ' HB2' ' A' ' 152' ' ' ALA . 37.8 pt -134.07 157.83 76.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.595 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.24 0.623 0 C-N-CA 122.446 2.098 . . . . 0.0 112.054 178.636 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' MET . 27.6 m . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.65 144.18 53.81 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.496 2.13 . . . . 0.0 111.501 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.649 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -116.49 -2.67 11.96 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.71 -127.29 1.0 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.724 -1.703 . . . . 0.0 114.163 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 96' ' ' LEU . 4.0 mp -101.63 140.43 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-O 121.591 0.71 . . . . 0.0 111.918 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.639 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.4 t-20 -109.13 155.49 20.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.397 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.599 HG22 HD23 ' A' ' 96' ' ' LEU . 87.9 t -124.58 135.74 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 122.905 0.482 . . . . 0.0 110.467 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.16 151.41 30.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 120.79 0.328 . . . . 0.0 110.566 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 82.9 p -90.8 163.18 31.01 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.037 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 71.9 Cg_endo -75.75 63.25 6.59 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.385 2.057 . . . . 0.0 112.426 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.421 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 33.6 mmtp -110.89 -172.77 2.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.674 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -143.03 120.23 11.49 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.35 -125.49 5.79 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.242 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -112.99 142.41 45.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -127.03 152.3 47.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.852 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.553 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 9.1 tmtm? -76.75 125.98 30.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.67 136.48 54.5 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.987 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.576 ' HG3' HG21 ' A' ' 120' ' ' ILE . 24.8 mm-40 -95.77 164.01 12.93 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.328 0.585 . . . . 0.0 112.058 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.71 131.04 68.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.427 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.461 ' HB3' HG22 ' A' ' 132' ' ' VAL . 44.1 ttm -116.75 135.49 53.72 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.645 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.31 126.45 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.645 HD12 ' HG2' ' A' ' 173' ' ' GLU . 42.7 pt -119.28 175.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.407 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.13 3.3 9.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.491 . . . . 0.0 111.496 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.645 ' HG2' HD12 ' A' ' 171' ' ' ILE . 1.8 pm0 -98.78 137.03 37.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.621 0.724 . . . . 0.0 111.262 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -95.86 150.59 20.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.831 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.0 pt -127.18 153.94 36.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.512 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.67 107.61 13.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -74.51 -35.3 63.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.606 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.508 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 86.1 mt 79.98 96.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.772 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -110.28 -19.38 13.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.697 175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.2 p -126.33 162.24 25.97 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.096 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.71 -35.07 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.956 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -62.07 -41.78 98.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 73.3 m-20 -63.96 -41.73 97.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 109.571 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.612 HD12 HD21 ' A' ' 24' ' ' LEU . 60.0 tp -61.51 -48.35 81.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.194 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 62.9 tttm -63.4 -44.33 94.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.138 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.66 -44.65 96.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 0.0 110.02 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.81 -42.47 99.06 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.705 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.3 pt-20 -70.97 -36.11 72.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 95.0 mtp -63.99 -42.37 97.21 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -65.19 -36.02 82.89 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.955 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.0 mt -63.48 -46.14 87.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--N 1.314 -0.958 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.71 -179.587 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 42.6 m-20 -96.52 165.91 11.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.81 137.87 51.75 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.7 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 98' ' ' VAL . 8.5 mt -96.58 135.78 38.01 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.785 174.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.586 ' HA ' HG22 ' A' ' 98' ' ' VAL . 75.7 mt -127.59 100.03 5.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.4 ptm -95.5 99.08 11.02 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 123.269 1.509 . . . . 0.0 112.248 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.0 110.53 20.2 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 112.378 -2.192 . . . . 0.0 109.615 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.966 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.722 -179.291 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 25.4 Cg_exo . . . . . 0 C--O 1.233 0.253 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 73.4 mt -95.93 18.27 13.64 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.471 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 184' ' ' LEU . 95.1 mt -62.83 118.81 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.883 0.849 . . . . 0.0 109.296 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 58.4 pttt -86.14 131.2 34.3 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.991 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -132.57 125.46 30.55 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.737 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 52.28 30.0 7.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.45 -9.19 58.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.509 -0.853 . . . . 0.0 115.063 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.702 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.7 mtt180 -127.01 153.84 45.4 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.826 1.313 . . . . 0.0 111.846 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 77.3 m -80.26 164.09 23.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 33' ' ' VAL . 77.6 mt -59.05 -43.99 91.75 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.075 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.58 -39.88 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.702 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.3 t70 -64.55 -43.61 93.4 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.276 0.56 . . . . 0.0 110.193 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 7.5 m-85 -63.24 -34.17 77.08 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.622 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.8 t -69.34 -42.12 81.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.915 0.388 . . . . 0.0 110.543 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 30' ' ' ILE . 66.2 t -62.45 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.793 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.553 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 67.8 m -53.47 -52.29 68.05 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 53.2 Cg_exo -60.33 -43.1 36.57 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 121.789 1.66 . . . . 0.0 112.484 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.586 HD11 HG11 ' A' ' 98' ' ' VAL . 93.2 mt -66.68 -38.31 86.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 110.563 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.33 -44.7 92.58 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.385 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 35' ' ' SER . 61.1 pttt -91.18 -4.39 56.14 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.8 p -82.46 -176.55 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 111.071 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -54.22 -22.45 11.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.642 1.177 . . . . 0.0 112.23 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -54.49 137.59 15.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -72.0 -79.44 0.07 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.153 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -115.58 155.76 27.02 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.258 0.552 . . . . 0.0 110.567 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.9 mm -107.05 116.05 49.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.046 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 116.54 32.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.796 HG21 HD13 ' A' ' 60' ' ' ILE . 82.1 mt -98.96 116.69 42.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.38 123.99 32.92 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.17 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.5 p -129.26 161.9 29.14 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.664 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -117.12 151.4 47.62 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.895 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.82 -19.08 53.22 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.867 2.378 . . . . 0.0 111.245 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.15 -10.86 59.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.5 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -140.76 66.7 27.69 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.558 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 98.2 Cg_endo -102.64 88.8 0.03 OUTLIER 'Trans proline' 1 N--CA 1.376 -5.41 0 C-N-CA 117.197 -1.402 . . . . 0.0 110.345 171.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -150.9 -47.35 0.12 Allowed 'General case' 1 C--N 1.205 -5.699 0 CA-C-N 110.368 -3.106 . . . . 0.0 102.865 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD21 ' A' ' 21' ' ' LEU . 99.4 m -63.38 -48.27 78.58 Favored 'General case' 0 N--CA 1.386 -3.64 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.679 164.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -62.91 -45.12 94.02 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.522 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 54' ' ' PRO . 32.0 mm-40 -57.3 -43.52 83.3 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.182 -1.407 . . . . 0.0 110.975 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -60.98 -51.59 68.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.845 0.355 . . . . 0.0 111.89 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.796 HD13 HG21 ' A' ' 47' ' ' ILE . 87.2 mt -63.98 -45.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.736 -176.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 54.9 t-20 -58.8 -39.38 80.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -86.74 -31.1 21.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.831 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.17 -34.67 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.408 ' CD2' HG23 ' A' ' 60' ' ' ILE . 91.8 m-85 -103.6 6.82 37.46 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.892 -175.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.4 pttt -61.32 -23.7 65.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 110.835 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.46 -33.58 71.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.536 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -80.15 140.81 36.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.334 0.588 . . . . 0.0 112.38 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -86.9 -43.53 12.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.606 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.562 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -82.14 -0.77 46.37 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.949 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -106.37 121.25 58.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.2 t -123.28 130.68 74.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.248 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.38 131.59 45.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.497 HG13 ' HA ' ' A' ' 48' ' ' ALA . 40.6 pt -126.89 156.71 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.267 0.556 . . . . 0.0 110.573 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.08 134.22 55.03 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 8.9 t -158.42 -171.16 3.35 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.1 m -66.69 1.86 1.61 Allowed 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 126.696 1.999 . . . . 0.0 114.774 -174.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.594 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.37 -24.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.056 0 C-N-CA 125.877 1.703 . . . . 0.0 116.841 -174.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.0 tmtt? -53.31 -33.83 54.94 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.06 120.23 4.66 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -59.22 -50.55 73.57 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.08 -44.8 97.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.94 0.876 . . . . 0.0 109.823 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.96 -42.02 97.47 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.71 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.594 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 8.0 t0 -58.68 -50.94 72.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.17 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.6 mm? -58.78 -42.59 89.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.998 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.532 ' HA ' HG12 ' A' ' 88' ' ' ILE . 17.8 m-80 -59.98 -41.27 91.66 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 67.0 mm-40 -64.52 -44.84 89.6 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.271 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.3 m -63.47 -44.75 93.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 160' ' ' LYS . 24.6 pt -65.06 -28.42 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 0.0 110.79 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.61 -37.77 94.75 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.455 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.56 -2.23 42.18 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -97.51 156.74 16.36 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.752 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -118.58 1.25 11.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.09 155.22 80.27 Favored Pre-proline 0 CA--C 1.502 -0.878 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -56.65 141.92 91.21 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.868 2.379 . . . . 0.0 110.509 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 42.2 p90 -141.83 158.4 43.84 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.372 0.606 . . . . 0.0 111.755 -178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -86.03 143.84 27.9 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.118 -175.025 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 75.6 t -120.32 130.73 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.935 0.894 . . . . 0.0 109.765 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 5' ' ' ILE . 18.7 m -131.34 159.64 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.514 0.674 . . . . 0.0 112.774 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 42.3 t -99.97 153.72 18.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' HG21 ' A' ' 33' ' ' VAL . 80.5 p -88.58 -0.19 57.0 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -173.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 24.7 p-10 -108.82 -3.59 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -174.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.553 ' CD2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER -87.98 115.28 25.34 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.181 177.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -96.27 8.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.72 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.536 ' CB ' HG22 ' A' ' 175' ' ' ILE . 21.9 t-20 -55.93 143.88 30.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.126 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.4 mm? -69.61 80.0 0.42 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.169 0.985 . . . . 0.0 109.257 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -74.38 -1.08 19.38 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.574 -1.648 . . . . 0.0 113.724 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.7 t -57.31 -45.34 84.31 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -76.95 -26.33 53.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.588 0.708 . . . . 0.0 109.841 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 113' ' ' ILE . 37.6 mm -69.73 -43.0 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.646 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.425 ' HA ' HD11 ' A' ' 154' ' ' ILE . 63.5 mt -58.62 -48.54 85.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.381 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -64.6 -41.23 96.37 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.252 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -62.9 -39.38 94.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.086 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.5 mm -61.01 -47.87 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.99 -47.57 92.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.433 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -61.91 -43.7 98.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.081 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.571 ' CD2' ' HE2' ' A' ' 169' ' ' MET . 83.2 t80 -63.86 -49.02 74.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.9 0.381 . . . . 0.0 111.04 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.57 -47.8 84.14 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.89 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.663 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 31.8 m-85 -65.83 -31.4 72.33 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.028 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.93 -45.07 94.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.478 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.9 mt -63.22 -49.44 83.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.329 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 14.8 ptmt -63.64 -23.43 67.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.938 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.34 -41.86 97.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.53 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.11 -41.3 10.56 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 111.23 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 29.6 m -127.47 91.99 44.48 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.54 -12.0 32.35 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 122.595 2.197 . . . . 0.0 112.508 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 23.3 t70 -64.86 -28.84 69.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.123 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 124' ' ' THR . 7.7 p -54.13 130.06 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.19 0.519 . . . . 0.0 111.32 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.6 ' HB3' ' OE1' ' A' ' 164' ' ' GLN . 47.1 mt-10 -115.01 -12.52 11.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.057 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.2 163.34 40.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.939 0.4 . . . . 0.0 111.612 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -138.89 133.3 31.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.752 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -123.6 139.13 54.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.808 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 113' ' ' ILE . 58.4 t -118.22 122.67 70.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.115 0.484 . . . . 0.0 110.505 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -145.0 166.67 24.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.695 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.444 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 9.1 pt -124.39 158.53 61.11 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.645 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 32.3 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 C-N-CA 121.885 1.723 . . . . 0.0 112.119 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.351 0.596 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -61.09 142.03 95.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.595 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.445 ' HB3' HD11 ' A' ' 171' ' ' ILE . . . -126.91 -47.36 1.52 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.111 0.482 . . . . 0.0 111.29 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.33 -153.49 26.42 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.457 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.552 ' HB ' HD11 ' A' ' 96' ' ' LEU . 20.2 pt -107.91 160.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.296 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.8 t-20 -109.9 151.83 26.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.864 -172.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.4 t -123.35 131.75 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 122.963 0.505 . . . . 0.0 110.097 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 155' ' ' ASN . 23.5 m -131.83 150.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.186 0.517 . . . . 0.0 111.238 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.576 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 59.7 m -97.55 160.78 27.91 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.613 174.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 158' ' ' SER . 74.1 Cg_endo -74.06 52.5 2.68 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.672 2.248 . . . . 0.0 111.963 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.64 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.1 mmmt -112.61 109.41 18.93 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -61.99 146.37 50.29 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.281 0.363 . . . . 0.0 111.284 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.13 -146.05 19.49 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.58 141.59 36.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.917 0.389 . . . . 0.0 110.002 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.6 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 27.5 pt20 -133.84 160.8 36.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.82 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -59.37 118.69 6.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.019 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -120.9 126.28 49.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.134 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.52 164.14 13.11 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 121.773 0.797 . . . . 0.0 112.509 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 130.2 67.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 114.231 -1.349 . . . . 0.0 112.745 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.571 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 46.6 ttm -114.14 130.21 56.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.046 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.53 123.11 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.53 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 42.4 pt -112.45 173.22 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.768 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.96 1.72 9.86 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.605 0.717 . . . . 0.0 110.288 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.53 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.2 pm0 -98.73 134.18 42.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.049 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.77 149.61 21.06 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.561 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.536 HG22 ' CB ' ' A' ' 104' ' ' ASN . 1.9 pp -104.08 154.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.559 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.16 113.55 26.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 101' ' ' ASP . 97.6 m-20 -113.43 153.44 28.62 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.67 109.88 21.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASN . . . . . 0.419 ' HB2' ' OD2' ' A' ' 183' ' ' ASP . 45.1 m-80 -104.63 -34.63 8.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.492 0.663 . . . . 0.0 109.67 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -149.47 -178.5 6.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.54 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.486 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -62.58 -36.81 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.826 0.45 . . . . 0.0 111.973 -177.401 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 29.9 m-20 -60.37 -36.02 77.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 58.6 m-20 -61.69 -33.94 74.88 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.936 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.629 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 97.7 mt -61.29 -42.36 98.52 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -61.85 -41.85 98.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.831 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.08 -47.87 84.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.201 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.418 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.91 -46.19 91.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.914 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 9.0 pt-20 -68.9 -31.01 69.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.99 0.424 . . . . 0.0 110.998 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.9 ttm -61.58 -46.07 91.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.298 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.89 -30.64 64.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.335 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.508 0.671 . . . . 0.0 109.624 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 192' ' ' LYS . 7.8 tmtm? . . . . . 0 C--N 1.318 -0.776 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.104 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.8 ptm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.484 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 45.3 m-20 -104.83 165.71 10.88 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.614 0.245 . . . . 0.0 110.801 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.46 134.45 55.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.896 0.379 . . . . 0.0 111.181 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.37 126.25 51.9 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.603 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.666 ' HA ' HG22 ' A' ' 98' ' ' VAL . 70.4 mt -117.55 102.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.476 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 10.2 ptm -92.34 99.06 11.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.964 1.364 . . . . 0.0 111.3 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -114.87 96.7 5.84 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.895 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.799 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.164 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 60.3 Cg_endo . . . . . 0 CA--C 1.532 0.385 0 N-CA-C 113.583 0.57 . . . . 0.0 113.583 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 56' ' ' THR . 35.8 mt -82.22 16.85 1.83 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.29 121.18 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -81.07 125.56 30.35 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.041 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 188' ' ' GLU . 31.3 tp -144.92 117.18 8.43 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.283 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 54.17 39.66 30.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.19 -27.12 10.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.339 0.895 . . . . 0.0 115.339 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.738 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 25.8 ptt180 -146.18 171.8 14.39 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.835 1.318 . . . . 0.0 111.941 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.3 m -82.36 153.57 25.69 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.021 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.5 tt -53.51 -38.9 64.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.092 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 14.0 tt -62.85 -39.67 85.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.68 -39.55 94.3 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.738 ' CE2' ' HG3' ' A' ' 27' ' ' ARG . 27.5 m-85 -61.08 -35.41 76.92 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.493 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 29' ' ' LEU . 76.5 t -71.3 -45.89 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.799 0.333 . . . . 0.0 111.41 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.88 -42.55 96.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.534 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -51.36 -55.43 28.97 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 41.2 Cg_endo -67.86 -37.05 16.53 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.314 1.343 . . . . 0.0 112.584 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.659 HD11 HG11 ' A' ' 98' ' ' VAL . 78.9 mt -65.49 -42.18 92.44 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.414 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.4 tt -63.36 -45.03 93.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.987 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 19.0 ptmt -79.04 -7.84 58.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -74.96 179.7 4.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.32 -22.7 61.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.615 0.766 . . . . 0.0 112.934 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.0 160.75 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.484 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.5 t30 -83.09 -73.24 0.41 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.578 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.69 156.71 26.65 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.037 0.446 . . . . 0.0 110.645 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.86 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -106.79 117.9 35.26 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 60' ' ' ILE . 88.6 mt -100.05 118.92 47.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.609 0.718 . . . . 0.0 110.524 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.22 121.98 31.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.399 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 7' ' ' ALA . 73.0 p -129.83 166.76 19.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.738 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -130.92 158.12 75.97 Favored Pre-proline 0 C--N 1.298 -1.634 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.884 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.17 -21.06 72.26 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.633 2.222 . . . . 0.0 110.902 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -70.45 -23.17 62.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.817 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -138.17 68.36 48.16 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.715 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 69.9 Cg_endo -99.35 84.08 0.05 OUTLIER 'Trans proline' 1 N--CA 1.392 -4.492 0 C-N-CA 116.659 -1.761 . . . . 0.0 108.688 169.244 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.7 mttt -146.1 -52.18 0.24 Allowed 'General case' 1 C--N 1.222 -4.945 0 CA-C-N 109.568 -3.469 . . . . 0.0 102.799 -177.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.523 ' HA ' HD11 ' A' ' 21' ' ' LEU . 96.0 m -63.71 -47.37 81.42 Favored 'General case' 0 N--CA 1.385 -3.708 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.493 164.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.715 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -62.39 -49.36 75.82 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.148 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 4.8 pt-20 -58.09 -36.58 73.07 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 117.564 -1.654 . . . . 0.0 111.526 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -63.68 -51.22 66.06 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.986 0.422 . . . . 0.0 111.63 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.839 HD13 HG21 ' A' ' 47' ' ' ILE . 89.6 mt -61.85 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.192 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.725 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 54.6 t-20 -57.85 -45.3 86.47 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.694 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -73.49 -44.92 56.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.396 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.22 90.26 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.327 0.584 . . . . 0.0 111.349 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 68.2 m-85 -109.94 33.56 4.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.253 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 2.7 mmpt? -60.75 -25.49 66.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -90.95 11.53 22.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 55.0 p90 -43.71 133.96 4.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.02 -48.97 3.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.414 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.7 p-10 -118.92 10.11 12.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.013 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 86.4 mt -100.66 122.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.606 0.717 . . . . 0.0 111.312 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.78 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.802 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.06 131.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.53 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.3 pt -125.78 155.81 35.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.65 131.3 56.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.196 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -160.12 -167.94 2.07 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 51.6 m -64.03 1.96 0.61 Allowed 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 127.126 2.17 . . . . 0.0 114.556 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.03 -18.76 0.0 OUTLIER Glycine 0 N--CA 1.514 3.851 0 C-N-CA 126.484 1.993 . . . . 0.0 117.265 -175.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -58.23 -38.24 76.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -112.33 129.76 9.21 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -61.34 -51.25 69.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -74.14 -30.32 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.746 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.07 -43.13 88.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.531 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.8 t0 -61.52 -50.83 71.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.947 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 88' ' ' ILE . 1.7 mm? -55.69 -47.83 76.12 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.925 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.0 m-80 -60.14 -42.86 95.77 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.56 -44.42 86.83 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.362 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.91 -42.0 97.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.225 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' A' ' 85' ' ' ASN . 22.3 pt -68.56 -23.67 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.374 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.02 -14.09 80.54 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.456 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -98.93 -0.52 42.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 99.3 m-85 -126.5 150.08 48.97 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.658 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -109.9 3.48 20.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.599 0.714 . . . . 0.0 109.626 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -128.92 153.34 80.1 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.498 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.92 148.75 76.95 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.679 2.253 . . . . 0.0 112.058 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 50.6 p90 -144.24 163.17 34.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.26 0.553 . . . . 0.0 111.79 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.556 HD21 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -85.63 140.92 30.17 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.735 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 79.6 t -117.29 133.41 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.174 0.99 . . . . 0.0 108.824 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 5' ' ' ILE . 14.1 m -128.39 162.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.88 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 t -98.6 142.58 30.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.3 p -70.95 -13.26 61.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -110.84 12.32 22.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 70.4 mt -77.21 113.2 14.71 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.205 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 tt -129.49 122.04 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.719 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 63.4 t30 162.02 178.93 0.01 OUTLIER 'General case' 0 C--O 1.248 0.985 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.4 103.51 4.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.576 ' HA ' HD12 ' A' ' 109' ' ' ILE . 37.6 mtmm -99.79 -1.11 38.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.404 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -56.64 -41.11 76.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -169.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -85.07 -25.83 27.35 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.984 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 106' ' ' LYS . 84.4 mt -65.62 -42.75 93.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.536 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HA ' HD11 ' A' ' 154' ' ' ILE . 58.5 mt -59.71 -49.54 83.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.066 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.21 -38.85 92.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -62.64 -42.39 99.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.55 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.0 mm -63.96 -48.31 86.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.097 0.475 . . . . 0.0 110.793 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 1' ' ' MET . 79.2 t -60.75 -48.0 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.534 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -61.85 -47.5 84.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.301 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.513 ' CE2' HD11 ' A' ' 120' ' ' ILE . 44.7 t80 -64.42 -45.07 89.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 77.1 t80 -58.33 -48.62 79.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.229 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.426 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 20.0 m-85 -60.68 -37.05 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.437 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.65 -44.72 96.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.279 0.561 . . . . 0.0 109.55 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.552 ' CG2' HG21 ' A' ' 127' ' ' VAL . 74.8 mt -62.99 -43.5 99.11 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.801 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -60.1 -42.59 95.0 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.615 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.53 96.01 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.457 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -83.03 -36.85 24.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 0.0 111.797 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.7 m -133.66 89.36 31.07 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.28 -15.51 35.35 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.95 -31.96 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.206 0.603 . . . . 0.0 111.533 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.583 HG22 ' HE2' ' A' ' 165' ' ' LYS . 87.9 t -69.45 126.51 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -120.62 5.37 10.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.585 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.37 24.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.687 0.28 . . . . 0.0 111.205 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -137.46 129.5 29.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.05 142.08 51.02 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 152' ' ' ALA . 18.9 m -121.24 144.75 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.439 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.455 ' C ' ' HB2' ' A' ' 152' ' ' ALA . 63.3 mtm -134.99 153.84 51.94 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 171' ' ' ILE . 9.3 pt -131.84 145.53 57.87 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.026 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 51.4 Cg_exo . . . . . 0 C--O 1.235 0.372 0 C-N-CA 122.425 2.083 . . . . 0.0 113.12 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.681 0.277 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.45 146.76 56.82 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.264 1.976 . . . . 0.0 111.715 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 132' ' ' VAL . . . -88.95 -10.22 48.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.782 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 161.48 -99.0 0.17 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.748 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.556 HD12 HD21 ' A' ' 96' ' ' LEU . 30.6 pt -118.79 161.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.237 0.541 . . . . 0.0 112.23 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.516 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.3 t-20 -119.54 156.59 30.0 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.476 -176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' A' ' 117' ' ' PHE . 94.0 t -124.84 133.54 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 122.334 0.253 . . . . 0.0 110.609 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.42 HG13 ' OD1' ' A' ' 155' ' ' ASN . 32.3 m -131.12 150.33 34.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.367 0.603 . . . . 0.0 111.988 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -98.92 159.13 31.03 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.095 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 17.3 Cg_exo -68.15 91.28 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.362 2.041 . . . . 0.0 112.037 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -125.19 -165.85 1.46 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.073 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.74 147.4 39.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.73 -116.82 5.84 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.261 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -129.87 145.27 51.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -134.36 163.89 28.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 127' ' ' VAL . 1.6 tmtp? -61.03 128.01 34.34 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.09 139.28 52.6 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.095 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.68 160.78 14.83 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 121.727 0.775 . . . . 0.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.83 129.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 14.7 tmm? -137.27 136.04 37.7 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.15 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.7 129.93 63.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.062 0.458 . . . . 0.0 110.769 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.4 pt -120.52 176.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.426 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.55 69.54 1.31 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.664 0.745 . . . . 0.0 109.128 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' A' ' 171' ' ' ILE . 77.5 mm-40 -128.59 143.59 50.99 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.205 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.95 140.63 31.2 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.985 0.898 . . . . 0.0 113.082 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.9 pt -139.55 151.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.435 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 103' ' ' ILE . 93.0 m-85 -120.55 107.93 13.44 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.176 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.457 ' OD1' HD23 ' A' ' 102' ' ' LEU . 98.0 m-20 -93.96 110.8 22.46 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 183' ' ' ASP . 98.2 mt -81.32 114.44 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.354 0.597 . . . . 0.0 111.337 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -113.75 -20.97 10.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.1 p -131.59 164.9 24.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.269 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.752 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -60.87 -27.63 68.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.104 176.311 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -68.58 -39.24 81.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.44 0.638 . . . . 0.0 109.95 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.704 ' HB2' HG23 ' A' ' 178' ' ' ILE . 71.9 m-20 -61.52 -33.57 74.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.514 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 178' ' ' ILE . 96.1 mt -59.95 -44.77 94.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.224 0.535 . . . . 0.0 109.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 7.8 tmtm? -67.5 -42.46 82.84 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.759 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tt -62.09 -46.93 86.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.944 0.402 . . . . 0.0 110.102 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.5 -41.24 98.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.757 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.9 pp20? -68.02 -30.91 70.26 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.651 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.1 mmm -61.51 -43.8 98.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.4 pp -74.85 -39.74 61.41 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.127 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.3 -40.59 96.24 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.44 0.638 . . . . 0.0 110.275 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 C--N 1.302 -1.458 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.575 179.553 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.1 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -113.53 165.11 12.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.433 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -117.29 142.69 46.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 48' ' ' ALA . 30.2 tp -120.35 127.51 52.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.275 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 98' ' ' VAL . 64.5 mt -117.69 108.27 24.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.016 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.412 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 60.4 ttm -82.31 92.71 7.01 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-O 121.84 0.829 . . . . 0.0 111.545 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.62 97.53 5.91 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.406 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.058 0 C-N-CA 119.968 -1.11 . . . . 0.0 113.129 177.85 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 24.4 Cg_exo . . . . . 0 N--CA 1.48 0.73 0 CA-C-O 120.998 0.333 . . . . 0.0 112.263 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 59' ' ' TYR . 8.8 mp -77.23 26.87 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.6 119.44 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.81 136.65 32.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-O 122.011 0.91 . . . . 0.0 113.048 -174.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 184' ' ' LEU . 80.2 mt -136.83 124.69 22.62 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.291 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 191' ' ' LEU . 74.3 m 53.95 30.54 11.83 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.39 20.54 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.913 -1.136 . . . . 0.0 115.794 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 34.7 ptt180 -146.22 166.35 26.47 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.085 1.443 . . . . 0.0 112.434 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.3 m -73.29 156.58 38.31 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.222 -176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 20' ' ' PRO . 5.1 tt -57.53 -44.69 85.31 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 124.395 1.078 . . . . 0.0 110.475 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -60.2 -39.94 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.434 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 13.8 t70 -63.95 -41.69 97.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.249 0.547 . . . . 0.0 109.569 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' CD2' ' HG3' ' A' ' 27' ' ' ARG . 5.7 m-85 -61.06 -36.57 79.93 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.158 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.1 t -66.87 -42.99 89.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 0.0 110.811 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.6 t -62.85 -45.02 99.91 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.576 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -50.91 -53.61 45.85 Favored Pre-proline 0 CA--C 1.57 1.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 28.8 Cg_endo -63.94 -39.42 32.83 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.518 1.479 . . . . 0.0 112.387 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.585 HD11 HG11 ' A' ' 98' ' ' VAL . 83.3 mt -67.13 -39.68 86.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.609 0.719 . . . . 0.0 110.018 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.2 tp -59.31 -45.67 90.68 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.515 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 22.2 ptmt -84.99 -8.71 58.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.493 ' OG ' HG12 ' A' ' 42' ' ' VAL . 77.9 p -74.58 174.74 8.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.213 0.53 . . . . 0.0 111.668 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -60.32 -18.51 50.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.056 0.942 . . . . 0.0 112.603 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 3' ' ' ALA . 11.4 p -63.64 150.76 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 120.909 0.385 . . . . 0.0 111.999 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -76.7 -75.91 0.18 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -110.43 152.13 26.67 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.057 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.47 110.99 33.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -104.16 117.86 35.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 60' ' ' ILE . 95.6 mt -97.88 119.19 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.602 0.715 . . . . 0.0 110.568 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.37 122.13 32.3 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.811 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 7' ' ' ALA . 41.9 p -126.59 155.0 43.17 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 50.1 m -98.79 145.1 29.35 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.871 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 75' ' ' THR . 51.8 Cg_exo -59.27 -28.78 88.58 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.197 2.598 . . . . 0.0 111.348 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 -6.89 58.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.963 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 7.7 p -134.63 66.47 69.59 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.414 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 83.0 Cg_endo -103.73 85.62 0.03 OUTLIER 'Trans proline' 1 N--CA 1.377 -5.332 0 C-N-CA 116.764 -1.691 . . . . 0.0 109.246 169.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 34.4 mmtp -145.45 -52.04 0.26 Allowed 'General case' 1 C--N 1.214 -5.318 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.45 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 99.0 m -63.48 -48.39 77.86 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 111.958 -2.383 . . . . 0.0 106.363 165.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.699 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -63.1 -48.18 79.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.913 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.8 pt-20 -58.64 -34.97 71.79 Favored 'General case' 0 C--N 1.365 1.266 0 C-N-CA 117.481 -1.687 . . . . 0.0 110.335 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.501 ' CB ' HD21 ' A' ' 21' ' ' LEU . 48.8 t80 -67.57 -52.25 40.9 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 120.86 0.362 . . . . 0.0 111.828 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 47' ' ' ILE . 96.8 mt -63.62 -46.54 94.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.837 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.1 t30 -58.92 -44.0 91.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 34.5 t -69.72 -44.62 69.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.18 90.14 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.305 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' HD2' HG23 ' A' ' 60' ' ' ILE . 78.7 m-85 -105.83 25.69 10.55 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.194 -176.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 9.9 mmmm -62.22 -21.39 65.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.857 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.26 10.57 21.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.374 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.3 p90 -44.18 138.04 3.18 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -176.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.596 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -101.62 -52.55 3.18 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.913 0.863 . . . . 0.0 109.361 172.59 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -121.45 12.67 10.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.163 -1.381 . . . . 0.0 111.467 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.6 mt -99.1 128.44 50.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.291 0.567 . . . . 0.0 111.053 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 67.3 t -128.04 132.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.18 132.15 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 4' ' ' LEU . 40.1 pt -126.96 156.89 38.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.624 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 51' ' ' PRO . 10.5 t70 -114.74 131.96 56.6 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.201 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.496 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 12.9 t -161.95 -171.87 3.04 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.95 0.881 . . . . 0.0 113.218 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.1 m -74.18 3.58 6.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.602 1.961 . . . . 0.0 114.605 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.94 -21.82 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 C-N-CA 126.638 2.066 . . . . 0.0 117.605 -173.126 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 76' ' ' SER . 58.4 tptt -58.53 -37.88 76.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.88 123.11 6.26 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.478 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.8 t80 -59.45 -50.4 74.07 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.14 -47.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 55.1 mt-10 -59.83 -44.94 93.8 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.798 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.615 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 5.5 t0 -59.29 -51.39 70.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.437 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.2 mm? -59.98 -41.74 92.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.962 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.418 ' HA ' HG12 ' A' ' 88' ' ' ILE . 91.6 m-20 -60.42 -43.19 97.0 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 72.4 mm-40 -65.72 -44.42 86.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.57 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.8 m -62.31 -43.16 99.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.114 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.9 pt -66.08 -24.64 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.28 77.47 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.411 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -104.75 -21.47 13.36 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 82.2 m-85 -89.1 140.92 28.96 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.986 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -104.42 -6.32 20.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.417 0.627 . . . . 0.0 109.817 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -132.24 152.49 80.22 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.443 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.94 142.03 54.27 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 123.515 2.81 . . . . 0.0 112.223 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -139.64 154.12 47.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.503 0.668 . . . . 0.0 111.595 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 154' ' ' ILE . 2.1 tm? -87.05 132.81 33.7 Favored 'General case' 0 C--O 1.193 -1.889 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.726 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 68.4 t -108.37 127.87 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.225 0.61 . . . . 0.0 109.559 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 5' ' ' ILE . 8.4 m -126.53 156.62 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.759 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.47 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 67.7 m -101.03 132.92 46.23 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 170.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.48 ' O ' HD21 ' A' ' 29' ' ' LEU . 69.3 m -67.46 -37.39 82.87 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.499 0.666 . . . . 0.0 111.532 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.37 -0.85 34.42 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.4 pp -91.63 116.26 28.73 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.15 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.4 mt -103.1 119.6 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.036 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.439 HD21 ' HB2' ' A' ' 173' ' ' GLU . 64.9 t30 178.38 163.5 0.71 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.145 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.54 98.6 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.636 ' HA ' HD12 ' A' ' 109' ' ' ILE . 15.6 ptpt -97.8 -2.28 41.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.908 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -60.26 -38.94 85.03 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.61 -27.17 37.4 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.432 1.111 . . . . 0.0 109.36 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.726 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -70.08 -39.52 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.759 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 107' ' ' SER . 65.3 mt -56.92 -49.21 79.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.944 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -65.07 -40.86 95.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.195 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.7 m -63.32 -40.67 97.97 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.548 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.726 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.26 -48.33 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.209 0.528 . . . . 0.0 110.674 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.658 HG22 ' SD ' ' A' ' 1' ' ' MET . 69.4 t -61.43 -48.21 89.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.93 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.67 -43.79 97.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.966 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.751 ' CE2' HD11 ' A' ' 120' ' ' ILE . 73.1 t80 -63.83 -46.58 84.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -58.11 -48.19 80.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.891 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.502 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 30.0 m-85 -62.03 -36.19 80.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.299 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.9 t -61.53 -46.66 88.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.997 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.751 HD11 ' CE2' ' A' ' 116' ' ' TYR . 67.3 mt -66.03 -47.06 86.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.854 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -64.03 -25.09 67.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.997 -178.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.55 99.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.788 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -83.91 -39.05 20.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.038 0.447 . . . . 0.0 110.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.621 ' O ' HG12 ' A' ' 127' ' ' VAL . 90.2 m -132.65 92.51 26.89 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.31 -19.04 48.59 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.263 2.642 . . . . 0.0 113.069 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 39.0 t70 -62.01 -32.31 72.78 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.624 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -70.61 118.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.596 0.712 . . . . 0.0 109.829 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.3 mt-10 -122.43 13.11 10.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.402 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.3 155.01 37.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 133.25 27.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -122.79 139.61 53.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.373 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.614 HG21 ' CD1' ' A' ' 113' ' ' ILE . 95.8 t -121.18 123.39 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.54 0.686 . . . . 0.0 111.179 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 3.1 ptm -145.48 162.5 37.22 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.551 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 150' ' ' VAL . 22.6 pt -123.15 158.07 59.05 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.455 -0.752 0 C-N-CA 121.816 1.677 . . . . 0.0 110.675 177.135 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 134' ' ' ILE . 29.6 m . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.36 139.02 87.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.504 2.136 . . . . 0.0 110.676 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.669 ' HA ' HD13 ' A' ' 175' ' ' ILE . . . -132.62 -36.84 1.07 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.264 0.554 . . . . 0.0 111.337 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.81 -149.55 25.8 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.521 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 96' ' ' LEU . 17.2 pt -119.44 161.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.045 -0.577 . . . . 0.0 110.46 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.571 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.6 t-20 -110.27 152.12 26.53 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.475 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.87 131.6 72.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.321 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.7 m -134.45 149.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.399 0.619 . . . . 0.0 111.243 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 58.5 m -98.51 153.63 37.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 14.8 Cg_exo -69.79 89.81 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.951 1.768 . . . . 0.0 110.99 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -116.72 -160.14 0.75 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -136.97 149.47 47.56 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 62.93 -124.17 31.96 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.657 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.02 149.22 50.46 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -131.62 163.99 26.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.008 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -57.77 128.5 37.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.027 0.441 . . . . 0.0 111.873 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -125.53 129.4 49.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.67 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -94.56 161.96 14.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.593 0.711 . . . . 0.0 112.212 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 131' ' ' ALA . 46.8 mm -115.69 130.84 69.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.303 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -131.17 138.75 49.58 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.681 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 133' ' ' MET . 76.0 t -108.12 129.64 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.79 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.541 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 36.7 pt -101.3 174.51 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.986 0.422 . . . . 0.0 111.321 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -99.77 -21.18 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HG3' HD11 ' A' ' 109' ' ' ILE . 1.6 pm0 -99.08 138.32 36.36 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.811 0.815 . . . . 0.0 112.568 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.02 151.92 18.76 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.458 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 152' ' ' ALA . 23.6 pt -107.41 155.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -102.98 106.91 17.54 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.112 0.482 . . . . 0.0 110.824 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.85 121.47 37.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 184' ' ' LEU . 40.9 mm -71.19 85.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.339 0.59 . . . . 0.0 112.396 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -70.65 -38.8 73.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.323 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 81.0 p -129.57 162.92 27.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.104 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.522 178.124 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.45 -36.29 79.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.108 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.43 -40.38 96.36 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.482 ' CD1' HD21 ' A' ' 24' ' ' LEU . 51.6 tp -62.64 -42.71 99.75 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.059 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.8 ttmt -61.0 -42.54 98.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.67 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.93 -43.21 99.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.01 99.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.022 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.7 pt-20 -71.05 -36.02 72.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.887 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 35.2 mmt -64.4 -39.99 94.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.28 -47.47 84.19 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.403 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.46 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 mt -63.9 -43.2 96.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.902 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.044 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.9 ttp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 61.8 m-20 -98.88 166.97 11.04 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.934 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -114.34 130.98 56.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 98' ' ' VAL . 38.4 tp -106.69 125.46 51.04 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.521 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.681 ' HA ' HG22 ' A' ' 98' ' ' VAL . 60.4 mt -116.65 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.533 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 12.7 ptm -95.92 92.11 6.34 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.941 1.353 . . . . 0.0 112.908 -173.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.597 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -116.82 97.79 6.16 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.936 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.149 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.797 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.476 0.452 0 N-CA-C 113.052 0.366 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 69.1 mt -88.83 11.34 18.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mt -69.87 115.73 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -82.11 140.88 33.56 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.663 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.404 HD13 ' CD1' ' A' ' 184' ' ' LEU . 62.8 tp -130.97 107.59 9.21 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.698 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m 58.25 20.94 7.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.218 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 -80.87 0.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.926 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.549 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.5 mtt180 -93.7 172.2 8.4 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.422 0.629 . . . . 0.0 112.107 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.1 m -79.25 162.75 25.47 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.37 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.5 mt -59.08 -45.52 90.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.218 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.597 HD12 ' CB ' ' A' ' 7' ' ' ALA . 11.8 tt -65.49 -37.91 81.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.168 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 6.9 t0 -60.59 -43.13 97.73 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-O 121.636 0.731 . . . . 0.0 109.075 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -65.86 -36.53 83.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.595 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 29' ' ' LEU . 58.6 t -66.11 -43.29 92.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.8 t -63.49 -45.35 98.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.075 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -49.75 -52.59 49.94 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.06 -36.51 29.45 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.412 1.408 . . . . 0.0 112.44 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.533 HD11 HG11 ' A' ' 98' ' ' VAL . 83.7 mt -68.48 -37.57 80.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.576 0.703 . . . . 0.0 110.553 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.1 tp -59.11 -43.93 91.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.38 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -89.3 -7.19 55.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.523 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.49 ' OG ' HG12 ' A' ' 42' ' ' VAL . 83.3 p -72.52 172.0 11.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.206 0.527 . . . . 0.0 111.605 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.82 5.08 2.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.783 -175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' A' ' 3' ' ' ALA . 11.2 p -77.96 152.53 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.821 -0.549 . . . . 0.0 111.2 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.447 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.6 t30 -69.23 -77.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.32 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -117.69 156.46 28.18 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 111.021 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.3 114.61 47.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.86 119.79 40.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.626 HG21 HD13 ' A' ' 60' ' ' ILE . 95.9 mt -99.91 119.66 48.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.565 0.698 . . . . 0.0 110.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 6' ' ' MET . . . -89.42 121.82 32.03 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.293 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.3 p -131.7 169.53 16.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.031 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.3 p -131.29 158.83 74.13 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.412 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.21 -19.24 68.14 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.576 2.184 . . . . 0.0 110.782 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -70.3 -25.39 63.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.595 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -135.76 66.65 63.38 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.676 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.8 Cg_endo -101.26 85.32 0.04 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.814 0 C-N-CA 116.869 -1.62 . . . . 0.0 109.087 169.303 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 32.1 mmtm -155.29 -46.82 0.08 Allowed 'General case' 1 C--N 1.209 -5.511 0 CA-C-N 109.182 -3.644 . . . . 0.0 102.462 -179.072 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' HD21 ' A' ' 21' ' ' LEU . 97.8 m -64.05 -49.07 73.79 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 163.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.676 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -62.85 -50.36 71.24 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.1 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.6 pt-20 -64.35 -30.05 71.11 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 116.722 -1.991 . . . . 0.0 112.759 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.07 -50.94 66.38 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.327 0.584 . . . . 0.0 111.208 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.626 HD13 HG21 ' A' ' 47' ' ' ILE . 93.3 mt -63.13 -45.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.426 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -57.87 -44.04 86.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.576 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 27.7 t -69.64 -40.89 76.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.804 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.51 93.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.958 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.531 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 57.0 m-85 -116.41 42.31 2.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 62' ' ' SER . 56.4 mtmt -58.93 -35.46 73.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.218 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -88.47 12.37 14.54 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.15 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 53.6 p90 -39.64 131.87 1.7 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 -48.22 4.26 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -116.82 13.17 14.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.147 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -104.99 124.46 59.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.267 0.556 . . . . 0.0 110.426 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.29 133.51 68.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -103.57 130.68 53.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.276 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 48' ' ' ALA . 43.1 pt -128.48 157.1 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.749 0.785 . . . . 0.0 111.347 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -107.82 136.52 47.41 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.703 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 7.8 t -159.96 -173.84 4.27 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -74.34 5.09 4.9 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 127.328 2.251 . . . . 0.0 114.19 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.21 -13.81 0.0 OUTLIER Glycine 1 N--CA 1.525 4.632 0 C-N-CA 127.184 2.326 . . . . 0.0 117.646 -174.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -57.39 -39.56 76.34 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.531 ' HA3' ' OE1' ' A' ' 82' ' ' GLU . . . -116.32 132.8 10.38 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.443 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.4 t80 -61.29 -52.81 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.6 -39.81 76.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 121.755 0.788 . . . . 0.0 110.071 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' OE1' ' HA3' ' A' ' 79' ' ' GLY . 48.7 mt-10 -57.93 -43.49 86.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.548 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.56 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.5 t0 -60.59 -49.89 75.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.671 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 mm? -57.14 -40.44 77.16 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.772 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.453 ' HA ' HG12 ' A' ' 88' ' ' ILE . 93.2 m-20 -60.05 -42.96 95.6 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.626 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.658 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 46.0 mm-40 -66.86 -43.38 83.76 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.15 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.522 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.1 m -62.18 -45.01 95.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.277 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 160' ' ' LYS . 30.3 pt -64.92 -27.44 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 120.789 0.328 . . . . 0.0 110.911 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.45 -22.1 69.22 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.87 7.25 19.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.522 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 76.9 m-85 -109.86 143.17 40.14 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.05 -0.406 . . . . 0.0 111.274 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.6 m -100.67 -11.63 19.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.337 0.589 . . . . 0.0 110.382 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 38.6 mt-10 -133.19 162.46 57.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.327 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 1' ' ' MET . 38.1 Cg_endo -64.65 156.73 59.53 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.872 . . . . 0.0 111.466 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.497 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 46.6 p90 -143.94 156.6 44.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.526 0.679 . . . . 0.0 111.663 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 154' ' ' ILE . 1.6 tm? -86.33 135.45 33.52 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.616 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 63.6 t -110.85 130.21 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 123.5 0.72 . . . . 0.0 109.146 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 5' ' ' ILE . 4.9 m -128.34 163.35 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.272 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 69.8 m -98.7 141.92 30.92 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -88.21 -3.41 58.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 177' ' ' ASN . 10.9 p-10 -108.95 3.98 22.83 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 175' ' ' ILE . 75.0 mt -91.11 132.98 35.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.29 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -68.3 171.24 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.123 0.487 . . . . 0.0 111.717 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -81.72 78.53 8.44 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -122.42 -6.27 8.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.677 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.4 pttp -84.41 0.16 50.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.85 -1.523 . . . . 0.0 113.83 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.3 p -53.86 -42.9 69.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -86.59 -26.8 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.071 0.939 . . . . 0.0 109.852 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.695 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -64.57 -37.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.405 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.6 mt -54.77 -49.18 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.584 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -67.55 -39.04 84.98 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.507 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.9 m -60.63 -42.22 96.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -63.54 -47.77 89.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.165 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.465 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.4 t -61.56 -48.76 87.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.328 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.39 -42.57 98.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.988 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CE2' HD11 ' A' ' 120' ' ' ILE . 58.0 t80 -64.55 -47.33 79.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.734 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 72.3 t80 -59.04 -48.26 82.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.015 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 25.1 m-85 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.521 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 47.7 t -61.69 -47.08 86.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.108 0.48 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.667 HG22 HG11 ' A' ' 127' ' ' VAL . 68.4 mt -65.04 -48.83 82.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.886 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.545 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 19.8 ptmt -66.03 -26.6 67.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.95 97.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.598 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.57 -38.05 26.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.874 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 127' ' ' VAL . 45.7 m -132.1 96.49 19.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.694 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.2 -14.14 42.07 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 122.772 2.315 . . . . 0.0 113.273 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 35.4 t70 -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.667 HG11 HG22 ' A' ' 120' ' ' ILE . 9.1 p -71.33 120.59 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.376 0.607 . . . . 0.0 110.069 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 41.4 mt-10 -127.64 19.2 6.75 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.782 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.27 150.15 29.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.485 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 167' ' ' GLU . 0.4 OUTLIER -137.81 130.75 30.14 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.157 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.7 54.93 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.715 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.848 HG12 ' HB3' ' A' ' 152' ' ' ALA . 47.4 t -116.95 122.46 70.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 ptm -144.69 158.26 43.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.6 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' A' ' 152' ' ' ALA . 6.6 pt -130.77 165.6 33.51 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.107 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 C--N 1.348 0.552 0 C-N-CA 122.536 2.157 . . . . 0.0 112.378 178.315 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 134' ' ' ILE . 31.7 m . . . . . 0 N--CA 1.444 -0.736 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 139.6 89.08 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.75 2.3 . . . . 0.0 110.931 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.848 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -103.13 2.88 35.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 166.87 -100.66 0.17 Allowed Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 118.937 -1.602 . . . . 0.0 113.503 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.515 ' CG1' HG13 ' A' ' 113' ' ' ILE . 28.2 pt -124.77 161.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.75 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.544 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 7.7 t-20 -120.17 155.11 33.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.861 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.72 130.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 122.383 0.273 . . . . 0.0 110.612 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.526 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.9 m -136.68 152.0 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.41 0.624 . . . . 0.0 112.001 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.1 t -97.33 145.11 29.08 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 64.9 Cg_endo -70.85 74.66 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 88' ' ' ILE . 75.8 mmtt -105.0 132.0 51.8 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.582 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -81.87 74.0 8.88 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.05 -146.25 13.71 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -118.74 144.19 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.048 0.424 . . . . 0.0 109.992 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -134.28 166.38 22.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.29 129.8 43.84 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -125.07 126.89 46.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.57 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 130' ' ' LEU . 28.7 mm-40 -93.96 162.36 13.92 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 121.558 0.694 . . . . 0.0 111.582 176.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -117.31 129.57 73.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.977 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.463 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 49.8 ttm -116.16 131.53 56.92 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.623 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 133' ' ' MET . 7.4 p -119.68 128.21 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.543 HD11 ' HB1' ' A' ' 152' ' ' ALA . 33.6 pt -119.95 172.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.541 -176.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -109.33 -2.33 17.91 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.458 ' CG ' HD12 ' A' ' 171' ' ' ILE . 4.1 pt-20 -97.99 131.13 44.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.666 0.746 . . . . 0.0 110.401 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.19 149.38 21.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.937 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.543 HD13 HD22 ' A' ' 102' ' ' LEU . 1.7 pp -123.84 154.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.218 171.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.85 137.38 52.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.552 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 9.3 p30 -110.39 127.73 55.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.08 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.535 HD13 ' OD2' ' A' ' 183' ' ' ASP . 16.9 mm -88.59 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.77 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.3 -0.37 56.71 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.313 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.8 t -148.11 151.39 35.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.655 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.658 ' HD2' ' H ' ' A' ' 181' ' ' LYS . 0.2 OUTLIER -62.09 -37.14 83.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.302 -177.642 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -61.56 -41.72 97.79 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.417 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.535 ' OD2' HD13 ' A' ' 178' ' ' ILE . 11.6 t70 -63.6 -36.05 82.54 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 178' ' ' ILE . 59.4 tp -58.52 -43.44 89.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.625 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 60.7 tttm -62.21 -43.72 98.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.718 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.7 tt -61.39 -45.05 95.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.04 98.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.013 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 12.5 pt-20 -66.34 -33.43 75.72 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -64.89 -40.25 94.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.643 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 88.2 mt -64.83 -43.19 93.86 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.362 0.601 . . . . 0.0 110.09 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.26 -40.76 97.27 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.584 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.518 178.679 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 19.3 m-20 -97.93 165.9 11.7 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -114.69 130.48 56.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.279 0.562 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.0 122.15 45.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.704 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -117.98 116.23 50.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.238 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.501 ' CE ' HD22 ' A' ' 84' ' ' LEU . 38.3 mtt -89.05 96.57 10.78 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 122.32 1.057 . . . . 0.0 113.638 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.43 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.284 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.479 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.446 -178.813 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 114.523 0.932 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 39.6 mt -97.75 4.69 49.85 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.31 123.78 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.93 139.38 31.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.818 -177.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.55 108.16 12.82 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.299 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.9 m 54.5 26.24 7.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.135 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.91 -101.58 0.2 Allowed Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.668 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 75.3 mtt-85 -88.03 168.36 12.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.105 0.479 . . . . 0.0 111.969 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.9 m -79.5 163.81 24.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 33' ' ' VAL . 67.1 mt -57.89 -45.28 86.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -39.5 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.785 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 18.8 t70 -65.74 -39.58 91.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 110.038 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -63.69 -34.62 78.26 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.605 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 100' ' ' SER . 75.8 t -66.4 -45.36 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.3 -41.04 88.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.592 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -50.88 -54.52 36.07 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 40' ' ' SER . 56.5 Cg_endo -71.36 -36.47 6.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.585 1.523 . . . . 0.0 112.249 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.453 HD11 HG11 ' A' ' 98' ' ' VAL . 84.8 mt -64.97 -41.8 95.12 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -59.95 -46.32 89.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -82.03 -9.07 59.67 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 59.3 p -74.28 -177.94 3.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.539 0.685 . . . . 0.0 112.202 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HD2' HG11 ' A' ' 114' ' ' VAL . 23.8 ttmm -56.26 -26.32 51.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.253 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.69 161.91 2.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.677 0.751 . . . . 0.0 112.989 -174.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -81.07 -78.42 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -117.99 161.95 18.97 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.027 0.441 . . . . 0.0 111.128 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 3' ' ' ALA . 48.9 mm -109.34 116.53 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.72 114.81 28.71 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.526 HG21 HD13 ' A' ' 60' ' ' ILE . 94.3 mt -97.24 117.82 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.569 0.7 . . . . 0.0 110.66 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.85 119.29 28.04 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.381 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 7' ' ' ALA . 69.8 p -121.42 155.92 33.82 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.57 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 35.8 m -105.45 145.66 31.24 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.733 -177.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 53.6 Cg_exo -57.96 -29.83 87.86 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.449 2.766 . . . . 0.0 112.01 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.16 -2.84 56.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 2.1 p -139.03 67.07 40.47 Favored Pre-proline 0 CA--C 1.498 -1.049 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.968 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.4 Cg_endo -106.99 86.59 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.11 0 C-N-CA 117.115 -1.456 . . . . 0.0 110.486 169.206 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 29.5 mtmm -144.06 -48.1 0.28 Allowed 'General case' 1 C--N 1.219 -5.081 0 CA-C-N 109.973 -3.285 . . . . 0.0 103.424 177.743 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.419 HG21 ' HB1' ' A' ' 7' ' ' ALA . 96.7 m -61.8 -48.9 78.53 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 112.549 -2.114 . . . . 0.0 106.054 164.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.13 -49.66 75.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.963 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.2 pt-20 -59.78 -34.52 73.11 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.698 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.14 -50.8 66.76 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.103 0.477 . . . . 0.0 111.088 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.526 HD13 HG21 ' A' ' 47' ' ' ILE . 97.3 mt -64.0 -41.59 92.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.884 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 57' ' ' LYS . 87.9 m-20 -57.74 -40.99 80.94 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.264 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 4.5 t -82.04 -39.12 23.96 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.895 0.378 . . . . 0.0 110.575 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.09 93.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.363 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 60' ' ' ILE . 81.0 m-85 -110.19 34.59 3.81 Favored 'General case' 0 C--O 1.206 -1.191 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.757 -176.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 10.9 mmmm -61.51 -25.04 67.02 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.09 0.471 . . . . 0.0 111.035 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -89.38 11.08 20.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.299 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 53.8 p90 -43.32 127.4 4.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -103.0 -49.05 3.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.945 0.878 . . . . 0.0 109.661 172.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -117.97 11.87 13.54 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.935 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.96 125.21 57.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.27 0.557 . . . . 0.0 110.302 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.45 131.76 71.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.378 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.5 132.63 53.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.138 0.494 . . . . 0.0 109.67 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.6 pt -125.98 152.16 32.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.288 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -119.83 130.49 54.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.452 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.47 HG23 ' CG ' ' A' ' 83' ' ' ASP . 11.6 t -165.26 -167.42 1.17 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 78' ' ' LYS . 73.7 m -59.42 0.59 0.11 Allowed 'General case' 0 C--O 1.198 -1.61 0 C-N-CA 127.383 2.273 . . . . 0.0 116.082 -173.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' N ' ' HB2' ' A' ' 83' ' ' ASP . . . -31.61 -22.36 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 C-N-CA 125.805 1.669 . . . . 0.0 116.972 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.2 tmmt? -56.84 -35.51 68.91 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.83 113.62 3.81 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -59.31 -49.08 79.19 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.96 -48.21 89.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.713 0.768 . . . . 0.0 110.4 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.53 -45.91 92.18 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.271 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 75' ' ' THR . 28.6 t0 -63.09 -50.03 72.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.385 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -53.61 -47.39 70.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.237 0.542 . . . . 0.0 109.61 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.556 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.2 m-80 -61.98 -40.44 95.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.032 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.84 -42.99 84.87 Favored 'General case' 1 N--CA 1.374 -4.235 0 O-C-N 122.092 -0.38 . . . . 0.0 110.632 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 91.3 m -62.98 -42.07 99.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.774 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 95' ' ' PHE . 26.3 pt -67.01 -28.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.29 -38.24 96.14 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.976 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -84.0 -12.09 55.78 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.483 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 81.2 m-85 -96.06 145.26 25.61 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.887 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.7 p -105.67 -2.74 23.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.806 0.813 . . . . 0.0 109.208 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -128.82 157.1 76.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.032 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.37 148.61 74.04 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.357 2.038 . . . . 0.0 111.626 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 40.7 p90 -143.28 159.33 42.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.279 0.561 . . . . 0.0 111.394 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.699 HD21 HD12 ' A' ' 154' ' ' ILE . 30.7 tp -86.41 143.05 28.0 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 92.2 t -115.2 126.32 72.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.6 m -130.85 157.22 43.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.355 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . 33.8 t -100.23 150.93 22.04 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 171.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.623 ' HA ' HG21 ' A' ' 33' ' ' VAL . 68.3 m -88.39 1.33 54.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' HD12 ' A' ' 102' ' ' LEU . 40.5 p-10 -104.14 4.18 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 99' ' ' SER . 7.2 mp -88.57 140.53 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.099 -0.376 . . . . 0.0 111.106 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.535 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 41.7 pt -64.36 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.555 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -82.24 4.31 24.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.03 11.84 1.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.689 0.757 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HE2' ' O ' ' A' ' 103' ' ' ILE . 57.9 mtmt -83.86 -1.4 54.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.278 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.6 t -57.31 -46.39 83.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -78.59 -23.8 45.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.716 0.77 . . . . 0.0 109.463 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.74 ' O ' HG12 ' A' ' 113' ' ' ILE . 39.2 mm -67.12 -41.52 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.117 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 106' ' ' LYS . 59.6 mt -58.28 -48.89 83.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.83 -177.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 59.5 m-80 -65.9 -39.85 90.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.1 m -61.76 -40.2 94.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.849 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -62.84 -47.54 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.471 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 72.6 t -61.85 -48.83 86.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.556 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -62.03 -43.46 98.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.463 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.519 ' CE2' HD11 ' A' ' 120' ' ' ILE . 68.8 t80 -64.84 -49.86 68.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.1 t80 -59.37 -48.63 80.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.278 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 36.4 m-85 -65.85 -30.7 71.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.334 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.26 -45.51 92.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.519 HD11 ' CE2' ' A' ' 116' ' ' TYR . 75.0 mt -64.63 -42.97 96.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.584 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HD2' HG13 ' A' ' 127' ' ' VAL . 17.1 mmmt -59.93 -42.38 93.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.269 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.07 85.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.064 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.41 -34.07 15.78 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.098 0.475 . . . . 0.0 111.076 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 26.0 m -133.23 98.39 15.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 123.184 0.594 . . . . 0.0 109.717 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.93 -15.32 36.42 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.394 2.063 . . . . 0.0 112.327 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 40.1 m-20 -63.28 -31.23 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 121' ' ' LYS . 9.8 p -66.31 127.23 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.711 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.8 mt-10 -119.52 6.27 11.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.606 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.31 159.25 25.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.859 0.361 . . . . 0.0 111.622 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -138.33 135.03 35.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.4 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -124.24 137.66 54.49 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 113' ' ' ILE . 72.1 t -115.39 117.02 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 121.257 0.551 . . . . 0.0 109.666 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -146.48 159.07 43.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.2 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.65 HG12 ' HB2' ' A' ' 152' ' ' ALA . 18.1 pt -132.6 158.37 75.88 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.792 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 30.9 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 121.451 1.434 . . . . 0.0 111.722 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.133 0.492 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.06 142.99 48.02 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.331 2.021 . . . . 0.0 111.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.65 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -109.09 -13.03 14.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.732 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.28 -117.74 0.44 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.309 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.699 HD12 HD21 ' A' ' 96' ' ' LEU . 17.8 pt -122.98 160.93 25.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 122.656 0.382 . . . . 0.0 111.443 -175.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.596 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.7 t-20 -116.61 153.71 31.79 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.9 t -123.51 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.423 0.289 . . . . 0.0 110.378 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.4 m -130.79 149.79 33.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.412 0.625 . . . . 0.0 112.1 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 159' ' ' PRO . 23.1 t -98.19 151.62 37.61 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 29.1 Cg_endo -63.11 82.17 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.844 2.363 . . . . 0.0 112.582 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.96 -172.64 2.16 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.034 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -137.2 92.24 2.7 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.96 -137.09 10.95 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.96 139.87 41.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.136 0.494 . . . . 0.0 110.746 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.91 166.59 22.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -54.31 121.62 8.64 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -129.78 129.42 44.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.545 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -93.84 162.95 13.71 Favored 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 121.936 0.874 . . . . 0.0 112.716 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 131' ' ' ALA . 49.6 mm -116.12 128.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.579 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 55.4 ttp -125.79 129.99 50.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.419 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 133' ' ' MET . 60.0 t -106.63 129.94 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.015 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.3 pt -115.87 175.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -176.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -113.4 11.44 18.51 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.657 ' HB2' HD12 ' A' ' 171' ' ' ILE . 29.2 mp0 -97.41 131.45 44.05 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.791 0.805 . . . . 0.0 110.882 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.7 139.63 32.49 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.667 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 175' ' ' ILE . 2.0 pp -120.84 148.85 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.946 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.48 117.34 30.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.892 0.377 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -105.26 13.99 29.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.257 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 184' ' ' LEU . 11.7 mm 55.46 71.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.62 -41.99 83.09 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.429 0.633 . . . . 0.0 110.277 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -145.88 -175.34 4.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.336 -173.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.558 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 1.3 mptp? -59.48 -36.49 76.12 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.222 0.609 . . . . 0.0 111.328 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -58.23 -43.3 87.66 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.473 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 63.9 m-20 -70.7 -39.52 73.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.303 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 178' ' ' ILE . 64.3 tp -59.45 -50.49 73.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.2 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -64.36 -43.26 95.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.93 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.8 tt -61.03 -49.01 79.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.737 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.04 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 pt-20 -66.26 -37.45 85.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.049 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -66.69 -37.56 84.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.715 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 89.5 mt -62.46 -44.39 96.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.452 0.644 . . . . 0.0 109.323 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.49 -42.97 98.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.467 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.306 -1.293 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.077 179.14 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.1 ttm . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.813 0.34 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.572 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 75.9 m-20 -105.38 166.27 10.54 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.46 127.39 56.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -103.26 119.68 39.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.782 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.644 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.6 mt -118.88 104.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.552 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.46 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.0 ptm -92.83 102.19 14.57 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.008 1.385 . . . . 0.0 112.047 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' ' HG2' ' A' ' 20' ' ' PRO . . . -115.12 98.29 6.7 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.795 -2.002 . . . . 0.0 111.139 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.775 178.646 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.474 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 20.7 Cg_exo . . . . . 0 CA--C 1.519 -0.271 0 CA-C-O 121.12 0.383 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 21.7 mt -87.05 6.07 34.38 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 87.6 mt -74.13 110.56 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.7 pttm -81.67 131.39 35.27 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.685 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 184' ' ' LEU . 57.6 tp -122.71 112.07 17.49 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.155 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m 58.2 17.95 4.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.87 -95.48 0.15 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.146 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HG2' ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -87.29 172.41 9.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 111.34 -176.144 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 76.6 m -76.07 163.42 27.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 98.9 mt -59.61 -39.18 83.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.8 tp -57.68 -45.18 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.035 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 17.7 t70 -64.56 -40.34 95.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.493 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CD2' ' HG2' ' A' ' 27' ' ' ARG . 11.2 m-85 -61.26 -37.99 85.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.15 -44.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.409 . . . . 0.0 111.148 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.14 -41.97 94.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.3 m -51.67 -55.67 27.75 Favored Pre-proline 0 CA--C 1.562 1.436 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.23 -37.27 14.46 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.512 1.475 . . . . 0.0 112.409 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.663 HD11 HG11 ' A' ' 98' ' ' VAL . 82.1 mt -66.26 -41.53 89.78 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.845 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.33 -46.26 91.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.684 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.16 -9.29 59.52 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.409 ' OG ' HG22 ' A' ' 42' ' ' VAL . 54.7 p -72.08 -177.7 2.15 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.934 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -73.34 2.54 7.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.811 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG22 ' OG ' ' A' ' 40' ' ' SER . 34.2 m -80.42 162.03 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.342 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.572 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.6 t30 -81.63 -71.78 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.947 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -120.52 160.14 23.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.256 0.55 . . . . 0.0 111.396 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.1 mm -109.8 117.54 54.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 83.7 m-85 -109.46 116.86 32.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 60' ' ' ILE . 96.0 mt -97.39 116.22 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 121.715 0.769 . . . . 0.0 110.467 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.18 120.53 28.55 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.65 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 7' ' ' ALA . 45.1 p -127.93 154.72 45.23 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m -100.58 149.36 36.06 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.56 -17.58 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.714 2.276 . . . . 0.0 110.169 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.07 -11.1 59.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.599 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 p -140.17 67.55 33.07 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.117 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 77.3 Cg_endo -102.46 85.76 0.03 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.629 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.107 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.651 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.7 mmtm -149.8 -48.45 0.13 Allowed 'General case' 1 C--N 1.22 -5.049 0 CA-C-N 109.845 -3.343 . . . . 0.0 103.074 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.436 ' HA ' HD21 ' A' ' 21' ' ' LEU . 99.3 m -62.81 -48.63 78.26 Favored 'General case' 0 N--CA 1.386 -3.659 0 CA-C-N 113.104 -1.862 . . . . 0.0 105.987 163.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.32 -50.42 70.08 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.341 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 7.8 pt-20 -62.6 -34.14 76.42 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 117.159 -1.817 . . . . 0.0 112.138 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD2' HD22 ' A' ' 21' ' ' LEU . 51.0 t80 -64.55 -51.09 64.63 Favored 'General case' 0 C--O 1.211 -0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 111.728 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 47' ' ' ILE . 95.5 mt -62.59 -41.25 91.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.1 -46.02 79.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.065 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.694 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.2 t -73.06 -40.26 65.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.38 0.61 . . . . 0.0 110.848 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.78 86.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -177.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.432 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 89.5 m-85 -114.75 42.29 2.18 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.544 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.694 ' HG3' ' O ' ' A' ' 62' ' ' SER . 39.2 mtmm -60.55 -22.21 63.41 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.221 0.534 . . . . 0.0 110.25 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.98 10.64 18.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.235 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 55.4 p90 -44.33 117.27 1.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 3.9 mmpt? -103.06 -49.35 3.78 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.444 1.116 . . . . 0.0 109.088 171.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.42 9.92 18.21 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.577 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.48 123.87 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.083 0.468 . . . . 0.0 110.124 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 65.5 t -124.02 131.9 72.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.347 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.2 131.89 53.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.112 0.482 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.3 pt -125.89 156.53 35.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.307 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -117.36 129.59 55.97 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -158.74 -170.19 2.97 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.5 m -66.18 2.36 1.2 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 127.268 2.227 . . . . 0.0 115.011 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.621 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.17 -22.61 0.0 OUTLIER Glycine 1 N--CA 1.52 4.262 0 C-N-CA 126.187 1.851 . . . . 0.0 117.02 -174.46 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -55.65 -39.87 71.48 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.482 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.14 122.64 6.98 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -59.82 -50.56 73.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.218 0.509 . . . . 0.0 111.454 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.9 pt -72.88 -30.81 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.774 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.87 -43.34 93.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 109.353 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.621 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.5 t0 -61.45 -51.09 70.13 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.15 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -57.61 -43.2 84.56 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.499 ' HA ' HG12 ' A' ' 88' ' ' ILE . 14.9 m-80 -60.39 -42.62 96.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -63.84 -45.71 88.29 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.286 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.9 m -62.56 -41.95 99.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.158 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -66.0 -29.51 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.24 -39.59 96.14 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.637 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -71.38 -40.97 70.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.8 m-85 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.943 0.402 . . . . 0.0 111.916 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -105.16 -2.36 24.32 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.67 157.02 78.17 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.975 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.39 141.94 59.59 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 123.486 2.791 . . . . 0.0 112.237 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 32.4 p90 -141.66 156.4 45.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.354 0.597 . . . . 0.0 111.543 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.601 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.34 138.78 31.55 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.178 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 63.5 t -113.96 129.99 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.663 HG11 HD11 ' A' ' 37' ' ' LEU . 7.3 m -129.47 160.17 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.484 0.659 . . . . 0.0 112.505 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.452 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 62.4 m -100.44 138.26 37.74 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.772 172.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -64.79 -21.46 66.78 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -112.27 22.76 14.39 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 95.9 mt -68.81 138.4 54.75 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.915 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -92.99 142.81 12.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 79.37 171.65 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.527 1.131 . . . . 0.0 112.799 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.75 134.33 47.34 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.212 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -101.81 -1.65 31.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.431 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.568 ' HA ' HD12 ' A' ' 110' ' ' ILE . 69.6 m -57.19 -40.73 77.97 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -170.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.507 ' HG3' HG13 ' A' ' 109' ' ' ILE . 17.2 ptmt -74.34 -38.22 63.31 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.065 0.936 . . . . 0.0 110.304 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.783 ' O ' HG12 ' A' ' 113' ' ' ILE . 58.8 mt -66.49 -40.43 86.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.23 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 107' ' ' SER . 62.6 mt -58.42 -45.8 89.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.913 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -60.95 -45.14 95.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.986 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -62.99 -39.85 96.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.624 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.783 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -61.69 -48.66 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.205 0.526 . . . . 0.0 110.331 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.04 -48.19 89.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.687 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -62.26 -45.68 92.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.694 ' CE2' HD11 ' A' ' 120' ' ' ILE . 80.1 t80 -64.08 -47.79 78.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 79.6 t80 -58.37 -46.02 87.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.453 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -60.4 -37.15 79.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.96 -42.72 99.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.913 0.387 . . . . 0.0 110.528 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.694 HD11 ' CE2' ' A' ' 116' ' ' TYR . 71.2 mt -68.26 -44.19 84.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.711 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -66.73 -37.0 83.78 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.585 -178.716 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.422 ' N ' ' HD3' ' A' ' 121' ' ' LYS . . . -62.01 -42.71 99.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 0.0 111.16 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -80.14 -39.42 29.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.073 0.464 . . . . 0.0 111.034 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 126' ' ' ASP . 35.8 m -132.36 99.97 15.61 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.12 -11.9 34.0 Favored 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 123.002 2.468 . . . . 0.0 112.231 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 124' ' ' THR . 25.4 t70 -61.49 -32.63 72.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.208 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.428 HG22 ' HE2' ' A' ' 165' ' ' LYS . 60.4 t -81.3 119.24 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.282 0.563 . . . . 0.0 111.011 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.597 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 39.5 mt-10 -122.55 7.12 9.49 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.658 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.59 153.75 39.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -139.37 139.0 37.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.191 -177.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -128.14 139.0 52.73 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.191 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.566 HG21 ' CD1' ' A' ' 113' ' ' ILE . 98.4 t -115.32 117.51 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 121.74 0.781 . . . . 0.0 110.683 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 5.2 ptm -146.5 161.87 39.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.113 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.9 pt -128.77 159.59 67.49 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.459 -0.526 0 C-N-CA 122.261 1.974 . . . . 0.0 111.298 178.462 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.15 0.5 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 175' ' ' ILE . 61.8 Cg_endo -71.73 149.94 55.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.483 2.122 . . . . 0.0 111.218 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 175' ' ' ILE . . . -132.4 -31.82 1.38 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.974 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -117.03 -134.16 5.21 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.993 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.601 HD12 HD11 ' A' ' 96' ' ' LEU . 22.6 pt -126.08 160.36 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.399 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.62 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.5 m-20 -111.78 158.03 19.85 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.1 132.31 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.785 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.9 153.72 38.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.379 0.609 . . . . 0.0 111.808 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.597 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 34.3 t -97.99 151.19 37.43 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.893 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.461 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 61.3 Cg_endo -70.28 59.18 1.87 Allowed 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.281 2.654 . . . . 0.0 112.684 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -88.72 -172.33 3.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.259 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -134.31 94.86 3.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.92 -119.99 4.1 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.689 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -127.82 140.99 51.7 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -135.37 167.0 21.84 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.846 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HE2' HG22 ' A' ' 127' ' ' VAL . 20.3 tptm -55.25 128.33 33.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.137 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -132.58 130.59 40.49 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.298 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -98.94 162.34 13.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 121.701 0.762 . . . . 0.0 112.996 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 131' ' ' ALA . 50.0 mm -118.09 130.16 73.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.696 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.6 ttp -127.9 137.97 52.5 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.6 t -110.1 130.39 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.073 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.5 pt -113.74 172.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.018 0.437 . . . . 0.0 110.503 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.7 9.98 31.05 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.311 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.426 ' HB2' HD12 ' A' ' 171' ' ' ILE . 35.6 mt-10 -101.65 129.04 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.804 0.811 . . . . 0.0 111.247 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.75 150.76 20.34 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.508 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.497 HD11 ' O ' ' A' ' 151' ' ' PRO . 23.3 pt -133.79 155.4 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.952 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.08 127.32 54.77 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.635 0.255 . . . . 0.0 110.483 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -84.41 109.36 17.81 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 183' ' ' ASP . 94.5 mt -85.63 115.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.537 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -119.73 -18.72 8.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.319 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.6 p -128.38 167.21 17.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.33 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -59.72 -38.9 82.94 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.847 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.54 -39.96 92.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.605 ' HB2' HG23 ' A' ' 178' ' ' ILE . 71.7 m-20 -62.44 -42.0 99.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.296 0.569 . . . . 0.0 109.871 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.48 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.2 tp -62.12 -43.96 97.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.291 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.585 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 6.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.24 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 10.1 tt -62.46 -46.09 90.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.58 99.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.759 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.74 -31.88 72.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.533 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -64.32 -39.74 94.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.642 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 87.4 mt -63.77 -43.68 95.69 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 0.0 109.624 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.78 -39.28 93.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.418 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.316 177.496 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.856 0.36 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 35.5 m-20 -106.28 166.12 10.75 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.26 129.83 55.7 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.94 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 98' ' ' VAL . 25.5 tp -105.31 125.23 50.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.0 mt -117.1 103.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.512 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 58.2 ttm -83.04 96.84 8.48 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-O 121.711 0.767 . . . . 0.0 110.887 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.96 97.69 6.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.598 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.662 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 N--CA 1.473 0.293 0 N-CA-C 112.869 0.296 . . . . 0.0 112.869 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 42.8 mt -97.02 14.87 24.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.0 mt -75.3 114.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.6 ptmm? -85.45 125.04 32.71 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.82 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 62.4 tp -126.38 115.68 20.01 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.94 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.9 t 58.84 19.19 6.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.975 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.3 -62.92 0.54 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.253 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.704 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 96.2 mtt180 -104.85 167.47 9.69 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 117.508 0.654 . . . . 0.0 111.476 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 76.1 m -82.15 160.84 23.0 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.704 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 33' ' ' VAL . 90.1 mt -59.41 -39.65 84.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.949 0.155 . . . . 0.0 111.246 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.7 tp -57.04 -46.1 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.704 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 11.4 t70 -64.87 -41.64 95.49 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.138 0.494 . . . . 0.0 110.403 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 27' ' ' ARG . 18.8 m-85 -64.4 -34.34 77.95 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' LEU . 77.0 t -66.99 -43.87 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 121.327 0.584 . . . . 0.0 110.206 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 30' ' ' ILE . 79.0 t -63.35 -41.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.38 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -51.28 -55.93 24.57 Favored Pre-proline 0 CA--C 1.565 1.547 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 45.8 Cg_endo -69.23 -36.1 12.88 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 121.573 1.516 . . . . 0.0 112.491 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.634 HD11 HG11 ' A' ' 98' ' ' VAL . 99.4 mt -67.46 -41.79 84.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.642 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.48 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.8 tt -63.0 -44.54 95.73 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.049 0.452 . . . . 0.0 110.886 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 22.1 ptmt -75.26 -12.31 60.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.0 p -71.24 -178.9 2.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.144 0.497 . . . . 0.0 110.588 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -76.51 0.32 20.34 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.67 159.38 5.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -77.35 -73.18 0.31 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.755 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -121.17 159.46 25.8 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.171 0.51 . . . . 0.0 111.132 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.16 116.31 50.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.11 114.95 29.11 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.637 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -95.03 117.8 39.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.501 0.667 . . . . 0.0 110.182 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.1 119.68 28.72 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.219 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 7' ' ' ALA . 77.6 p -129.88 166.86 19.13 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.565 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.5 p -131.3 158.84 74.12 Favored Pre-proline 0 C--N 1.298 -1.65 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.856 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.23 -19.79 65.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.809 2.339 . . . . 0.0 111.435 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.63 -13.9 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.881 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -142.09 67.16 21.63 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 85.6 Cg_endo -104.29 86.58 0.03 OUTLIER 'Trans proline' 1 N--CA 1.385 -4.863 0 C-N-CA 116.827 -1.649 . . . . 0.0 110.108 169.512 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 73.6 mmtt -146.96 -47.51 0.18 Allowed 'General case' 1 C--N 1.222 -4.964 0 CA-C-N 110.08 -3.236 . . . . 0.0 103.405 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.445 HG21 ' HB1' ' A' ' 7' ' ' ALA . 99.8 m -61.93 -48.59 79.73 Favored 'General case' 0 N--CA 1.379 -3.996 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.16 -50.68 69.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.558 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.3 pt-20 -64.36 -26.39 68.45 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 117.098 -1.841 . . . . 0.0 112.879 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -70.52 -51.23 30.21 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.277 0.561 . . . . 0.0 111.483 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.637 HD13 HG21 ' A' ' 47' ' ' ILE . 94.5 mt -63.55 -43.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.493 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.73 -45.01 82.2 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.495 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.0 t -69.18 -42.28 76.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.631 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.05 93.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.199 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 70.9 m-85 -114.61 41.61 2.3 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.39 -176.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.0 mmmm -58.93 -37.01 75.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.131 0.491 . . . . 0.0 110.951 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -83.52 11.9 6.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.478 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 49.8 p90 -44.46 130.65 6.63 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 68' ' ' LYS . 3.6 tmmm? -102.55 -48.28 4.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.21 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.48 HD21 ' HG ' ' A' ' 38' ' ' LEU . 24.1 p-10 -118.12 7.89 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.251 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.1 mp -100.09 116.34 43.21 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.1 t -117.7 130.74 72.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.77 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -104.09 127.69 58.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.5 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.1 pt -120.85 153.3 24.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.331 0.586 . . . . 0.0 110.959 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.08 131.21 56.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.841 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 t -166.67 -166.22 0.83 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 67.5 m -57.58 1.5 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 126.965 2.106 . . . . 0.0 115.344 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -33.07 -12.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.069 0 C-N-CA 126.048 1.785 . . . . 0.0 116.587 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -58.13 -38.96 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' HA3' ' OE2' ' A' ' 82' ' ' GLU . . . -114.92 131.83 10.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.08 -51.33 69.58 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.067 0.433 . . . . 0.0 111.957 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.6 pt -79.45 -25.99 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.199 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 47.1 mt-10 -62.18 -44.73 95.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 10.6 t0 -63.45 -48.57 77.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.18 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -54.82 -46.96 74.62 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.792 178.252 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' HG12 ' A' ' 88' ' ' ILE . 29.1 m-80 -61.43 -40.5 94.68 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.861 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 76.8 mm-40 -63.36 -45.66 90.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.135 0.493 . . . . 0.0 109.744 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.572 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 98.0 m -63.07 -42.2 99.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.526 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 84' ' ' LEU . 36.4 pt -64.83 -28.73 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.37 -20.24 75.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.302 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -103.78 -28.25 11.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.563 0.682 . . . . 0.0 112.786 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.572 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 71.8 m-85 -77.24 141.28 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -105.87 -1.95 23.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.507 0.67 . . . . 0.0 109.868 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 40.4 mt-10 -132.99 160.0 70.44 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 41.6 Cg_endo -67.65 145.46 69.94 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.729 1.619 . . . . 0.0 110.761 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.1 157.98 44.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.61 0.719 . . . . 0.0 111.488 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 154' ' ' ILE . 26.6 tp -87.43 141.46 28.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.457 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 94.0 t -112.87 130.92 65.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -128.82 168.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.283 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.2 m -98.45 144.61 27.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.013 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 6' ' ' MET . 88.0 p -73.16 -12.51 60.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -174.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 7.9 p-10 -116.9 11.67 14.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.38 157.2 30.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.74 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -116.64 174.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.003 0.43 . . . . 0.0 111.911 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -62.31 178.42 0.4 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.829 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.3 mt 81.47 5.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.576 1.15 . . . . 0.0 109.893 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 48.5 mmtm -98.69 1.88 46.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.288 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.736 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.2 p -58.01 -35.29 71.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.92 -29.69 62.17 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.169 0.985 . . . . 0.0 108.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.613 ' O ' HG12 ' A' ' 113' ' ' ILE . 25.7 mm -64.59 -38.69 83.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' A' ' 107' ' ' SER . 73.8 mt -59.31 -45.31 93.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.307 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -61.31 -43.62 98.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.96 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.0 m -64.73 -41.68 95.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.591 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.9 mm -62.86 -45.51 98.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.27 0.557 . . . . 0.0 109.873 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.432 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 53.8 t -60.44 -47.34 92.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.355 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.9 -47.61 85.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.03 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.613 ' CE2' HD11 ' A' ' 120' ' ' ILE . 54.3 t80 -64.56 -45.76 85.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.88 0.372 . . . . 0.0 110.554 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.27 -48.8 80.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.106 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.3 m-85 -62.81 -36.24 82.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.897 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.78 -41.59 97.92 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.3 mt -68.96 -46.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -68.22 -27.68 66.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.062 -177.575 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.23 99.34 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -83.92 -38.24 21.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.387 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.1 m -126.65 96.45 35.47 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.643 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.66 -15.61 48.03 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 122.804 2.336 . . . . 0.0 112.349 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.67 -32.08 73.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.814 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 116.45 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.835 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.555 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 38.7 mt-10 -126.72 14.07 7.49 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.113 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.91 31.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.404 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.5 tp -140.83 143.27 34.7 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.178 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.18 143.21 50.65 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.279 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 154' ' ' ILE . 12.1 p -123.24 133.27 69.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.159 0.504 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 71.5 mtm -134.01 157.04 47.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.361 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 171' ' ' ILE . 7.7 pt -127.8 151.81 76.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.788 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo . . . . . 0 N--CA 1.458 -0.59 0 C-N-CA 122.55 2.167 . . . . 0.0 112.448 179.236 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.458 0.17 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.487 ' O ' HD11 ' A' ' 175' ' ' ILE . 52.6 Cg_exo -58.82 144.56 98.4 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.003 2.469 . . . . 0.0 111.725 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.515 ' CB ' HG23 ' A' ' 134' ' ' ILE . . . -103.69 -15.42 15.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 170.11 -89.14 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.39 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 96' ' ' LEU . 22.3 pt -133.85 159.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.113 0.483 . . . . 0.0 111.722 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.63 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.4 m-20 -122.57 157.77 31.38 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.51 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.12 127.95 72.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 122.322 -0.236 . . . . 0.0 110.745 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.68 151.23 25.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.245 0.545 . . . . 0.0 111.795 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.522 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 88.8 p -97.29 169.78 8.16 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 37.4 Cg_endo -67.88 67.69 0.88 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.906 1.738 . . . . 0.0 110.978 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.541 ' HB3' ' NE2' ' A' ' 164' ' ' GLN . 61.0 pttt -67.15 123.42 20.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.016 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -62.44 -43.03 99.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.547 0.689 . . . . 0.0 109.197 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 160' ' ' LYS . . . -128.77 -177.31 14.81 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -72.31 128.46 35.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 118.066 0.933 . . . . 0.0 108.629 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.555 ' OE1' ' HB2' ' A' ' 128' ' ' GLU . 29.9 pt20 -117.8 168.09 10.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.586 -169.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -56.91 121.0 8.88 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 110.086 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.62 130.65 52.98 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.9 161.64 14.4 Favored 'General case' 0 CA--C 1.471 -2.07 0 CA-C-O 121.976 0.893 . . . . 0.0 112.954 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.6 mm -118.44 129.6 74.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 113.713 -1.585 . . . . 0.0 111.583 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 62.0 ttp -129.72 134.14 47.45 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.332 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 133' ' ' MET . 49.8 t -112.14 126.47 69.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 173' ' ' GLU . 47.8 pt -113.47 175.82 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.056 0.455 . . . . 0.0 111.052 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -111.18 16.07 21.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.32 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.692 ' HB2' HD12 ' A' ' 171' ' ' ILE . 75.0 mm-40 -98.76 133.28 43.3 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.672 0.749 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.0 mt -97.09 149.5 21.89 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.514 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 151' ' ' PRO . 12.9 pt -127.73 155.83 39.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.863 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.6 112.3 24.1 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.541 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASN . . . . . 0.437 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 7.8 t-20 -95.13 103.67 15.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.015 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.475 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 1.9 mp -81.92 113.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.521 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.91 -22.48 7.89 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 64.9 p -130.37 165.87 21.63 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.163 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.8 mppt? -65.98 -28.39 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 109.777 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.46 -42.35 98.64 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.227 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 49.3 m-20 -61.3 -41.03 96.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 109.535 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.403 ' CD1' HD13 ' A' ' 24' ' ' LEU . 59.2 tp -61.62 -45.05 95.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 30.4 mmmt -62.47 -39.87 94.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.501 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.01 -45.99 89.76 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.83 -42.78 97.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.472 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.9 OUTLIER -70.59 -34.68 72.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.757 0.313 . . . . 0.0 111.674 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.5 ttm -62.35 -43.38 98.96 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.301 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.1 pp -69.72 -37.94 76.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.87 -42.72 97.44 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.315 0.578 . . . . 0.0 110.385 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.763 178.186 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.612 ' O ' HG23 ' A' ' 42' ' ' VAL . 59.8 ttm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 1' ' ' MET . 52.6 m-20 -105.73 160.73 14.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.523 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -122.51 140.43 52.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.692 -177.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 98' ' ' VAL . 28.9 tp -112.42 123.73 50.93 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.362 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.721 ' HA ' HG22 ' A' ' 98' ' ' VAL . 55.1 mt -116.46 104.94 17.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.439 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 11.8 ptm -95.25 97.39 9.83 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.738 1.256 . . . . 0.0 112.465 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -115.94 96.98 5.84 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.094 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.66 0.57 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' VAL . . . 85.65 10.94 75.45 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.873 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.15 146.48 50.7 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.365 0.602 . . . . 0.0 111.959 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.49 -176.44 39.93 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -97.04 85.4 3.73 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.723 0.762 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -142.87 -80.0 0.21 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.771 -177.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.5 mtm -130.42 -53.47 1.09 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.057 0.456 . . . . 0.0 111.0 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.74 -169.09 26.18 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.48 -121.96 21.67 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.6 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 14.4 m -123.5 98.41 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -72.49 147.66 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -106.37 104.97 52.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.939 0.4 . . . . 0.0 110.887 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.81 -5.0 13.75 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.208 2.605 . . . . 0.0 112.866 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 56' ' ' THR . 43.4 mt -94.64 10.99 32.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.38 118.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -98.35 142.41 30.02 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.267 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.7 tp -137.21 115.87 12.1 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.106 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.1 m 56.06 24.14 7.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.57 2.22 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.01 -1.567 . . . . 0.0 115.436 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.703 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 69.5 mtt-85 -126.03 159.57 32.4 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 118.353 1.077 . . . . 0.0 111.059 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 72.7 m -83.85 157.99 21.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 101' ' ' ASP . 0.6 OUTLIER -46.7 -53.29 12.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 7' ' ' ALA . 12.4 tt -62.07 -36.4 73.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HA ' HG12 ' A' ' 34' ' ' VAL . 12.7 t70 -63.02 -40.51 97.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.703 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 25.1 m-85 -64.69 -37.17 86.68 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.573 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.37 -47.76 83.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.036 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 31' ' ' ASP . 12.2 p -72.1 -35.15 52.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.551 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 35.1 t -53.9 -54.08 50.81 Favored Pre-proline 0 CA--C 1.562 1.438 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 46.0 Cg_exo -61.45 -39.34 56.67 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.002 1.801 . . . . 0.0 112.023 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.45 HD12 HD11 ' A' ' 5' ' ' ILE . 81.2 mt -63.67 -42.08 98.1 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.459 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.487 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.9 tt -60.01 -45.79 91.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.0 -12.07 59.44 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.523 ' OG ' HG12 ' A' ' 42' ' ' VAL . 72.7 p -76.49 -175.86 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -51.48 -33.77 32.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.666 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 1' ' ' MET . 7.5 p -69.05 140.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 121.444 0.64 . . . . 0.0 111.616 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -83.6 -69.75 0.61 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.285 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -101.23 146.46 27.49 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.357 0.599 . . . . 0.0 111.156 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.429 HG21 HG23 ' A' ' 34' ' ' VAL . 47.7 mm -110.98 116.87 53.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.845 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 96.1 m-85 -103.39 114.96 29.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.759 HG21 HD13 ' A' ' 60' ' ' ILE . 88.0 mt -98.96 118.34 45.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.649 0.738 . . . . 0.0 110.482 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.33 124.36 33.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.374 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.1 p -132.2 168.63 17.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.213 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.1 m -129.89 155.01 81.21 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.506 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.63 -21.47 65.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.925 2.416 . . . . 0.0 111.044 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.16 -13.12 60.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.453 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -142.37 66.47 19.4 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.63 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 76.4 Cg_endo -107.99 87.0 0.02 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.591 0 CA-C-N 120.884 1.351 . . . . 0.0 111.363 170.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.5 mmtm -151.01 -44.58 0.12 Allowed 'General case' 1 C--N 1.221 -5.001 0 CA-C-N 109.599 -3.455 . . . . 0.0 102.649 176.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' HD11 ' A' ' 21' ' ' LEU . 74.9 m -62.68 -49.51 74.83 Favored 'General case' 0 N--CA 1.387 -3.615 0 CA-C-N 113.022 -1.899 . . . . 0.0 105.974 161.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.23 -50.26 70.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.628 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.668 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.5 pt-20 -62.14 -30.26 70.91 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 116.517 -2.073 . . . . 0.0 112.573 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.01 -50.31 66.81 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.759 HD13 HG21 ' A' ' 47' ' ' ILE . 85.5 mt -60.62 -45.03 98.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.154 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -56.54 -45.53 81.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.634 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 70.1 m -71.1 -41.62 70.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.136 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.28 86.28 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 111.381 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' OH ' HG11 ' A' ' 34' ' ' VAL . 34.9 m-85 -115.99 39.79 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.952 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.2 mtmt -61.12 -29.04 69.53 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.131 0.491 . . . . 0.0 110.828 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.59 10.31 13.58 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 51.6 p90 -35.69 113.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.44 -48.61 5.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.487 HD21 ' HG ' ' A' ' 38' ' ' LEU . 20.1 p-10 -117.54 5.26 12.43 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 4.5 mp -95.11 122.58 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 75.8 t -124.01 128.49 74.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -105.82 129.13 59.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.363 0.601 . . . . 0.0 109.71 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.8 pt -121.88 156.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.293 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.89 128.58 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -158.72 -168.14 2.32 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-O 121.728 0.775 . . . . 0.0 112.916 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -69.06 1.48 3.5 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 126.184 1.794 . . . . 0.0 114.198 -176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.07 -20.35 0.0 OUTLIER Glycine 1 N--CA 1.521 4.365 0 C-N-CA 126.192 1.854 . . . . 0.0 116.903 -176.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -56.81 -38.05 72.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.51 127.81 8.5 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -60.9 -51.19 70.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 0.0 112.099 -172.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.3 pt -76.9 -27.43 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.485 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 50.7 mt-10 -63.36 -44.49 94.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.615 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 20.5 t0 -62.51 -50.69 70.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.278 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.5 mm? -54.55 -46.28 73.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.631 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.498 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.1 m-80 -59.92 -42.99 95.15 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.385 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 28.9 mm-40 -65.18 -47.18 77.86 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.93 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.4 m -63.35 -42.56 98.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.329 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 84' ' ' LEU . 40.7 pt -65.87 -28.43 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.15 -10.65 85.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.775 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -109.17 -24.62 11.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 159' ' ' PRO . 76.9 m-85 -82.11 148.48 28.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.038 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 m -96.36 -12.28 24.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 111.153 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.02 158.77 66.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.588 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.71 141.84 33.72 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.384 2.723 . . . . 0.0 112.15 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.14 157.02 45.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.715 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 154' ' ' ILE . 23.7 tp -87.83 143.2 27.26 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.733 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 72.6 t -113.11 129.64 68.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -132.26 160.57 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.136 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 51.2 m -100.38 137.11 39.25 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.5 p -77.05 -10.46 59.39 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.499 ' HA ' HD22 ' A' ' 29' ' ' LEU . 19.6 p-10 -99.19 9.61 43.09 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 175' ' ' ILE . 61.2 mt -91.52 115.9 28.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 85.4 mt -108.03 119.81 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 110.703 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 65.8 t30 170.04 153.15 0.05 OUTLIER 'General case' 0 C--O 1.247 0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.31 117.5 14.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -95.84 -1.37 49.65 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.462 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -56.36 -38.87 72.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.74 -25.61 32.72 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.045 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.531 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.5 mm -71.32 -43.72 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.658 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 40' ' ' SER . 60.2 mt -60.07 -48.48 87.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.126 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -64.64 -42.11 95.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.439 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -66.18 -43.0 88.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.538 HG13 ' CG1' ' A' ' 154' ' ' ILE . 38.7 mm -63.45 -48.62 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 120.907 0.384 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.483 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 66.3 t -61.29 -47.8 91.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.702 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -47.49 84.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.655 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.508 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.3 t80 -63.13 -44.26 96.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.375 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 58.4 t80 -58.39 -48.11 81.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 28.2 m-85 -63.1 -35.19 79.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.62 -40.35 96.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.121 0.486 . . . . 0.0 109.899 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 116' ' ' TYR . 80.0 mt -64.28 -45.73 95.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.688 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -62.68 -37.26 85.73 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.102 0.477 . . . . 0.0 110.672 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.98 88.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.288 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -83.84 -38.84 20.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.45 . . . . 0.0 111.314 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.3 m -130.07 94.1 31.82 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.184 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.05 -22.97 58.27 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.313 2.675 . . . . 0.0 113.126 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.49 -28.51 70.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.407 HG22 ' HE3' ' A' ' 165' ' ' LYS . 74.9 t -70.26 126.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.64 -13.18 10.23 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.224 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 166' ' ' GLU . . . -140.67 157.04 46.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.4 . . . . 0.0 111.777 -177.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 1.2 tm? -136.17 135.69 39.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.27 132.27 48.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 154' ' ' ILE . 14.1 p -114.66 126.56 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.92 160.99 41.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 152' ' ' ALA . 12.5 pt -132.73 147.41 65.41 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.632 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.55 ' HD2' ' HE2' ' A' ' 138' ' ' LYS . 77.4 Cg_exo -56.92 137.64 82.61 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.413 2.075 . . . . 0.0 111.769 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 146' ' ' PHE . 21.1 tptm -61.94 -29.67 70.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.054 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 146' ' ' PHE . 37.8 tt0 -60.72 -39.88 90.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.55 ' HE2' ' HD2' ' A' ' 135' ' ' PRO . 63.2 pttt -91.62 -11.97 35.59 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.691 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -62.31 127.2 89.4 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.358 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.63 -21.24 65.58 Favored 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.267 2.645 . . . . 0.0 115.224 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -132.41 90.23 34.36 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.91 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.94 117.99 2.0 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.407 2.738 . . . . 0.0 111.076 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.3 t -66.04 -46.33 78.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 79.4 mt -123.53 -55.75 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.999 0.428 . . . . 0.0 111.402 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.78 166.58 30.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.912 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' A' ' 137' ' ' GLU . 50.6 p90 -85.78 7.6 23.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.948 0.404 . . . . 0.0 111.932 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.75 127.46 32.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.6 179.9 19.06 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.883 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.83 153.45 41.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.93 148.74 68.23 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.06 141.13 75.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.099 1.866 . . . . 0.0 110.567 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' A' ' 171' ' ' ILE . . . -90.36 -8.11 51.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.426 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.85 -86.58 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.637 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.618 HG22 HG12 ' A' ' 98' ' ' VAL . 28.0 pt -123.75 160.17 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.217 0.532 . . . . 0.0 112.086 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.679 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.9 t-20 -128.61 151.99 48.85 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.469 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.6 t -123.43 131.04 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.522 0.201 . . . . 0.0 110.932 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.64 150.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.7 p -87.85 154.2 52.68 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' PHE . 67.2 Cg_endo -84.11 84.92 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.514 2.143 . . . . 0.0 113.307 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -130.81 -179.55 5.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.394 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -105.55 98.43 8.13 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.95 -170.29 21.32 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.845 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -96.62 150.01 21.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.776 0.322 . . . . 0.0 110.224 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.89 165.9 23.57 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.683 -171.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HE3' HG22 ' A' ' 127' ' ' VAL . 65.0 tttp -64.03 124.71 22.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 44.2 tt0 -120.62 132.9 55.36 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.114 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.28 161.3 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 121.559 0.695 . . . . 0.0 112.057 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.8 mm -118.36 129.04 75.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.566 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.4 ' CE ' HD13 ' A' ' 113' ' ' ILE . 58.4 ttp -132.06 136.63 47.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.35 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.84 130.26 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.649 HD11 ' HB1' ' A' ' 152' ' ' ALA . 49.4 pt -120.33 175.45 4.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.766 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -120.09 24.09 10.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.586 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HB2' HD12 ' A' ' 171' ' ' ILE . 2.3 mp0 -99.4 131.95 45.07 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.41 149.9 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.499 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.724 HD12 HD22 ' A' ' 102' ' ' LEU . 2.4 pt -119.59 148.89 22.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.644 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.51 118.24 33.2 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.469 HD21 HD23 ' A' ' 102' ' ' LEU . 1.9 m-20 -107.62 149.18 28.38 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.151 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.83 121.98 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.855 0.359 . . . . 0.0 111.507 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -130.12 -30.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.108 0.48 . . . . 0.0 110.406 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 t -140.92 -178.4 5.54 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.235 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -61.52 -41.79 97.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.381 0.672 . . . . 0.0 112.623 -175.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.4 -38.15 86.02 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.21 -40.6 94.58 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.273 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.81 -43.68 98.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 13.4 tmtt? -62.23 -44.23 97.04 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.534 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.66 -50.58 73.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.291 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.09 -39.91 90.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.458 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.2 pp20? -67.11 -28.69 68.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.336 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.6 mmm -63.26 -40.92 98.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.8 pp -71.3 -37.39 71.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.476 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.53 -39.73 94.3 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.804 0.812 . . . . 0.0 109.509 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -60.77 -43.13 98.43 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.659 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.48 -42.31 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.337 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.78 -27.61 66.05 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.262 0.553 . . . . 0.0 110.82 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.52 -21.68 79.37 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.188 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--O 1.261 1.696 0 CA-C-O 117.745 -1.122 . . . . 0.0 110.042 179.639 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.1 tpp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -110.49 166.6 10.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.528 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -113.09 139.93 48.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.242 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -119.51 114.55 22.45 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.655 ' HA ' HG22 ' A' ' 98' ' ' VAL . 69.0 mt -118.55 106.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.427 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.5 ptm -98.92 104.36 16.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.815 1.293 . . . . 0.0 112.621 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.57 6.14 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.73 90.15 0.08 OUTLIER Glycine 0 C--N 1.305 -1.165 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.491 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.13 41.5 60.18 Favored Glycine 0 C--O 1.221 -0.684 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.54 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -53.12 131.29 36.45 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.13 -154.66 16.61 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.549 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.1 t -149.83 153.31 36.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 14' ' ' MET . 73.7 ttp85 63.37 53.79 2.11 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 13' ' ' ARG . 66.5 mtt 76.03 168.85 0.26 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.678 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.86 124.33 6.98 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.309 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.78 96.71 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -99.83 130.77 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.28 -49.75 76.64 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 123.213 0.32 . . . . 0.0 110.921 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -164.92 145.01 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.563 0.22 . . . . 0.0 111.066 174.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 22.7 Cg_exo -70.03 -9.33 25.76 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.489 2.793 . . . . 0.0 113.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.2 mt -89.15 13.04 14.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 94.8 mt -70.39 119.18 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 63.0 pttt -102.79 137.2 41.31 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-O 122.243 1.02 . . . . 0.0 113.123 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.32 131.68 50.39 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.174 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' ' HE3' ' A' ' 192' ' ' LYS . 83.7 m 53.48 32.36 13.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.77 -17.4 49.57 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.843 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 92.4 mtt180 -128.61 152.38 48.41 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 119.018 1.409 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 81.7 m -74.87 162.84 28.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.319 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 100' ' ' SER . 84.0 mt -58.73 -40.89 85.11 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.144 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 60' ' ' ILE . 5.1 tp -58.08 -44.45 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.443 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.741 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 13.1 t70 -65.06 -43.57 91.82 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.97 0.414 . . . . 0.0 111.23 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.843 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 32.5 m-85 -67.33 -26.39 66.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.481 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.7 t -73.7 -46.79 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.47 173.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.09 -47.72 88.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 66.1 m -54.61 -50.35 86.04 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HG2' ' NZ ' ' A' ' 106' ' ' LYS . 78.3 Cg_exo -57.69 -42.59 58.44 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.75 1.634 . . . . 0.0 112.109 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.658 HD11 HG11 ' A' ' 98' ' ' VAL . 90.0 mt -67.51 -39.48 85.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD12 HD21 ' A' ' 69' ' ' ASN . 61.8 tp -57.15 -43.68 82.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.44 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 35' ' ' SER . 19.0 ptpt -88.74 -6.15 57.62 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.525 ' OG ' HG12 ' A' ' 42' ' ' VAL . 57.6 p -81.55 -176.96 6.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.727 0.775 . . . . 0.0 112.212 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -63.63 -16.14 60.12 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.372 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 3' ' ' ALA . 13.3 p -75.28 147.69 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 122.189 -0.32 . . . . 0.0 111.691 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.03 -75.58 0.35 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-20 -100.19 147.2 25.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.972 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.03 112.08 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.609 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -104.45 114.56 28.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 5' ' ' ILE . 96.7 mt -97.26 116.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.674 0.749 . . . . 0.0 110.853 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.3 121.77 30.19 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.386 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 7' ' ' ALA . 53.2 p -132.69 162.38 31.54 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.414 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.6 m -117.87 154.75 51.33 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 29.1 Cg_endo -63.38 -18.86 66.58 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.028 2.485 . . . . 0.0 110.842 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -70.89 -20.72 62.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.084 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 p -137.59 66.69 50.59 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.741 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.708 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 63.2 Cg_endo -103.55 85.43 0.03 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.603 0 C-N-CA 116.974 -1.55 . . . . 0.0 110.162 170.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.641 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.1 ttpt -154.63 -47.24 0.09 Allowed 'General case' 1 C--N 1.211 -5.436 0 CA-C-N 109.393 -3.549 . . . . 0.0 102.27 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -63.42 -48.74 76.56 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 162.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.708 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.74 -50.4 71.24 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.834 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -63.6 -32.5 73.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 116.485 -2.086 . . . . 0.0 112.472 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.36 -51.21 64.44 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.192 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 30' ' ' ILE . 96.9 mt -64.91 -46.27 92.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.98 -175.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.4 -41.82 90.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 39.7 t -67.95 -42.87 80.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.508 0.671 . . . . 0.0 110.387 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.92 89.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.339 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.61 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 71.8 m-85 -112.0 18.26 18.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 62' ' ' SER . 64.6 pttt -65.03 -17.47 64.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.62 2.66 52.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' HA ' ' A' ' 64' ' ' TYR . 74.5 m-85 -102.66 130.38 49.55 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.076 -0.39 . . . . 0.0 111.137 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.15 60.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.384 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.453 HD21 HD12 ' A' ' 38' ' ' LEU . 21.6 p-10 -85.97 2.09 47.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.03 123.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.5 135.1 65.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.93 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.92 129.1 58.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 48' ' ' ALA . 42.9 pt -122.27 156.64 27.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.366 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.84 133.11 56.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.528 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.0 t -167.06 -167.29 0.91 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 52.6 m -64.08 1.17 0.74 Allowed 'General case' 0 C--O 1.197 -1.698 0 C-N-CA 126.826 2.05 . . . . 0.0 114.6 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.54 -28.21 0.01 OUTLIER Glycine 0 N--CA 1.515 3.922 0 C-N-CA 125.604 1.573 . . . . 0.0 116.713 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -56.12 -33.0 64.74 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.65 115.85 4.0 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -58.39 -50.72 72.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.2 -46.02 92.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.55 0.691 . . . . 0.0 110.742 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.48 -42.38 96.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.595 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.51 -50.1 74.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.901 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -57.06 -44.05 82.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' HG12 ' A' ' 88' ' ' ILE . 93.9 m-20 -60.7 -42.3 96.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.41 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.19 -45.22 89.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.145 0.498 . . . . 0.0 110.572 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.615 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 95.5 m -64.65 -41.77 95.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.089 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 84' ' ' LEU . 39.2 pt -68.45 -31.02 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 121.98 -0.45 . . . . 0.0 110.952 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.86 95.55 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.158 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -101.94 9.78 40.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.615 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 62.8 m-85 -112.62 150.57 31.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.82 0.343 . . . . 0.0 111.823 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -102.41 -6.68 22.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.295 0.569 . . . . 0.0 109.951 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -125.49 156.76 69.98 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.432 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.89 153.6 42.49 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.622 2.215 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.92 152.55 43.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 0.0 112.657 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 155' ' ' ASN . 2.4 tm? -86.31 124.01 32.2 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.177 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 57.8 t -99.04 130.8 47.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 123.395 0.678 . . . . 0.0 109.805 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.658 HG11 HD11 ' A' ' 37' ' ' LEU . 13.3 m -129.37 166.38 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 121.871 0.843 . . . . 0.0 112.454 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.5 m -98.85 157.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.937 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 81.2 p -88.94 -6.25 57.4 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.309 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -117.59 9.96 13.3 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.96 122.32 31.43 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.073 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 103' ' ' ILE . 28.0 pt -122.47 101.51 10.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.663 0.744 . . . . 0.0 111.516 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -160.01 177.71 10.46 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.401 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.29 59.6 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.735 0.779 . . . . 0.0 109.93 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.777 ' HA ' HD12 ' A' ' 109' ' ' ILE . 16.9 pttp -69.72 -3.69 16.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.79 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -59.17 -41.9 89.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.544 ' HD3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -88.6 -23.16 23.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.812 0.815 . . . . 0.0 110.566 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.777 HD12 ' HA ' ' A' ' 106' ' ' LYS . 74.2 mt -64.34 -38.79 83.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.882 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.1 mt -55.44 -47.85 77.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.769 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -63.69 -41.34 98.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.462 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.6 m -63.43 -39.8 95.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.749 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.2 mm -61.28 -47.69 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.041 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.502 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 67.9 t -60.43 -48.07 89.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.263 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.77 -47.64 84.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.607 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CE2' HD11 ' A' ' 120' ' ' ILE . 75.0 t80 -61.43 -48.24 82.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.658 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -59.56 -47.59 84.95 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.246 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.8 m-85 -61.82 -37.94 86.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.331 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.7 t -61.12 -46.43 90.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.399 0.619 . . . . 0.0 109.908 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.593 HD11 ' CE2' ' A' ' 116' ' ' TYR . 80.0 mt -62.46 -45.98 97.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -62.85 -37.44 86.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.994 0.426 . . . . 0.0 110.833 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.49 91.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.398 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -81.27 -36.02 30.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.071 0.462 . . . . 0.0 111.206 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.7 m -139.89 100.1 7.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.169 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.03 -16.72 53.46 Favored 'Trans proline' 0 N--CA 1.481 0.775 0 C-N-CA 123.087 2.525 . . . . 0.0 113.241 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -69.48 -13.39 62.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.489 HG21 ' CG2' ' A' ' 120' ' ' ILE . 94.3 t -76.85 120.04 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.29 11.85 10.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.504 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.0 23.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -137.0 135.97 38.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.123 -178.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.0 137.78 52.35 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.27 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 113' ' ' ILE . 57.6 t -112.29 116.91 53.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 4.3 ptm -145.46 155.55 43.19 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.956 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 152' ' ' ALA . 24.0 pt -130.03 157.48 76.85 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.919 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 39.5 Cg_endo -67.2 140.81 54.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.763 1.642 . . . . 0.0 111.772 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -16.93 62.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.014 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.34 -38.73 92.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.068 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.15 -16.83 16.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.192 0.52 . . . . 0.0 111.348 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -59.6 131.48 88.42 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.063 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.71 -32.13 92.76 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.939 2.426 . . . . 0.0 114.702 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -142.63 78.15 16.32 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.532 0.682 . . . . 0.0 111.3 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.58 -5.73 11.68 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 123.735 2.956 . . . . 0.0 112.027 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.6 m 63.3 -161.19 0.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.2 pt -104.59 149.15 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 146' ' ' PHE . 21.3 t70 56.2 -134.66 1.33 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.418 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 38.5 t80 53.73 61.75 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.342 0.592 . . . . 0.0 111.047 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.37 110.4 17.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.158 0.504 . . . . 0.0 110.032 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.23 -154.63 11.86 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 149' ' ' LEU . 2.4 pt? -108.54 149.68 28.51 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.914 0.357 . . . . 0.0 110.243 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.62 146.0 59.34 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.91 147.5 55.63 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.198 1.932 . . . . 0.0 111.891 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.657 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -117.45 -6.64 11.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.226 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.05 -116.89 0.39 Allowed Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.48 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 96' ' ' LEU . 22.2 pt -124.55 160.08 29.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 120.7 0.286 . . . . 0.0 111.02 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.608 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.0 m-20 -117.65 159.27 23.21 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.91 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.67 133.46 69.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.88 148.45 31.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.479 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -92.43 149.29 38.02 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.13 75.2 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -104.11 -170.97 1.85 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.171 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -132.33 125.94 32.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.45 -105.99 3.34 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.207 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -147.03 140.5 25.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -133.3 166.96 21.28 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.451 ' HE3' HG22 ' A' ' 127' ' ' VAL . 63.6 tttp -58.47 125.7 24.45 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.828 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.14 128.31 49.08 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.143 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -93.9 163.49 13.48 Favored 'General case' 0 CA--C 1.477 -1.852 0 CA-C-O 121.687 0.756 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.33 130.12 69.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.537 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.558 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 51.3 ttm -112.45 129.85 56.19 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.376 175.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.54 126.32 66.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.2 pt -121.55 174.29 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 112.029 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -111.48 4.89 19.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.059 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 171' ' ' ILE . 34.9 mt-10 -99.34 130.29 45.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 111.03 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.49 151.15 19.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.249 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.99 150.49 31.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.325 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.01 122.82 43.05 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.164 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.415 ' C ' HD12 ' A' ' 178' ' ' ILE . 23.7 p-10 -94.08 168.17 11.11 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.787 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 184' ' ' LEU . 2.0 mp -120.32 121.05 64.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.873 0.368 . . . . 0.0 111.093 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -111.72 -32.34 6.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.422 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.1 t -138.39 176.6 8.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.022 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -64.24 -29.13 70.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.83 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.28 -39.11 91.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.414 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -61.42 -35.76 78.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.388 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 178' ' ' ILE . 96.0 mt -60.68 -43.7 97.4 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.354 0.597 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.644 ' O ' ' HG3' ' A' ' 189' ' ' MET . 60.0 tptt -62.84 -43.61 98.35 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.707 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.56 -48.21 82.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.71 -43.14 99.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.306 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 192' ' ' LYS . 13.2 pt-20 -70.2 -29.59 66.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.932 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -61.44 -39.71 91.83 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -70.67 -33.41 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.96 -40.57 87.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.66 0.743 . . . . 0.0 110.558 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 188' ' ' GLU . 34.8 mmtp -65.66 -37.58 86.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 193' ' ' LYS . 9.2 tmtt? -60.65 -42.21 96.53 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.501 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.73 2.85 54.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.496 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.35 97.66 0.45 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.1 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.2 tp . . . . . 0 C--O 1.266 1.954 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.029 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 64.2 m-20 -97.35 165.91 11.79 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -117.9 130.07 56.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.901 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 48' ' ' ALA . 36.1 tp -100.93 124.72 47.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.369 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.662 ' HA ' HG22 ' A' ' 98' ' ' VAL . 68.5 mt -117.59 104.88 17.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.0 ptm -96.64 107.64 20.12 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.786 1.279 . . . . 0.0 112.505 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -114.92 96.92 5.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.801 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.78 -105.99 0.51 Allowed Glycine 0 C--N 1.297 -1.623 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.654 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.14 178.63 24.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.988 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' A' ' 14' ' ' MET . 60.1 mtpt -127.51 -176.54 3.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.012 0.525 . . . . 0.0 110.084 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.54 49.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m 63.57 26.68 14.78 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.973 0.892 . . . . 0.0 110.212 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 64.22 27.57 13.93 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.519 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.471 ' HG2' ' H ' ' A' ' 10' ' ' LYS . 98.7 mtp 70.08 133.81 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 144.96 17.66 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.68 -43.87 98.35 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.535 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -70.1 -39.8 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.491 0.662 . . . . 0.0 110.72 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.65 102.52 0.93 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.103 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.3 ptmt -148.02 148.34 29.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.485 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 44.1 Cg_exo -61.39 -17.82 55.63 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.235 2.624 . . . . 0.0 112.402 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.607 HD21 ' CB ' ' A' ' 59' ' ' TYR . 9.6 mp -83.51 15.71 2.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 19' ' ' LYS . 88.1 mt -69.73 123.19 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -80.75 132.08 35.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.575 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 HD13 HD12 ' A' ' 184' ' ' LEU . 59.8 tp -137.83 125.33 22.06 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.152 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t 58.64 26.17 14.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.278 0.561 . . . . 0.0 110.74 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 -13.85 56.86 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -134.4 169.81 16.68 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 118.945 1.372 . . . . 0.0 111.434 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 75.6 m -85.73 163.79 18.01 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.672 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 82.3 mt -59.43 -39.69 84.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.268 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.3 tp -57.17 -45.17 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.201 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.43 -41.65 93.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.973 0.416 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -61.52 -33.89 74.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.409 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.54 -42.95 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.774 0.321 . . . . 0.0 111.412 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.4 t -63.39 -44.81 99.13 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -52.87 -50.47 81.28 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 28.9 Cg_endo -64.13 -40.95 24.04 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.367 1.378 . . . . 0.0 112.489 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD11 HG11 ' A' ' 98' ' ' VAL . 88.6 mt -66.7 -37.71 85.26 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.498 0.666 . . . . 0.0 110.436 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.22 -44.12 88.05 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.284 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 36' ' ' PRO . 64.3 pttt -90.32 -3.23 57.89 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.206 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.422 ' CB ' HG21 ' A' ' 110' ' ' ILE . 59.5 p -81.43 -178.9 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.778 0.799 . . . . 0.0 112.997 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -59.94 -25.28 65.05 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 3' ' ' ALA . 30.2 m -64.26 161.78 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.2 t30 -83.38 -76.31 0.29 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.218 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.7 m-20 -115.16 157.44 23.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.074 0.464 . . . . 0.0 110.82 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.63 115.89 50.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -107.81 117.32 33.8 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -96.88 119.41 44.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.736 0.779 . . . . 0.0 110.583 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -91.05 121.0 32.48 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.758 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.1 p -132.07 165.81 23.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.44 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.9 p -128.45 157.57 74.36 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.081 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 51.8 Cg_exo -58.2 -25.68 72.91 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.916 2.41 . . . . 0.0 110.963 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -75.46 -14.04 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.712 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -141.76 65.94 21.09 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.8 Cg_endo -106.26 86.72 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.113 0 C-N-CA 117.148 -1.435 . . . . 0.0 109.586 168.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 ttmt -147.83 -50.43 0.18 Allowed 'General case' 1 C--N 1.209 -5.534 0 CA-C-N 109.489 -3.505 . . . . 0.0 101.675 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.514 HG22 HD12 ' A' ' 60' ' ' ILE . 98.0 m -62.52 -48.41 79.65 Favored 'General case' 0 N--CA 1.382 -3.85 0 CA-C-N 111.712 -2.494 . . . . 0.0 106.047 164.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.23 -49.1 77.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.004 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 18.9 pt-20 -56.17 -35.96 67.8 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 117.589 -1.644 . . . . 0.0 110.988 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' HD21 ' A' ' 21' ' ' LEU . 57.7 t80 -70.76 -52.05 23.22 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.744 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 HD12 HG22 ' A' ' 56' ' ' THR . 97.1 mt -63.92 -45.12 97.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.508 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.734 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 49.2 t30 -57.08 -47.33 81.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.907 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 t -71.47 -43.68 66.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.733 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.96 89.32 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.377 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 95.2 m-85 -104.52 20.16 19.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.734 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtpt -63.32 -23.14 67.28 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 174.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.03 10.02 15.43 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.22 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 45.1 p90 -50.51 148.55 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -103.55 -52.88 2.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.448 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -121.14 16.57 11.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.557 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 79.1 mt -103.87 127.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.54 0.686 . . . . 0.0 111.838 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 69.2 t -125.84 134.0 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.879 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.32 132.7 49.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.189 0.519 . . . . 0.0 109.973 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.51 157.04 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.901 0.857 . . . . 0.0 111.672 -176.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -106.6 133.79 50.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.981 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.8 t -159.75 -168.6 2.3 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 78' ' ' LYS . 65.7 m -77.37 3.28 13.58 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 126.001 1.72 . . . . 0.0 113.725 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.51 -14.56 0.0 OUTLIER Glycine 1 N--CA 1.522 4.372 0 C-N-CA 127.11 2.29 . . . . 0.0 117.992 -174.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.8 tmtt? -59.93 -37.11 78.55 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.68 130.35 8.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.48 -51.04 71.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.484 HD12 ' OH ' ' A' ' 163' ' ' TYR . 45.7 pt -71.32 -36.41 61.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.52 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.37 -40.01 92.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.124 0.488 . . . . 0.0 109.834 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.501 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 19.0 t0 -59.66 -51.03 71.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.962 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.2 mm? -56.34 -45.4 80.41 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.783 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.521 ' HA ' HG12 ' A' ' 88' ' ' ILE . 24.6 m-80 -60.32 -41.31 93.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.597 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 77.4 mm-40 -65.19 -46.06 82.32 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.538 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.4 m -63.02 -43.76 97.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.238 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 84' ' ' LEU . 34.7 pt -67.72 -29.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.822 0.344 . . . . 0.0 110.403 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.31 96.09 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.71 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.5 3.89 50.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.45 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 63.8 m-85 -108.74 143.26 38.1 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.581 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.3 p -102.78 -0.76 30.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.484 . . . . 0.0 111.11 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -133.24 156.75 79.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.864 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.76 146.34 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.409 2.072 . . . . 0.0 111.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.25 161.69 38.28 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.488 0.661 . . . . 0.0 112.362 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.773 HD11 HD12 ' A' ' 154' ' ' ILE . 1.5 tm? -84.81 143.08 29.32 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.222 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.613 ' N ' HD13 ' A' ' 96' ' ' LEU . 99.8 t -119.59 130.15 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.86 0.864 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 37' ' ' LEU . 14.6 m -130.87 161.95 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.207 0.527 . . . . 0.0 112.136 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.8 t -99.37 140.74 33.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -72.24 -10.86 60.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -104.15 9.69 36.15 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.28 122.86 27.96 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 122.086 -0.384 . . . . 0.0 110.931 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 pt -62.98 166.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -89.56 72.53 7.84 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.17 -14.01 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 168.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 25.0 pttm -67.66 -0.44 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.002 -1.908 . . . . 0.0 114.454 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.4 m -58.09 -40.67 81.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -82.49 -23.99 34.41 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.738 0.78 . . . . 0.0 110.303 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.6 mm -64.02 -40.22 88.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.112 -174.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.57 ' HA ' HD11 ' A' ' 154' ' ' ILE . 58.1 mt -57.89 -48.57 83.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.644 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -65.12 -39.75 93.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.58 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.6 m -61.33 -40.16 93.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.634 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -61.8 -49.18 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.695 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 71.4 t -62.85 -47.76 91.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.425 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.12 -45.83 93.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.731 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.628 ' CE2' HD11 ' A' ' 120' ' ' ILE . 62.3 t80 -62.85 -48.38 79.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.813 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.53 -47.64 84.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.363 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.448 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 25.5 m-85 -61.8 -37.77 85.64 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.459 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -63.66 -39.75 95.11 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.277 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.628 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.6 mt -63.35 -46.36 95.69 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.078 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HG2' HG13 ' A' ' 127' ' ' VAL . 52.5 mtmt -61.74 -38.66 88.77 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.908 0.385 . . . . 0.0 111.178 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.6 87.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.398 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -86.93 -35.25 19.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.017 0.437 . . . . 0.0 111.627 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 127' ' ' VAL . 34.4 m -136.88 94.53 12.81 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 122.806 0.443 . . . . 0.0 110.848 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.34 -15.8 31.43 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.388 2.725 . . . . 0.0 113.051 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.9 -32.92 72.37 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.495 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 12.0 p -65.54 132.14 31.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.215 0.531 . . . . 0.0 111.947 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -119.56 -15.79 8.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.167 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.82 160.23 43.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 23.1 tp -134.61 144.26 47.8 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.96 140.73 51.53 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.317 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.557 HG21 ' CD1' ' A' ' 113' ' ' ILE . 84.2 t -118.58 120.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 ptm -145.49 154.62 42.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.787 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 152' ' ' ALA . 28.2 pt -129.87 156.29 79.22 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.382 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.4 142.05 97.12 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.209 1.939 . . . . 0.0 110.739 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -62.03 -19.05 62.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.35 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.27 -39.54 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.072 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.433 ' HG3' HD12 ' A' ' 134' ' ' ILE . 19.5 ptpt -90.19 -21.47 22.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.752 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -67.29 126.09 92.03 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 174' ' ' LEU . 37.0 Cg_endo -65.79 -67.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.732 2.288 . . . . 0.0 113.876 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -132.24 145.47 57.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.527 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.04 -33.15 82.34 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 124.136 3.224 . . . . 0.0 114.785 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m 59.81 27.13 16.4 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.6 mt 71.72 148.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.032 0.533 . . . . 0.0 111.504 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 62.88 29.79 16.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.134 0.492 . . . . 0.0 111.057 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.82 134.68 55.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.604 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -124.85 172.22 9.53 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.21 94.77 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.99 139.84 40.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 15.1 m -127.42 118.86 21.65 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 150' ' ' VAL . 48.2 Cg_exo -60.45 142.48 98.12 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.028 2.485 . . . . 0.0 111.166 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HA ' HD11 ' A' ' 175' ' ' ILE . . . -135.25 -30.19 1.05 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.239 0.543 . . . . 0.0 111.431 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.39 -141.91 11.66 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 119.715 -1.231 . . . . 0.0 112.49 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 96' ' ' LEU . 17.6 pt -126.37 160.69 33.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.926 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.0 m-20 -109.53 159.74 16.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.33 132.39 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.34 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.96 152.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.108 0.48 . . . . 0.0 111.513 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.568 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.2 m -97.07 160.12 29.79 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.374 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.5 83.24 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.783 2.322 . . . . 0.0 111.615 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.542 ' HG3' ' HB3' ' A' ' 164' ' ' GLN . 30.8 mmmt -114.31 150.3 34.69 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.864 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.79 -42.45 90.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.788 0.328 . . . . 0.0 110.469 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.01 -148.29 7.28 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.594 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.484 ' OH ' HD12 ' A' ' 81' ' ' ILE . 97.7 m-85 -75.98 149.47 37.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.0 110.893 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.568 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 16.3 pt20 -134.23 167.61 20.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 1.9 tmtm? -60.71 131.4 50.57 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.999 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -134.56 130.58 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.727 0.299 . . . . 0.0 111.69 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -95.08 164.09 13.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.8 mm -119.13 131.69 71.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -135.8 140.66 44.43 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.312 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.9 t -108.38 129.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.398 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.79 170.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 112.01 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 3.05 56.31 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.975 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.487 ' CD ' HD11 ' A' ' 109' ' ' ILE . 12.1 pt-20 -130.09 142.37 50.61 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.815 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.46 ' HB2' ' HD3' ' A' ' 140' ' ' PRO . 2.7 pp -97.23 149.66 21.79 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.625 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 175' ' ' ILE . 2.3 pp -131.41 145.35 35.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.398 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -131.01 149.68 52.5 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -98.39 178.94 4.88 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.97 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.15 119.72 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -125.49 -22.0 4.39 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.386 0.612 . . . . 0.0 109.731 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.1 p -130.03 164.21 24.82 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.521 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.412 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 mppt? -63.28 -35.79 81.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.92 -44.32 94.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.118 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.34 -41.43 96.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.177 0.513 . . . . 0.0 109.647 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 24' ' ' LEU . 53.0 tp -61.19 -47.73 84.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.522 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.629 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 86.6 tttt -68.11 -35.88 78.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.583 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.5 tp -58.5 -48.36 81.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.748 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.474 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.34 -42.45 98.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.274 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.3 -32.38 73.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.848 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -61.87 -44.8 96.09 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.687 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.84 -35.83 67.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.146 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.1 mt -65.11 -41.08 95.26 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.845 0.831 . . . . 0.0 109.845 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 192' ' ' LYS . 41.0 ttmt -61.54 -46.5 89.67 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.346 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -66.79 -31.56 72.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.63 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.04 -23.91 67.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.957 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.94 -90.42 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.271 2.228 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.85 179.41 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 68.9 m-20 -94.82 166.02 12.19 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -113.8 127.73 56.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.121 0.486 . . . . 0.0 110.519 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.88 121.97 45.15 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.614 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.9 mt -118.83 114.27 44.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.8 ttm -84.7 97.11 9.47 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-O 121.936 0.874 . . . . 0.0 111.302 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -114.42 100.82 8.6 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.038 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.96 -1.18 7.84 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.974 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.24 164.12 28.17 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -136.65 -9.51 1.87 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 80' ' ' TYR . . . 71.83 -154.1 50.76 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.663 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 p -97.62 11.84 35.62 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.953 0.501 . . . . 0.0 111.999 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -114.27 20.7 15.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.837 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt 71.71 -37.4 0.39 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.507 0.723 . . . . 0.0 112.297 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.39 61.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.483 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.5 55.43 4.09 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.953 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.42 150.54 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 158.88 19.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.928 0.394 . . . . 0.0 111.111 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.1 pttm -63.73 154.73 79.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.334 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 28.5 Cg_endo -62.58 -5.73 7.61 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.659 2.906 . . . . 0.0 113.647 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' A' ' 56' ' ' THR . 72.7 mt -86.84 23.07 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 19' ' ' LYS . 95.6 mt -70.4 116.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.5 pttm -96.24 131.82 42.34 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.205 1.003 . . . . 0.0 112.759 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -128.93 138.54 52.05 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 113.395 -1.729 . . . . 0.0 108.634 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.492 ' SG ' HD13 ' A' ' 191' ' ' LEU . 81.0 m 63.33 -75.65 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.55 0.531 . . . . 0.0 112.263 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.18 0.58 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.669 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 7.7 ptm180 -150.6 170.1 19.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.402 1.101 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 96.3 m -78.07 156.96 29.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -53.01 -46.94 68.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.327 0.651 . . . . 0.0 110.929 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -63.95 -36.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.817 0.341 . . . . 0.0 110.762 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.56 -40.8 97.93 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.539 ' CE2' ' HG2' ' A' ' 27' ' ' ARG . 7.7 m-85 -61.63 -36.75 81.65 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 29' ' ' LEU . 78.9 t -65.77 -42.35 92.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.924 0.392 . . . . 0.0 110.881 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.421 HG23 HD13 ' A' ' 30' ' ' ILE . 74.0 t -64.01 -41.61 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 t -48.04 -56.5 13.49 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 42.4 Cg_endo -67.91 -37.37 15.6 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 121.719 1.612 . . . . 0.0 112.435 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.57 HD11 HG11 ' A' ' 98' ' ' VAL . 82.0 mt -65.52 -42.59 91.86 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' A' ' 69' ' ' ASN . 6.6 tt -61.45 -46.92 88.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.283 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 19.0 ptpt -76.34 -12.8 60.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.1 p -72.17 -178.41 2.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.925 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -70.04 -4.56 21.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.997 -1.002 . . . . 0.0 113.529 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.32 162.07 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.483 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.555 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.1 t30 -80.12 -75.44 0.26 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.201 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -120.0 161.04 21.6 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.039 0.447 . . . . 0.0 110.8 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 3' ' ' ALA . 46.8 mm -108.99 116.49 52.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.301 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 88.6 m-85 -109.89 118.1 35.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 60' ' ' ILE . 90.2 mt -101.57 118.77 48.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.567 0.699 . . . . 0.0 111.023 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -84.48 117.99 24.01 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.074 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 7' ' ' ALA . 71.5 p -125.26 164.32 20.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -126.53 156.14 73.52 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.491 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 54.4 Cg_exo -58.07 -24.29 65.23 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.98 2.453 . . . . 0.0 111.154 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -70.1 -20.86 63.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.021 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -139.6 67.64 37.06 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.654 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 86.3 Cg_endo -100.76 84.9 0.04 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.618 0 C-N-CA 116.682 -1.745 . . . . 0.0 109.522 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -151.43 -45.78 0.11 Allowed 'General case' 1 C--N 1.213 -5.362 0 CA-C-N 110.311 -3.131 . . . . 0.0 102.938 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.491 ' HA ' HD21 ' A' ' 21' ' ' LEU . 87.4 m -63.6 -46.1 87.34 Favored 'General case' 0 N--CA 1.386 -3.628 0 CA-C-N 112.933 -1.939 . . . . 0.0 105.824 163.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.7 tmtt? -61.18 -50.28 73.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.239 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 57.9 mt-10 -59.79 -43.93 94.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 118.274 -1.371 . . . . 0.0 112.348 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.15 -50.87 71.41 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -63.1 -42.52 96.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.333 0.587 . . . . 0.0 110.414 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.22 -44.84 84.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.054 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 68.5 m -70.39 -40.19 74.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.736 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.78 89.83 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.26 0.552 . . . . 0.0 110.956 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 62.0 m-85 -112.73 41.39 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.169 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 62' ' ' SER . 12.7 mmmm -59.7 -37.3 78.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.112 177.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.62 11.15 15.78 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.807 0.443 . . . . 0.0 111.024 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 47.7 p90 -39.51 132.96 1.49 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.0 -48.18 4.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.515 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.1 p-10 -118.81 9.7 12.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.843 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.5 mp -99.7 119.17 47.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.615 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.0 t -121.22 131.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.737 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.69 130.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.513 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.3 pt -125.4 156.63 34.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.127 0.489 . . . . 0.0 110.562 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -118.23 134.91 54.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -160.57 -169.22 2.36 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.6 m -64.32 2.35 0.61 Allowed 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 127.169 2.188 . . . . 0.0 114.674 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.43 -22.32 0.0 OUTLIER Glycine 0 N--CA 1.511 3.64 0 C-N-CA 126.358 1.932 . . . . 0.0 116.929 -174.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.7 OUTLIER -56.42 -36.82 69.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.337 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.04 125.74 7.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 90.3 t80 -60.59 -51.6 68.7 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.1 pt -75.49 -30.72 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.375 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 43.7 mt-10 -65.52 -41.86 92.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.825 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.576 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.9 t0 -60.21 -51.27 70.27 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.991 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -59.41 -44.36 92.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 88' ' ' ILE . 22.7 m-80 -61.2 -40.32 93.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.92 0.39 . . . . 0.0 111.774 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 63.4 mm-40 -62.79 -46.45 87.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 99.5 m -62.15 -43.15 99.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.085 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.0 pt -65.68 -27.72 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.032 0.444 . . . . 0.0 110.316 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.99 -20.28 74.51 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.713 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -105.3 -23.58 12.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 60.0 m-85 -75.2 149.57 38.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -97.11 -15.48 20.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -139.83 160.91 58.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.808 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -52.91 143.19 49.99 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 111.778 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 42.7 p90 -137.57 156.16 48.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.439 0.638 . . . . 0.0 111.687 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 154' ' ' ILE . 1.5 tm? -86.86 133.87 33.59 Favored 'General case' 0 C--O 1.189 -2.131 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.057 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.7 t -107.03 128.54 61.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.141 0.576 . . . . 0.0 109.756 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 5' ' ' ILE . 4.4 m -130.53 161.53 40.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.495 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 70.2 m -99.73 144.28 28.98 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.731 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.514 ' O ' HD22 ' A' ' 29' ' ' LEU . 63.6 m -88.03 -1.48 58.02 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -108.32 7.78 27.36 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 65.9 mt -81.44 114.91 20.5 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.176 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.35 112.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 173.58 176.95 0.12 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.0 tp -84.21 103.06 13.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -96.98 -3.84 40.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.686 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -59.77 -45.01 93.58 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.057 0.456 . . . . 0.0 111.778 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -79.15 -23.57 43.88 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.365 0.602 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.716 ' O ' HG12 ' A' ' 113' ' ' ILE . 35.1 mm -68.98 -41.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.395 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.07 -46.55 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.376 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.22 -42.42 99.29 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.256 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.4 m -64.76 -41.71 95.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.55 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.8 mm -64.21 -49.96 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.008 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.41 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 64.8 t -61.6 -47.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.769 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.41 -46.42 88.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.823 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CE2' HD11 ' A' ' 120' ' ' ILE . 67.0 t80 -63.43 -46.51 86.01 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.795 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.62 -48.3 81.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.907 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.418 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 23.1 m-85 -63.21 -33.79 76.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.427 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.01 -46.92 87.09 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.286 0.565 . . . . 0.0 109.676 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.8 mt -64.18 -48.58 85.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.577 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -65.55 -26.53 67.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.413 -178.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.49 99.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.57 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 19.0 ptpt -82.24 -37.0 26.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.669 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 127' ' ' VAL . 85.9 m -132.65 91.72 29.2 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.15 -17.44 38.73 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 123.379 2.72 . . . . 0.0 112.921 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.75 -32.27 73.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 124' ' ' THR . 9.9 p -73.33 127.64 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 45.0 mt-10 -122.19 2.9 9.83 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.193 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.51 155.23 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.971 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.8 tp -137.58 146.1 43.63 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.93 137.12 53.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.338 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 113' ' ' ILE . 98.9 t -114.24 115.77 50.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.379 0.609 . . . . 0.0 109.615 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.5 ptm -145.9 156.61 43.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.785 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.637 HG12 ' HB2' ' A' ' 152' ' ' ALA . 22.2 pt -131.5 158.39 75.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.652 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.51 142.21 95.34 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.411 2.074 . . . . 0.0 111.706 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.06 -24.83 68.09 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.362 0.601 . . . . 0.0 109.696 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.32 -36.1 82.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.461 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.07 -24.25 19.22 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.426 0.632 . . . . 0.0 110.996 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.526 ' HD1' HD11 ' A' ' 134' ' ' ILE . 59.7 t80 -92.0 118.17 68.08 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.773 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.84 -76.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.515 2.143 . . . . 0.0 114.555 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -129.56 127.41 22.99 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.401 ' N ' ' HE2' ' A' ' 139' ' ' TYR . 23.0 Cg_exo -67.07 169.73 14.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.465 2.777 . . . . 0.0 111.961 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.1 m -59.96 -39.64 86.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.09 -68.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -176.52 148.25 0.71 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.084 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -145.98 129.9 17.29 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -88.33 125.64 34.79 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.31 -44.58 2.62 Favored Glycine 0 CA--C 1.506 -0.494 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.148 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 159.71 41.65 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.92 135.87 28.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 141.65 48.54 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.039 1.826 . . . . 0.0 111.252 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.637 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -114.69 -5.11 12.7 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.295 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.25 -116.95 0.45 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.557 -1.306 . . . . 0.0 113.176 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.628 HD12 HD11 ' A' ' 96' ' ' LEU . 25.2 pt -119.05 161.15 18.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.991 0.424 . . . . 0.0 111.768 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.609 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.7 t-20 -120.18 156.02 31.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.118 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 81.3 t -124.25 130.27 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 122.253 0.221 . . . . 0.0 110.75 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.517 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.7 m -135.52 155.16 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.055 0.455 . . . . 0.0 111.346 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.536 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.6 m -97.06 157.45 34.97 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.187 174.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.34 69.22 7.26 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.873 2.382 . . . . 0.0 111.731 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.31 169.58 10.27 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.918 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -110.22 22.07 15.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.622 0.725 . . . . 0.0 109.606 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -170.27 -176.32 39.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.509 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -72.22 146.17 47.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.091 0.446 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.536 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 19.9 pt20 -133.37 166.6 22.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -173.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.47 127.62 33.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.763 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.13 132.15 53.15 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.65 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.431 ' HG3' HG21 ' A' ' 120' ' ' ILE . 45.8 mm-40 -93.49 163.05 13.72 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.641 0.734 . . . . 0.0 112.207 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.4 mm -116.16 127.77 73.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.442 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.8 ttp -131.19 132.86 45.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.911 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 133' ' ' MET . 78.8 t -107.87 131.78 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.163 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.648 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 39.2 pt -114.55 172.62 3.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -117.97 8.02 12.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.352 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.648 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.1 pm0 -104.32 134.67 47.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.708 0.766 . . . . 0.0 110.828 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.73 151.05 19.72 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.536 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 102' ' ' LEU . 7.6 pt -110.37 146.16 15.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.436 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.34 111.8 24.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -110.12 153.02 25.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.747 HG23 ' HB2' ' A' ' 183' ' ' ASP . 92.6 mt -110.73 119.59 59.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -176.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -114.4 -24.8 8.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.561 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.1 p -128.26 163.96 23.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.695 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -61.8 -32.46 72.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.18 -37.54 85.63 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.366 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.747 ' HB2' HG23 ' A' ' 178' ' ' ILE . 57.3 m-20 -60.89 -35.28 76.24 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.007 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 178' ' ' ILE . 96.0 mt -60.02 -46.2 90.27 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.87 0.843 . . . . 0.0 109.184 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.625 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 65.7 tttm -65.82 -40.05 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.505 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 189' ' ' MET . 10.5 tt -64.13 -44.36 92.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 0.0 110.187 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.06 -43.03 99.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.332 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -70.33 -29.74 66.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.064 0.459 . . . . 0.0 110.607 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 186' ' ' LEU . 60.0 ttm -61.87 -47.91 82.9 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.325 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -70.1 -31.38 68.91 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.768 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.492 HD13 ' SG ' ' A' ' 25' ' ' CYS . 83.5 mt -62.11 -45.02 95.34 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.339 0.59 . . . . 0.0 110.678 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -70.75 -47.56 59.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.27 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -66.55 -42.81 86.54 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -104.57 5.9 34.17 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.38 99.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.247 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.268 2.056 0 CA-C-O 117.478 -1.248 . . . . 0.0 109.862 178.16 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 59.2 ttm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' HA ' HG13 ' A' ' 42' ' ' VAL . 63.6 m-20 -103.94 164.6 11.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.614 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -114.7 129.79 56.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.178 0.513 . . . . 0.0 111.168 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.2 tm? -103.57 119.27 38.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 98' ' ' VAL . 68.6 mt -116.6 115.69 49.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.138 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.568 ' CE ' HD22 ' A' ' 84' ' ' LEU . 47.2 mtt -89.66 97.47 11.21 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 122.48 1.133 . . . . 0.0 113.591 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.86 110.62 19.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.07 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.86 -14.35 49.31 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.13 170.61 49.51 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.11 153.93 48.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.962 0.411 . . . . 0.0 110.907 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 1.81 72.63 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.284 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m 70.75 102.39 0.06 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.025 0.441 . . . . 0.0 109.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 70.13 10.34 7.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.281 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 98.3 mtp -136.0 137.16 40.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.354 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.43 -158.97 9.7 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -10.4 72.05 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.791 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.411 ' HB ' ' OG ' ' A' ' 100' ' ' SER . 35.9 m -104.25 3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.454 0.645 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.42 168.02 12.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.15 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.533 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 tppp? 62.91 59.36 2.21 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.611 0.764 . . . . 0.0 110.972 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 36.6 Cg_exo -64.96 -9.4 21.32 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.445 2.764 . . . . 0.0 112.402 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.519 HD21 ' CB ' ' A' ' 59' ' ' TYR . 10.8 mp -79.69 6.31 11.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.47 125.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -109.54 146.09 35.23 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.647 0.737 . . . . 0.0 112.386 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 184' ' ' LEU . 96.4 mt -129.45 124.71 34.75 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.848 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 192' ' ' LYS . 79.6 m 65.66 -74.32 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.732 0.645 . . . . 0.0 112.418 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.9 -68.96 0.55 Allowed Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.529 -0.843 . . . . 0.0 114.221 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 98.5 mtt180 -115.76 172.86 6.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 112.349 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.4 m -71.84 154.47 41.25 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.466 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -42.21 20.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.436 1.094 . . . . 0.0 111.219 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.1 tp -58.18 -48.2 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 19.0 t70 -63.74 -40.01 95.7 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.036 0.446 . . . . 0.0 110.584 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 7.0 m-30 -62.13 -37.4 85.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.865 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.45 -43.66 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.701 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.4 t -64.62 -42.18 94.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.643 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -50.04 -54.99 27.35 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.12 -38.09 9.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.205 1.27 . . . . 0.0 112.583 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 HG11 ' A' ' 98' ' ' VAL . 91.1 mt -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.967 0.413 . . . . 0.0 111.405 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.604 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.5 tt -63.09 -46.88 85.29 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.07 -12.93 60.03 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 p -74.62 -176.75 2.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.932 0.396 . . . . 0.0 110.803 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.28 -9.51 3.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.883 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 2' ' ' ASP . 69.0 t -64.51 133.11 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.171 0.51 . . . . 0.0 110.588 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -80.26 -68.3 0.69 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.988 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -111.12 148.38 32.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.405 0.621 . . . . 0.0 111.217 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.9 mm -108.47 117.12 53.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.765 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.24 113.83 27.23 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -95.23 116.3 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.427 0 CA-C-O 121.657 0.741 . . . . 0.0 110.042 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.6 120.6 29.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.826 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 7' ' ' ALA . 76.0 p -125.61 160.16 30.32 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.254 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.9 m -109.66 150.44 41.26 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.999 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.27 -27.6 75.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.103 2.536 . . . . 0.0 111.801 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -81.05 -6.62 59.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.476 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.8 66.34 40.58 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.9 Cg_endo -109.24 85.79 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.842 0 CA-C-N 120.713 1.29 . . . . 0.0 110.159 168.092 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.0 mttt -146.45 -45.63 0.19 Allowed 'General case' 1 C--N 1.217 -5.187 0 CA-C-N 109.852 -3.34 . . . . 0.0 102.327 177.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 77.1 m -62.03 -47.99 82.3 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 112.033 -2.349 . . . . 0.0 105.989 162.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.32 -50.1 72.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.061 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.2 pt-20 -59.33 -35.15 73.32 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.858 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CB ' HD21 ' A' ' 21' ' ' LEU . 56.4 t80 -67.25 -51.61 51.02 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.932 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.454 HG23 ' CD2' ' A' ' 64' ' ' TYR . 97.7 mt -63.47 -44.91 99.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.536 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -58.77 -42.65 89.42 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.516 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 35.2 t -70.33 -43.2 70.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.847 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.48 89.73 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.798 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 68.3 m-85 -108.11 34.69 3.47 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.185 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.8 mmmt -62.64 -20.23 64.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.564 0.697 . . . . 0.0 110.128 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.7 10.84 16.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.938 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 52.9 p90 -46.78 126.48 8.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -104.34 -49.37 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.604 HD21 ' HG ' ' A' ' 38' ' ' LEU . 24.9 p-10 -117.01 15.73 15.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.255 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 78.8 mt -105.32 127.58 59.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.248 0.547 . . . . 0.0 110.851 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.03 132.98 68.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.83 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.61 130.96 60.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.484 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.4 155.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 122.038 0.923 . . . . 0.0 112.372 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -111.13 132.61 54.15 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.189 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 2.6 t -161.14 -172.05 3.28 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.8 m -66.69 2.08 1.51 Allowed 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 127.236 2.214 . . . . 0.0 114.68 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.11 -23.98 0.0 OUTLIER Glycine 0 N--CA 1.51 3.596 0 C-N-CA 126.237 1.875 . . . . 0.0 117.038 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -55.38 -35.3 65.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.18 121.77 5.51 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.29 -50.44 73.61 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.9 mt -65.99 -43.62 92.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.585 0.707 . . . . 0.0 110.172 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.1 -44.12 91.91 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.295 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 33.7 t0 -62.07 -48.15 81.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.282 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -53.76 -41.54 67.27 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.861 177.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.586 ' O ' HG12 ' A' ' 88' ' ' ILE . 28.0 m-80 -60.09 -43.99 95.12 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.365 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 53.3 mm-40 -65.67 -41.91 91.93 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.264 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 84' ' ' LEU . 26.1 pt -66.23 -25.12 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.335 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.18 92.28 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.121 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -80.75 -8.99 59.84 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -119.81 145.97 46.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.4 m -115.73 10.73 15.5 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -133.36 157.65 77.6 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.121 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.84 146.05 64.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.195 1.93 . . . . 0.0 111.557 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -139.2 158.26 44.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.686 HD21 HD12 ' A' ' 154' ' ' ILE . 27.0 tp -86.27 140.62 29.93 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.928 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 60.3 t -115.17 131.34 67.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' A' ' 5' ' ' ILE . 11.0 m -126.97 157.02 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.691 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 36.3 t -99.71 136.5 39.54 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 17' ' ' VAL . 74.8 p -64.54 -34.03 77.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -174.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -88.79 1.95 54.37 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.629 HD22 HD13 ' A' ' 175' ' ' ILE . 70.3 mt -91.26 114.11 26.55 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.757 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -121.88 130.29 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -176.91 -178.08 0.82 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.97 71.7 1.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.694 ' HA ' HD12 ' A' ' 109' ' ' ILE . 58.6 mtpt -79.98 -8.05 59.13 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.546 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.8 t -59.75 -45.94 90.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -82.97 -24.26 33.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.797 0.808 . . . . 0.0 110.169 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 106' ' ' LYS . 78.6 mt -65.63 -39.24 84.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.03 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 106' ' ' LYS . 60.3 mt -57.09 -46.47 84.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.279 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -61.66 -43.9 97.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.12 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -63.98 -40.77 97.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.738 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.693 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.01 -49.11 85.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.217 0.532 . . . . 0.0 110.373 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.507 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.7 t -62.48 -46.83 95.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.244 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.61 -43.81 98.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.113 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD2' ' HG3' ' A' ' 169' ' ' MET . 37.5 t80 -66.77 -42.75 85.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.147 0.498 . . . . 0.0 110.287 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.2 t80 -57.46 -47.3 82.2 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.333 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.507 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 39.8 m-85 -67.95 -30.75 70.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.39 -39.79 95.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -65.34 -42.33 93.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.409 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.922 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.418 ' N ' ' HE3' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -57.33 -38.5 74.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.67 177.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.48 91.17 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.561 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -88.59 -37.39 15.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 111.612 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.6 m -141.27 92.06 8.49 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.411 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.262 2.641 . . . . 0.0 112.295 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.39 -30.47 70.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.463 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.544 HG22 ' HE3' ' A' ' 165' ' ' LYS . 61.9 t -67.05 127.45 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.087 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 158' ' ' SER . 30.1 mt-10 -102.44 -34.11 9.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.234 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -131.45 165.6 23.17 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -140.22 134.25 30.85 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.807 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.51 135.93 51.03 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.671 HG21 HD12 ' A' ' 113' ' ' ILE . 78.3 t -117.24 118.61 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.68 41.92 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.747 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.687 HD11 ' HD1' ' A' ' 139' ' ' TYR . 34.8 pt -124.58 163.28 37.71 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 10.7 Cg_endo -57.1 124.83 17.15 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.82 1.68 . . . . 0.0 110.772 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -60.76 -24.34 65.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.059 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.41 -39.2 88.83 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -82.94 -22.23 33.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.431 0.634 . . . . 0.0 110.432 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.687 ' HD1' HD11 ' A' ' 134' ' ' ILE . 43.9 t80 -71.54 138.12 83.47 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.357 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.59 -73.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.363 2.042 . . . . 0.0 112.271 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.424 ' O ' ' HE2' ' A' ' 139' ' ' TYR . 31.6 p30 -158.16 143.18 11.99 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.702 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.452 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 35.2 Cg_exo -62.72 145.35 94.96 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.541 2.161 . . . . 0.0 111.682 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 53.7 m -73.99 101.87 3.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.4 mm 71.86 -38.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.593 0.757 . . . . 0.0 112.864 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 142' ' ' PRO . 8.9 t0 -61.41 133.23 55.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -70.86 -42.05 70.62 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -171.81 132.07 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.755 0.312 . . . . 0.0 111.325 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.86 -148.2 13.84 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.7 mp -88.35 140.92 28.98 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m -117.53 118.67 35.08 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.529 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.96 144.92 48.87 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.271 1.981 . . . . 0.0 110.977 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -128.79 16.65 6.34 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.785 0.326 . . . . 0.0 111.525 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.18 -114.86 0.33 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.89 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.686 HD12 HD21 ' A' ' 96' ' ' LEU . 13.0 pt -134.45 160.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.239 -0.481 . . . . 0.0 110.348 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.482 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.7 t30 -118.19 155.91 29.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.69 130.36 73.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 122.421 0.289 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.53 147.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.134 0.492 . . . . 0.0 111.13 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 8.4 t -99.28 158.45 32.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 28.7 Cg_exo -62.98 93.93 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.373 1.382 . . . . 0.0 110.669 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 163' ' ' TYR . 20.6 pttp -78.01 174.83 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.843 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -124.08 -68.81 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.069 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -113.46 47.23 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.502 ' HA ' ' HD2' ' A' ' 160' ' ' LYS . 91.8 m-85 74.9 148.9 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.566 0.746 . . . . 0.0 110.542 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 158' ' ' SER . 26.7 pt20 -133.84 165.11 25.75 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.544 ' HE3' HG22 ' A' ' 127' ' ' VAL . 64.9 tttp -67.85 121.97 17.14 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.204 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -123.38 126.74 47.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.848 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -94.37 163.05 13.58 Favored 'General case' 0 CA--C 1.469 -2.172 0 CA-C-O 121.895 0.855 . . . . 0.0 113.218 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.0 129.51 69.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.006 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.496 ' SD ' HG23 ' A' ' 171' ' ' ILE . 15.0 tmm? -131.31 138.24 49.15 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.738 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.22 131.09 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.921 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.572 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 2.2 pp -114.63 178.52 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.889 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -115.81 3.36 13.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.572 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 1.8 pm0 -98.83 136.85 38.26 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.81 0.814 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.68 139.27 32.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.965 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.629 HD13 HD22 ' A' ' 102' ' ' LEU . 1.8 pp -101.93 155.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -98.99 107.31 19.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -92.3 124.92 36.72 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.634 HG21 HD23 ' A' ' 184' ' ' LEU . 85.5 mt -108.86 110.01 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.725 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -124.4 -13.72 7.07 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 43.1 p -127.04 167.75 15.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.381 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -65.09 -35.18 80.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.83 -42.45 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.054 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.568 ' HB2' HG23 ' A' ' 178' ' ' ILE . 73.2 m-20 -62.28 -37.8 86.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.143 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.634 HD23 HG21 ' A' ' 178' ' ' ILE . 95.5 mt -60.26 -46.79 88.6 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.765 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 189' ' ' MET . 28.9 mtpp -64.93 -38.41 90.89 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.368 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.98 -50.5 73.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.154 0.502 . . . . 0.0 110.078 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.35 -41.92 88.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.435 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.503 ' CG ' ' HA ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER -68.98 -30.8 69.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.4 mtp -64.61 -41.57 96.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.747 0.308 . . . . 0.0 111.684 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -77.84 -33.02 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.923 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 190' ' ' LEU . 86.9 mt -61.28 -47.42 86.1 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.414 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mtmm -70.56 -40.93 73.07 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.988 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -68.06 -43.14 79.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.824 0.345 . . . . 0.0 111.648 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -71.76 -26.23 62.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.912 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -60.61 -40.56 98.07 Favored Glycine 0 C--N 1.321 -0.265 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.146 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.272 2.256 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.12 179.258 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.637 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 36.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -90.37 166.2 13.42 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.021 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -123.29 134.01 54.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.66 127.28 52.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.148 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.619 ' HA ' HG22 ' A' ' 98' ' ' VAL . 61.4 mt -118.11 106.83 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttm -80.5 101.53 9.15 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 121.898 0.856 . . . . 0.0 111.021 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -115.54 97.72 6.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.35 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.33 106.26 0.55 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.984 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . 164.41 -163.13 35.94 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.087 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.74 105.33 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.35 154.28 19.73 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.268 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.4 p -92.15 -16.43 26.3 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.151 0.5 . . . . 0.0 110.132 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -130.5 149.77 52.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.047 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -95.77 116.44 28.89 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.73 134.21 11.35 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.85 -129.58 46.79 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.17 -68.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 116.999 0.399 . . . . 0.0 109.973 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HA ' HD11 ' A' ' 22' ' ' ILE . 46.7 mt-10 49.69 -162.45 0.05 OUTLIER 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.215 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER 67.26 176.25 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.051 175.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 19' ' ' LYS . 51.1 Cg_exo -59.16 -8.96 7.2 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.607 2.205 . . . . 0.0 113.546 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 49.7 mt -89.08 6.34 40.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 18' ' ' GLU . 97.3 mt -63.58 114.21 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 60.4 pttt -95.6 131.77 41.45 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.583 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 188' ' ' GLU . 61.9 tp -136.13 120.97 18.57 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.322 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.6 m 58.54 24.09 11.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.86 -31.36 4.57 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.223 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.722 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 95.8 mtt180 -126.39 157.54 38.25 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.787 1.294 . . . . 0.0 111.764 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.5 m -81.54 163.52 22.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.535 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 33' ' ' VAL . 84.9 mt -58.77 -39.7 81.79 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.592 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.7 tp -56.21 -47.47 80.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.245 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.683 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.1 t70 -65.02 -42.86 94.02 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.168 0.508 . . . . 0.0 110.634 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.722 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 30.8 m-85 -64.07 -36.94 85.66 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.427 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.513 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 79.1 t -70.07 -41.05 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 30' ' ' ILE . 59.8 t -61.47 -43.27 96.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.899 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 65.8 m -52.76 -52.46 64.31 Favored Pre-proline 0 CA--C 1.571 1.768 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 33' ' ' VAL . 51.9 Cg_exo -60.53 -42.46 40.24 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 121.758 1.639 . . . . 0.0 111.982 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.566 HD11 HG11 ' A' ' 98' ' ' VAL . 96.1 mt -68.2 -37.23 80.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.722 0.772 . . . . 0.0 110.585 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 69' ' ' ASN . 59.7 tp -58.33 -45.77 87.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.989 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.11 -1.61 58.17 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.414 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.627 ' HB2' HG21 ' A' ' 110' ' ' ILE . 60.3 p -75.69 175.4 8.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.9 ttmm -58.26 -27.01 63.62 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.493 0.717 . . . . 0.0 112.469 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG22 ' OG ' ' A' ' 40' ' ' SER . 30.7 m -59.94 154.51 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.16 -69.0 0.56 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.844 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -120.92 153.67 36.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.207 0.527 . . . . 0.0 111.16 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.8 mm -106.64 115.26 47.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 87.0 m-85 -104.91 116.09 31.39 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.719 HG21 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -94.97 116.05 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-O 121.574 0.702 . . . . 0.0 110.319 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.66 120.74 28.29 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.439 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.9 p -125.06 158.0 34.86 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.472 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 28.9 t -111.9 142.29 26.44 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.169 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 75.6 Cg_exo -55.48 -25.89 51.29 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.457 2.771 . . . . 0.0 111.949 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -75.84 -9.0 58.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -140.35 67.12 31.41 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-O 119.244 -0.408 . . . . 0.0 112.011 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 67.0 Cg_endo -104.68 85.26 0.02 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.781 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.413 170.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 97.6 mttt -147.63 -46.78 0.17 Allowed 'General case' 1 C--N 1.214 -5.308 0 CA-C-N 109.932 -3.304 . . . . 0.0 103.721 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.472 HG21 ' HB1' ' A' ' 7' ' ' ALA . 87.9 m -61.93 -47.43 84.96 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 164.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -62.68 -49.62 74.39 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.016 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.1 pt-20 -59.19 -37.73 78.12 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.876 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.48 -50.25 70.4 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 47' ' ' ILE . 94.7 mt -63.47 -41.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.601 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.546 ' OD1' HG11 ' A' ' 72' ' ' VAL . 92.7 m-20 -57.06 -45.73 83.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.866 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 58.3 m -71.32 -41.96 69.22 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.262 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 -38.91 92.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.328 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 70.3 m-85 -113.55 37.86 3.1 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.71 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 10.8 mmmm -62.47 -23.38 66.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.316 0.579 . . . . 0.0 110.758 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -92.55 11.28 26.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.332 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 53.0 p90 -43.25 128.6 4.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -101.36 -52.03 3.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.023 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.513 HD21 HD12 ' A' ' 38' ' ' LEU . 6.8 p-10 -119.48 14.31 12.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.71 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.52 125.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 59.3 t -125.42 133.17 69.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' A' ' 61' ' ' ASN . 7.2 p -104.5 134.47 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.2 pt -129.25 157.1 42.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.585 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -116.07 136.13 53.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 12.7 t -160.2 -172.4 3.58 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -66.73 3.81 0.95 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 127.543 2.337 . . . . 0.0 114.592 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.98 -20.73 0.0 OUTLIER Glycine 1 N--CA 1.517 4.099 0 C-N-CA 126.51 2.005 . . . . 0.0 116.947 -173.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 76' ' ' SER . 55.8 tptt -56.55 -39.78 73.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.26 122.37 6.09 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.15 -50.44 73.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.219 0.533 . . . . 0.0 111.718 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.3 -45.65 95.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.71 0.766 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 48.3 mt-10 -60.07 -42.48 94.65 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.83 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.79 -51.61 69.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.347 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.628 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.0 mm? -58.76 -43.56 90.35 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.629 ' O ' HG12 ' A' ' 88' ' ' ILE . 30.0 m-80 -61.61 -39.93 93.02 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.332 0.587 . . . . 0.0 112.4 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 54.6 mm-40 -65.91 -42.21 90.47 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.506 -0.746 . . . . 0.0 109.009 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.5 m -61.73 -43.21 99.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.961 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.629 HG12 ' O ' ' A' ' 85' ' ' ASN . 33.1 pt -63.64 -27.1 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.687 0.28 . . . . 0.0 110.344 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.73 -24.87 64.88 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.566 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -99.93 2.87 44.08 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.85 135.6 54.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 112.285 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -103.66 -2.35 26.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.1 mt-10 -131.55 160.83 65.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.1 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.637 ' O ' ' HG3' ' A' ' 1' ' ' MET . 48.7 Cg_endo -67.31 157.67 60.66 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.445 2.096 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -144.71 159.25 43.14 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.367 0.603 . . . . 0.0 111.699 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 3' ' ' ALA . 21.9 tp -86.64 145.98 26.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.726 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 95.8 t -116.63 130.11 72.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 124.07 0.948 . . . . 0.0 108.601 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.4 m -131.77 163.97 35.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.26 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 46.9 t -99.8 139.71 35.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.4 p -89.6 -1.3 57.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.01 9.54 13.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.517 ' O ' HD12 ' A' ' 102' ' ' LEU . 2.8 pp -92.53 143.48 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.938 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 18.0 tt -140.26 132.41 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.074 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 18.9 t-20 173.28 167.61 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.163 0.985 . . . . 0.0 108.415 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tt -80.19 88.32 5.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.581 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -101.82 3.6 39.52 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.5 p -52.76 -36.04 57.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.429 ' CG ' HD12 ' A' ' 109' ' ' ILE . 21.5 pttp -73.15 -28.51 62.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.254 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.751 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.0 mp -61.4 -43.05 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.304 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.627 HG21 ' HB2' ' A' ' 40' ' ' SER . 5.2 mm -54.16 -49.82 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 121.821 0.819 . . . . 0.0 109.743 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 62.3 m-80 -61.98 -42.93 99.69 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.662 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -61.81 -38.35 87.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.726 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -60.83 -49.15 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.11 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.54 -47.76 91.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.863 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.08 -46.91 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.731 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.662 ' CE2' HD11 ' A' ' 120' ' ' ILE . 45.2 t80 -66.53 -46.05 77.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.637 0.256 . . . . 0.0 111.483 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 62.9 t80 -58.19 -47.58 83.01 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.073 0.464 . . . . 0.0 110.694 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -62.84 -37.36 86.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.204 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 91.7 m -63.75 -40.15 96.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.024 0.44 . . . . 0.0 110.568 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.662 HD11 ' CE2' ' A' ' 116' ' ' TYR . 81.2 mt -65.45 -46.02 91.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.138 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 52.8 mtmt -63.08 -37.52 87.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.218 0.533 . . . . 0.0 110.531 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.61 91.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.293 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -82.2 -35.0 28.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.024 0.44 . . . . 0.0 111.513 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 66.4 m -137.24 97.51 10.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.447 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.04 -20.52 54.13 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.412 2.742 . . . . 0.0 113.036 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.77 -30.39 71.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.787 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.447 HG22 ' HE3' ' A' ' 165' ' ' LYS . 67.5 t -73.77 125.38 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.82 2.58 7.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.995 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -143.0 156.08 44.78 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.962 0.41 . . . . 0.0 111.468 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -140.39 133.1 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.404 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -120.37 129.98 54.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.86 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.722 HG21 ' CD1' ' A' ' 113' ' ' ILE . 60.8 t -115.01 121.74 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 6.5 ptm -145.89 156.8 43.79 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.661 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 152' ' ' ALA . 14.3 pt -128.54 156.52 77.09 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.633 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.9 131.78 48.07 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.219 1.946 . . . . 0.0 111.95 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.89 -19.7 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.521 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.09 -37.01 86.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.42 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -93.99 -23.6 17.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 110.207 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -64.55 135.35 96.33 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.652 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -49.96 -66.97 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.883 2.389 . . . . 0.0 112.952 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -156.57 133.86 6.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 143' ' ' SER . 50.2 Cg_exo -59.37 -41.52 57.62 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.553 2.169 . . . . 0.0 112.207 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 142' ' ' PRO . 23.3 t 171.2 -63.34 0.01 OUTLIER 'General case' 0 CA--C 1.524 -0.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.285 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.2 tt -155.6 -39.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.042 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -107.81 149.46 28.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.761 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -88.22 -179.66 6.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.3 t30 75.7 161.64 0.24 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.996 0.918 . . . . 0.0 111.567 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.98 179.44 35.86 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 149' ' ' LEU . 2.5 pt? -106.98 149.97 26.97 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.358 0.579 . . . . 0.0 110.434 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.31 135.49 26.94 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.086 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.26 153.61 56.46 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.843 2.362 . . . . 0.0 111.792 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.694 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -102.32 -7.69 21.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.117 0.484 . . . . 0.0 111.371 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.86 -88.9 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.749 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.668 HD11 HG13 ' A' ' 113' ' ' ILE . 16.9 pt -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.237 0.541 . . . . 0.0 112.308 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.563 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 9.9 t-20 -120.65 153.82 36.35 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.928 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.91 131.18 72.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 O-C-N 122.368 -0.207 . . . . 0.0 111.141 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.32 155.07 36.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.192 0.52 . . . . 0.0 111.141 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.445 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 72.3 m -97.51 158.79 32.51 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 84.5 Cg_endo -75.61 59.39 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.108 1.872 . . . . 0.0 112.484 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -117.87 138.5 52.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.95 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -72.54 133.71 44.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.83 -130.35 9.75 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.936 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.99 141.68 46.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.353 0.597 . . . . 0.0 111.635 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.445 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 22.9 pt20 -134.91 162.72 31.63 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.664 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.447 ' HE3' HG22 ' A' ' 127' ' ' VAL . 63.9 tttp -60.68 128.13 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.4 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -124.76 131.55 53.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 120' ' ' ILE . 28.8 mm-40 -97.35 163.15 13.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 131' ' ' ALA . 50.0 mm -115.52 131.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.256 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.6 ttp -133.42 132.67 41.41 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.967 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.6 t -112.49 131.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 173' ' ' GLU . 50.7 pt -115.63 176.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.742 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.52 -3.27 31.03 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.205 0.526 . . . . 0.0 110.861 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.569 ' HB2' HD12 ' A' ' 171' ' ' ILE . 56.7 mp0 -98.83 130.47 45.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.922 0.868 . . . . 0.0 112.775 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 174' ' ' LEU . 1.4 pt? -97.72 153.83 17.99 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.754 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.08 149.18 14.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.429 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.48 115.2 29.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.52 150.29 24.06 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.616 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.652 HG23 ' HB2' ' A' ' 183' ' ' ASP . 88.1 mt -116.28 117.66 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.998 0.427 . . . . 0.0 111.28 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -120.73 -18.9 7.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.121 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.3 p -128.96 164.21 23.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.403 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -60.87 -29.5 69.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.262 0.553 . . . . 0.0 109.531 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.58 -41.35 98.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.335 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.652 ' HB2' HG23 ' A' ' 178' ' ' ILE . 72.6 m-20 -64.21 -28.4 69.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 96.4 mt -61.54 -45.25 94.96 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.546 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -62.09 -42.66 99.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.747 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.43 -49.84 76.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.456 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.76 -42.54 99.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 8.0 pt-20 -68.15 -33.98 75.48 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.9 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -63.67 -41.42 98.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 111.35 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -77.2 -31.17 55.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.131 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 69.3 tp -64.42 -45.08 89.1 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.483 0.658 . . . . 0.0 110.165 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.1 -37.71 86.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.654 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -58.1 -41.68 84.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.19 -3.59 30.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.382 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -63.16 -39.32 97.81 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.27 2.15 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.871 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' HG23 ' A' ' 42' ' ' VAL . 54.2 tpp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.639 0.257 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -113.93 166.19 11.83 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.533 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -114.6 130.86 56.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.261 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.9 tp -105.42 124.21 49.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.614 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -118.71 101.05 11.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.7 ptm -91.76 106.2 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.851 1.31 . . . . 0.0 111.984 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.05 103.75 11.21 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.59 -166.9 21.21 Favored Glycine 0 C--N 1.292 -1.865 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.65 139.01 29.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -85.6 80.57 8.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.811 0.339 . . . . 0.0 111.261 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.14 -62.61 3.34 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.905 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -101.1 125.23 47.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -80.73 -11.5 59.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtt -123.96 145.73 48.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.655 0.265 . . . . 0.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.39 173.99 18.99 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.34 16.77 57.7 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.34 165.11 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.511 ' OE2' ' HG3' ' A' ' 181' ' ' LYS . 24.5 mp0 -70.34 144.43 51.65 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.274 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 97.7 mttt -123.04 157.27 61.05 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.451 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 19' ' ' LYS . 27.5 Cg_endo -61.13 -15.72 41.42 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.174 2.583 . . . . 0.0 114.346 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 59' ' ' TYR . 44.4 mt -92.69 5.87 49.5 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.723 HG21 HD21 ' A' ' 184' ' ' LEU . 77.2 mt -76.73 118.55 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.93 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -76.75 130.62 37.96 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.056 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 188' ' ' GLU . 81.8 mt -127.75 125.43 39.91 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.522 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.8 m 54.31 28.88 9.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.21 35.32 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.764 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 98.8 mtt180 -129.77 153.35 48.3 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 118.181 0.99 . . . . 0.0 112.435 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 61.2 m -80.16 164.4 23.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.32 -39.24 82.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.793 0.33 . . . . 0.0 110.87 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.453 HG13 HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -62.75 -39.76 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.728 178.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 21.2 m-20 -62.29 -40.93 97.9 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.153 0.501 . . . . 0.0 110.497 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 10.1 m-85 -63.04 -37.14 86.02 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.693 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.67 -42.41 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 0.0 110.766 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 30' ' ' ILE . 67.7 t -63.35 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.777 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.0 m -53.58 -51.94 71.57 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.37 -38.17 35.68 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 121.531 1.487 . . . . 0.0 112.082 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD11 HG11 ' A' ' 98' ' ' VAL . 93.1 mt -68.45 -40.04 81.23 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.401 0.619 . . . . 0.0 110.782 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.65 -44.04 89.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.398 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -84.03 -14.73 49.87 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.538 ' OG ' HG12 ' A' ' 42' ' ' VAL . 85.5 p -74.37 172.35 12.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.973 0.416 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -65.49 -7.06 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.7 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG12 ' OG ' ' A' ' 40' ' ' SER . 12.2 p -71.24 144.98 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 O-C-N 122.183 -0.323 . . . . 0.0 110.771 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -82.33 -72.37 0.44 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -104.57 147.08 28.01 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.528 0.68 . . . . 0.0 111.656 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.09 113.66 44.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.61 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -103.31 115.17 30.04 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -95.21 116.46 36.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.7 0.762 . . . . 0.0 110.368 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -89.9 118.8 29.75 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.245 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.4 p -129.63 158.15 40.13 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 63.3 m -105.63 148.84 37.11 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.376 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 52.6 Cg_exo -58.07 -24.99 68.79 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.06 2.507 . . . . 0.0 111.085 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -77.92 -5.89 52.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.185 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -139.84 66.87 34.47 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 119.401 -0.333 . . . . 0.0 111.879 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 96.1 Cg_endo -105.8 86.57 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.813 0 CA-C-N 120.982 1.386 . . . . 0.0 109.653 168.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 mmtm -155.61 -46.18 0.08 Allowed 'General case' 1 C--N 1.212 -5.405 0 CA-C-N 109.709 -3.405 . . . . 0.0 102.443 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 21' ' ' LEU . 97.9 m -63.99 -49.31 72.99 Favored 'General case' 0 N--CA 1.381 -3.9 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 162.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.666 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.59 -51.28 66.0 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.11 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.3 pt-20 -63.66 -29.4 70.64 Favored 'General case' 0 C--N 1.37 1.469 0 C-N-CA 116.639 -2.024 . . . . 0.0 112.907 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CD2' HD22 ' A' ' 21' ' ' LEU . 55.8 t80 -64.96 -50.37 66.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.434 0.635 . . . . 0.0 110.623 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 30' ' ' ILE . 98.0 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.0 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -57.63 -45.97 84.75 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.902 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 42.3 t -67.04 -42.45 84.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.547 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.03 92.85 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.166 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 45.8 m-85 -115.84 37.98 3.46 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.059 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.6 mmmm -60.68 -24.21 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.162 0.506 . . . . 0.0 111.057 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.67 10.47 25.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.609 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.2 p90 -45.02 131.4 7.36 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -102.5 -48.92 4.0 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.597 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -118.28 16.35 13.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.786 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.9 mt -107.62 131.06 58.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.512 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.3 t -125.17 133.05 70.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.27 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.43 130.46 56.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.314 0.578 . . . . 0.0 110.313 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.88 156.53 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 CA-C-O 121.967 0.889 . . . . 0.0 111.37 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.01 130.76 55.49 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.435 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 11.2 t -158.06 -173.24 4.25 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.734 0.778 . . . . 0.0 112.891 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 49.2 m -71.53 2.09 5.57 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 126.472 1.909 . . . . 0.0 114.637 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.67 -23.73 0.0 OUTLIER Glycine 1 N--CA 1.521 4.331 0 C-N-CA 126.462 1.982 . . . . 0.0 117.393 -173.664 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 12.1 tmtt? -56.17 -36.48 68.37 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 172.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.73 122.4 6.2 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -60.27 -51.05 71.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 pt -77.68 -28.64 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.802 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.91 -41.68 99.53 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.607 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 14.0 t0 -60.2 -51.48 69.4 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.049 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -57.71 -43.71 85.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.538 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.5 m-80 -60.29 -41.33 93.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 70.3 mm-40 -63.95 -46.95 82.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.375 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.1 m -62.71 -42.99 99.93 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.351 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 85' ' ' ASN . 37.2 pt -65.46 -30.6 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.962 0.41 . . . . 0.0 110.431 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.44 -39.29 95.65 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.245 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -82.01 -36.78 27.46 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 75.2 m-85 -71.31 146.53 48.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.19 0.519 . . . . 0.0 111.801 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -102.06 -10.61 19.55 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.369 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.46 160.32 64.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.667 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.77 142.45 41.53 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 123.27 2.647 . . . . 0.0 112.307 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -142.99 155.62 44.7 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.057 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 155' ' ' ASN . 42.4 tp -86.37 143.91 27.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.221 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 66.5 t -115.49 133.79 60.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 108.93 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 37' ' ' LEU . 11.1 m -129.98 164.82 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.371 0.605 . . . . 0.0 112.225 -178.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 50.6 m -99.21 152.79 19.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.0 p -73.61 -10.79 60.07 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.605 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 45.4 p-10 -117.23 16.55 14.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.58 ' CD1' ' HB2' ' A' ' 99' ' ' SER . 11.0 mp -61.54 153.13 28.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 111.798 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.89 174.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.686 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 105' ' ' LEU . 65.6 t30 -63.68 162.59 12.9 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.013 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 104' ' ' ASN . 51.5 tp 82.52 3.28 1.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.576 1.151 . . . . 0.0 110.213 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -94.02 -1.23 54.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.604 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.501 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -62.21 -24.73 67.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.155 0.502 . . . . 0.0 111.786 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.98 -20.91 61.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.15 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.455 HD11 ' HG3' ' A' ' 173' ' ' GLU . 28.5 mm -68.57 -41.42 82.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 107' ' ' SER . 61.7 mt -60.99 -44.46 98.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.41 -46.84 86.77 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.03 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.3 m -64.15 -42.62 96.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.026 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.637 HG13 ' N ' ' A' ' 114' ' ' VAL . 36.0 pt -67.76 -43.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.637 ' N ' HG13 ' A' ' 113' ' ' ILE . 62.9 t -62.44 -49.15 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.824 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.55 -45.36 93.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.464 -0.494 . . . . 0.0 112.247 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.709 ' CE2' HD11 ' A' ' 120' ' ' ILE . 54.2 t80 -65.84 -46.12 79.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.623 0.249 . . . . 0.0 110.918 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -58.8 -47.9 83.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.408 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 15.8 m-85 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.081 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 93.2 m -63.72 -40.37 96.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.672 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -66.85 -47.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 124' ' ' THR . 54.6 pttt -65.15 -26.26 68.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.302 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.04 99.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.918 0.39 . . . . 0.0 110.455 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 65.3 pttt -83.24 -34.04 25.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 50.7 m -139.52 97.42 8.34 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.663 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.53 -11.77 31.87 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.933 2.422 . . . . 0.0 112.856 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.29 -32.7 73.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.547 HG21 ' HG2' ' A' ' 167' ' ' GLU . 7.6 p -87.29 122.41 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.975 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 41.6 mt-10 -127.38 19.15 6.89 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -142.19 148.75 38.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.0 tp -139.63 148.08 41.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.816 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.8 136.18 52.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.09 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' A' ' 152' ' ' ALA . 99.2 t -111.12 115.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.244 0.545 . . . . 0.0 109.722 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -145.61 157.46 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.775 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 152' ' ' ALA . 17.0 pt -134.97 155.51 79.14 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.11 137.05 73.02 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.356 2.037 . . . . 0.0 110.797 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 139' ' ' TYR . 14.6 ptmm? -69.93 -16.35 63.2 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.1 -38.93 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -89.91 -15.03 32.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.476 0.655 . . . . 0.0 110.434 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 136' ' ' LYS . 50.7 t80 -82.77 112.94 41.58 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.986 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.42 -27.77 22.92 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.083 2.522 . . . . 0.0 115.905 -172.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -130.54 78.94 73.18 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.61 148.26 41.81 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.301 2.668 . . . . 0.0 112.825 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.7 m -131.31 150.95 51.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.066 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 54.2 mt 69.94 114.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.831 0.852 . . . . 0.0 111.282 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.27 135.68 47.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 46.3 t80 83.31 -7.94 1.13 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.08 -37.84 88.81 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.546 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.76 -41.8 2.75 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.429 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.75 154.29 21.72 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.417 HG21 ' CG ' ' A' ' 139' ' ' TYR . 30.5 m -130.0 149.21 72.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.414 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.34 143.92 60.07 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.183 1.922 . . . . 0.0 110.456 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.554 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -112.27 4.98 18.09 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 164.54 -97.98 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 118.759 -1.686 . . . . 0.0 114.346 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 96' ' ' LEU . 15.0 pt -130.17 160.85 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.695 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.0 m-20 -123.74 158.78 30.9 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.46 129.58 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.29 156.04 40.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.638 0.732 . . . . 0.0 112.06 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 33.3 t -98.28 146.48 31.61 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.528 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.01 66.99 4.1 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.691 2.261 . . . . 0.0 112.549 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.37 175.81 6.79 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -104.7 -11.63 16.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.268 0.556 . . . . 0.0 109.732 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -122.45 -156.28 9.61 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.838 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -106.7 134.34 49.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.342 0.591 . . . . 0.0 109.987 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.431 HE21 ' H ' ' A' ' 158' ' ' SER . 20.1 pm0 -121.2 167.19 12.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -55.18 130.08 40.71 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.321 0.581 . . . . 0.0 112.151 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -123.52 132.55 53.94 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.259 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.547 ' HG2' HG21 ' A' ' 127' ' ' VAL . 25.5 mm-40 -96.75 162.6 13.36 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 121.603 0.716 . . . . 0.0 111.967 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.019 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.0 ttp -128.74 129.94 46.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.266 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 133' ' ' MET . 89.6 t -102.23 129.3 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' A' ' 173' ' ' GLU . 50.0 pt -110.55 174.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.42 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.57 0.65 31.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.692 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 171' ' ' ILE . 79.1 mm-40 -98.51 139.38 34.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.776 0.798 . . . . 0.0 112.641 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.29 143.89 26.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.628 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.6 155.6 41.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.88 111.04 19.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.876 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.605 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 26.5 t-20 -91.02 109.58 20.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.474 ' HA ' ' OD2' ' A' ' 183' ' ' ASP . 51.4 mm -66.26 123.84 20.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.431 0.634 . . . . 0.0 112.652 -172.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -102.45 -36.43 8.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.466 ' H ' ' HB3' ' A' ' 183' ' ' ASP . 61.5 p -137.72 165.74 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.599 0.237 . . . . 0.0 111.469 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.511 ' HG3' ' OE2' ' A' ' 18' ' ' GLU . 15.1 mtmm -62.03 -37.37 84.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.641 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.44 -40.62 97.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.272 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 178' ' ' ILE . 38.8 t70 -64.57 -38.92 92.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.723 HD21 HG21 ' A' ' 22' ' ' ILE . 54.2 tp -59.3 -46.89 87.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.275 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.9 ttpt -62.5 -40.63 97.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.338 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.53 -49.03 79.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.294 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.499 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.79 -41.23 97.46 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.775 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.675 ' HB3' HD22 ' A' ' 24' ' ' LEU . 13.6 pt-20 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.855 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.61 -32.53 68.1 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.37 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.15 -28.66 63.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.761 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 85.6 mt -61.62 -44.99 95.96 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.491 0.662 . . . . 0.0 109.802 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -68.07 -45.3 74.21 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.758 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.15 -44.59 96.27 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.774 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -88.98 -4.86 58.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.91 0.386 . . . . 0.0 111.689 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -90.23 -7.04 68.13 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.742 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.2 tt . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.347 -178.491 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' HG23 ' A' ' 42' ' ' VAL . 58.8 ttm . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -113.42 164.41 13.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -114.25 140.47 48.56 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.097 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 28.4 tp -115.63 120.61 39.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HA ' ' HB ' ' A' ' 98' ' ' VAL . 69.4 mt -111.71 108.72 26.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.528 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 60.4 ttm -80.25 104.8 11.05 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 121.643 0.735 . . . . 0.0 110.583 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -112.43 97.78 6.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.745 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.16 174.85 43.64 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.493 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' ' 53' ' ' THR . . . -82.27 147.59 25.96 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.297 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 60.47 39.22 18.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.79 0.436 . . . . 0.0 112.165 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 16' ' ' GLY . . . -92.29 -143.84 13.01 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER 55.99 -144.32 0.68 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.808 0.304 . . . . 0.0 110.65 177.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 12' ' ' THR . 67.6 ttt180 -136.86 142.66 42.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.1 mmt 73.41 -74.64 0.08 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.881 0.872 . . . . 0.0 111.282 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.08 86.42 0.31 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.494 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 11' ' ' GLY . . . -69.19 151.64 51.36 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.127 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.22 127.45 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.865 0.364 . . . . 0.0 110.489 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 44.8 tt0 -66.13 -40.89 91.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.792 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 22' ' ' ILE . 17.0 tppt? -113.09 98.54 46.16 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.832 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 18' ' ' GLU . 23.8 Cg_exo -68.54 -12.78 35.73 Favored 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 123.301 2.667 . . . . 0.0 111.664 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 56' ' ' THR . 73.3 mt -92.3 14.05 17.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 19' ' ' LYS . 46.4 mm -63.09 125.71 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 61.3 mttp -95.28 133.64 38.95 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.819 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' O ' ' HE2' ' A' ' 32' ' ' TYR . 56.6 tp -130.08 121.5 26.5 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 113.316 -1.766 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.0 t 58.04 27.04 14.29 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.393 0.616 . . . . 0.0 110.73 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.31 -8.87 69.62 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.012 -0.614 . . . . 0.0 114.548 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.592 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 85.9 mtt180 -117.07 155.03 29.96 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 118.169 0.985 . . . . 0.0 110.717 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 72.2 m -82.08 163.15 22.24 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.834 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.503 HD21 ' CG1' ' A' ' 178' ' ' ILE . 83.7 mt -59.22 -44.48 92.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 110.256 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -62.75 -36.82 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.77 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.45 -45.23 91.82 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.337 0.589 . . . . 0.0 110.4 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 8.5 m-85 -65.72 -30.19 70.82 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 100' ' ' SER . 66.6 t -70.1 -43.23 79.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 120.649 0.261 . . . . 0.0 111.574 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.507 HG23 HD13 ' A' ' 30' ' ' ILE . 79.8 t -65.34 -43.58 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.541 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 67.5 m -50.59 -53.58 44.61 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 33.8 Cg_exo -62.4 -41.28 34.3 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.931 1.754 . . . . 0.0 112.286 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.87 -42.32 90.51 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.89 -45.37 94.87 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.757 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 35' ' ' SER . 64.1 pttt -80.98 -9.31 59.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.58 ' OG ' HG12 ' A' ' 42' ' ' VAL . 84.2 p -77.85 175.55 9.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 111.514 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.16 -22.12 60.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.141 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' OG ' ' A' ' 40' ' ' SER . 12.7 p -66.07 145.03 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.671 -177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -78.37 -79.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -102.6 152.48 21.13 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.451 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.4 mm -110.06 116.42 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.118 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 93.8 m-85 -106.93 117.09 33.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.639 HG21 HD13 ' A' ' 60' ' ' ILE . 94.7 mt -98.74 118.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.527 0.68 . . . . 0.0 110.576 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.23 116.4 24.39 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.795 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.483 HG23 HG22 ' A' ' 47' ' ' ILE . 66.3 p -127.28 162.87 25.22 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.028 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.5 p -129.44 157.25 76.9 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.906 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.69 -19.09 67.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.834 2.356 . . . . 0.0 110.896 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.92 -24.95 62.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.744 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.439 HG21 ' N ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -141.16 67.33 26.3 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.624 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.6 Cg_endo -103.87 85.45 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.683 0 C-N-CA 117.172 -1.419 . . . . 0.0 109.906 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.632 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 36.0 mmtm -148.99 -44.98 0.14 Allowed 'General case' 1 C--N 1.215 -5.272 0 CA-C-N 109.605 -3.452 . . . . 0.0 102.638 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.624 HG21 ' HB1' ' A' ' 7' ' ' ALA . 96.8 m -63.16 -47.77 81.26 Favored 'General case' 1 N--CA 1.379 -4.006 0 CA-C-N 112.307 -2.224 . . . . 0.0 105.773 163.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.08 -51.19 68.95 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.796 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.632 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 pt-20 -64.58 -30.73 71.75 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.341 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.91 -50.21 71.74 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.071 0.462 . . . . 0.0 111.18 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.639 HD13 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -62.68 -42.75 97.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.964 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -58.25 -41.38 84.08 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.574 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.671 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t -73.74 -43.31 59.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 111.233 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.53 90.8 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.337 0.589 . . . . 0.0 111.105 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.459 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 58.1 m-85 -114.44 42.59 2.07 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.002 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HG3' ' O ' ' A' ' 62' ' ' SER . 38.1 mtmm -59.82 -26.79 66.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.028 0.442 . . . . 0.0 110.971 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.42 10.13 18.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.055 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.479 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 53.8 p90 -44.59 122.77 3.27 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.47 -49.44 3.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.36 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -110.26 7.74 23.26 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.095 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 4.8 mp -100.31 119.62 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.257 0.551 . . . . 0.0 110.028 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 78.3 t -120.55 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.312 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.487 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.9 pt -123.66 154.74 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.161 0.505 . . . . 0.0 109.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -117.08 127.82 54.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 t -155.96 -167.98 2.63 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -67.81 2.41 1.98 Allowed 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 126.633 1.973 . . . . 0.0 114.22 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.19 -16.62 0.0 OUTLIER Glycine 0 N--CA 1.516 3.971 0 C-N-CA 126.693 2.092 . . . . 0.0 117.376 -175.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 14.2 tmtt? -58.61 -38.45 78.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.6 127.48 7.73 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.459 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -59.97 -49.91 75.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.093 0.473 . . . . 0.0 111.987 -176.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.83 -47.49 90.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.547 0.689 . . . . 0.0 110.294 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 53.6 mt-10 -60.91 -43.28 98.79 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.784 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.528 ' CG ' ' HE2' ' A' ' 6' ' ' MET . 7.4 t0 -60.05 -50.77 72.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.116 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -59.62 -42.87 93.66 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.169 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 88' ' ' ILE . 96.4 m-20 -60.56 -42.02 95.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.257 0.551 . . . . 0.0 111.053 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 66.0 mm-40 -65.58 -45.65 82.46 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.0 m -63.57 -41.82 98.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.497 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 84' ' ' LEU . 38.1 pt -65.92 -29.88 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.081 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.41 96.56 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.941 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -71.9 -40.12 69.06 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.1 m-85 -79.01 154.08 29.77 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.8 m -113.24 -4.52 13.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 159' ' ' PRO . 40.0 mt-10 -132.74 156.02 80.55 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.275 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.44 140.0 64.41 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.207 2.604 . . . . 0.0 111.649 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.55 156.7 45.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.34 0.591 . . . . 0.0 110.748 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 154' ' ' ILE . 24.3 tp -87.53 144.4 26.72 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.029 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 93.7 t -107.14 125.89 63.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 60.8 t -130.47 141.11 47.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.5 m -96.09 142.49 28.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.782 174.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.549 ' HA ' HG21 ' A' ' 33' ' ' VAL . 67.9 m -89.45 0.78 56.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -104.93 -4.2 22.41 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 177' ' ' ASN . 75.2 mt -82.6 136.63 34.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.278 0.49 . . . . 0.0 110.599 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.8 pt -75.67 -174.24 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.953 0.406 . . . . 0.0 111.35 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -78.53 71.18 4.98 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.39 -3.84 4.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 11.7 ptmm? -88.38 -2.24 58.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.217 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 p -60.99 -41.57 96.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -80.43 -22.44 41.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.895 0.855 . . . . 0.0 109.725 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 113' ' ' ILE . 38.4 mm -67.7 -37.61 78.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.953 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 106' ' ' LYS . 64.4 mt -57.26 -50.0 78.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.064 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -70.74 -39.65 73.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.172 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.8 m -63.36 -42.95 98.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.07 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.2 mm -64.39 -44.78 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.8 t -60.44 -46.71 94.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.273 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.75 -46.1 91.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.657 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CE2' HD11 ' A' ' 120' ' ' ILE . 31.8 t80 -70.19 -41.82 73.2 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.2 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.5 t80 -59.18 -48.35 81.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 21.3 m-85 -62.88 -35.5 80.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.658 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.8 -47.5 86.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.966 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' A' ' 116' ' ' TYR . 70.5 mt -66.45 -49.37 75.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.484 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 16.0 ptmt -65.34 -25.85 67.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.965 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.56 98.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 120' ' ' ILE . 63.6 pttt -85.69 -36.83 19.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.309 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 127' ' ' VAL . 32.0 m -130.9 96.21 23.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.154 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.91 -14.2 40.6 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.918 2.412 . . . . 0.0 113.197 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.47 -32.94 74.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.889 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.587 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -75.79 120.53 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.606 0.717 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 45.8 mt-10 -123.04 15.0 9.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.872 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.71 150.07 33.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.931 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -140.86 135.04 30.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.034 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.33 140.84 51.65 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.727 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 152' ' ' ALA . 14.8 p -123.22 135.95 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 75.1 mtm -134.47 158.02 44.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.747 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 152' ' ' ALA . 9.9 pt -130.12 154.55 81.33 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.21 134.91 64.84 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.62 2.213 . . . . 0.0 113.253 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -60.83 -37.57 82.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.813 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -59.67 -37.03 77.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.005 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -99.82 -16.45 18.06 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.091 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.515 ' CG ' HG21 ' A' ' 150' ' ' VAL . 55.6 t80 -64.77 137.23 97.08 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.5 -70.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.249 . . . . 0.0 112.651 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -167.33 141.0 2.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.21 -21.15 27.37 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.85 2.367 . . . . 0.0 112.494 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.515 ' HA ' ' OD1' ' A' ' 179' ' ' ASN . 13.9 p -176.73 -66.85 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.6 mt -142.59 -66.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -150.87 86.52 1.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 111.794 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.28 152.53 47.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.43 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -111.81 130.93 55.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.999 0.428 . . . . 0.0 111.13 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 165.55 -174.79 41.33 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.72 144.68 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.223 0.512 . . . . 0.0 110.334 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.515 HG21 ' CG ' ' A' ' 139' ' ' TYR . 35.9 m -115.64 148.94 42.17 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.289 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.25 148.74 56.16 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.52 2.146 . . . . 0.0 111.517 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.62 ' HB3' HG13 ' A' ' 132' ' ' VAL . . . -91.75 -4.26 55.23 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 102' ' ' LEU . . . 152.5 -75.06 0.24 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.338 -1.411 . . . . 0.0 114.376 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 96' ' ' LEU . 25.0 pt -128.32 161.49 36.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -173.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.629 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 11.5 t-20 -127.75 155.55 43.84 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.884 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -120.97 130.3 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 O-C-N 122.167 -0.333 . . . . 0.0 110.691 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.45 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.2 m -133.1 154.24 39.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.656 0.741 . . . . 0.0 111.967 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.684 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 45.0 t -98.52 144.27 27.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.115 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 72.2 Cg_endo -72.89 67.07 4.01 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.116 2.544 . . . . 0.0 113.35 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 164' ' ' GLN . 69.0 mttm -99.99 -168.37 1.58 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -133.56 90.03 2.67 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.889 0.852 . . . . 0.0 109.221 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.41 -136.74 6.65 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.26 142.74 51.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.815 0.34 . . . . 0.0 110.347 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.449 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . 18.6 pm0 -134.02 166.1 23.5 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.924 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -60.08 127.81 33.72 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.109 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -128.04 133.57 49.11 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.86 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -93.5 160.93 14.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-O 121.609 0.719 . . . . 0.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.6 128.87 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.192 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 61.7 ttp -127.35 135.21 50.19 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.14 126.63 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 152' ' ' ALA . 50.4 pt -116.18 174.94 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.003 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -117.66 21.5 12.93 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.143 0.496 . . . . 0.0 110.544 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' HB3' HD12 ' A' ' 171' ' ' ILE . 35.7 tp10 -98.33 133.17 43.11 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.3 150.69 19.98 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.401 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 102' ' ' LEU . 5.0 pt -130.11 153.26 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.33 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -125.69 144.48 50.59 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.552 ' HB3' HD23 ' A' ' 102' ' ' LEU . 28.4 p-10 -137.29 156.76 47.88 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 184' ' ' LEU . 31.9 mm -94.97 81.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.546 0.688 . . . . 0.0 111.171 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 143' ' ' SER . 66.9 m-80 -65.96 -40.1 90.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.515 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 182' ' ' ASP . 13.5 t -149.36 177.41 9.71 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.051 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -57.89 -28.35 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.932 0.493 . . . . 0.0 111.418 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 180' ' ' THR . 27.3 t70 -60.13 -46.77 88.53 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 109.943 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 44.7 m-20 -64.78 -35.67 81.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.212 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.641 ' HA ' HD12 ' A' ' 178' ' ' ILE . 59.8 tp -59.36 -45.32 91.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.833 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 12.9 mmtt -64.08 -38.23 90.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.04 -49.76 74.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.268 0.556 . . . . 0.0 109.524 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.534 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.1 -43.3 98.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.751 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 4.3 pt-20 -67.72 -34.12 76.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.461 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.431 ' N ' ' HG3' ' A' ' 188' ' ' GLU . 57.8 ttm -62.13 -45.49 93.24 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.692 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.4 pp -70.38 -37.16 74.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.366 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.58 -44.44 90.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.347 0.594 . . . . 0.0 110.53 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -64.86 -42.77 94.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.862 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.38 -39.9 94.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.766 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.77 -28.36 68.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.256 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.521 ' C ' HD13 ' A' ' 196' ' ' LEU . . . -94.13 7.56 72.77 Favored Glycine 0 C--N 1.311 -0.85 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.872 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.521 HD13 ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.265 1.881 0 CA-C-O 117.274 -1.345 . . . . 0.0 113.935 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 37.0 m-20 -111.59 164.73 12.68 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -113.8 132.03 56.01 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.881 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 48' ' ' ALA . 33.3 tp -106.32 125.66 51.27 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.024 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.625 ' HA ' HG22 ' A' ' 98' ' ' VAL . 69.4 mt -117.24 104.76 16.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.403 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 11.1 ptm -95.98 97.93 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.892 1.329 . . . . 0.0 112.042 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.66 97.15 5.97 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.23 32.47 0.03 OUTLIER Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.765 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.6 142.95 16.43 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.442 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -133.79 147.47 51.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.2 -174.25 46.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.431 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.3 p -67.75 -33.25 74.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.552 0.692 . . . . 0.0 109.999 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 5.8 tpm_? -137.18 129.12 29.11 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.01 137.89 56.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 0.0 111.308 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.52 5.96 2.78 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.602 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.87 -143.41 12.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.472 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.99 86.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.803 0.811 . . . . 0.0 110.017 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 19' ' ' LYS . 13.2 pt-20 -161.59 -164.64 1.15 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.731 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 29.4 mtpp 61.4 72.02 0.72 Allowed Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 121.162 0.506 . . . . 0.0 111.127 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.33 -17.75 41.74 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.469 2.78 . . . . 0.0 113.474 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 56' ' ' THR . 41.5 mt -90.49 12.59 18.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 19' ' ' LYS . 93.5 mt -66.23 117.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -82.16 134.79 35.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.675 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 188' ' ' GLU . 46.6 tp -136.29 112.47 9.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.257 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t 61.27 20.14 10.76 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.381 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.34 -23.2 5.8 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.837 -1.173 . . . . 0.0 115.422 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.762 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 90.5 mtt180 -131.06 158.75 39.52 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.579 1.19 . . . . 0.0 111.088 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 71.6 m -76.2 150.79 37.04 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.199 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -49.22 -45.6 44.72 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.832 0.453 . . . . 0.0 111.298 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.36 -38.0 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.233 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.685 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.7 t70 -64.03 -42.59 97.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.212 0.529 . . . . 0.0 109.867 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.762 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 28.2 m-85 -61.03 -38.08 84.83 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.738 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.45 -42.54 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 110.671 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 30' ' ' ILE . 77.5 t -62.31 -43.34 97.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.566 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.576 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 44.5 t -50.3 -57.94 11.32 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 37.2 Cg_exo -62.07 -41.09 38.11 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.803 1.669 . . . . 0.0 112.359 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.697 HD11 HG11 ' A' ' 98' ' ' VAL . 90.5 mt -66.09 -42.11 89.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.184 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.411 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.7 tt -63.37 -45.43 91.16 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.073 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.04 -15.92 61.5 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.406 ' CB ' HD13 ' A' ' 110' ' ' ILE . 71.6 p -70.57 172.51 8.44 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.246 0.546 . . . . 0.0 111.231 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -70.03 2.24 3.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.537 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 3' ' ' ALA . 9.7 p -72.67 152.89 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 122.182 -0.324 . . . . 0.0 111.137 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.424 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 59.5 t30 -68.17 -79.62 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -121.04 163.96 17.51 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.238 0.542 . . . . 0.0 111.074 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -107.89 115.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.997 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -106.52 117.16 33.31 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.746 HG21 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -97.58 118.09 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-O 121.774 0.797 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.4 122.92 33.08 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.853 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 7' ' ' ALA . 56.8 p -130.48 156.61 44.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.552 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 75' ' ' THR . 35.4 t -105.04 143.15 26.14 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.283 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -56.79 -25.22 59.85 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.074 2.516 . . . . 0.0 111.033 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.44 -2.85 47.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -141.77 66.43 21.97 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.597 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.717 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 95.3 Cg_endo -105.14 86.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.144 0 C-N-CA 116.759 -1.694 . . . . 0.0 109.854 170.24 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 39.1 ttmt -148.84 -50.83 0.16 Allowed 'General case' 1 C--N 1.212 -5.386 0 CA-C-N 109.89 -3.323 . . . . 0.0 103.044 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 21' ' ' LEU . 86.4 m -62.07 -47.53 84.28 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.918 -1.946 . . . . 0.0 105.906 163.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.717 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.71 -47.96 81.34 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.949 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.583 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.4 pt-20 -57.23 -38.02 73.14 Favored 'General case' 0 C--N 1.369 1.431 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -65.89 -51.62 57.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 120.912 0.387 . . . . 0.0 111.714 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.746 HD13 HG21 ' A' ' 47' ' ' ILE . 97.0 mt -62.99 -46.26 96.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.505 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.589 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 65.1 t30 -59.25 -39.97 84.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.381 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 t -74.91 -47.43 29.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.31 87.95 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -108.82 14.83 24.01 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.635 -0.426 . . . . 0.0 112.015 -173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.0 pttt -62.9 -22.09 66.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -88.36 -1.19 57.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.81 128.54 49.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.943 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -70.23 -41.25 73.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.834 -178.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.411 HD21 ' HG ' ' A' ' 38' ' ' LEU . 10.1 p-10 -80.17 -0.67 37.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.2 mt -108.06 122.67 62.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.515 0.674 . . . . 0.0 110.206 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.9 135.68 63.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.929 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -106.95 131.03 57.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.061 0.458 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.6 pt -125.56 157.57 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.339 0.59 . . . . 0.0 111.814 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -102.32 133.32 47.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.389 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.2 t -161.77 -177.94 6.19 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.113 0.959 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 57.4 m -75.09 5.21 5.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 126.943 2.097 . . . . 0.0 113.158 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.04 -19.62 0.0 OUTLIER Glycine 0 N--CA 1.513 3.793 0 C-N-CA 127.876 2.655 . . . . 0.0 118.134 -171.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 11.5 tmtt? -59.29 -38.85 81.2 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 171.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.12 8.56 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -62.2 -50.51 71.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.17 -45.35 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.872 0.844 . . . . 0.0 110.575 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.84 -43.57 94.55 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.378 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.2 t0 -58.4 -50.12 74.83 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.874 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -56.87 -41.86 78.74 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.041 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.496 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.0 m-80 -60.03 -43.72 95.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 62.7 mm-40 -66.74 -42.61 85.95 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.79 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.58 -42.52 99.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -67.95 -26.57 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -38.64 96.95 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.929 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -70.5 -40.06 73.79 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.01 150.66 27.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -111.75 -0.96 15.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.047 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 28.2 mt-10 -134.86 159.01 73.75 Favored Pre-proline 0 CA--C 1.508 -0.663 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.161 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 36.5 Cg_endo -65.02 147.85 89.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.157 1.904 . . . . 0.0 111.124 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 51.2 p90 -141.69 162.13 36.23 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.588 0.709 . . . . 0.0 111.707 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.645 HD11 ' HB ' ' A' ' 154' ' ' ILE . 1.1 tm? -86.17 139.41 31.11 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.597 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.704 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 89.3 t -117.12 134.08 61.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.78 0.832 . . . . 0.0 108.857 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 37' ' ' LEU . 8.6 m -127.79 159.88 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.246 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -100.19 135.3 41.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.546 ' O ' HD22 ' A' ' 29' ' ' LEU . 81.0 p -74.95 -12.03 60.25 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -102.32 3.28 37.87 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 175' ' ' ILE . 70.0 mt -91.22 121.01 32.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.882 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.577 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 86.2 mt -118.33 118.67 58.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.193 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 60.8 t30 166.87 168.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.676 0.79 . . . . 0.0 110.386 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.18 93.48 3.95 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.546 0.689 . . . . 0.0 109.914 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HE3' HG13 ' A' ' 109' ' ' ILE . 31.8 mmmt -99.43 2.88 45.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.266 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.618 ' HA ' HD12 ' A' ' 110' ' ' ILE . 71.9 p -53.65 -32.56 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -70.7 -27.78 64.25 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.745 0.783 . . . . 0.0 110.008 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.486 HG13 ' HE3' ' A' ' 106' ' ' LYS . 28.1 mm -71.57 -40.57 71.46 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.304 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 107' ' ' SER . 70.0 mt -60.4 -45.79 96.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.933 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -64.64 -43.37 93.89 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.436 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.9 t -61.9 -45.54 93.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.533 HG13 ' N ' ' A' ' 114' ' ' VAL . 42.6 pt -65.04 -41.57 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.533 ' N ' HG13 ' A' ' 113' ' ' ILE . 57.6 t -62.16 -49.13 85.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.98 -43.18 93.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.852 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.518 ' CE2' HD11 ' A' ' 120' ' ' ILE . 71.7 t80 -63.7 -49.48 72.93 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 110.949 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.433 ' HB2' HD22 ' A' ' 130' ' ' LEU . 70.4 t80 -59.04 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.986 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 114' ' ' VAL . 28.1 m-85 -65.03 -31.83 73.25 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 50.3 t -62.02 -46.85 87.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.445 0.641 . . . . 0.0 109.421 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.659 HG22 HG11 ' A' ' 127' ' ' VAL . 71.6 mt -64.59 -43.54 96.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.352 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -60.48 -41.74 94.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.279 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.44 -44.33 95.92 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.648 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -77.85 -32.42 52.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.999 0.428 . . . . 0.0 111.33 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 127' ' ' VAL . 46.9 m -143.57 100.69 5.14 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.8 -13.75 39.55 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.8 2.333 . . . . 0.0 112.966 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.01 -32.73 74.15 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -71.37 129.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -128.45 4.6 5.66 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.637 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.05 153.41 39.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.939 0.4 . . . . 0.0 111.374 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 117' ' ' PHE . 23.4 tp -137.64 146.34 43.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.52 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.88 129.41 46.85 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.943 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 152' ' ' ALA . 63.9 t -105.06 115.11 46.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.3 ptm -145.82 157.53 43.91 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.19 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 152' ' ' ALA . 14.5 pt -133.03 155.0 81.57 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.834 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.36 128.09 28.99 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.361 2.04 . . . . 0.0 111.923 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 142' ' ' PRO . 1.5 pptp? -69.38 -21.97 63.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.56 -36.46 83.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -87.26 -22.8 24.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.577 0.703 . . . . 0.0 109.92 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -63.45 133.61 95.56 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.662 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.83 -36.65 83.5 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.569 2.846 . . . . 0.0 113.54 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -126.03 84.11 61.95 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-O 121.852 0.834 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.578 ' HB3' ' O ' ' A' ' 136' ' ' LYS . 74.2 Cg_endo -74.47 148.89 38.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.57 2.847 . . . . 0.0 113.508 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.1 t -89.37 70.41 8.11 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.09 -38.47 82.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.607 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -56.54 -40.96 76.0 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.424 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -108.69 -13.05 14.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.711 0.291 . . . . 0.0 111.033 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.9 t30 55.73 39.28 30.81 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.928 0.87 . . . . 0.0 109.467 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.4 28.87 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.073 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.58 152.96 21.12 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 124.14 29.05 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.809 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.47 136.76 77.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.993 1.795 . . . . 0.0 110.352 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -93.47 0.78 56.88 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.386 0.613 . . . . 0.0 110.617 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.79 -91.26 0.08 OUTLIER Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.993 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.645 ' HB ' HD11 ' A' ' 96' ' ' LEU . 14.4 pt -139.66 162.12 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.171 0.51 . . . . 0.0 112.173 -176.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.704 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.4 m120 -112.45 156.6 22.29 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.45 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 91.6 t -125.4 129.47 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 122.788 0.435 . . . . 0.0 109.889 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.35 155.27 31.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.048 0.451 . . . . 0.0 111.56 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.518 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 61.3 m -98.17 155.06 37.39 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.954 173.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 72.4 Cg_endo -76.52 86.11 1.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.579 2.186 . . . . 0.0 111.519 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -108.54 -175.42 2.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -128.9 28.16 5.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.875 0.845 . . . . 0.0 109.627 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.72 38.26 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -77.4 143.15 38.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.43 0.615 . . . . 0.0 109.545 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.518 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 20.9 pt20 -130.06 161.31 31.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.754 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.38 125.95 26.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.835 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.69 127.33 52.78 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.758 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -93.76 162.79 13.79 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 121.528 0.68 . . . . 0.0 111.716 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -117.42 129.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.891 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.4 ttp -128.45 126.02 39.69 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.686 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.8 t -105.38 132.06 53.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 173' ' ' GLU . 43.3 pt -119.78 171.73 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.208 0.527 . . . . 0.0 111.211 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -109.02 13.94 24.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.657 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.8 mm-40 -97.95 135.77 39.19 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.871 0.843 . . . . 0.0 111.278 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.9 153.67 18.11 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.459 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 102' ' ' LEU . 1.8 pt -132.78 151.02 33.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.386 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.12 116.94 27.86 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.474 ' HB3' HD23 ' A' ' 102' ' ' LEU . 31.0 p-10 -116.13 175.78 5.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 184' ' ' LEU . 46.4 mm -116.3 120.13 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.975 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 -47.25 5.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.82 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.5 p -128.03 166.54 18.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.19 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.35 -42.11 95.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.557 0.694 . . . . 0.0 109.754 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.58 -39.39 94.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.679 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.688 ' HA ' HD12 ' A' ' 178' ' ' ILE . 57.8 tp -61.02 -42.36 98.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.486 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 61.4 tttp -61.56 -40.92 96.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.872 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.9 -45.57 94.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.74 98.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.947 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 11.5 pt-20 -64.86 -37.75 88.69 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.526 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 193' ' ' LYS . 94.8 mmm -63.54 -39.65 94.97 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.979 0.418 . . . . 0.0 110.349 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.1 tp -62.6 -44.86 95.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.908 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.432 HD12 ' HG ' ' A' ' 24' ' ' LEU . 94.3 mt -64.14 -39.43 94.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.337 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 99.3 mttt -61.89 -17.29 56.06 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.345 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 189' ' ' MET . 68.7 mttm -75.06 -8.01 55.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.01 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 -19.73 64.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.322 0.582 . . . . 0.0 109.804 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.82 -154.77 26.02 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.8 tp . . . . . 0 C--O 1.26 1.643 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.338 178.628 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 95' ' ' PHE . 59.8 tpp . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.258 0.551 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -122.04 166.3 14.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.2 127.14 56.08 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.942 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.517 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.7 tp -101.48 126.21 48.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.677 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -119.08 107.97 22.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.598 ' O ' ' HB3' ' A' ' 100' ' ' SER . 60.6 ttm -80.93 98.07 7.72 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.513 0.673 . . . . 0.0 111.47 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.533 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.22 98.04 6.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.364 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.86 81.3 0.23 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.347 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.27 -154.24 11.46 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.171 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.63 -11.44 19.2 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.17 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.05 -98.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.904 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 14' ' ' MET . 84.9 m -64.39 139.82 58.8 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -60.51 -37.38 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.736 0.303 . . . . 0.0 111.368 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.444 ' H ' HG22 ' A' ' 12' ' ' THR . 24.3 mmt -79.49 -5.08 54.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.974 0.416 . . . . 0.0 111.05 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.61 179.47 42.11 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.131 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA3' ' OG ' ' A' ' 143' ' ' SER . . . 123.91 -122.97 5.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.786 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.612 HG11 ' ND2' ' A' ' 177' ' ' ASN . 12.7 p -65.41 142.45 16.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 2.3 tm-20 169.49 -153.14 0.01 OUTLIER 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 55.9 mmtt 61.19 77.98 0.34 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.488 0.661 . . . . 0.0 110.349 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 27.4 Cg_endo -62.12 -4.75 5.43 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.905 3.07 . . . . 0.0 114.639 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.09 4.95 24.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 90.6 mt -71.68 126.11 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 62.9 pttt -115.11 143.18 45.6 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 184' ' ' LEU . 89.4 mt -127.47 140.25 52.27 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.735 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.7 m 48.42 35.43 5.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.74 -12.7 53.57 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.23 161.28 38.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 119.476 1.638 . . . . 0.0 112.124 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 80.8 m -77.82 164.91 24.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.505 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 92.6 mt -58.35 -39.73 80.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.151 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.523 HG12 HG12 ' A' ' 60' ' ' ILE . 4.6 tp -58.32 -45.24 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.199 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.77 -42.41 97.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.12 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HE2' ' O ' ' A' ' 24' ' ' LEU . 4.2 m-85 -62.65 -36.17 81.99 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.773 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 29' ' ' LEU . 74.7 t -72.17 -45.2 63.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 120.818 0.342 . . . . 0.0 111.04 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 30' ' ' ILE . 76.0 t -63.85 -44.98 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.581 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 74.7 m -53.0 -54.58 42.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -173.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 51.3 Cg_exo -60.67 -40.3 56.47 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.009 1.806 . . . . 0.0 112.299 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.561 HD11 HG11 ' A' ' 98' ' ' VAL . 81.7 mt -67.3 -43.2 82.31 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.919 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -61.9 -46.06 91.03 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 21.6 ptmt -72.99 -15.57 61.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.485 ' OG ' HG12 ' A' ' 42' ' ' VAL . 79.9 p -75.41 173.71 10.57 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.195 0.521 . . . . 0.0 111.007 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -60.6 -18.39 52.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.746 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG12 ' OG ' ' A' ' 40' ' ' SER . 11.9 p -64.98 146.41 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.991 0.424 . . . . 0.0 111.108 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -79.79 -73.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -106.05 150.78 25.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.452 0.644 . . . . 0.0 111.799 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.06 116.12 51.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.553 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 84.4 m-85 -106.12 117.79 34.94 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -98.64 118.48 45.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.645 0.736 . . . . 0.0 110.301 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -88.18 117.85 27.36 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.964 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 7' ' ' ALA . 70.0 p -125.94 157.85 36.69 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.6 p -109.27 155.65 40.72 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.326 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.29 -18.44 62.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.598 2.199 . . . . 0.0 111.002 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -83.38 -7.4 59.57 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.999 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.0 p -141.37 66.74 24.41 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.749 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.0 Cg_endo -102.09 84.22 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.699 0 C-N-CA 116.469 -1.888 . . . . 0.0 108.577 168.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 53.5 mtmt -150.68 -50.34 0.13 Allowed 'General case' 1 C--N 1.216 -5.198 0 CA-C-N 109.446 -3.524 . . . . 0.0 103.184 -176.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.3 m -62.82 -46.97 85.46 Favored 'General case' 0 N--CA 1.391 -3.41 0 CA-C-N 112.692 -2.049 . . . . 0.0 106.125 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.749 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -61.5 -49.27 77.42 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.383 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.566 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 14.3 pt-20 -58.71 -38.48 78.38 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.03 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.76 -50.26 69.74 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.704 0.287 . . . . 0.0 111.458 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 47' ' ' ILE . 96.7 mt -63.59 -43.65 98.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.879 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -58.23 -44.36 88.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.346 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 75.1 m -68.74 -40.16 79.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.348 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.16 90.57 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.42 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 60.0 m-85 -115.96 42.19 2.4 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.549 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.2 mmmt -60.62 -21.39 62.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.143 0.497 . . . . 0.0 110.976 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -93.24 11.69 27.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.631 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.4 p90 -43.4 122.34 2.57 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.33 -50.0 3.58 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -111.05 10.96 22.07 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.531 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 85.9 mt -105.99 124.27 61.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.295 0.569 . . . . 0.0 110.35 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 60.3 t -125.28 133.7 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.687 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.41 132.46 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.091 0.472 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.9 pt -127.83 156.03 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-O 121.912 0.863 . . . . 0.0 111.325 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -110.35 133.14 53.55 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.496 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 10.1 t -162.22 -169.81 2.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 53.8 m -69.6 1.77 3.82 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 126.56 1.944 . . . . 0.0 114.438 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.46 -21.53 0.0 OUTLIER Glycine 1 N--CA 1.519 4.226 0 C-N-CA 126.209 1.862 . . . . 0.0 117.019 -174.158 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 76' ' ' SER . 2.5 tmmt? -56.57 -34.2 66.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.78 126.08 6.57 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -60.26 -51.69 68.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.48 -45.76 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 121.727 0.775 . . . . 0.0 110.795 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 69.5 mm-40 -60.99 -42.69 98.9 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.859 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.503 ' HB3' ' HE1' ' A' ' 6' ' ' MET . 8.7 t0 -58.94 -50.69 73.09 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.9 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.3 mm? -57.5 -43.98 84.6 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.055 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.523 ' HA ' HG12 ' A' ' 88' ' ' ILE . 7.3 m-20 -61.36 -40.1 93.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.968 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 70.7 mm-40 -67.17 -44.27 80.13 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.565 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 97.0 m -63.92 -41.63 97.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.619 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 84' ' ' LEU . 35.4 pt -66.73 -35.3 74.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.197 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.33 94.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.345 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.0 -49.19 77.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.958 . . . . 0.0 112.969 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.565 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 75.5 m-85 -74.2 148.23 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.176 0.512 . . . . 0.0 112.103 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.4 m -96.26 -8.41 32.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 15.5 pt-20 -151.55 173.47 4.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 93' ' ' GLU . 58.1 Cg_endo -69.35 148.48 67.82 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.072 1.848 . . . . 0.0 113.795 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 40.6 p90 -146.18 162.39 38.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 154' ' ' ILE . 91.2 mt -84.44 150.13 25.51 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.542 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 87.3 t -121.84 129.57 75.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.434 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.7 m -131.65 162.96 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.088 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.1 t -99.4 145.89 26.9 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 6' ' ' MET . 80.0 p -65.49 -20.5 66.37 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 177' ' ' ASN . 53.7 p-10 -105.14 12.41 32.06 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.21 115.37 11.37 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.929 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 29' ' ' LEU . 73.6 mt -122.45 117.02 50.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 33.6 t-20 173.88 169.62 0.2 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.62 73.71 5.16 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.76 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.2 pttp -82.64 -1.84 52.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.185 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.623 ' HA ' HD12 ' A' ' 110' ' ' ILE . 71.2 m -58.95 -40.61 85.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.52 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -71.33 -40.35 70.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.558 1.17 . . . . 0.0 109.895 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 106' ' ' LYS . 66.7 mt -63.02 -39.56 85.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.127 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 107' ' ' SER . 59.8 mt -57.52 -47.61 84.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -63.9 -39.97 95.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.718 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.7 m -61.66 -37.44 84.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.184 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -60.05 -48.38 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.323 0.582 . . . . 0.0 109.622 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.84 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.162 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.55 -47.56 85.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.157 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.528 ' CE2' HD11 ' A' ' 120' ' ' ILE . 80.9 t80 -64.18 -49.52 71.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.239 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.8 t80 -59.44 -47.92 83.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 4.2 m-85 -61.5 -35.46 77.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.15 -46.71 85.9 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.23 0.538 . . . . 0.0 109.733 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.528 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -65.08 -49.92 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.481 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.588 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 20.4 ptmt -66.32 -27.31 67.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.3 96.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.566 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 20.5 pttp -83.45 -39.71 20.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.917 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 25.2 m -130.49 98.83 19.69 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.403 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -9.56 26.62 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 122.842 2.361 . . . . 0.0 112.55 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.17 -32.81 72.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.856 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 10.3 p -74.72 124.99 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 0.0 110.993 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 41.1 mt-10 -117.85 -2.61 11.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.702 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.78 41.73 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.859 0.361 . . . . 0.0 111.289 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.428 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -135.16 131.98 37.44 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' HB2' ' CD ' ' A' ' 166' ' ' GLU . . . -119.06 127.08 53.07 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.575 HG21 ' CD1' ' A' ' 113' ' ' ILE . 90.1 t -107.55 112.55 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 9.9 ptm -146.22 158.4 43.88 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.225 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 152' ' ' ALA . 25.7 pt -134.22 157.0 78.55 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.147 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.96 139.86 91.87 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.235 1.956 . . . . 0.0 111.878 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 14.0 tmtt? -59.92 -25.91 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.939 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.27 -38.05 79.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.201 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HD3' ' HB ' ' A' ' 134' ' ' ILE . 22.8 ptmt -93.86 -21.96 18.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 111.149 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.59 128.63 83.56 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.72 51.94 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.918 2.412 . . . . 0.0 114.002 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 59.69 107.56 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.574 ' HG3' HG12 ' A' ' 150' ' ' VAL . 72.2 Cg_endo -74.6 -20.42 17.88 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 123.128 2.552 . . . . 0.0 112.507 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.427 ' OG ' ' HA3' ' A' ' 16' ' ' GLY . 22.9 t -164.68 -175.65 3.92 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.1 -44.52 99.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.53 149.0 38.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.096 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.418 ' HD2' ' H ' ' A' ' 148' ' ' GLY . 43.8 p90 -84.7 158.63 20.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 111.528 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -99.39 24.47 8.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.74 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' H ' ' HD2' ' A' ' 146' ' ' PHE . . . 89.25 -57.48 3.93 Favored Glycine 0 C--N 1.32 -0.353 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 pp -131.3 159.0 39.14 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.574 HG12 ' HG3' ' A' ' 142' ' ' PRO . 32.7 m -121.85 124.85 26.91 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.907 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.408 ' O ' HD11 ' A' ' 175' ' ' ILE . 58.9 Cg_endo -70.58 147.89 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.395 2.063 . . . . 0.0 110.891 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -114.22 0.22 14.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 176.21 -123.72 0.93 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.268 -1.444 . . . . 0.0 113.648 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 113' ' ' ILE . 4.1 mp -101.17 137.09 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 121.679 0.752 . . . . 0.0 111.713 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.626 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.9 t-20 -109.6 156.7 19.87 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.48 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.531 HG22 HD23 ' A' ' 96' ' ' LEU . 94.7 t -123.62 130.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 C-N-CA 122.667 0.387 . . . . 0.0 110.243 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.429 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.9 m -133.96 150.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.379 0.609 . . . . 0.0 111.415 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.472 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 53.0 p -98.25 164.58 16.93 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.383 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 77.9 Cg_endo -75.72 76.1 3.79 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.55 2.167 . . . . 0.0 111.826 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.82 -172.08 2.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -127.46 131.78 50.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.583 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.91 -114.09 3.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.975 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.33 145.34 51.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.52 166.98 21.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 2.5 tmtm? -55.81 127.66 31.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.152 0.501 . . . . 0.0 110.615 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' CD ' ' HB2' ' A' ' 131' ' ' ALA . 44.1 tt0 -137.52 134.72 36.02 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.587 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.428 ' HG3' HG21 ' A' ' 120' ' ' ILE . 34.5 mm-40 -94.11 162.84 13.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.485 0.66 . . . . 0.0 111.646 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.01 130.08 73.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.081 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.484 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.7 ttp -129.6 130.99 46.37 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.691 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.9 t -111.42 131.51 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 173' ' ' GLU . 42.1 pt -117.66 169.69 7.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.777 0.799 . . . . 0.0 112.482 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -93.51 2.84 56.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' A' ' 171' ' ' ILE . 57.7 mm-40 -99.45 131.71 45.27 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 122.076 0.941 . . . . 0.0 113.149 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.08 149.47 21.91 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.886 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.408 HD11 ' O ' ' A' ' 151' ' ' PRO . 2.2 pt -123.64 139.81 49.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.833 176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -113.53 126.44 55.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.612 ' ND2' HG11 ' A' ' 17' ' ' VAL . 34.1 p-10 -119.13 19.33 12.93 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.555 0.693 . . . . 0.0 111.595 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 184' ' ' LEU . 23.2 mm 77.21 -93.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.515 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 143' ' ' SER . 38.1 m-80 69.91 -36.69 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.9 p -128.55 162.36 27.43 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.143 -0.348 . . . . 0.0 111.71 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.62 -39.12 83.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -48.66 80.81 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.52 -36.54 84.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.743 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.655 ' HA ' HD12 ' A' ' 178' ' ' ILE . 47.9 tp -59.98 -50.25 74.5 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.433 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.95 -40.5 91.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -60.61 -43.53 97.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.977 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.79 -43.51 98.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.698 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 24' ' ' LEU . 53.7 mm-40 -60.7 -45.48 94.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.24 0.543 . . . . 0.0 110.201 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 98.5 mtp -63.36 -42.28 98.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.698 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.4 -42.26 92.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 120.884 0.373 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -60.99 -43.25 99.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.354 0.597 . . . . 0.0 110.003 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -64.22 -43.21 95.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.433 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -62.13 -43.69 98.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.736 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -93.35 -25.77 17.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.863 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -90.21 -13.0 60.9 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.178 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.5 tp . . . . . 0 C--O 1.267 1.987 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.362 -179.116 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 94' ' ' PRO . 59.2 ttm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 38.9 m-20 -115.8 166.1 12.33 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.81 127.4 55.99 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.09 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.38 124.8 49.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.444 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.693 ' HA ' HG22 ' A' ' 98' ' ' VAL . 64.0 mt -118.3 106.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.484 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 14.1 ptm -99.69 100.36 11.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.905 1.336 . . . . 0.0 113.736 -172.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -116.54 96.8 5.68 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.537 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.03 54.14 0.52 Allowed Glycine 0 C--N 1.305 -1.158 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.197 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA2' HG13 ' A' ' 17' ' ' VAL . . . 71.71 42.87 53.09 Favored Glycine 0 C--O 1.235 0.212 0 C-N-CA 120.508 -0.853 . . . . 0.0 114.559 176.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.66 106.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.72 19.13 78.24 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.383 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -116.18 133.82 55.6 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.9 -78.84 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.627 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.8 tpt -70.36 -38.36 74.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.578 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 172.59 42.0 Favored Glycine 0 C--N 1.319 -0.369 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.825 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.67 19.94 44.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 20' ' ' PRO . 4.8 t 70.4 58.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.7 0.8 . . . . 0.0 110.561 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -80.49 65.99 5.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.558 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' O ' HD12 ' A' ' 29' ' ' LEU . 24.9 ttmm -140.0 -63.53 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.009 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 56.5 Cg_endo -68.53 -19.8 42.13 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 121.752 1.635 . . . . 0.0 111.712 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 59' ' ' TYR . 35.0 mt -95.43 7.32 46.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.334 -0.393 . . . . 0.0 112.042 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.76 119.83 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 39.9 pttt -100.55 138.39 37.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.029 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 188' ' ' GLU . 27.0 tp -136.47 115.9 12.75 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.197 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.2 m 60.53 19.66 9.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.85 -89.1 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.013 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 99.0 mtt180 -103.84 170.03 8.17 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.24 0.543 . . . . 0.0 111.954 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 69.7 m -76.71 163.72 26.56 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.462 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 19' ' ' LYS . 77.0 mt -58.78 -39.43 81.01 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.283 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.6 tp -56.73 -46.32 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.183 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 11.7 t70 -67.35 -40.76 85.84 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.044 0.45 . . . . 0.0 110.947 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 13.5 m-30 -62.29 -33.99 75.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.36 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -71.55 -42.91 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 30' ' ' ILE . 74.2 t -63.92 -43.79 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.2 m -52.42 -54.55 41.03 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.56 -39.51 16.0 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.565 1.51 . . . . 0.0 112.275 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.24 -42.82 92.99 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 120.801 0.334 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.4 tt -61.3 -46.52 89.96 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.708 0.29 . . . . 0.0 111.19 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -76.3 -13.15 60.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -73.82 -178.49 3.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 112.126 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.5 ttmm -59.48 -24.95 64.01 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.941 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.56 156.02 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.176 0.513 . . . . 0.0 112.29 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.524 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -77.74 -86.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 59.3 m-20 -107.72 156.85 18.64 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 111.454 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mm -107.85 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 89.7 m-85 -108.91 121.29 44.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -102.33 118.9 49.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.667 0.746 . . . . 0.0 110.715 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 6' ' ' MET . . . -87.77 126.43 34.99 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.752 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -133.85 170.78 15.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.4 m -127.34 150.88 73.73 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 -27.16 80.94 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.501 2.801 . . . . 0.0 111.986 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.15 5.01 40.02 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.996 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.5 p -140.77 66.08 26.08 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.43 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 88.4 Cg_endo -106.73 88.12 0.02 OUTLIER 'Trans proline' 1 N--CA 1.379 -5.212 0 C-N-CA 117.212 -1.392 . . . . 0.0 110.66 170.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.665 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 72.6 mmtt -151.39 -50.41 0.12 Allowed 'General case' 1 C--N 1.22 -5.04 0 CA-C-N 109.862 -3.335 . . . . 0.0 103.054 177.078 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.497 HG22 HD12 ' A' ' 60' ' ' ILE . 86.8 m -63.83 -48.34 77.2 Favored 'General case' 0 N--CA 1.384 -3.759 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.107 163.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.685 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 13.5 tmtt? -64.66 -52.37 57.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -60.13 -33.07 71.63 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 116.701 -1.999 . . . . 0.0 112.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.569 ' CD2' HD22 ' A' ' 21' ' ' LEU . 58.0 t80 -70.34 -52.73 20.51 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.483 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 47' ' ' ILE . 97.1 mt -63.44 -45.91 96.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.57 -42.26 92.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.264 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.1 t -71.67 -41.72 68.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.491 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.19 90.05 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.538 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 77.5 m-85 -106.69 32.51 4.48 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.502 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.4 mtmt -63.34 -18.66 63.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.474 0.654 . . . . 0.0 110.08 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.31 10.4 24.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.641 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.1 p90 -45.84 128.1 8.58 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -102.48 -51.48 3.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.846 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.547 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.0 p-10 -118.74 15.74 13.55 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.885 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -106.45 129.8 59.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.854 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.7 t -127.86 131.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.52 129.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 48' ' ' ALA . 44.0 pt -125.63 157.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.473 0.654 . . . . 0.0 111.818 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -108.05 134.3 51.13 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.844 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.6 t -161.18 -172.18 3.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.565 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 66.1 m -77.65 4.66 10.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 126.921 2.088 . . . . 0.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.6 -23.66 0.0 OUTLIER Glycine 0 N--CA 1.513 3.822 0 C-N-CA 127.167 2.317 . . . . 0.0 117.623 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 22.3 tptm -58.01 -37.11 73.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.19 122.95 6.7 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' HD23 ' A' ' 84' ' ' LEU . 87.5 t80 -59.89 -51.3 70.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.44 -43.98 87.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.677 0.751 . . . . 0.0 110.523 -177.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -59.89 -42.87 94.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.551 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.601 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 34.9 t0 -60.07 -50.27 74.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.952 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.6 mm? -56.64 -41.76 77.73 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.583 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' O ' HG12 ' A' ' 88' ' ' ILE . 6.7 m-20 -61.37 -42.1 98.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.849 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 64.4 mm-40 -66.16 -44.24 84.65 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.4 m -63.4 -41.52 98.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.324 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 160' ' ' LYS . 34.4 pt -64.42 -30.16 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.67 96.53 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.331 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.55 -38.18 71.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.41 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 92.2 m-85 -92.55 136.8 32.91 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 m -100.68 -4.53 28.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.441 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 41.3 mt-10 -134.46 160.58 67.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.559 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.5 Cg_endo -63.06 143.54 90.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.082 1.855 . . . . 0.0 111.843 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.49 162.04 37.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.719 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.582 HD23 HG22 ' A' ' 156' ' ' VAL . 92.8 mt -84.73 149.82 25.51 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.914 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 59.7 t -122.14 125.12 72.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.104 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.3 m -136.37 158.13 37.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.302 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.465 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.2 t -100.9 143.49 30.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.241 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 7' ' ' ALA . 49.9 m -76.73 -9.35 58.61 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -106.27 11.18 31.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.57 HD22 HD12 ' A' ' 175' ' ' ILE . 62.5 mt -91.63 114.67 27.26 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.85 135.06 65.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 112.009 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 178.61 -178.89 0.31 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.83 58.69 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 109' ' ' ILE . 16.6 ptmt -66.23 -8.1 22.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.9 -1.5 . . . . 0.0 113.519 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 110' ' ' ILE . 60.3 m -58.72 -41.44 86.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -72.82 -37.85 67.36 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.6 mm -60.78 -40.81 86.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.188 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 107' ' ' SER . 59.4 mt -58.33 -48.65 84.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.445 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 55.0 m-80 -65.65 -39.91 91.9 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.3 m -61.55 -37.23 83.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.754 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.7 mm -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.872 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.89 -44.66 99.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.687 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -60.03 -48.19 82.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.8 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.75 ' CE2' HD11 ' A' ' 120' ' ' ILE . 78.9 t80 -63.98 -47.21 81.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.4 -46.61 83.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 14.4 m-85 -62.13 -38.3 88.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.49 -41.51 98.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.339 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.75 HD11 ' CE2' ' A' ' 116' ' ' TYR . 74.7 mt -67.9 -48.63 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.204 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.17 -25.46 68.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.543 -177.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.72 98.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.819 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.99 -39.52 19.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.7 m -130.67 95.37 26.52 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.656 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.07 -13.14 35.85 Favored 'Trans proline' 0 N--CA 1.474 0.38 0 C-N-CA 122.738 2.292 . . . . 0.0 111.952 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.91 -31.01 71.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.069 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 124' ' ' THR . 13.4 p -65.53 133.1 31.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.061 0.458 . . . . 0.0 111.154 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.535 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 43.7 mt-10 -124.34 -3.28 7.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.899 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.26 156.8 43.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.801 0.334 . . . . 0.0 111.433 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.78 137.74 38.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.7 139.32 52.77 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.037 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 113' ' ' ILE . 67.8 t -113.97 117.06 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.9 ptm -145.72 152.81 40.19 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.872 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 152' ' ' ALA . 36.4 pt -132.02 159.55 71.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.051 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.35 134.04 61.11 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.003 1.802 . . . . 0.0 110.784 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.36 -16.34 63.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.977 0.418 . . . . 0.0 111.157 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -63.21 -39.57 95.0 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.64 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -93.27 -15.76 25.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.272 0.558 . . . . 0.0 110.78 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.44 128.37 93.74 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.81 -44.37 21.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.231 1.954 . . . . 0.0 113.928 -174.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 28.5 p-10 -172.84 129.16 0.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.529 0.204 . . . . 0.0 111.104 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 45.7 Cg_exo -60.97 137.17 70.37 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.41 2.073 . . . . 0.0 111.226 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.1 t -64.23 -48.14 76.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 109.785 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.4 pt -140.17 148.14 22.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.583 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 146' ' ' PHE . 13.6 t70 54.3 -156.81 0.21 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.593 0.558 . . . . 0.0 110.161 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.488 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 98.9 m-85 -110.64 -30.37 7.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.1 m120 64.2 138.48 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.927 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.64 97.95 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 pp -139.3 149.8 44.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.37 121.31 31.22 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-O 121.069 0.461 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 59.1 Cg_endo -71.0 144.29 47.03 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.709 2.273 . . . . 0.0 112.102 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -118.39 -6.03 10.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.34 -120.35 1.26 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.934 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.619 ' CG1' HG13 ' A' ' 113' ' ' ILE . 40.5 pt -121.21 158.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 120.903 0.382 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.682 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.1 t-20 -116.5 152.23 34.49 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.409 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 96' ' ' LEU . 93.6 t -121.41 129.46 75.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 122.51 0.324 . . . . 0.0 110.409 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 155' ' ' ASN . 31.6 m -135.3 149.01 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.143 0.497 . . . . 0.0 111.391 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 77.1 p -98.79 163.7 18.35 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.543 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 62.4 Cg_endo -73.4 74.65 3.1 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.258 1.972 . . . . 0.0 112.079 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.593 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.3 mmmt -115.33 137.68 51.78 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.748 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -93.18 107.05 18.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.336 0.589 . . . . 0.0 110.23 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.02 -128.95 6.37 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -136.29 129.27 31.19 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -117.53 166.5 12.29 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.607 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.0 120.37 9.53 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.301 0.572 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -121.02 130.1 53.65 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.801 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.482 ' HG3' HG21 ' A' ' 120' ' ' ILE . 42.8 mm-40 -92.8 161.9 14.33 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 121.731 0.777 . . . . 0.0 112.196 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.2 mm -117.89 127.05 75.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.652 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.56 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.3 ttp -124.77 128.71 49.17 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.92 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.3 t -107.97 128.75 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.492 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.671 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.6 pt -115.51 175.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.019 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -121.69 23.07 10.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.769 0.795 . . . . 0.0 109.889 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.671 ' HB2' HD12 ' A' ' 171' ' ' ILE . 20.0 mp0 -98.7 130.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.988 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.03 143.03 28.27 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.287 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.57 HD12 HD22 ' A' ' 102' ' ' LEU . 10.1 pt -121.6 154.06 25.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.409 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.38 106.1 13.91 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.672 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -68.05 -35.79 78.82 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.088 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 183' ' ' ASP . 98.7 mt 66.32 109.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.045 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -120.93 -15.26 8.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.217 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.8 p -127.54 166.34 18.19 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.414 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.51 -36.91 85.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.04 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.54 -40.6 87.78 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 178' ' ' ILE . 77.0 m-20 -61.27 -41.71 97.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.491 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 178' ' ' ILE . 89.9 mt -61.94 -47.63 84.02 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.312 0.577 . . . . 0.0 109.949 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 88.0 tttt -61.92 -42.68 99.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.623 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 186' ' ' LEU . 8.6 tt -60.47 -47.97 83.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.937 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -64.91 -42.11 95.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.202 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 pt-20 -69.5 -31.65 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 96.5 mtp -62.73 -40.96 98.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.646 0.26 . . . . 0.0 111.537 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.6 -36.27 60.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.189 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 190' ' ' LEU . 92.3 mt -62.95 -45.77 90.89 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.443 0.64 . . . . 0.0 110.525 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.96 -46.03 86.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.994 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.5 -42.5 98.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.617 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.89 -29.48 66.68 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.07 -40.65 95.2 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.084 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.263 1.764 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.811 -178.822 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.4 ttm . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 33.5 m-20 -100.12 166.17 11.15 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -115.58 130.77 56.99 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.924 0.392 . . . . 0.0 111.101 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.8 tp -106.06 125.07 50.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.181 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.693 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -117.68 102.22 13.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.438 ' O ' ' HB3' ' A' ' 100' ' ' SER . 12.1 ptm -96.22 98.52 10.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.987 1.375 . . . . 0.0 112.093 -175.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.44 98.23 6.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.196 -1.82 . . . . 0.0 110.332 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.24 14.58 0.02 OUTLIER Glycine 0 C--N 1.302 -1.331 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.843 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.68 100.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.179 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -146.73 22.83 1.26 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.99 32.04 66.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.3 p -96.66 141.67 29.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -121.49 -27.62 4.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 60.1 mtt -103.37 -57.03 2.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.4 143.8 14.4 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.513 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.66 145.2 36.64 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.76 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG12 ' HG3' ' A' ' 19' ' ' LYS . 64.8 t -84.83 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.6 mp0 -75.3 22.18 0.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 97.3 mttt -56.82 -48.5 97.21 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 118.298 0.499 . . . . 0.0 112.064 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 42.9 Cg_endo -68.15 -14.51 40.86 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.767 1.645 . . . . 0.0 111.77 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 59' ' ' TYR . 57.8 mt -102.59 7.61 39.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 18' ' ' GLU . 95.7 mt -69.41 118.37 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.592 0.711 . . . . 0.0 109.129 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 48.8 pttt -87.68 125.92 34.67 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.999 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 188' ' ' GLU . 60.3 tp -131.71 119.69 21.69 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.003 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.1 m 57.29 28.72 15.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.25 -76.02 0.39 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.019 -1.086 . . . . 0.0 114.48 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.713 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 44.3 mtt180 -101.73 166.42 10.69 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 112.36 -172.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 75.7 m -76.15 151.79 36.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.674 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.1 tt -48.91 -47.93 42.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.26 0.624 . . . . 0.0 111.711 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 60' ' ' ILE . 5.7 tp -57.61 -42.49 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 0.0 111.811 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.713 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 15.0 t70 -65.24 -39.73 93.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.142 0.496 . . . . 0.0 109.933 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -63.73 -37.34 86.99 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.969 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 29' ' ' LEU . 72.3 t -65.27 -43.43 95.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 110.239 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -63.61 -43.0 98.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.583 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -49.99 -57.01 13.85 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 40' ' ' SER . 41.8 Cg_endo -67.83 -37.99 14.52 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 121.57 1.514 . . . . 0.0 112.462 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.528 HD11 HG11 ' A' ' 98' ' ' VAL . 83.3 mt -65.09 -41.22 95.19 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.879 0.371 . . . . 0.0 111.67 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.488 ' HG ' HD21 ' A' ' 69' ' ' ASN . 5.7 tt -59.97 -46.58 88.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.035 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -83.31 -5.87 59.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 57.4 p -75.79 -178.38 4.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.518 0.675 . . . . 0.0 111.585 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 24.5 ttmm -57.44 -24.8 57.8 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.719 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 3' ' ' ALA . 22.7 m -67.38 161.8 3.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.517 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 60.1 t30 -80.43 -76.83 0.21 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.544 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -117.56 159.77 22.34 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.909 0.385 . . . . 0.0 110.767 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.67 114.06 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.3 m-85 -107.88 116.75 32.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.567 HG21 HD13 ' A' ' 60' ' ' ILE . 96.1 mt -97.98 116.15 39.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.558 0.694 . . . . 0.0 110.543 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.51 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.81 125.35 34.4 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.705 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -129.34 158.94 37.7 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 38.0 m -103.93 149.76 37.53 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.575 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.9 -20.63 57.99 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.745 2.297 . . . . 0.0 111.309 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -89.04 1.66 55.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 20.3 p -138.08 67.51 48.07 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.653 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 90.8 Cg_endo -100.99 87.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.384 -4.939 0 C-N-CA 117.303 -1.331 . . . . 0.0 109.17 169.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.7 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.5 mmtm -156.94 -52.7 0.08 Allowed 'General case' 1 C--N 1.215 -5.268 0 CA-C-N 110.183 -3.19 . . . . 0.0 103.057 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.518 HG22 HD12 ' A' ' 60' ' ' ILE . 93.3 m -63.77 -50.03 70.62 Favored 'General case' 0 N--CA 1.379 -3.991 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 165.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -65.25 -49.25 70.35 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.7 pt-20 -60.83 -31.36 70.78 Favored 'General case' 0 C--N 1.374 1.664 0 C-N-CA 116.16 -2.216 . . . . 0.0 112.17 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.518 ' CD2' HD22 ' A' ' 21' ' ' LEU . 52.9 t80 -72.2 -51.22 22.1 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.582 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.567 HD13 HG21 ' A' ' 47' ' ' ILE . 97.8 mt -62.35 -44.92 99.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.689 -174.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.71 -44.01 90.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.499 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 73.1 m -68.8 -41.21 79.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.384 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.58 88.08 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.45 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.59 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 66.5 m-85 -110.54 31.82 5.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.409 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.3 mmmm -61.77 -24.19 66.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.16 0.505 . . . . 0.0 110.739 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.27 10.97 25.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.017 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.4 p90 -45.44 134.26 6.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -175.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.06 -49.53 3.74 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.488 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.2 p-10 -119.25 11.65 12.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.563 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 80.8 mt -106.2 127.29 61.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.27 0.557 . . . . 0.0 110.697 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 76.9 t -126.45 132.23 70.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.732 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.85 130.58 52.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 48' ' ' ALA . 37.7 pt -124.07 155.73 31.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.391 0.615 . . . . 0.0 110.396 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.72 132.35 56.49 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.865 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 86' ' ' GLU . 14.2 t -163.66 -167.42 1.4 Allowed 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.5 m -66.04 1.0 1.61 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 127.017 2.127 . . . . 0.0 114.349 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.56 -22.39 0.0 OUTLIER Glycine 0 N--CA 1.514 3.875 0 C-N-CA 126.026 1.774 . . . . 0.0 116.67 -175.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 76' ' ' SER . 13.9 tmtt? -57.39 -36.6 71.49 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.38 122.84 6.23 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.58 -50.47 73.76 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 pt -71.49 -32.16 45.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.097 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.53 -43.46 89.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.467 0.651 . . . . 0.0 109.891 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.608 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.1 t0 -61.3 -50.5 72.74 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.859 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -57.44 -45.09 85.1 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.035 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.6 m-80 -60.69 -42.63 97.53 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.535 ' HG2' ' OG1' ' A' ' 75' ' ' THR . 16.8 tp10 -65.37 -46.43 80.15 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.534 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 99.0 m -63.78 -41.01 98.03 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.403 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.2 pt -65.18 -36.82 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.393 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.63 -38.97 95.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.4 174.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.35 -49.22 74.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.64 0.776 . . . . 0.0 112.814 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.534 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 83.3 m-85 -75.76 149.83 37.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -103.06 -5.29 23.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.386 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.78 158.33 74.31 Favored Pre-proline 0 CA--C 1.505 -0.787 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.94 141.62 77.83 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.858 2.372 . . . . 0.0 110.534 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 45.5 p90 -141.84 156.81 45.53 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.543 0.687 . . . . 0.0 111.923 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.534 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.42 138.5 31.73 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.931 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 64.3 t -116.94 131.67 68.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 123.311 0.644 . . . . 0.0 109.291 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 5' ' ' ILE . 17.7 m -126.72 164.04 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 112.02 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.443 ' O ' HD22 ' A' ' 102' ' ' LEU . 47.6 t -82.54 159.95 22.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.009 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 6' ' ' MET . 81.1 p -86.1 -26.07 25.46 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.6 28.77 7.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.443 HD22 ' O ' ' A' ' 99' ' ' SER . 1.5 pt? -86.55 156.88 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.694 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.7 pt -96.74 174.09 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 96.2 m-20 -69.19 -170.29 0.25 Allowed 'General case' 0 C--O 1.247 0.932 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.041 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 104' ' ' ASN . 4.2 mm? 75.03 14.74 3.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.311 1.044 . . . . 0.0 109.97 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HA ' HG12 ' A' ' 109' ' ' ILE . 47.9 mmtm -99.52 -0.81 39.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.032 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' HD12 ' A' ' 110' ' ' ILE . 75.4 p -59.31 -37.1 76.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.97 -24.77 59.66 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.87 0.843 . . . . 0.0 109.747 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 113' ' ' ILE . 41.2 mm -67.17 -39.77 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.27 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 107' ' ' SER . 66.3 mt -57.24 -49.07 81.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.13 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 52.7 m-80 -66.12 -40.41 90.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.195 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -62.77 -41.09 99.08 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.97 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 109' ' ' ILE . 47.7 mm -62.12 -48.69 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.044 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.47 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.1 t -61.98 -48.77 87.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.428 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.57 -41.99 98.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.057 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.82 -41.65 78.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.927 0.394 . . . . 0.0 110.354 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.75 -46.68 86.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.93 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 17.2 m-85 -60.05 -37.01 78.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.492 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.05 -41.14 97.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 109.563 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.1 mt -68.55 -41.36 82.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.298 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 127' ' ' VAL . 17.7 mmmt -59.94 -43.11 95.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.478 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.56 93.51 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.724 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.29 -34.73 31.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.519 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.3 m -140.31 95.43 8.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.31 -25.12 77.24 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.207 2.605 . . . . 0.0 112.688 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.66 -31.75 72.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.511 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 121' ' ' LYS . 63.3 t -69.26 122.6 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 33.8 mt-10 -130.93 18.83 5.04 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 156' ' ' VAL . . . -151.0 151.55 32.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.043 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 113' ' ' ILE . 18.7 tp -138.89 143.29 38.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.905 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.55 138.56 52.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.472 HG21 ' CD1' ' A' ' 113' ' ' ILE . 60.0 t -117.5 117.03 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 4.3 ptm -146.01 161.77 39.37 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.53 -176.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.457 HD11 ' HD2' ' A' ' 139' ' ' TYR . 22.7 pt -132.66 154.58 81.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.558 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.519 ' O ' ' HG2' ' A' ' 138' ' ' LYS . 65.1 Cg_exo -56.77 131.29 44.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.971 1.78 . . . . 0.0 110.1 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 142' ' ' PRO . 65.6 pttt -64.42 -21.98 66.81 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.863 0.363 . . . . 0.0 111.532 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.49 -37.57 88.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.474 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 135' ' ' PRO . 13.7 ptmm? -83.35 -21.52 33.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.226 0.536 . . . . 0.0 110.829 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.457 ' HD2' HD11 ' A' ' 134' ' ' ILE . 35.0 t80 -78.03 120.55 81.68 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.472 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.0 126.75 18.67 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.409 2.072 . . . . 0.0 111.937 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.99 59.77 7.59 Favored Pre-proline 0 N--CA 1.483 1.195 0 CA-C-O 121.598 0.713 . . . . 0.0 111.421 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 63.5 Cg_endo -72.89 -27.03 14.9 Favored 'Trans proline' 0 C--N 1.327 -0.586 0 C-N-CA 123.533 2.822 . . . . 0.0 113.747 -177.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.0 m 65.21 178.94 0.19 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.522 0.513 . . . . 0.0 110.464 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm 51.2 85.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.427 0.632 . . . . 0.0 111.787 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -63.26 -40.55 97.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.328 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -102.3 119.1 38.24 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.483 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.0 -174.26 0.14 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.127 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.04 157.96 34.09 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.068 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 pp -140.53 158.98 43.18 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.74 121.94 28.03 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-O 121.149 0.5 . . . . 0.0 111.912 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.01 151.2 55.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.501 2.134 . . . . 0.0 110.432 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -131.98 -28.3 1.77 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.895 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.57 -136.63 6.75 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.977 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 96' ' ' LEU . 20.6 pt -123.66 161.02 26.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.735 -177.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.605 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.7 t-20 -112.13 152.52 28.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.449 -174.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' ALA . 71.6 t -124.59 130.86 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.201 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' A' ' 155' ' ' ASN . 20.1 m -133.75 149.03 30.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.513 0.673 . . . . 0.0 111.396 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.594 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 23.3 t -97.83 151.66 37.7 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.411 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 43.2 Cg_endo -67.32 77.73 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.589 2.193 . . . . 0.0 111.61 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.71 -175.67 2.83 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.13 115.9 15.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.71 -123.78 7.12 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.275 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.91 140.7 50.91 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -134.12 164.14 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.649 0.261 . . . . 0.0 111.653 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.435 ' CG ' HG22 ' A' ' 127' ' ' VAL . 49.4 tptt -57.08 127.98 34.7 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.506 0.67 . . . . 0.0 112.22 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -128.63 137.26 51.57 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.538 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.1 163.19 12.67 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.53 130.97 69.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.597 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.7 ttm -122.63 141.76 51.38 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 133' ' ' MET . 57.9 t -117.06 131.41 69.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.4 pt -120.76 175.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.12 5.5 30.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.328 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.693 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.4 mp0 -96.84 130.24 44.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.195 0.998 . . . . 0.0 111.917 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.2 mt -97.05 152.22 18.96 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.115 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.61 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.833 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.1 119.34 28.34 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -82.26 118.91 23.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.84 105.68 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.107 0.479 . . . . 0.0 110.402 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -113.1 -19.18 11.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.163 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -147.64 165.92 28.96 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.12 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -58.26 -31.91 67.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.844 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.51 -43.01 99.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 176.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.1 -42.32 98.3 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.459 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.446 ' CD1' HD13 ' A' ' 24' ' ' LEU . 58.9 tp -62.08 -46.67 88.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 63.5 tttm -64.24 -42.13 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.989 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.15 -45.38 93.26 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.13 -40.89 98.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.996 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 8.7 pt-20 -67.42 -36.28 80.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.872 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.0 mtp -62.59 -39.08 92.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.33 -34.96 61.26 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.3 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -46.06 64.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.066 0.46 . . . . 0.0 112.157 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -67.89 -28.44 67.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.214 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -64.85 -41.4 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.092 0.472 . . . . 0.0 110.238 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.36 -28.01 66.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.847 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -81.06 -60.53 2.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.978 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.8 tp . . . . . 0 C--O 1.263 1.803 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.109 179.75 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 23.5 ptp . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 22.7 m-20 -95.33 163.36 13.29 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.428 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -121.09 128.51 52.66 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 40.9 tp -103.75 127.45 51.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 98' ' ' VAL . 63.6 mt -117.63 103.48 14.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.51 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 14.7 ptm -98.25 115.94 29.44 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-O 123.474 1.607 . . . . 0.0 112.07 -176.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.91 -173.22 2.24 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 111.226 -2.716 . . . . 0.0 109.819 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.03 -73.48 0.2 Allowed Glycine 0 C--N 1.267 -3.271 0 CA-C-N 114.12 -1.4 . . . . 0.0 111.283 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.62 167.95 39.85 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.605 ' O ' ' HA3' ' A' ' 15' ' ' GLY . 75.1 mmtt -122.4 143.41 49.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.07 0.435 . . . . 0.0 110.169 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 137.02 5.16 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.655 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.428 HG22 ' HA2' ' A' ' 79' ' ' GLY . 12.8 p -80.95 -77.44 0.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.014 0.435 . . . . 0.0 111.031 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 -65.29 -41.94 93.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.298 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -139.7 148.9 43.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.953 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 10' ' ' LYS . . . -161.5 131.26 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.195 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.81 -0.42 68.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.052 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.8 t -122.33 123.2 68.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -163.41 178.53 8.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.97 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.4 tptp 60.34 67.8 1.54 Allowed Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 123.568 0.542 . . . . 0.0 110.147 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.75 -7.54 7.66 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 123.76 2.973 . . . . 0.0 113.517 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 64.3 mt -88.11 10.76 18.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 19' ' ' LYS . 97.8 mt -63.87 126.81 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 173.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 62.6 mttp -102.32 141.15 35.62 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 122.264 1.03 . . . . 0.0 113.705 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.612 HD21 HD12 ' A' ' 184' ' ' LEU . 86.4 mt -125.41 110.25 13.72 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.222 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.38 33.44 18.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.657 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -20.01 39.19 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.904 1.121 . . . . 0.0 115.904 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.678 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 89.6 mtt180 -117.71 152.31 35.5 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 119.235 1.518 . . . . 0.0 112.327 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 81.7 m -75.27 162.45 28.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.779 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 100' ' ' SER . 88.6 mt -59.86 -40.67 89.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.051 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.668 HG12 HD11 ' A' ' 60' ' ' ILE . 3.8 tp -59.77 -43.08 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.638 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 9.9 t70 -62.86 -44.08 97.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.292 0.568 . . . . 0.0 110.029 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 23.9 m-85 -65.11 -33.3 75.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.646 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.627 ' HA ' ' NZ ' ' A' ' 106' ' ' LYS . 69.7 t -71.9 -44.61 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.606 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 30' ' ' ILE . 72.2 t -64.57 -43.76 96.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.549 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 73.4 m -52.22 -54.61 39.71 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 42.4 Cg_exo -62.41 -41.91 30.66 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.11 1.874 . . . . 0.0 112.479 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.565 HD11 HG11 ' A' ' 98' ' ' VAL . 87.2 mt -67.11 -40.28 86.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.087 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.473 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.2 tt -62.28 -46.3 89.43 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.0 0.429 . . . . 0.0 109.891 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.61 -17.15 60.75 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.404 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.429 ' CB ' HG21 ' A' ' 110' ' ' ILE . 78.7 p -70.69 170.05 13.16 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.185 0.517 . . . . 0.0 111.757 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -71.85 24.77 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.1 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.92 162.38 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.828 -0.545 . . . . 0.0 110.767 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 64.5 t30 -72.27 -76.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.619 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -125.9 160.19 30.57 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.952 0.406 . . . . 0.0 110.438 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 3' ' ' ALA . 49.0 mm -108.4 116.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.7 m-85 -109.72 116.97 32.69 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.581 HG21 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -98.15 119.85 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.562 0.696 . . . . 0.0 111.039 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.479 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -95.19 119.8 34.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.984 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.3 p -125.95 150.99 47.58 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.419 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 75' ' ' THR . 54.8 m -83.77 152.2 62.58 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.009 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.32 -18.43 63.16 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.152 2.568 . . . . 0.0 111.4 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -89.95 -0.63 57.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.6 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -141.32 68.17 26.3 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 97.5 Cg_endo -104.65 85.67 0.02 OUTLIER 'Trans proline' 1 N--CA 1.382 -5.056 0 C-N-CA 116.845 -1.637 . . . . 0.0 108.889 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.685 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 35.1 mmtp -144.94 -50.14 0.26 Allowed 'General case' 1 C--N 1.224 -4.857 0 CA-C-N 110.299 -3.137 . . . . 0.0 103.78 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.517 ' HA ' HD21 ' A' ' 21' ' ' LEU . 68.4 m -62.41 -45.8 91.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -61.95 -50.86 70.42 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.896 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.685 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.3 pt-20 -63.12 -32.19 73.51 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.039 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -62.59 -50.5 71.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.91 0.386 . . . . 0.0 111.466 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 30' ' ' ILE . 92.1 mt -63.29 -43.75 98.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.104 -176.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -57.65 -43.71 85.12 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.5 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t -71.82 -43.07 66.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.48 93.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.347 0.594 . . . . 0.0 110.891 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 90.2 m-85 -111.6 41.65 1.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.006 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.5 mtmt -61.3 -21.79 64.28 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.261 0.553 . . . . 0.0 110.423 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -91.2 10.59 26.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.4 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 35.3 p90 -35.62 113.79 0.22 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' C ' ' HD3' ' A' ' 68' ' ' LYS . 4.6 tmtm? -93.16 -51.93 4.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.066 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.473 HD21 ' HG ' ' A' ' 38' ' ' LEU . 27.2 p-10 -118.74 13.92 13.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.767 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.19 126.48 56.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.403 0.62 . . . . 0.0 111.527 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.8 t -126.06 133.1 69.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.56 132.71 54.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.34 155.28 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.426 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -118.11 131.18 56.44 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.222 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 50' ' ' SER . 13.0 t -165.41 -173.66 2.89 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.137 0.97 . . . . 0.0 113.582 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 78' ' ' LYS . 48.9 m -64.67 3.48 0.51 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.404 2.282 . . . . 0.0 115.497 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.14 -29.36 0.01 OUTLIER Glycine 1 N--CA 1.519 4.186 0 C-N-CA 126.434 1.969 . . . . 0.0 117.602 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' SER . 53.6 tptt -58.08 -38.91 77.26 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' HA2' HG22 ' A' ' 12' ' ' THR . . . -100.46 114.58 5.05 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.74 -47.77 84.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.63 -49.01 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.629 0.728 . . . . 0.0 109.797 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.7 -47.16 86.74 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.631 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.591 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.4 t0 -61.12 -51.9 67.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.733 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -58.29 -44.99 88.74 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.805 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.415 ' HA ' HG12 ' A' ' 88' ' ' ILE . 5.4 m-80 -58.29 -46.49 85.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.083 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.91 -46.97 82.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.176 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 96.4 m -63.6 -43.47 96.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.194 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 84' ' ' LEU . 35.8 pt -65.73 -30.86 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 120.855 0.36 . . . . 0.0 110.27 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.94 -39.67 97.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.983 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -74.99 -34.75 62.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 74.6 m-85 -76.16 142.65 41.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -103.69 1.14 31.49 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.981 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 36.5 mt-10 -138.39 160.86 62.07 Favored Pre-proline 0 CA--C 1.503 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.464 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.608 ' O ' ' HB2' ' A' ' 1' ' ' MET . 42.9 Cg_endo -68.19 145.4 66.37 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.808 1.672 . . . . 0.0 109.792 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -145.21 161.91 38.38 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.201 0.524 . . . . 0.0 112.192 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.599 HD23 HG22 ' A' ' 156' ' ' VAL . 93.3 mt -85.63 149.74 25.11 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.693 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.9 t -120.77 125.47 74.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 5' ' ' ILE . 6.1 m -131.44 162.4 39.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.325 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.517 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 49.0 m -99.45 143.3 29.86 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.16 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 78.2 p -73.15 -10.01 59.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.299 0.571 . . . . 0.0 111.605 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 99' ' ' SER . 4.7 p-10 -101.41 16.78 24.51 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.251 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.45 117.17 28.94 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 122.007 -0.433 . . . . 0.0 110.619 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 47.4 pt -69.93 -172.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.782 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.44 -175.42 2.79 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.1 tp 80.73 24.32 0.32 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 110.023 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.627 ' NZ ' ' HA ' ' A' ' 33' ' ' VAL . 50.0 mtmt -98.79 -1.86 39.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.829 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.0 m -58.07 -43.75 87.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -86.82 -20.64 27.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG12 ' A' ' 113' ' ' ILE . 43.2 mm -63.73 -45.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.961 -175.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 40' ' ' SER . 58.3 mt -59.52 -48.58 86.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.556 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -63.92 -39.67 94.71 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.084 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.2 m -62.45 -38.04 88.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.855 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.6 mm -59.61 -48.23 88.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.219 0.533 . . . . 0.0 109.932 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 78.7 t -62.71 -49.51 83.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.495 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.02 -41.97 99.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.287 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.518 ' CE2' HD11 ' A' ' 120' ' ' ILE . 46.0 t80 -63.92 -46.68 83.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.148 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.46 -47.69 84.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.989 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 27.2 m-85 -61.02 -36.88 80.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.169 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.8 t -62.21 -45.37 93.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.455 0.645 . . . . 0.0 109.71 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.576 HG21 ' HG3' ' A' ' 167' ' ' GLU . 84.7 mt -63.38 -49.22 83.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.497 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.64 -25.0 67.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.59 99.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.552 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -83.83 -34.33 24.7 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 54.4 m -137.73 97.23 10.26 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.33 -13.4 39.27 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.049 2.499 . . . . 0.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.69 -29.64 70.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.425 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.553 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 85.7 t -67.21 126.48 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.214 0.531 . . . . 0.0 110.681 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.509 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 39.8 mt-10 -108.25 -25.22 11.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.798 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.7 38.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.115 0.483 . . . . 0.0 112.111 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -135.96 132.21 36.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.174 -178.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -122.28 135.41 54.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 113' ' ' ILE . 59.0 t -113.72 119.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -146.22 157.88 43.85 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.563 -177.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.649 HG12 ' HB2' ' A' ' 152' ' ' ALA . 37.8 pt -134.07 157.83 76.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.595 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.97 139.08 89.13 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.446 2.098 . . . . 0.0 112.054 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.641 ' O ' ' HD2' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -62.66 -21.15 65.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.83 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.33 -38.76 81.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.589 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -99.12 -20.26 16.76 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -63.23 133.18 95.36 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.35 -63.14 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.684 2.256 . . . . 0.0 112.883 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -161.61 154.52 17.35 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.2 71.28 2.29 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.699 2.266 . . . . 0.0 111.481 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 179' ' ' ASN . 70.1 m -60.02 -36.52 77.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 50.7 mm -58.7 -27.82 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.134 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 73.14 26.77 2.09 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 110.188 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.72 124.51 44.42 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.848 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -82.59 177.31 8.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.097 0.475 . . . . 0.0 112.14 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.39 -134.33 11.88 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 mp -89.88 146.5 24.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.843 0.354 . . . . 0.0 110.097 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' MET . 27.6 m -118.32 138.54 25.77 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.348 -176.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.65 144.18 53.81 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.496 2.13 . . . . 0.0 111.501 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.649 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -116.49 -2.67 11.96 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.71 -127.29 1.0 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.724 -1.703 . . . . 0.0 114.163 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 96' ' ' LEU . 4.0 mp -101.63 140.43 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-O 121.591 0.71 . . . . 0.0 111.918 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.639 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.4 t-20 -109.13 155.49 20.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.397 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.599 HG22 HD23 ' A' ' 96' ' ' LEU . 87.9 t -124.58 135.74 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 122.905 0.482 . . . . 0.0 110.467 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.16 151.41 30.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 120.79 0.328 . . . . 0.0 110.566 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 82.9 p -90.8 163.18 31.01 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.037 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 71.9 Cg_endo -75.75 63.25 6.59 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.385 2.057 . . . . 0.0 112.426 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.421 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 33.6 mmtp -110.89 -172.77 2.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.674 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -143.03 120.23 11.49 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.35 -125.49 5.79 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.242 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -112.99 142.41 45.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -127.03 152.3 47.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.852 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.553 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 9.1 tmtm? -76.75 125.98 30.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.67 136.48 54.5 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.987 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.576 ' HG3' HG21 ' A' ' 120' ' ' ILE . 24.8 mm-40 -95.77 164.01 12.93 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.328 0.585 . . . . 0.0 112.058 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.71 131.04 68.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.427 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.461 ' HB3' HG22 ' A' ' 132' ' ' VAL . 44.1 ttm -116.75 135.49 53.72 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.645 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.31 126.45 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.645 HD12 ' HG2' ' A' ' 173' ' ' GLU . 42.7 pt -119.28 175.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.407 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.13 3.3 9.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.491 . . . . 0.0 111.496 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.645 ' HG2' HD12 ' A' ' 171' ' ' ILE . 1.8 pm0 -98.78 137.03 37.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.621 0.724 . . . . 0.0 111.262 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -95.86 150.59 20.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.831 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.0 pt -127.18 153.94 36.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.512 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.67 107.61 13.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 143' ' ' SER . 7.3 m120 -74.51 -35.3 63.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.606 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.508 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 86.1 mt 79.98 96.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.772 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 143' ' ' SER . 27.3 t-20 -110.28 -19.38 13.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.697 175.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.2 p -126.33 162.24 25.97 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.096 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.71 -35.07 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.956 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -62.07 -41.78 98.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 73.3 m-20 -63.96 -41.73 97.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 109.571 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.612 HD12 HD21 ' A' ' 24' ' ' LEU . 60.0 tp -61.51 -48.35 81.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.194 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 62.9 tttm -63.4 -44.33 94.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.138 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.66 -44.65 96.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 0.0 110.02 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.81 -42.47 99.06 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.705 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.3 pt-20 -70.97 -36.11 72.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 95.0 mtp -63.99 -42.37 97.21 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -65.19 -36.02 82.89 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.955 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.0 mt -63.48 -46.14 87.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.71 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -63.89 -39.51 94.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.28 -26.55 66.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.166 0.508 . . . . 0.0 111.096 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.43 -11.94 70.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.921 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.7 pp . . . . . 0 C--O 1.271 2.21 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.601 -179.241 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 42.6 m-20 -96.52 165.91 11.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.81 137.87 51.75 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.7 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 98' ' ' VAL . 8.5 mt -96.58 135.78 38.01 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.785 174.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.586 ' HA ' HG22 ' A' ' 98' ' ' VAL . 75.7 mt -127.59 100.03 5.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.4 ptm -95.5 99.08 11.02 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 123.269 1.509 . . . . 0.0 112.248 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.0 110.53 20.2 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 112.378 -2.192 . . . . 0.0 109.615 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.23 -2.36 5.44 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.722 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.66 73.26 1.67 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.134 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -139.95 123.12 16.85 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.15 -13.94 59.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.175 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -83.9 169.87 14.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.695 0.283 . . . . 0.0 111.196 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -86.39 -148.35 0.13 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 0.0 111.081 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 9.7 tpt -69.25 76.47 0.36 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.606 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.94 176.26 42.57 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.22 -121.7 27.49 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.5 93.94 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 172.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 36.8 tt0 -60.42 -50.14 74.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.983 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.0 mttt -143.42 129.8 10.35 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 25.4 Cg_exo -68.71 -11.22 31.3 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.406 2.071 . . . . 0.0 109.08 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 73.4 mt -95.93 18.27 13.64 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.471 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 19' ' ' LYS . 95.1 mt -62.83 118.81 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.883 0.849 . . . . 0.0 109.296 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 58.4 pttt -86.14 131.2 34.3 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.991 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -132.57 125.46 30.55 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.737 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 52.28 30.0 7.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.45 -9.19 58.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.509 -0.853 . . . . 0.0 115.063 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.702 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.7 mtt180 -127.01 153.84 45.4 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.826 1.313 . . . . 0.0 111.846 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 77.3 m -80.26 164.09 23.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 33' ' ' VAL . 77.6 mt -59.05 -43.99 91.75 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.075 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.58 -39.88 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.702 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.3 t70 -64.55 -43.61 93.4 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.276 0.56 . . . . 0.0 110.193 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 7.5 m-85 -63.24 -34.17 77.08 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.622 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.8 t -69.34 -42.12 81.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.915 0.388 . . . . 0.0 110.543 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 30' ' ' ILE . 66.2 t -62.45 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.793 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.553 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 67.8 m -53.47 -52.29 68.05 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 53.2 Cg_exo -60.33 -43.1 36.57 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 121.789 1.66 . . . . 0.0 112.484 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.586 HD11 HG11 ' A' ' 98' ' ' VAL . 93.2 mt -66.68 -38.31 86.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 110.563 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.33 -44.7 92.58 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.385 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 35' ' ' SER . 61.1 pttt -91.18 -4.39 56.14 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.8 p -82.46 -176.55 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 111.071 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -54.22 -22.45 11.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.642 1.177 . . . . 0.0 112.23 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -54.49 137.59 15.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -72.0 -79.44 0.07 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.153 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -115.58 155.76 27.02 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.258 0.552 . . . . 0.0 110.567 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.9 mm -107.05 116.05 49.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.046 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 116.54 32.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.796 HG21 HD13 ' A' ' 60' ' ' ILE . 82.1 mt -98.96 116.69 42.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.38 123.99 32.92 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.17 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.5 p -129.26 161.9 29.14 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.664 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -117.12 151.4 47.62 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.895 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.82 -19.08 53.22 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.867 2.378 . . . . 0.0 111.245 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.15 -10.86 59.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.5 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -140.76 66.7 27.69 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.558 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 98.2 Cg_endo -102.64 88.8 0.03 OUTLIER 'Trans proline' 1 N--CA 1.376 -5.41 0 C-N-CA 117.197 -1.402 . . . . 0.0 110.345 171.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -150.9 -47.35 0.12 Allowed 'General case' 1 C--N 1.205 -5.699 0 CA-C-N 110.368 -3.106 . . . . 0.0 102.865 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD21 ' A' ' 21' ' ' LEU . 99.4 m -63.38 -48.27 78.58 Favored 'General case' 0 N--CA 1.386 -3.64 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.679 164.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -62.91 -45.12 94.02 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.522 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 54' ' ' PRO . 32.0 mm-40 -57.3 -43.52 83.3 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.182 -1.407 . . . . 0.0 110.975 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -60.98 -51.59 68.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.845 0.355 . . . . 0.0 111.89 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.796 HD13 HG21 ' A' ' 47' ' ' ILE . 87.2 mt -63.98 -45.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.736 -176.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 54.9 t-20 -58.8 -39.38 80.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -86.74 -31.1 21.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.831 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.17 -34.67 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.408 ' CD2' HG23 ' A' ' 60' ' ' ILE . 91.8 m-85 -103.6 6.82 37.46 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.892 -175.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.4 pttt -61.32 -23.7 65.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 110.835 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.46 -33.58 71.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.536 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -80.15 140.81 36.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.334 0.588 . . . . 0.0 112.38 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -86.9 -43.53 12.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.606 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.562 ' H ' HD21 ' A' ' 69' ' ' ASN . 0.0 OUTLIER -82.14 -0.77 46.37 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.949 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -106.37 121.25 58.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.2 t -123.28 130.68 74.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.248 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.38 131.59 45.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.497 HG13 ' HA ' ' A' ' 48' ' ' ALA . 40.6 pt -126.89 156.71 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.267 0.556 . . . . 0.0 110.573 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.08 134.22 55.03 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 8.9 t -158.42 -171.16 3.35 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.1 m -66.69 1.86 1.61 Allowed 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 126.696 1.999 . . . . 0.0 114.774 -174.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.594 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.37 -24.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.056 0 C-N-CA 125.877 1.703 . . . . 0.0 116.841 -174.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.0 tmtt? -53.31 -33.83 54.94 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.06 120.23 4.66 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -59.22 -50.55 73.57 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.08 -44.8 97.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.94 0.876 . . . . 0.0 109.823 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.96 -42.02 97.47 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.71 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.594 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 8.0 t0 -58.68 -50.94 72.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.17 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.6 mm? -58.78 -42.59 89.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.998 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.532 ' HA ' HG12 ' A' ' 88' ' ' ILE . 17.8 m-80 -59.98 -41.27 91.66 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 67.0 mm-40 -64.52 -44.84 89.6 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.271 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.3 m -63.47 -44.75 93.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 160' ' ' LYS . 24.6 pt -65.06 -28.42 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 0.0 110.79 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.61 -37.77 94.75 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.455 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.56 -2.23 42.18 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -97.51 156.74 16.36 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.752 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -118.58 1.25 11.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.09 155.22 80.27 Favored Pre-proline 0 CA--C 1.502 -0.878 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -56.65 141.92 91.21 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.868 2.379 . . . . 0.0 110.509 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 42.2 p90 -141.83 158.4 43.84 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.372 0.606 . . . . 0.0 111.755 -178.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -86.03 143.84 27.9 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.118 -175.025 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 75.6 t -120.32 130.73 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.935 0.894 . . . . 0.0 109.765 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 5' ' ' ILE . 18.7 m -131.34 159.64 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.514 0.674 . . . . 0.0 112.774 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 42.3 t -99.97 153.72 18.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' HG21 ' A' ' 33' ' ' VAL . 80.5 p -88.58 -0.19 57.0 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -173.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 24.7 p-10 -108.82 -3.59 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -174.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' CD2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER -87.98 115.28 25.34 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.181 177.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -96.27 8.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.72 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.536 ' CB ' HG22 ' A' ' 175' ' ' ILE . 21.9 t-20 -55.93 143.88 30.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.126 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.4 mm? -69.61 80.0 0.42 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.169 0.985 . . . . 0.0 109.257 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -74.38 -1.08 19.38 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.574 -1.648 . . . . 0.0 113.724 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.7 t -57.31 -45.34 84.31 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -76.95 -26.33 53.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.588 0.708 . . . . 0.0 109.841 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 113' ' ' ILE . 37.6 mm -69.73 -43.0 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.646 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.425 ' HA ' HD11 ' A' ' 154' ' ' ILE . 63.5 mt -58.62 -48.54 85.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.381 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -64.6 -41.23 96.37 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.252 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -62.9 -39.38 94.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.086 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.5 mm -61.01 -47.87 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.99 -47.57 92.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.433 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -61.91 -43.7 98.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.081 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.571 ' CD2' ' HE2' ' A' ' 169' ' ' MET . 83.2 t80 -63.86 -49.02 74.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.9 0.381 . . . . 0.0 111.04 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.57 -47.8 84.14 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.89 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.663 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 31.8 m-85 -65.83 -31.4 72.33 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.028 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.93 -45.07 94.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.478 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.9 mt -63.22 -49.44 83.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.329 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 14.8 ptmt -63.64 -23.43 67.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.938 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.34 -41.86 97.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.53 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.11 -41.3 10.56 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 111.23 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 29.6 m -127.47 91.99 44.48 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.54 -12.0 32.35 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 122.595 2.197 . . . . 0.0 112.508 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 23.3 t70 -64.86 -28.84 69.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.123 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 124' ' ' THR . 7.7 p -54.13 130.06 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.19 0.519 . . . . 0.0 111.32 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.6 ' HB3' ' OE1' ' A' ' 164' ' ' GLN . 47.1 mt-10 -115.01 -12.52 11.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.057 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.2 163.34 40.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.939 0.4 . . . . 0.0 111.612 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -138.89 133.3 31.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.752 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -123.6 139.13 54.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.808 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 113' ' ' ILE . 58.4 t -118.22 122.67 70.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.115 0.484 . . . . 0.0 110.505 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -145.0 166.67 24.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.695 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.444 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 9.1 pt -124.39 158.53 61.11 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.645 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 32.3 Cg_endo -64.97 129.47 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.885 1.723 . . . . 0.0 112.119 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.09 -35.74 77.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.453 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -59.75 -37.37 78.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.839 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -88.57 -22.65 23.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.217 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -79.71 118.86 74.63 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.518 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.98 53.28 4.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.81 2.34 . . . . 0.0 113.418 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 64.93 140.85 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.253 0.621 . . . . 0.0 112.103 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.81 -78.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.735 1.624 . . . . 0.0 113.282 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 179' ' ' ASN . 57.1 p -131.8 20.75 4.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.276 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.7 mt 67.53 82.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.15 -166.11 2.42 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -63.91 137.33 57.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.513 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -92.56 134.21 35.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.204 0.526 . . . . 0.0 111.444 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.4 -131.16 1.29 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.01 143.04 27.13 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.319 0.559 . . . . 0.0 109.577 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.33 98.42 50.43 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-O 121.351 0.596 . . . . 0.0 112.475 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -61.09 142.03 95.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.595 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.445 ' HB3' HD11 ' A' ' 171' ' ' ILE . . . -126.91 -47.36 1.52 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.111 0.482 . . . . 0.0 111.29 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.33 -153.49 26.42 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.457 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.552 ' HB ' HD11 ' A' ' 96' ' ' LEU . 20.2 pt -107.91 160.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.296 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.8 t-20 -109.9 151.83 26.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.864 -172.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.4 t -123.35 131.75 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 122.963 0.505 . . . . 0.0 110.097 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 155' ' ' ASN . 23.5 m -131.83 150.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.186 0.517 . . . . 0.0 111.238 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.576 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 59.7 m -97.55 160.78 27.91 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.613 174.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 158' ' ' SER . 74.1 Cg_endo -74.06 52.5 2.68 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.672 2.248 . . . . 0.0 111.963 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.64 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.1 mmmt -112.61 109.41 18.93 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -61.99 146.37 50.29 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.281 0.363 . . . . 0.0 111.284 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.13 -146.05 19.49 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.58 141.59 36.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.917 0.389 . . . . 0.0 110.002 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.6 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 27.5 pt20 -133.84 160.8 36.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.82 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -59.37 118.69 6.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.019 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -120.9 126.28 49.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.134 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.52 164.14 13.11 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 121.773 0.797 . . . . 0.0 112.509 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 130.2 67.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 114.231 -1.349 . . . . 0.0 112.745 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.571 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 46.6 ttm -114.14 130.21 56.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.046 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.53 123.11 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.53 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 42.4 pt -112.45 173.22 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.768 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.96 1.72 9.86 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.605 0.717 . . . . 0.0 110.288 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.53 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.2 pm0 -98.73 134.18 42.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.049 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.77 149.61 21.06 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.561 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.536 HG22 ' CB ' ' A' ' 104' ' ' ASN . 1.9 pp -104.08 154.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.559 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.16 113.55 26.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 101' ' ' ASP . 97.6 m-20 -113.43 153.44 28.62 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.67 109.88 21.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 143' ' ' SER . 45.1 m-80 -104.63 -34.63 8.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.492 0.663 . . . . 0.0 109.67 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -149.47 -178.5 6.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.54 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.486 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -62.58 -36.81 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.826 0.45 . . . . 0.0 111.973 -177.401 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 29.9 m-20 -60.37 -36.02 77.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 58.6 m-20 -61.69 -33.94 74.88 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.936 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.629 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 97.7 mt -61.29 -42.36 98.52 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -61.85 -41.85 98.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.831 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.08 -47.87 84.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.201 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.418 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.91 -46.19 91.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.914 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 9.0 pt-20 -68.9 -31.01 69.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.99 0.424 . . . . 0.0 110.998 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.9 ttm -61.58 -46.07 91.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.298 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.89 -30.64 64.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.335 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.508 0.671 . . . . 0.0 109.624 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 192' ' ' LYS . 7.8 tmtm? -63.82 -39.6 94.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -35.11 74.38 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.47 -26.94 68.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.4 0.619 . . . . 0.0 109.778 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -96.08 57.13 1.51 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.713 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.8 ptm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.484 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 45.3 m-20 -104.83 165.71 10.88 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.614 0.245 . . . . 0.0 110.801 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.46 134.45 55.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.896 0.379 . . . . 0.0 111.181 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.37 126.25 51.9 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.603 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.666 ' HA ' HG22 ' A' ' 98' ' ' VAL . 70.4 mt -117.55 102.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.476 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 10.2 ptm -92.34 99.06 11.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.964 1.364 . . . . 0.0 111.3 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -114.87 96.7 5.84 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.895 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.57 33.15 0.63 Allowed Glycine 0 C--N 1.294 -1.799 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.6 173.04 45.66 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.41 86.88 7.28 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.359 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.37 -8.74 59.85 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.045 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 t -60.46 -18.02 48.67 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -138.72 -76.11 0.37 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.15 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.4 mmt -113.84 -55.39 2.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.42 168.96 44.63 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.435 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.27 -63.5 4.13 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.437 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.53 -39.72 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.12 123.33 48.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -139.94 155.9 70.78 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.681 -175.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 60.3 Cg_endo -72.23 -4.18 14.72 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.224 2.616 . . . . 0.0 113.583 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 56' ' ' THR . 35.8 mt -82.22 16.85 1.83 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.29 121.18 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -81.07 125.56 30.35 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.041 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 188' ' ' GLU . 31.3 tp -144.92 117.18 8.43 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.283 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 54.17 39.66 30.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.19 -27.12 10.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.339 0.895 . . . . 0.0 115.339 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.738 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 25.8 ptt180 -146.18 171.8 14.39 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.835 1.318 . . . . 0.0 111.941 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.3 m -82.36 153.57 25.69 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.021 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.5 tt -53.51 -38.9 64.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.092 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 14.0 tt -62.85 -39.67 85.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.68 -39.55 94.3 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.738 ' CE2' ' HG3' ' A' ' 27' ' ' ARG . 27.5 m-85 -61.08 -35.41 76.92 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.493 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 29' ' ' LEU . 76.5 t -71.3 -45.89 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.799 0.333 . . . . 0.0 111.41 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.88 -42.55 96.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.534 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -51.36 -55.43 28.97 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 41.2 Cg_endo -67.86 -37.05 16.53 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.314 1.343 . . . . 0.0 112.584 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.659 HD11 HG11 ' A' ' 98' ' ' VAL . 78.9 mt -65.49 -42.18 92.44 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.414 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.4 tt -63.36 -45.03 93.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.987 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 19.0 ptmt -79.04 -7.84 58.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -74.96 179.7 4.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.32 -22.7 61.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.615 0.766 . . . . 0.0 112.934 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.0 160.75 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.484 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.5 t30 -83.09 -73.24 0.41 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.578 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.69 156.71 26.65 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.037 0.446 . . . . 0.0 110.645 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.86 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -106.79 117.9 35.26 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 60' ' ' ILE . 88.6 mt -100.05 118.92 47.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.609 0.718 . . . . 0.0 110.524 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.22 121.98 31.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.399 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 7' ' ' ALA . 73.0 p -129.83 166.76 19.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.738 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -130.92 158.12 75.97 Favored Pre-proline 0 C--N 1.298 -1.634 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.884 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.17 -21.06 72.26 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.633 2.222 . . . . 0.0 110.902 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -70.45 -23.17 62.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.817 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -138.17 68.36 48.16 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.715 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 69.9 Cg_endo -99.35 84.08 0.05 OUTLIER 'Trans proline' 1 N--CA 1.392 -4.492 0 C-N-CA 116.659 -1.761 . . . . 0.0 108.688 169.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.7 mttt -146.1 -52.18 0.24 Allowed 'General case' 1 C--N 1.222 -4.945 0 CA-C-N 109.568 -3.469 . . . . 0.0 102.799 -177.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.523 ' HA ' HD11 ' A' ' 21' ' ' LEU . 96.0 m -63.71 -47.37 81.42 Favored 'General case' 0 N--CA 1.385 -3.708 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.493 164.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.715 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -62.39 -49.36 75.82 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.148 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 4.8 pt-20 -58.09 -36.58 73.07 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 117.564 -1.654 . . . . 0.0 111.526 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -63.68 -51.22 66.06 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.986 0.422 . . . . 0.0 111.63 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.839 HD13 HG21 ' A' ' 47' ' ' ILE . 89.6 mt -61.85 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.192 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.725 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 54.6 t-20 -57.85 -45.3 86.47 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.694 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -73.49 -44.92 56.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.396 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.22 90.26 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.327 0.584 . . . . 0.0 111.349 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 68.2 m-85 -109.94 33.56 4.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.253 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 2.7 mmpt? -60.75 -25.49 66.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -90.95 11.53 22.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 55.0 p90 -43.71 133.96 4.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.02 -48.97 3.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.414 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.7 p-10 -118.92 10.11 12.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.013 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 86.4 mt -100.66 122.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.606 0.717 . . . . 0.0 111.312 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.78 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.802 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.06 131.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.53 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.3 pt -125.78 155.81 35.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.65 131.3 56.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.196 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -160.12 -167.94 2.07 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 51.6 m -64.03 1.96 0.61 Allowed 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 127.126 2.17 . . . . 0.0 114.556 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.03 -18.76 0.0 OUTLIER Glycine 0 N--CA 1.514 3.851 0 C-N-CA 126.484 1.993 . . . . 0.0 117.265 -175.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -58.23 -38.24 76.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -112.33 129.76 9.21 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -61.34 -51.25 69.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -74.14 -30.32 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.746 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.07 -43.13 88.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.531 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.8 t0 -61.52 -50.83 71.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.947 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 88' ' ' ILE . 1.7 mm? -55.69 -47.83 76.12 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.925 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.0 m-80 -60.14 -42.86 95.77 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.56 -44.42 86.83 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.362 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.91 -42.0 97.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.225 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' A' ' 85' ' ' ASN . 22.3 pt -68.56 -23.67 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.374 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.02 -14.09 80.54 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.456 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -98.93 -0.52 42.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 99.3 m-85 -126.5 150.08 48.97 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.658 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -109.9 3.48 20.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.599 0.714 . . . . 0.0 109.626 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -128.92 153.34 80.1 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.498 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.92 148.75 76.95 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.679 2.253 . . . . 0.0 112.058 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 50.6 p90 -144.24 163.17 34.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.26 0.553 . . . . 0.0 111.79 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.556 HD21 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -85.63 140.92 30.17 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.735 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 79.6 t -117.29 133.41 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.174 0.99 . . . . 0.0 108.824 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 5' ' ' ILE . 14.1 m -128.39 162.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.88 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 t -98.6 142.58 30.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.3 p -70.95 -13.26 61.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -110.84 12.32 22.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 70.4 mt -77.21 113.2 14.71 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.205 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 tt -129.49 122.04 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.719 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 63.4 t30 162.02 178.93 0.01 OUTLIER 'General case' 0 C--O 1.248 0.985 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.4 103.51 4.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.576 ' HA ' HD12 ' A' ' 109' ' ' ILE . 37.6 mtmm -99.79 -1.11 38.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.404 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -56.64 -41.11 76.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -169.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -85.07 -25.83 27.35 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.984 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 106' ' ' LYS . 84.4 mt -65.62 -42.75 93.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.536 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HA ' HD11 ' A' ' 154' ' ' ILE . 58.5 mt -59.71 -49.54 83.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.066 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.21 -38.85 92.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -62.64 -42.39 99.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.55 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.0 mm -63.96 -48.31 86.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.097 0.475 . . . . 0.0 110.793 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 1' ' ' MET . 79.2 t -60.75 -48.0 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.534 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -61.85 -47.5 84.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.301 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.513 ' CE2' HD11 ' A' ' 120' ' ' ILE . 44.7 t80 -64.42 -45.07 89.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 77.1 t80 -58.33 -48.62 79.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.229 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.426 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 20.0 m-85 -60.68 -37.05 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.437 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.65 -44.72 96.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.279 0.561 . . . . 0.0 109.55 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.552 ' CG2' HG21 ' A' ' 127' ' ' VAL . 74.8 mt -62.99 -43.5 99.11 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.801 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -60.1 -42.59 95.0 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.615 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.53 96.01 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.457 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -83.03 -36.85 24.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 0.0 111.797 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.7 m -133.66 89.36 31.07 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.28 -15.51 35.35 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.95 -31.96 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.206 0.603 . . . . 0.0 111.533 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.583 HG22 ' HE2' ' A' ' 165' ' ' LYS . 87.9 t -69.45 126.51 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -120.62 5.37 10.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.585 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.37 24.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.687 0.28 . . . . 0.0 111.205 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -137.46 129.5 29.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.05 142.08 51.02 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 152' ' ' ALA . 18.9 m -121.24 144.75 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.439 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.455 ' C ' ' HB2' ' A' ' 152' ' ' ALA . 63.3 mtm -134.99 153.84 51.94 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 171' ' ' ILE . 9.3 pt -131.84 145.53 57.87 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.026 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 51.4 Cg_exo -57.7 137.67 82.35 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.425 2.083 . . . . 0.0 113.12 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.456 ' HE3' ' OD1' ' A' ' 145' ' ' ASP . 25.0 ttmm -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.794 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -62.27 -37.54 85.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -84.83 -23.09 29.23 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.311 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.09 125.03 91.81 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.82 126.44 13.94 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.971 1.781 . . . . 0.0 110.471 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 66.48 77.06 0.27 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 122.174 0.988 . . . . 0.0 109.829 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.88 -1.69 11.86 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 123.736 2.958 . . . . 0.0 112.336 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.8 t 60.1 40.79 18.01 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.1 mt 65.26 -84.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.721 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' OD1' ' HE3' ' A' ' 136' ' ' LYS . 29.8 t70 -171.63 -77.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.011 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 58.65 26.16 14.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 0.0 111.933 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 61.89 19.27 10.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.194 0.598 . . . . 0.0 111.236 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.81 143.89 16.31 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.102 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.54 160.1 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.7 137.36 20.01 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.5 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.45 146.76 56.82 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.264 1.976 . . . . 0.0 111.715 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 132' ' ' VAL . . . -88.95 -10.22 48.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.782 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 161.48 -99.0 0.17 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.748 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.556 HD12 HD21 ' A' ' 96' ' ' LEU . 30.6 pt -118.79 161.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.237 0.541 . . . . 0.0 112.23 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.516 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.3 t-20 -119.54 156.59 30.0 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.476 -176.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' A' ' 117' ' ' PHE . 94.0 t -124.84 133.54 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 122.334 0.253 . . . . 0.0 110.609 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.42 HG13 ' OD1' ' A' ' 155' ' ' ASN . 32.3 m -131.12 150.33 34.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.367 0.603 . . . . 0.0 111.988 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -98.92 159.13 31.03 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.095 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 17.3 Cg_exo -68.15 91.28 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.362 2.041 . . . . 0.0 112.037 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -125.19 -165.85 1.46 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.073 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.74 147.4 39.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.73 -116.82 5.84 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.261 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -129.87 145.27 51.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -134.36 163.89 28.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 127' ' ' VAL . 1.6 tmtp? -61.03 128.01 34.34 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.09 139.28 52.6 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.095 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.68 160.78 14.83 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 121.727 0.775 . . . . 0.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.83 129.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 14.7 tmm? -137.27 136.04 37.7 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.15 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.7 129.93 63.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.062 0.458 . . . . 0.0 110.769 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.4 pt -120.52 176.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.426 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.55 69.54 1.31 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.664 0.745 . . . . 0.0 109.128 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' A' ' 171' ' ' ILE . 77.5 mm-40 -128.59 143.59 50.99 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.205 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.95 140.63 31.2 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.985 0.898 . . . . 0.0 113.082 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.9 pt -139.55 151.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.435 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 103' ' ' ILE . 93.0 m-85 -120.55 107.93 13.44 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.176 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.457 ' OD1' HD23 ' A' ' 102' ' ' LEU . 98.0 m-20 -93.96 110.8 22.46 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 183' ' ' ASP . 98.2 mt -81.32 114.44 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.354 0.597 . . . . 0.0 111.337 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -113.75 -20.97 10.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.1 p -131.59 164.9 24.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.269 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.752 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -60.87 -27.63 68.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.104 176.311 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -68.58 -39.24 81.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.44 0.638 . . . . 0.0 109.95 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.704 ' HB2' HG23 ' A' ' 178' ' ' ILE . 71.9 m-20 -61.52 -33.57 74.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.514 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 178' ' ' ILE . 96.1 mt -59.95 -44.77 94.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.224 0.535 . . . . 0.0 109.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 7.8 tmtm? -67.5 -42.46 82.84 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.759 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tt -62.09 -46.93 86.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.944 0.402 . . . . 0.0 110.102 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.5 -41.24 98.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.757 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.9 pp20? -68.02 -30.91 70.26 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.651 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.1 mmm -61.51 -43.8 98.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.4 pp -74.85 -39.74 61.41 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.127 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.3 -40.59 96.24 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.44 0.638 . . . . 0.0 110.275 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.575 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 189' ' ' MET . 35.2 mmtp -66.18 -41.4 90.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 111.181 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -83.67 -26.21 30.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.196 0.522 . . . . 0.0 112.052 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -92.3 -1.82 68.89 Favored Glycine 0 C--N 1.31 -0.894 0 CA-C-N 115.886 -0.597 . . . . 0.0 114.307 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 61.3 tp . . . . . 0 C--O 1.269 2.084 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.786 -179.658 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.1 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -113.53 165.11 12.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.433 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -117.29 142.69 46.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 48' ' ' ALA . 30.2 tp -120.35 127.51 52.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.275 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 98' ' ' VAL . 64.5 mt -117.69 108.27 24.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.016 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.412 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 60.4 ttm -82.31 92.71 7.01 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-O 121.84 0.829 . . . . 0.0 111.545 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.62 97.53 5.91 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.406 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.21 89.96 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.968 -1.11 . . . . 0.0 113.129 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.37 18.95 67.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.177 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -114.2 126.74 55.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.787 0.327 . . . . 0.0 111.203 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.4 119.51 0.92 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m 65.92 91.1 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 66.46 -93.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 79.3 mtm -132.39 153.5 50.74 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 -161.76 44.56 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.14 149.35 7.82 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.421 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.15 -7.01 11.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.54 143.65 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.694 . . . . 0.0 112.423 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.18 154.68 86.35 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.655 -176.293 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 24.4 Cg_exo -69.97 -5.7 16.95 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.119 3.213 . . . . 0.0 112.263 174.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 59' ' ' TYR . 8.8 mp -77.23 26.87 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.6 119.44 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.81 136.65 32.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-O 122.011 0.91 . . . . 0.0 113.048 -174.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 184' ' ' LEU . 80.2 mt -136.83 124.69 22.62 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.291 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 191' ' ' LEU . 74.3 m 53.95 30.54 11.83 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.39 20.54 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.913 -1.136 . . . . 0.0 115.794 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 34.7 ptt180 -146.22 166.35 26.47 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.085 1.443 . . . . 0.0 112.434 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.3 m -73.29 156.58 38.31 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.222 -176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 20' ' ' PRO . 5.1 tt -57.53 -44.69 85.31 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 124.395 1.078 . . . . 0.0 110.475 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -60.2 -39.94 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.434 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 13.8 t70 -63.95 -41.69 97.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.249 0.547 . . . . 0.0 109.569 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' CD2' ' HG3' ' A' ' 27' ' ' ARG . 5.7 m-85 -61.06 -36.57 79.93 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.158 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.1 t -66.87 -42.99 89.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 0.0 110.811 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.6 t -62.85 -45.02 99.91 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.576 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -50.91 -53.61 45.85 Favored Pre-proline 0 CA--C 1.57 1.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 28.8 Cg_endo -63.94 -39.42 32.83 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.518 1.479 . . . . 0.0 112.387 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.585 HD11 HG11 ' A' ' 98' ' ' VAL . 83.3 mt -67.13 -39.68 86.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.609 0.719 . . . . 0.0 110.018 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.2 tp -59.31 -45.67 90.68 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.515 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 22.2 ptmt -84.99 -8.71 58.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.493 ' OG ' HG12 ' A' ' 42' ' ' VAL . 77.9 p -74.58 174.74 8.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.213 0.53 . . . . 0.0 111.668 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -60.32 -18.51 50.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.056 0.942 . . . . 0.0 112.603 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 3' ' ' ALA . 11.4 p -63.64 150.76 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 120.909 0.385 . . . . 0.0 111.999 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -76.7 -75.91 0.18 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -110.43 152.13 26.67 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.057 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.47 110.99 33.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -104.16 117.86 35.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 60' ' ' ILE . 95.6 mt -97.88 119.19 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.602 0.715 . . . . 0.0 110.568 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.37 122.13 32.3 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.811 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 7' ' ' ALA . 41.9 p -126.59 155.0 43.17 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 50.1 m -98.79 145.1 29.35 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.871 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 75' ' ' THR . 51.8 Cg_exo -59.27 -28.78 88.58 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.197 2.598 . . . . 0.0 111.348 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 -6.89 58.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.963 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 7.7 p -134.63 66.47 69.59 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.414 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 83.0 Cg_endo -103.73 85.62 0.03 OUTLIER 'Trans proline' 1 N--CA 1.377 -5.332 0 C-N-CA 116.764 -1.691 . . . . 0.0 109.246 169.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 34.4 mmtp -145.45 -52.04 0.26 Allowed 'General case' 1 C--N 1.214 -5.318 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.45 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 99.0 m -63.48 -48.39 77.86 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 111.958 -2.383 . . . . 0.0 106.363 165.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.699 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -63.1 -48.18 79.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.913 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.8 pt-20 -58.64 -34.97 71.79 Favored 'General case' 0 C--N 1.365 1.266 0 C-N-CA 117.481 -1.687 . . . . 0.0 110.335 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.501 ' CB ' HD21 ' A' ' 21' ' ' LEU . 48.8 t80 -67.57 -52.25 40.9 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 120.86 0.362 . . . . 0.0 111.828 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 47' ' ' ILE . 96.8 mt -63.62 -46.54 94.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.837 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.1 t30 -58.92 -44.0 91.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 34.5 t -69.72 -44.62 69.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.18 90.14 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.305 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' HD2' HG23 ' A' ' 60' ' ' ILE . 78.7 m-85 -105.83 25.69 10.55 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.194 -176.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 9.9 mmmm -62.22 -21.39 65.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.857 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.26 10.57 21.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.374 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.3 p90 -44.18 138.04 3.18 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -176.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.596 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -101.62 -52.55 3.18 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.913 0.863 . . . . 0.0 109.361 172.59 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -121.45 12.67 10.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.163 -1.381 . . . . 0.0 111.467 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.6 mt -99.1 128.44 50.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.291 0.567 . . . . 0.0 111.053 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 67.3 t -128.04 132.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.18 132.15 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 4' ' ' LEU . 40.1 pt -126.96 156.89 38.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.624 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 51' ' ' PRO . 10.5 t70 -114.74 131.96 56.6 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.201 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.496 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 12.9 t -161.95 -171.87 3.04 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.95 0.881 . . . . 0.0 113.218 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.1 m -74.18 3.58 6.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.602 1.961 . . . . 0.0 114.605 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.94 -21.82 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 C-N-CA 126.638 2.066 . . . . 0.0 117.605 -173.126 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 76' ' ' SER . 58.4 tptt -58.53 -37.88 76.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.88 123.11 6.26 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.478 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.8 t80 -59.45 -50.4 74.07 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.14 -47.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 55.1 mt-10 -59.83 -44.94 93.8 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.798 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.615 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 5.5 t0 -59.29 -51.39 70.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.437 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.2 mm? -59.98 -41.74 92.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.962 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.418 ' HA ' HG12 ' A' ' 88' ' ' ILE . 91.6 m-20 -60.42 -43.19 97.0 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 72.4 mm-40 -65.72 -44.42 86.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.57 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.8 m -62.31 -43.16 99.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.114 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.9 pt -66.08 -24.64 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.28 77.47 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.411 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -104.75 -21.47 13.36 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 82.2 m-85 -89.1 140.92 28.96 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.986 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -104.42 -6.32 20.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.417 0.627 . . . . 0.0 109.817 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -132.24 152.49 80.22 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.443 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.94 142.03 54.27 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 123.515 2.81 . . . . 0.0 112.223 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -139.64 154.12 47.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.503 0.668 . . . . 0.0 111.595 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 154' ' ' ILE . 2.1 tm? -87.05 132.81 33.7 Favored 'General case' 0 C--O 1.193 -1.889 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.726 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 68.4 t -108.37 127.87 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.225 0.61 . . . . 0.0 109.559 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 5' ' ' ILE . 8.4 m -126.53 156.62 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.759 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.47 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 67.7 m -101.03 132.92 46.23 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 170.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.48 ' O ' HD21 ' A' ' 29' ' ' LEU . 69.3 m -67.46 -37.39 82.87 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.499 0.666 . . . . 0.0 111.532 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.37 -0.85 34.42 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.4 pp -91.63 116.26 28.73 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.15 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.4 mt -103.1 119.6 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.036 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.439 HD21 ' HB2' ' A' ' 173' ' ' GLU . 64.9 t30 178.38 163.5 0.71 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.145 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.54 98.6 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.636 ' HA ' HD12 ' A' ' 109' ' ' ILE . 15.6 ptpt -97.8 -2.28 41.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.908 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -60.26 -38.94 85.03 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.61 -27.17 37.4 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.432 1.111 . . . . 0.0 109.36 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.726 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -70.08 -39.52 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.759 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 107' ' ' SER . 65.3 mt -56.92 -49.21 79.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.944 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -65.07 -40.86 95.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.195 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.7 m -63.32 -40.67 97.97 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.548 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.726 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.26 -48.33 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.209 0.528 . . . . 0.0 110.674 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.658 HG22 ' SD ' ' A' ' 1' ' ' MET . 69.4 t -61.43 -48.21 89.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.93 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.67 -43.79 97.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.966 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.751 ' CE2' HD11 ' A' ' 120' ' ' ILE . 73.1 t80 -63.83 -46.58 84.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -58.11 -48.19 80.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.891 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.502 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 30.0 m-85 -62.03 -36.19 80.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.299 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.9 t -61.53 -46.66 88.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.997 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.751 HD11 ' CE2' ' A' ' 116' ' ' TYR . 67.3 mt -66.03 -47.06 86.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.854 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -64.03 -25.09 67.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.997 -178.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.55 99.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.788 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -83.91 -39.05 20.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.038 0.447 . . . . 0.0 110.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.621 ' O ' HG12 ' A' ' 127' ' ' VAL . 90.2 m -132.65 92.51 26.89 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.31 -19.04 48.59 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.263 2.642 . . . . 0.0 113.069 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 39.0 t70 -62.01 -32.31 72.78 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.624 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -70.61 118.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.596 0.712 . . . . 0.0 109.829 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.3 mt-10 -122.43 13.11 10.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.402 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.3 155.01 37.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 133.25 27.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -122.79 139.61 53.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.373 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.614 HG21 ' CD1' ' A' ' 113' ' ' ILE . 95.8 t -121.18 123.39 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.54 0.686 . . . . 0.0 111.179 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 3.1 ptm -145.48 162.5 37.22 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.551 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 150' ' ' VAL . 22.6 pt -123.15 158.07 59.05 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.31 132.5 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.816 1.677 . . . . 0.0 110.675 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.7 -21.8 66.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.105 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -65.52 -37.55 87.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.354 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.22 -25.27 42.68 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 121.482 0.658 . . . . 0.0 110.649 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -75.37 132.51 75.85 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.257 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.96 -62.35 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.883 2.389 . . . . 0.0 113.607 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -129.09 96.67 28.15 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.19 -30.98 15.24 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 123.233 2.622 . . . . 0.0 113.546 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 147' ' ' ASN . 36.5 t -177.18 152.54 0.89 Allowed 'General case' 0 C--O 1.24 0.571 0 CA-C-O 120.784 0.325 . . . . 0.0 110.532 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.8 tt -71.92 -28.95 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.345 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -127.78 -73.48 0.6 Allowed 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.46 133.4 32.69 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 143' ' ' SER . 64.2 t30 -162.65 104.27 1.06 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.809 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.25 98.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.86 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 149' ' ' LEU . 2.6 pt? -135.49 150.96 49.93 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 134' ' ' ILE . 29.6 m -119.5 98.91 50.14 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.086 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.36 139.02 87.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.504 2.136 . . . . 0.0 110.676 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.669 ' HA ' HD13 ' A' ' 175' ' ' ILE . . . -132.62 -36.84 1.07 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.264 0.554 . . . . 0.0 111.337 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.81 -149.55 25.8 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.521 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 96' ' ' LEU . 17.2 pt -119.44 161.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.045 -0.577 . . . . 0.0 110.46 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.571 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.6 t-20 -110.27 152.12 26.53 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.475 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.87 131.6 72.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.321 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.7 m -134.45 149.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.399 0.619 . . . . 0.0 111.243 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 58.5 m -98.51 153.63 37.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 14.8 Cg_exo -69.79 89.81 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.951 1.768 . . . . 0.0 110.99 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -116.72 -160.14 0.75 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -136.97 149.47 47.56 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 62.93 -124.17 31.96 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.657 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.02 149.22 50.46 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -131.62 163.99 26.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.008 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -57.77 128.5 37.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.027 0.441 . . . . 0.0 111.873 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -125.53 129.4 49.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.67 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -94.56 161.96 14.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.593 0.711 . . . . 0.0 112.212 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 131' ' ' ALA . 46.8 mm -115.69 130.84 69.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.303 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -131.17 138.75 49.58 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.681 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 133' ' ' MET . 76.0 t -108.12 129.64 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.79 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.541 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 36.7 pt -101.3 174.51 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.986 0.422 . . . . 0.0 111.321 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -99.77 -21.18 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HG3' HD11 ' A' ' 109' ' ' ILE . 1.6 pm0 -99.08 138.32 36.36 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.811 0.815 . . . . 0.0 112.568 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.02 151.92 18.76 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.458 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 152' ' ' ALA . 23.6 pt -107.41 155.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -102.98 106.91 17.54 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.112 0.482 . . . . 0.0 110.824 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.85 121.47 37.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 184' ' ' LEU . 40.9 mm -71.19 85.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.339 0.59 . . . . 0.0 112.396 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -70.65 -38.8 73.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.323 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 81.0 p -129.57 162.92 27.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.104 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.522 178.124 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.45 -36.29 79.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.108 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.43 -40.38 96.36 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.482 ' CD1' HD21 ' A' ' 24' ' ' LEU . 51.6 tp -62.64 -42.71 99.75 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.059 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.8 ttmt -61.0 -42.54 98.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.67 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.93 -43.21 99.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.01 99.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.022 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.7 pt-20 -71.05 -36.02 72.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.887 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 35.2 mmt -64.4 -39.99 94.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.28 -47.47 84.19 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.403 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.46 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 mt -63.9 -43.2 96.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.902 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.74 -49.49 76.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.044 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -71.78 -42.67 66.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.92 -25.02 18.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.24 -43.37 99.19 Favored Glycine 0 C--N 1.314 -0.651 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.733 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.263 1.776 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.146 179.658 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.9 ttp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 61.8 m-20 -98.88 166.97 11.04 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.934 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -114.34 130.98 56.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 98' ' ' VAL . 38.4 tp -106.69 125.46 51.04 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.521 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.681 ' HA ' HG22 ' A' ' 98' ' ' VAL . 60.4 mt -116.65 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.533 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 12.7 ptm -95.92 92.11 6.34 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.941 1.353 . . . . 0.0 112.908 -173.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.597 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -116.82 97.79 6.16 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.936 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.84 32.61 0.03 OUTLIER Glycine 0 C--N 1.287 -2.149 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.76 177.16 29.08 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.331 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -150.57 147.77 27.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.55 152.69 23.03 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -168.51 150.22 4.98 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.561 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 tpm_? -118.38 74.09 0.94 Allowed 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.5 tpt 71.86 -49.99 0.69 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.459 -175.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.56 165.85 21.29 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.0 162.55 38.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.634 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -136.81 145.01 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.846 0.355 . . . . 0.0 110.583 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.07 124.06 43.88 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.964 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.67 148.18 16.0 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 120.753 0.311 . . . . 0.0 111.411 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.03 -5.75 16.64 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.486 2.791 . . . . 0.0 113.052 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 69.1 mt -88.83 11.34 18.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mt -69.87 115.73 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -82.11 140.88 33.56 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.663 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.404 HD13 ' CD1' ' A' ' 184' ' ' LEU . 62.8 tp -130.97 107.59 9.21 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.698 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m 58.25 20.94 7.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.218 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 -80.87 0.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.926 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.549 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.5 mtt180 -93.7 172.2 8.4 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.422 0.629 . . . . 0.0 112.107 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.1 m -79.25 162.75 25.47 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.37 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.5 mt -59.08 -45.52 90.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.218 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.597 HD12 ' CB ' ' A' ' 7' ' ' ALA . 11.8 tt -65.49 -37.91 81.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.168 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 6.9 t0 -60.59 -43.13 97.73 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-O 121.636 0.731 . . . . 0.0 109.075 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -65.86 -36.53 83.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.595 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 29' ' ' LEU . 58.6 t -66.11 -43.29 92.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.8 t -63.49 -45.35 98.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.075 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -49.75 -52.59 49.94 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.06 -36.51 29.45 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.412 1.408 . . . . 0.0 112.44 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.533 HD11 HG11 ' A' ' 98' ' ' VAL . 83.7 mt -68.48 -37.57 80.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.576 0.703 . . . . 0.0 110.553 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.1 tp -59.11 -43.93 91.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.38 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -89.3 -7.19 55.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.523 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.49 ' OG ' HG12 ' A' ' 42' ' ' VAL . 83.3 p -72.52 172.0 11.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.206 0.527 . . . . 0.0 111.605 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.82 5.08 2.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.783 -175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' A' ' 3' ' ' ALA . 11.2 p -77.96 152.53 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.821 -0.549 . . . . 0.0 111.2 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.6 t30 -69.23 -77.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.32 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -117.69 156.46 28.18 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 111.021 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.3 114.61 47.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.86 119.79 40.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.626 HG21 HD13 ' A' ' 60' ' ' ILE . 95.9 mt -99.91 119.66 48.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.565 0.698 . . . . 0.0 110.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 6' ' ' MET . . . -89.42 121.82 32.03 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.293 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.3 p -131.7 169.53 16.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.031 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.3 p -131.29 158.83 74.13 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.412 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.21 -19.24 68.14 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.576 2.184 . . . . 0.0 110.782 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -70.3 -25.39 63.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.595 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -135.76 66.65 63.38 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.676 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.8 Cg_endo -101.26 85.32 0.04 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.814 0 C-N-CA 116.869 -1.62 . . . . 0.0 109.087 169.303 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 32.1 mmtm -155.29 -46.82 0.08 Allowed 'General case' 1 C--N 1.209 -5.511 0 CA-C-N 109.182 -3.644 . . . . 0.0 102.462 -179.072 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' HD21 ' A' ' 21' ' ' LEU . 97.8 m -64.05 -49.07 73.79 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 163.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.676 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -62.85 -50.36 71.24 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.1 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.6 pt-20 -64.35 -30.05 71.11 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 116.722 -1.991 . . . . 0.0 112.759 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.07 -50.94 66.38 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.327 0.584 . . . . 0.0 111.208 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.626 HD13 HG21 ' A' ' 47' ' ' ILE . 93.3 mt -63.13 -45.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.426 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -57.87 -44.04 86.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.576 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 27.7 t -69.64 -40.89 76.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.804 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.51 93.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.958 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.531 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 57.0 m-85 -116.41 42.31 2.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 62' ' ' SER . 56.4 mtmt -58.93 -35.46 73.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.218 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -88.47 12.37 14.54 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.15 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 53.6 p90 -39.64 131.87 1.7 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 -48.22 4.26 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -116.82 13.17 14.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.147 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -104.99 124.46 59.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.267 0.556 . . . . 0.0 110.426 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.29 133.51 68.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -103.57 130.68 53.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.276 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 48' ' ' ALA . 43.1 pt -128.48 157.1 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.749 0.785 . . . . 0.0 111.347 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -107.82 136.52 47.41 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.703 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 7.8 t -159.96 -173.84 4.27 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -74.34 5.09 4.9 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 127.328 2.251 . . . . 0.0 114.19 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.21 -13.81 0.0 OUTLIER Glycine 1 N--CA 1.525 4.632 0 C-N-CA 127.184 2.326 . . . . 0.0 117.646 -174.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -57.39 -39.56 76.34 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.531 ' HA3' ' OE1' ' A' ' 82' ' ' GLU . . . -116.32 132.8 10.38 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.4 t80 -61.29 -52.81 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.6 -39.81 76.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 121.755 0.788 . . . . 0.0 110.071 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' OE1' ' HA3' ' A' ' 79' ' ' GLY . 48.7 mt-10 -57.93 -43.49 86.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.548 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.56 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.5 t0 -60.59 -49.89 75.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.671 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 mm? -57.14 -40.44 77.16 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.772 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.453 ' HA ' HG12 ' A' ' 88' ' ' ILE . 93.2 m-20 -60.05 -42.96 95.6 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.626 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.658 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 46.0 mm-40 -66.86 -43.38 83.76 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.15 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.522 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.1 m -62.18 -45.01 95.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.277 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 160' ' ' LYS . 30.3 pt -64.92 -27.44 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 120.789 0.328 . . . . 0.0 110.911 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.45 -22.1 69.22 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.87 7.25 19.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.522 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 76.9 m-85 -109.86 143.17 40.14 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.05 -0.406 . . . . 0.0 111.274 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.6 m -100.67 -11.63 19.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.337 0.589 . . . . 0.0 110.382 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 38.6 mt-10 -133.19 162.46 57.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.327 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 1' ' ' MET . 38.1 Cg_endo -64.65 156.73 59.53 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.872 . . . . 0.0 111.466 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.497 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 46.6 p90 -143.94 156.6 44.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.526 0.679 . . . . 0.0 111.663 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 154' ' ' ILE . 1.6 tm? -86.33 135.45 33.52 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.616 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 63.6 t -110.85 130.21 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 123.5 0.72 . . . . 0.0 109.146 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 5' ' ' ILE . 4.9 m -128.34 163.35 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.272 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 69.8 m -98.7 141.92 30.92 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -88.21 -3.41 58.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 177' ' ' ASN . 10.9 p-10 -108.95 3.98 22.83 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 175' ' ' ILE . 75.0 mt -91.11 132.98 35.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.29 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -68.3 171.24 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.123 0.487 . . . . 0.0 111.717 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -81.72 78.53 8.44 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -122.42 -6.27 8.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.677 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.4 pttp -84.41 0.16 50.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.85 -1.523 . . . . 0.0 113.83 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.3 p -53.86 -42.9 69.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -86.59 -26.8 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.071 0.939 . . . . 0.0 109.852 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.695 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -64.57 -37.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.405 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.6 mt -54.77 -49.18 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.584 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -67.55 -39.04 84.98 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.507 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.9 m -60.63 -42.22 96.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -63.54 -47.77 89.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.165 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.465 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.4 t -61.56 -48.76 87.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.328 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.39 -42.57 98.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.988 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CE2' HD11 ' A' ' 120' ' ' ILE . 58.0 t80 -64.55 -47.33 79.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.734 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 72.3 t80 -59.04 -48.26 82.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.015 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 25.1 m-85 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.521 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 47.7 t -61.69 -47.08 86.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.108 0.48 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.667 HG22 HG11 ' A' ' 127' ' ' VAL . 68.4 mt -65.04 -48.83 82.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.886 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.545 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 19.8 ptmt -66.03 -26.6 67.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.95 97.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.598 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.57 -38.05 26.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.874 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 127' ' ' VAL . 45.7 m -132.1 96.49 19.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.694 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.2 -14.14 42.07 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 122.772 2.315 . . . . 0.0 113.273 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 35.4 t70 -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.667 HG11 HG22 ' A' ' 120' ' ' ILE . 9.1 p -71.33 120.59 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.376 0.607 . . . . 0.0 110.069 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 41.4 mt-10 -127.64 19.2 6.75 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.782 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.27 150.15 29.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.485 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 167' ' ' GLU . 0.4 OUTLIER -137.81 130.75 30.14 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.157 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.7 54.93 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.715 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.848 HG12 ' HB3' ' A' ' 152' ' ' ALA . 47.4 t -116.95 122.46 70.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 ptm -144.69 158.26 43.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.6 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' A' ' 152' ' ' ALA . 6.6 pt -130.77 165.6 33.51 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.107 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.99 136.25 73.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.536 2.157 . . . . 0.0 112.378 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' HE2' ' O ' ' A' ' 148' ' ' GLY . 99.5 mttt -61.16 -39.93 91.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.213 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.06 -37.14 86.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -82.35 -13.43 56.9 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 121.395 0.617 . . . . 0.0 110.832 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -84.92 114.62 56.81 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.24 -36.24 47.4 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 122.569 2.179 . . . . 0.0 114.866 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -160.82 95.15 1.45 Allowed Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.612 ' HB3' HG12 ' A' ' 150' ' ' VAL . 32.0 Cg_endo -81.67 -67.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.781 1.654 . . . . 0.0 110.228 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.9 p -160.88 153.41 20.65 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 145' ' ' ASP . 3.4 mp -111.83 80.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 144' ' ' ILE . 34.8 t70 173.04 -86.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.417 -177.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -64.15 -47.37 80.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.398 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.7 m120 63.12 -104.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.681 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.543 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . 71.31 -152.49 49.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.983 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.2 151.47 22.14 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.612 HG12 ' HB3' ' A' ' 142' ' ' PRO . 31.7 m -106.23 118.97 53.51 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 139.6 89.08 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.75 2.3 . . . . 0.0 110.931 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.848 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -103.13 2.88 35.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 166.87 -100.66 0.17 Allowed Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 118.937 -1.602 . . . . 0.0 113.503 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.515 ' CG1' HG13 ' A' ' 113' ' ' ILE . 28.2 pt -124.77 161.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.75 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.544 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 7.7 t-20 -120.17 155.11 33.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.861 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.72 130.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 122.383 0.273 . . . . 0.0 110.612 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.526 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.9 m -136.68 152.0 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.41 0.624 . . . . 0.0 112.001 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.1 t -97.33 145.11 29.08 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 64.9 Cg_endo -70.85 74.66 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 88' ' ' ILE . 75.8 mmtt -105.0 132.0 51.8 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.582 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -81.87 74.0 8.88 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.05 -146.25 13.71 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -118.74 144.19 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.048 0.424 . . . . 0.0 109.992 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -134.28 166.38 22.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.29 129.8 43.84 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -125.07 126.89 46.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.57 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 130' ' ' LEU . 28.7 mm-40 -93.96 162.36 13.92 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 121.558 0.694 . . . . 0.0 111.582 176.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -117.31 129.57 73.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.977 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.463 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 49.8 ttm -116.16 131.53 56.92 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.623 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 133' ' ' MET . 7.4 p -119.68 128.21 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.543 HD11 ' HB1' ' A' ' 152' ' ' ALA . 33.6 pt -119.95 172.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.541 -176.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -109.33 -2.33 17.91 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.458 ' CG ' HD12 ' A' ' 171' ' ' ILE . 4.1 pt-20 -97.99 131.13 44.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.666 0.746 . . . . 0.0 110.401 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.19 149.38 21.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.937 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.543 HD13 HD22 ' A' ' 102' ' ' LEU . 1.7 pp -123.84 154.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.218 171.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.85 137.38 52.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.552 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 9.3 p30 -110.39 127.73 55.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.08 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.535 HD13 ' OD2' ' A' ' 183' ' ' ASP . 16.9 mm -88.59 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.77 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.3 -0.37 56.71 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.313 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.8 t -148.11 151.39 35.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.655 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.658 ' HD2' ' H ' ' A' ' 181' ' ' LYS . 0.2 OUTLIER -62.09 -37.14 83.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.302 -177.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -61.56 -41.72 97.79 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.417 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.535 ' OD2' HD13 ' A' ' 178' ' ' ILE . 11.6 t70 -63.6 -36.05 82.54 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 178' ' ' ILE . 59.4 tp -58.52 -43.44 89.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.625 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 60.7 tttm -62.21 -43.72 98.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.718 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.7 tt -61.39 -45.05 95.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.04 98.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.013 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 12.5 pt-20 -66.34 -33.43 75.72 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -64.89 -40.25 94.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.643 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 88.2 mt -64.83 -43.19 93.86 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.362 0.601 . . . . 0.0 110.09 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.26 -40.76 97.27 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.584 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.0 -44.42 96.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.518 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 189' ' ' MET . 31.4 mmmt -85.07 -42.33 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -88.65 -25.82 22.2 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -95.1 -50.95 1.98 Allowed Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.603 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.5 tp . . . . . 0 C--O 1.269 2.132 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.233 -178.754 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 19.3 m-20 -97.93 165.9 11.7 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -114.69 130.48 56.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.279 0.562 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.0 122.15 45.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.704 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -117.98 116.23 50.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.238 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.501 ' CE ' HD22 ' A' ' 84' ' ' LEU . 38.3 mtt -89.05 96.57 10.78 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 122.32 1.057 . . . . 0.0 113.638 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.43 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.284 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.64 -118.94 0.79 Allowed Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.446 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.15 140.33 32.39 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.89 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -108.85 14.29 24.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.388 0.613 . . . . 0.0 109.757 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.54 -150.28 18.6 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.175 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.8 p -88.57 -3.08 58.88 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.189 0.519 . . . . 0.0 110.948 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -92.3 113.7 26.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.293 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.2 mtt -119.66 112.65 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.946 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.05 -158.5 28.65 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.839 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 -179.26 47.39 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.971 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.85 -0.32 10.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.149 0.5 . . . . 0.0 110.295 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -97.42 119.66 36.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.663 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.536 ' O ' HD12 ' A' ' 29' ' ' LEU . 61.5 mtpt -136.84 142.03 37.22 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.13 -20.24 66.94 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.973 2.449 . . . . 0.0 114.523 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 39.6 mt -97.75 4.69 49.85 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.31 123.78 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.93 139.38 31.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.818 -177.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.55 108.16 12.82 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.299 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.9 m 54.5 26.24 7.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.135 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.91 -101.58 0.2 Allowed Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.668 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 75.3 mtt-85 -88.03 168.36 12.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.105 0.479 . . . . 0.0 111.969 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.9 m -79.5 163.81 24.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 33' ' ' VAL . 67.1 mt -57.89 -45.28 86.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -39.5 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.785 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 18.8 t70 -65.74 -39.58 91.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 110.038 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -63.69 -34.62 78.26 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.605 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 100' ' ' SER . 75.8 t -66.4 -45.36 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.3 -41.04 88.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.592 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -50.88 -54.52 36.07 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 40' ' ' SER . 56.5 Cg_endo -71.36 -36.47 6.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.585 1.523 . . . . 0.0 112.249 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.453 HD11 HG11 ' A' ' 98' ' ' VAL . 84.8 mt -64.97 -41.8 95.12 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -59.95 -46.32 89.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -82.03 -9.07 59.67 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 59.3 p -74.28 -177.94 3.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.539 0.685 . . . . 0.0 112.202 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HD2' HG11 ' A' ' 114' ' ' VAL . 23.8 ttmm -56.26 -26.32 51.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.253 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.69 161.91 2.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.677 0.751 . . . . 0.0 112.989 -174.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -81.07 -78.42 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -117.99 161.95 18.97 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.027 0.441 . . . . 0.0 111.128 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 3' ' ' ALA . 48.9 mm -109.34 116.53 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.72 114.81 28.71 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.526 HG21 HD13 ' A' ' 60' ' ' ILE . 94.3 mt -97.24 117.82 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.569 0.7 . . . . 0.0 110.66 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.85 119.29 28.04 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.381 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 7' ' ' ALA . 69.8 p -121.42 155.92 33.82 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.57 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 35.8 m -105.45 145.66 31.24 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.733 -177.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 53.6 Cg_exo -57.96 -29.83 87.86 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.449 2.766 . . . . 0.0 112.01 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.16 -2.84 56.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 2.1 p -139.03 67.07 40.47 Favored Pre-proline 0 CA--C 1.498 -1.049 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.968 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.4 Cg_endo -106.99 86.59 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.11 0 C-N-CA 117.115 -1.456 . . . . 0.0 110.486 169.206 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 29.5 mtmm -144.06 -48.1 0.28 Allowed 'General case' 1 C--N 1.219 -5.081 0 CA-C-N 109.973 -3.285 . . . . 0.0 103.424 177.743 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.419 HG21 ' HB1' ' A' ' 7' ' ' ALA . 96.7 m -61.8 -48.9 78.53 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 112.549 -2.114 . . . . 0.0 106.054 164.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.13 -49.66 75.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.963 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.2 pt-20 -59.78 -34.52 73.11 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.698 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.14 -50.8 66.76 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.103 0.477 . . . . 0.0 111.088 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.526 HD13 HG21 ' A' ' 47' ' ' ILE . 97.3 mt -64.0 -41.59 92.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.884 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 57' ' ' LYS . 87.9 m-20 -57.74 -40.99 80.94 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.264 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 4.5 t -82.04 -39.12 23.96 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.895 0.378 . . . . 0.0 110.575 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.09 93.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.363 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 60' ' ' ILE . 81.0 m-85 -110.19 34.59 3.81 Favored 'General case' 0 C--O 1.206 -1.191 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.757 -176.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 10.9 mmmm -61.51 -25.04 67.02 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.09 0.471 . . . . 0.0 111.035 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -89.38 11.08 20.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.299 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 53.8 p90 -43.32 127.4 4.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -103.0 -49.05 3.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.945 0.878 . . . . 0.0 109.661 172.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -117.97 11.87 13.54 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.935 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.96 125.21 57.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.27 0.557 . . . . 0.0 110.302 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.45 131.76 71.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.378 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.5 132.63 53.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.138 0.494 . . . . 0.0 109.67 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.6 pt -125.98 152.16 32.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.288 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -119.83 130.49 54.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.452 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.47 HG23 ' CG ' ' A' ' 83' ' ' ASP . 11.6 t -165.26 -167.42 1.17 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 78' ' ' LYS . 73.7 m -59.42 0.59 0.11 Allowed 'General case' 0 C--O 1.198 -1.61 0 C-N-CA 127.383 2.273 . . . . 0.0 116.082 -173.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' N ' ' HB2' ' A' ' 83' ' ' ASP . . . -31.61 -22.36 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 C-N-CA 125.805 1.669 . . . . 0.0 116.972 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.2 tmmt? -56.84 -35.51 68.91 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.83 113.62 3.81 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -59.31 -49.08 79.19 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.96 -48.21 89.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.713 0.768 . . . . 0.0 110.4 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.53 -45.91 92.18 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.271 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 75' ' ' THR . 28.6 t0 -63.09 -50.03 72.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.385 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -53.61 -47.39 70.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.237 0.542 . . . . 0.0 109.61 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.556 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.2 m-80 -61.98 -40.44 95.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.032 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.84 -42.99 84.87 Favored 'General case' 1 N--CA 1.374 -4.235 0 O-C-N 122.092 -0.38 . . . . 0.0 110.632 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 91.3 m -62.98 -42.07 99.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.774 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 95' ' ' PHE . 26.3 pt -67.01 -28.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.29 -38.24 96.14 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.976 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -84.0 -12.09 55.78 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.483 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 81.2 m-85 -96.06 145.26 25.61 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.887 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.7 p -105.67 -2.74 23.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.806 0.813 . . . . 0.0 109.208 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -128.82 157.1 76.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.032 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.37 148.61 74.04 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.357 2.038 . . . . 0.0 111.626 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 40.7 p90 -143.28 159.33 42.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.279 0.561 . . . . 0.0 111.394 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.699 HD21 HD12 ' A' ' 154' ' ' ILE . 30.7 tp -86.41 143.05 28.0 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 92.2 t -115.2 126.32 72.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.6 m -130.85 157.22 43.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.355 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . 33.8 t -100.23 150.93 22.04 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 171.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.623 ' HA ' HG21 ' A' ' 33' ' ' VAL . 68.3 m -88.39 1.33 54.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' HD12 ' A' ' 102' ' ' LEU . 40.5 p-10 -104.14 4.18 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 99' ' ' SER . 7.2 mp -88.57 140.53 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.099 -0.376 . . . . 0.0 111.106 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.535 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 41.7 pt -64.36 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.555 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -82.24 4.31 24.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.03 11.84 1.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.689 0.757 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HE2' ' O ' ' A' ' 103' ' ' ILE . 57.9 mtmt -83.86 -1.4 54.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.278 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.6 t -57.31 -46.39 83.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -78.59 -23.8 45.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.716 0.77 . . . . 0.0 109.463 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.74 ' O ' HG12 ' A' ' 113' ' ' ILE . 39.2 mm -67.12 -41.52 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.117 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 106' ' ' LYS . 59.6 mt -58.28 -48.89 83.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.83 -177.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 59.5 m-80 -65.9 -39.85 90.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.1 m -61.76 -40.2 94.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.849 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -62.84 -47.54 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.471 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 72.6 t -61.85 -48.83 86.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.556 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -62.03 -43.46 98.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.463 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.519 ' CE2' HD11 ' A' ' 120' ' ' ILE . 68.8 t80 -64.84 -49.86 68.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.1 t80 -59.37 -48.63 80.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.278 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 36.4 m-85 -65.85 -30.7 71.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.334 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.26 -45.51 92.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.519 HD11 ' CE2' ' A' ' 116' ' ' TYR . 75.0 mt -64.63 -42.97 96.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.584 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HD2' HG13 ' A' ' 127' ' ' VAL . 17.1 mmmt -59.93 -42.38 93.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.269 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.07 85.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.064 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.41 -34.07 15.78 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.098 0.475 . . . . 0.0 111.076 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 26.0 m -133.23 98.39 15.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 123.184 0.594 . . . . 0.0 109.717 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.93 -15.32 36.42 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.394 2.063 . . . . 0.0 112.327 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 40.1 m-20 -63.28 -31.23 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 121' ' ' LYS . 9.8 p -66.31 127.23 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.711 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.8 mt-10 -119.52 6.27 11.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.606 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.31 159.25 25.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.859 0.361 . . . . 0.0 111.622 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -138.33 135.03 35.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.4 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -124.24 137.66 54.49 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 113' ' ' ILE . 72.1 t -115.39 117.02 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 121.257 0.551 . . . . 0.0 109.666 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -146.48 159.07 43.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.2 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.65 HG12 ' HB2' ' A' ' 152' ' ' ALA . 18.1 pt -132.6 158.37 75.88 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.792 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 30.9 Cg_endo -64.58 130.91 27.83 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.451 1.434 . . . . 0.0 111.722 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 139' ' ' TYR . 65.6 pttt -62.65 -16.42 56.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.554 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.43 -37.55 87.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.106 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.71 -21.93 17.29 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.495 0.664 . . . . 0.0 110.022 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 136' ' ' LYS . 31.4 t80 -67.53 124.43 89.18 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.716 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.1 -72.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.236 1.958 . . . . 0.0 113.128 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.509 ' OD1' ' HD2' ' A' ' 142' ' ' PRO . 60.0 t30 -163.62 127.6 1.86 Allowed Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.509 ' HD2' ' OD1' ' A' ' 141' ' ' ASN . 72.5 Cg_endo -75.9 148.41 31.88 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.654 2.236 . . . . 0.0 112.654 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.6 p -63.91 -38.92 92.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.241 0.543 . . . . 0.0 110.765 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.5 pt -80.89 138.29 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.708 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.22 85.5 7.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.234 0.54 . . . . 0.0 110.455 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.38 126.52 4.12 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.318 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.63 108.55 21.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.316 0.579 . . . . 0.0 110.663 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.93 -108.41 0.21 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.5 mt -109.52 140.96 42.65 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.351 0.596 . . . . 0.0 110.385 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.88 120.88 43.56 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.875 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.06 142.99 48.02 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.331 2.021 . . . . 0.0 111.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.65 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -109.09 -13.03 14.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.732 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.28 -117.74 0.44 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.309 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.699 HD12 HD21 ' A' ' 96' ' ' LEU . 17.8 pt -122.98 160.93 25.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 122.656 0.382 . . . . 0.0 111.443 -175.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.596 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.7 t-20 -116.61 153.71 31.79 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.9 t -123.51 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.423 0.289 . . . . 0.0 110.378 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.4 m -130.79 149.79 33.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.412 0.625 . . . . 0.0 112.1 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 159' ' ' PRO . 23.1 t -98.19 151.62 37.61 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 29.1 Cg_endo -63.11 82.17 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.844 2.363 . . . . 0.0 112.582 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.96 -172.64 2.16 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.034 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -137.2 92.24 2.7 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.96 -137.09 10.95 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.96 139.87 41.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.136 0.494 . . . . 0.0 110.746 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.91 166.59 22.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -54.31 121.62 8.64 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -129.78 129.42 44.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.545 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -93.84 162.95 13.71 Favored 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 121.936 0.874 . . . . 0.0 112.716 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 131' ' ' ALA . 49.6 mm -116.12 128.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.579 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 55.4 ttp -125.79 129.99 50.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.419 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 133' ' ' MET . 60.0 t -106.63 129.94 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.015 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.3 pt -115.87 175.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -176.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -113.4 11.44 18.51 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.657 ' HB2' HD12 ' A' ' 171' ' ' ILE . 29.2 mp0 -97.41 131.45 44.05 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.791 0.805 . . . . 0.0 110.882 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.7 139.63 32.49 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.667 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 175' ' ' ILE . 2.0 pp -120.84 148.85 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.946 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.48 117.34 30.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.892 0.377 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -105.26 13.99 29.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.257 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 184' ' ' LEU . 11.7 mm 55.46 71.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.62 -41.99 83.09 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.429 0.633 . . . . 0.0 110.277 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -145.88 -175.34 4.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.336 -173.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.558 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 1.3 mptp? -59.48 -36.49 76.12 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.222 0.609 . . . . 0.0 111.328 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -58.23 -43.3 87.66 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.473 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 63.9 m-20 -70.7 -39.52 73.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.303 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 178' ' ' ILE . 64.3 tp -59.45 -50.49 73.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.2 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -64.36 -43.26 95.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.93 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.8 tt -61.03 -49.01 79.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.737 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.04 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 pt-20 -66.26 -37.45 85.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.049 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -66.69 -37.56 84.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.715 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 89.5 mt -62.46 -44.39 96.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.452 0.644 . . . . 0.0 109.323 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.49 -42.97 98.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.467 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.35 -45.7 92.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.077 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -68.39 -41.43 80.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.155 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.87 -27.15 66.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.302 0.572 . . . . 0.0 110.722 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -96.84 29.96 9.7 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.784 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--O 1.267 1.983 0 C-N-CA 124.72 1.208 . . . . 0.0 111.323 -179.481 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.1 ttm . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.813 0.34 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.572 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 75.9 m-20 -105.38 166.27 10.54 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.46 127.39 56.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -103.26 119.68 39.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.782 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.644 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.6 mt -118.88 104.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.552 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.46 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.0 ptm -92.83 102.19 14.57 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.008 1.385 . . . . 0.0 112.047 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' ' HG2' ' A' ' 20' ' ' PRO . . . -115.12 98.29 6.7 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.795 -2.002 . . . . 0.0 111.139 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.75 107.36 1.11 Allowed Glycine 0 C--N 1.302 -1.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.775 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.1 -13.38 67.16 Favored Glycine 0 N--CA 1.465 0.611 0 C-N-CA 121.602 -0.332 . . . . 0.0 112.57 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 3.9 tmtt? -77.71 148.06 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.76 0.314 . . . . 0.0 111.034 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.43 150.18 21.92 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -68.69 -38.91 80.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.287 0.543 . . . . 0.0 111.01 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 7.0 ptm180 -71.73 -31.82 67.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 27.4 ptm 169.81 -36.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.8 0.84 . . . . 0.0 110.114 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.11 -177.49 47.65 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.61 -163.26 27.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.798 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -82.29 107.34 14.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 38.7 tp10 -101.38 127.29 48.08 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.525 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -125.93 85.01 60.08 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 121.362 0.601 . . . . 0.0 110.29 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.474 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 20.7 Cg_exo -69.34 -5.26 15.51 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.608 2.872 . . . . 0.0 111.579 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 21.7 mt -87.05 6.07 34.38 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 87.6 mt -74.13 110.56 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.7 pttm -81.67 131.39 35.27 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.685 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 184' ' ' LEU . 57.6 tp -122.71 112.07 17.49 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.155 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m 58.2 17.95 4.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.87 -95.48 0.15 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.146 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HG2' ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -87.29 172.41 9.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 111.34 -176.144 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 76.6 m -76.07 163.42 27.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 98.9 mt -59.61 -39.18 83.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.8 tp -57.68 -45.18 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.035 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 17.7 t70 -64.56 -40.34 95.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.493 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CD2' ' HG2' ' A' ' 27' ' ' ARG . 11.2 m-85 -61.26 -37.99 85.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.15 -44.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.409 . . . . 0.0 111.148 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.14 -41.97 94.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.3 m -51.67 -55.67 27.75 Favored Pre-proline 0 CA--C 1.562 1.436 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.23 -37.27 14.46 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.512 1.475 . . . . 0.0 112.409 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.663 HD11 HG11 ' A' ' 98' ' ' VAL . 82.1 mt -66.26 -41.53 89.78 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.845 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.33 -46.26 91.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.684 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.16 -9.29 59.52 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.409 ' OG ' HG22 ' A' ' 42' ' ' VAL . 54.7 p -72.08 -177.7 2.15 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.934 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -73.34 2.54 7.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.811 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG22 ' OG ' ' A' ' 40' ' ' SER . 34.2 m -80.42 162.03 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.342 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.6 t30 -81.63 -71.78 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.947 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -120.52 160.14 23.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.256 0.55 . . . . 0.0 111.396 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.1 mm -109.8 117.54 54.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 83.7 m-85 -109.46 116.86 32.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 60' ' ' ILE . 96.0 mt -97.39 116.22 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 121.715 0.769 . . . . 0.0 110.467 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.18 120.53 28.55 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.65 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 7' ' ' ALA . 45.1 p -127.93 154.72 45.23 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m -100.58 149.36 36.06 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.56 -17.58 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.714 2.276 . . . . 0.0 110.169 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.07 -11.1 59.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.599 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 p -140.17 67.55 33.07 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.117 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 77.3 Cg_endo -102.46 85.76 0.03 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.629 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.107 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.651 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.7 mmtm -149.8 -48.45 0.13 Allowed 'General case' 1 C--N 1.22 -5.049 0 CA-C-N 109.845 -3.343 . . . . 0.0 103.074 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.436 ' HA ' HD21 ' A' ' 21' ' ' LEU . 99.3 m -62.81 -48.63 78.26 Favored 'General case' 0 N--CA 1.386 -3.659 0 CA-C-N 113.104 -1.862 . . . . 0.0 105.987 163.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.32 -50.42 70.08 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.341 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 7.8 pt-20 -62.6 -34.14 76.42 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 117.159 -1.817 . . . . 0.0 112.138 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD2' HD22 ' A' ' 21' ' ' LEU . 51.0 t80 -64.55 -51.09 64.63 Favored 'General case' 0 C--O 1.211 -0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 111.728 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 47' ' ' ILE . 95.5 mt -62.59 -41.25 91.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.1 -46.02 79.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.065 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.694 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.2 t -73.06 -40.26 65.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.38 0.61 . . . . 0.0 110.848 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.78 86.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -177.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.432 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 89.5 m-85 -114.75 42.29 2.18 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.544 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.694 ' HG3' ' O ' ' A' ' 62' ' ' SER . 39.2 mtmm -60.55 -22.21 63.41 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.221 0.534 . . . . 0.0 110.25 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.98 10.64 18.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.235 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 55.4 p90 -44.33 117.27 1.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 3.9 mmpt? -103.06 -49.35 3.78 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.444 1.116 . . . . 0.0 109.088 171.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.42 9.92 18.21 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.577 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.48 123.87 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.083 0.468 . . . . 0.0 110.124 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 65.5 t -124.02 131.9 72.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.347 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.2 131.89 53.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.112 0.482 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.3 pt -125.89 156.53 35.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.307 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -117.36 129.59 55.97 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -158.74 -170.19 2.97 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.5 m -66.18 2.36 1.2 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 127.268 2.227 . . . . 0.0 115.011 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.621 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.17 -22.61 0.0 OUTLIER Glycine 1 N--CA 1.52 4.262 0 C-N-CA 126.187 1.851 . . . . 0.0 117.02 -174.46 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -55.65 -39.87 71.48 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.482 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.14 122.64 6.98 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -59.82 -50.56 73.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.218 0.509 . . . . 0.0 111.454 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.9 pt -72.88 -30.81 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.774 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.87 -43.34 93.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 109.353 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.621 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.5 t0 -61.45 -51.09 70.13 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.15 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -57.61 -43.2 84.56 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.499 ' HA ' HG12 ' A' ' 88' ' ' ILE . 14.9 m-80 -60.39 -42.62 96.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -63.84 -45.71 88.29 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.286 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.9 m -62.56 -41.95 99.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.158 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -66.0 -29.51 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.24 -39.59 96.14 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.637 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -71.38 -40.97 70.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.8 m-85 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.943 0.402 . . . . 0.0 111.916 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -105.16 -2.36 24.32 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.67 157.02 78.17 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.975 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.39 141.94 59.59 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 123.486 2.791 . . . . 0.0 112.237 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 32.4 p90 -141.66 156.4 45.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.354 0.597 . . . . 0.0 111.543 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.601 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.34 138.78 31.55 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.178 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 63.5 t -113.96 129.99 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.663 HG11 HD11 ' A' ' 37' ' ' LEU . 7.3 m -129.47 160.17 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.484 0.659 . . . . 0.0 112.505 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.452 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 62.4 m -100.44 138.26 37.74 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.772 172.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -64.79 -21.46 66.78 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.537 ' CG ' ' HZ1' ' A' ' 10' ' ' LYS . 39.9 p-10 -112.27 22.76 14.39 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 95.9 mt -68.81 138.4 54.75 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.915 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -92.99 142.81 12.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 79.37 171.65 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.527 1.131 . . . . 0.0 112.799 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.75 134.33 47.34 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.212 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -101.81 -1.65 31.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.431 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.568 ' HA ' HD12 ' A' ' 110' ' ' ILE . 69.6 m -57.19 -40.73 77.97 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -170.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.507 ' HG3' HG13 ' A' ' 109' ' ' ILE . 17.2 ptmt -74.34 -38.22 63.31 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.065 0.936 . . . . 0.0 110.304 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.783 ' O ' HG12 ' A' ' 113' ' ' ILE . 58.8 mt -66.49 -40.43 86.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.23 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 107' ' ' SER . 62.6 mt -58.42 -45.8 89.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.913 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -60.95 -45.14 95.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.986 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -62.99 -39.85 96.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.624 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.783 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -61.69 -48.66 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.205 0.526 . . . . 0.0 110.331 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.04 -48.19 89.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.687 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -62.26 -45.68 92.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.694 ' CE2' HD11 ' A' ' 120' ' ' ILE . 80.1 t80 -64.08 -47.79 78.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 79.6 t80 -58.37 -46.02 87.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.453 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -60.4 -37.15 79.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.96 -42.72 99.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.913 0.387 . . . . 0.0 110.528 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.694 HD11 ' CE2' ' A' ' 116' ' ' TYR . 71.2 mt -68.26 -44.19 84.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.711 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -66.73 -37.0 83.78 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.585 -178.716 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.422 ' N ' ' HD3' ' A' ' 121' ' ' LYS . . . -62.01 -42.71 99.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 0.0 111.16 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -80.14 -39.42 29.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.073 0.464 . . . . 0.0 111.034 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 126' ' ' ASP . 35.8 m -132.36 99.97 15.61 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.12 -11.9 34.0 Favored 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 123.002 2.468 . . . . 0.0 112.231 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 124' ' ' THR . 25.4 t70 -61.49 -32.63 72.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.208 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.428 HG22 ' HE2' ' A' ' 165' ' ' LYS . 60.4 t -81.3 119.24 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.282 0.563 . . . . 0.0 111.011 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.597 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 39.5 mt-10 -122.55 7.12 9.49 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.658 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.59 153.75 39.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -139.37 139.0 37.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.191 -177.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -128.14 139.0 52.73 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.191 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.566 HG21 ' CD1' ' A' ' 113' ' ' ILE . 98.4 t -115.32 117.51 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 121.74 0.781 . . . . 0.0 110.683 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.463 ' SD ' HD23 ' A' ' 149' ' ' LEU . 5.2 ptm -146.5 161.87 39.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.113 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.9 pt -128.77 159.59 67.49 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.96 144.65 99.06 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.261 1.974 . . . . 0.0 111.298 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -57.76 -39.89 78.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.805 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -64.83 -37.13 86.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.115 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.31 -27.27 56.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.534 0.683 . . . . 0.0 110.075 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.406 ' HB2' HG21 ' A' ' 150' ' ' VAL . 46.2 t80 -68.31 139.2 92.09 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.268 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.44 55.85 2.08 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.669 2.246 . . . . 0.0 112.813 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 18.0 m120 67.3 119.55 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.061 0.944 . . . . 0.0 112.556 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.64 140.18 92.64 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.695 2.263 . . . . 0.0 110.395 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.0 m -113.49 88.5 2.85 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 144' ' ' ILE . 26.4 mm 66.38 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.093 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 29.9 m-20 -63.58 -51.15 66.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.598 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 46.88 29.09 0.94 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -98.27 -1.23 42.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.288 0.566 . . . . 0.0 111.236 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.49 -59.1 4.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.142 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.463 HD23 ' SD ' ' A' ' 133' ' ' MET . 4.0 mp -90.4 148.07 23.04 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 139' ' ' TYR . 29.0 m -126.72 116.06 22.58 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.242 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 175' ' ' ILE . 61.8 Cg_endo -71.73 149.94 55.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.483 2.122 . . . . 0.0 111.218 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 175' ' ' ILE . . . -132.4 -31.82 1.38 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.974 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -117.03 -134.16 5.21 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.993 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.601 HD12 HD11 ' A' ' 96' ' ' LEU . 22.6 pt -126.08 160.36 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.399 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.62 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.5 m-20 -111.78 158.03 19.85 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.1 132.31 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.785 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.9 153.72 38.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.379 0.609 . . . . 0.0 111.808 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.597 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 34.3 t -97.99 151.19 37.43 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.893 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.461 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 61.3 Cg_endo -70.28 59.18 1.87 Allowed 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.281 2.654 . . . . 0.0 112.684 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -88.72 -172.33 3.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.259 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -134.31 94.86 3.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.92 -119.99 4.1 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.689 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -127.82 140.99 51.7 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -135.37 167.0 21.84 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.846 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HE2' HG22 ' A' ' 127' ' ' VAL . 20.3 tptm -55.25 128.33 33.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.137 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -132.58 130.59 40.49 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.298 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -98.94 162.34 13.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 121.701 0.762 . . . . 0.0 112.996 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 131' ' ' ALA . 50.0 mm -118.09 130.16 73.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.696 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.6 ttp -127.9 137.97 52.5 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.6 t -110.1 130.39 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.073 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.5 pt -113.74 172.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.018 0.437 . . . . 0.0 110.503 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.7 9.98 31.05 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.311 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.426 ' HB2' HD12 ' A' ' 171' ' ' ILE . 35.6 mt-10 -101.65 129.04 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.804 0.811 . . . . 0.0 111.247 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.75 150.76 20.34 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.508 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.497 HD11 ' O ' ' A' ' 151' ' ' PRO . 23.3 pt -133.79 155.4 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.952 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.08 127.32 54.77 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.635 0.255 . . . . 0.0 110.483 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -84.41 109.36 17.81 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 183' ' ' ASP . 94.5 mt -85.63 115.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.537 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -119.73 -18.72 8.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.319 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.6 p -128.38 167.21 17.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.33 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -59.72 -38.9 82.94 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.847 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.54 -39.96 92.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.605 ' HB2' HG23 ' A' ' 178' ' ' ILE . 71.7 m-20 -62.44 -42.0 99.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.296 0.569 . . . . 0.0 109.871 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.48 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.2 tp -62.12 -43.96 97.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.291 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.585 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 6.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.24 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 10.1 tt -62.46 -46.09 90.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.58 99.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.759 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.74 -31.88 72.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.533 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -64.32 -39.74 94.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.642 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 87.4 mt -63.77 -43.68 95.69 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 0.0 109.624 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.78 -39.28 93.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.418 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.82 -45.66 93.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.316 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -62.41 -41.84 98.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.824 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.28 11.52 18.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.273 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.87 8.38 79.93 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 68.7 tp . . . . . 0 C--O 1.265 1.914 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.896 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.856 0.36 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 35.5 m-20 -106.28 166.12 10.75 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.26 129.83 55.7 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.94 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 98' ' ' VAL . 25.5 tp -105.31 125.23 50.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.0 mt -117.1 103.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.512 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 58.2 ttm -83.04 96.84 8.48 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-O 121.711 0.767 . . . . 0.0 110.887 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.96 97.69 6.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -98.41 0.12 Allowed Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.662 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.08 168.25 51.86 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.703 -176.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -168.32 -36.07 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.52 179.73 51.5 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p -90.58 130.54 36.6 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.394 0.597 . . . . 0.0 112.415 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 58.68 -91.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.7 mtp -108.72 151.79 25.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.106 0.479 . . . . 0.0 112.032 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.65 89.85 1.5 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.03 61.18 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.961 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.446 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 39.2 t 56.32 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.732 0.813 . . . . 0.0 112.51 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.01 93.3 3.25 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.86 -0.525 . . . . 0.0 111.864 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.625 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 2.5 mppt? -105.81 -60.11 0.05 OUTLIER Pre-proline 0 C--O 1.219 -0.518 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.284 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 19' ' ' LYS . 24.2 Cg_exo -65.4 -24.12 57.57 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.318 2.012 . . . . 0.0 112.869 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 42.8 mt -97.02 14.87 24.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.0 mt -75.3 114.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.6 ptmm? -85.45 125.04 32.71 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.82 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 62.4 tp -126.38 115.68 20.01 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.94 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.9 t 58.84 19.19 6.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.975 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.3 -62.92 0.54 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.253 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.704 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 96.2 mtt180 -104.85 167.47 9.69 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 117.508 0.654 . . . . 0.0 111.476 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 76.1 m -82.15 160.84 23.0 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.704 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 19' ' ' LYS . 90.1 mt -59.41 -39.65 84.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.949 0.155 . . . . 0.0 111.246 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.7 tp -57.04 -46.1 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.704 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 11.4 t70 -64.87 -41.64 95.49 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.138 0.494 . . . . 0.0 110.403 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 27' ' ' ARG . 18.8 m-85 -64.4 -34.34 77.95 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' LEU . 77.0 t -66.99 -43.87 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 121.327 0.584 . . . . 0.0 110.206 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 30' ' ' ILE . 79.0 t -63.35 -41.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.38 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -51.28 -55.93 24.57 Favored Pre-proline 0 CA--C 1.565 1.547 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 45.8 Cg_endo -69.23 -36.1 12.88 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 121.573 1.516 . . . . 0.0 112.491 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.634 HD11 HG11 ' A' ' 98' ' ' VAL . 99.4 mt -67.46 -41.79 84.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.642 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.48 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.8 tt -63.0 -44.54 95.73 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.049 0.452 . . . . 0.0 110.886 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 22.1 ptmt -75.26 -12.31 60.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.0 p -71.24 -178.9 2.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.144 0.497 . . . . 0.0 110.588 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -76.51 0.32 20.34 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.67 159.38 5.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -77.35 -73.18 0.31 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.755 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -121.17 159.46 25.8 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.171 0.51 . . . . 0.0 111.132 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.16 116.31 50.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.11 114.95 29.11 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.637 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -95.03 117.8 39.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.501 0.667 . . . . 0.0 110.182 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.1 119.68 28.72 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.219 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 7' ' ' ALA . 77.6 p -129.88 166.86 19.13 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.565 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.5 p -131.3 158.84 74.12 Favored Pre-proline 0 C--N 1.298 -1.65 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.856 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.23 -19.79 65.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.809 2.339 . . . . 0.0 111.435 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.63 -13.9 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.881 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -142.09 67.16 21.63 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 85.6 Cg_endo -104.29 86.58 0.03 OUTLIER 'Trans proline' 1 N--CA 1.385 -4.863 0 C-N-CA 116.827 -1.649 . . . . 0.0 110.108 169.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 73.6 mmtt -146.96 -47.51 0.18 Allowed 'General case' 1 C--N 1.222 -4.964 0 CA-C-N 110.08 -3.236 . . . . 0.0 103.405 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.445 HG21 ' HB1' ' A' ' 7' ' ' ALA . 99.8 m -61.93 -48.59 79.73 Favored 'General case' 0 N--CA 1.379 -3.996 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.16 -50.68 69.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.558 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.3 pt-20 -64.36 -26.39 68.45 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 117.098 -1.841 . . . . 0.0 112.879 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -70.52 -51.23 30.21 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.277 0.561 . . . . 0.0 111.483 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.637 HD13 HG21 ' A' ' 47' ' ' ILE . 94.5 mt -63.55 -43.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.493 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.73 -45.01 82.2 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.495 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.0 t -69.18 -42.28 76.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.631 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.05 93.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.199 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 70.9 m-85 -114.61 41.61 2.3 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.39 -176.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.0 mmmm -58.93 -37.01 75.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.131 0.491 . . . . 0.0 110.951 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -83.52 11.9 6.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.478 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 49.8 p90 -44.46 130.65 6.63 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 68' ' ' LYS . 3.6 tmmm? -102.55 -48.28 4.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.21 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.48 HD21 ' HG ' ' A' ' 38' ' ' LEU . 24.1 p-10 -118.12 7.89 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.251 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.1 mp -100.09 116.34 43.21 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.1 t -117.7 130.74 72.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.77 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -104.09 127.69 58.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.5 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.1 pt -120.85 153.3 24.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.331 0.586 . . . . 0.0 110.959 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.08 131.21 56.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.841 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 t -166.67 -166.22 0.83 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 67.5 m -57.58 1.5 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 126.965 2.106 . . . . 0.0 115.344 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -33.07 -12.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.069 0 C-N-CA 126.048 1.785 . . . . 0.0 116.587 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -58.13 -38.96 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' HA3' ' OE2' ' A' ' 82' ' ' GLU . . . -114.92 131.83 10.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.08 -51.33 69.58 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.067 0.433 . . . . 0.0 111.957 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.6 pt -79.45 -25.99 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.199 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 47.1 mt-10 -62.18 -44.73 95.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 10.6 t0 -63.45 -48.57 77.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.18 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -54.82 -46.96 74.62 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.792 178.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' HG12 ' A' ' 88' ' ' ILE . 29.1 m-80 -61.43 -40.5 94.68 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.861 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 76.8 mm-40 -63.36 -45.66 90.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.135 0.493 . . . . 0.0 109.744 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.572 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 98.0 m -63.07 -42.2 99.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.526 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 84' ' ' LEU . 36.4 pt -64.83 -28.73 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.37 -20.24 75.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.302 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -103.78 -28.25 11.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.563 0.682 . . . . 0.0 112.786 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.572 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 71.8 m-85 -77.24 141.28 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -105.87 -1.95 23.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.507 0.67 . . . . 0.0 109.868 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 40.4 mt-10 -132.99 160.0 70.44 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 41.6 Cg_endo -67.65 145.46 69.94 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.729 1.619 . . . . 0.0 110.761 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.1 157.98 44.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.61 0.719 . . . . 0.0 111.488 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 154' ' ' ILE . 26.6 tp -87.43 141.46 28.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.457 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 94.0 t -112.87 130.92 65.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -128.82 168.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.283 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.2 m -98.45 144.61 27.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.013 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 6' ' ' MET . 88.0 p -73.16 -12.51 60.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -174.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 7.9 p-10 -116.9 11.67 14.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.38 157.2 30.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.74 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -116.64 174.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.003 0.43 . . . . 0.0 111.911 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -62.31 178.42 0.4 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.829 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.3 mt 81.47 5.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.576 1.15 . . . . 0.0 109.893 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 48.5 mmtm -98.69 1.88 46.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.288 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.736 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.2 p -58.01 -35.29 71.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.92 -29.69 62.17 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.169 0.985 . . . . 0.0 108.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.613 ' O ' HG12 ' A' ' 113' ' ' ILE . 25.7 mm -64.59 -38.69 83.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' A' ' 107' ' ' SER . 73.8 mt -59.31 -45.31 93.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.307 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -61.31 -43.62 98.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.96 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.0 m -64.73 -41.68 95.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.591 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.9 mm -62.86 -45.51 98.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.27 0.557 . . . . 0.0 109.873 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.432 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 53.8 t -60.44 -47.34 92.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.355 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.9 -47.61 85.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.03 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.613 ' CE2' HD11 ' A' ' 120' ' ' ILE . 54.3 t80 -64.56 -45.76 85.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.88 0.372 . . . . 0.0 110.554 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.27 -48.8 80.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.106 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.3 m-85 -62.81 -36.24 82.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.897 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.78 -41.59 97.92 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.3 mt -68.96 -46.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -68.22 -27.68 66.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.062 -177.575 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.23 99.34 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -83.92 -38.24 21.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.387 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.1 m -126.65 96.45 35.47 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.643 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.66 -15.61 48.03 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 122.804 2.336 . . . . 0.0 112.349 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.67 -32.08 73.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.814 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 116.45 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.835 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.555 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 38.7 mt-10 -126.72 14.07 7.49 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.113 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.91 31.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.404 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.5 tp -140.83 143.27 34.7 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.178 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.18 143.21 50.65 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.279 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 154' ' ' ILE . 12.1 p -123.24 133.27 69.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.159 0.504 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 71.5 mtm -134.01 157.04 47.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.361 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 171' ' ' ILE . 7.7 pt -127.8 151.81 76.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.788 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.64 141.54 95.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.55 2.167 . . . . 0.0 112.448 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.06 -38.76 80.16 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.02 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.03 -37.63 85.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.726 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.05 -22.63 33.46 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.414 0.626 . . . . 0.0 111.322 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -59.57 134.66 89.02 Favored Pre-proline 0 C--N 1.291 -1.977 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.607 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.01 -32.7 98.05 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.871 2.381 . . . . 0.0 113.001 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -144.54 90.44 6.51 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.37 144.18 45.07 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.23 2.62 . . . . 0.0 112.608 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.2 m -82.79 90.53 6.92 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.003 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 pt -81.37 87.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.887 0.851 . . . . 0.0 110.307 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -153.65 -58.26 0.12 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.929 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.95 6.5 6.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.878 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 55.69 -115.49 0.94 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.784 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.86 -152.96 52.78 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.021 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.4 147.72 45.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.85 150.94 42.03 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.26 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.487 ' O ' HD11 ' A' ' 175' ' ' ILE . 52.6 Cg_exo -58.82 144.56 98.4 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.003 2.469 . . . . 0.0 111.725 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.515 ' CB ' HG23 ' A' ' 134' ' ' ILE . . . -103.69 -15.42 15.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 170.11 -89.14 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.39 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 96' ' ' LEU . 22.3 pt -133.85 159.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.113 0.483 . . . . 0.0 111.722 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.63 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.4 m-20 -122.57 157.77 31.38 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.51 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.12 127.95 72.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 122.322 -0.236 . . . . 0.0 110.745 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.68 151.23 25.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.245 0.545 . . . . 0.0 111.795 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.522 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 88.8 p -97.29 169.78 8.16 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 37.4 Cg_endo -67.88 67.69 0.88 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.906 1.738 . . . . 0.0 110.978 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.541 ' HB3' ' NE2' ' A' ' 164' ' ' GLN . 61.0 pttt -67.15 123.42 20.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.016 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -62.44 -43.03 99.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.547 0.689 . . . . 0.0 109.197 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 160' ' ' LYS . . . -128.77 -177.31 14.81 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -72.31 128.46 35.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 118.066 0.933 . . . . 0.0 108.629 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.555 ' OE1' ' HB2' ' A' ' 128' ' ' GLU . 29.9 pt20 -117.8 168.09 10.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.586 -169.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -56.91 121.0 8.88 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 110.086 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.62 130.65 52.98 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.9 161.64 14.4 Favored 'General case' 0 CA--C 1.471 -2.07 0 CA-C-O 121.976 0.893 . . . . 0.0 112.954 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.6 mm -118.44 129.6 74.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 113.713 -1.585 . . . . 0.0 111.583 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 62.0 ttp -129.72 134.14 47.45 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.332 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 133' ' ' MET . 49.8 t -112.14 126.47 69.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 173' ' ' GLU . 47.8 pt -113.47 175.82 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.056 0.455 . . . . 0.0 111.052 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -111.18 16.07 21.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.32 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.692 ' HB2' HD12 ' A' ' 171' ' ' ILE . 75.0 mm-40 -98.76 133.28 43.3 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.672 0.749 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.0 mt -97.09 149.5 21.89 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.514 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 151' ' ' PRO . 12.9 pt -127.73 155.83 39.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.863 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.6 112.3 24.1 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.541 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.437 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 7.8 t-20 -95.13 103.67 15.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.015 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.475 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 1.9 mp -81.92 113.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.521 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.91 -22.48 7.89 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 64.9 p -130.37 165.87 21.63 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.163 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.8 mppt? -65.98 -28.39 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 109.777 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.46 -42.35 98.64 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.227 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 49.3 m-20 -61.3 -41.03 96.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 109.535 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.403 ' CD1' HD13 ' A' ' 24' ' ' LEU . 59.2 tp -61.62 -45.05 95.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 30.4 mmmt -62.47 -39.87 94.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.501 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.01 -45.99 89.76 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.83 -42.78 97.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.472 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.9 OUTLIER -70.59 -34.68 72.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.757 0.313 . . . . 0.0 111.674 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.5 ttm -62.35 -43.38 98.96 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.301 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.1 pp -69.72 -37.94 76.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.87 -42.72 97.44 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.315 0.578 . . . . 0.0 110.385 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.74 -40.98 98.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.763 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.6 -42.02 91.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.614 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -84.63 -9.59 58.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.071 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.33 -39.79 97.73 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.359 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.269 2.11 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.445 179.2 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.612 ' O ' HG23 ' A' ' 42' ' ' VAL . 59.8 ttm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 1' ' ' MET . 52.6 m-20 -105.73 160.73 14.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.523 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -122.51 140.43 52.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.692 -177.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 98' ' ' VAL . 28.9 tp -112.42 123.73 50.93 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.362 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.721 ' HA ' HG22 ' A' ' 98' ' ' VAL . 55.1 mt -116.46 104.94 17.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.439 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 11.8 ptm -95.25 97.39 9.83 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.738 1.256 . . . . 0.0 112.465 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -115.94 96.98 5.84 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.094 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.582 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 CA--C 1.531 0.374 0 N-CA-C 112.866 0.294 . . . . 0.0 112.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 56' ' ' THR . 43.4 mt -94.64 10.99 32.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.38 118.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -98.35 142.41 30.02 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.267 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.7 tp -137.21 115.87 12.1 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.106 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.1 m 56.06 24.14 7.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.57 2.22 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.01 -1.567 . . . . 0.0 115.436 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.703 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 69.5 mtt-85 -126.03 159.57 32.4 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 118.353 1.077 . . . . 0.0 111.059 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 72.7 m -83.85 157.99 21.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 101' ' ' ASP . 0.6 OUTLIER -46.7 -53.29 12.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 7' ' ' ALA . 12.4 tt -62.07 -36.4 73.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HA ' HG12 ' A' ' 34' ' ' VAL . 12.7 t70 -63.02 -40.51 97.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.703 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 25.1 m-85 -64.69 -37.17 86.68 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.573 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.37 -47.76 83.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.036 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 31' ' ' ASP . 12.2 p -72.1 -35.15 52.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.551 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 35.1 t -53.9 -54.08 50.81 Favored Pre-proline 0 CA--C 1.562 1.438 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 46.0 Cg_exo -61.45 -39.34 56.67 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.002 1.801 . . . . 0.0 112.023 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.45 HD12 HD11 ' A' ' 5' ' ' ILE . 81.2 mt -63.67 -42.08 98.1 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.459 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.487 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.9 tt -60.01 -45.79 91.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.0 -12.07 59.44 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.523 ' OG ' HG12 ' A' ' 42' ' ' VAL . 72.7 p -76.49 -175.86 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -51.48 -33.77 32.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.666 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 1' ' ' MET . 7.5 p -69.05 140.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 121.444 0.64 . . . . 0.0 111.616 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -83.6 -69.75 0.61 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.285 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -101.23 146.46 27.49 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.357 0.599 . . . . 0.0 111.156 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.429 HG21 HG23 ' A' ' 34' ' ' VAL . 47.7 mm -110.98 116.87 53.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.845 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 96.1 m-85 -103.39 114.96 29.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.759 HG21 HD13 ' A' ' 60' ' ' ILE . 88.0 mt -98.96 118.34 45.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.649 0.738 . . . . 0.0 110.482 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.33 124.36 33.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.374 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.1 p -132.2 168.63 17.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.213 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.1 m -129.89 155.01 81.21 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.506 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.63 -21.47 65.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.925 2.416 . . . . 0.0 111.044 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.16 -13.12 60.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.453 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -142.37 66.47 19.4 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.63 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 76.4 Cg_endo -107.99 87.0 0.02 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.591 0 CA-C-N 120.884 1.351 . . . . 0.0 111.363 170.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.5 mmtm -151.01 -44.58 0.12 Allowed 'General case' 1 C--N 1.221 -5.001 0 CA-C-N 109.599 -3.455 . . . . 0.0 102.649 176.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' HD11 ' A' ' 21' ' ' LEU . 74.9 m -62.68 -49.51 74.83 Favored 'General case' 0 N--CA 1.387 -3.615 0 CA-C-N 113.022 -1.899 . . . . 0.0 105.974 161.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.23 -50.26 70.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.628 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.668 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.5 pt-20 -62.14 -30.26 70.91 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 116.517 -2.073 . . . . 0.0 112.573 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.01 -50.31 66.81 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.759 HD13 HG21 ' A' ' 47' ' ' ILE . 85.5 mt -60.62 -45.03 98.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.154 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -56.54 -45.53 81.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.634 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 70.1 m -71.1 -41.62 70.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.136 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.28 86.28 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 111.381 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.443 ' OH ' HG11 ' A' ' 34' ' ' VAL . 34.9 m-85 -115.99 39.79 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.952 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.2 mtmt -61.12 -29.04 69.53 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.131 0.491 . . . . 0.0 110.828 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.59 10.31 13.58 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 51.6 p90 -35.69 113.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.44 -48.61 5.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.487 HD21 ' HG ' ' A' ' 38' ' ' LEU . 20.1 p-10 -117.54 5.26 12.43 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 4.5 mp -95.11 122.58 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 75.8 t -124.01 128.49 74.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -105.82 129.13 59.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.363 0.601 . . . . 0.0 109.71 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.8 pt -121.88 156.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.293 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.89 128.58 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -158.72 -168.14 2.32 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-O 121.728 0.775 . . . . 0.0 112.916 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -69.06 1.48 3.5 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 126.184 1.794 . . . . 0.0 114.198 -176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.07 -20.35 0.0 OUTLIER Glycine 1 N--CA 1.521 4.365 0 C-N-CA 126.192 1.854 . . . . 0.0 116.903 -176.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -56.81 -38.05 72.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.51 127.81 8.5 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -60.9 -51.19 70.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 0.0 112.099 -172.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.3 pt -76.9 -27.43 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.485 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 50.7 mt-10 -63.36 -44.49 94.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.615 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 20.5 t0 -62.51 -50.69 70.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.278 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.5 mm? -54.55 -46.28 73.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.631 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.498 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.1 m-80 -59.92 -42.99 95.15 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.385 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 28.9 mm-40 -65.18 -47.18 77.86 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.93 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.4 m -63.35 -42.56 98.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.329 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 84' ' ' LEU . 40.7 pt -65.87 -28.43 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.15 -10.65 85.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.775 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -109.17 -24.62 11.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 159' ' ' PRO . 76.9 m-85 -82.11 148.48 28.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.038 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 m -96.36 -12.28 24.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 111.153 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.02 158.77 66.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.588 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.71 141.84 33.72 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.384 2.723 . . . . 0.0 112.15 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.14 157.02 45.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.715 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 154' ' ' ILE . 23.7 tp -87.83 143.2 27.26 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.733 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 72.6 t -113.11 129.64 68.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -132.26 160.57 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.136 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 51.2 m -100.38 137.11 39.25 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.5 p -77.05 -10.46 59.39 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.499 ' HA ' HD22 ' A' ' 29' ' ' LEU . 19.6 p-10 -99.19 9.61 43.09 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 175' ' ' ILE . 61.2 mt -91.52 115.9 28.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 85.4 mt -108.03 119.81 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 110.703 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 65.8 t30 170.04 153.15 0.05 OUTLIER 'General case' 0 C--O 1.247 0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.31 117.5 14.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -95.84 -1.37 49.65 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.462 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -56.36 -38.87 72.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.74 -25.61 32.72 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.045 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.531 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.5 mm -71.32 -43.72 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.658 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 40' ' ' SER . 60.2 mt -60.07 -48.48 87.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.126 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -64.64 -42.11 95.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.439 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -66.18 -43.0 88.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.538 HG13 ' CG1' ' A' ' 154' ' ' ILE . 38.7 mm -63.45 -48.62 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 120.907 0.384 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.483 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 66.3 t -61.29 -47.8 91.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.702 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -47.49 84.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.655 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.508 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.3 t80 -63.13 -44.26 96.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.375 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 58.4 t80 -58.39 -48.11 81.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 28.2 m-85 -63.1 -35.19 79.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.62 -40.35 96.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.121 0.486 . . . . 0.0 109.899 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 116' ' ' TYR . 80.0 mt -64.28 -45.73 95.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.688 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -62.68 -37.26 85.73 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.102 0.477 . . . . 0.0 110.672 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.98 88.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.288 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -83.84 -38.84 20.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.45 . . . . 0.0 111.314 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.3 m -130.07 94.1 31.82 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.184 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.05 -22.97 58.27 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.313 2.675 . . . . 0.0 113.126 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.49 -28.51 70.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.407 HG22 ' HE3' ' A' ' 165' ' ' LYS . 74.9 t -70.26 126.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.64 -13.18 10.23 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.224 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 166' ' ' GLU . . . -140.67 157.04 46.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.4 . . . . 0.0 111.777 -177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 1.2 tm? -136.17 135.69 39.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.27 132.27 48.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 154' ' ' ILE . 14.1 p -114.66 126.56 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.92 160.99 41.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 152' ' ' ALA . 12.5 pt -132.73 147.41 65.41 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.632 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 C--O 1.239 0.532 0 C-N-CA 122.413 2.075 . . . . 0.0 111.769 177.536 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 CA--C 1.517 -0.292 0 N-CA-C 110.646 -0.131 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.06 141.13 75.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.099 1.866 . . . . 0.0 110.567 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' A' ' 171' ' ' ILE . . . -90.36 -8.11 51.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.426 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.85 -86.58 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.637 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.618 HG22 HG12 ' A' ' 98' ' ' VAL . 28.0 pt -123.75 160.17 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.217 0.532 . . . . 0.0 112.086 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.679 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.9 t-20 -128.61 151.99 48.85 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.469 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.6 t -123.43 131.04 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.522 0.201 . . . . 0.0 110.932 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.64 150.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.7 p -87.85 154.2 52.68 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' PHE . 67.2 Cg_endo -84.11 84.92 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.514 2.143 . . . . 0.0 113.307 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -130.81 -179.55 5.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.394 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -105.55 98.43 8.13 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.95 -170.29 21.32 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.845 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -96.62 150.01 21.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.776 0.322 . . . . 0.0 110.224 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.89 165.9 23.57 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.683 -171.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HE3' HG22 ' A' ' 127' ' ' VAL . 65.0 tttp -64.03 124.71 22.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 44.2 tt0 -120.62 132.9 55.36 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.114 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.28 161.3 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 121.559 0.695 . . . . 0.0 112.057 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.8 mm -118.36 129.04 75.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.566 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.4 ' CE ' HD13 ' A' ' 113' ' ' ILE . 58.4 ttp -132.06 136.63 47.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.35 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.84 130.26 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.649 HD11 ' HB1' ' A' ' 152' ' ' ALA . 49.4 pt -120.33 175.45 4.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.766 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -120.09 24.09 10.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.586 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HB2' HD12 ' A' ' 171' ' ' ILE . 2.3 mp0 -99.4 131.95 45.07 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.41 149.9 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.499 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.724 HD12 HD22 ' A' ' 102' ' ' LEU . 2.4 pt -119.59 148.89 22.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.644 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.51 118.24 33.2 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.469 HD21 HD23 ' A' ' 102' ' ' LEU . 1.9 m-20 -107.62 149.18 28.38 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.151 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.83 121.98 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.855 0.359 . . . . 0.0 111.507 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -130.12 -30.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.108 0.48 . . . . 0.0 110.406 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 t -140.92 -178.4 5.54 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.235 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -61.52 -41.79 97.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.381 0.672 . . . . 0.0 112.623 -175.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.4 -38.15 86.02 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.21 -40.6 94.58 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.273 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.81 -43.68 98.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 13.4 tmtt? -62.23 -44.23 97.04 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.534 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.66 -50.58 73.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.291 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.09 -39.91 90.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.458 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.2 pp20? -67.11 -28.69 68.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.336 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.6 mmm -63.26 -40.92 98.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.8 pp -71.3 -37.39 71.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.476 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.53 -39.73 94.3 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.804 0.812 . . . . 0.0 109.509 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt . . . . . 0 C--N 1.308 -1.23 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.659 177.525 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.1 tpp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -110.49 166.6 10.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.528 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -113.09 139.93 48.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.242 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -119.51 114.55 22.45 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.655 ' HA ' HG22 ' A' ' 98' ' ' VAL . 69.0 mt -118.55 106.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.427 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.5 ptm -98.92 104.36 16.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.815 1.293 . . . . 0.0 112.621 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.57 6.14 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.165 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.491 178.641 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 N--CA 1.476 0.497 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.2 mt -89.15 13.04 14.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 94.8 mt -70.39 119.18 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 63.0 pttt -102.79 137.2 41.31 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-O 122.243 1.02 . . . . 0.0 113.123 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.32 131.68 50.39 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.174 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' ' HE3' ' A' ' 192' ' ' LYS . 83.7 m 53.48 32.36 13.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.77 -17.4 49.57 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.843 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 92.4 mtt180 -128.61 152.38 48.41 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 119.018 1.409 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 81.7 m -74.87 162.84 28.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.319 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 100' ' ' SER . 84.0 mt -58.73 -40.89 85.11 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.144 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 60' ' ' ILE . 5.1 tp -58.08 -44.45 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.443 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.741 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 13.1 t70 -65.06 -43.57 91.82 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.97 0.414 . . . . 0.0 111.23 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.843 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 32.5 m-85 -67.33 -26.39 66.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.481 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.7 t -73.7 -46.79 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.47 173.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.09 -47.72 88.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 66.1 m -54.61 -50.35 86.04 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HG2' ' NZ ' ' A' ' 106' ' ' LYS . 78.3 Cg_exo -57.69 -42.59 58.44 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.75 1.634 . . . . 0.0 112.109 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.658 HD11 HG11 ' A' ' 98' ' ' VAL . 90.0 mt -67.51 -39.48 85.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD12 HD21 ' A' ' 69' ' ' ASN . 61.8 tp -57.15 -43.68 82.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.44 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 35' ' ' SER . 19.0 ptpt -88.74 -6.15 57.62 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.525 ' OG ' HG12 ' A' ' 42' ' ' VAL . 57.6 p -81.55 -176.96 6.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.727 0.775 . . . . 0.0 112.212 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -63.63 -16.14 60.12 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.372 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 3' ' ' ALA . 13.3 p -75.28 147.69 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 122.189 -0.32 . . . . 0.0 111.691 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.03 -75.58 0.35 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -100.19 147.2 25.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.972 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.03 112.08 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.609 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -104.45 114.56 28.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 5' ' ' ILE . 96.7 mt -97.26 116.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.674 0.749 . . . . 0.0 110.853 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.3 121.77 30.19 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.386 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 7' ' ' ALA . 53.2 p -132.69 162.38 31.54 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.414 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.6 m -117.87 154.75 51.33 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.444 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 29.1 Cg_endo -63.38 -18.86 66.58 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.028 2.485 . . . . 0.0 110.842 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -70.89 -20.72 62.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.084 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 p -137.59 66.69 50.59 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.741 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.708 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 63.2 Cg_endo -103.55 85.43 0.03 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.603 0 C-N-CA 116.974 -1.55 . . . . 0.0 110.162 170.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.641 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.1 ttpt -154.63 -47.24 0.09 Allowed 'General case' 1 C--N 1.211 -5.436 0 CA-C-N 109.393 -3.549 . . . . 0.0 102.27 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -63.42 -48.74 76.56 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 162.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.708 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.74 -50.4 71.24 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.834 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -63.6 -32.5 73.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 116.485 -2.086 . . . . 0.0 112.472 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.36 -51.21 64.44 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.192 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 30' ' ' ILE . 96.9 mt -64.91 -46.27 92.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.98 -175.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.4 -41.82 90.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 39.7 t -67.95 -42.87 80.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.508 0.671 . . . . 0.0 110.387 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.92 89.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.339 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.61 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 71.8 m-85 -112.0 18.26 18.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 62' ' ' SER . 64.6 pttt -65.03 -17.47 64.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.62 2.66 52.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' HA ' ' A' ' 64' ' ' TYR . 74.5 m-85 -102.66 130.38 49.55 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.076 -0.39 . . . . 0.0 111.137 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.15 60.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.384 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.453 HD21 HD12 ' A' ' 38' ' ' LEU . 21.6 p-10 -85.97 2.09 47.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.03 123.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.5 135.1 65.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.93 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.92 129.1 58.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 48' ' ' ALA . 42.9 pt -122.27 156.64 27.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.366 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.84 133.11 56.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.528 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.0 t -167.06 -167.29 0.91 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 52.6 m -64.08 1.17 0.74 Allowed 'General case' 0 C--O 1.197 -1.698 0 C-N-CA 126.826 2.05 . . . . 0.0 114.6 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.54 -28.21 0.01 OUTLIER Glycine 0 N--CA 1.515 3.922 0 C-N-CA 125.604 1.573 . . . . 0.0 116.713 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -56.12 -33.0 64.74 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.65 115.85 4.0 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -58.39 -50.72 72.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.2 -46.02 92.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.55 0.691 . . . . 0.0 110.742 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.48 -42.38 96.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.595 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.51 -50.1 74.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.901 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -57.06 -44.05 82.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' HG12 ' A' ' 88' ' ' ILE . 11.4 m120 -60.7 -42.3 96.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.41 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.19 -45.22 89.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.145 0.498 . . . . 0.0 110.572 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.615 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 95.5 m -64.65 -41.77 95.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.089 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 84' ' ' LEU . 39.2 pt -68.45 -31.02 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 121.98 -0.45 . . . . 0.0 110.952 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.86 95.55 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.158 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -101.94 9.78 40.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.615 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 62.8 m-85 -112.62 150.57 31.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.82 0.343 . . . . 0.0 111.823 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -102.41 -6.68 22.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.295 0.569 . . . . 0.0 109.951 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -125.49 156.76 69.98 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.432 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.89 153.6 42.49 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.622 2.215 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.92 152.55 43.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 0.0 112.657 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 155' ' ' ASN . 2.4 tm? -86.31 124.01 32.2 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.177 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 57.8 t -99.04 130.8 47.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 123.395 0.678 . . . . 0.0 109.805 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.658 HG11 HD11 ' A' ' 37' ' ' LEU . 13.3 m -129.37 166.38 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 121.871 0.843 . . . . 0.0 112.454 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.5 m -98.85 157.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.937 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 81.2 p -88.94 -6.25 57.4 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.309 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -117.59 9.96 13.3 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.96 122.32 31.43 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.073 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 103' ' ' ILE . 28.0 pt -122.47 101.51 10.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.663 0.744 . . . . 0.0 111.516 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -160.01 177.71 10.46 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.401 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.29 59.6 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.735 0.779 . . . . 0.0 109.93 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.777 ' HA ' HD12 ' A' ' 109' ' ' ILE . 16.9 pttp -69.72 -3.69 16.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.79 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -59.17 -41.9 89.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.544 ' HD3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -88.6 -23.16 23.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.812 0.815 . . . . 0.0 110.566 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.777 HD12 ' HA ' ' A' ' 106' ' ' LYS . 74.2 mt -64.34 -38.79 83.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.882 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.1 mt -55.44 -47.85 77.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.769 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -63.69 -41.34 98.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.462 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.6 m -63.43 -39.8 95.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.749 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.2 mm -61.28 -47.69 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.041 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.502 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 67.9 t -60.43 -48.07 89.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.263 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.77 -47.64 84.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.607 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CE2' HD11 ' A' ' 120' ' ' ILE . 75.0 t80 -61.43 -48.24 82.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.658 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -59.56 -47.59 84.95 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.246 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.8 m-85 -61.82 -37.94 86.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.331 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.7 t -61.12 -46.43 90.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.399 0.619 . . . . 0.0 109.908 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.593 HD11 ' CE2' ' A' ' 116' ' ' TYR . 80.0 mt -62.46 -45.98 97.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -62.85 -37.44 86.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.994 0.426 . . . . 0.0 110.833 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.49 91.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.398 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -81.27 -36.02 30.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.071 0.462 . . . . 0.0 111.206 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.7 m -139.89 100.1 7.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.169 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.03 -16.72 53.46 Favored 'Trans proline' 0 N--CA 1.481 0.775 0 C-N-CA 123.087 2.525 . . . . 0.0 113.241 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -69.48 -13.39 62.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.489 HG21 ' CG2' ' A' ' 120' ' ' ILE . 94.3 t -76.85 120.04 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.29 11.85 10.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.504 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.0 23.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -137.0 135.97 38.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.123 -178.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.0 137.78 52.35 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.27 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 113' ' ' ILE . 57.6 t -112.29 116.91 53.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 4.3 ptm -145.46 155.55 43.19 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.956 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 152' ' ' ALA . 24.0 pt -130.03 157.48 76.85 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.919 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 39.5 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 121.763 1.642 . . . . 0.0 111.772 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.91 147.5 55.63 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.198 1.932 . . . . 0.0 111.891 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.657 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -117.45 -6.64 11.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.226 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.05 -116.89 0.39 Allowed Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.48 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 96' ' ' LEU . 22.2 pt -124.55 160.08 29.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 120.7 0.286 . . . . 0.0 111.02 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.608 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.0 m-20 -117.65 159.27 23.21 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.91 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.67 133.46 69.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.88 148.45 31.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.479 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -92.43 149.29 38.02 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.13 75.2 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -104.11 -170.97 1.85 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.171 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -132.33 125.94 32.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.45 -105.99 3.34 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.207 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -147.03 140.5 25.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -133.3 166.96 21.28 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.451 ' HE3' HG22 ' A' ' 127' ' ' VAL . 63.6 tttp -58.47 125.7 24.45 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.828 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.14 128.31 49.08 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.143 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -93.9 163.49 13.48 Favored 'General case' 0 CA--C 1.477 -1.852 0 CA-C-O 121.687 0.756 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.33 130.12 69.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.537 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.558 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 51.3 ttm -112.45 129.85 56.19 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.376 175.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.54 126.32 66.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.2 pt -121.55 174.29 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 112.029 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -111.48 4.89 19.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.059 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 171' ' ' ILE . 34.9 mt-10 -99.34 130.29 45.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 111.03 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.49 151.15 19.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.249 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.99 150.49 31.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.325 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.01 122.82 43.05 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.164 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.415 ' C ' HD12 ' A' ' 178' ' ' ILE . 23.7 p-10 -94.08 168.17 11.11 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.787 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 184' ' ' LEU . 2.0 mp -120.32 121.05 64.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.873 0.368 . . . . 0.0 111.093 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -111.72 -32.34 6.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.422 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.1 t -138.39 176.6 8.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.022 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -64.24 -29.13 70.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.83 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.28 -39.11 91.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.414 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -61.42 -35.76 78.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.388 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 178' ' ' ILE . 96.0 mt -60.68 -43.7 97.4 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.354 0.597 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.644 ' O ' ' HG3' ' A' ' 189' ' ' MET . 60.0 tptt -62.84 -43.61 98.35 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.707 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.56 -48.21 82.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.71 -43.14 99.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.306 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 192' ' ' LYS . 13.2 pt-20 -70.2 -29.59 66.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.932 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -61.44 -39.71 91.83 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -70.67 -33.41 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.96 -40.57 87.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.66 0.743 . . . . 0.0 110.558 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 188' ' ' GLU . 34.8 mmtp . . . . . 0 C--N 1.308 -1.203 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.368 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 64.2 m-20 -97.35 165.91 11.79 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -117.9 130.07 56.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.901 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 48' ' ' ALA . 36.1 tp -100.93 124.72 47.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.369 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.662 ' HA ' HG22 ' A' ' 98' ' ' VAL . 68.5 mt -117.59 104.88 17.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.0 ptm -96.64 107.64 20.12 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.786 1.279 . . . . 0.0 112.505 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -114.92 96.92 5.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.801 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.623 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.654 -179.032 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 44.1 Cg_exo . . . . . 0 N--CA 1.48 0.715 0 CA-C-O 121.348 0.478 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.607 HD21 ' CB ' ' A' ' 59' ' ' TYR . 9.6 mp -83.51 15.71 2.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -69.73 123.19 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -80.75 132.08 35.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.575 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 HD13 HD12 ' A' ' 184' ' ' LEU . 59.8 tp -137.83 125.33 22.06 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.152 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t 58.64 26.17 14.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.278 0.561 . . . . 0.0 110.74 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 -13.85 56.86 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -134.4 169.81 16.68 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 118.945 1.372 . . . . 0.0 111.434 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 75.6 m -85.73 163.79 18.01 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.672 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 82.3 mt -59.43 -39.69 84.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.268 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.3 tp -57.17 -45.17 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.201 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.43 -41.65 93.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.973 0.416 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -61.52 -33.89 74.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.409 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.54 -42.95 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.774 0.321 . . . . 0.0 111.412 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.4 t -63.39 -44.81 99.13 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -52.87 -50.47 81.28 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 28.9 Cg_endo -64.13 -40.95 24.04 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.367 1.378 . . . . 0.0 112.489 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.761 HD11 HG11 ' A' ' 98' ' ' VAL . 88.6 mt -66.7 -37.71 85.26 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.498 0.666 . . . . 0.0 110.436 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.22 -44.12 88.05 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.284 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 36' ' ' PRO . 64.3 pttt -90.32 -3.23 57.89 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.206 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.422 ' CB ' HG21 ' A' ' 110' ' ' ILE . 59.5 p -81.43 -178.9 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.778 0.799 . . . . 0.0 112.997 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -59.94 -25.28 65.05 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 3' ' ' ALA . 30.2 m -64.26 161.78 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.2 t30 -83.38 -76.31 0.29 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.218 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -115.16 157.44 23.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.074 0.464 . . . . 0.0 110.82 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.63 115.89 50.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -107.81 117.32 33.8 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -96.88 119.41 44.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.736 0.779 . . . . 0.0 110.583 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -91.05 121.0 32.48 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.758 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.1 p -132.07 165.81 23.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.44 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.9 p -128.45 157.57 74.36 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.081 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 51.8 Cg_exo -58.2 -25.68 72.91 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.916 2.41 . . . . 0.0 110.963 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -75.46 -14.04 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.712 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -141.76 65.94 21.09 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.8 Cg_endo -106.26 86.72 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.113 0 C-N-CA 117.148 -1.435 . . . . 0.0 109.586 168.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 ttmt -147.83 -50.43 0.18 Allowed 'General case' 1 C--N 1.209 -5.534 0 CA-C-N 109.489 -3.505 . . . . 0.0 101.675 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.514 HG22 HD12 ' A' ' 60' ' ' ILE . 98.0 m -62.52 -48.41 79.65 Favored 'General case' 0 N--CA 1.382 -3.85 0 CA-C-N 111.712 -2.494 . . . . 0.0 106.047 164.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.23 -49.1 77.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.004 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 18.9 pt-20 -56.17 -35.96 67.8 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 117.589 -1.644 . . . . 0.0 110.988 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' HD21 ' A' ' 21' ' ' LEU . 57.7 t80 -70.76 -52.05 23.22 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.744 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 HD12 HG22 ' A' ' 56' ' ' THR . 97.1 mt -63.92 -45.12 97.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.508 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.734 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 49.2 t30 -57.08 -47.33 81.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.907 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 t -71.47 -43.68 66.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.733 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.96 89.32 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.377 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.529 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 95.2 m-85 -104.52 20.16 19.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.734 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtpt -63.32 -23.14 67.28 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 174.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.03 10.02 15.43 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.22 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 45.1 p90 -50.51 148.55 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -103.55 -52.88 2.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.448 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -121.14 16.57 11.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.557 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 79.1 mt -103.87 127.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.54 0.686 . . . . 0.0 111.838 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 69.2 t -125.84 134.0 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.879 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.32 132.7 49.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.189 0.519 . . . . 0.0 109.973 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.51 157.04 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.901 0.857 . . . . 0.0 111.672 -176.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -106.6 133.79 50.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.981 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.8 t -159.75 -168.6 2.3 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 78' ' ' LYS . 65.7 m -77.37 3.28 13.58 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 126.001 1.72 . . . . 0.0 113.725 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.51 -14.56 0.0 OUTLIER Glycine 1 N--CA 1.522 4.372 0 C-N-CA 127.11 2.29 . . . . 0.0 117.992 -174.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.8 tmtt? -59.93 -37.11 78.55 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.68 130.35 8.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.48 -51.04 71.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.484 HD12 ' OH ' ' A' ' 163' ' ' TYR . 45.7 pt -71.32 -36.41 61.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.52 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.37 -40.01 92.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.124 0.488 . . . . 0.0 109.834 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.501 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 19.0 t0 -59.66 -51.03 71.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.962 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.2 mm? -56.34 -45.4 80.41 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.783 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.521 ' HA ' HG12 ' A' ' 88' ' ' ILE . 24.6 m-80 -60.32 -41.31 93.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.597 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 77.4 mm-40 -65.19 -46.06 82.32 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.538 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.4 m -63.02 -43.76 97.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.238 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 84' ' ' LEU . 34.7 pt -67.72 -29.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.822 0.344 . . . . 0.0 110.403 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.31 96.09 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.71 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.5 3.89 50.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.45 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 63.8 m-85 -108.74 143.26 38.1 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.581 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.3 p -102.78 -0.76 30.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.484 . . . . 0.0 111.11 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -133.24 156.75 79.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.864 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.76 146.34 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.409 2.072 . . . . 0.0 111.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.25 161.69 38.28 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.488 0.661 . . . . 0.0 112.362 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.773 HD11 HD12 ' A' ' 154' ' ' ILE . 1.5 tm? -84.81 143.08 29.32 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.222 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.613 ' N ' HD13 ' A' ' 96' ' ' LEU . 99.8 t -119.59 130.15 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.86 0.864 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 37' ' ' LEU . 14.6 m -130.87 161.95 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.207 0.527 . . . . 0.0 112.136 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.8 t -99.37 140.74 33.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -72.24 -10.86 60.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -104.15 9.69 36.15 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.28 122.86 27.96 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 122.086 -0.384 . . . . 0.0 110.931 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 pt -62.98 166.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -89.56 72.53 7.84 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.17 -14.01 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 168.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 25.0 pttm -67.66 -0.44 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.002 -1.908 . . . . 0.0 114.454 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.4 m -58.09 -40.67 81.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -82.49 -23.99 34.41 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.738 0.78 . . . . 0.0 110.303 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.6 mm -64.02 -40.22 88.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.112 -174.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.57 ' HA ' HD11 ' A' ' 154' ' ' ILE . 58.1 mt -57.89 -48.57 83.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.644 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -65.12 -39.75 93.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.58 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.6 m -61.33 -40.16 93.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.634 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -61.8 -49.18 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.695 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 71.4 t -62.85 -47.76 91.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.425 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.12 -45.83 93.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.731 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.628 ' CE2' HD11 ' A' ' 120' ' ' ILE . 62.3 t80 -62.85 -48.38 79.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.813 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.53 -47.64 84.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.363 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.448 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 25.5 m-85 -61.8 -37.77 85.64 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.459 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -63.66 -39.75 95.11 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.277 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.628 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.6 mt -63.35 -46.36 95.69 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.078 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HG2' HG13 ' A' ' 127' ' ' VAL . 52.5 mtmt -61.74 -38.66 88.77 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.908 0.385 . . . . 0.0 111.178 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.6 87.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.398 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -86.93 -35.25 19.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.017 0.437 . . . . 0.0 111.627 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 127' ' ' VAL . 34.4 m -136.88 94.53 12.81 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 122.806 0.443 . . . . 0.0 110.848 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.34 -15.8 31.43 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.388 2.725 . . . . 0.0 113.051 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.9 -32.92 72.37 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.495 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 12.0 p -65.54 132.14 31.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.215 0.531 . . . . 0.0 111.947 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -119.56 -15.79 8.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.167 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.82 160.23 43.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 23.1 tp -134.61 144.26 47.8 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.96 140.73 51.53 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.317 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.557 HG21 ' CD1' ' A' ' 113' ' ' ILE . 84.2 t -118.58 120.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 ptm -145.49 154.62 42.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.787 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 152' ' ' ALA . 28.2 pt -129.87 156.29 79.22 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.382 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.209 1.939 . . . . 0.0 110.739 176.155 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 15.1 m . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 150' ' ' VAL . 48.2 Cg_exo -60.45 142.48 98.12 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.028 2.485 . . . . 0.0 111.166 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HA ' HD11 ' A' ' 175' ' ' ILE . . . -135.25 -30.19 1.05 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.239 0.543 . . . . 0.0 111.431 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.39 -141.91 11.66 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 119.715 -1.231 . . . . 0.0 112.49 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 96' ' ' LEU . 17.6 pt -126.37 160.69 33.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.926 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.0 m-20 -109.53 159.74 16.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.33 132.39 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.34 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.96 152.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.108 0.48 . . . . 0.0 111.513 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.568 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.2 m -97.07 160.12 29.79 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.374 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.5 83.24 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.783 2.322 . . . . 0.0 111.615 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.542 ' HG3' ' HB3' ' A' ' 164' ' ' GLN . 30.8 mmmt -114.31 150.3 34.69 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.864 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.79 -42.45 90.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.788 0.328 . . . . 0.0 110.469 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.01 -148.29 7.28 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.594 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.484 ' OH ' HD12 ' A' ' 81' ' ' ILE . 97.7 m-85 -75.98 149.47 37.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.0 110.893 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.568 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 16.3 pt20 -134.23 167.61 20.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 1.9 tmtm? -60.71 131.4 50.57 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.999 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -134.56 130.58 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.727 0.299 . . . . 0.0 111.69 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -95.08 164.09 13.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.8 mm -119.13 131.69 71.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -135.8 140.66 44.43 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.312 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.9 t -108.38 129.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.398 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.79 170.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 112.01 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 3.05 56.31 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.975 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.487 ' CD ' HD11 ' A' ' 109' ' ' ILE . 12.1 pt-20 -130.09 142.37 50.61 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.815 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.428 ' O ' HD12 ' A' ' 174' ' ' LEU . 2.7 pp -97.23 149.66 21.79 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.625 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 175' ' ' ILE . 2.3 pp -131.41 145.35 35.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.398 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -131.01 149.68 52.5 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -98.39 178.94 4.88 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.97 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.15 119.72 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -125.49 -22.0 4.39 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.386 0.612 . . . . 0.0 109.731 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.1 p -130.03 164.21 24.82 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.521 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.412 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 mppt? -63.28 -35.79 81.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.92 -44.32 94.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.118 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.34 -41.43 96.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.177 0.513 . . . . 0.0 109.647 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 24' ' ' LEU . 53.0 tp -61.19 -47.73 84.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.522 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.629 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 86.6 tttt -68.11 -35.88 78.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.583 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.5 tp -58.5 -48.36 81.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.748 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.474 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.34 -42.45 98.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.274 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.3 -32.38 73.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.848 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -61.87 -44.8 96.09 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.687 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.84 -35.83 67.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.146 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.1 mt -65.11 -41.08 95.26 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.845 0.831 . . . . 0.0 109.845 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 192' ' ' LYS . 41.0 ttmt . . . . . 0 C--N 1.309 -1.154 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.346 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 68.9 m-20 -94.82 166.02 12.19 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -113.8 127.73 56.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.121 0.486 . . . . 0.0 110.519 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.88 121.97 45.15 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.614 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.702 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.9 mt -118.83 114.27 44.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.8 ttm -84.7 97.11 9.47 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-O 121.936 0.874 . . . . 0.0 111.302 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -114.42 100.82 8.6 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.038 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.467 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.974 -178.221 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.482 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 28.5 Cg_endo . . . . . 0 N--CA 1.479 0.65 0 N-CA-C 113.647 0.595 . . . . 0.0 113.647 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' A' ' 56' ' ' THR . 72.7 mt -86.84 23.07 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.6 mt -70.4 116.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.5 pttm -96.24 131.82 42.34 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.205 1.003 . . . . 0.0 112.759 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -128.93 138.54 52.05 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 113.395 -1.729 . . . . 0.0 108.634 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.492 ' SG ' HD13 ' A' ' 191' ' ' LEU . 81.0 m 63.33 -75.65 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.55 0.531 . . . . 0.0 112.263 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.18 0.58 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.669 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 7.7 ptm180 -150.6 170.1 19.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.402 1.101 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 96.3 m -78.07 156.96 29.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -53.01 -46.94 68.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.327 0.651 . . . . 0.0 110.929 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -63.95 -36.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.817 0.341 . . . . 0.0 110.762 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.56 -40.8 97.93 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.539 ' CE2' ' HG2' ' A' ' 27' ' ' ARG . 7.7 m-85 -61.63 -36.75 81.65 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 29' ' ' LEU . 78.9 t -65.77 -42.35 92.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.924 0.392 . . . . 0.0 110.881 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.421 HG23 HD13 ' A' ' 30' ' ' ILE . 74.0 t -64.01 -41.61 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 t -48.04 -56.5 13.49 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 42.4 Cg_endo -67.91 -37.37 15.6 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 121.719 1.612 . . . . 0.0 112.435 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.57 HD11 HG11 ' A' ' 98' ' ' VAL . 82.0 mt -65.52 -42.59 91.86 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' A' ' 69' ' ' ASN . 6.6 tt -61.45 -46.92 88.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.283 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 19.0 ptpt -76.34 -12.8 60.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.1 p -72.17 -178.41 2.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.925 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -70.04 -4.56 21.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.997 -1.002 . . . . 0.0 113.529 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.32 162.07 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.483 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.555 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.1 t30 -80.12 -75.44 0.26 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.201 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.0 161.04 21.6 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.039 0.447 . . . . 0.0 110.8 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 3' ' ' ALA . 46.8 mm -108.99 116.49 52.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.301 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 88.6 m-85 -109.89 118.1 35.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 60' ' ' ILE . 90.2 mt -101.57 118.77 48.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.567 0.699 . . . . 0.0 111.023 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -84.48 117.99 24.01 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.074 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 7' ' ' ALA . 71.5 p -125.26 164.32 20.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -126.53 156.14 73.52 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.491 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 54.4 Cg_exo -58.07 -24.29 65.23 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.98 2.453 . . . . 0.0 111.154 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -70.1 -20.86 63.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.021 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -139.6 67.64 37.06 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.654 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 86.3 Cg_endo -100.76 84.9 0.04 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.618 0 C-N-CA 116.682 -1.745 . . . . 0.0 109.522 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -151.43 -45.78 0.11 Allowed 'General case' 1 C--N 1.213 -5.362 0 CA-C-N 110.311 -3.131 . . . . 0.0 102.938 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.491 ' HA ' HD21 ' A' ' 21' ' ' LEU . 87.4 m -63.6 -46.1 87.34 Favored 'General case' 0 N--CA 1.386 -3.628 0 CA-C-N 112.933 -1.939 . . . . 0.0 105.824 163.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.7 tmtt? -61.18 -50.28 73.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.239 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 57.9 mt-10 -59.79 -43.93 94.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 118.274 -1.371 . . . . 0.0 112.348 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.15 -50.87 71.41 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -63.1 -42.52 96.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.333 0.587 . . . . 0.0 110.414 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.22 -44.84 84.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.054 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 68.5 m -70.39 -40.19 74.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.736 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.78 89.83 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.26 0.552 . . . . 0.0 110.956 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 62.0 m-85 -112.73 41.39 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.169 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 62' ' ' SER . 12.7 mmmm -59.7 -37.3 78.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.112 177.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.62 11.15 15.78 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.807 0.443 . . . . 0.0 111.024 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.498 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 47.7 p90 -39.51 132.96 1.49 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.0 -48.18 4.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.515 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.1 p-10 -118.81 9.7 12.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.843 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.5 mp -99.7 119.17 47.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.615 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.0 t -121.22 131.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.737 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.69 130.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.513 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.3 pt -125.4 156.63 34.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.127 0.489 . . . . 0.0 110.562 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -118.23 134.91 54.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -160.57 -169.22 2.36 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.6 m -64.32 2.35 0.61 Allowed 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 127.169 2.188 . . . . 0.0 114.674 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.43 -22.32 0.0 OUTLIER Glycine 0 N--CA 1.511 3.64 0 C-N-CA 126.358 1.932 . . . . 0.0 116.929 -174.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.7 OUTLIER -56.42 -36.82 69.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.04 125.74 7.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.59 -51.6 68.7 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.1 pt -75.49 -30.72 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.375 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 43.7 mt-10 -65.52 -41.86 92.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.825 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.576 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.9 t0 -60.21 -51.27 70.27 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.991 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -59.41 -44.36 92.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 88' ' ' ILE . 22.7 m-80 -61.2 -40.32 93.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.92 0.39 . . . . 0.0 111.774 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 63.4 mm-40 -62.79 -46.45 87.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 99.5 m -62.15 -43.15 99.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.085 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.0 pt -65.68 -27.72 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.032 0.444 . . . . 0.0 110.316 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.99 -20.28 74.51 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.713 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -105.3 -23.58 12.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 60.0 m-85 -75.2 149.57 38.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -97.11 -15.48 20.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -139.83 160.91 58.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.808 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -52.91 143.19 49.99 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 111.778 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 42.7 p90 -137.57 156.16 48.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.439 0.638 . . . . 0.0 111.687 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 154' ' ' ILE . 1.5 tm? -86.86 133.87 33.59 Favored 'General case' 0 C--O 1.189 -2.131 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.057 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.7 t -107.03 128.54 61.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.141 0.576 . . . . 0.0 109.756 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 5' ' ' ILE . 4.4 m -130.53 161.53 40.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.495 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 70.2 m -99.73 144.28 28.98 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.731 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.514 ' O ' HD22 ' A' ' 29' ' ' LEU . 63.6 m -88.03 -1.48 58.02 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -108.32 7.78 27.36 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 65.9 mt -81.44 114.91 20.5 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.176 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.35 112.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 173.58 176.95 0.12 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.0 tp -84.21 103.06 13.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -96.98 -3.84 40.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.686 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -59.77 -45.01 93.58 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.057 0.456 . . . . 0.0 111.778 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -79.15 -23.57 43.88 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.365 0.602 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.716 ' O ' HG12 ' A' ' 113' ' ' ILE . 35.1 mm -68.98 -41.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.395 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.07 -46.55 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.376 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.22 -42.42 99.29 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.256 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.4 m -64.76 -41.71 95.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.55 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.8 mm -64.21 -49.96 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.008 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.41 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 64.8 t -61.6 -47.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.769 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.41 -46.42 88.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.823 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CE2' HD11 ' A' ' 120' ' ' ILE . 67.0 t80 -63.43 -46.51 86.01 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.795 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.62 -48.3 81.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.907 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.418 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 23.1 m-85 -63.21 -33.79 76.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.427 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.01 -46.92 87.09 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.286 0.565 . . . . 0.0 109.676 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.8 mt -64.18 -48.58 85.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.577 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -65.55 -26.53 67.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.413 -178.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.49 99.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.57 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 19.0 ptpt -82.24 -37.0 26.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.669 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 127' ' ' VAL . 85.9 m -132.65 91.72 29.2 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.15 -17.44 38.73 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 123.379 2.72 . . . . 0.0 112.921 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.75 -32.27 73.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 124' ' ' THR . 9.9 p -73.33 127.64 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 45.0 mt-10 -122.19 2.9 9.83 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.193 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.51 155.23 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.971 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.8 tp -137.58 146.1 43.63 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.93 137.12 53.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.338 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 113' ' ' ILE . 98.9 t -114.24 115.77 50.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.379 0.609 . . . . 0.0 109.615 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.5 ptm -145.9 156.61 43.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.785 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.637 HG12 ' HB2' ' A' ' 152' ' ' ALA . 22.2 pt -131.5 158.39 75.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.652 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo . . . . . 0 C--O 1.239 0.546 0 C-N-CA 122.411 2.074 . . . . 0.0 111.706 179.629 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.442 -0.85 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 141.65 48.54 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.039 1.826 . . . . 0.0 111.252 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.637 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -114.69 -5.11 12.7 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.295 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.25 -116.95 0.45 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.557 -1.306 . . . . 0.0 113.176 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.628 HD12 HD11 ' A' ' 96' ' ' LEU . 25.2 pt -119.05 161.15 18.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.991 0.424 . . . . 0.0 111.768 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.609 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.7 t-20 -120.18 156.02 31.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.118 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 81.3 t -124.25 130.27 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 122.253 0.221 . . . . 0.0 110.75 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.517 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.7 m -135.52 155.16 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.055 0.455 . . . . 0.0 111.346 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.536 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.6 m -97.06 157.45 34.97 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.187 174.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.34 69.22 7.26 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.873 2.382 . . . . 0.0 111.731 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.31 169.58 10.27 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.918 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -110.22 22.07 15.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.622 0.725 . . . . 0.0 109.606 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -170.27 -176.32 39.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.509 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -72.22 146.17 47.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.091 0.446 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.536 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 19.9 pt20 -133.37 166.6 22.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -173.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.47 127.62 33.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.763 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.13 132.15 53.15 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.65 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.431 ' HG3' HG21 ' A' ' 120' ' ' ILE . 45.8 mm-40 -93.49 163.05 13.72 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.641 0.734 . . . . 0.0 112.207 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.4 mm -116.16 127.77 73.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.442 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.8 ttp -131.19 132.86 45.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.911 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 133' ' ' MET . 78.8 t -107.87 131.78 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.163 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.648 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 39.2 pt -114.55 172.62 3.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -117.97 8.02 12.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.352 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.648 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.1 pm0 -104.32 134.67 47.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.708 0.766 . . . . 0.0 110.828 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.73 151.05 19.72 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.536 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 102' ' ' LEU . 7.6 pt -110.37 146.16 15.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.436 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.34 111.8 24.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -110.12 153.02 25.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.747 HG23 ' HB2' ' A' ' 183' ' ' ASP . 92.6 mt -110.73 119.59 59.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -176.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -114.4 -24.8 8.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.561 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.1 p -128.26 163.96 23.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.695 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -61.8 -32.46 72.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.18 -37.54 85.63 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.366 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.747 ' HB2' HG23 ' A' ' 178' ' ' ILE . 57.3 m-20 -60.89 -35.28 76.24 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.007 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 178' ' ' ILE . 96.0 mt -60.02 -46.2 90.27 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.87 0.843 . . . . 0.0 109.184 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.625 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 65.7 tttm -65.82 -40.05 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.505 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 189' ' ' MET . 10.5 tt -64.13 -44.36 92.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 0.0 110.187 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.06 -43.03 99.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.332 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -70.33 -29.74 66.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.064 0.459 . . . . 0.0 110.607 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 186' ' ' LEU . 60.0 ttm -61.87 -47.91 82.9 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.325 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -70.1 -31.38 68.91 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.768 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.492 HD13 ' SG ' ' A' ' 25' ' ' CYS . 83.5 mt -62.11 -45.02 95.34 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.339 0.59 . . . . 0.0 110.678 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 C--N 1.307 -1.257 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.27 178.351 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 59.2 ttm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.517 ' HA ' HG13 ' A' ' 42' ' ' VAL . 63.6 m-20 -103.94 164.6 11.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.614 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -114.7 129.79 56.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.178 0.513 . . . . 0.0 111.168 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.2 tm? -103.57 119.27 38.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 98' ' ' VAL . 68.6 mt -116.6 115.69 49.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.138 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.568 ' CE ' HD22 ' A' ' 84' ' ' LEU . 47.2 mtt -89.66 97.47 11.21 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 122.48 1.133 . . . . 0.0 113.591 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.86 110.62 19.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.07 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.78 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -178.481 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 N--CA 1.478 0.571 0 CA-C-O 121.064 0.36 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.519 HD21 ' CB ' ' A' ' 59' ' ' TYR . 10.8 mp -79.69 6.31 11.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.47 125.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.608 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -109.54 146.09 35.23 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.647 0.737 . . . . 0.0 112.386 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 184' ' ' LEU . 96.4 mt -129.45 124.71 34.75 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.848 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 192' ' ' LYS . 79.6 m 65.66 -74.32 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.732 0.645 . . . . 0.0 112.418 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.9 -68.96 0.55 Allowed Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.529 -0.843 . . . . 0.0 114.221 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 98.5 mtt180 -115.76 172.86 6.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 112.349 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.4 m -71.84 154.47 41.25 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.466 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -42.21 20.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.436 1.094 . . . . 0.0 111.219 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.1 tp -58.18 -48.2 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 19.0 t70 -63.74 -40.01 95.7 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.036 0.446 . . . . 0.0 110.584 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 7.0 m-30 -62.13 -37.4 85.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.865 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.45 -43.66 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.701 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.4 t -64.62 -42.18 94.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.643 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -50.04 -54.99 27.35 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.12 -38.09 9.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.205 1.27 . . . . 0.0 112.583 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 HG11 ' A' ' 98' ' ' VAL . 91.1 mt -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.967 0.413 . . . . 0.0 111.405 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.604 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.5 tt -63.09 -46.88 85.29 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.07 -12.93 60.03 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 p -74.62 -176.75 2.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.932 0.396 . . . . 0.0 110.803 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.28 -9.51 3.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.883 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 2' ' ' ASP . 69.0 t -64.51 133.11 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.171 0.51 . . . . 0.0 110.588 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -80.26 -68.3 0.69 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.988 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -111.12 148.38 32.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.405 0.621 . . . . 0.0 111.217 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.9 mm -108.47 117.12 53.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.765 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.24 113.83 27.23 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -95.23 116.3 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.427 0 CA-C-O 121.657 0.741 . . . . 0.0 110.042 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.6 120.6 29.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.826 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 7' ' ' ALA . 76.0 p -125.61 160.16 30.32 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.254 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.9 m -109.66 150.44 41.26 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.999 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.27 -27.6 75.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.103 2.536 . . . . 0.0 111.801 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -81.05 -6.62 59.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.476 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.8 66.34 40.58 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.9 Cg_endo -109.24 85.79 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.842 0 CA-C-N 120.713 1.29 . . . . 0.0 110.159 168.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.0 mttt -146.45 -45.63 0.19 Allowed 'General case' 1 C--N 1.217 -5.187 0 CA-C-N 109.852 -3.34 . . . . 0.0 102.327 177.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 77.1 m -62.03 -47.99 82.3 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 112.033 -2.349 . . . . 0.0 105.989 162.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.32 -50.1 72.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.061 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.2 pt-20 -59.33 -35.15 73.32 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.858 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CB ' HD21 ' A' ' 21' ' ' LEU . 56.4 t80 -67.25 -51.61 51.02 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.932 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.454 HG23 ' CD2' ' A' ' 64' ' ' TYR . 97.7 mt -63.47 -44.91 99.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.536 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -58.77 -42.65 89.42 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.516 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 35.2 t -70.33 -43.2 70.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.847 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.48 89.73 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.798 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 68.3 m-85 -108.11 34.69 3.47 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.185 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.8 mmmt -62.64 -20.23 64.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.564 0.697 . . . . 0.0 110.128 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.7 10.84 16.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.938 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 52.9 p90 -46.78 126.48 8.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -104.34 -49.37 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.604 HD21 ' HG ' ' A' ' 38' ' ' LEU . 24.9 p-10 -117.01 15.73 15.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.255 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 78.8 mt -105.32 127.58 59.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.248 0.547 . . . . 0.0 110.851 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.03 132.98 68.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.83 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.61 130.96 60.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.484 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.4 155.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 122.038 0.923 . . . . 0.0 112.372 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -111.13 132.61 54.15 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.189 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 2.6 t -161.14 -172.05 3.28 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.8 m -66.69 2.08 1.51 Allowed 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 127.236 2.214 . . . . 0.0 114.68 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.11 -23.98 0.0 OUTLIER Glycine 0 N--CA 1.51 3.596 0 C-N-CA 126.237 1.875 . . . . 0.0 117.038 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -55.38 -35.3 65.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.18 121.77 5.51 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.29 -50.44 73.61 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.9 mt -65.99 -43.62 92.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.585 0.707 . . . . 0.0 110.172 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.1 -44.12 91.91 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.295 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 33.7 t0 -62.07 -48.15 81.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.282 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -53.76 -41.54 67.27 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.861 177.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.586 ' O ' HG12 ' A' ' 88' ' ' ILE . 28.0 m-80 -60.09 -43.99 95.12 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.365 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 53.3 mm-40 -65.67 -41.91 91.93 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.264 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 84' ' ' LEU . 26.1 pt -66.23 -25.12 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.335 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.18 92.28 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.121 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -80.75 -8.99 59.84 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -119.81 145.97 46.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.4 m -115.73 10.73 15.5 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -133.36 157.65 77.6 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.121 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.84 146.05 64.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.195 1.93 . . . . 0.0 111.557 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -139.2 158.26 44.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.686 HD21 HD12 ' A' ' 154' ' ' ILE . 27.0 tp -86.27 140.62 29.93 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.928 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 60.3 t -115.17 131.34 67.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' A' ' 5' ' ' ILE . 11.0 m -126.97 157.02 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.691 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 36.3 t -99.71 136.5 39.54 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 74.8 p -64.54 -34.03 77.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -174.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -88.79 1.95 54.37 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.629 HD22 HD13 ' A' ' 175' ' ' ILE . 70.3 mt -91.26 114.11 26.55 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.757 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -121.88 130.29 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -176.91 -178.08 0.82 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.97 71.7 1.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.694 ' HA ' HD12 ' A' ' 109' ' ' ILE . 58.6 mtpt -79.98 -8.05 59.13 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.546 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.8 t -59.75 -45.94 90.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -82.97 -24.26 33.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.797 0.808 . . . . 0.0 110.169 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 106' ' ' LYS . 78.6 mt -65.63 -39.24 84.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.03 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 106' ' ' LYS . 60.3 mt -57.09 -46.47 84.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.279 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -61.66 -43.9 97.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.12 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -63.98 -40.77 97.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.738 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.693 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.01 -49.11 85.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.217 0.532 . . . . 0.0 110.373 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.507 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.7 t -62.48 -46.83 95.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.244 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.61 -43.81 98.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.113 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD2' ' HG3' ' A' ' 169' ' ' MET . 37.5 t80 -66.77 -42.75 85.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.147 0.498 . . . . 0.0 110.287 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.2 t80 -57.46 -47.3 82.2 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.333 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.507 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 39.8 m-85 -67.95 -30.75 70.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.39 -39.79 95.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -65.34 -42.33 93.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.409 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.922 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.418 ' N ' ' HE3' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -57.33 -38.5 74.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.67 177.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.48 91.17 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.561 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -88.59 -37.39 15.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 111.612 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.6 m -141.27 92.06 8.49 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.411 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.262 2.641 . . . . 0.0 112.295 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.39 -30.47 70.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.463 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.544 HG22 ' HE3' ' A' ' 165' ' ' LYS . 61.9 t -67.05 127.45 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.087 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 158' ' ' SER . 30.1 mt-10 -102.44 -34.11 9.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.234 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -131.45 165.6 23.17 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -140.22 134.25 30.85 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.807 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.51 135.93 51.03 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.671 HG21 HD12 ' A' ' 113' ' ' ILE . 78.3 t -117.24 118.61 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.68 41.92 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.747 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.577 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 34.8 pt -124.58 163.28 37.71 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 10.7 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 121.82 1.68 . . . . 0.0 110.772 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.444 -0.761 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.96 144.92 48.87 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.271 1.981 . . . . 0.0 110.977 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -128.79 16.65 6.34 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.785 0.326 . . . . 0.0 111.525 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.18 -114.86 0.33 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.89 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.686 HD12 HD21 ' A' ' 96' ' ' LEU . 13.0 pt -134.45 160.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.239 -0.481 . . . . 0.0 110.348 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.482 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.7 t30 -118.19 155.91 29.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.69 130.36 73.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 122.421 0.289 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.53 147.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.134 0.492 . . . . 0.0 111.13 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 8.4 t -99.28 158.45 32.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 28.7 Cg_exo -62.98 93.93 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.373 1.382 . . . . 0.0 110.669 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 163' ' ' TYR . 20.6 pttp -78.01 174.83 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.843 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -124.08 -68.81 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.069 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -113.46 47.23 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.502 ' HA ' ' HD2' ' A' ' 160' ' ' LYS . 91.8 m-85 74.9 148.9 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.566 0.746 . . . . 0.0 110.542 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 158' ' ' SER . 26.7 pt20 -133.84 165.11 25.75 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.544 ' HE3' HG22 ' A' ' 127' ' ' VAL . 64.9 tttp -67.85 121.97 17.14 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.204 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -123.38 126.74 47.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.848 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -94.37 163.05 13.58 Favored 'General case' 0 CA--C 1.469 -2.172 0 CA-C-O 121.895 0.855 . . . . 0.0 113.218 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.0 129.51 69.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.006 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.496 ' SD ' HG23 ' A' ' 171' ' ' ILE . 15.0 tmm? -131.31 138.24 49.15 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.738 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.22 131.09 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.921 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.572 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 2.2 pp -114.63 178.52 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.889 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -115.81 3.36 13.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.572 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 1.8 pm0 -98.83 136.85 38.26 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.81 0.814 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.68 139.27 32.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.965 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.629 HD13 HD22 ' A' ' 102' ' ' LEU . 1.8 pp -101.93 155.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -98.99 107.31 19.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -92.3 124.92 36.72 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.634 HG21 HD23 ' A' ' 184' ' ' LEU . 85.5 mt -108.86 110.01 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.725 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -124.4 -13.72 7.07 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 43.1 p -127.04 167.75 15.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.381 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -65.09 -35.18 80.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.83 -42.45 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.054 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.568 ' HB2' HG23 ' A' ' 178' ' ' ILE . 73.2 m-20 -62.28 -37.8 86.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.143 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.634 HD23 HG21 ' A' ' 178' ' ' ILE . 95.5 mt -60.26 -46.79 88.6 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.765 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 189' ' ' MET . 28.9 mtpp -64.93 -38.41 90.89 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.368 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.98 -50.5 73.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.154 0.502 . . . . 0.0 110.078 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.35 -41.92 88.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.435 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.503 ' CG ' ' HA ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER -68.98 -30.8 69.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.4 mtp -64.61 -41.57 96.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.747 0.308 . . . . 0.0 111.684 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -77.84 -33.02 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.923 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 190' ' ' LEU . 86.9 mt -61.28 -47.42 86.1 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.414 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mtmm . . . . . 0 C--N 1.311 -1.107 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.988 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.637 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 36.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -90.37 166.2 13.42 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.021 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -123.29 134.01 54.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.66 127.28 52.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.148 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.619 ' HA ' HG22 ' A' ' 98' ' ' VAL . 61.4 mt -118.11 106.83 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttm -80.5 101.53 9.15 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 121.898 0.856 . . . . 0.0 111.021 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -115.54 97.72 6.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.35 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.984 178.644 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 CA--C 1.538 0.678 0 N-CA-C 113.546 0.556 . . . . 0.0 113.546 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 49.7 mt -89.08 6.34 40.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.58 114.21 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 60.4 pttt -95.6 131.77 41.45 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.583 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 188' ' ' GLU . 61.9 tp -136.13 120.97 18.57 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.322 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.6 m 58.54 24.09 11.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.86 -31.36 4.57 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.223 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.722 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 95.8 mtt180 -126.39 157.54 38.25 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.787 1.294 . . . . 0.0 111.764 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.5 m -81.54 163.52 22.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.535 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 33' ' ' VAL . 84.9 mt -58.77 -39.7 81.79 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.592 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.7 tp -56.21 -47.47 80.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.245 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.683 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.1 t70 -65.02 -42.86 94.02 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.168 0.508 . . . . 0.0 110.634 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.722 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 30.8 m-85 -64.07 -36.94 85.66 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.427 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.513 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 79.1 t -70.07 -41.05 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 30' ' ' ILE . 59.8 t -61.47 -43.27 96.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.899 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 65.8 m -52.76 -52.46 64.31 Favored Pre-proline 0 CA--C 1.571 1.768 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 33' ' ' VAL . 51.9 Cg_exo -60.53 -42.46 40.24 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 121.758 1.639 . . . . 0.0 111.982 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.566 HD11 HG11 ' A' ' 98' ' ' VAL . 96.1 mt -68.2 -37.23 80.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.722 0.772 . . . . 0.0 110.585 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 69' ' ' ASN . 59.7 tp -58.33 -45.77 87.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.989 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.11 -1.61 58.17 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.414 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.627 ' HB2' HG21 ' A' ' 110' ' ' ILE . 60.3 p -75.69 175.4 8.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.9 ttmm -58.26 -27.01 63.62 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.493 0.717 . . . . 0.0 112.469 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG22 ' OG ' ' A' ' 40' ' ' SER . 30.7 m -59.94 154.51 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.16 -69.0 0.56 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.844 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.92 153.67 36.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.207 0.527 . . . . 0.0 111.16 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.8 mm -106.64 115.26 47.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 87.0 m-85 -104.91 116.09 31.39 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.719 HG21 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -94.97 116.05 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-O 121.574 0.702 . . . . 0.0 110.319 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.66 120.74 28.29 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.439 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.9 p -125.06 158.0 34.86 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.472 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 28.9 t -111.9 142.29 26.44 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.169 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 75.6 Cg_exo -55.48 -25.89 51.29 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.457 2.771 . . . . 0.0 111.949 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -75.84 -9.0 58.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -140.35 67.12 31.41 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-O 119.244 -0.408 . . . . 0.0 112.011 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 67.0 Cg_endo -104.68 85.26 0.02 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.781 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.413 170.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 97.6 mttt -147.63 -46.78 0.17 Allowed 'General case' 1 C--N 1.214 -5.308 0 CA-C-N 109.932 -3.304 . . . . 0.0 103.721 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.472 HG21 ' HB1' ' A' ' 7' ' ' ALA . 87.9 m -61.93 -47.43 84.96 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 164.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -62.68 -49.62 74.39 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.016 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.1 pt-20 -59.19 -37.73 78.12 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.876 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.48 -50.25 70.4 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 47' ' ' ILE . 94.7 mt -63.47 -41.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.601 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.546 ' OD1' HG11 ' A' ' 72' ' ' VAL . 92.7 m-20 -57.06 -45.73 83.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.866 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 58.3 m -71.32 -41.96 69.22 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.262 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 -38.91 92.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.328 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.462 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 70.3 m-85 -113.55 37.86 3.1 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.71 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 10.8 mmmm -62.47 -23.38 66.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.316 0.579 . . . . 0.0 110.758 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -92.55 11.28 26.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.332 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 53.0 p90 -43.25 128.6 4.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -101.36 -52.03 3.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.023 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.513 HD21 HD12 ' A' ' 38' ' ' LEU . 6.8 p-10 -119.48 14.31 12.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.71 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.52 125.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 59.3 t -125.42 133.17 69.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' A' ' 61' ' ' ASN . 7.2 p -104.5 134.47 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.2 pt -129.25 157.1 42.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.585 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -116.07 136.13 53.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 12.7 t -160.2 -172.4 3.58 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -66.73 3.81 0.95 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 127.543 2.337 . . . . 0.0 114.592 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.98 -20.73 0.0 OUTLIER Glycine 1 N--CA 1.517 4.099 0 C-N-CA 126.51 2.005 . . . . 0.0 116.947 -173.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 76' ' ' SER . 55.8 tptt -56.55 -39.78 73.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.26 122.37 6.09 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.15 -50.44 73.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.219 0.533 . . . . 0.0 111.718 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.3 -45.65 95.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.71 0.766 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 48.3 mt-10 -60.07 -42.48 94.65 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.83 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.79 -51.61 69.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.347 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.628 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.0 mm? -58.76 -43.56 90.35 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.629 ' O ' HG12 ' A' ' 88' ' ' ILE . 30.0 m-80 -61.61 -39.93 93.02 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.332 0.587 . . . . 0.0 112.4 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 54.6 mm-40 -65.91 -42.21 90.47 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.506 -0.746 . . . . 0.0 109.009 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.5 m -61.73 -43.21 99.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.961 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.629 HG12 ' O ' ' A' ' 85' ' ' ASN . 33.1 pt -63.64 -27.1 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.687 0.28 . . . . 0.0 110.344 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.73 -24.87 64.88 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.566 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -99.93 2.87 44.08 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.85 135.6 54.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 112.285 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -103.66 -2.35 26.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.1 mt-10 -131.55 160.83 65.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.1 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.637 ' O ' ' HG3' ' A' ' 1' ' ' MET . 48.7 Cg_endo -67.31 157.67 60.66 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.445 2.096 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -144.71 159.25 43.14 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.367 0.603 . . . . 0.0 111.699 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 3' ' ' ALA . 21.9 tp -86.64 145.98 26.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.726 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 95.8 t -116.63 130.11 72.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 124.07 0.948 . . . . 0.0 108.601 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.4 m -131.77 163.97 35.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.26 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 46.9 t -99.8 139.71 35.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.4 p -89.6 -1.3 57.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.01 9.54 13.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.517 ' O ' HD12 ' A' ' 102' ' ' LEU . 2.8 pp -92.53 143.48 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.938 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 18.0 tt -140.26 132.41 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.074 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 18.9 t-20 173.28 167.61 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.163 0.985 . . . . 0.0 108.415 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tt -80.19 88.32 5.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.581 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -101.82 3.6 39.52 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.5 p -52.76 -36.04 57.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.429 ' CG ' HD12 ' A' ' 109' ' ' ILE . 21.5 pttp -73.15 -28.51 62.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.254 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.751 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.0 mp -61.4 -43.05 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.304 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.627 HG21 ' HB2' ' A' ' 40' ' ' SER . 5.2 mm -54.16 -49.82 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 121.821 0.819 . . . . 0.0 109.743 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 62.3 m-80 -61.98 -42.93 99.69 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.662 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -61.81 -38.35 87.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.726 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -60.83 -49.15 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.11 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.54 -47.76 91.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.863 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.08 -46.91 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.731 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.662 ' CE2' HD11 ' A' ' 120' ' ' ILE . 45.2 t80 -66.53 -46.05 77.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.637 0.256 . . . . 0.0 111.483 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 62.9 t80 -58.19 -47.58 83.01 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.073 0.464 . . . . 0.0 110.694 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -62.84 -37.36 86.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.204 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 91.7 m -63.75 -40.15 96.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.024 0.44 . . . . 0.0 110.568 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.662 HD11 ' CE2' ' A' ' 116' ' ' TYR . 81.2 mt -65.45 -46.02 91.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.138 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 52.8 mtmt -63.08 -37.52 87.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.218 0.533 . . . . 0.0 110.531 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.61 91.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.293 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -82.2 -35.0 28.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.024 0.44 . . . . 0.0 111.513 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 66.4 m -137.24 97.51 10.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.447 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.04 -20.52 54.13 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.412 2.742 . . . . 0.0 113.036 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.77 -30.39 71.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.787 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.447 HG22 ' HE3' ' A' ' 165' ' ' LYS . 67.5 t -73.77 125.38 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.82 2.58 7.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.995 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -143.0 156.08 44.78 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.962 0.41 . . . . 0.0 111.468 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -140.39 133.1 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.404 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -120.37 129.98 54.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.86 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.722 HG21 ' CD1' ' A' ' 113' ' ' ILE . 60.8 t -115.01 121.74 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 6.5 ptm -145.89 156.8 43.79 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.661 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 152' ' ' ALA . 14.3 pt -128.54 156.52 77.09 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.633 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 N--CA 1.458 -0.572 0 C-N-CA 122.219 1.946 . . . . 0.0 111.95 -179.669 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 120.823 0.344 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.26 153.61 56.46 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.843 2.362 . . . . 0.0 111.792 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.694 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -102.32 -7.69 21.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.117 0.484 . . . . 0.0 111.371 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.86 -88.9 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.749 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.668 HD11 HG13 ' A' ' 113' ' ' ILE . 16.9 pt -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.237 0.541 . . . . 0.0 112.308 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.563 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 9.9 t-20 -120.65 153.82 36.35 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.928 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.91 131.18 72.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 O-C-N 122.368 -0.207 . . . . 0.0 111.141 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.32 155.07 36.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.192 0.52 . . . . 0.0 111.141 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.445 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 72.3 m -97.51 158.79 32.51 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 84.5 Cg_endo -75.61 59.39 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.108 1.872 . . . . 0.0 112.484 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -117.87 138.5 52.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.95 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -72.54 133.71 44.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.83 -130.35 9.75 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.936 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.99 141.68 46.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.353 0.597 . . . . 0.0 111.635 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.445 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 22.9 pt20 -134.91 162.72 31.63 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.664 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.447 ' HE3' HG22 ' A' ' 127' ' ' VAL . 63.9 tttp -60.68 128.13 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.4 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -124.76 131.55 53.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 120' ' ' ILE . 28.8 mm-40 -97.35 163.15 13.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 131' ' ' ALA . 50.0 mm -115.52 131.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.256 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.6 ttp -133.42 132.67 41.41 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.967 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.6 t -112.49 131.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 173' ' ' GLU . 50.7 pt -115.63 176.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.742 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.52 -3.27 31.03 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.205 0.526 . . . . 0.0 110.861 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.569 ' HB2' HD12 ' A' ' 171' ' ' ILE . 56.7 mp0 -98.83 130.47 45.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.922 0.868 . . . . 0.0 112.775 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 174' ' ' LEU . 1.4 pt? -97.72 153.83 17.99 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.754 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.08 149.18 14.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.429 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.48 115.2 29.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.52 150.29 24.06 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.616 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.652 HG23 ' HB2' ' A' ' 183' ' ' ASP . 88.1 mt -116.28 117.66 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.998 0.427 . . . . 0.0 111.28 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -120.73 -18.9 7.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.121 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.3 p -128.96 164.21 23.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.403 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -60.87 -29.5 69.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.262 0.553 . . . . 0.0 109.531 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.58 -41.35 98.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.335 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.652 ' HB2' HG23 ' A' ' 178' ' ' ILE . 72.6 m-20 -64.21 -28.4 69.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 96.4 mt -61.54 -45.25 94.96 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.546 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -62.09 -42.66 99.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.747 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.43 -49.84 76.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.456 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.76 -42.54 99.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 8.0 pt-20 -68.15 -33.98 75.48 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.9 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -63.67 -41.42 98.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 111.35 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -77.2 -31.17 55.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.131 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 69.3 tp -64.42 -45.08 89.1 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.483 0.658 . . . . 0.0 110.165 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 63.5 tttm . . . . . 0 C--N 1.318 -0.787 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.654 176.447 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' HG23 ' A' ' 42' ' ' VAL . 54.2 tpp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.639 0.257 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -113.93 166.19 11.83 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.533 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -114.6 130.86 56.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.261 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.9 tp -105.42 124.21 49.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.614 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -118.71 101.05 11.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.7 ptm -91.76 106.2 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.851 1.31 . . . . 0.0 111.984 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.05 103.75 11.21 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.292 -1.865 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 CA--C 1.536 0.592 0 N-CA-C 114.346 0.864 . . . . 0.0 114.346 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 59' ' ' TYR . 44.4 mt -92.69 5.87 49.5 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.723 HG21 HD21 ' A' ' 184' ' ' LEU . 77.2 mt -76.73 118.55 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.93 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -76.75 130.62 37.96 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.056 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 188' ' ' GLU . 81.8 mt -127.75 125.43 39.91 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.522 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.8 m 54.31 28.88 9.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.21 35.32 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.764 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 98.8 mtt180 -129.77 153.35 48.3 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 118.181 0.99 . . . . 0.0 112.435 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 61.2 m -80.16 164.4 23.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.32 -39.24 82.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.793 0.33 . . . . 0.0 110.87 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.453 HG13 HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -62.75 -39.76 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.728 178.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 21.2 m-20 -62.29 -40.93 97.9 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.153 0.501 . . . . 0.0 110.497 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 10.1 m-85 -63.04 -37.14 86.02 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.693 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.67 -42.41 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 0.0 110.766 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 30' ' ' ILE . 67.7 t -63.35 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.777 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.0 m -53.58 -51.94 71.57 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.37 -38.17 35.68 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 121.531 1.487 . . . . 0.0 112.082 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.7 HD11 HG11 ' A' ' 98' ' ' VAL . 93.1 mt -68.45 -40.04 81.23 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.401 0.619 . . . . 0.0 110.782 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.65 -44.04 89.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.398 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -84.03 -14.73 49.87 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.538 ' OG ' HG12 ' A' ' 42' ' ' VAL . 85.5 p -74.37 172.35 12.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.973 0.416 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -65.49 -7.06 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.7 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG12 ' OG ' ' A' ' 40' ' ' SER . 12.2 p -71.24 144.98 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 O-C-N 122.183 -0.323 . . . . 0.0 110.771 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -82.33 -72.37 0.44 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.57 147.08 28.01 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.528 0.68 . . . . 0.0 111.656 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.09 113.66 44.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.61 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -103.31 115.17 30.04 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -95.21 116.46 36.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.7 0.762 . . . . 0.0 110.368 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -89.9 118.8 29.75 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.245 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.4 p -129.63 158.15 40.13 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 63.3 m -105.63 148.84 37.11 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.376 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 52.6 Cg_exo -58.07 -24.99 68.79 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.06 2.507 . . . . 0.0 111.085 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -77.92 -5.89 52.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.185 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -139.84 66.87 34.47 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 119.401 -0.333 . . . . 0.0 111.879 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 96.1 Cg_endo -105.8 86.57 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.813 0 CA-C-N 120.982 1.386 . . . . 0.0 109.653 168.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 mmtm -155.61 -46.18 0.08 Allowed 'General case' 1 C--N 1.212 -5.405 0 CA-C-N 109.709 -3.405 . . . . 0.0 102.443 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 21' ' ' LEU . 97.9 m -63.99 -49.31 72.99 Favored 'General case' 0 N--CA 1.381 -3.9 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 162.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.666 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.59 -51.28 66.0 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.11 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.3 pt-20 -63.66 -29.4 70.64 Favored 'General case' 0 C--N 1.37 1.469 0 C-N-CA 116.639 -2.024 . . . . 0.0 112.907 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CD2' HD22 ' A' ' 21' ' ' LEU . 55.8 t80 -64.96 -50.37 66.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.434 0.635 . . . . 0.0 110.623 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 30' ' ' ILE . 98.0 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.0 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -57.63 -45.97 84.75 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.902 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 42.3 t -67.04 -42.45 84.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.547 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.03 92.85 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.166 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.516 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 45.8 m-85 -115.84 37.98 3.46 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.059 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.6 mmmm -60.68 -24.21 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.162 0.506 . . . . 0.0 111.057 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.67 10.47 25.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.609 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.2 p90 -45.02 131.4 7.36 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -102.5 -48.92 4.0 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.597 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -118.28 16.35 13.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.786 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.9 mt -107.62 131.06 58.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.512 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.3 t -125.17 133.05 70.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.27 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.43 130.46 56.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.314 0.578 . . . . 0.0 110.313 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.88 156.53 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 CA-C-O 121.967 0.889 . . . . 0.0 111.37 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.01 130.76 55.49 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.435 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 11.2 t -158.06 -173.24 4.25 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.734 0.778 . . . . 0.0 112.891 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 49.2 m -71.53 2.09 5.57 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 126.472 1.909 . . . . 0.0 114.637 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.67 -23.73 0.0 OUTLIER Glycine 1 N--CA 1.521 4.331 0 C-N-CA 126.462 1.982 . . . . 0.0 117.393 -173.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 12.1 tmtt? -56.17 -36.48 68.37 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 172.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.73 122.4 6.2 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -60.27 -51.05 71.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 pt -77.68 -28.64 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.802 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.91 -41.68 99.53 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.607 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 14.0 t0 -60.2 -51.48 69.4 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.049 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -57.71 -43.71 85.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.538 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.5 m-80 -60.29 -41.33 93.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 70.3 mm-40 -63.95 -46.95 82.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.375 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.1 m -62.71 -42.99 99.93 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.351 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 85' ' ' ASN . 37.2 pt -65.46 -30.6 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.962 0.41 . . . . 0.0 110.431 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.44 -39.29 95.65 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.245 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -82.01 -36.78 27.46 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 75.2 m-85 -71.31 146.53 48.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.19 0.519 . . . . 0.0 111.801 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -102.06 -10.61 19.55 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.369 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.46 160.32 64.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.667 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.77 142.45 41.53 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 123.27 2.647 . . . . 0.0 112.307 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -142.99 155.62 44.7 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.057 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 155' ' ' ASN . 42.4 tp -86.37 143.91 27.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.221 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 66.5 t -115.49 133.79 60.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 108.93 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 37' ' ' LEU . 11.1 m -129.98 164.82 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.371 0.605 . . . . 0.0 112.225 -178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 50.6 m -99.21 152.79 19.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.0 p -73.61 -10.79 60.07 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.605 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 45.4 p-10 -117.23 16.55 14.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.58 ' CD1' ' HB2' ' A' ' 99' ' ' SER . 11.0 mp -61.54 153.13 28.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 111.798 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.89 174.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.686 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 105' ' ' LEU . 65.6 t30 -63.68 162.59 12.9 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.013 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 104' ' ' ASN . 51.5 tp 82.52 3.28 1.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.576 1.151 . . . . 0.0 110.213 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -94.02 -1.23 54.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.604 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.501 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -62.21 -24.73 67.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.155 0.502 . . . . 0.0 111.786 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.98 -20.91 61.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.15 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.455 HD11 ' HG3' ' A' ' 173' ' ' GLU . 28.5 mm -68.57 -41.42 82.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 107' ' ' SER . 61.7 mt -60.99 -44.46 98.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.41 -46.84 86.77 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.03 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.3 m -64.15 -42.62 96.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.026 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.637 HG13 ' N ' ' A' ' 114' ' ' VAL . 36.0 pt -67.76 -43.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.637 ' N ' HG13 ' A' ' 113' ' ' ILE . 62.9 t -62.44 -49.15 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.824 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.55 -45.36 93.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.464 -0.494 . . . . 0.0 112.247 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.709 ' CE2' HD11 ' A' ' 120' ' ' ILE . 54.2 t80 -65.84 -46.12 79.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.623 0.249 . . . . 0.0 110.918 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -58.8 -47.9 83.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.408 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 15.8 m-85 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.081 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 93.2 m -63.72 -40.37 96.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.672 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -66.85 -47.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 124' ' ' THR . 54.6 pttt -65.15 -26.26 68.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.302 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.04 99.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.918 0.39 . . . . 0.0 110.455 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 65.3 pttt -83.24 -34.04 25.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 50.7 m -139.52 97.42 8.34 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.663 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.53 -11.77 31.87 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.933 2.422 . . . . 0.0 112.856 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.29 -32.7 73.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.547 HG21 ' HG2' ' A' ' 167' ' ' GLU . 7.6 p -87.29 122.41 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.975 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 41.6 mt-10 -127.38 19.15 6.89 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -142.19 148.75 38.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.0 tp -139.63 148.08 41.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.816 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.8 136.18 52.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.09 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' A' ' 152' ' ' ALA . 99.2 t -111.12 115.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.244 0.545 . . . . 0.0 109.722 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -145.61 157.46 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.775 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 152' ' ' ALA . 17.0 pt -134.97 155.51 79.14 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 C--O 1.24 0.584 0 C-N-CA 122.356 2.037 . . . . 0.0 110.797 176.402 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.444 -0.738 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.34 143.92 60.07 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.183 1.922 . . . . 0.0 110.456 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.554 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -112.27 4.98 18.09 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 164.54 -97.98 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 118.759 -1.686 . . . . 0.0 114.346 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 96' ' ' LEU . 15.0 pt -130.17 160.85 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.695 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.0 m-20 -123.74 158.78 30.9 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.46 129.58 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.29 156.04 40.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.638 0.732 . . . . 0.0 112.06 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 33.3 t -98.28 146.48 31.61 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.528 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.01 66.99 4.1 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.691 2.261 . . . . 0.0 112.549 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.37 175.81 6.79 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -104.7 -11.63 16.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.268 0.556 . . . . 0.0 109.732 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -122.45 -156.28 9.61 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.838 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -106.7 134.34 49.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.342 0.591 . . . . 0.0 109.987 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.431 HE21 ' H ' ' A' ' 158' ' ' SER . 20.1 pm0 -121.2 167.19 12.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -55.18 130.08 40.71 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.321 0.581 . . . . 0.0 112.151 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -123.52 132.55 53.94 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.259 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.547 ' HG2' HG21 ' A' ' 127' ' ' VAL . 25.5 mm-40 -96.75 162.6 13.36 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 121.603 0.716 . . . . 0.0 111.967 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.019 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.0 ttp -128.74 129.94 46.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.266 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 133' ' ' MET . 89.6 t -102.23 129.3 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' A' ' 173' ' ' GLU . 50.0 pt -110.55 174.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.42 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.57 0.65 31.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.692 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 171' ' ' ILE . 79.1 mm-40 -98.51 139.38 34.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.776 0.798 . . . . 0.0 112.641 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.29 143.89 26.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.628 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.6 155.6 41.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.88 111.04 19.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.876 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.605 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 26.5 t-20 -91.02 109.58 20.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.474 ' HA ' ' OD2' ' A' ' 183' ' ' ASP . 51.4 mm -66.26 123.84 20.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.431 0.634 . . . . 0.0 112.652 -172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.45 -36.43 8.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.466 ' H ' ' HB3' ' A' ' 183' ' ' ASP . 61.5 p -137.72 165.74 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.599 0.237 . . . . 0.0 111.469 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 184' ' ' LEU . 15.1 mtmm -62.03 -37.37 84.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.641 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.44 -40.62 97.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.272 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 178' ' ' ILE . 38.8 t70 -64.57 -38.92 92.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.723 HD21 HG21 ' A' ' 22' ' ' ILE . 54.2 tp -59.3 -46.89 87.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.275 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.9 ttpt -62.5 -40.63 97.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.338 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.53 -49.03 79.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.294 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.499 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.79 -41.23 97.46 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.775 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.675 ' HB3' HD22 ' A' ' 24' ' ' LEU . 13.6 pt-20 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.855 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.61 -32.53 68.1 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.37 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.15 -28.66 63.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.761 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 85.6 mt -61.62 -44.99 95.96 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.491 0.662 . . . . 0.0 109.802 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.758 177.327 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' HG23 ' A' ' 42' ' ' VAL . 58.8 ttm . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -113.42 164.41 13.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -114.25 140.47 48.56 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.097 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 28.4 tp -115.63 120.61 39.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HA ' ' HB ' ' A' ' 98' ' ' VAL . 69.4 mt -111.71 108.72 26.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.528 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 60.4 ttm -80.25 104.8 11.05 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 121.643 0.735 . . . . 0.0 110.583 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -112.43 97.78 6.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.745 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.548 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.493 -179.691 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo . . . . . 0 N--CA 1.476 0.492 0 CA-C-O 121.084 0.368 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 56' ' ' THR . 73.3 mt -92.3 14.05 17.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.09 125.71 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 61.3 mttp -95.28 133.64 38.95 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.819 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' O ' ' HE2' ' A' ' 32' ' ' TYR . 56.6 tp -130.08 121.5 26.5 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 113.316 -1.766 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.0 t 58.04 27.04 14.29 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.393 0.616 . . . . 0.0 110.73 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.31 -8.87 69.62 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.012 -0.614 . . . . 0.0 114.548 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.592 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 85.9 mtt180 -117.07 155.03 29.96 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 118.169 0.985 . . . . 0.0 110.717 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 72.2 m -82.08 163.15 22.24 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.834 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.503 HD21 ' CG1' ' A' ' 178' ' ' ILE . 83.7 mt -59.22 -44.48 92.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 110.256 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -62.75 -36.82 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.77 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.45 -45.23 91.82 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.337 0.589 . . . . 0.0 110.4 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 8.5 m-85 -65.72 -30.19 70.82 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 100' ' ' SER . 66.6 t -70.1 -43.23 79.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 120.649 0.261 . . . . 0.0 111.574 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.507 HG23 HD13 ' A' ' 30' ' ' ILE . 79.8 t -65.34 -43.58 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.541 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 67.5 m -50.59 -53.58 44.61 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 33.8 Cg_exo -62.4 -41.28 34.3 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.931 1.754 . . . . 0.0 112.286 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.87 -42.32 90.51 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.89 -45.37 94.87 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.757 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 35' ' ' SER . 64.1 pttt -80.98 -9.31 59.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.58 ' OG ' HG12 ' A' ' 42' ' ' VAL . 84.2 p -77.85 175.55 9.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 111.514 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.16 -22.12 60.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.141 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' OG ' ' A' ' 40' ' ' SER . 12.7 p -66.07 145.03 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.671 -177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -78.37 -79.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -102.6 152.48 21.13 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.451 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.4 mm -110.06 116.42 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.118 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 93.8 m-85 -106.93 117.09 33.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.639 HG21 HD13 ' A' ' 60' ' ' ILE . 94.7 mt -98.74 118.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.527 0.68 . . . . 0.0 110.576 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.23 116.4 24.39 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.795 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.483 HG23 HG22 ' A' ' 47' ' ' ILE . 66.3 p -127.28 162.87 25.22 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.028 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.5 p -129.44 157.25 76.9 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.906 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.69 -19.09 67.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.834 2.356 . . . . 0.0 110.896 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.92 -24.95 62.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.744 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.16 67.33 26.3 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.624 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.6 Cg_endo -103.87 85.45 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.683 0 C-N-CA 117.172 -1.419 . . . . 0.0 109.906 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.632 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 36.0 mmtm -148.99 -44.98 0.14 Allowed 'General case' 1 C--N 1.215 -5.272 0 CA-C-N 109.605 -3.452 . . . . 0.0 102.638 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.624 HG21 ' HB1' ' A' ' 7' ' ' ALA . 96.8 m -63.16 -47.77 81.26 Favored 'General case' 1 N--CA 1.379 -4.006 0 CA-C-N 112.307 -2.224 . . . . 0.0 105.773 163.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.08 -51.19 68.95 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.796 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.632 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 pt-20 -64.58 -30.73 71.75 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.341 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.91 -50.21 71.74 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.071 0.462 . . . . 0.0 111.18 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.639 HD13 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -62.68 -42.75 97.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.964 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -58.25 -41.38 84.08 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.574 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.671 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t -73.74 -43.31 59.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 111.233 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.53 90.8 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.337 0.589 . . . . 0.0 111.105 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.459 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 58.1 m-85 -114.44 42.59 2.07 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.002 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HG3' ' O ' ' A' ' 62' ' ' SER . 38.1 mtmm -59.82 -26.79 66.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.028 0.442 . . . . 0.0 110.971 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.42 10.13 18.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.055 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.479 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 53.8 p90 -44.59 122.77 3.27 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.47 -49.44 3.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.36 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -110.26 7.74 23.26 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.095 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 4.8 mp -100.31 119.62 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.257 0.551 . . . . 0.0 110.028 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 78.3 t -120.55 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.312 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.487 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.9 pt -123.66 154.74 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.161 0.505 . . . . 0.0 109.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -117.08 127.82 54.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 t -155.96 -167.98 2.63 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -67.81 2.41 1.98 Allowed 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 126.633 1.973 . . . . 0.0 114.22 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.19 -16.62 0.0 OUTLIER Glycine 0 N--CA 1.516 3.971 0 C-N-CA 126.693 2.092 . . . . 0.0 117.376 -175.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 14.2 tmtt? -58.61 -38.45 78.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.6 127.48 7.73 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.459 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -59.97 -49.91 75.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.093 0.473 . . . . 0.0 111.987 -176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.83 -47.49 90.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.547 0.689 . . . . 0.0 110.294 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 53.6 mt-10 -60.91 -43.28 98.79 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.784 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.528 ' CG ' ' HE2' ' A' ' 6' ' ' MET . 7.4 t0 -60.05 -50.77 72.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.116 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -59.62 -42.87 93.66 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.169 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 88' ' ' ILE . 10.1 m120 -60.56 -42.02 95.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.257 0.551 . . . . 0.0 111.053 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 66.0 mm-40 -65.58 -45.65 82.46 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.0 m -63.57 -41.82 98.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.497 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 84' ' ' LEU . 38.1 pt -65.92 -29.88 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.081 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.41 96.56 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.941 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -71.9 -40.12 69.06 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.1 m-85 -79.01 154.08 29.77 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.8 m -113.24 -4.52 13.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 159' ' ' PRO . 40.0 mt-10 -132.74 156.02 80.55 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.275 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.44 140.0 64.41 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.207 2.604 . . . . 0.0 111.649 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.55 156.7 45.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.34 0.591 . . . . 0.0 110.748 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 154' ' ' ILE . 24.3 tp -87.53 144.4 26.72 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.029 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 93.7 t -107.14 125.89 63.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 60.8 t -130.47 141.11 47.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.5 m -96.09 142.49 28.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.782 174.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.549 ' HA ' HG21 ' A' ' 33' ' ' VAL . 67.9 m -89.45 0.78 56.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -104.93 -4.2 22.41 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 177' ' ' ASN . 75.2 mt -82.6 136.63 34.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.278 0.49 . . . . 0.0 110.599 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.8 pt -75.67 -174.24 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.953 0.406 . . . . 0.0 111.35 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -78.53 71.18 4.98 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.39 -3.84 4.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 11.7 ptmm? -88.38 -2.24 58.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.217 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 p -60.99 -41.57 96.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -80.43 -22.44 41.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.895 0.855 . . . . 0.0 109.725 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 113' ' ' ILE . 38.4 mm -67.7 -37.61 78.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.953 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 106' ' ' LYS . 64.4 mt -57.26 -50.0 78.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.064 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -70.74 -39.65 73.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.172 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.8 m -63.36 -42.95 98.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.07 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.2 mm -64.39 -44.78 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.8 t -60.44 -46.71 94.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.273 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.75 -46.1 91.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.657 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CE2' HD11 ' A' ' 120' ' ' ILE . 31.8 t80 -70.19 -41.82 73.2 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.2 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.5 t80 -59.18 -48.35 81.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 21.3 m-85 -62.88 -35.5 80.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.658 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.8 -47.5 86.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.966 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' A' ' 116' ' ' TYR . 70.5 mt -66.45 -49.37 75.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.484 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 16.0 ptmt -65.34 -25.85 67.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.965 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.56 98.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 120' ' ' ILE . 63.6 pttt -85.69 -36.83 19.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.309 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 127' ' ' VAL . 32.0 m -130.9 96.21 23.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.154 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.91 -14.2 40.6 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.918 2.412 . . . . 0.0 113.197 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.47 -32.94 74.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.889 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.587 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -75.79 120.53 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.606 0.717 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 45.8 mt-10 -123.04 15.0 9.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.872 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.71 150.07 33.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.931 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -140.86 135.04 30.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.034 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.33 140.84 51.65 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.727 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 152' ' ' ALA . 14.8 p -123.22 135.95 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 75.1 mtm -134.47 158.02 44.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.747 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 152' ' ' ALA . 9.9 pt -130.12 154.55 81.33 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo . . . . . 0 C--O 1.237 0.453 0 C-N-CA 122.62 2.213 . . . . 0.0 113.253 -178.16 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.444 -0.763 0 CA-C-O 120.752 0.31 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.25 148.74 56.16 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.52 2.146 . . . . 0.0 111.517 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.62 ' HB3' HG13 ' A' ' 132' ' ' VAL . . . -91.75 -4.26 55.23 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 102' ' ' LEU . . . 152.5 -75.06 0.24 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.338 -1.411 . . . . 0.0 114.376 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 96' ' ' LEU . 25.0 pt -128.32 161.49 36.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -173.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.629 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 11.5 t-20 -127.75 155.55 43.84 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.884 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -120.97 130.3 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 O-C-N 122.167 -0.333 . . . . 0.0 110.691 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.45 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.2 m -133.1 154.24 39.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.656 0.741 . . . . 0.0 111.967 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.684 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 45.0 t -98.52 144.27 27.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.115 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 72.2 Cg_endo -72.89 67.07 4.01 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.116 2.544 . . . . 0.0 113.35 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 164' ' ' GLN . 69.0 mttm -99.99 -168.37 1.58 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -133.56 90.03 2.67 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.889 0.852 . . . . 0.0 109.221 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.41 -136.74 6.65 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.26 142.74 51.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.815 0.34 . . . . 0.0 110.347 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.449 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . 18.6 pm0 -134.02 166.1 23.5 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.924 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -60.08 127.81 33.72 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.109 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -128.04 133.57 49.11 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.86 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -93.5 160.93 14.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-O 121.609 0.719 . . . . 0.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.6 128.87 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.192 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 61.7 ttp -127.35 135.21 50.19 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.14 126.63 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 152' ' ' ALA . 50.4 pt -116.18 174.94 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.003 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -117.66 21.5 12.93 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.143 0.496 . . . . 0.0 110.544 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' HB3' HD12 ' A' ' 171' ' ' ILE . 35.7 tp10 -98.33 133.17 43.11 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.3 150.69 19.98 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.401 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 102' ' ' LEU . 5.0 pt -130.11 153.26 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.33 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -125.69 144.48 50.59 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.552 ' HB3' HD23 ' A' ' 102' ' ' LEU . 28.4 p-10 -137.29 156.76 47.88 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 184' ' ' LEU . 31.9 mm -94.97 81.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.546 0.688 . . . . 0.0 111.171 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.491 ' HB2' ' OD2' ' A' ' 183' ' ' ASP . 66.9 m-80 -65.96 -40.1 90.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.515 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 182' ' ' ASP . 13.5 t -149.36 177.41 9.71 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.051 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -57.89 -28.35 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.932 0.493 . . . . 0.0 111.418 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 180' ' ' THR . 27.3 t70 -60.13 -46.77 88.53 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 109.943 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 44.7 m-20 -64.78 -35.67 81.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.212 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.641 ' HA ' HD12 ' A' ' 178' ' ' ILE . 59.8 tp -59.36 -45.32 91.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.833 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 12.9 mmtt -64.08 -38.23 90.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.04 -49.76 74.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.268 0.556 . . . . 0.0 109.524 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.534 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.1 -43.3 98.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.751 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 4.3 pt-20 -67.72 -34.12 76.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.461 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.431 ' N ' ' HG3' ' A' ' 188' ' ' GLU . 57.8 ttm -62.13 -45.49 93.24 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.692 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.4 pp -70.38 -37.16 74.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.366 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.58 -44.44 90.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.347 0.594 . . . . 0.0 110.53 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.929 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.862 179.576 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.485 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 37.0 m-20 -111.59 164.73 12.68 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -113.8 132.03 56.01 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.881 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 48' ' ' ALA . 33.3 tp -106.32 125.66 51.27 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.024 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.625 ' HA ' HG22 ' A' ' 98' ' ' VAL . 69.4 mt -117.24 104.76 16.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.403 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 11.1 ptm -95.98 97.93 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.892 1.329 . . . . 0.0 112.042 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.66 97.15 5.97 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.765 178.836 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo . . . . . 0 CA--C 1.534 0.517 0 N-CA-C 113.474 0.528 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 56' ' ' THR . 41.5 mt -90.49 12.59 18.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -66.23 117.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -82.16 134.79 35.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.675 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 188' ' ' GLU . 46.6 tp -136.29 112.47 9.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.257 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t 61.27 20.14 10.76 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.381 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.34 -23.2 5.8 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.837 -1.173 . . . . 0.0 115.422 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.762 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 90.5 mtt180 -131.06 158.75 39.52 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.579 1.19 . . . . 0.0 111.088 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 71.6 m -76.2 150.79 37.04 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.199 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -49.22 -45.6 44.72 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.832 0.453 . . . . 0.0 111.298 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.36 -38.0 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.233 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.685 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.7 t70 -64.03 -42.59 97.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.212 0.529 . . . . 0.0 109.867 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.762 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 28.2 m-85 -61.03 -38.08 84.83 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.738 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.45 -42.54 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 110.671 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 30' ' ' ILE . 77.5 t -62.31 -43.34 97.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.566 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.576 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 44.5 t -50.3 -57.94 11.32 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 37.2 Cg_exo -62.07 -41.09 38.11 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.803 1.669 . . . . 0.0 112.359 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.697 HD11 HG11 ' A' ' 98' ' ' VAL . 90.5 mt -66.09 -42.11 89.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.184 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.411 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.7 tt -63.37 -45.43 91.16 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.073 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.04 -15.92 61.5 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.406 ' CB ' HD13 ' A' ' 110' ' ' ILE . 71.6 p -70.57 172.51 8.44 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.246 0.546 . . . . 0.0 111.231 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -70.03 2.24 3.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.537 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 3' ' ' ALA . 9.7 p -72.67 152.89 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 122.182 -0.324 . . . . 0.0 111.137 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' C ' HD22 ' A' ' 44' ' ' ASN . 59.5 t30 -68.17 -79.62 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -121.04 163.96 17.51 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.238 0.542 . . . . 0.0 111.074 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -107.89 115.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.997 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -106.52 117.16 33.31 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.746 HG21 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -97.58 118.09 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-O 121.774 0.797 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.4 122.92 33.08 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.853 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 7' ' ' ALA . 56.8 p -130.48 156.61 44.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.552 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 75' ' ' THR . 35.4 t -105.04 143.15 26.14 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.283 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -56.79 -25.22 59.85 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.074 2.516 . . . . 0.0 111.033 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.44 -2.85 47.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -141.77 66.43 21.97 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.597 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.717 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 95.3 Cg_endo -105.14 86.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.144 0 C-N-CA 116.759 -1.694 . . . . 0.0 109.854 170.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 39.1 ttmt -148.84 -50.83 0.16 Allowed 'General case' 1 C--N 1.212 -5.386 0 CA-C-N 109.89 -3.323 . . . . 0.0 103.044 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 21' ' ' LEU . 86.4 m -62.07 -47.53 84.28 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.918 -1.946 . . . . 0.0 105.906 163.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.717 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.71 -47.96 81.34 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.949 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.583 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.4 pt-20 -57.23 -38.02 73.14 Favored 'General case' 0 C--N 1.369 1.431 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -65.89 -51.62 57.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 120.912 0.387 . . . . 0.0 111.714 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.746 HD13 HG21 ' A' ' 47' ' ' ILE . 97.0 mt -62.99 -46.26 96.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.505 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.589 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 65.1 t30 -59.25 -39.97 84.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.381 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 t -74.91 -47.43 29.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.31 87.95 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -108.82 14.83 24.01 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.635 -0.426 . . . . 0.0 112.015 -173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.0 pttt -62.9 -22.09 66.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -88.36 -1.19 57.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.81 128.54 49.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.943 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -70.23 -41.25 73.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.834 -178.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.411 HD21 ' HG ' ' A' ' 38' ' ' LEU . 10.1 p-10 -80.17 -0.67 37.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.2 mt -108.06 122.67 62.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.515 0.674 . . . . 0.0 110.206 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.9 135.68 63.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.929 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -106.95 131.03 57.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.061 0.458 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.6 pt -125.56 157.57 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.339 0.59 . . . . 0.0 111.814 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -102.32 133.32 47.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.389 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.2 t -161.77 -177.94 6.19 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.113 0.959 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 57.4 m -75.09 5.21 5.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 126.943 2.097 . . . . 0.0 113.158 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.04 -19.62 0.0 OUTLIER Glycine 0 N--CA 1.513 3.793 0 C-N-CA 127.876 2.655 . . . . 0.0 118.134 -171.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 11.5 tmtt? -59.29 -38.85 81.2 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 171.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.12 8.56 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -62.2 -50.51 71.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.17 -45.35 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.872 0.844 . . . . 0.0 110.575 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.84 -43.57 94.55 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.378 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.65 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.2 t0 -58.4 -50.12 74.83 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.874 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -56.87 -41.86 78.74 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.041 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.496 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.0 m-80 -60.03 -43.72 95.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 62.7 mm-40 -66.74 -42.61 85.95 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.79 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.58 -42.52 99.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -67.95 -26.57 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -38.64 96.95 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.929 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -70.5 -40.06 73.79 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.01 150.66 27.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -111.75 -0.96 15.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.047 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 28.2 mt-10 -134.86 159.01 73.75 Favored Pre-proline 0 CA--C 1.508 -0.663 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.161 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 36.5 Cg_endo -65.02 147.85 89.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.157 1.904 . . . . 0.0 111.124 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 51.2 p90 -141.69 162.13 36.23 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.588 0.709 . . . . 0.0 111.707 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.645 HD11 ' HB ' ' A' ' 154' ' ' ILE . 1.1 tm? -86.17 139.41 31.11 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.597 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.704 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 89.3 t -117.12 134.08 61.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.78 0.832 . . . . 0.0 108.857 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 37' ' ' LEU . 8.6 m -127.79 159.88 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.246 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -100.19 135.3 41.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.546 ' O ' HD22 ' A' ' 29' ' ' LEU . 81.0 p -74.95 -12.03 60.25 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -102.32 3.28 37.87 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 175' ' ' ILE . 70.0 mt -91.22 121.01 32.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.882 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.577 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 86.2 mt -118.33 118.67 58.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.193 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 60.8 t30 166.87 168.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.676 0.79 . . . . 0.0 110.386 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.18 93.48 3.95 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.546 0.689 . . . . 0.0 109.914 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HE3' HG13 ' A' ' 109' ' ' ILE . 31.8 mmmt -99.43 2.88 45.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.266 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.618 ' HA ' HD12 ' A' ' 110' ' ' ILE . 71.9 p -53.65 -32.56 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -70.7 -27.78 64.25 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.745 0.783 . . . . 0.0 110.008 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.486 HG13 ' HE3' ' A' ' 106' ' ' LYS . 28.1 mm -71.57 -40.57 71.46 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.304 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 107' ' ' SER . 70.0 mt -60.4 -45.79 96.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.933 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -64.64 -43.37 93.89 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.436 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.9 t -61.9 -45.54 93.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.533 HG13 ' N ' ' A' ' 114' ' ' VAL . 42.6 pt -65.04 -41.57 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.533 ' N ' HG13 ' A' ' 113' ' ' ILE . 57.6 t -62.16 -49.13 85.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.98 -43.18 93.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.852 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.518 ' CE2' HD11 ' A' ' 120' ' ' ILE . 71.7 t80 -63.7 -49.48 72.93 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 110.949 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.433 ' HB2' HD22 ' A' ' 130' ' ' LEU . 70.4 t80 -59.04 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.986 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 114' ' ' VAL . 28.1 m-85 -65.03 -31.83 73.25 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 50.3 t -62.02 -46.85 87.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.445 0.641 . . . . 0.0 109.421 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.659 HG22 HG11 ' A' ' 127' ' ' VAL . 71.6 mt -64.59 -43.54 96.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.352 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -60.48 -41.74 94.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.279 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.44 -44.33 95.92 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.648 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -77.85 -32.42 52.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.999 0.428 . . . . 0.0 111.33 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 127' ' ' VAL . 46.9 m -143.57 100.69 5.14 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.8 -13.75 39.55 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.8 2.333 . . . . 0.0 112.966 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.01 -32.73 74.15 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -71.37 129.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -128.45 4.6 5.66 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.637 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.05 153.41 39.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.939 0.4 . . . . 0.0 111.374 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 117' ' ' PHE . 23.4 tp -137.64 146.34 43.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.52 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.88 129.41 46.85 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.943 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 152' ' ' ALA . 63.9 t -105.06 115.11 46.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.3 ptm -145.82 157.53 43.91 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.19 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 152' ' ' ALA . 14.5 pt -133.03 155.0 81.57 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.834 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo . . . . . 0 C--O 1.237 0.445 0 C-N-CA 122.361 2.04 . . . . 0.0 111.923 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.438 -1.053 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.47 136.76 77.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.993 1.795 . . . . 0.0 110.352 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -93.47 0.78 56.88 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.386 0.613 . . . . 0.0 110.617 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.79 -91.26 0.08 OUTLIER Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.993 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.645 ' HB ' HD11 ' A' ' 96' ' ' LEU . 14.4 pt -139.66 162.12 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.171 0.51 . . . . 0.0 112.173 -176.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.704 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.4 m120 -112.45 156.6 22.29 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.45 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 91.6 t -125.4 129.47 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 122.788 0.435 . . . . 0.0 109.889 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.35 155.27 31.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.048 0.451 . . . . 0.0 111.56 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.518 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 61.3 m -98.17 155.06 37.39 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.954 173.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 72.4 Cg_endo -76.52 86.11 1.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.579 2.186 . . . . 0.0 111.519 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -108.54 -175.42 2.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -128.9 28.16 5.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.875 0.845 . . . . 0.0 109.627 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.72 38.26 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -77.4 143.15 38.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.43 0.615 . . . . 0.0 109.545 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.518 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 20.9 pt20 -130.06 161.31 31.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.754 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.38 125.95 26.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.835 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.69 127.33 52.78 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.758 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -93.76 162.79 13.79 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 121.528 0.68 . . . . 0.0 111.716 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -117.42 129.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.891 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.4 ttp -128.45 126.02 39.69 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.686 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.8 t -105.38 132.06 53.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 173' ' ' GLU . 43.3 pt -119.78 171.73 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.208 0.527 . . . . 0.0 111.211 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -109.02 13.94 24.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.657 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.8 mm-40 -97.95 135.77 39.19 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.871 0.843 . . . . 0.0 111.278 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.9 153.67 18.11 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.459 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 102' ' ' LEU . 1.8 pt -132.78 151.02 33.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.386 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.12 116.94 27.86 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.474 ' HB3' HD23 ' A' ' 102' ' ' LEU . 31.0 p-10 -116.13 175.78 5.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 184' ' ' LEU . 46.4 mm -116.3 120.13 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.975 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 -47.25 5.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.82 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.5 p -128.03 166.54 18.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.19 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.35 -42.11 95.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.557 0.694 . . . . 0.0 109.754 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.58 -39.39 94.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.679 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.688 ' HA ' HD12 ' A' ' 178' ' ' ILE . 57.8 tp -61.02 -42.36 98.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.486 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 61.4 tttp -61.56 -40.92 96.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.872 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.9 -45.57 94.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.74 98.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.947 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 11.5 pt-20 -64.86 -37.75 88.69 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.526 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 94.8 mmm -63.54 -39.65 94.97 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.979 0.418 . . . . 0.0 110.349 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.1 tp -62.6 -44.86 95.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.908 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.432 HD12 ' HG ' ' A' ' 24' ' ' LEU . 94.3 mt -64.14 -39.43 94.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.337 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 99.3 mttt . . . . . 0 C--N 1.313 -1.014 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.345 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 95' ' ' PHE . 59.8 tpp . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.258 0.551 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -122.04 166.3 14.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.2 127.14 56.08 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.942 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.517 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.7 tp -101.48 126.21 48.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.677 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -119.08 107.97 22.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.598 ' O ' ' HB3' ' A' ' 100' ' ' SER . 60.6 ttm -80.93 98.07 7.72 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.513 0.673 . . . . 0.0 111.47 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.533 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.22 98.04 6.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.364 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -0.99 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.347 177.874 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 27.4 Cg_endo . . . . . 0 C--O 1.226 -0.098 0 N-CA-C 114.639 0.976 . . . . 0.0 114.639 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.09 4.95 24.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 90.6 mt -71.68 126.11 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 62.9 pttt -115.11 143.18 45.6 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 184' ' ' LEU . 89.4 mt -127.47 140.25 52.27 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.735 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.7 m 48.42 35.43 5.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.74 -12.7 53.57 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.23 161.28 38.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 119.476 1.638 . . . . 0.0 112.124 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 80.8 m -77.82 164.91 24.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.505 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 92.6 mt -58.35 -39.73 80.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.151 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.523 HG12 HG12 ' A' ' 60' ' ' ILE . 4.6 tp -58.32 -45.24 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.199 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.77 -42.41 97.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.12 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HE2' ' O ' ' A' ' 24' ' ' LEU . 4.2 m-85 -62.65 -36.17 81.99 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.773 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 29' ' ' LEU . 74.7 t -72.17 -45.2 63.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 120.818 0.342 . . . . 0.0 111.04 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 30' ' ' ILE . 76.0 t -63.85 -44.98 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.581 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 74.7 m -53.0 -54.58 42.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -173.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 51.3 Cg_exo -60.67 -40.3 56.47 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.009 1.806 . . . . 0.0 112.299 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.561 HD11 HG11 ' A' ' 98' ' ' VAL . 81.7 mt -67.3 -43.2 82.31 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.919 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -61.9 -46.06 91.03 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 21.6 ptmt -72.99 -15.57 61.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.485 ' OG ' HG12 ' A' ' 42' ' ' VAL . 79.9 p -75.41 173.71 10.57 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.195 0.521 . . . . 0.0 111.007 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -60.6 -18.39 52.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.746 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.485 HG12 ' OG ' ' A' ' 40' ' ' SER . 11.9 p -64.98 146.41 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.991 0.424 . . . . 0.0 111.108 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -79.79 -73.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.05 150.78 25.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.452 0.644 . . . . 0.0 111.799 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.06 116.12 51.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.553 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 84.4 m-85 -106.12 117.79 34.94 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -98.64 118.48 45.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.645 0.736 . . . . 0.0 110.301 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -88.18 117.85 27.36 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.964 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 7' ' ' ALA . 70.0 p -125.94 157.85 36.69 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.6 p -109.27 155.65 40.72 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.326 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.29 -18.44 62.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.598 2.199 . . . . 0.0 111.002 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -83.38 -7.4 59.57 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.999 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.0 p -141.37 66.74 24.41 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.749 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.0 Cg_endo -102.09 84.22 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.699 0 C-N-CA 116.469 -1.888 . . . . 0.0 108.577 168.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 53.5 mtmt -150.68 -50.34 0.13 Allowed 'General case' 1 C--N 1.216 -5.198 0 CA-C-N 109.446 -3.524 . . . . 0.0 103.184 -176.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.3 m -62.82 -46.97 85.46 Favored 'General case' 0 N--CA 1.391 -3.41 0 CA-C-N 112.692 -2.049 . . . . 0.0 106.125 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.749 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -61.5 -49.27 77.42 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.383 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.566 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 14.3 pt-20 -58.71 -38.48 78.38 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.03 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.76 -50.26 69.74 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.704 0.287 . . . . 0.0 111.458 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 47' ' ' ILE . 96.7 mt -63.59 -43.65 98.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.879 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -58.23 -44.36 88.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.346 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 75.1 m -68.74 -40.16 79.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.348 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.16 90.57 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.42 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 60.0 m-85 -115.96 42.19 2.4 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.549 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.2 mmmt -60.62 -21.39 62.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.143 0.497 . . . . 0.0 110.976 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -93.24 11.69 27.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.631 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.465 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.4 p90 -43.4 122.34 2.57 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.33 -50.0 3.58 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -111.05 10.96 22.07 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.531 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 85.9 mt -105.99 124.27 61.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.295 0.569 . . . . 0.0 110.35 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 60.3 t -125.28 133.7 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.687 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.41 132.46 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.091 0.472 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.9 pt -127.83 156.03 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-O 121.912 0.863 . . . . 0.0 111.325 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -110.35 133.14 53.55 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.496 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 10.1 t -162.22 -169.81 2.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 53.8 m -69.6 1.77 3.82 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 126.56 1.944 . . . . 0.0 114.438 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.46 -21.53 0.0 OUTLIER Glycine 1 N--CA 1.519 4.226 0 C-N-CA 126.209 1.862 . . . . 0.0 117.019 -174.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 76' ' ' SER . 2.5 tmmt? -56.57 -34.2 66.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.78 126.08 6.57 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -60.26 -51.69 68.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.48 -45.76 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 121.727 0.775 . . . . 0.0 110.795 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 69.5 mm-40 -60.99 -42.69 98.9 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.859 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.503 ' HB3' ' HE1' ' A' ' 6' ' ' MET . 8.7 t0 -58.94 -50.69 73.09 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.9 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.3 mm? -57.5 -43.98 84.6 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.055 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.523 ' HA ' HG12 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -61.36 -40.1 93.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.968 178.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 70.7 mm-40 -67.17 -44.27 80.13 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.565 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 97.0 m -63.92 -41.63 97.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.619 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 84' ' ' LEU . 35.4 pt -66.73 -35.3 74.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.197 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.33 94.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.345 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.0 -49.19 77.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.958 . . . . 0.0 112.969 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.565 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 75.5 m-85 -74.2 148.23 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.176 0.512 . . . . 0.0 112.103 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.4 m -96.26 -8.41 32.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 15.5 pt-20 -151.55 173.47 4.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 93' ' ' GLU . 58.1 Cg_endo -69.35 148.48 67.82 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.072 1.848 . . . . 0.0 113.795 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 40.6 p90 -146.18 162.39 38.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 154' ' ' ILE . 91.2 mt -84.44 150.13 25.51 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.542 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 87.3 t -121.84 129.57 75.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.434 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.7 m -131.65 162.96 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.088 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.1 t -99.4 145.89 26.9 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 6' ' ' MET . 80.0 p -65.49 -20.5 66.37 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 177' ' ' ASN . 53.7 p-10 -105.14 12.41 32.06 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.21 115.37 11.37 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.929 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 29' ' ' LEU . 73.6 mt -122.45 117.02 50.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 33.6 t-20 173.88 169.62 0.2 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.62 73.71 5.16 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.76 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.2 pttp -82.64 -1.84 52.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.185 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.623 ' HA ' HD12 ' A' ' 110' ' ' ILE . 71.2 m -58.95 -40.61 85.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.52 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -71.33 -40.35 70.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.558 1.17 . . . . 0.0 109.895 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 106' ' ' LYS . 66.7 mt -63.02 -39.56 85.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.127 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 107' ' ' SER . 59.8 mt -57.52 -47.61 84.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -63.9 -39.97 95.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.718 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.7 m -61.66 -37.44 84.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.184 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -60.05 -48.38 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.323 0.582 . . . . 0.0 109.622 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.84 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.162 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.55 -47.56 85.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.157 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.528 ' CE2' HD11 ' A' ' 120' ' ' ILE . 80.9 t80 -64.18 -49.52 71.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.239 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.8 t80 -59.44 -47.92 83.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 4.2 m-85 -61.5 -35.46 77.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.15 -46.71 85.9 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.23 0.538 . . . . 0.0 109.733 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.528 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -65.08 -49.92 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.481 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.588 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 20.4 ptmt -66.32 -27.31 67.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.3 96.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.566 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 20.5 pttp -83.45 -39.71 20.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.917 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 25.2 m -130.49 98.83 19.69 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.403 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -9.56 26.62 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 122.842 2.361 . . . . 0.0 112.55 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.17 -32.81 72.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.856 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 10.3 p -74.72 124.99 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 0.0 110.993 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 41.1 mt-10 -117.85 -2.61 11.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.702 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.78 41.73 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.859 0.361 . . . . 0.0 111.289 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.428 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -135.16 131.98 37.44 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' HB2' ' CD ' ' A' ' 166' ' ' GLU . . . -119.06 127.08 53.07 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.575 HG21 ' CD1' ' A' ' 113' ' ' ILE . 90.1 t -107.55 112.55 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 9.9 ptm -146.22 158.4 43.88 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.225 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 152' ' ' ALA . 25.7 pt -134.22 157.0 78.55 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.147 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.239 0.536 0 C-N-CA 122.235 1.956 . . . . 0.0 111.878 178.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.445 -0.699 0 CA-C-O 121.056 0.455 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.408 ' O ' HD11 ' A' ' 175' ' ' ILE . 58.9 Cg_endo -70.58 147.89 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.395 2.063 . . . . 0.0 110.891 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -114.22 0.22 14.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 176.21 -123.72 0.93 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.268 -1.444 . . . . 0.0 113.648 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 113' ' ' ILE . 4.1 mp -101.17 137.09 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 121.679 0.752 . . . . 0.0 111.713 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.626 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.9 t-20 -109.6 156.7 19.87 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.48 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.531 HG22 HD23 ' A' ' 96' ' ' LEU . 94.7 t -123.62 130.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 C-N-CA 122.667 0.387 . . . . 0.0 110.243 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.429 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.9 m -133.96 150.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.379 0.609 . . . . 0.0 111.415 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.472 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 53.0 p -98.25 164.58 16.93 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.383 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 77.9 Cg_endo -75.72 76.1 3.79 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.55 2.167 . . . . 0.0 111.826 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.82 -172.08 2.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -127.46 131.78 50.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.583 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.91 -114.09 3.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.975 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.33 145.34 51.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.52 166.98 21.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 2.5 tmtm? -55.81 127.66 31.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.152 0.501 . . . . 0.0 110.615 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' CD ' ' HB2' ' A' ' 131' ' ' ALA . 44.1 tt0 -137.52 134.72 36.02 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.587 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.428 ' HG3' HG21 ' A' ' 120' ' ' ILE . 34.5 mm-40 -94.11 162.84 13.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.485 0.66 . . . . 0.0 111.646 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.01 130.08 73.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.081 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.484 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.7 ttp -129.6 130.99 46.37 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.691 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.9 t -111.42 131.51 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 173' ' ' GLU . 42.1 pt -117.66 169.69 7.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.777 0.799 . . . . 0.0 112.482 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -93.51 2.84 56.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' A' ' 171' ' ' ILE . 57.7 mm-40 -99.45 131.71 45.27 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 122.076 0.941 . . . . 0.0 113.149 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.08 149.47 21.91 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.886 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.408 HD11 ' O ' ' A' ' 151' ' ' PRO . 2.2 pt -123.64 139.81 49.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.833 176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -113.53 126.44 55.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 101' ' ' ASP . 34.1 p-10 -119.13 19.33 12.93 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.555 0.693 . . . . 0.0 111.595 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 184' ' ' LEU . 23.2 mm 77.21 -93.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.515 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 69.91 -36.69 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.9 p -128.55 162.36 27.43 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.143 -0.348 . . . . 0.0 111.71 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.62 -39.12 83.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -48.66 80.81 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.52 -36.54 84.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.743 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.655 ' HA ' HD12 ' A' ' 178' ' ' ILE . 47.9 tp -59.98 -50.25 74.5 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.433 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.95 -40.5 91.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -60.61 -43.53 97.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.977 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.79 -43.51 98.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.698 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 24' ' ' LEU . 53.7 mm-40 -60.7 -45.48 94.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.24 0.543 . . . . 0.0 110.201 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 98.5 mtp -63.36 -42.28 98.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.698 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.4 -42.26 92.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 120.884 0.373 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -60.99 -43.25 99.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.354 0.597 . . . . 0.0 110.003 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.433 176.202 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 94' ' ' PRO . 59.2 ttm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.524 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 38.9 m-20 -115.8 166.1 12.33 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.81 127.4 55.99 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.09 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.38 124.8 49.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.444 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.693 ' HA ' HG22 ' A' ' 98' ' ' VAL . 64.0 mt -118.3 106.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.484 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 14.1 ptm -99.69 100.36 11.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.905 1.336 . . . . 0.0 113.736 -172.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -116.54 96.8 5.68 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.537 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.158 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.197 -176.946 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.958 0.316 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 59' ' ' TYR . 35.0 mt -95.43 7.32 46.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.334 -0.393 . . . . 0.0 112.042 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.76 119.83 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 39.9 pttt -100.55 138.39 37.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.029 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 188' ' ' GLU . 27.0 tp -136.47 115.9 12.75 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.197 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.2 m 60.53 19.66 9.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.85 -89.1 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.013 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 99.0 mtt180 -103.84 170.03 8.17 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.24 0.543 . . . . 0.0 111.954 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 69.7 m -76.71 163.72 26.56 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.462 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 77.0 mt -58.78 -39.43 81.01 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.283 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.6 tp -56.73 -46.32 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.183 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.538 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 11.7 t70 -67.35 -40.76 85.84 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.044 0.45 . . . . 0.0 110.947 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 13.5 m-30 -62.29 -33.99 75.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.36 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -71.55 -42.91 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 30' ' ' ILE . 74.2 t -63.92 -43.79 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.2 m -52.42 -54.55 41.03 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.56 -39.51 16.0 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.565 1.51 . . . . 0.0 112.275 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.24 -42.82 92.99 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 120.801 0.334 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.4 tt -61.3 -46.52 89.96 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.708 0.29 . . . . 0.0 111.19 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -76.3 -13.15 60.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -73.82 -178.49 3.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 112.126 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.5 ttmm -59.48 -24.95 64.01 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.941 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.56 156.02 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.176 0.513 . . . . 0.0 112.29 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.524 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -77.74 -86.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 10.0 m120 -107.72 156.85 18.64 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 111.454 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mm -107.85 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 89.7 m-85 -108.91 121.29 44.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -102.33 118.9 49.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.667 0.746 . . . . 0.0 110.715 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 6' ' ' MET . . . -87.77 126.43 34.99 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.752 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -133.85 170.78 15.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.4 m -127.34 150.88 73.73 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 -27.16 80.94 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.501 2.801 . . . . 0.0 111.986 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.15 5.01 40.02 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.996 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.5 p -140.77 66.08 26.08 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.43 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 88.4 Cg_endo -106.73 88.12 0.02 OUTLIER 'Trans proline' 1 N--CA 1.379 -5.212 0 C-N-CA 117.212 -1.392 . . . . 0.0 110.66 170.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.665 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 72.6 mmtt -151.39 -50.41 0.12 Allowed 'General case' 1 C--N 1.22 -5.04 0 CA-C-N 109.862 -3.335 . . . . 0.0 103.054 177.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.497 HG22 HD12 ' A' ' 60' ' ' ILE . 86.8 m -63.83 -48.34 77.2 Favored 'General case' 0 N--CA 1.384 -3.759 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.107 163.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.685 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 13.5 tmtt? -64.66 -52.37 57.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -60.13 -33.07 71.63 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 116.701 -1.999 . . . . 0.0 112.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.569 ' CD2' HD22 ' A' ' 21' ' ' LEU . 58.0 t80 -70.34 -52.73 20.51 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.483 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 47' ' ' ILE . 97.1 mt -63.44 -45.91 96.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.57 -42.26 92.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.264 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.1 t -71.67 -41.72 68.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.491 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.19 90.05 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.538 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 77.5 m-85 -106.69 32.51 4.48 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.502 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.4 mtmt -63.34 -18.66 63.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.474 0.654 . . . . 0.0 110.08 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.31 10.4 24.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.641 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.1 p90 -45.84 128.1 8.58 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -102.48 -51.48 3.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.846 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.547 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.0 p-10 -118.74 15.74 13.55 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.885 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -106.45 129.8 59.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.854 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.7 t -127.86 131.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.52 129.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 48' ' ' ALA . 44.0 pt -125.63 157.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.473 0.654 . . . . 0.0 111.818 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -108.05 134.3 51.13 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.844 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.6 t -161.18 -172.18 3.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.565 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 66.1 m -77.65 4.66 10.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 126.921 2.088 . . . . 0.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.6 -23.66 0.0 OUTLIER Glycine 0 N--CA 1.513 3.822 0 C-N-CA 127.167 2.317 . . . . 0.0 117.623 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 22.3 tptm -58.01 -37.11 73.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.19 122.95 6.7 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' HD23 ' A' ' 84' ' ' LEU . 87.5 t80 -59.89 -51.3 70.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.44 -43.98 87.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.677 0.751 . . . . 0.0 110.523 -177.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -59.89 -42.87 94.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.551 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.601 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 34.9 t0 -60.07 -50.27 74.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.952 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.6 mm? -56.64 -41.76 77.73 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.583 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.455 ' O ' HG12 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -61.37 -42.1 98.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.849 178.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 64.4 mm-40 -66.16 -44.24 84.65 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.4 m -63.4 -41.52 98.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.324 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 160' ' ' LYS . 34.4 pt -64.42 -30.16 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.67 96.53 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.331 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.55 -38.18 71.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.41 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 92.2 m-85 -92.55 136.8 32.91 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 m -100.68 -4.53 28.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.441 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 41.3 mt-10 -134.46 160.58 67.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.559 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.5 Cg_endo -63.06 143.54 90.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.082 1.855 . . . . 0.0 111.843 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.49 162.04 37.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.719 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.582 HD23 HG22 ' A' ' 156' ' ' VAL . 92.8 mt -84.73 149.82 25.51 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.914 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 59.7 t -122.14 125.12 72.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.104 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.3 m -136.37 158.13 37.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.302 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.465 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.2 t -100.9 143.49 30.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.241 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 7' ' ' ALA . 49.9 m -76.73 -9.35 58.61 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -106.27 11.18 31.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.57 HD22 HD12 ' A' ' 175' ' ' ILE . 62.5 mt -91.63 114.67 27.26 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.85 135.06 65.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 112.009 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 178.61 -178.89 0.31 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.83 58.69 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 109' ' ' ILE . 16.6 ptmt -66.23 -8.1 22.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.9 -1.5 . . . . 0.0 113.519 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 110' ' ' ILE . 60.3 m -58.72 -41.44 86.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -72.82 -37.85 67.36 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.6 mm -60.78 -40.81 86.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.188 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 107' ' ' SER . 59.4 mt -58.33 -48.65 84.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.445 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 55.0 m-80 -65.65 -39.91 91.9 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.3 m -61.55 -37.23 83.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.754 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.7 mm -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.872 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.89 -44.66 99.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.687 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -60.03 -48.19 82.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.8 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.75 ' CE2' HD11 ' A' ' 120' ' ' ILE . 78.9 t80 -63.98 -47.21 81.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.4 -46.61 83.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 14.4 m-85 -62.13 -38.3 88.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.49 -41.51 98.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.339 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.75 HD11 ' CE2' ' A' ' 116' ' ' TYR . 74.7 mt -67.9 -48.63 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.204 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.17 -25.46 68.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.543 -177.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.72 98.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.819 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.99 -39.52 19.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.7 m -130.67 95.37 26.52 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.656 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.07 -13.14 35.85 Favored 'Trans proline' 0 N--CA 1.474 0.38 0 C-N-CA 122.738 2.292 . . . . 0.0 111.952 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.91 -31.01 71.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.069 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 124' ' ' THR . 13.4 p -65.53 133.1 31.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.061 0.458 . . . . 0.0 111.154 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.535 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 43.7 mt-10 -124.34 -3.28 7.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.899 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.26 156.8 43.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.801 0.334 . . . . 0.0 111.433 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.78 137.74 38.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.7 139.32 52.77 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.037 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 113' ' ' ILE . 67.8 t -113.97 117.06 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.9 ptm -145.72 152.81 40.19 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.872 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 152' ' ' ALA . 36.4 pt -132.02 159.55 71.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.051 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 C--O 1.238 0.477 0 C-N-CA 122.003 1.802 . . . . 0.0 110.784 177.856 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.447 -0.585 0 CA-C-O 121.069 0.461 . . . . 0.0 111.851 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 59.1 Cg_endo -71.0 144.29 47.03 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.709 2.273 . . . . 0.0 112.102 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -118.39 -6.03 10.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.34 -120.35 1.26 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.934 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.619 ' CG1' HG13 ' A' ' 113' ' ' ILE . 40.5 pt -121.21 158.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 120.903 0.382 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.682 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.1 t-20 -116.5 152.23 34.49 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.409 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 96' ' ' LEU . 93.6 t -121.41 129.46 75.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 122.51 0.324 . . . . 0.0 110.409 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 155' ' ' ASN . 31.6 m -135.3 149.01 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.143 0.497 . . . . 0.0 111.391 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 77.1 p -98.79 163.7 18.35 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.543 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 62.4 Cg_endo -73.4 74.65 3.1 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.258 1.972 . . . . 0.0 112.079 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.593 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.3 mmmt -115.33 137.68 51.78 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.748 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -93.18 107.05 18.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.336 0.589 . . . . 0.0 110.23 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.02 -128.95 6.37 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -136.29 129.27 31.19 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -117.53 166.5 12.29 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.607 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.0 120.37 9.53 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.301 0.572 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -121.02 130.1 53.65 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.801 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.482 ' HG3' HG21 ' A' ' 120' ' ' ILE . 42.8 mm-40 -92.8 161.9 14.33 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 121.731 0.777 . . . . 0.0 112.196 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.2 mm -117.89 127.05 75.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.652 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.56 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.3 ttp -124.77 128.71 49.17 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.92 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.3 t -107.97 128.75 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.492 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.671 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.6 pt -115.51 175.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.019 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -121.69 23.07 10.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.769 0.795 . . . . 0.0 109.889 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.671 ' HB2' HD12 ' A' ' 171' ' ' ILE . 20.0 mp0 -98.7 130.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.988 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.03 143.03 28.27 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.287 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.57 HD12 HD22 ' A' ' 102' ' ' LEU . 10.1 pt -121.6 154.06 25.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.409 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.38 106.1 13.91 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.672 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -68.05 -35.79 78.82 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.088 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 183' ' ' ASP . 98.7 mt 66.32 109.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.045 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -120.93 -15.26 8.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.217 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.8 p -127.54 166.34 18.19 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.414 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.51 -36.91 85.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.04 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.54 -40.6 87.78 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 178' ' ' ILE . 77.0 m-20 -61.27 -41.71 97.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.491 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 178' ' ' ILE . 89.9 mt -61.94 -47.63 84.02 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.312 0.577 . . . . 0.0 109.949 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 88.0 tttt -61.92 -42.68 99.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.623 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 186' ' ' LEU . 8.6 tt -60.47 -47.97 83.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.937 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -64.91 -42.11 95.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.202 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 pt-20 -69.5 -31.65 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 96.5 mtp -62.73 -40.96 98.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.646 0.26 . . . . 0.0 111.537 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.6 -36.27 60.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.189 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 190' ' ' LEU . 92.3 mt -62.95 -45.77 90.89 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.443 0.64 . . . . 0.0 110.525 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? . . . . . 0 C--N 1.314 -0.965 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.994 178.944 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.471 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.4 ttm . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 33.5 m-20 -100.12 166.17 11.15 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -115.58 130.77 56.99 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.924 0.392 . . . . 0.0 111.101 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.8 tp -106.06 125.07 50.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.181 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.693 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -117.68 102.22 13.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.438 ' O ' ' HB3' ' A' ' 100' ' ' SER . 12.1 ptm -96.22 98.52 10.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.987 1.375 . . . . 0.0 112.093 -175.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.44 98.23 6.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.196 -1.82 . . . . 0.0 110.332 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.331 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.843 179.317 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 CA--C 1.534 0.493 0 CA-C-O 121.011 0.338 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 59' ' ' TYR . 57.8 mt -102.59 7.61 39.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.41 118.37 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.592 0.711 . . . . 0.0 109.129 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 48.8 pttt -87.68 125.92 34.67 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.999 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 188' ' ' GLU . 60.3 tp -131.71 119.69 21.69 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.003 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.1 m 57.29 28.72 15.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.25 -76.02 0.39 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.019 -1.086 . . . . 0.0 114.48 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.713 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 44.3 mtt180 -101.73 166.42 10.69 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 112.36 -172.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 75.7 m -76.15 151.79 36.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.674 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.1 tt -48.91 -47.93 42.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.26 0.624 . . . . 0.0 111.711 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 60' ' ' ILE . 5.7 tp -57.61 -42.49 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 0.0 111.811 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.713 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 15.0 t70 -65.24 -39.73 93.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.142 0.496 . . . . 0.0 109.933 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -63.73 -37.34 86.99 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.969 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 29' ' ' LEU . 72.3 t -65.27 -43.43 95.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 110.239 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -63.61 -43.0 98.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.583 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -49.99 -57.01 13.85 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 40' ' ' SER . 41.8 Cg_endo -67.83 -37.99 14.52 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 121.57 1.514 . . . . 0.0 112.462 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.528 HD11 HG11 ' A' ' 98' ' ' VAL . 83.3 mt -65.09 -41.22 95.19 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.879 0.371 . . . . 0.0 111.67 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.488 ' HG ' HD21 ' A' ' 69' ' ' ASN . 5.7 tt -59.97 -46.58 88.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.035 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -83.31 -5.87 59.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 57.4 p -75.79 -178.38 4.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.518 0.675 . . . . 0.0 111.585 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 24.5 ttmm -57.44 -24.8 57.8 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.719 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 3' ' ' ALA . 22.7 m -67.38 161.8 3.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.517 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 60.1 t30 -80.43 -76.83 0.21 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.544 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -117.56 159.77 22.34 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.909 0.385 . . . . 0.0 110.767 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.67 114.06 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.3 m-85 -107.88 116.75 32.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.567 HG21 HD13 ' A' ' 60' ' ' ILE . 96.1 mt -97.98 116.15 39.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.558 0.694 . . . . 0.0 110.543 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.51 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.81 125.35 34.4 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.705 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -129.34 158.94 37.7 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 38.0 m -103.93 149.76 37.53 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.575 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.9 -20.63 57.99 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.745 2.297 . . . . 0.0 111.309 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -89.04 1.66 55.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 20.3 p -138.08 67.51 48.07 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.653 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 90.8 Cg_endo -100.99 87.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.384 -4.939 0 C-N-CA 117.303 -1.331 . . . . 0.0 109.17 169.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.7 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.5 mmtm -156.94 -52.7 0.08 Allowed 'General case' 1 C--N 1.215 -5.268 0 CA-C-N 110.183 -3.19 . . . . 0.0 103.057 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.518 HG22 HD12 ' A' ' 60' ' ' ILE . 93.3 m -63.77 -50.03 70.62 Favored 'General case' 0 N--CA 1.379 -3.991 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 165.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -65.25 -49.25 70.35 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.7 pt-20 -60.83 -31.36 70.78 Favored 'General case' 0 C--N 1.374 1.664 0 C-N-CA 116.16 -2.216 . . . . 0.0 112.17 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.518 ' CD2' HD22 ' A' ' 21' ' ' LEU . 52.9 t80 -72.2 -51.22 22.1 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.582 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.567 HD13 HG21 ' A' ' 47' ' ' ILE . 97.8 mt -62.35 -44.92 99.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.689 -174.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.71 -44.01 90.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.499 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 73.1 m -68.8 -41.21 79.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.384 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.58 88.08 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.45 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.59 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 66.5 m-85 -110.54 31.82 5.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.409 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.3 mmmm -61.77 -24.19 66.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.16 0.505 . . . . 0.0 110.739 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.27 10.97 25.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.017 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.495 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.4 p90 -45.44 134.26 6.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -175.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.06 -49.53 3.74 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.488 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.2 p-10 -119.25 11.65 12.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.563 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 80.8 mt -106.2 127.29 61.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.27 0.557 . . . . 0.0 110.697 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 76.9 t -126.45 132.23 70.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.732 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.85 130.58 52.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 48' ' ' ALA . 37.7 pt -124.07 155.73 31.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.391 0.615 . . . . 0.0 110.396 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.72 132.35 56.49 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.865 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 86' ' ' GLU . 14.2 t -163.66 -167.42 1.4 Allowed 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.5 m -66.04 1.0 1.61 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 127.017 2.127 . . . . 0.0 114.349 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.56 -22.39 0.0 OUTLIER Glycine 0 N--CA 1.514 3.875 0 C-N-CA 126.026 1.774 . . . . 0.0 116.67 -175.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 76' ' ' SER . 13.9 tmtt? -57.39 -36.6 71.49 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.38 122.84 6.23 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.58 -50.47 73.76 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 pt -71.49 -32.16 45.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.097 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.53 -43.46 89.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.467 0.651 . . . . 0.0 109.891 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.608 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.1 t0 -61.3 -50.5 72.74 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.859 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -57.44 -45.09 85.1 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.035 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.6 m-80 -60.69 -42.63 97.53 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.535 ' HG2' ' OG1' ' A' ' 75' ' ' THR . 16.8 tp10 -65.37 -46.43 80.15 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.534 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 99.0 m -63.78 -41.01 98.03 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.403 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.2 pt -65.18 -36.82 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.393 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.63 -38.97 95.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.4 174.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.35 -49.22 74.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.64 0.776 . . . . 0.0 112.814 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.534 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 83.3 m-85 -75.76 149.83 37.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -103.06 -5.29 23.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.386 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.78 158.33 74.31 Favored Pre-proline 0 CA--C 1.505 -0.787 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.94 141.62 77.83 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.858 2.372 . . . . 0.0 110.534 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 45.5 p90 -141.84 156.81 45.53 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.543 0.687 . . . . 0.0 111.923 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.534 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.42 138.5 31.73 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.931 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 64.3 t -116.94 131.67 68.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 123.311 0.644 . . . . 0.0 109.291 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 5' ' ' ILE . 17.7 m -126.72 164.04 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 112.02 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.443 ' O ' HD22 ' A' ' 102' ' ' LEU . 47.6 t -82.54 159.95 22.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.009 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 6' ' ' MET . 81.1 p -86.1 -26.07 25.46 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.6 28.77 7.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.443 HD22 ' O ' ' A' ' 99' ' ' SER . 1.5 pt? -86.55 156.88 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.694 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.7 pt -96.74 174.09 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 96.2 m-20 -69.19 -170.29 0.25 Allowed 'General case' 0 C--O 1.247 0.932 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.041 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 104' ' ' ASN . 4.2 mm? 75.03 14.74 3.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.311 1.044 . . . . 0.0 109.97 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HA ' HG12 ' A' ' 109' ' ' ILE . 47.9 mmtm -99.52 -0.81 39.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.032 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' HD12 ' A' ' 110' ' ' ILE . 75.4 p -59.31 -37.1 76.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.97 -24.77 59.66 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.87 0.843 . . . . 0.0 109.747 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 113' ' ' ILE . 41.2 mm -67.17 -39.77 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.27 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 107' ' ' SER . 66.3 mt -57.24 -49.07 81.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.13 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.401 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 52.7 m-80 -66.12 -40.41 90.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.195 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -62.77 -41.09 99.08 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.97 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 109' ' ' ILE . 47.7 mm -62.12 -48.69 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.044 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.47 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.1 t -61.98 -48.77 87.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.428 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.57 -41.99 98.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.057 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.82 -41.65 78.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.927 0.394 . . . . 0.0 110.354 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.75 -46.68 86.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.93 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 17.2 m-85 -60.05 -37.01 78.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.492 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.05 -41.14 97.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 109.563 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.1 mt -68.55 -41.36 82.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.298 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 127' ' ' VAL . 17.7 mmmt -59.94 -43.11 95.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.478 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.56 93.51 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.724 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.29 -34.73 31.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.519 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.3 m -140.31 95.43 8.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.31 -25.12 77.24 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.207 2.605 . . . . 0.0 112.688 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.66 -31.75 72.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.511 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 121' ' ' LYS . 63.3 t -69.26 122.6 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 33.8 mt-10 -130.93 18.83 5.04 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 156' ' ' VAL . . . -151.0 151.55 32.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.043 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 113' ' ' ILE . 18.7 tp -138.89 143.29 38.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.905 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.55 138.56 52.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.472 HG21 ' CD1' ' A' ' 113' ' ' ILE . 60.0 t -117.5 117.03 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 4.3 ptm -146.01 161.77 39.37 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.53 -176.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 152' ' ' ALA . 22.7 pt -132.66 154.58 81.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.558 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo . . . . . 0 N--CA 1.456 -0.703 0 C-N-CA 121.971 1.78 . . . . 0.0 110.1 176.626 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 N--CA 1.447 -0.579 0 CA-C-O 121.149 0.5 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.01 151.2 55.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.501 2.134 . . . . 0.0 110.432 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -131.98 -28.3 1.77 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.895 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.57 -136.63 6.75 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.977 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 96' ' ' LEU . 20.6 pt -123.66 161.02 26.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.735 -177.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.605 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.7 t-20 -112.13 152.52 28.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.449 -174.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' ALA . 71.6 t -124.59 130.86 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.201 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' A' ' 155' ' ' ASN . 20.1 m -133.75 149.03 30.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.513 0.673 . . . . 0.0 111.396 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.594 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 23.3 t -97.83 151.66 37.7 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.411 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 43.2 Cg_endo -67.32 77.73 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.589 2.193 . . . . 0.0 111.61 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.71 -175.67 2.83 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.13 115.9 15.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.71 -123.78 7.12 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.275 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.91 140.7 50.91 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -134.12 164.14 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.649 0.261 . . . . 0.0 111.653 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.435 ' CG ' HG22 ' A' ' 127' ' ' VAL . 49.4 tptt -57.08 127.98 34.7 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.506 0.67 . . . . 0.0 112.22 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -128.63 137.26 51.57 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.538 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.1 163.19 12.67 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.53 130.97 69.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.597 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.7 ttm -122.63 141.76 51.38 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 133' ' ' MET . 57.9 t -117.06 131.41 69.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.4 pt -120.76 175.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.12 5.5 30.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.328 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.693 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.4 mp0 -96.84 130.24 44.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.195 0.998 . . . . 0.0 111.917 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.2 mt -97.05 152.22 18.96 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.115 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.61 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.833 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.1 119.34 28.34 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -82.26 118.91 23.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.84 105.68 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.107 0.479 . . . . 0.0 110.402 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -113.1 -19.18 11.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.163 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -147.64 165.92 28.96 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.12 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -58.26 -31.91 67.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.844 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.51 -43.01 99.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.1 -42.32 98.3 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.459 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.446 ' CD1' HD13 ' A' ' 24' ' ' LEU . 58.9 tp -62.08 -46.67 88.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 63.5 tttm -64.24 -42.13 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.989 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.15 -45.38 93.26 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.13 -40.89 98.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.996 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 8.7 pt-20 -67.42 -36.28 80.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.872 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.0 mtp -62.59 -39.08 92.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.33 -34.96 61.26 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.3 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -46.06 64.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.066 0.46 . . . . 0.0 112.157 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.214 -177.386 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 23.5 ptp . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 22.7 m-20 -95.33 163.36 13.29 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.428 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -121.09 128.51 52.66 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 40.9 tp -103.75 127.45 51.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 98' ' ' VAL . 63.6 mt -117.63 103.48 14.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.51 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 14.7 ptm -98.25 115.94 29.44 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-O 123.474 1.607 . . . . 0.0 112.07 -176.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.91 -173.22 2.24 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 111.226 -2.716 . . . . 0.0 109.819 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.267 -3.271 0 CA-C-N 114.12 -1.4 . . . . 0.0 111.283 -178.121 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.482 0.819 0 N-CA-C 113.517 0.545 . . . . 0.0 113.517 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 64.3 mt -88.11 10.76 18.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.87 126.81 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 173.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 62.6 mttp -102.32 141.15 35.62 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 122.264 1.03 . . . . 0.0 113.705 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.612 HD21 HD12 ' A' ' 184' ' ' LEU . 86.4 mt -125.41 110.25 13.72 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.222 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.38 33.44 18.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.657 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -20.01 39.19 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.904 1.121 . . . . 0.0 115.904 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.678 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 89.6 mtt180 -117.71 152.31 35.5 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 119.235 1.518 . . . . 0.0 112.327 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 81.7 m -75.27 162.45 28.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.779 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 100' ' ' SER . 88.6 mt -59.86 -40.67 89.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.051 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.668 HG12 HD11 ' A' ' 60' ' ' ILE . 3.8 tp -59.77 -43.08 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.638 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 9.9 t70 -62.86 -44.08 97.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.292 0.568 . . . . 0.0 110.029 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 23.9 m-85 -65.11 -33.3 75.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.646 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.627 ' HA ' ' NZ ' ' A' ' 106' ' ' LYS . 69.7 t -71.9 -44.61 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.606 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 30' ' ' ILE . 72.2 t -64.57 -43.76 96.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.549 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 73.4 m -52.22 -54.61 39.71 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 42.4 Cg_exo -62.41 -41.91 30.66 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.11 1.874 . . . . 0.0 112.479 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.565 HD11 HG11 ' A' ' 98' ' ' VAL . 87.2 mt -67.11 -40.28 86.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.087 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.473 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.2 tt -62.28 -46.3 89.43 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.0 0.429 . . . . 0.0 109.891 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.61 -17.15 60.75 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.404 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.429 ' CB ' HG21 ' A' ' 110' ' ' ILE . 78.7 p -70.69 170.05 13.16 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.185 0.517 . . . . 0.0 111.757 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -71.85 24.77 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.1 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.92 162.38 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.828 -0.545 . . . . 0.0 110.767 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 64.5 t30 -72.27 -76.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.619 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -125.9 160.19 30.57 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.952 0.406 . . . . 0.0 110.438 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 3' ' ' ALA . 49.0 mm -108.4 116.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.7 m-85 -109.72 116.97 32.69 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.581 HG21 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -98.15 119.85 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.562 0.696 . . . . 0.0 111.039 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.479 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -95.19 119.8 34.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.984 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.3 p -125.95 150.99 47.58 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.419 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 75' ' ' THR . 54.8 m -83.77 152.2 62.58 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.009 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.32 -18.43 63.16 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.152 2.568 . . . . 0.0 111.4 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -89.95 -0.63 57.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.6 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -141.32 68.17 26.3 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 97.5 Cg_endo -104.65 85.67 0.02 OUTLIER 'Trans proline' 1 N--CA 1.382 -5.056 0 C-N-CA 116.845 -1.637 . . . . 0.0 108.889 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.685 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 35.1 mmtp -144.94 -50.14 0.26 Allowed 'General case' 1 C--N 1.224 -4.857 0 CA-C-N 110.299 -3.137 . . . . 0.0 103.78 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.517 ' HA ' HD21 ' A' ' 21' ' ' LEU . 68.4 m -62.41 -45.8 91.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -61.95 -50.86 70.42 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.896 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.685 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.3 pt-20 -63.12 -32.19 73.51 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.039 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -62.59 -50.5 71.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.91 0.386 . . . . 0.0 111.466 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 30' ' ' ILE . 92.1 mt -63.29 -43.75 98.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.104 -176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -57.65 -43.71 85.12 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.5 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t -71.82 -43.07 66.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.48 93.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.347 0.594 . . . . 0.0 110.891 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 90.2 m-85 -111.6 41.65 1.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.006 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.5 mtmt -61.3 -21.79 64.28 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.261 0.553 . . . . 0.0 110.423 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -91.2 10.59 26.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.4 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 35.3 p90 -35.62 113.79 0.22 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.51 ' C ' ' HD3' ' A' ' 68' ' ' LYS . 4.6 tmtm? -93.16 -51.93 4.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.066 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.473 HD21 ' HG ' ' A' ' 38' ' ' LEU . 27.2 p-10 -118.74 13.92 13.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.767 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.19 126.48 56.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.403 0.62 . . . . 0.0 111.527 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.8 t -126.06 133.1 69.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.56 132.71 54.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.34 155.28 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.426 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -118.11 131.18 56.44 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.222 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 50' ' ' SER . 13.0 t -165.41 -173.66 2.89 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.137 0.97 . . . . 0.0 113.582 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 78' ' ' LYS . 48.9 m -64.67 3.48 0.51 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.404 2.282 . . . . 0.0 115.497 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.14 -29.36 0.01 OUTLIER Glycine 1 N--CA 1.519 4.186 0 C-N-CA 126.434 1.969 . . . . 0.0 117.602 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' SER . 53.6 tptt -58.08 -38.91 77.26 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -100.46 114.58 5.05 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 175.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.74 -47.77 84.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.63 -49.01 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.629 0.728 . . . . 0.0 109.797 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.7 -47.16 86.74 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.631 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.591 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.4 t0 -61.12 -51.9 67.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.733 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -58.29 -44.99 88.74 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.805 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.415 ' HA ' HG12 ' A' ' 88' ' ' ILE . 4.4 m120 -58.29 -46.49 85.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.083 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.91 -46.97 82.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.176 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 96.4 m -63.6 -43.47 96.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.194 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 84' ' ' LEU . 35.8 pt -65.73 -30.86 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 120.855 0.36 . . . . 0.0 110.27 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.94 -39.67 97.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.983 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -74.99 -34.75 62.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 74.6 m-85 -76.16 142.65 41.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -103.69 1.14 31.49 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.981 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 36.5 mt-10 -138.39 160.86 62.07 Favored Pre-proline 0 CA--C 1.503 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.464 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.608 ' O ' ' HB2' ' A' ' 1' ' ' MET . 42.9 Cg_endo -68.19 145.4 66.37 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.808 1.672 . . . . 0.0 109.792 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -145.21 161.91 38.38 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.201 0.524 . . . . 0.0 112.192 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.599 HD23 HG22 ' A' ' 156' ' ' VAL . 93.3 mt -85.63 149.74 25.11 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.693 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.9 t -120.77 125.47 74.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 5' ' ' ILE . 6.1 m -131.44 162.4 39.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.325 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.517 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 49.0 m -99.45 143.3 29.86 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.16 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 78.2 p -73.15 -10.01 59.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.299 0.571 . . . . 0.0 111.605 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 99' ' ' SER . 4.7 p-10 -101.41 16.78 24.51 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.251 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.45 117.17 28.94 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 122.007 -0.433 . . . . 0.0 110.619 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 47.4 pt -69.93 -172.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.782 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.44 -175.42 2.79 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.1 tp 80.73 24.32 0.32 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 110.023 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.627 ' NZ ' ' HA ' ' A' ' 33' ' ' VAL . 50.0 mtmt -98.79 -1.86 39.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.829 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.0 m -58.07 -43.75 87.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -86.82 -20.64 27.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG12 ' A' ' 113' ' ' ILE . 43.2 mm -63.73 -45.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.961 -175.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 40' ' ' SER . 58.3 mt -59.52 -48.58 86.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.556 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -63.92 -39.67 94.71 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.084 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.2 m -62.45 -38.04 88.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.855 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.6 mm -59.61 -48.23 88.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.219 0.533 . . . . 0.0 109.932 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.53 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 78.7 t -62.71 -49.51 83.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.495 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.02 -41.97 99.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.287 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.518 ' CE2' HD11 ' A' ' 120' ' ' ILE . 46.0 t80 -63.92 -46.68 83.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.148 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.46 -47.69 84.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.989 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 27.2 m-85 -61.02 -36.88 80.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.169 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.8 t -62.21 -45.37 93.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.455 0.645 . . . . 0.0 109.71 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.576 HG21 ' HG3' ' A' ' 167' ' ' GLU . 84.7 mt -63.38 -49.22 83.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.497 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.64 -25.0 67.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.59 99.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.552 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -83.83 -34.33 24.7 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 54.4 m -137.73 97.23 10.26 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.33 -13.4 39.27 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.049 2.499 . . . . 0.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.69 -29.64 70.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.425 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.553 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 85.7 t -67.21 126.48 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.214 0.531 . . . . 0.0 110.681 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.509 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 39.8 mt-10 -108.25 -25.22 11.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.798 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.7 38.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.115 0.483 . . . . 0.0 112.111 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -135.96 132.21 36.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.174 -178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -122.28 135.41 54.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 113' ' ' ILE . 59.0 t -113.72 119.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -146.22 157.88 43.85 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.563 -177.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.649 HG12 ' HB2' ' A' ' 152' ' ' ALA . 37.8 pt -134.07 157.83 76.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.595 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--O 1.24 0.623 0 C-N-CA 122.446 2.098 . . . . 0.0 112.054 178.636 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' MET . 27.6 m . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.663 0.268 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.65 144.18 53.81 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.496 2.13 . . . . 0.0 111.501 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.649 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -116.49 -2.67 11.96 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.71 -127.29 1.0 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.724 -1.703 . . . . 0.0 114.163 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 96' ' ' LEU . 4.0 mp -101.63 140.43 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-O 121.591 0.71 . . . . 0.0 111.918 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.639 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.4 t-20 -109.13 155.49 20.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.397 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.599 HG22 HD23 ' A' ' 96' ' ' LEU . 87.9 t -124.58 135.74 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 122.905 0.482 . . . . 0.0 110.467 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.16 151.41 30.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 120.79 0.328 . . . . 0.0 110.566 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 82.9 p -90.8 163.18 31.01 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.037 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 71.9 Cg_endo -75.75 63.25 6.59 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.385 2.057 . . . . 0.0 112.426 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.421 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 33.6 mmtp -110.89 -172.77 2.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.674 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -143.03 120.23 11.49 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.35 -125.49 5.79 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.242 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -112.99 142.41 45.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.03 152.3 47.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.852 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.553 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 9.1 tmtm? -76.75 125.98 30.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.67 136.48 54.5 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.987 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.576 ' HG3' HG21 ' A' ' 120' ' ' ILE . 24.8 mm-40 -95.77 164.01 12.93 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.328 0.585 . . . . 0.0 112.058 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.71 131.04 68.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.427 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.461 ' HB3' HG22 ' A' ' 132' ' ' VAL . 44.1 ttm -116.75 135.49 53.72 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.645 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.31 126.45 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.645 HD12 ' HG2' ' A' ' 173' ' ' GLU . 42.7 pt -119.28 175.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.407 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.13 3.3 9.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.491 . . . . 0.0 111.496 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.645 ' HG2' HD12 ' A' ' 171' ' ' ILE . 1.8 pm0 -98.78 137.03 37.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.621 0.724 . . . . 0.0 111.262 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -95.86 150.59 20.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.831 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.0 pt -127.18 153.94 36.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.512 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.67 107.61 13.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -74.51 -35.3 63.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.606 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.508 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 86.1 mt 79.98 96.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.772 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -110.28 -19.38 13.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.697 175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.2 p -126.33 162.24 25.97 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.096 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.71 -35.07 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.956 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -62.07 -41.78 98.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 73.3 m-20 -63.96 -41.73 97.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 109.571 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.612 HD12 HD21 ' A' ' 24' ' ' LEU . 60.0 tp -61.51 -48.35 81.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.194 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 62.9 tttm -63.4 -44.33 94.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.138 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.66 -44.65 96.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 0.0 110.02 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.81 -42.47 99.06 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.705 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.3 pt-20 -70.97 -36.11 72.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 95.0 mtp -63.99 -42.37 97.21 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -65.19 -36.02 82.89 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.955 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.0 mt -63.48 -46.14 87.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--N 1.314 -0.958 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.71 -179.587 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 42.6 m-20 -96.52 165.91 11.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.81 137.87 51.75 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.7 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 98' ' ' VAL . 8.5 mt -96.58 135.78 38.01 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.785 174.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.586 ' HA ' HG22 ' A' ' 98' ' ' VAL . 75.7 mt -127.59 100.03 5.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.4 ptm -95.5 99.08 11.02 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 123.269 1.509 . . . . 0.0 112.248 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.0 110.53 20.2 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 112.378 -2.192 . . . . 0.0 109.615 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.291 -1.966 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.722 -179.291 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 25.4 Cg_exo . . . . . 0 C--O 1.233 0.253 0 N-CA-C 109.08 -1.161 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 73.4 mt -95.93 18.27 13.64 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.471 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 184' ' ' LEU . 95.1 mt -62.83 118.81 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.883 0.849 . . . . 0.0 109.296 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 58.4 pttt -86.14 131.2 34.3 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.991 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -132.57 125.46 30.55 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.737 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 52.28 30.0 7.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.45 -9.19 58.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.509 -0.853 . . . . 0.0 115.063 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.702 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.7 mtt180 -127.01 153.84 45.4 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.826 1.313 . . . . 0.0 111.846 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 77.3 m -80.26 164.09 23.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 33' ' ' VAL . 77.6 mt -59.05 -43.99 91.75 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.075 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.58 -39.88 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.702 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.3 t70 -64.55 -43.61 93.4 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.276 0.56 . . . . 0.0 110.193 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 7.5 m-85 -63.24 -34.17 77.08 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.622 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.8 t -69.34 -42.12 81.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.915 0.388 . . . . 0.0 110.543 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 30' ' ' ILE . 66.2 t -62.45 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.793 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.553 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 67.8 m -53.47 -52.29 68.05 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 53.2 Cg_exo -60.33 -43.1 36.57 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 121.789 1.66 . . . . 0.0 112.484 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.586 HD11 HG11 ' A' ' 98' ' ' VAL . 93.2 mt -66.68 -38.31 86.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 110.563 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.613 HD12 HD21 ' A' ' 69' ' ' ASN . 62.1 tp -59.33 -44.7 92.58 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.385 178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 35' ' ' SER . 61.1 pttt -91.18 -4.39 56.14 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.8 p -82.46 -176.55 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 111.071 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -54.22 -22.45 11.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.642 1.177 . . . . 0.0 112.23 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -54.49 137.59 15.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.512 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -72.0 -79.44 0.07 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.153 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.466 HD22 ' C ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -115.58 155.76 27.02 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.258 0.552 . . . . 0.0 110.567 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.9 mm -107.05 116.05 49.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.046 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 116.54 32.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.796 HG21 HD13 ' A' ' 60' ' ' ILE . 82.1 mt -98.96 116.69 42.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.38 123.99 32.92 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.17 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.5 p -129.26 161.9 29.14 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.664 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -117.12 151.4 47.62 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.895 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.82 -19.08 53.22 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.867 2.378 . . . . 0.0 111.245 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.15 -10.86 59.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.5 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -140.76 66.7 27.69 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.558 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 98.2 Cg_endo -102.64 88.8 0.03 OUTLIER 'Trans proline' 1 N--CA 1.376 -5.41 0 C-N-CA 117.197 -1.402 . . . . 0.0 110.345 171.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -150.9 -47.35 0.12 Allowed 'General case' 1 C--N 1.205 -5.699 0 CA-C-N 110.368 -3.106 . . . . 0.0 102.865 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD21 ' A' ' 21' ' ' LEU . 99.4 m -63.38 -48.27 78.58 Favored 'General case' 0 N--CA 1.386 -3.64 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.679 164.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -62.91 -45.12 94.02 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.522 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 54' ' ' PRO . 32.0 mm-40 -57.3 -43.52 83.3 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.182 -1.407 . . . . 0.0 110.975 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -60.98 -51.59 68.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.845 0.355 . . . . 0.0 111.89 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.796 HD13 HG21 ' A' ' 47' ' ' ILE . 87.2 mt -63.98 -45.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.736 -176.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 54.9 t-20 -58.8 -39.38 80.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -86.74 -31.1 21.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.831 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.17 -34.67 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.408 ' CD2' HG23 ' A' ' 60' ' ' ILE . 91.8 m-85 -103.6 6.82 37.46 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.892 -175.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.4 pttt -61.32 -23.7 65.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 110.835 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.46 -33.58 71.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.536 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -80.15 140.81 36.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.334 0.588 . . . . 0.0 112.38 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -86.9 -43.53 12.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.606 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.613 HD21 HD12 ' A' ' 38' ' ' LEU . 15.9 p-10 -82.14 -0.77 46.37 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.949 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -106.37 121.25 58.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.2 t -123.28 130.68 74.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.248 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.38 131.59 45.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.497 HG13 ' HA ' ' A' ' 48' ' ' ALA . 40.6 pt -126.89 156.71 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.267 0.556 . . . . 0.0 110.573 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.08 134.22 55.03 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 8.9 t -158.42 -171.16 3.35 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.1 m -66.69 1.86 1.61 Allowed 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 126.696 1.999 . . . . 0.0 114.774 -174.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.594 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.37 -24.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.056 0 C-N-CA 125.877 1.703 . . . . 0.0 116.841 -174.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.0 tmtt? -53.31 -33.83 54.94 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.06 120.23 4.66 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -59.22 -50.55 73.57 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.08 -44.8 97.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.94 0.876 . . . . 0.0 109.823 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.96 -42.02 97.47 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.71 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.594 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 8.0 t0 -58.68 -50.94 72.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.17 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.6 mm? -58.78 -42.59 89.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.998 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.532 ' HA ' HG12 ' A' ' 88' ' ' ILE . 17.8 m-80 -59.98 -41.27 91.66 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 67.0 mm-40 -64.52 -44.84 89.6 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.271 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.3 m -63.47 -44.75 93.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 160' ' ' LYS . 24.6 pt -65.06 -28.42 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 0.0 110.79 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.61 -37.77 94.75 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.455 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.56 -2.23 42.18 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -97.51 156.74 16.36 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.752 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -118.58 1.25 11.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.09 155.22 80.27 Favored Pre-proline 0 CA--C 1.502 -0.878 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -56.65 141.92 91.21 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.868 2.379 . . . . 0.0 110.509 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 42.2 p90 -141.83 158.4 43.84 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.372 0.606 . . . . 0.0 111.755 -178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -86.03 143.84 27.9 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.118 -175.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 75.6 t -120.32 130.73 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.935 0.894 . . . . 0.0 109.765 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 5' ' ' ILE . 18.7 m -131.34 159.64 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.514 0.674 . . . . 0.0 112.774 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 42.3 t -99.97 153.72 18.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' HG21 ' A' ' 33' ' ' VAL . 80.5 p -88.58 -0.19 57.0 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -173.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 24.7 p-10 -108.82 -3.59 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -174.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.553 ' CD2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER -87.98 115.28 25.34 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.181 177.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -96.27 8.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.72 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.536 ' CB ' HG22 ' A' ' 175' ' ' ILE . 21.9 t-20 -55.93 143.88 30.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.126 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.4 mm? -69.61 80.0 0.42 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.169 0.985 . . . . 0.0 109.257 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -74.38 -1.08 19.38 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.574 -1.648 . . . . 0.0 113.724 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.7 t -57.31 -45.34 84.31 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -76.95 -26.33 53.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.588 0.708 . . . . 0.0 109.841 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 113' ' ' ILE . 37.6 mm -69.73 -43.0 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.646 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.425 ' HA ' HD11 ' A' ' 154' ' ' ILE . 63.5 mt -58.62 -48.54 85.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.381 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -64.6 -41.23 96.37 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.252 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -62.9 -39.38 94.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.086 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.5 mm -61.01 -47.87 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.99 -47.57 92.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.433 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -61.91 -43.7 98.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.081 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.571 ' CD2' ' HE2' ' A' ' 169' ' ' MET . 83.2 t80 -63.86 -49.02 74.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.9 0.381 . . . . 0.0 111.04 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.57 -47.8 84.14 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.89 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.663 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 31.8 m-85 -65.83 -31.4 72.33 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.028 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.93 -45.07 94.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.478 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.9 mt -63.22 -49.44 83.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.329 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 14.8 ptmt -63.64 -23.43 67.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.938 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.34 -41.86 97.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.53 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.11 -41.3 10.56 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 111.23 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 29.6 m -127.47 91.99 44.48 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.54 -12.0 32.35 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 122.595 2.197 . . . . 0.0 112.508 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 23.3 t70 -64.86 -28.84 69.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.123 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 124' ' ' THR . 7.7 p -54.13 130.06 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.19 0.519 . . . . 0.0 111.32 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.6 ' HB3' ' OE1' ' A' ' 164' ' ' GLN . 47.1 mt-10 -115.01 -12.52 11.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.057 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.2 163.34 40.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.939 0.4 . . . . 0.0 111.612 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -138.89 133.3 31.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.752 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -123.6 139.13 54.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.808 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 113' ' ' ILE . 58.4 t -118.22 122.67 70.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.115 0.484 . . . . 0.0 110.505 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -145.0 166.67 24.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.695 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.444 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 9.1 pt -124.39 158.53 61.11 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.645 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 32.3 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 C-N-CA 121.885 1.723 . . . . 0.0 112.119 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 121.351 0.596 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -61.09 142.03 95.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.595 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.445 ' HB3' HD11 ' A' ' 171' ' ' ILE . . . -126.91 -47.36 1.52 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.111 0.482 . . . . 0.0 111.29 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.33 -153.49 26.42 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.457 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.552 ' HB ' HD11 ' A' ' 96' ' ' LEU . 20.2 pt -107.91 160.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.296 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.8 t-20 -109.9 151.83 26.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.864 -172.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.4 t -123.35 131.75 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 122.963 0.505 . . . . 0.0 110.097 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 155' ' ' ASN . 23.5 m -131.83 150.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.186 0.517 . . . . 0.0 111.238 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.576 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 59.7 m -97.55 160.78 27.91 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.613 174.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 158' ' ' SER . 74.1 Cg_endo -74.06 52.5 2.68 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.672 2.248 . . . . 0.0 111.963 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.64 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.1 mmmt -112.61 109.41 18.93 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -61.99 146.37 50.29 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.281 0.363 . . . . 0.0 111.284 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.13 -146.05 19.49 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.58 141.59 36.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.917 0.389 . . . . 0.0 110.002 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.6 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 27.5 pt20 -133.84 160.8 36.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.82 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -59.37 118.69 6.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.019 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -120.9 126.28 49.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.134 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.52 164.14 13.11 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 121.773 0.797 . . . . 0.0 112.509 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 130.2 67.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 114.231 -1.349 . . . . 0.0 112.745 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.571 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 46.6 ttm -114.14 130.21 56.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.046 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.53 123.11 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.53 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 42.4 pt -112.45 173.22 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.768 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.96 1.72 9.86 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.605 0.717 . . . . 0.0 110.288 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.53 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.2 pm0 -98.73 134.18 42.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.049 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.77 149.61 21.06 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.561 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.536 HG22 ' CB ' ' A' ' 104' ' ' ASN . 1.9 pp -104.08 154.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.559 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.16 113.55 26.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 101' ' ' ASP . 97.6 m-20 -113.43 153.44 28.62 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.67 109.88 21.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . 0.419 ' HB2' ' OD2' ' A' ' 183' ' ' ASP . 45.1 m-80 -104.63 -34.63 8.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.492 0.663 . . . . 0.0 109.67 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -149.47 -178.5 6.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.54 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.486 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -62.58 -36.81 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.826 0.45 . . . . 0.0 111.973 -177.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 29.9 m-20 -60.37 -36.02 77.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 58.6 m-20 -61.69 -33.94 74.88 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.936 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.629 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 97.7 mt -61.29 -42.36 98.52 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -61.85 -41.85 98.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.831 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.08 -47.87 84.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.201 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.418 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.91 -46.19 91.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.914 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 9.0 pt-20 -68.9 -31.01 69.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.99 0.424 . . . . 0.0 110.998 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.9 ttm -61.58 -46.07 91.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.298 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.89 -30.64 64.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.335 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.508 0.671 . . . . 0.0 109.624 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 192' ' ' LYS . 7.8 tmtm? . . . . . 0 C--N 1.318 -0.776 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.104 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.8 ptm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.484 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 45.3 m-20 -104.83 165.71 10.88 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.614 0.245 . . . . 0.0 110.801 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.46 134.45 55.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.896 0.379 . . . . 0.0 111.181 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.37 126.25 51.9 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.603 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.666 ' HA ' HG22 ' A' ' 98' ' ' VAL . 70.4 mt -117.55 102.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.476 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 10.2 ptm -92.34 99.06 11.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.964 1.364 . . . . 0.0 111.3 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -114.87 96.7 5.84 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.895 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.799 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.164 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 60.3 Cg_endo . . . . . 0 CA--C 1.532 0.385 0 N-CA-C 113.583 0.57 . . . . 0.0 113.583 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 56' ' ' THR . 35.8 mt -82.22 16.85 1.83 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.29 121.18 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -81.07 125.56 30.35 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.041 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 188' ' ' GLU . 31.3 tp -144.92 117.18 8.43 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.283 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 54.17 39.66 30.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.19 -27.12 10.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.339 0.895 . . . . 0.0 115.339 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.738 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 25.8 ptt180 -146.18 171.8 14.39 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.835 1.318 . . . . 0.0 111.941 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.3 m -82.36 153.57 25.69 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.021 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.5 tt -53.51 -38.9 64.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.092 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 14.0 tt -62.85 -39.67 85.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.68 -39.55 94.3 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.738 ' CE2' ' HG3' ' A' ' 27' ' ' ARG . 27.5 m-85 -61.08 -35.41 76.92 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.493 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 29' ' ' LEU . 76.5 t -71.3 -45.89 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.799 0.333 . . . . 0.0 111.41 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.88 -42.55 96.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.534 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -51.36 -55.43 28.97 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 41.2 Cg_endo -67.86 -37.05 16.53 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.314 1.343 . . . . 0.0 112.584 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.659 HD11 HG11 ' A' ' 98' ' ' VAL . 78.9 mt -65.49 -42.18 92.44 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.414 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.4 tt -63.36 -45.03 93.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.987 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 19.0 ptmt -79.04 -7.84 58.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -74.96 179.7 4.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.32 -22.7 61.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.615 0.766 . . . . 0.0 112.934 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.0 160.75 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.484 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.5 t30 -83.09 -73.24 0.41 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.578 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.69 156.71 26.65 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.037 0.446 . . . . 0.0 110.645 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.86 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -106.79 117.9 35.26 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 60' ' ' ILE . 88.6 mt -100.05 118.92 47.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.609 0.718 . . . . 0.0 110.524 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.22 121.98 31.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.399 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 7' ' ' ALA . 73.0 p -129.83 166.76 19.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.738 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -130.92 158.12 75.97 Favored Pre-proline 0 C--N 1.298 -1.634 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.884 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.17 -21.06 72.26 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.633 2.222 . . . . 0.0 110.902 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -70.45 -23.17 62.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.817 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -138.17 68.36 48.16 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.715 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 69.9 Cg_endo -99.35 84.08 0.05 OUTLIER 'Trans proline' 1 N--CA 1.392 -4.492 0 C-N-CA 116.659 -1.761 . . . . 0.0 108.688 169.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.7 mttt -146.1 -52.18 0.24 Allowed 'General case' 1 C--N 1.222 -4.945 0 CA-C-N 109.568 -3.469 . . . . 0.0 102.799 -177.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.523 ' HA ' HD11 ' A' ' 21' ' ' LEU . 96.0 m -63.71 -47.37 81.42 Favored 'General case' 0 N--CA 1.385 -3.708 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.493 164.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.715 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -62.39 -49.36 75.82 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.148 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 4.8 pt-20 -58.09 -36.58 73.07 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 117.564 -1.654 . . . . 0.0 111.526 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -63.68 -51.22 66.06 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.986 0.422 . . . . 0.0 111.63 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.839 HD13 HG21 ' A' ' 47' ' ' ILE . 89.6 mt -61.85 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.192 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.725 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 54.6 t-20 -57.85 -45.3 86.47 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.694 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -73.49 -44.92 56.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.396 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.22 90.26 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.327 0.584 . . . . 0.0 111.349 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.451 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 68.2 m-85 -109.94 33.56 4.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.253 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 2.7 mmpt? -60.75 -25.49 66.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -90.95 11.53 22.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 55.0 p90 -43.71 133.96 4.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.02 -48.97 3.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.414 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.7 p-10 -118.92 10.11 12.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.013 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 86.4 mt -100.66 122.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.606 0.717 . . . . 0.0 111.312 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.78 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.802 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.06 131.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.53 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.3 pt -125.78 155.81 35.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.65 131.3 56.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.196 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -160.12 -167.94 2.07 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 51.6 m -64.03 1.96 0.61 Allowed 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 127.126 2.17 . . . . 0.0 114.556 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.03 -18.76 0.0 OUTLIER Glycine 0 N--CA 1.514 3.851 0 C-N-CA 126.484 1.993 . . . . 0.0 117.265 -175.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -58.23 -38.24 76.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -112.33 129.76 9.21 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -61.34 -51.25 69.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -74.14 -30.32 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.746 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.07 -43.13 88.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.531 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.8 t0 -61.52 -50.83 71.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.947 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 88' ' ' ILE . 1.7 mm? -55.69 -47.83 76.12 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.925 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.0 m-80 -60.14 -42.86 95.77 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.56 -44.42 86.83 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.362 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.91 -42.0 97.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.225 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' A' ' 85' ' ' ASN . 22.3 pt -68.56 -23.67 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.374 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.02 -14.09 80.54 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.456 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -98.93 -0.52 42.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 99.3 m-85 -126.5 150.08 48.97 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.658 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -109.9 3.48 20.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.599 0.714 . . . . 0.0 109.626 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -128.92 153.34 80.1 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.498 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.92 148.75 76.95 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.679 2.253 . . . . 0.0 112.058 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 50.6 p90 -144.24 163.17 34.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.26 0.553 . . . . 0.0 111.79 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.556 HD21 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -85.63 140.92 30.17 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.735 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 79.6 t -117.29 133.41 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.174 0.99 . . . . 0.0 108.824 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 5' ' ' ILE . 14.1 m -128.39 162.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.88 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 t -98.6 142.58 30.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.3 p -70.95 -13.26 61.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -110.84 12.32 22.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 70.4 mt -77.21 113.2 14.71 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.205 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 tt -129.49 122.04 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.719 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 63.4 t30 162.02 178.93 0.01 OUTLIER 'General case' 0 C--O 1.248 0.985 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.4 103.51 4.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.576 ' HA ' HD12 ' A' ' 109' ' ' ILE . 37.6 mtmm -99.79 -1.11 38.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.404 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -56.64 -41.11 76.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -169.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -85.07 -25.83 27.35 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.984 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 106' ' ' LYS . 84.4 mt -65.62 -42.75 93.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.536 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HA ' HD11 ' A' ' 154' ' ' ILE . 58.5 mt -59.71 -49.54 83.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.066 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.21 -38.85 92.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -62.64 -42.39 99.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.55 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.0 mm -63.96 -48.31 86.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.097 0.475 . . . . 0.0 110.793 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 1' ' ' MET . 79.2 t -60.75 -48.0 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.534 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -61.85 -47.5 84.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.301 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.513 ' CE2' HD11 ' A' ' 120' ' ' ILE . 44.7 t80 -64.42 -45.07 89.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 77.1 t80 -58.33 -48.62 79.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.229 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.426 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 20.0 m-85 -60.68 -37.05 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.437 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.65 -44.72 96.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.279 0.561 . . . . 0.0 109.55 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.552 ' CG2' HG21 ' A' ' 127' ' ' VAL . 74.8 mt -62.99 -43.5 99.11 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.801 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -60.1 -42.59 95.0 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.615 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.53 96.01 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.457 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -83.03 -36.85 24.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 0.0 111.797 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.7 m -133.66 89.36 31.07 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.28 -15.51 35.35 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.95 -31.96 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.206 0.603 . . . . 0.0 111.533 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.583 HG22 ' HE2' ' A' ' 165' ' ' LYS . 87.9 t -69.45 126.51 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -120.62 5.37 10.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.585 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.37 24.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.687 0.28 . . . . 0.0 111.205 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -137.46 129.5 29.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.05 142.08 51.02 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 152' ' ' ALA . 18.9 m -121.24 144.75 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.439 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.455 ' C ' ' HB2' ' A' ' 152' ' ' ALA . 63.3 mtm -134.99 153.84 51.94 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 171' ' ' ILE . 9.3 pt -131.84 145.53 57.87 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.026 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 51.4 Cg_exo . . . . . 0 C--O 1.235 0.372 0 C-N-CA 122.425 2.083 . . . . 0.0 113.12 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.447 -0.606 0 CA-C-O 120.681 0.277 . . . . 0.0 110.5 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.45 146.76 56.82 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.264 1.976 . . . . 0.0 111.715 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 132' ' ' VAL . . . -88.95 -10.22 48.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.782 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 161.48 -99.0 0.17 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.748 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.556 HD12 HD21 ' A' ' 96' ' ' LEU . 30.6 pt -118.79 161.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.237 0.541 . . . . 0.0 112.23 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.516 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.3 t-20 -119.54 156.59 30.0 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.476 -176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' A' ' 117' ' ' PHE . 94.0 t -124.84 133.54 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 122.334 0.253 . . . . 0.0 110.609 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.42 HG13 ' OD1' ' A' ' 155' ' ' ASN . 32.3 m -131.12 150.33 34.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.367 0.603 . . . . 0.0 111.988 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -98.92 159.13 31.03 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.095 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 17.3 Cg_exo -68.15 91.28 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.362 2.041 . . . . 0.0 112.037 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -125.19 -165.85 1.46 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.073 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.74 147.4 39.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.73 -116.82 5.84 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.261 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -129.87 145.27 51.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -134.36 163.89 28.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 127' ' ' VAL . 1.6 tmtp? -61.03 128.01 34.34 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.09 139.28 52.6 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.095 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.68 160.78 14.83 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 121.727 0.775 . . . . 0.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.83 129.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 14.7 tmm? -137.27 136.04 37.7 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.15 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.7 129.93 63.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.062 0.458 . . . . 0.0 110.769 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.4 pt -120.52 176.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.426 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.55 69.54 1.31 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.664 0.745 . . . . 0.0 109.128 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' A' ' 171' ' ' ILE . 77.5 mm-40 -128.59 143.59 50.99 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.205 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.95 140.63 31.2 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.985 0.898 . . . . 0.0 113.082 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.9 pt -139.55 151.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.435 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 103' ' ' ILE . 93.0 m-85 -120.55 107.93 13.44 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.176 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.457 ' OD1' HD23 ' A' ' 102' ' ' LEU . 98.0 m-20 -93.96 110.8 22.46 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 183' ' ' ASP . 98.2 mt -81.32 114.44 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.354 0.597 . . . . 0.0 111.337 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -113.75 -20.97 10.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.1 p -131.59 164.9 24.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.269 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.752 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -60.87 -27.63 68.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.104 176.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -68.58 -39.24 81.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.44 0.638 . . . . 0.0 109.95 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.704 ' HB2' HG23 ' A' ' 178' ' ' ILE . 71.9 m-20 -61.52 -33.57 74.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.514 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 178' ' ' ILE . 96.1 mt -59.95 -44.77 94.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.224 0.535 . . . . 0.0 109.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 7.8 tmtm? -67.5 -42.46 82.84 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.759 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tt -62.09 -46.93 86.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.944 0.402 . . . . 0.0 110.102 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.5 -41.24 98.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.757 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.9 pp20? -68.02 -30.91 70.26 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.651 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.1 mmm -61.51 -43.8 98.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.4 pp -74.85 -39.74 61.41 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.127 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.3 -40.59 96.24 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.44 0.638 . . . . 0.0 110.275 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt . . . . . 0 C--N 1.302 -1.458 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.575 179.553 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.1 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -113.53 165.11 12.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.433 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -117.29 142.69 46.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 48' ' ' ALA . 30.2 tp -120.35 127.51 52.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.275 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 98' ' ' VAL . 64.5 mt -117.69 108.27 24.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.016 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.412 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 60.4 ttm -82.31 92.71 7.01 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-O 121.84 0.829 . . . . 0.0 111.545 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.478 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.62 97.53 5.91 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.406 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.058 0 C-N-CA 119.968 -1.11 . . . . 0.0 113.129 177.85 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.518 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 24.4 Cg_exo . . . . . 0 N--CA 1.48 0.73 0 CA-C-O 120.998 0.333 . . . . 0.0 112.263 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 59' ' ' TYR . 8.8 mp -77.23 26.87 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.6 119.44 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.81 136.65 32.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-O 122.011 0.91 . . . . 0.0 113.048 -174.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 184' ' ' LEU . 80.2 mt -136.83 124.69 22.62 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.291 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 191' ' ' LEU . 74.3 m 53.95 30.54 11.83 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.39 20.54 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.913 -1.136 . . . . 0.0 115.794 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 34.7 ptt180 -146.22 166.35 26.47 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.085 1.443 . . . . 0.0 112.434 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.3 m -73.29 156.58 38.31 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.222 -176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 20' ' ' PRO . 5.1 tt -57.53 -44.69 85.31 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 124.395 1.078 . . . . 0.0 110.475 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -60.2 -39.94 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.434 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 13.8 t70 -63.95 -41.69 97.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.249 0.547 . . . . 0.0 109.569 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' CD2' ' HG3' ' A' ' 27' ' ' ARG . 5.7 m-85 -61.06 -36.57 79.93 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.158 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.1 t -66.87 -42.99 89.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 0.0 110.811 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.6 t -62.85 -45.02 99.91 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.576 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -50.91 -53.61 45.85 Favored Pre-proline 0 CA--C 1.57 1.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 28.8 Cg_endo -63.94 -39.42 32.83 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.518 1.479 . . . . 0.0 112.387 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.585 HD11 HG11 ' A' ' 98' ' ' VAL . 83.3 mt -67.13 -39.68 86.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.609 0.719 . . . . 0.0 110.018 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.2 tp -59.31 -45.67 90.68 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.515 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 22.2 ptmt -84.99 -8.71 58.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.493 ' OG ' HG12 ' A' ' 42' ' ' VAL . 77.9 p -74.58 174.74 8.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.213 0.53 . . . . 0.0 111.668 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -60.32 -18.51 50.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.056 0.942 . . . . 0.0 112.603 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 3' ' ' ALA . 11.4 p -63.64 150.76 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 120.909 0.385 . . . . 0.0 111.999 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -76.7 -75.91 0.18 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -110.43 152.13 26.67 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.057 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.47 110.99 33.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -104.16 117.86 35.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 60' ' ' ILE . 95.6 mt -97.88 119.19 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.602 0.715 . . . . 0.0 110.568 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.37 122.13 32.3 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.811 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 7' ' ' ALA . 41.9 p -126.59 155.0 43.17 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 50.1 m -98.79 145.1 29.35 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.871 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 75' ' ' THR . 51.8 Cg_exo -59.27 -28.78 88.58 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.197 2.598 . . . . 0.0 111.348 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 -6.89 58.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.963 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 7.7 p -134.63 66.47 69.59 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.414 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 83.0 Cg_endo -103.73 85.62 0.03 OUTLIER 'Trans proline' 1 N--CA 1.377 -5.332 0 C-N-CA 116.764 -1.691 . . . . 0.0 109.246 169.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 34.4 mmtp -145.45 -52.04 0.26 Allowed 'General case' 1 C--N 1.214 -5.318 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.45 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 99.0 m -63.48 -48.39 77.86 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 111.958 -2.383 . . . . 0.0 106.363 165.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.699 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -63.1 -48.18 79.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.913 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.8 pt-20 -58.64 -34.97 71.79 Favored 'General case' 0 C--N 1.365 1.266 0 C-N-CA 117.481 -1.687 . . . . 0.0 110.335 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.501 ' CB ' HD21 ' A' ' 21' ' ' LEU . 48.8 t80 -67.57 -52.25 40.9 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 120.86 0.362 . . . . 0.0 111.828 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 47' ' ' ILE . 96.8 mt -63.62 -46.54 94.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.837 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.1 t30 -58.92 -44.0 91.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 34.5 t -69.72 -44.62 69.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.18 90.14 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.305 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.434 ' HD2' HG23 ' A' ' 60' ' ' ILE . 78.7 m-85 -105.83 25.69 10.55 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.194 -176.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 9.9 mmmm -62.22 -21.39 65.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.857 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.26 10.57 21.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.374 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.3 p90 -44.18 138.04 3.18 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -176.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.596 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -101.62 -52.55 3.18 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.913 0.863 . . . . 0.0 109.361 172.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -121.45 12.67 10.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.163 -1.381 . . . . 0.0 111.467 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.6 mt -99.1 128.44 50.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.291 0.567 . . . . 0.0 111.053 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 67.3 t -128.04 132.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.18 132.15 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 4' ' ' LEU . 40.1 pt -126.96 156.89 38.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.624 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 51' ' ' PRO . 10.5 t70 -114.74 131.96 56.6 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.201 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.496 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 12.9 t -161.95 -171.87 3.04 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.95 0.881 . . . . 0.0 113.218 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.1 m -74.18 3.58 6.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.602 1.961 . . . . 0.0 114.605 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.94 -21.82 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 C-N-CA 126.638 2.066 . . . . 0.0 117.605 -173.126 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 76' ' ' SER . 58.4 tptt -58.53 -37.88 76.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.88 123.11 6.26 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.478 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.8 t80 -59.45 -50.4 74.07 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.14 -47.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 55.1 mt-10 -59.83 -44.94 93.8 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.798 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.615 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 5.5 t0 -59.29 -51.39 70.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.437 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.2 mm? -59.98 -41.74 92.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.962 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.418 ' HA ' HG12 ' A' ' 88' ' ' ILE . 9.2 m120 -60.42 -43.19 97.0 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.483 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 72.4 mm-40 -65.72 -44.42 86.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.57 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.8 m -62.31 -43.16 99.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.114 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.9 pt -66.08 -24.64 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.28 77.47 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.411 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -104.75 -21.47 13.36 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 82.2 m-85 -89.1 140.92 28.96 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.986 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -104.42 -6.32 20.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.417 0.627 . . . . 0.0 109.817 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -132.24 152.49 80.22 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.443 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.94 142.03 54.27 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 123.515 2.81 . . . . 0.0 112.223 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -139.64 154.12 47.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.503 0.668 . . . . 0.0 111.595 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 154' ' ' ILE . 2.1 tm? -87.05 132.81 33.7 Favored 'General case' 0 C--O 1.193 -1.889 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.726 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 68.4 t -108.37 127.87 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.225 0.61 . . . . 0.0 109.559 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 5' ' ' ILE . 8.4 m -126.53 156.62 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.759 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.47 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 67.7 m -101.03 132.92 46.23 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 170.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.48 ' O ' HD21 ' A' ' 29' ' ' LEU . 69.3 m -67.46 -37.39 82.87 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.499 0.666 . . . . 0.0 111.532 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.37 -0.85 34.42 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.4 pp -91.63 116.26 28.73 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.15 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.4 mt -103.1 119.6 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.036 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.439 HD21 ' HB2' ' A' ' 173' ' ' GLU . 64.9 t30 178.38 163.5 0.71 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.145 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.54 98.6 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.636 ' HA ' HD12 ' A' ' 109' ' ' ILE . 15.6 ptpt -97.8 -2.28 41.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.908 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -60.26 -38.94 85.03 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.61 -27.17 37.4 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.432 1.111 . . . . 0.0 109.36 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.726 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -70.08 -39.52 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.759 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 107' ' ' SER . 65.3 mt -56.92 -49.21 79.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.944 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -65.07 -40.86 95.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.195 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.7 m -63.32 -40.67 97.97 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.548 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.726 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.26 -48.33 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.209 0.528 . . . . 0.0 110.674 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.658 HG22 ' SD ' ' A' ' 1' ' ' MET . 69.4 t -61.43 -48.21 89.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.93 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.67 -43.79 97.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.966 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.751 ' CE2' HD11 ' A' ' 120' ' ' ILE . 73.1 t80 -63.83 -46.58 84.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -58.11 -48.19 80.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.891 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.502 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 30.0 m-85 -62.03 -36.19 80.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.299 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.9 t -61.53 -46.66 88.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.997 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.751 HD11 ' CE2' ' A' ' 116' ' ' TYR . 67.3 mt -66.03 -47.06 86.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.854 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -64.03 -25.09 67.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.997 -178.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.55 99.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.788 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -83.91 -39.05 20.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.038 0.447 . . . . 0.0 110.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.621 ' O ' HG12 ' A' ' 127' ' ' VAL . 90.2 m -132.65 92.51 26.89 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.31 -19.04 48.59 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.263 2.642 . . . . 0.0 113.069 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 39.0 t70 -62.01 -32.31 72.78 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.624 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -70.61 118.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.596 0.712 . . . . 0.0 109.829 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.3 mt-10 -122.43 13.11 10.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.402 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.3 155.01 37.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 133.25 27.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -122.79 139.61 53.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.373 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.614 HG21 ' CD1' ' A' ' 113' ' ' ILE . 95.8 t -121.18 123.39 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.54 0.686 . . . . 0.0 111.179 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 3.1 ptm -145.48 162.5 37.22 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.551 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 150' ' ' VAL . 22.6 pt -123.15 158.07 59.05 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo . . . . . 0 N--CA 1.455 -0.752 0 C-N-CA 121.816 1.677 . . . . 0.0 110.675 177.135 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 134' ' ' ILE . 29.6 m . . . . . 0 N--CA 1.441 -0.925 0 CA-C-O 121.337 0.589 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.36 139.02 87.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.504 2.136 . . . . 0.0 110.676 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.669 ' HA ' HD13 ' A' ' 175' ' ' ILE . . . -132.62 -36.84 1.07 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.264 0.554 . . . . 0.0 111.337 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.81 -149.55 25.8 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.521 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 96' ' ' LEU . 17.2 pt -119.44 161.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.045 -0.577 . . . . 0.0 110.46 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.571 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.6 t-20 -110.27 152.12 26.53 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.475 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.87 131.6 72.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.321 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.7 m -134.45 149.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.399 0.619 . . . . 0.0 111.243 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 58.5 m -98.51 153.63 37.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 14.8 Cg_exo -69.79 89.81 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.951 1.768 . . . . 0.0 110.99 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -116.72 -160.14 0.75 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -136.97 149.47 47.56 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 62.93 -124.17 31.96 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.657 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.02 149.22 50.46 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -131.62 163.99 26.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.008 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -57.77 128.5 37.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.027 0.441 . . . . 0.0 111.873 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -125.53 129.4 49.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.67 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -94.56 161.96 14.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.593 0.711 . . . . 0.0 112.212 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 131' ' ' ALA . 46.8 mm -115.69 130.84 69.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.303 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -131.17 138.75 49.58 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.681 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 133' ' ' MET . 76.0 t -108.12 129.64 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.79 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.541 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 36.7 pt -101.3 174.51 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.986 0.422 . . . . 0.0 111.321 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -99.77 -21.18 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HG3' HD11 ' A' ' 109' ' ' ILE . 1.6 pm0 -99.08 138.32 36.36 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.811 0.815 . . . . 0.0 112.568 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.02 151.92 18.76 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.458 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 152' ' ' ALA . 23.6 pt -107.41 155.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -102.98 106.91 17.54 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.112 0.482 . . . . 0.0 110.824 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.85 121.47 37.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 184' ' ' LEU . 40.9 mm -71.19 85.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.339 0.59 . . . . 0.0 112.396 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -70.65 -38.8 73.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.323 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 81.0 p -129.57 162.92 27.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.104 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.522 178.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.45 -36.29 79.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.108 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.43 -40.38 96.36 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.482 ' CD1' HD21 ' A' ' 24' ' ' LEU . 51.6 tp -62.64 -42.71 99.75 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.059 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.8 ttmt -61.0 -42.54 98.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.67 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.93 -43.21 99.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.01 99.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.022 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.7 pt-20 -71.05 -36.02 72.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.887 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 35.2 mmt -64.4 -39.99 94.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.28 -47.47 84.19 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.403 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.46 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 mt -63.9 -43.2 96.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.902 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 62.6 tttm . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.044 179.756 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.9 ttp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 61.8 m-20 -98.88 166.97 11.04 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.934 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -114.34 130.98 56.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 98' ' ' VAL . 38.4 tp -106.69 125.46 51.04 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.521 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.681 ' HA ' HG22 ' A' ' 98' ' ' VAL . 60.4 mt -116.65 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.533 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 12.7 ptm -95.92 92.11 6.34 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.941 1.353 . . . . 0.0 112.908 -173.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.597 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -116.82 97.79 6.16 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.936 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.287 -2.149 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.797 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.476 0.452 0 N-CA-C 113.052 0.366 . . . . 0.0 113.052 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 69.1 mt -88.83 11.34 18.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mt -69.87 115.73 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -82.11 140.88 33.56 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.663 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.404 HD13 ' CD1' ' A' ' 184' ' ' LEU . 62.8 tp -130.97 107.59 9.21 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.698 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m 58.25 20.94 7.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.218 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 -80.87 0.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.926 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.549 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.5 mtt180 -93.7 172.2 8.4 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.422 0.629 . . . . 0.0 112.107 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.1 m -79.25 162.75 25.47 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.37 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.5 mt -59.08 -45.52 90.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.218 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.597 HD12 ' CB ' ' A' ' 7' ' ' ALA . 11.8 tt -65.49 -37.91 81.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.168 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 6.9 t0 -60.59 -43.13 97.73 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-O 121.636 0.731 . . . . 0.0 109.075 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -65.86 -36.53 83.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.595 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 29' ' ' LEU . 58.6 t -66.11 -43.29 92.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.8 t -63.49 -45.35 98.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.075 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -49.75 -52.59 49.94 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.06 -36.51 29.45 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.412 1.408 . . . . 0.0 112.44 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.533 HD11 HG11 ' A' ' 98' ' ' VAL . 83.7 mt -68.48 -37.57 80.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.576 0.703 . . . . 0.0 110.553 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.1 tp -59.11 -43.93 91.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.38 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -89.3 -7.19 55.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.523 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.49 ' OG ' HG12 ' A' ' 42' ' ' VAL . 83.3 p -72.52 172.0 11.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.206 0.527 . . . . 0.0 111.605 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.82 5.08 2.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.783 -175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' A' ' 3' ' ' ALA . 11.2 p -77.96 152.53 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.821 -0.549 . . . . 0.0 111.2 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.447 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.6 t30 -69.23 -77.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.32 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -117.69 156.46 28.18 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 111.021 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.3 114.61 47.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.86 119.79 40.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.626 HG21 HD13 ' A' ' 60' ' ' ILE . 95.9 mt -99.91 119.66 48.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.565 0.698 . . . . 0.0 110.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 6' ' ' MET . . . -89.42 121.82 32.03 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.293 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.3 p -131.7 169.53 16.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.031 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.3 p -131.29 158.83 74.13 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.412 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.21 -19.24 68.14 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.576 2.184 . . . . 0.0 110.782 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -70.3 -25.39 63.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.595 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -135.76 66.65 63.38 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.676 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.8 Cg_endo -101.26 85.32 0.04 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.814 0 C-N-CA 116.869 -1.62 . . . . 0.0 109.087 169.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 32.1 mmtm -155.29 -46.82 0.08 Allowed 'General case' 1 C--N 1.209 -5.511 0 CA-C-N 109.182 -3.644 . . . . 0.0 102.462 -179.072 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' HD21 ' A' ' 21' ' ' LEU . 97.8 m -64.05 -49.07 73.79 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 163.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.676 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -62.85 -50.36 71.24 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.1 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.6 pt-20 -64.35 -30.05 71.11 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 116.722 -1.991 . . . . 0.0 112.759 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.07 -50.94 66.38 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.327 0.584 . . . . 0.0 111.208 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.626 HD13 HG21 ' A' ' 47' ' ' ILE . 93.3 mt -63.13 -45.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.426 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -57.87 -44.04 86.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.576 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 27.7 t -69.64 -40.89 76.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.804 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.51 93.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.958 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.531 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 57.0 m-85 -116.41 42.31 2.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 62' ' ' SER . 56.4 mtmt -58.93 -35.46 73.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.218 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -88.47 12.37 14.54 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.15 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 53.6 p90 -39.64 131.87 1.7 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 -48.22 4.26 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -116.82 13.17 14.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.147 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -104.99 124.46 59.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.267 0.556 . . . . 0.0 110.426 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.29 133.51 68.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -103.57 130.68 53.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.276 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 48' ' ' ALA . 43.1 pt -128.48 157.1 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.749 0.785 . . . . 0.0 111.347 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -107.82 136.52 47.41 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.703 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 7.8 t -159.96 -173.84 4.27 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -74.34 5.09 4.9 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 127.328 2.251 . . . . 0.0 114.19 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.21 -13.81 0.0 OUTLIER Glycine 1 N--CA 1.525 4.632 0 C-N-CA 127.184 2.326 . . . . 0.0 117.646 -174.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -57.39 -39.56 76.34 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.531 ' HA3' ' OE1' ' A' ' 82' ' ' GLU . . . -116.32 132.8 10.38 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.443 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.4 t80 -61.29 -52.81 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.6 -39.81 76.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 121.755 0.788 . . . . 0.0 110.071 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.531 ' OE1' ' HA3' ' A' ' 79' ' ' GLY . 48.7 mt-10 -57.93 -43.49 86.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.548 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.56 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.5 t0 -60.59 -49.89 75.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.671 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 mm? -57.14 -40.44 77.16 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.772 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.453 ' HA ' HG12 ' A' ' 88' ' ' ILE . 11.3 m120 -60.05 -42.96 95.6 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.626 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.658 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 46.0 mm-40 -66.86 -43.38 83.76 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.15 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.522 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.1 m -62.18 -45.01 95.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.277 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 160' ' ' LYS . 30.3 pt -64.92 -27.44 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 120.789 0.328 . . . . 0.0 110.911 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.45 -22.1 69.22 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.87 7.25 19.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.522 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 76.9 m-85 -109.86 143.17 40.14 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.05 -0.406 . . . . 0.0 111.274 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.6 m -100.67 -11.63 19.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.337 0.589 . . . . 0.0 110.382 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 38.6 mt-10 -133.19 162.46 57.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.327 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 1' ' ' MET . 38.1 Cg_endo -64.65 156.73 59.53 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.872 . . . . 0.0 111.466 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.497 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 46.6 p90 -143.94 156.6 44.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.526 0.679 . . . . 0.0 111.663 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 154' ' ' ILE . 1.6 tm? -86.33 135.45 33.52 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.616 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 63.6 t -110.85 130.21 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 123.5 0.72 . . . . 0.0 109.146 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 5' ' ' ILE . 4.9 m -128.34 163.35 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.272 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 69.8 m -98.7 141.92 30.92 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -88.21 -3.41 58.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 177' ' ' ASN . 10.9 p-10 -108.95 3.98 22.83 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 175' ' ' ILE . 75.0 mt -91.11 132.98 35.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.29 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -68.3 171.24 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.123 0.487 . . . . 0.0 111.717 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -81.72 78.53 8.44 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -122.42 -6.27 8.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.677 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.4 pttp -84.41 0.16 50.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.85 -1.523 . . . . 0.0 113.83 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.3 p -53.86 -42.9 69.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -86.59 -26.8 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.071 0.939 . . . . 0.0 109.852 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.695 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -64.57 -37.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.405 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.6 mt -54.77 -49.18 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.584 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -67.55 -39.04 84.98 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.507 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.9 m -60.63 -42.22 96.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -63.54 -47.77 89.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.165 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.465 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.4 t -61.56 -48.76 87.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.328 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.39 -42.57 98.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.988 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CE2' HD11 ' A' ' 120' ' ' ILE . 58.0 t80 -64.55 -47.33 79.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.734 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 72.3 t80 -59.04 -48.26 82.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.015 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 25.1 m-85 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.521 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 47.7 t -61.69 -47.08 86.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.108 0.48 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.667 HG22 HG11 ' A' ' 127' ' ' VAL . 68.4 mt -65.04 -48.83 82.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.886 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.545 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 19.8 ptmt -66.03 -26.6 67.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.95 97.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.598 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.57 -38.05 26.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.874 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 127' ' ' VAL . 45.7 m -132.1 96.49 19.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.694 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.2 -14.14 42.07 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 122.772 2.315 . . . . 0.0 113.273 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 35.4 t70 -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.667 HG11 HG22 ' A' ' 120' ' ' ILE . 9.1 p -71.33 120.59 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.376 0.607 . . . . 0.0 110.069 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 41.4 mt-10 -127.64 19.2 6.75 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.782 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.27 150.15 29.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.485 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 167' ' ' GLU . 0.4 OUTLIER -137.81 130.75 30.14 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.7 54.93 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.715 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.848 HG12 ' HB3' ' A' ' 152' ' ' ALA . 47.4 t -116.95 122.46 70.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 ptm -144.69 158.26 43.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.6 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' A' ' 152' ' ' ALA . 6.6 pt -130.77 165.6 33.51 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.107 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo . . . . . 0 C--N 1.348 0.552 0 C-N-CA 122.536 2.157 . . . . 0.0 112.378 178.315 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.405 HG23 HG13 ' A' ' 134' ' ' ILE . 31.7 m . . . . . 0 N--CA 1.444 -0.736 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 139.6 89.08 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.75 2.3 . . . . 0.0 110.931 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.848 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -103.13 2.88 35.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 166.87 -100.66 0.17 Allowed Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 118.937 -1.602 . . . . 0.0 113.503 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.515 ' CG1' HG13 ' A' ' 113' ' ' ILE . 28.2 pt -124.77 161.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.75 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.544 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 7.7 t-20 -120.17 155.11 33.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.861 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.72 130.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 122.383 0.273 . . . . 0.0 110.612 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.526 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.9 m -136.68 152.0 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.41 0.624 . . . . 0.0 112.001 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.1 t -97.33 145.11 29.08 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 64.9 Cg_endo -70.85 74.66 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 88' ' ' ILE . 75.8 mmtt -105.0 132.0 51.8 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.582 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -81.87 74.0 8.88 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.05 -146.25 13.71 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -118.74 144.19 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.048 0.424 . . . . 0.0 109.992 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -134.28 166.38 22.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.29 129.8 43.84 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -125.07 126.89 46.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.57 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 130' ' ' LEU . 28.7 mm-40 -93.96 162.36 13.92 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 121.558 0.694 . . . . 0.0 111.582 176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -117.31 129.57 73.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.977 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.463 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 49.8 ttm -116.16 131.53 56.92 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.623 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 133' ' ' MET . 7.4 p -119.68 128.21 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.543 HD11 ' HB1' ' A' ' 152' ' ' ALA . 33.6 pt -119.95 172.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.541 -176.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -109.33 -2.33 17.91 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.458 ' CG ' HD12 ' A' ' 171' ' ' ILE . 4.1 pt-20 -97.99 131.13 44.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.666 0.746 . . . . 0.0 110.401 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.19 149.38 21.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.937 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.543 HD13 HD22 ' A' ' 102' ' ' LEU . 1.7 pp -123.84 154.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.218 171.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.85 137.38 52.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.552 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 9.3 p30 -110.39 127.73 55.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.08 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.535 HD13 ' OD2' ' A' ' 183' ' ' ASP . 16.9 mm -88.59 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.77 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.3 -0.37 56.71 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.313 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.8 t -148.11 151.39 35.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.655 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.658 ' HD2' ' H ' ' A' ' 181' ' ' LYS . 0.2 OUTLIER -62.09 -37.14 83.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.302 -177.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -61.56 -41.72 97.79 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.417 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.535 ' OD2' HD13 ' A' ' 178' ' ' ILE . 11.6 t70 -63.6 -36.05 82.54 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 178' ' ' ILE . 59.4 tp -58.52 -43.44 89.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.625 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 60.7 tttm -62.21 -43.72 98.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.718 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.7 tt -61.39 -45.05 95.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.04 98.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.013 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 12.5 pt-20 -66.34 -33.43 75.72 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -64.89 -40.25 94.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.643 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 88.2 mt -64.83 -43.19 93.86 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.362 0.601 . . . . 0.0 110.09 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.26 -40.76 97.27 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.584 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt . . . . . 0 C--N 1.301 -1.538 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.518 178.679 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 19.3 m-20 -97.93 165.9 11.7 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -114.69 130.48 56.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.279 0.562 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.0 122.15 45.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.704 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -117.98 116.23 50.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.238 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.501 ' CE ' HD22 ' A' ' 84' ' ' LEU . 38.3 mtt -89.05 96.57 10.78 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 122.32 1.057 . . . . 0.0 113.638 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.43 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.284 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.479 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.446 -178.813 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo . . . . . 0 CA--C 1.535 0.543 0 N-CA-C 114.523 0.932 . . . . 0.0 114.523 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 39.6 mt -97.75 4.69 49.85 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.31 123.78 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.93 139.38 31.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.818 -177.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.55 108.16 12.82 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.299 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.9 m 54.5 26.24 7.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.135 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.91 -101.58 0.2 Allowed Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.668 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 75.3 mtt-85 -88.03 168.36 12.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.105 0.479 . . . . 0.0 111.969 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.9 m -79.5 163.81 24.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 33' ' ' VAL . 67.1 mt -57.89 -45.28 86.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -39.5 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.785 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 18.8 t70 -65.74 -39.58 91.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 110.038 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -63.69 -34.62 78.26 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.605 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 100' ' ' SER . 75.8 t -66.4 -45.36 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.3 -41.04 88.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.592 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -50.88 -54.52 36.07 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 40' ' ' SER . 56.5 Cg_endo -71.36 -36.47 6.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.585 1.523 . . . . 0.0 112.249 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.453 HD11 HG11 ' A' ' 98' ' ' VAL . 84.8 mt -64.97 -41.8 95.12 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -59.95 -46.32 89.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -82.03 -9.07 59.67 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 59.3 p -74.28 -177.94 3.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.539 0.685 . . . . 0.0 112.202 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HD2' HG11 ' A' ' 114' ' ' VAL . 23.8 ttmm -56.26 -26.32 51.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.253 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.69 161.91 2.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.677 0.751 . . . . 0.0 112.989 -174.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -81.07 -78.42 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.99 161.95 18.97 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.027 0.441 . . . . 0.0 111.128 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 3' ' ' ALA . 48.9 mm -109.34 116.53 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.72 114.81 28.71 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.526 HG21 HD13 ' A' ' 60' ' ' ILE . 94.3 mt -97.24 117.82 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.569 0.7 . . . . 0.0 110.66 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.85 119.29 28.04 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.381 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 7' ' ' ALA . 69.8 p -121.42 155.92 33.82 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.57 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 35.8 m -105.45 145.66 31.24 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.733 -177.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 53.6 Cg_exo -57.96 -29.83 87.86 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.449 2.766 . . . . 0.0 112.01 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.16 -2.84 56.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 2.1 p -139.03 67.07 40.47 Favored Pre-proline 0 CA--C 1.498 -1.049 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.968 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.4 Cg_endo -106.99 86.59 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.11 0 C-N-CA 117.115 -1.456 . . . . 0.0 110.486 169.206 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 29.5 mtmm -144.06 -48.1 0.28 Allowed 'General case' 1 C--N 1.219 -5.081 0 CA-C-N 109.973 -3.285 . . . . 0.0 103.424 177.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.419 HG21 ' HB1' ' A' ' 7' ' ' ALA . 96.7 m -61.8 -48.9 78.53 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 112.549 -2.114 . . . . 0.0 106.054 164.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.13 -49.66 75.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.963 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.2 pt-20 -59.78 -34.52 73.11 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.698 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.14 -50.8 66.76 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.103 0.477 . . . . 0.0 111.088 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.526 HD13 HG21 ' A' ' 47' ' ' ILE . 97.3 mt -64.0 -41.59 92.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.884 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 57' ' ' LYS . 87.9 m-20 -57.74 -40.99 80.94 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.264 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 4.5 t -82.04 -39.12 23.96 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.895 0.378 . . . . 0.0 110.575 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.09 93.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.363 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 60' ' ' ILE . 81.0 m-85 -110.19 34.59 3.81 Favored 'General case' 0 C--O 1.206 -1.191 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.757 -176.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 10.9 mmmm -61.51 -25.04 67.02 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.09 0.471 . . . . 0.0 111.035 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -89.38 11.08 20.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.299 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 53.8 p90 -43.32 127.4 4.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -103.0 -49.05 3.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.945 0.878 . . . . 0.0 109.661 172.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -117.97 11.87 13.54 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.935 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.96 125.21 57.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.27 0.557 . . . . 0.0 110.302 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.45 131.76 71.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.378 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.5 132.63 53.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.138 0.494 . . . . 0.0 109.67 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.6 pt -125.98 152.16 32.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.288 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -119.83 130.49 54.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.452 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.47 HG23 ' CG ' ' A' ' 83' ' ' ASP . 11.6 t -165.26 -167.42 1.17 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 78' ' ' LYS . 73.7 m -59.42 0.59 0.11 Allowed 'General case' 0 C--O 1.198 -1.61 0 C-N-CA 127.383 2.273 . . . . 0.0 116.082 -173.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.464 ' N ' ' HB2' ' A' ' 83' ' ' ASP . . . -31.61 -22.36 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 C-N-CA 125.805 1.669 . . . . 0.0 116.972 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.2 tmmt? -56.84 -35.51 68.91 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.83 113.62 3.81 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -59.31 -49.08 79.19 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.96 -48.21 89.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.713 0.768 . . . . 0.0 110.4 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.53 -45.91 92.18 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.271 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 75' ' ' THR . 28.6 t0 -63.09 -50.03 72.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.385 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -53.61 -47.39 70.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.237 0.542 . . . . 0.0 109.61 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.556 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.2 m-80 -61.98 -40.44 95.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.032 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.84 -42.99 84.87 Favored 'General case' 1 N--CA 1.374 -4.235 0 O-C-N 122.092 -0.38 . . . . 0.0 110.632 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 91.3 m -62.98 -42.07 99.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.774 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 95' ' ' PHE . 26.3 pt -67.01 -28.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.29 -38.24 96.14 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.976 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -84.0 -12.09 55.78 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.483 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 81.2 m-85 -96.06 145.26 25.61 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.887 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.7 p -105.67 -2.74 23.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.806 0.813 . . . . 0.0 109.208 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -128.82 157.1 76.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.032 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.37 148.61 74.04 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.357 2.038 . . . . 0.0 111.626 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 40.7 p90 -143.28 159.33 42.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.279 0.561 . . . . 0.0 111.394 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.699 HD21 HD12 ' A' ' 154' ' ' ILE . 30.7 tp -86.41 143.05 28.0 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 92.2 t -115.2 126.32 72.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.6 m -130.85 157.22 43.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.355 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . 33.8 t -100.23 150.93 22.04 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 171.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.623 ' HA ' HG21 ' A' ' 33' ' ' VAL . 68.3 m -88.39 1.33 54.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' HD12 ' A' ' 102' ' ' LEU . 40.5 p-10 -104.14 4.18 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 99' ' ' SER . 7.2 mp -88.57 140.53 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.099 -0.376 . . . . 0.0 111.106 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.535 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 41.7 pt -64.36 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.555 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -82.24 4.31 24.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.03 11.84 1.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.689 0.757 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HE2' ' O ' ' A' ' 103' ' ' ILE . 57.9 mtmt -83.86 -1.4 54.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.278 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.6 t -57.31 -46.39 83.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -78.59 -23.8 45.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.716 0.77 . . . . 0.0 109.463 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.74 ' O ' HG12 ' A' ' 113' ' ' ILE . 39.2 mm -67.12 -41.52 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.117 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 106' ' ' LYS . 59.6 mt -58.28 -48.89 83.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.83 -177.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.414 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 59.5 m-80 -65.9 -39.85 90.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.1 m -61.76 -40.2 94.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.849 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -62.84 -47.54 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.471 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 72.6 t -61.85 -48.83 86.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.556 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -62.03 -43.46 98.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.463 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.519 ' CE2' HD11 ' A' ' 120' ' ' ILE . 68.8 t80 -64.84 -49.86 68.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.1 t80 -59.37 -48.63 80.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.278 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 36.4 m-85 -65.85 -30.7 71.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.334 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.26 -45.51 92.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.519 HD11 ' CE2' ' A' ' 116' ' ' TYR . 75.0 mt -64.63 -42.97 96.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.584 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HD2' HG13 ' A' ' 127' ' ' VAL . 17.1 mmmt -59.93 -42.38 93.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.269 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.07 85.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.064 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.41 -34.07 15.78 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.098 0.475 . . . . 0.0 111.076 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 26.0 m -133.23 98.39 15.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 123.184 0.594 . . . . 0.0 109.717 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.93 -15.32 36.42 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.394 2.063 . . . . 0.0 112.327 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 40.1 m-20 -63.28 -31.23 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 121' ' ' LYS . 9.8 p -66.31 127.23 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.711 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.8 mt-10 -119.52 6.27 11.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.606 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.31 159.25 25.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.859 0.361 . . . . 0.0 111.622 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -138.33 135.03 35.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.4 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -124.24 137.66 54.49 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 113' ' ' ILE . 72.1 t -115.39 117.02 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 121.257 0.551 . . . . 0.0 109.666 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -146.48 159.07 43.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.2 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.65 HG12 ' HB2' ' A' ' 152' ' ' ALA . 18.1 pt -132.6 158.37 75.88 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.792 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 30.9 Cg_endo . . . . . 0 N--CA 1.452 -0.92 0 C-N-CA 121.451 1.434 . . . . 0.0 111.722 -178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.133 0.492 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.06 142.99 48.02 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.331 2.021 . . . . 0.0 111.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.65 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -109.09 -13.03 14.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.732 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.28 -117.74 0.44 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.309 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.699 HD12 HD21 ' A' ' 96' ' ' LEU . 17.8 pt -122.98 160.93 25.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 122.656 0.382 . . . . 0.0 111.443 -175.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.596 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.7 t-20 -116.61 153.71 31.79 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.9 t -123.51 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.423 0.289 . . . . 0.0 110.378 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.4 m -130.79 149.79 33.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.412 0.625 . . . . 0.0 112.1 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 159' ' ' PRO . 23.1 t -98.19 151.62 37.61 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 29.1 Cg_endo -63.11 82.17 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.844 2.363 . . . . 0.0 112.582 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.96 -172.64 2.16 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.034 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -137.2 92.24 2.7 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.96 -137.09 10.95 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.96 139.87 41.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.136 0.494 . . . . 0.0 110.746 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.91 166.59 22.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -54.31 121.62 8.64 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -129.78 129.42 44.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.545 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -93.84 162.95 13.71 Favored 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 121.936 0.874 . . . . 0.0 112.716 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 131' ' ' ALA . 49.6 mm -116.12 128.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.579 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 55.4 ttp -125.79 129.99 50.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.419 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 133' ' ' MET . 60.0 t -106.63 129.94 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.015 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.3 pt -115.87 175.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -176.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -113.4 11.44 18.51 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.657 ' HB2' HD12 ' A' ' 171' ' ' ILE . 29.2 mp0 -97.41 131.45 44.05 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.791 0.805 . . . . 0.0 110.882 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.7 139.63 32.49 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.667 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 175' ' ' ILE . 2.0 pp -120.84 148.85 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.946 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.48 117.34 30.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.892 0.377 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -105.26 13.99 29.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.257 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 184' ' ' LEU . 11.7 mm 55.46 71.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.62 -41.99 83.09 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.429 0.633 . . . . 0.0 110.277 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -145.88 -175.34 4.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.336 -173.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.558 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 1.3 mptp? -59.48 -36.49 76.12 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.222 0.609 . . . . 0.0 111.328 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -58.23 -43.3 87.66 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.473 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 63.9 m-20 -70.7 -39.52 73.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.303 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 178' ' ' ILE . 64.3 tp -59.45 -50.49 73.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.2 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -64.36 -43.26 95.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.93 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.8 tt -61.03 -49.01 79.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.737 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.04 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 pt-20 -66.26 -37.45 85.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.049 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -66.69 -37.56 84.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.715 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 89.5 mt -62.46 -44.39 96.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.452 0.644 . . . . 0.0 109.323 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.49 -42.97 98.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.467 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.2 tttt . . . . . 0 C--N 1.306 -1.293 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.077 179.14 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.1 ttm . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.813 0.34 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.572 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 75.9 m-20 -105.38 166.27 10.54 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.46 127.39 56.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -103.26 119.68 39.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.782 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.644 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.6 mt -118.88 104.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.552 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.46 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.0 ptm -92.83 102.19 14.57 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.008 1.385 . . . . 0.0 112.047 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' ' HG2' ' A' ' 20' ' ' PRO . . . -115.12 98.29 6.7 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.795 -2.002 . . . . 0.0 111.139 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.775 178.646 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.474 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 20.7 Cg_exo . . . . . 0 CA--C 1.519 -0.271 0 CA-C-O 121.12 0.383 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 21.7 mt -87.05 6.07 34.38 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 87.6 mt -74.13 110.56 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.7 pttm -81.67 131.39 35.27 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.685 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 184' ' ' LEU . 57.6 tp -122.71 112.07 17.49 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.155 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m 58.2 17.95 4.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.87 -95.48 0.15 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.146 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HG2' ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -87.29 172.41 9.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 111.34 -176.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 76.6 m -76.07 163.42 27.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 98.9 mt -59.61 -39.18 83.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.8 tp -57.68 -45.18 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.035 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 17.7 t70 -64.56 -40.34 95.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.493 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CD2' ' HG2' ' A' ' 27' ' ' ARG . 11.2 m-85 -61.26 -37.99 85.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.15 -44.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.409 . . . . 0.0 111.148 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.14 -41.97 94.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.3 m -51.67 -55.67 27.75 Favored Pre-proline 0 CA--C 1.562 1.436 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.23 -37.27 14.46 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.512 1.475 . . . . 0.0 112.409 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.663 HD11 HG11 ' A' ' 98' ' ' VAL . 82.1 mt -66.26 -41.53 89.78 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.845 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.33 -46.26 91.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.684 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.16 -9.29 59.52 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.409 ' OG ' HG22 ' A' ' 42' ' ' VAL . 54.7 p -72.08 -177.7 2.15 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.934 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -73.34 2.54 7.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.811 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG22 ' OG ' ' A' ' 40' ' ' SER . 34.2 m -80.42 162.03 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.342 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.572 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.6 t30 -81.63 -71.78 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.947 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -120.52 160.14 23.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.256 0.55 . . . . 0.0 111.396 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.1 mm -109.8 117.54 54.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 83.7 m-85 -109.46 116.86 32.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 60' ' ' ILE . 96.0 mt -97.39 116.22 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 121.715 0.769 . . . . 0.0 110.467 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.18 120.53 28.55 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.65 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 7' ' ' ALA . 45.1 p -127.93 154.72 45.23 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m -100.58 149.36 36.06 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.56 -17.58 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.714 2.276 . . . . 0.0 110.169 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.07 -11.1 59.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.599 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 p -140.17 67.55 33.07 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.117 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 77.3 Cg_endo -102.46 85.76 0.03 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.629 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.107 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.651 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.7 mmtm -149.8 -48.45 0.13 Allowed 'General case' 1 C--N 1.22 -5.049 0 CA-C-N 109.845 -3.343 . . . . 0.0 103.074 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.436 ' HA ' HD21 ' A' ' 21' ' ' LEU . 99.3 m -62.81 -48.63 78.26 Favored 'General case' 0 N--CA 1.386 -3.659 0 CA-C-N 113.104 -1.862 . . . . 0.0 105.987 163.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.32 -50.42 70.08 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.341 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 7.8 pt-20 -62.6 -34.14 76.42 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 117.159 -1.817 . . . . 0.0 112.138 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD2' HD22 ' A' ' 21' ' ' LEU . 51.0 t80 -64.55 -51.09 64.63 Favored 'General case' 0 C--O 1.211 -0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 111.728 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 47' ' ' ILE . 95.5 mt -62.59 -41.25 91.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.1 -46.02 79.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.065 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.694 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.2 t -73.06 -40.26 65.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.38 0.61 . . . . 0.0 110.848 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.78 86.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -177.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.432 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 89.5 m-85 -114.75 42.29 2.18 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.544 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.694 ' HG3' ' O ' ' A' ' 62' ' ' SER . 39.2 mtmm -60.55 -22.21 63.41 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.221 0.534 . . . . 0.0 110.25 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.98 10.64 18.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.235 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 55.4 p90 -44.33 117.27 1.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 3.9 mmpt? -103.06 -49.35 3.78 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.444 1.116 . . . . 0.0 109.088 171.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.42 9.92 18.21 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.577 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.48 123.87 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.083 0.468 . . . . 0.0 110.124 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 65.5 t -124.02 131.9 72.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.347 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.2 131.89 53.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.112 0.482 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.3 pt -125.89 156.53 35.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.307 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -117.36 129.59 55.97 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -158.74 -170.19 2.97 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.5 m -66.18 2.36 1.2 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 127.268 2.227 . . . . 0.0 115.011 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.621 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.17 -22.61 0.0 OUTLIER Glycine 1 N--CA 1.52 4.262 0 C-N-CA 126.187 1.851 . . . . 0.0 117.02 -174.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -55.65 -39.87 71.48 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.14 122.64 6.98 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -59.82 -50.56 73.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.218 0.509 . . . . 0.0 111.454 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.9 pt -72.88 -30.81 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.774 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.87 -43.34 93.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 109.353 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.621 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.5 t0 -61.45 -51.09 70.13 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.15 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -57.61 -43.2 84.56 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.499 ' HA ' HG12 ' A' ' 88' ' ' ILE . 14.9 m-80 -60.39 -42.62 96.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -63.84 -45.71 88.29 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.286 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.9 m -62.56 -41.95 99.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.158 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -66.0 -29.51 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.24 -39.59 96.14 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.637 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -71.38 -40.97 70.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.8 m-85 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.943 0.402 . . . . 0.0 111.916 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -105.16 -2.36 24.32 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.67 157.02 78.17 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.975 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.39 141.94 59.59 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 123.486 2.791 . . . . 0.0 112.237 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 32.4 p90 -141.66 156.4 45.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.354 0.597 . . . . 0.0 111.543 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.601 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.34 138.78 31.55 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.178 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 63.5 t -113.96 129.99 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.663 HG11 HD11 ' A' ' 37' ' ' LEU . 7.3 m -129.47 160.17 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.484 0.659 . . . . 0.0 112.505 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.452 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 62.4 m -100.44 138.26 37.74 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.772 172.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -64.79 -21.46 66.78 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.9 p-10 -112.27 22.76 14.39 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 95.9 mt -68.81 138.4 54.75 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.915 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -92.99 142.81 12.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 79.37 171.65 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.527 1.131 . . . . 0.0 112.799 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.75 134.33 47.34 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.212 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -101.81 -1.65 31.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.431 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.568 ' HA ' HD12 ' A' ' 110' ' ' ILE . 69.6 m -57.19 -40.73 77.97 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -170.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.507 ' HG3' HG13 ' A' ' 109' ' ' ILE . 17.2 ptmt -74.34 -38.22 63.31 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.065 0.936 . . . . 0.0 110.304 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.783 ' O ' HG12 ' A' ' 113' ' ' ILE . 58.8 mt -66.49 -40.43 86.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.23 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 107' ' ' SER . 62.6 mt -58.42 -45.8 89.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.913 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -60.95 -45.14 95.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.986 179.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -62.99 -39.85 96.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.624 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.783 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -61.69 -48.66 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.205 0.526 . . . . 0.0 110.331 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.04 -48.19 89.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.687 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -62.26 -45.68 92.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.694 ' CE2' HD11 ' A' ' 120' ' ' ILE . 80.1 t80 -64.08 -47.79 78.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 79.6 t80 -58.37 -46.02 87.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.453 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -60.4 -37.15 79.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.96 -42.72 99.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.913 0.387 . . . . 0.0 110.528 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.694 HD11 ' CE2' ' A' ' 116' ' ' TYR . 71.2 mt -68.26 -44.19 84.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.711 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -66.73 -37.0 83.78 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.585 -178.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.422 ' N ' ' HD3' ' A' ' 121' ' ' LYS . . . -62.01 -42.71 99.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 0.0 111.16 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -80.14 -39.42 29.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.073 0.464 . . . . 0.0 111.034 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 126' ' ' ASP . 35.8 m -132.36 99.97 15.61 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.12 -11.9 34.0 Favored 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 123.002 2.468 . . . . 0.0 112.231 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 124' ' ' THR . 25.4 t70 -61.49 -32.63 72.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.208 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.428 HG22 ' HE2' ' A' ' 165' ' ' LYS . 60.4 t -81.3 119.24 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.282 0.563 . . . . 0.0 111.011 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.597 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 39.5 mt-10 -122.55 7.12 9.49 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.658 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.59 153.75 39.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -139.37 139.0 37.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.191 -177.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -128.14 139.0 52.73 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.191 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.566 HG21 ' CD1' ' A' ' 113' ' ' ILE . 98.4 t -115.32 117.51 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 121.74 0.781 . . . . 0.0 110.683 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.433 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 5.2 ptm -146.5 161.87 39.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.113 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.9 pt -128.77 159.59 67.49 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.459 -0.526 0 C-N-CA 122.261 1.974 . . . . 0.0 111.298 178.462 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.442 -0.833 0 CA-C-O 121.15 0.5 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 175' ' ' ILE . 61.8 Cg_endo -71.73 149.94 55.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.483 2.122 . . . . 0.0 111.218 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 175' ' ' ILE . . . -132.4 -31.82 1.38 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.974 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -117.03 -134.16 5.21 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.993 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.601 HD12 HD11 ' A' ' 96' ' ' LEU . 22.6 pt -126.08 160.36 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.399 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.62 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.5 m-20 -111.78 158.03 19.85 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.1 132.31 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.785 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.9 153.72 38.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.379 0.609 . . . . 0.0 111.808 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.597 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 34.3 t -97.99 151.19 37.43 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.893 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.461 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 61.3 Cg_endo -70.28 59.18 1.87 Allowed 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.281 2.654 . . . . 0.0 112.684 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -88.72 -172.33 3.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.259 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -134.31 94.86 3.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.92 -119.99 4.1 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.689 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -127.82 140.99 51.7 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -135.37 167.0 21.84 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.846 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HE2' HG22 ' A' ' 127' ' ' VAL . 20.3 tptm -55.25 128.33 33.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.137 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -132.58 130.59 40.49 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.298 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -98.94 162.34 13.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 121.701 0.762 . . . . 0.0 112.996 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 131' ' ' ALA . 50.0 mm -118.09 130.16 73.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.696 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.6 ttp -127.9 137.97 52.5 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.6 t -110.1 130.39 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.073 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.5 pt -113.74 172.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.018 0.437 . . . . 0.0 110.503 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.7 9.98 31.05 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.311 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.426 ' HB2' HD12 ' A' ' 171' ' ' ILE . 35.6 mt-10 -101.65 129.04 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.804 0.811 . . . . 0.0 111.247 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.75 150.76 20.34 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.508 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.497 HD11 ' O ' ' A' ' 151' ' ' PRO . 23.3 pt -133.79 155.4 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.952 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.08 127.32 54.77 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.635 0.255 . . . . 0.0 110.483 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -84.41 109.36 17.81 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 183' ' ' ASP . 94.5 mt -85.63 115.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.537 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -119.73 -18.72 8.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.319 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.6 p -128.38 167.21 17.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.33 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -59.72 -38.9 82.94 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.847 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.54 -39.96 92.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.605 ' HB2' HG23 ' A' ' 178' ' ' ILE . 71.7 m-20 -62.44 -42.0 99.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.296 0.569 . . . . 0.0 109.871 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.48 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.2 tp -62.12 -43.96 97.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.291 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.585 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 6.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.24 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 10.1 tt -62.46 -46.09 90.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.58 99.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.759 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.74 -31.88 72.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.533 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -64.32 -39.74 94.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.642 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 87.4 mt -63.77 -43.68 95.69 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 0.0 109.624 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.78 -39.28 93.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.418 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--N 1.308 -1.215 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.316 177.496 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.856 0.36 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 35.5 m-20 -106.28 166.12 10.75 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.26 129.83 55.7 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.94 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 98' ' ' VAL . 25.5 tp -105.31 125.23 50.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.0 mt -117.1 103.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.512 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 58.2 ttm -83.04 96.84 8.48 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-O 121.711 0.767 . . . . 0.0 110.887 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.96 97.69 6.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.598 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.662 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 N--CA 1.473 0.293 0 N-CA-C 112.869 0.296 . . . . 0.0 112.869 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 42.8 mt -97.02 14.87 24.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.0 mt -75.3 114.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.6 ptmm? -85.45 125.04 32.71 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.82 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 62.4 tp -126.38 115.68 20.01 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.94 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.9 t 58.84 19.19 6.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.975 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.3 -62.92 0.54 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.253 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.704 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 96.2 mtt180 -104.85 167.47 9.69 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 117.508 0.654 . . . . 0.0 111.476 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 76.1 m -82.15 160.84 23.0 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.704 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.552 ' O ' HG23 ' A' ' 33' ' ' VAL . 90.1 mt -59.41 -39.65 84.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.949 0.155 . . . . 0.0 111.246 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.7 tp -57.04 -46.1 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.704 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 11.4 t70 -64.87 -41.64 95.49 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.138 0.494 . . . . 0.0 110.403 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 27' ' ' ARG . 18.8 m-85 -64.4 -34.34 77.95 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' LEU . 77.0 t -66.99 -43.87 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 121.327 0.584 . . . . 0.0 110.206 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 30' ' ' ILE . 79.0 t -63.35 -41.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.38 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -51.28 -55.93 24.57 Favored Pre-proline 0 CA--C 1.565 1.547 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 45.8 Cg_endo -69.23 -36.1 12.88 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 121.573 1.516 . . . . 0.0 112.491 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.634 HD11 HG11 ' A' ' 98' ' ' VAL . 99.4 mt -67.46 -41.79 84.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.642 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.48 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.8 tt -63.0 -44.54 95.73 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.049 0.452 . . . . 0.0 110.886 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 22.1 ptmt -75.26 -12.31 60.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.0 p -71.24 -178.9 2.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.144 0.497 . . . . 0.0 110.588 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -76.51 0.32 20.34 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.67 159.38 5.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -77.35 -73.18 0.31 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.755 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -121.17 159.46 25.8 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.171 0.51 . . . . 0.0 111.132 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.16 116.31 50.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.11 114.95 29.11 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.637 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -95.03 117.8 39.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.501 0.667 . . . . 0.0 110.182 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.1 119.68 28.72 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.219 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 7' ' ' ALA . 77.6 p -129.88 166.86 19.13 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.565 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.5 p -131.3 158.84 74.12 Favored Pre-proline 0 C--N 1.298 -1.65 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.856 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.23 -19.79 65.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.809 2.339 . . . . 0.0 111.435 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.63 -13.9 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.881 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -142.09 67.16 21.63 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 85.6 Cg_endo -104.29 86.58 0.03 OUTLIER 'Trans proline' 1 N--CA 1.385 -4.863 0 C-N-CA 116.827 -1.649 . . . . 0.0 110.108 169.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 73.6 mmtt -146.96 -47.51 0.18 Allowed 'General case' 1 C--N 1.222 -4.964 0 CA-C-N 110.08 -3.236 . . . . 0.0 103.405 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.445 HG21 ' HB1' ' A' ' 7' ' ' ALA . 99.8 m -61.93 -48.59 79.73 Favored 'General case' 0 N--CA 1.379 -3.996 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.16 -50.68 69.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.558 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.3 pt-20 -64.36 -26.39 68.45 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 117.098 -1.841 . . . . 0.0 112.879 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -70.52 -51.23 30.21 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.277 0.561 . . . . 0.0 111.483 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.637 HD13 HG21 ' A' ' 47' ' ' ILE . 94.5 mt -63.55 -43.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.493 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.73 -45.01 82.2 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.495 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.0 t -69.18 -42.28 76.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.631 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.05 93.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.199 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 70.9 m-85 -114.61 41.61 2.3 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.39 -176.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.0 mmmm -58.93 -37.01 75.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.131 0.491 . . . . 0.0 110.951 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -83.52 11.9 6.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.478 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 49.8 p90 -44.46 130.65 6.63 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 68' ' ' LYS . 3.6 tmmm? -102.55 -48.28 4.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.21 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.48 HD21 ' HG ' ' A' ' 38' ' ' LEU . 24.1 p-10 -118.12 7.89 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.251 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.1 mp -100.09 116.34 43.21 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.1 t -117.7 130.74 72.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.77 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -104.09 127.69 58.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.5 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.1 pt -120.85 153.3 24.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.331 0.586 . . . . 0.0 110.959 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.08 131.21 56.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.841 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 t -166.67 -166.22 0.83 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 67.5 m -57.58 1.5 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 126.965 2.106 . . . . 0.0 115.344 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -33.07 -12.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.069 0 C-N-CA 126.048 1.785 . . . . 0.0 116.587 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -58.13 -38.96 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.419 ' HA3' ' OE2' ' A' ' 82' ' ' GLU . . . -114.92 131.83 10.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.08 -51.33 69.58 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.067 0.433 . . . . 0.0 111.957 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.6 pt -79.45 -25.99 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.199 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 47.1 mt-10 -62.18 -44.73 95.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 10.6 t0 -63.45 -48.57 77.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.18 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -54.82 -46.96 74.62 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.792 178.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' HG12 ' A' ' 88' ' ' ILE . 29.1 m-80 -61.43 -40.5 94.68 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.861 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 76.8 mm-40 -63.36 -45.66 90.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.135 0.493 . . . . 0.0 109.744 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.572 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 98.0 m -63.07 -42.2 99.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.526 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 84' ' ' LEU . 36.4 pt -64.83 -28.73 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.37 -20.24 75.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.302 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -103.78 -28.25 11.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.563 0.682 . . . . 0.0 112.786 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.572 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 71.8 m-85 -77.24 141.28 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -105.87 -1.95 23.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.507 0.67 . . . . 0.0 109.868 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 40.4 mt-10 -132.99 160.0 70.44 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 41.6 Cg_endo -67.65 145.46 69.94 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.729 1.619 . . . . 0.0 110.761 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.1 157.98 44.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.61 0.719 . . . . 0.0 111.488 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 154' ' ' ILE . 26.6 tp -87.43 141.46 28.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.457 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 94.0 t -112.87 130.92 65.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -128.82 168.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.283 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.2 m -98.45 144.61 27.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.013 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 6' ' ' MET . 88.0 p -73.16 -12.51 60.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -174.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 7.9 p-10 -116.9 11.67 14.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.38 157.2 30.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.74 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -116.64 174.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.003 0.43 . . . . 0.0 111.911 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -62.31 178.42 0.4 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.829 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.3 mt 81.47 5.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.576 1.15 . . . . 0.0 109.893 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 48.5 mmtm -98.69 1.88 46.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.288 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.736 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.2 p -58.01 -35.29 71.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.92 -29.69 62.17 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.169 0.985 . . . . 0.0 108.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.613 ' O ' HG12 ' A' ' 113' ' ' ILE . 25.7 mm -64.59 -38.69 83.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' A' ' 107' ' ' SER . 73.8 mt -59.31 -45.31 93.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.307 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -61.31 -43.62 98.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.96 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.0 m -64.73 -41.68 95.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.591 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.9 mm -62.86 -45.51 98.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.27 0.557 . . . . 0.0 109.873 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.432 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 53.8 t -60.44 -47.34 92.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.355 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.9 -47.61 85.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.03 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.613 ' CE2' HD11 ' A' ' 120' ' ' ILE . 54.3 t80 -64.56 -45.76 85.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.88 0.372 . . . . 0.0 110.554 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.27 -48.8 80.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.106 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.3 m-85 -62.81 -36.24 82.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.897 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.78 -41.59 97.92 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.3 mt -68.96 -46.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -68.22 -27.68 66.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.062 -177.575 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.23 99.34 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -83.92 -38.24 21.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.387 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.1 m -126.65 96.45 35.47 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.643 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.66 -15.61 48.03 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 122.804 2.336 . . . . 0.0 112.349 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.67 -32.08 73.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.814 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 116.45 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.835 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.555 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 38.7 mt-10 -126.72 14.07 7.49 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.113 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.91 31.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.404 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.5 tp -140.83 143.27 34.7 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.178 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.18 143.21 50.65 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.279 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 154' ' ' ILE . 12.1 p -123.24 133.27 69.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.159 0.504 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 71.5 mtm -134.01 157.04 47.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.361 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 171' ' ' ILE . 7.7 pt -127.8 151.81 76.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.788 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo . . . . . 0 N--CA 1.458 -0.59 0 C-N-CA 122.55 2.167 . . . . 0.0 112.448 179.236 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.4 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.458 0.17 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.487 ' O ' HD11 ' A' ' 175' ' ' ILE . 52.6 Cg_exo -58.82 144.56 98.4 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.003 2.469 . . . . 0.0 111.725 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.515 ' CB ' HG23 ' A' ' 134' ' ' ILE . . . -103.69 -15.42 15.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 170.11 -89.14 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.39 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 96' ' ' LEU . 22.3 pt -133.85 159.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.113 0.483 . . . . 0.0 111.722 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.63 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.4 m-20 -122.57 157.77 31.38 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.51 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.12 127.95 72.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 122.322 -0.236 . . . . 0.0 110.745 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.68 151.23 25.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.245 0.545 . . . . 0.0 111.795 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.522 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 88.8 p -97.29 169.78 8.16 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 37.4 Cg_endo -67.88 67.69 0.88 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.906 1.738 . . . . 0.0 110.978 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.541 ' HB3' ' NE2' ' A' ' 164' ' ' GLN . 61.0 pttt -67.15 123.42 20.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.016 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -62.44 -43.03 99.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.547 0.689 . . . . 0.0 109.197 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 160' ' ' LYS . . . -128.77 -177.31 14.81 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -72.31 128.46 35.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 118.066 0.933 . . . . 0.0 108.629 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.555 ' OE1' ' HB2' ' A' ' 128' ' ' GLU . 29.9 pt20 -117.8 168.09 10.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.586 -169.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -56.91 121.0 8.88 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 110.086 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.62 130.65 52.98 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.9 161.64 14.4 Favored 'General case' 0 CA--C 1.471 -2.07 0 CA-C-O 121.976 0.893 . . . . 0.0 112.954 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.6 mm -118.44 129.6 74.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 113.713 -1.585 . . . . 0.0 111.583 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 62.0 ttp -129.72 134.14 47.45 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.332 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 133' ' ' MET . 49.8 t -112.14 126.47 69.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 173' ' ' GLU . 47.8 pt -113.47 175.82 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.056 0.455 . . . . 0.0 111.052 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -111.18 16.07 21.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.32 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.692 ' HB2' HD12 ' A' ' 171' ' ' ILE . 75.0 mm-40 -98.76 133.28 43.3 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.672 0.749 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.0 mt -97.09 149.5 21.89 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.514 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 151' ' ' PRO . 12.9 pt -127.73 155.83 39.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.863 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.6 112.3 24.1 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.541 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASN . . . . . 0.437 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 7.8 t-20 -95.13 103.67 15.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.015 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.475 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 1.9 mp -81.92 113.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.521 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.91 -22.48 7.89 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 64.9 p -130.37 165.87 21.63 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.163 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.8 mppt? -65.98 -28.39 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 109.777 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.46 -42.35 98.64 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.227 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 49.3 m-20 -61.3 -41.03 96.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 109.535 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.403 ' CD1' HD13 ' A' ' 24' ' ' LEU . 59.2 tp -61.62 -45.05 95.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 30.4 mmmt -62.47 -39.87 94.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.501 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.01 -45.99 89.76 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.83 -42.78 97.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.472 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.9 OUTLIER -70.59 -34.68 72.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.757 0.313 . . . . 0.0 111.674 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.5 ttm -62.35 -43.38 98.96 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.301 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.1 pp -69.72 -37.94 76.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.87 -42.72 97.44 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.315 0.578 . . . . 0.0 110.385 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 C--N 1.316 -0.855 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.763 178.186 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.612 ' O ' HG23 ' A' ' 42' ' ' VAL . 59.8 ttm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.434 ' O ' ' HG2' ' A' ' 1' ' ' MET . 52.6 m-20 -105.73 160.73 14.99 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.523 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -122.51 140.43 52.77 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.692 -177.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 98' ' ' VAL . 28.9 tp -112.42 123.73 50.93 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.362 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.721 ' HA ' HG22 ' A' ' 98' ' ' VAL . 55.1 mt -116.46 104.94 17.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 175.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.439 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 11.8 ptm -95.25 97.39 9.83 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.738 1.256 . . . . 0.0 112.465 -174.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.458 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -115.94 96.98 5.84 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.094 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.76 45.66 0.57 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' VAL . . . 85.65 10.94 75.45 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.873 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.15 146.48 50.7 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.365 0.602 . . . . 0.0 111.959 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -170.49 -176.44 39.93 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -97.04 85.4 3.73 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 117.723 0.762 . . . . 0.0 109.851 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -142.87 -80.0 0.21 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.771 -177.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 72.5 mtm -130.42 -53.47 1.09 Allowed 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.057 0.456 . . . . 0.0 111.0 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 143.74 -169.09 26.18 Favored Glycine 0 N--CA 1.436 -1.365 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.48 -121.96 21.67 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 119.708 -1.234 . . . . 0.0 111.6 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 14.4 m -123.5 98.41 5.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -72.49 147.66 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -106.37 104.97 52.76 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.939 0.4 . . . . 0.0 110.887 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.81 -5.0 13.75 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.208 2.605 . . . . 0.0 112.866 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD11 ' HA ' ' A' ' 56' ' ' THR . 43.4 mt -94.64 10.99 32.72 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.2 mt -69.38 118.66 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -98.35 142.41 30.02 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.267 -175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.7 tp -137.21 115.87 12.1 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.036 -1.438 . . . . 0.0 111.106 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 83.1 m 56.06 24.14 7.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 174.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.57 2.22 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 119.01 -1.567 . . . . 0.0 115.436 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.703 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 69.5 mtt-85 -126.03 159.57 32.4 Favored 'General case' 0 CA--C 1.492 -1.25 0 CA-C-N 118.353 1.077 . . . . 0.0 111.059 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 72.7 m -83.85 157.99 21.82 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 175.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.499 HD22 ' HA ' ' A' ' 101' ' ' ASP . 0.6 OUTLIER -46.7 -53.29 12.03 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -177.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.458 HD12 ' CB ' ' A' ' 7' ' ' ALA . 12.4 tt -62.07 -36.4 73.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.529 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HA ' HG12 ' A' ' 34' ' ' VAL . 12.7 t70 -63.02 -40.51 97.96 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.703 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 25.1 m-85 -64.69 -37.17 86.68 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.573 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.37 -47.76 83.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.305 -0.407 . . . . 0.0 112.036 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 31' ' ' ASP . 12.2 p -72.1 -35.15 52.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 -174.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.551 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 35.1 t -53.9 -54.08 50.81 Favored Pre-proline 0 CA--C 1.562 1.438 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 46.0 Cg_exo -61.45 -39.34 56.67 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 122.002 1.801 . . . . 0.0 112.023 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.45 HD12 HD11 ' A' ' 5' ' ' ILE . 81.2 mt -63.67 -42.08 98.1 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.459 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.487 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.9 tt -60.01 -45.79 91.6 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.024 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.0 -12.07 59.44 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.523 ' OG ' HG12 ' A' ' 42' ' ' VAL . 72.7 p -76.49 -175.86 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.117 0.484 . . . . 0.0 111.911 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -51.48 -33.77 32.79 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.666 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 1' ' ' MET . 7.5 p -69.05 140.31 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 CA-C-O 121.444 0.64 . . . . 0.0 111.616 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -83.6 -69.75 0.61 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.285 -175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -101.23 146.46 27.49 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-O 121.357 0.599 . . . . 0.0 111.156 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.429 HG21 HG23 ' A' ' 34' ' ' VAL . 47.7 mm -110.98 116.87 53.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 CA-C-N 114.913 -1.039 . . . . 0.0 108.845 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 96.1 m-85 -103.39 114.96 29.64 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.759 HG21 HD13 ' A' ' 60' ' ' ILE . 88.0 mt -98.96 118.34 45.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-O 121.649 0.738 . . . . 0.0 110.482 -178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.473 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.33 124.36 33.29 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.374 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 55.1 p -132.2 168.63 17.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.213 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.1 m -129.89 155.01 81.21 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.506 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.63 -21.47 65.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.925 2.416 . . . . 0.0 111.044 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -77.16 -13.12 60.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.453 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -142.37 66.47 19.4 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.63 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 76.4 Cg_endo -107.99 87.0 0.02 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.591 0 CA-C-N 120.884 1.351 . . . . 0.0 111.363 170.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.5 mmtm -151.01 -44.58 0.12 Allowed 'General case' 1 C--N 1.221 -5.001 0 CA-C-N 109.599 -3.455 . . . . 0.0 102.649 176.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' HD11 ' A' ' 21' ' ' LEU . 74.9 m -62.68 -49.51 74.83 Favored 'General case' 0 N--CA 1.387 -3.615 0 CA-C-N 113.022 -1.899 . . . . 0.0 105.974 161.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.63 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.23 -50.26 70.92 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.628 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.668 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.5 pt-20 -62.14 -30.26 70.91 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 116.517 -2.073 . . . . 0.0 112.573 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -65.01 -50.31 66.81 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.629 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.759 HD13 HG21 ' A' ' 47' ' ' ILE . 85.5 mt -60.62 -45.03 98.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.154 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -56.54 -45.53 81.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.634 178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 70.1 m -71.1 -41.62 70.36 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.136 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.28 86.28 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-O 121.299 0.571 . . . . 0.0 111.381 -176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.443 ' OH ' HG11 ' A' ' 34' ' ' VAL . 34.9 m-85 -115.99 39.79 2.97 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.952 -175.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.2 mtmt -61.12 -29.04 69.53 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.131 0.491 . . . . 0.0 110.828 178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -85.59 10.31 13.58 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.522 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.511 ' HB2' ' O ' ' A' ' 70' ' ' ILE . 51.6 p90 -35.69 113.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -174.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.44 -48.61 5.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.487 HD21 ' HG ' ' A' ' 38' ' ' LEU . 20.1 p-10 -117.54 5.26 12.43 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.762 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 4.5 mp -95.11 122.58 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.844 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 75.8 t -124.01 128.49 74.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -105.82 129.13 59.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-O 121.363 0.601 . . . . 0.0 109.71 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.8 pt -121.88 156.54 26.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.293 -177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -115.89 128.58 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -158.72 -168.14 2.32 Favored 'General case' 0 C--N 1.276 -2.596 0 CA-C-O 121.728 0.775 . . . . 0.0 112.916 -175.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -69.06 1.48 3.5 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 126.184 1.794 . . . . 0.0 114.198 -176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.07 -20.35 0.0 OUTLIER Glycine 1 N--CA 1.521 4.365 0 C-N-CA 126.192 1.854 . . . . 0.0 116.903 -176.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -56.81 -38.05 72.03 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 171.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.51 127.81 8.5 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -60.9 -51.19 70.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.968 0.413 . . . . 0.0 112.099 -172.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.3 pt -76.9 -27.43 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 C-N-CA 119.89 -0.724 . . . . 0.0 111.485 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 50.7 mt-10 -63.36 -44.49 94.68 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.615 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 20.5 t0 -62.51 -50.69 70.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.278 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.5 mm? -54.55 -46.28 73.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.631 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.498 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.1 m-80 -59.92 -42.99 95.15 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.385 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 28.9 mm-40 -65.18 -47.18 77.86 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.93 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.422 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.4 m -63.35 -42.56 98.92 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.329 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.56 HG23 ' O ' ' A' ' 84' ' ' LEU . 40.7 pt -65.87 -28.43 43.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.989 0.423 . . . . 0.0 110.254 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -80.15 -10.65 85.26 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.775 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -109.17 -24.62 11.05 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 159' ' ' PRO . 76.9 m-85 -82.11 148.48 28.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.038 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.7 m -96.36 -12.28 24.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.018 0.437 . . . . 0.0 111.153 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.02 158.77 66.55 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.588 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -50.71 141.84 33.72 Favored 'Trans proline' 0 C--O 1.241 0.634 0 C-N-CA 123.384 2.723 . . . . 0.0 112.15 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -142.14 157.02 45.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.715 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.502 HD11 HD12 ' A' ' 154' ' ' ILE . 23.7 tp -87.83 143.2 27.26 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.733 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.679 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 72.6 t -113.11 129.64 68.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -132.26 160.57 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 119.985 -0.686 . . . . 0.0 112.136 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 51.2 m -100.38 137.11 39.25 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 172.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 85.5 p -77.05 -10.46 59.39 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.499 ' HA ' HD22 ' A' ' 29' ' ' LEU . 19.6 p-10 -99.19 9.61 43.09 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -176.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 175' ' ' ILE . 61.2 mt -91.52 115.9 28.42 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.443 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 85.4 mt -108.03 119.81 58.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.036 0.446 . . . . 0.0 110.703 175.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 65.8 t30 170.04 153.15 0.05 OUTLIER 'General case' 0 C--O 1.247 0.968 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 55.0 tp -72.31 117.5 14.03 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -95.84 -1.37 49.65 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.462 -172.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -56.36 -38.87 72.0 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -82.74 -25.61 32.72 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.045 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.531 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.5 mm -71.32 -43.72 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.658 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.469 HD13 ' CB ' ' A' ' 40' ' ' SER . 60.2 mt -60.07 -48.48 87.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.126 -178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -64.64 -42.11 95.67 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.439 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -66.18 -43.0 88.13 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.538 HG13 ' CG1' ' A' ' 154' ' ' ILE . 38.7 mm -63.45 -48.62 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 CA-C-O 120.907 0.384 . . . . 0.0 111.228 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.483 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 66.3 t -61.29 -47.8 91.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.702 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.98 -47.49 84.57 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.655 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.508 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.3 t80 -63.13 -44.26 96.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.375 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.58 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 58.4 t80 -58.39 -48.11 81.69 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 28.2 m-85 -63.1 -35.19 79.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.82 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.2 m -63.62 -40.35 96.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.121 0.486 . . . . 0.0 109.899 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 116' ' ' TYR . 80.0 mt -64.28 -45.73 95.31 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.94 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.688 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -62.68 -37.26 85.73 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.102 0.477 . . . . 0.0 110.672 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.98 88.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.288 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -83.84 -38.84 20.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.45 . . . . 0.0 111.314 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 42.3 m -130.07 94.1 31.82 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.184 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.05 -22.97 58.27 Favored 'Trans proline' 0 N--CA 1.483 0.885 0 C-N-CA 123.313 2.675 . . . . 0.0 113.126 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -63.49 -28.51 70.01 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.407 HG22 ' HE3' ' A' ' 165' ' ' LYS . 74.9 t -70.26 126.66 30.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -117.64 -13.18 10.23 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.224 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 166' ' ' GLU . . . -140.67 157.04 46.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.941 0.4 . . . . 0.0 111.777 -177.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 1.2 tm? -136.17 135.69 39.38 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.11 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.27 132.27 48.71 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.209 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 154' ' ' ILE . 14.1 p -114.66 126.56 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.92 160.99 41.05 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.148 -176.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.559 HG23 ' HB2' ' A' ' 152' ' ' ALA . 12.5 pt -132.73 147.41 65.41 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.632 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.55 ' HD2' ' HE2' ' A' ' 138' ' ' LYS . 77.4 Cg_exo -56.92 137.64 82.61 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.413 2.075 . . . . 0.0 111.769 177.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 146' ' ' PHE . 21.1 tptm -61.94 -29.67 70.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.054 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 146' ' ' PHE . 37.8 tt0 -60.72 -39.88 90.23 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.55 ' HE2' ' HD2' ' A' ' 135' ' ' PRO . 63.2 pttt -91.62 -11.97 35.59 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.691 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -62.31 127.2 89.4 Favored Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.358 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -64.63 -21.24 65.58 Favored 'Trans proline' 0 N--CA 1.475 0.386 0 C-N-CA 123.267 2.645 . . . . 0.0 115.224 -172.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -132.41 90.23 34.36 Favored Pre-proline 0 C--N 1.322 -0.62 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.91 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.94 117.99 2.0 Allowed 'Trans proline' 0 C--N 1.317 -1.118 0 C-N-CA 123.407 2.738 . . . . 0.0 111.076 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.3 t -66.04 -46.33 78.23 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 79.4 mt -123.53 -55.75 2.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.999 0.428 . . . . 0.0 111.402 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -151.78 166.58 30.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.912 -176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' A' ' 137' ' ' GLU . 50.6 p90 -85.78 7.6 23.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.948 0.404 . . . . 0.0 111.932 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.75 127.46 32.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.817 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.6 179.9 19.06 Favored Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.883 177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.83 153.45 41.01 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.93 148.74 68.23 Favored Pre-proline 0 C--N 1.312 -1.06 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.646 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.06 141.13 75.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.099 1.866 . . . . 0.0 110.567 177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.649 ' HB1' HD11 ' A' ' 171' ' ' ILE . . . -90.36 -8.11 51.55 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.426 -175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 173.85 -86.58 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.507 0 C-N-CA 119.276 -1.44 . . . . 0.0 113.637 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.618 HG22 HG12 ' A' ' 98' ' ' VAL . 28.0 pt -123.75 160.17 27.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.217 0.532 . . . . 0.0 112.086 -174.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.679 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.9 t-20 -128.61 151.99 48.85 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.469 -176.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.6 t -123.43 131.04 73.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 120.522 0.201 . . . . 0.0 110.932 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.64 150.78 30.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.77 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 79.7 p -87.85 154.2 52.68 Favored Pre-proline 0 N--CA 1.443 -0.784 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 173.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HB2' ' O ' ' A' ' 91' ' ' PHE . 67.2 Cg_endo -84.11 84.92 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.514 2.143 . . . . 0.0 113.307 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -130.81 -179.55 5.38 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.394 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -105.55 98.43 8.13 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.95 -170.29 21.32 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.845 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -96.62 150.01 21.13 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.776 0.322 . . . . 0.0 110.224 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -132.89 165.9 23.57 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.683 -171.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.407 ' HE3' HG22 ' A' ' 127' ' ' VAL . 65.0 tttp -64.03 124.71 22.31 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 176.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 129' ' ' ALA . 44.2 tt0 -120.62 132.9 55.36 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.114 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -92.28 161.3 14.75 Favored 'General case' 0 CA--C 1.481 -1.685 0 CA-C-O 121.559 0.695 . . . . 0.0 112.057 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.8 mm -118.36 129.04 75.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 114.695 -1.139 . . . . 0.0 111.566 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.4 ' CE ' HD13 ' A' ' 113' ' ' ILE . 58.4 ttp -132.06 136.63 47.34 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.35 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.84 130.26 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.649 HD11 ' HB1' ' A' ' 152' ' ' ALA . 49.4 pt -120.33 175.45 4.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.766 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -120.09 24.09 10.65 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.586 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HB2' HD12 ' A' ' 171' ' ' ILE . 2.3 mp0 -99.4 131.95 45.07 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -96.41 149.9 21.2 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.499 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.724 HD12 HD22 ' A' ' 102' ' ' LEU . 2.4 pt -119.59 148.89 22.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 114.574 -1.193 . . . . 0.0 109.644 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.51 118.24 33.2 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.469 HD21 HD23 ' A' ' 102' ' ' LEU . 1.9 m-20 -107.62 149.18 28.38 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.151 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.83 121.98 65.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 120.855 0.359 . . . . 0.0 111.507 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.406 ' ND2' ' HG2' ' A' ' 13' ' ' ARG . 18.3 t-20 -130.12 -30.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.108 0.48 . . . . 0.0 110.406 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.8 t -140.92 -178.4 5.54 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.235 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -61.52 -41.79 97.84 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.381 0.672 . . . . 0.0 112.623 -175.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -61.4 -38.15 86.02 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.186 0.517 . . . . 0.0 110.727 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.21 -40.6 94.58 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.273 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 98.5 mt -61.81 -43.68 98.37 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.332 0.587 . . . . 0.0 109.509 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.568 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 13.4 tmtt? -62.23 -44.23 97.04 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.534 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 59.8 tp -59.66 -50.58 73.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.291 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.692 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.09 -39.91 90.38 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.458 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.568 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.2 pp20? -67.11 -28.69 68.36 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.336 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.6 mmm -63.26 -40.92 98.76 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.8 pp -71.3 -37.39 71.82 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.476 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.53 -39.73 94.3 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.804 0.812 . . . . 0.0 109.509 176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -60.77 -43.13 98.43 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.659 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.48 -42.31 98.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.337 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.78 -27.61 66.05 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.262 0.553 . . . . 0.0 110.82 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -72.52 -21.68 79.37 Favored Glycine 0 C--N 1.319 -0.393 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.188 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.1 tt . . . . . 0 C--O 1.261 1.696 0 CA-C-O 117.745 -1.122 . . . . 0.0 110.042 179.639 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' HG23 ' A' ' 42' ' ' VAL . 62.1 tpp . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 120.841 0.353 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -110.49 166.6 10.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.528 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -113.09 139.93 48.3 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.242 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -119.51 114.55 22.45 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.655 ' HA ' HG22 ' A' ' 98' ' ' VAL . 69.0 mt -118.55 106.94 20.55 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.427 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.5 ptm -98.92 104.36 16.39 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 122.815 1.293 . . . . 0.0 112.621 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.57 6.14 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 113.289 -1.778 . . . . 0.0 110.961 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.73 90.15 0.08 OUTLIER Glycine 0 C--N 1.305 -1.165 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.491 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.13 41.5 60.18 Favored Glycine 0 C--O 1.221 -0.684 0 C-N-CA 120.627 -0.796 . . . . 0.0 113.54 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -53.12 131.29 36.45 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.13 -154.66 16.61 Favored Glycine 0 N--CA 1.439 -1.115 0 C-N-CA 120.253 -0.975 . . . . 0.0 114.549 172.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.1 t -149.83 153.31 36.56 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 14' ' ' MET . 73.7 ttp85 63.37 53.79 2.11 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -174.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 13' ' ' ARG . 66.5 mtt 76.03 168.85 0.26 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.678 -176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.86 124.33 6.98 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.309 -176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.96 -39.78 96.71 Favored Glycine 0 N--CA 1.452 -0.285 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.8 t -99.83 130.77 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -59.28 -49.75 76.64 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 123.213 0.32 . . . . 0.0 110.921 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 0.3 OUTLIER -164.92 145.01 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.563 0.22 . . . . 0.0 111.066 174.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 22.7 Cg_exo -70.03 -9.33 25.76 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.489 2.793 . . . . 0.0 113.002 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.2 mt -89.15 13.04 14.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 94.8 mt -70.39 119.18 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 174.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 63.0 pttt -102.79 137.2 41.31 Favored 'General case' 0 C--N 1.283 -2.313 0 CA-C-O 122.243 1.02 . . . . 0.0 113.123 -175.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.1 mt -127.32 131.68 50.39 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.4 -1.727 . . . . 0.0 109.174 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' ' HE3' ' A' ' 192' ' ' LYS . 83.7 m 53.48 32.36 13.94 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.77 -17.4 49.57 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 116.136 1.214 . . . . 0.0 116.136 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.843 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 92.4 mtt180 -128.61 152.38 48.41 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-N 119.018 1.409 . . . . 0.0 111.923 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 81.7 m -74.87 162.84 28.27 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.319 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 100' ' ' SER . 84.0 mt -58.73 -40.89 85.11 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.144 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 60' ' ' ILE . 5.1 tp -58.08 -44.45 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.443 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.741 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 13.1 t70 -65.06 -43.57 91.82 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 120.97 0.414 . . . . 0.0 111.23 -177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.843 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 32.5 m-85 -67.33 -26.39 66.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.481 178.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.7 t -73.7 -46.79 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.47 173.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.09 -47.72 88.96 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.47 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 66.1 m -54.61 -50.35 86.04 Favored Pre-proline 0 CA--C 1.555 1.166 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -172.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HG2' ' NZ ' ' A' ' 106' ' ' LYS . 78.3 Cg_exo -57.69 -42.59 58.44 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.75 1.634 . . . . 0.0 112.109 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.658 HD11 HG11 ' A' ' 98' ' ' VAL . 90.0 mt -67.51 -39.48 85.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.499 0.666 . . . . 0.0 110.63 177.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD12 HD21 ' A' ' 69' ' ' ASN . 61.8 tp -57.15 -43.68 82.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.44 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 35' ' ' SER . 19.0 ptpt -88.74 -6.15 57.62 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.525 ' OG ' HG12 ' A' ' 42' ' ' VAL . 57.6 p -81.55 -176.96 6.32 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.727 0.775 . . . . 0.0 112.212 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -63.63 -16.14 60.12 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.165 -1.38 . . . . 0.0 113.372 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.528 HG21 ' HB2' ' A' ' 3' ' ' ALA . 13.3 p -75.28 147.69 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 122.189 -0.32 . . . . 0.0 111.691 -177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -85.03 -75.58 0.35 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -100.19 147.2 25.97 Favored 'General case' 0 CA--C 1.501 -0.909 0 C-N-CA 120.046 -0.661 . . . . 0.0 110.972 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.8 mm -109.03 112.08 38.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.609 178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -104.45 114.56 28.87 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 5' ' ' ILE . 96.7 mt -97.26 116.95 40.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-O 121.674 0.749 . . . . 0.0 110.853 -179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.3 121.77 30.19 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.386 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 7' ' ' ALA . 53.2 p -132.69 162.38 31.54 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.414 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.6 m -117.87 154.75 51.33 Favored Pre-proline 0 C--N 1.298 -1.636 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.551 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.444 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 29.1 Cg_endo -63.38 -18.86 66.58 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.028 2.485 . . . . 0.0 110.842 178.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -70.89 -20.72 62.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.084 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.1 p -137.59 66.69 50.59 Favored Pre-proline 0 N--CA 1.436 -1.144 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.741 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.708 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 63.2 Cg_endo -103.55 85.43 0.03 OUTLIER 'Trans proline' 1 N--CA 1.39 -4.603 0 C-N-CA 116.974 -1.55 . . . . 0.0 110.162 170.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.641 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.1 ttpt -154.63 -47.24 0.09 Allowed 'General case' 1 C--N 1.211 -5.436 0 CA-C-N 109.393 -3.549 . . . . 0.0 102.27 -179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -63.42 -48.74 76.56 Favored 'General case' 0 N--CA 1.387 -3.589 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 162.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.708 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.74 -50.4 71.24 Favored 'General case' 0 C--N 1.355 0.844 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.834 177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.641 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -63.6 -32.5 73.99 Favored 'General case' 0 C--N 1.368 1.397 0 C-N-CA 116.485 -2.086 . . . . 0.0 112.472 178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.36 -51.21 64.44 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.053 0.454 . . . . 0.0 111.192 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.486 HG12 HG12 ' A' ' 30' ' ' ILE . 96.9 mt -64.91 -46.27 92.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.98 -175.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -59.4 -41.82 90.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.036 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 39.7 t -67.95 -42.87 80.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.508 0.671 . . . . 0.0 110.387 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.92 89.18 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.339 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.61 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 71.8 m-85 -112.0 18.26 18.93 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HG2' ' O ' ' A' ' 62' ' ' SER . 64.6 pttt -65.03 -17.47 64.47 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.62 2.66 52.44 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.987 0.422 . . . . 0.0 111.38 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.422 ' CD1' ' HA ' ' A' ' 64' ' ' TYR . 74.5 m-85 -102.66 130.38 49.55 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.076 -0.39 . . . . 0.0 111.137 -178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.51 -46.15 60.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.384 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.453 HD21 HD12 ' A' ' 38' ' ' LEU . 21.6 p-10 -85.97 2.09 47.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -172.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.03 123.36 59.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.745 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.5 135.1 65.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.93 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.5 p -104.92 129.1 58.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.192 0.52 . . . . 0.0 109.802 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 48' ' ' ALA . 42.9 pt -122.27 156.64 27.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.366 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -117.84 133.11 56.26 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.528 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.0 t -167.06 -167.29 0.91 Allowed 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 52.6 m -64.08 1.17 0.74 Allowed 'General case' 0 C--O 1.197 -1.698 0 C-N-CA 126.826 2.05 . . . . 0.0 114.6 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.54 -28.21 0.01 OUTLIER Glycine 0 N--CA 1.515 3.922 0 C-N-CA 125.604 1.573 . . . . 0.0 116.713 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -56.12 -33.0 64.74 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.65 115.85 4.0 Favored Glycine 0 N--CA 1.437 -1.291 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -58.39 -50.72 72.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -171.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.9 mt -65.2 -46.02 92.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 121.55 0.691 . . . . 0.0 110.742 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.48 -42.38 96.14 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.595 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.51 -50.1 74.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.901 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -57.06 -44.05 82.64 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.864 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.474 ' HA ' HG12 ' A' ' 88' ' ' ILE . 11.4 m120 -60.7 -42.3 96.91 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.41 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.19 -45.22 89.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.145 0.498 . . . . 0.0 110.572 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.615 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 95.5 m -64.65 -41.77 95.9 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.473 -0.785 . . . . 0.0 112.089 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.535 HG23 ' O ' ' A' ' 84' ' ' LEU . 39.2 pt -68.45 -31.02 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 O-C-N 121.98 -0.45 . . . . 0.0 110.952 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.24 -37.86 95.55 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-N 115.834 -0.621 . . . . 0.0 114.158 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -101.94 9.78 40.26 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -172.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.615 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 62.8 m-85 -112.62 150.57 31.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.82 0.343 . . . . 0.0 111.823 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.9 m -102.41 -6.68 22.71 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.295 0.569 . . . . 0.0 109.951 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -125.49 156.76 69.98 Favored Pre-proline 0 CA--C 1.505 -0.755 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.432 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.89 153.6 42.49 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 122.622 2.215 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.92 152.55 43.65 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.7 0.762 . . . . 0.0 112.657 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.555 HD22 ' O ' ' A' ' 155' ' ' ASN . 2.4 tm? -86.31 124.01 32.2 Favored 'General case' 0 C--O 1.202 -1.439 0 CA-C-N 114.14 -1.391 . . . . 0.0 110.177 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 57.8 t -99.04 130.8 47.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 123.395 0.678 . . . . 0.0 109.805 -176.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.658 HG11 HD11 ' A' ' 37' ' ' LEU . 13.3 m -129.37 166.38 27.07 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-O 121.871 0.843 . . . . 0.0 112.454 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.5 m -98.85 157.07 16.54 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.266 -1.334 . . . . 0.0 107.937 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 81.2 p -88.94 -6.25 57.4 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.309 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -117.59 9.96 13.3 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -173.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -87.96 122.32 31.43 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.073 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.457 ' O ' HG13 ' A' ' 103' ' ' ILE . 28.0 pt -122.47 101.51 10.0 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 CA-C-O 121.663 0.744 . . . . 0.0 111.516 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -160.01 177.71 10.46 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.401 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.1 mt -81.29 59.6 4.04 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.735 0.779 . . . . 0.0 109.93 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.777 ' HA ' HD12 ' A' ' 109' ' ' ILE . 16.9 pttp -69.72 -3.69 16.47 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.79 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -59.17 -41.9 89.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.544 ' HD3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -88.6 -23.16 23.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.812 0.815 . . . . 0.0 110.566 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.777 HD12 ' HA ' ' A' ' 106' ' ' LYS . 74.2 mt -64.34 -38.79 83.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.882 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.1 mt -55.44 -47.85 77.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.769 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -63.69 -41.34 98.16 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.462 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.6 m -63.43 -39.8 95.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.174 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.749 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.2 mm -61.28 -47.69 92.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.041 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.502 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 67.9 t -60.43 -48.07 89.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.263 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.77 -47.64 84.26 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.607 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CE2' HD11 ' A' ' 120' ' ' ILE . 75.0 t80 -61.43 -48.24 82.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.658 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -59.56 -47.59 84.95 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.246 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.502 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.8 m-85 -61.82 -37.94 86.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.331 177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 51.7 t -61.12 -46.43 90.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.399 0.619 . . . . 0.0 109.908 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.593 HD11 ' CE2' ' A' ' 116' ' ' TYR . 80.0 mt -62.46 -45.98 97.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.174 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -62.85 -37.44 86.85 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.994 0.426 . . . . 0.0 110.833 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.49 91.59 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.398 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -81.27 -36.02 30.42 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.071 0.462 . . . . 0.0 111.206 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 57.7 m -139.89 100.1 7.37 Favored Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.169 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.03 -16.72 53.46 Favored 'Trans proline' 0 N--CA 1.481 0.775 0 C-N-CA 123.087 2.525 . . . . 0.0 113.241 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -69.48 -13.39 62.32 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.489 HG21 ' CG2' ' A' ' 120' ' ' ILE . 94.3 t -76.85 120.04 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -122.29 11.85 10.12 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.504 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.72 153.0 23.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.94 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.425 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.6 OUTLIER -137.0 135.97 38.08 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.123 -178.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.0 137.78 52.35 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.27 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 113' ' ' ILE . 57.6 t -112.29 116.91 53.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 4.3 ptm -145.46 155.55 43.19 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.956 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 152' ' ' ALA . 24.0 pt -130.03 157.48 76.85 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.919 177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.474 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 39.5 Cg_endo -67.2 140.81 54.85 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.763 1.642 . . . . 0.0 111.772 -178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.7 -16.93 62.35 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.014 -178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.34 -38.73 92.08 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.068 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -101.15 -16.83 16.91 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.192 0.52 . . . . 0.0 111.348 -177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -59.6 131.48 88.42 Favored Pre-proline 0 C--N 1.302 -1.495 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.063 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.71 -32.13 92.76 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.939 2.426 . . . . 0.0 114.702 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -142.63 78.15 16.32 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.532 0.682 . . . . 0.0 111.3 -178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.58 -5.73 11.68 Favored 'Trans proline' 0 C--N 1.316 -1.17 0 C-N-CA 123.735 2.956 . . . . 0.0 112.027 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 34.6 m 63.3 -161.19 0.3 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.082 -177.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 49.2 pt -104.59 149.15 8.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 146' ' ' PHE . 21.3 t70 56.2 -134.66 1.33 Allowed 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.418 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 38.5 t80 53.73 61.75 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.342 0.592 . . . . 0.0 111.047 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.37 110.4 17.48 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.158 0.504 . . . . 0.0 110.032 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.23 -154.63 11.86 Favored Glycine 0 N--CA 1.435 -1.373 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 149' ' ' LEU . 2.4 pt? -108.54 149.68 28.51 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.914 0.357 . . . . 0.0 110.243 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.62 146.0 59.34 Favored Pre-proline 0 C--N 1.309 -1.172 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.852 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.91 147.5 55.63 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.198 1.932 . . . . 0.0 111.891 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.657 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -117.45 -6.64 11.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.226 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -170.05 -116.89 0.39 Allowed Glycine 0 N--CA 1.434 -1.445 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.48 -177.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.52 HD12 HD11 ' A' ' 96' ' ' LEU . 22.2 pt -124.55 160.08 29.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 120.7 0.286 . . . . 0.0 111.02 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.608 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.0 m-20 -117.65 159.27 23.21 Favored 'General case' 0 C--O 1.207 -1.154 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.91 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.67 133.46 69.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.88 148.45 31.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.479 176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.0 t -92.43 149.29 38.02 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.13 75.2 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 122.702 2.268 . . . . 0.0 112.297 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -104.11 -170.97 1.85 Allowed 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.171 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -132.33 125.94 32.12 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.45 -105.99 3.34 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.34 -0.934 . . . . 0.0 112.207 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -147.03 140.5 25.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -133.3 166.96 21.28 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.451 ' HE3' HG22 ' A' ' 127' ' ' VAL . 63.6 tttp -58.47 125.7 24.45 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.828 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -124.14 128.31 49.08 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.143 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -93.9 163.49 13.48 Favored 'General case' 0 CA--C 1.477 -1.852 0 CA-C-O 121.687 0.756 . . . . 0.0 112.744 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.33 130.12 69.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.537 -174.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.558 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 51.3 ttm -112.45 129.85 56.19 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.376 175.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.54 126.32 66.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.2 pt -121.55 174.29 6.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.28 0.562 . . . . 0.0 112.029 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -111.48 4.89 19.18 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.059 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.538 ' HB2' HD12 ' A' ' 171' ' ' ILE . 34.9 mt-10 -99.34 130.29 45.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.617 0.722 . . . . 0.0 111.03 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -96.49 151.15 19.85 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.688 -1.142 . . . . 0.0 113.249 -176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.99 150.49 31.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.325 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.01 122.82 43.05 Favored 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.164 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.415 ' C ' HD12 ' A' ' 178' ' ' ILE . 23.7 p-10 -94.08 168.17 11.11 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.787 177.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 184' ' ' LEU . 2.0 mp -120.32 121.05 64.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 120.873 0.368 . . . . 0.0 111.093 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -111.72 -32.34 6.68 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.422 175.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.1 t -138.39 176.6 8.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.022 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt -64.24 -29.13 70.24 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.83 -175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -62.28 -39.11 91.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.204 0.526 . . . . 0.0 110.414 177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -61.42 -35.76 78.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.388 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 178' ' ' ILE . 96.0 mt -60.68 -43.7 97.4 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 121.354 0.597 . . . . 0.0 109.56 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.644 ' O ' ' HG3' ' A' ' 189' ' ' MET . 60.0 tptt -62.84 -43.61 98.35 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.707 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.56 -48.21 82.53 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.206 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.71 -43.14 99.43 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.306 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 192' ' ' LYS . 13.2 pt-20 -70.2 -29.59 66.48 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.932 -179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.644 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -61.44 -39.71 91.83 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -70.67 -33.41 70.91 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.96 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 95.6 mt -66.96 -40.57 87.52 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.66 0.743 . . . . 0.0 110.558 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 188' ' ' GLU . 34.8 mmtp -65.66 -37.58 86.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.368 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 193' ' ' LYS . 9.2 tmtt? -60.65 -42.21 96.53 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.501 -172.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -95.73 2.85 54.15 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.496 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -128.35 97.66 0.45 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 119.966 -1.111 . . . . 0.0 113.1 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.2 tp . . . . . 0 C--O 1.266 1.954 0 CA-C-O 117.513 -1.232 . . . . 0.0 110.029 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ttt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.449 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 64.2 m-20 -97.35 165.91 11.79 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.324 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.468 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -117.9 130.07 56.01 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.979 0.419 . . . . 0.0 110.901 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 48' ' ' ALA . 36.1 tp -100.93 124.72 47.06 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.369 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.662 ' HA ' HG22 ' A' ' 98' ' ' VAL . 68.5 mt -117.59 104.88 17.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.0 ptm -96.64 107.64 20.12 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.786 1.279 . . . . 0.0 112.505 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.428 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -114.92 96.92 5.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.801 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.78 -105.99 0.51 Allowed Glycine 0 C--N 1.297 -1.623 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.654 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.14 178.63 24.66 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.988 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' A' ' 14' ' ' MET . 60.1 mtpt -127.51 -176.54 3.78 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 123.012 0.525 . . . . 0.0 110.084 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.22 -176.54 49.97 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m 63.57 26.68 14.78 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.973 0.892 . . . . 0.0 110.212 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 64.22 27.57 13.93 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.519 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.471 ' HG2' ' H ' ' A' ' 10' ' ' LYS . 98.7 mtp 70.08 133.81 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 144.96 17.66 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -62.68 -43.87 98.35 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.535 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 72.4 t -70.1 -39.8 77.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.491 0.662 . . . . 0.0 110.72 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -66.65 102.52 0.93 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.103 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.468 ' O ' HG13 ' A' ' 22' ' ' ILE . 20.3 ptmt -148.02 148.34 29.45 Favored Pre-proline 0 C--N 1.317 -0.847 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.485 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 44.1 Cg_exo -61.39 -17.82 55.63 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.235 2.624 . . . . 0.0 112.402 178.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.607 HD21 ' CB ' ' A' ' 59' ' ' TYR . 9.6 mp -83.51 15.71 2.96 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 19' ' ' LYS . 88.1 mt -69.73 123.19 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 174.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.3 mtpp -80.75 132.08 35.49 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.575 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 HD13 HD12 ' A' ' 184' ' ' LEU . 59.8 tp -137.83 125.33 22.06 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.152 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.7 t 58.64 26.17 14.16 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.278 0.561 . . . . 0.0 110.74 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.36 -13.85 56.86 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 115.151 0.82 . . . . 0.0 115.151 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -134.4 169.81 16.68 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 118.945 1.372 . . . . 0.0 111.434 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 75.6 m -85.73 163.79 18.01 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.672 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 82.3 mt -59.43 -39.69 84.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.268 -178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.512 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.3 tp -57.17 -45.17 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.201 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.43 -41.65 93.29 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.973 0.416 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -61.52 -33.89 74.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.409 176.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.4 t -73.54 -42.95 55.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 120.774 0.321 . . . . 0.0 111.412 175.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.4 t -63.39 -44.81 99.13 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.623 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.506 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -52.87 -50.47 81.28 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.439 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 28.9 Cg_endo -64.13 -40.95 24.04 Favored 'Trans proline' 0 C--N 1.362 1.273 0 C-N-CA 121.367 1.378 . . . . 0.0 112.489 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.761 HD11 HG11 ' A' ' 98' ' ' VAL . 88.6 mt -66.7 -37.71 85.26 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.498 0.666 . . . . 0.0 110.436 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 tp -58.22 -44.12 88.05 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.284 177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 36' ' ' PRO . 64.3 pttt -90.32 -3.23 57.89 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.206 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.422 ' CB ' HG21 ' A' ' 110' ' ' ILE . 59.5 p -81.43 -178.9 7.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.778 0.799 . . . . 0.0 112.997 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -59.94 -25.28 65.05 Favored 'General case' 0 CA--C 1.553 1.079 0 CA-C-N 114.129 -1.396 . . . . 0.0 112.812 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG11 ' HB2' ' A' ' 3' ' ' ALA . 30.2 m -64.26 161.78 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -173.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.449 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.2 t30 -83.38 -76.31 0.29 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.218 -177.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -115.16 157.44 23.63 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.074 0.464 . . . . 0.0 110.82 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.6 mm -108.63 115.89 50.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -107.81 117.32 33.8 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -96.88 119.41 44.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 121.736 0.779 . . . . 0.0 110.583 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.488 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -91.05 121.0 32.48 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.758 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.1 p -132.07 165.81 23.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.44 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.9 p -128.45 157.57 74.36 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.081 -177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 51.8 Cg_exo -58.2 -25.68 72.91 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.916 2.41 . . . . 0.0 110.963 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -75.46 -14.04 60.41 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.712 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -141.76 65.94 21.09 Favored Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.678 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.8 Cg_endo -106.26 86.72 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.113 0 C-N-CA 117.148 -1.435 . . . . 0.0 109.586 168.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 ttmt -147.83 -50.43 0.18 Allowed 'General case' 1 C--N 1.209 -5.534 0 CA-C-N 109.489 -3.505 . . . . 0.0 101.675 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.514 HG22 HD12 ' A' ' 60' ' ' ILE . 98.0 m -62.52 -48.41 79.65 Favored 'General case' 0 N--CA 1.382 -3.85 0 CA-C-N 111.712 -2.494 . . . . 0.0 106.047 164.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.678 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.23 -49.1 77.08 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.004 176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.555 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 18.9 pt-20 -56.17 -35.96 67.8 Favored 'General case' 0 C--N 1.364 1.219 0 C-N-CA 117.589 -1.644 . . . . 0.0 110.988 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.607 ' CB ' HD21 ' A' ' 21' ' ' LEU . 57.7 t80 -70.76 -52.05 23.22 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.03 0.443 . . . . 0.0 111.744 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 HD12 HG22 ' A' ' 56' ' ' THR . 97.1 mt -63.92 -45.12 97.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.508 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.734 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 49.2 t30 -57.08 -47.33 81.29 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.907 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.3 t -71.47 -43.68 66.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.733 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.42 -37.96 89.32 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.377 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.529 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 95.2 m-85 -104.52 20.16 19.04 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 -175.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.734 ' HG3' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtpt -63.32 -23.14 67.28 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.59 0.71 . . . . 0.0 109.89 174.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -86.03 10.02 15.43 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.22 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.551 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 45.1 p90 -50.51 148.55 3.71 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt -103.55 -52.88 2.9 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.448 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -121.14 16.57 11.56 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.557 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 79.1 mt -103.87 127.94 57.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.54 0.686 . . . . 0.0 111.838 -175.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 69.2 t -125.84 134.0 67.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.879 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.5 p -103.32 132.7 49.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.189 0.519 . . . . 0.0 109.973 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.51 157.04 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.285 0 CA-C-O 121.901 0.857 . . . . 0.0 111.672 -176.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -106.6 133.79 50.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 CA-C-N 114.006 -1.452 . . . . 0.0 109.981 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.8 t -159.75 -168.6 2.3 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.442 0.639 . . . . 0.0 112.113 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 78' ' ' LYS . 65.7 m -77.37 3.28 13.58 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 126.001 1.72 . . . . 0.0 113.725 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.51 -14.56 0.0 OUTLIER Glycine 1 N--CA 1.522 4.372 0 C-N-CA 127.11 2.29 . . . . 0.0 117.992 -174.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.8 tmtt? -59.93 -37.11 78.55 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -117.68 130.35 8.76 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -60.48 -51.04 71.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.484 HD12 ' OH ' ' A' ' 163' ' ' TYR . 45.7 pt -71.32 -36.41 61.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.52 -177.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -65.37 -40.01 92.99 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.124 0.488 . . . . 0.0 109.834 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.501 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 19.0 t0 -59.66 -51.03 71.55 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.962 176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.2 mm? -56.34 -45.4 80.41 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.783 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.521 ' HA ' HG12 ' A' ' 88' ' ' ILE . 24.6 m-80 -60.32 -41.31 93.27 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.597 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 77.4 mm-40 -65.19 -46.06 82.32 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.31 -0.556 . . . . 0.0 109.538 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.4 m -63.02 -43.76 97.83 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.238 -178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 84' ' ' LEU . 34.7 pt -67.72 -29.25 44.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.822 0.344 . . . . 0.0 110.403 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.58 -38.31 96.09 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.71 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.5 3.89 50.6 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.45 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 63.8 m-85 -108.74 143.26 38.1 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.581 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 77.3 p -102.78 -0.76 30.99 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.117 0.484 . . . . 0.0 111.11 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -133.24 156.75 79.55 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.864 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -68.76 146.34 66.02 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.409 2.072 . . . . 0.0 111.243 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -144.25 161.69 38.28 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.488 0.661 . . . . 0.0 112.362 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.773 HD11 HD12 ' A' ' 154' ' ' ILE . 1.5 tm? -84.81 143.08 29.32 Favored 'General case' 0 C--O 1.202 -1.4 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.222 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.613 ' N ' HD13 ' A' ' 96' ' ' LEU . 99.8 t -119.59 130.15 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 123.86 0.864 . . . . 0.0 109.975 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.761 HG11 HD11 ' A' ' 37' ' ' LEU . 14.6 m -130.87 161.95 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.207 0.527 . . . . 0.0 112.136 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 39.8 t -99.37 140.74 33.11 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -72.24 -10.86 60.34 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -104.15 9.69 36.15 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 78.7 mt -81.28 122.86 27.96 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 122.086 -0.384 . . . . 0.0 110.931 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.7 pt -62.98 166.0 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.792 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -89.56 72.53 7.84 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 -175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -116.17 -14.01 11.14 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 168.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 25.0 pttm -67.66 -0.44 3.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 113.002 -1.908 . . . . 0.0 114.454 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 75.4 m -58.09 -40.67 81.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -82.49 -23.99 34.41 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.738 0.78 . . . . 0.0 110.303 178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 113' ' ' ILE . 44.6 mm -64.02 -40.22 88.28 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.068 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.112 -174.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.57 ' HA ' HD11 ' A' ' 154' ' ' ILE . 58.1 mt -57.89 -48.57 83.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.644 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.9 m-80 -65.12 -39.75 93.51 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.58 177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.6 m -61.33 -40.16 93.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.634 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -61.8 -49.18 85.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.695 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.448 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 71.4 t -62.85 -47.76 91.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.425 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -61.12 -45.83 93.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.731 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.628 ' CE2' HD11 ' A' ' 120' ' ' ILE . 62.3 t80 -62.85 -48.38 79.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.813 -177.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -59.53 -47.64 84.75 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.363 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.448 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 25.5 m-85 -61.8 -37.77 85.64 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.459 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 92.0 m -63.66 -39.75 95.11 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.277 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.628 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.6 mt -63.35 -46.36 95.69 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.404 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.078 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HG2' HG13 ' A' ' 127' ' ' VAL . 52.5 mtmt -61.74 -38.66 88.77 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-O 120.908 0.385 . . . . 0.0 111.178 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -58.88 -41.6 87.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.398 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -86.93 -35.25 19.03 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.017 0.437 . . . . 0.0 111.627 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.421 ' O ' HG12 ' A' ' 127' ' ' VAL . 34.4 m -136.88 94.53 12.81 Favored Pre-proline 0 C--N 1.319 -0.736 0 C-N-CA 122.806 0.443 . . . . 0.0 110.848 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.34 -15.8 31.43 Favored 'Trans proline' 0 N--CA 1.485 0.989 0 C-N-CA 123.388 2.725 . . . . 0.0 113.051 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.9 -32.92 72.37 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.495 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 12.0 p -65.54 132.14 31.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.215 0.531 . . . . 0.0 111.947 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -119.56 -15.79 8.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.167 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -148.82 160.23 43.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.894 0.378 . . . . 0.0 111.762 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 23.1 tp -134.61 144.26 47.8 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.819 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.96 140.73 51.53 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.317 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.557 HG21 ' CD1' ' A' ' 113' ' ' ILE . 84.2 t -118.58 120.64 64.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.711 0.767 . . . . 0.0 111.397 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 2.0 ptm -145.49 154.62 42.41 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.787 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.45 HG12 ' HB2' ' A' ' 152' ' ' ALA . 28.2 pt -129.87 156.29 79.22 Favored Pre-proline 0 C--N 1.308 -1.234 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.382 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.4 142.05 97.12 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.209 1.939 . . . . 0.0 110.739 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -62.03 -19.05 62.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.35 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -60.27 -39.54 87.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.072 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.433 ' HG3' HD12 ' A' ' 134' ' ' ILE . 19.5 ptpt -90.19 -21.47 22.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.752 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -67.29 126.09 92.03 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' A' ' 174' ' ' LEU . 37.0 Cg_endo -65.79 -67.43 0.04 OUTLIER 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.732 2.288 . . . . 0.0 113.876 -174.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -132.24 145.47 57.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.527 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.04 -33.15 82.34 Favored 'Trans proline' 0 N--CA 1.483 0.854 0 C-N-CA 124.136 3.224 . . . . 0.0 114.785 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 24.4 m 59.81 27.13 16.4 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 84.6 mt 71.72 148.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.032 0.533 . . . . 0.0 111.504 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 62.88 29.79 16.57 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.134 0.492 . . . . 0.0 111.057 -178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -63.82 134.68 55.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.604 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -124.85 172.22 9.53 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.21 94.77 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.7 pp -106.99 139.84 40.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 174.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 15.1 m -127.42 118.86 21.65 Favored Pre-proline 0 C--N 1.291 -1.961 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -175.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 150' ' ' VAL . 48.2 Cg_exo -60.45 142.48 98.12 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.028 2.485 . . . . 0.0 111.166 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.498 ' HA ' HD11 ' A' ' 175' ' ' ILE . . . -135.25 -30.19 1.05 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.239 0.543 . . . . 0.0 111.431 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -103.39 -141.91 11.66 Favored Glycine 0 N--CA 1.418 -2.532 0 C-N-CA 119.715 -1.231 . . . . 0.0 112.49 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.773 HD12 HD11 ' A' ' 96' ' ' LEU . 17.6 pt -126.37 160.69 33.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 114.769 -0.716 . . . . 0.0 109.926 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.585 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.0 m-20 -109.53 159.74 16.82 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.33 132.39 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.34 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.96 152.48 36.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.108 0.48 . . . . 0.0 111.513 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.568 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.2 m -97.07 160.12 29.79 Favored Pre-proline 0 C--N 1.314 -0.939 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.374 175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.5 83.24 1.06 Allowed 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.783 2.322 . . . . 0.0 111.615 177.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.542 ' HG3' ' HB3' ' A' ' 164' ' ' GLN . 30.8 mmmt -114.31 150.3 34.69 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.864 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -65.79 -42.45 90.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.788 0.328 . . . . 0.0 110.469 176.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -125.01 -148.29 7.28 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.594 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.484 ' OH ' HD12 ' A' ' 81' ' ' ILE . 97.7 m-85 -75.98 149.47 37.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.04 0.448 . . . . 0.0 110.893 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.568 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 16.3 pt20 -134.23 167.61 20.38 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -172.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.495 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 1.9 tmtm? -60.71 131.4 50.57 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 114.775 -1.102 . . . . 0.0 108.999 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -134.56 130.58 36.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.727 0.299 . . . . 0.0 111.69 -174.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -95.08 164.09 13.02 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.8 mm -119.13 131.69 71.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 114.499 -1.228 . . . . 0.0 111.703 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -135.8 140.66 44.43 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.312 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.9 t -108.38 129.35 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.398 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 36.9 pt -105.79 170.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.339 0.59 . . . . 0.0 112.01 -177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -92.65 3.05 56.31 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.975 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.487 ' CD ' HD11 ' A' ' 109' ' ' ILE . 12.1 pt-20 -130.09 142.37 50.61 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.11 -1.036 . . . . 0.0 112.815 -175.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.46 ' HB2' ' HD3' ' A' ' 140' ' ' PRO . 2.7 pp -97.23 149.66 21.79 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.625 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 175' ' ' ILE . 2.3 pp -131.41 145.35 35.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.398 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -131.01 149.68 52.5 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 34.8 p30 -98.39 178.94 4.88 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.97 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 44.4 mm -111.15 119.72 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.108 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -125.49 -22.0 4.39 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.386 0.612 . . . . 0.0 109.731 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.1 p -130.03 164.21 24.82 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.521 -177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.412 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.3 mppt? -63.28 -35.79 81.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.274 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.92 -44.32 94.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.118 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -64.34 -41.43 96.78 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.177 0.513 . . . . 0.0 109.647 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.459 HD12 HD13 ' A' ' 24' ' ' LEU . 53.0 tp -61.19 -47.73 84.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.522 -176.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.629 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 86.6 tttt -68.11 -35.88 78.85 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.101 0.477 . . . . 0.0 110.583 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.5 tp -58.5 -48.36 81.05 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.748 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.474 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.34 -42.45 98.94 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.274 177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.3 -32.38 73.33 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.848 -178.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -61.87 -44.8 96.09 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.687 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.84 -35.83 67.34 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 120.613 -0.435 . . . . 0.0 111.146 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.1 mt -65.11 -41.08 95.26 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 121.845 0.831 . . . . 0.0 109.845 176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 192' ' ' LYS . 41.0 ttmt -61.54 -46.5 89.67 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.346 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -66.79 -31.56 72.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.63 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -65.04 -23.91 67.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.957 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.94 -90.42 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.83 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--O 1.271 2.228 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.85 179.41 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.9 ttm . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.832 0.349 . . . . 0.0 110.815 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.555 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 68.9 m-20 -94.82 166.02 12.19 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -113.8 127.73 56.12 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.121 0.486 . . . . 0.0 110.519 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.88 121.97 45.15 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.614 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.702 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.9 mt -118.83 114.27 44.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 59.8 ttm -84.7 97.11 9.47 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-O 121.936 0.874 . . . . 0.0 111.302 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' HB2' HG13 ' A' ' 30' ' ' ILE . . . -114.42 100.82 8.6 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.038 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.96 -1.18 7.84 Favored Glycine 0 C--N 1.3 -1.467 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.974 -178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -92.24 164.12 28.17 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.976 178.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -136.65 -9.51 1.87 Allowed 'General case' 0 C--O 1.237 0.441 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 178.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 80' ' ' TYR . . . 71.83 -154.1 50.76 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.663 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 p -97.62 11.84 35.62 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 122.953 0.501 . . . . 0.0 111.999 -176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -114.27 20.7 15.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.837 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.7 tpt 71.71 -37.4 0.39 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.507 0.723 . . . . 0.0 112.297 178.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.39 61.29 0.89 Allowed Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.483 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.5 55.43 4.09 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.953 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.42 150.54 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 158.88 19.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.928 0.394 . . . . 0.0 111.111 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' O ' HG13 ' A' ' 22' ' ' ILE . 25.1 pttm -63.73 154.73 79.55 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.334 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.482 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 28.5 Cg_endo -62.58 -5.73 7.61 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.659 2.906 . . . . 0.0 113.647 -177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' A' ' 56' ' ' THR . 72.7 mt -86.84 23.07 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 19' ' ' LYS . 95.6 mt -70.4 116.26 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.5 pttm -96.24 131.82 42.34 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 122.205 1.003 . . . . 0.0 112.759 -176.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -128.93 138.54 52.05 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 113.395 -1.729 . . . . 0.0 108.634 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.492 ' SG ' HD13 ' A' ' 191' ' ' LEU . 81.0 m 63.33 -75.65 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.55 0.531 . . . . 0.0 112.263 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -149.18 0.58 0.5 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 119.813 -1.184 . . . . 0.0 114.669 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 7.7 ptm180 -150.6 170.1 19.97 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 118.402 1.101 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 96.3 m -78.07 156.96 29.74 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD22 ' O ' ' A' ' 100' ' ' SER . 1.0 OUTLIER -53.01 -46.94 68.61 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.327 0.651 . . . . 0.0 110.929 -178.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.482 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -63.95 -36.32 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-O 120.817 0.341 . . . . 0.0 110.762 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -63.56 -40.8 97.93 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.539 ' CE2' ' HG2' ' A' ' 27' ' ' ARG . 7.7 m-85 -61.63 -36.75 81.65 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.823 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 29' ' ' LEU . 78.9 t -65.77 -42.35 92.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.924 0.392 . . . . 0.0 110.881 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.421 HG23 HD13 ' A' ' 30' ' ' ILE . 74.0 t -64.01 -41.61 93.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.72 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.9 t -48.04 -56.5 13.49 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 42.4 Cg_endo -67.91 -37.37 15.6 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 121.719 1.612 . . . . 0.0 112.435 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.57 HD11 HG11 ' A' ' 98' ' ' VAL . 82.0 mt -65.52 -42.59 91.86 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 120.887 0.375 . . . . 0.0 111.292 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.515 ' HG ' HD21 ' A' ' 69' ' ' ASN . 6.6 tt -61.45 -46.92 88.05 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.283 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 19.0 ptpt -76.34 -12.8 60.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.1 p -72.17 -178.41 2.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.564 0.697 . . . . 0.0 111.925 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -70.04 -4.56 21.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.997 -1.002 . . . . 0.0 113.529 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.2 m -73.32 162.07 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.483 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.555 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.1 t30 -80.12 -75.44 0.26 Allowed 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.201 -177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -120.0 161.04 21.6 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.039 0.447 . . . . 0.0 110.8 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 3' ' ' ALA . 46.8 mm -108.99 116.49 52.13 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.301 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 88.6 m-85 -109.89 118.1 35.58 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 60' ' ' ILE . 90.2 mt -101.57 118.77 48.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 121.567 0.699 . . . . 0.0 111.023 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.513 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -84.48 117.99 24.01 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.166 -1.379 . . . . 0.0 110.074 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 7' ' ' ALA . 71.5 p -125.26 164.32 20.59 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -126.53 156.14 73.52 Favored Pre-proline 0 C--N 1.301 -1.507 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.491 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 54.4 Cg_exo -58.07 -24.29 65.23 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 122.98 2.453 . . . . 0.0 111.154 177.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -70.1 -20.86 63.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.021 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 p -139.6 67.64 37.06 Favored Pre-proline 0 N--CA 1.439 -0.994 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.654 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 86.3 Cg_endo -100.76 84.9 0.04 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.618 0 C-N-CA 116.682 -1.745 . . . . 0.0 109.522 169.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp -151.43 -45.78 0.11 Allowed 'General case' 1 C--N 1.213 -5.362 0 CA-C-N 110.311 -3.131 . . . . 0.0 102.938 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.491 ' HA ' HD21 ' A' ' 21' ' ' LEU . 87.4 m -63.6 -46.1 87.34 Favored 'General case' 0 N--CA 1.386 -3.628 0 CA-C-N 112.933 -1.939 . . . . 0.0 105.824 163.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.654 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 14.7 tmtt? -61.18 -50.28 73.78 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.239 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 54' ' ' PRO . 57.9 mt-10 -59.79 -43.93 94.17 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 118.274 -1.371 . . . . 0.0 112.348 177.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.15 -50.87 71.41 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -63.1 -42.52 96.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-O 121.333 0.587 . . . . 0.0 110.414 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -57.22 -44.84 84.12 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.054 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.449 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 68.5 m -70.39 -40.19 74.1 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.736 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.78 89.83 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.26 0.552 . . . . 0.0 110.956 -178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 62.0 m-85 -112.73 41.39 2.06 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.169 -176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 62' ' ' SER . 12.7 mmmm -59.7 -37.3 78.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.112 177.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -87.62 11.15 15.78 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 122.807 0.443 . . . . 0.0 111.024 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.498 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 47.7 p90 -39.51 132.96 1.49 Allowed 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 -175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.0 -48.18 4.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 171.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.515 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.1 p-10 -118.81 9.7 12.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.843 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.5 mp -99.7 119.17 47.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.615 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.0 t -121.22 131.3 73.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.737 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.69 130.2 56.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.513 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.3 pt -125.4 156.63 34.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.127 0.489 . . . . 0.0 110.562 -177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -118.23 134.91 54.6 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 13.8 t -160.57 -169.22 2.36 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.6 m -64.32 2.35 0.61 Allowed 'General case' 0 C--O 1.212 -0.918 0 C-N-CA 127.169 2.188 . . . . 0.0 114.674 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.43 -22.32 0.0 OUTLIER Glycine 0 N--CA 1.511 3.64 0 C-N-CA 126.358 1.932 . . . . 0.0 116.929 -174.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.7 OUTLIER -56.42 -36.82 69.4 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.337 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.04 125.74 7.48 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' HB2' ' HA2' ' A' ' 11' ' ' GLY . 90.3 t80 -60.59 -51.6 68.7 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -173.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.1 pt -75.49 -30.72 22.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.375 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.488 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 43.7 mt-10 -65.52 -41.86 92.67 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.825 178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.576 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.9 t0 -60.21 -51.27 70.27 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.991 176.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -59.41 -44.36 92.86 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.498 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 88' ' ' ILE . 22.7 m-80 -61.2 -40.32 93.51 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.92 0.39 . . . . 0.0 111.774 177.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 63.4 mm-40 -62.79 -46.45 87.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 99.5 m -62.15 -43.15 99.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.085 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.0 pt -65.68 -27.72 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 121.032 0.444 . . . . 0.0 110.316 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.99 -20.28 74.51 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.713 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -105.3 -23.58 12.84 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 60.0 m-85 -75.2 149.57 38.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.129 0.49 . . . . 0.0 111.95 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -97.11 -15.48 20.94 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 177.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -139.83 160.91 58.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.808 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -52.91 143.19 49.99 Favored 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 111.778 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 42.7 p90 -137.57 156.16 48.4 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.439 0.638 . . . . 0.0 111.687 -177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.628 HD11 HD12 ' A' ' 154' ' ' ILE . 1.5 tm? -86.86 133.87 33.59 Favored 'General case' 0 C--O 1.189 -2.131 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.057 -177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.609 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.7 t -107.03 128.54 61.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.141 0.576 . . . . 0.0 109.756 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 5' ' ' ILE . 4.4 m -130.53 161.53 40.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 C-N-CA 119.924 -0.71 . . . . 0.0 112.495 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 70.2 m -99.73 144.28 28.98 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.43 -1.259 . . . . 0.0 107.731 171.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.514 ' O ' HD22 ' A' ' 29' ' ' LEU . 63.6 m -88.03 -1.48 58.02 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -174.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -108.32 7.78 27.36 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 65.9 mt -81.44 114.91 20.5 Favored 'General case' 0 C--O 1.246 0.918 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.176 -178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.6 mt -107.35 112.93 42.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.0 110.3 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 173.58 176.95 0.12 Allowed 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.0 tp -84.21 103.06 13.09 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -96.98 -3.84 40.91 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.686 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 41.1 t -59.77 -45.01 93.58 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.057 0.456 . . . . 0.0 111.778 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -79.15 -23.57 43.88 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.365 0.602 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.716 ' O ' HG12 ' A' ' 113' ' ' ILE . 35.1 mm -68.98 -41.13 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.395 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.07 -46.55 91.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.376 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -62.22 -42.42 99.29 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.256 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.4 m -64.76 -41.71 95.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.55 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.716 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.8 mm -64.21 -49.96 78.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.008 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.41 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 64.8 t -61.6 -47.44 93.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.769 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.41 -46.42 88.66 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.823 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CE2' HD11 ' A' ' 120' ' ' ILE . 67.0 t80 -63.43 -46.51 86.01 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.815 0.341 . . . . 0.0 110.795 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.62 -48.3 81.47 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.907 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.418 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 23.1 m-85 -63.21 -33.79 76.25 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.427 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.01 -46.92 87.09 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.286 0.565 . . . . 0.0 109.676 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.634 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.8 mt -64.18 -48.58 85.03 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.577 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -65.55 -26.53 67.92 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.413 -178.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.71 -42.49 99.67 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.57 176.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 19.0 ptpt -82.24 -37.0 26.61 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.669 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.566 ' O ' HG12 ' A' ' 127' ' ' VAL . 85.9 m -132.65 91.72 29.2 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.69 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.15 -17.44 38.73 Favored 'Trans proline' 0 N--CA 1.483 0.891 0 C-N-CA 123.379 2.72 . . . . 0.0 112.921 -178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.75 -32.27 73.38 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.566 HG12 ' O ' ' A' ' 124' ' ' THR . 9.9 p -73.33 127.64 35.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.211 0.529 . . . . 0.0 110.775 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.486 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 45.0 mt-10 -122.19 2.9 9.83 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.193 -178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.51 155.23 42.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.029 0.443 . . . . 0.0 111.971 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 26.8 tp -137.58 146.1 43.63 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.99 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.93 137.12 53.08 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.338 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 113' ' ' ILE . 98.9 t -114.24 115.77 50.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 CA-C-O 121.379 0.609 . . . . 0.0 109.615 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.5 ptm -145.9 156.61 43.65 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.785 -177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.637 HG12 ' HB2' ' A' ' 152' ' ' ALA . 22.2 pt -131.5 158.39 75.46 Favored Pre-proline 0 C--N 1.309 -1.192 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.652 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -57.51 142.21 95.34 Favored 'Trans proline' 0 C--O 1.239 0.546 0 C-N-CA 122.411 2.074 . . . . 0.0 111.706 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -63.06 -24.83 68.09 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.362 0.601 . . . . 0.0 109.696 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.32 -36.1 82.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.461 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -92.07 -24.25 19.22 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.426 0.632 . . . . 0.0 110.996 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.526 ' HD1' HD11 ' A' ' 134' ' ' ILE . 59.7 t80 -92.0 118.17 68.08 Favored Pre-proline 0 C--N 1.289 -2.042 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.773 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.84 -76.92 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 122.515 2.143 . . . . 0.0 114.555 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -129.56 127.41 22.99 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.401 ' N ' ' HE2' ' A' ' 139' ' ' TYR . 23.0 Cg_exo -67.07 169.73 14.48 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.465 2.777 . . . . 0.0 111.961 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.1 m -59.96 -39.64 86.33 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.09 -68.29 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 171.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -176.52 148.25 0.71 Allowed 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.084 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -145.98 129.9 17.29 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -88.33 125.64 34.79 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.31 -44.58 2.62 Favored Glycine 0 CA--C 1.506 -0.494 0 CA-C-N 115.859 -0.61 . . . . 0.0 113.148 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -141.61 159.71 41.65 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.92 135.87 28.29 Favored Pre-proline 0 C--N 1.306 -1.314 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.1 141.65 48.54 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.039 1.826 . . . . 0.0 111.252 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.637 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -114.69 -5.11 12.7 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.295 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.25 -116.95 0.45 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.557 -1.306 . . . . 0.0 113.176 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.628 HD12 HD11 ' A' ' 96' ' ' LEU . 25.2 pt -119.05 161.15 18.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 120.991 0.424 . . . . 0.0 111.768 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.609 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.7 t-20 -120.18 156.02 31.94 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.118 -174.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 81.3 t -124.25 130.27 73.74 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 C-N-CA 122.253 0.221 . . . . 0.0 110.75 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.517 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.7 m -135.52 155.16 36.29 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.055 0.455 . . . . 0.0 111.346 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.536 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 58.6 m -97.06 157.45 34.97 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.187 174.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.34 69.22 7.26 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.873 2.382 . . . . 0.0 111.731 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -93.31 169.58 10.27 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.918 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.3 m170 -110.22 22.07 15.98 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.622 0.725 . . . . 0.0 109.606 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -170.27 -176.32 39.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.509 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -72.22 146.17 47.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 117.091 0.446 . . . . 0.0 110.32 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.536 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 19.9 pt20 -133.37 166.6 22.13 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -173.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -66.47 127.62 33.03 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.763 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -125.13 132.15 53.15 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.65 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.431 ' HG3' HG21 ' A' ' 120' ' ' ILE . 45.8 mm-40 -93.49 163.05 13.72 Favored 'General case' 0 CA--C 1.48 -1.725 0 CA-C-O 121.641 0.734 . . . . 0.0 112.207 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.4 mm -116.16 127.77 73.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.442 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.8 ttp -131.19 132.86 45.0 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.911 176.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 133' ' ' MET . 78.8 t -107.87 131.78 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.163 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.648 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 39.2 pt -114.55 172.62 3.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.434 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -117.97 8.02 12.44 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.352 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.648 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.1 pm0 -104.32 134.67 47.14 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.708 0.766 . . . . 0.0 110.828 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.73 151.05 19.72 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.503 -1.226 . . . . 0.0 112.536 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.426 HD12 HD22 ' A' ' 102' ' ' LEU . 7.6 pt -110.37 146.16 15.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.436 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -104.34 111.8 24.59 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -110.12 153.02 25.28 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.458 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.747 HG23 ' HB2' ' A' ' 183' ' ' ASP . 92.6 mt -110.73 119.59 59.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -176.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -114.4 -24.8 8.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.561 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 67.1 p -128.26 163.96 23.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.695 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -61.8 -32.46 72.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.007 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.18 -37.54 85.63 Favored 'General case' 0 CA--C 1.51 -0.585 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.366 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.747 ' HB2' HG23 ' A' ' 178' ' ' ILE . 57.3 m-20 -60.89 -35.28 76.24 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.007 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.542 HD23 HD13 ' A' ' 178' ' ' ILE . 96.0 mt -60.02 -46.2 90.27 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.87 0.843 . . . . 0.0 109.184 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.625 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 65.7 tttm -65.82 -40.05 91.44 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.505 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 189' ' ' MET . 10.5 tt -64.13 -44.36 92.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.044 0.45 . . . . 0.0 110.187 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.06 -43.03 99.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.332 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.625 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -70.33 -29.74 66.52 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.064 0.459 . . . . 0.0 110.607 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.436 ' HB3' ' O ' ' A' ' 186' ' ' LEU . 60.0 ttm -61.87 -47.91 82.9 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.325 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -70.1 -31.38 68.91 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.768 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.492 HD13 ' SG ' ' A' ' 25' ' ' CYS . 83.5 mt -62.11 -45.02 95.34 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.339 0.59 . . . . 0.0 110.678 178.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -70.75 -47.56 59.01 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.27 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -66.55 -42.81 86.54 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -104.57 5.9 34.17 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.3 -43.38 99.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.91 -1.138 . . . . 0.0 111.247 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 C--O 1.268 2.056 0 CA-C-O 117.478 -1.248 . . . . 0.0 109.862 178.16 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' ' HA ' ' A' ' 42' ' ' VAL . 59.2 ttm . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.784 0.326 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' HA ' HG13 ' A' ' 42' ' ' VAL . 63.6 m-20 -103.94 164.6 11.59 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.614 176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -114.7 129.79 56.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.178 0.513 . . . . 0.0 111.168 -178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' O ' HG22 ' A' ' 98' ' ' VAL . 2.2 tm? -103.57 119.27 38.57 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 98' ' ' VAL . 68.6 mt -116.6 115.69 49.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.138 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.568 ' CE ' HD22 ' A' ' 84' ' ' LEU . 47.2 mtt -89.66 97.47 11.21 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-O 122.48 1.133 . . . . 0.0 113.591 -178.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.86 110.62 19.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 112.953 -1.93 . . . . 0.0 110.07 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 104.86 -14.35 49.31 Favored Glycine 0 C--N 1.294 -1.78 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.13 170.61 49.51 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 176.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -131.11 153.93 48.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.962 0.411 . . . . 0.0 110.907 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 1.81 72.63 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 113.284 -175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m 70.75 102.39 0.06 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.025 0.441 . . . . 0.0 109.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtm180 70.13 10.34 7.33 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.281 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 98.3 mtp -136.0 137.16 40.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.354 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -129.43 -158.97 9.7 Favored Glycine 0 N--CA 1.442 -0.946 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -10.4 72.05 Favored Glycine 0 C--N 1.317 -0.51 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.791 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.411 ' HB ' ' OG ' ' A' ' 100' ' ' SER . 35.9 m -104.25 3.1 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 121.454 0.645 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.42 168.02 12.18 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.15 -179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.533 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 2.7 tppp? 62.91 59.36 2.21 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.611 0.764 . . . . 0.0 110.972 -177.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 36.6 Cg_exo -64.96 -9.4 21.32 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.445 2.764 . . . . 0.0 112.402 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.519 HD21 ' CB ' ' A' ' 59' ' ' TYR . 10.8 mp -79.69 6.31 11.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.4 mt -73.47 125.27 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.669 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' H ' ' HD3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -109.54 146.09 35.23 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.647 0.737 . . . . 0.0 112.386 -173.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 184' ' ' LEU . 96.4 mt -129.45 124.71 34.75 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.279 -1.328 . . . . 0.0 109.848 177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 192' ' ' LYS . 79.6 m 65.66 -74.32 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 O-C-N 123.732 0.645 . . . . 0.0 112.418 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -111.9 -68.96 0.55 Allowed Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.529 -0.843 . . . . 0.0 114.221 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 98.5 mtt180 -115.76 172.86 6.87 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-O 121.463 0.649 . . . . 0.0 112.349 -173.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.4 m -71.84 154.47 41.25 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.466 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.33 -42.21 20.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.436 1.094 . . . . 0.0 111.219 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.455 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.1 tp -58.18 -48.2 85.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 19.0 t70 -63.74 -40.01 95.7 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-O 121.036 0.446 . . . . 0.0 110.584 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.521 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 7.0 m-30 -62.13 -37.4 85.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.865 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.1 t -69.45 -43.66 80.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.005 0.431 . . . . 0.0 110.701 176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.4 t -64.62 -42.18 94.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.643 -178.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.1 m -50.04 -54.99 27.35 Favored Pre-proline 0 CA--C 1.559 1.298 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.12 -38.09 9.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 121.205 1.27 . . . . 0.0 112.583 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD11 HG11 ' A' ' 98' ' ' VAL . 91.1 mt -65.76 -42.0 91.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.967 0.413 . . . . 0.0 111.405 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.604 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.5 tt -63.09 -46.88 85.29 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.84 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -78.07 -12.93 60.03 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 p -74.62 -176.75 2.9 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 120.932 0.396 . . . . 0.0 110.803 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -60.28 -9.51 3.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.883 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 2' ' ' ASP . 69.0 t -64.51 133.11 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 CA-C-O 121.171 0.51 . . . . 0.0 110.588 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -80.26 -68.3 0.69 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.988 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -111.12 148.38 32.82 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 121.405 0.621 . . . . 0.0 111.217 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.9 mm -108.47 117.12 53.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.245 -0.888 . . . . 0.0 108.765 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -108.24 113.83 27.23 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -95.23 116.3 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.427 0 CA-C-O 121.657 0.741 . . . . 0.0 110.042 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.6 120.6 29.08 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.826 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 7' ' ' ALA . 76.0 p -125.61 160.16 30.32 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.254 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 56.9 m -109.66 150.44 41.26 Favored Pre-proline 0 C--N 1.302 -1.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.999 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.27 -27.6 75.88 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.103 2.536 . . . . 0.0 111.801 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -81.05 -6.62 59.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.476 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.8 66.34 40.58 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.618 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.9 Cg_endo -109.24 85.79 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.842 0 CA-C-N 120.713 1.29 . . . . 0.0 110.159 168.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.0 mttt -146.45 -45.63 0.19 Allowed 'General case' 1 C--N 1.217 -5.187 0 CA-C-N 109.852 -3.34 . . . . 0.0 102.327 177.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 77.1 m -62.03 -47.99 82.3 Favored 'General case' 0 N--CA 1.387 -3.6 0 CA-C-N 112.033 -2.349 . . . . 0.0 105.989 162.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.618 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.3 tttt -62.32 -50.1 72.99 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.061 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.587 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.2 pt-20 -59.33 -35.15 73.32 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 117.732 -1.587 . . . . 0.0 110.858 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CB ' HD21 ' A' ' 21' ' ' LEU . 56.4 t80 -67.25 -51.61 51.02 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.952 0.406 . . . . 0.0 111.932 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.454 HG23 ' CD2' ' A' ' 64' ' ' TYR . 97.7 mt -63.47 -44.91 99.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.536 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -58.77 -42.65 89.42 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.948 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.516 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 35.2 t -70.33 -43.2 70.77 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.847 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.48 89.73 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.798 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 68.3 m-85 -108.11 34.69 3.47 Favored 'General case' 0 N--CA 1.433 -1.288 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.185 -176.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.516 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.8 mmmt -62.64 -20.23 64.6 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.564 0.697 . . . . 0.0 110.128 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -87.7 10.84 16.87 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.938 178.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 52.9 p90 -46.78 126.48 8.66 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -177.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -104.34 -49.37 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 169.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.604 HD21 ' HG ' ' A' ' 38' ' ' LEU . 24.9 p-10 -117.01 15.73 15.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.255 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.446 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 78.8 mt -105.32 127.58 59.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-O 121.248 0.547 . . . . 0.0 110.851 -176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.03 132.98 68.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.83 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.61 130.96 60.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.484 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.4 155.73 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 122.038 0.923 . . . . 0.0 112.372 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -111.13 132.61 54.15 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 113.596 -1.638 . . . . 0.0 108.189 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 2.6 t -161.14 -172.05 3.28 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.8 m -66.69 2.08 1.51 Allowed 'General case' 0 C--O 1.206 -1.237 0 C-N-CA 127.236 2.214 . . . . 0.0 114.68 -175.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.534 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.11 -23.98 0.0 OUTLIER Glycine 0 N--CA 1.51 3.596 0 C-N-CA 126.237 1.875 . . . . 0.0 117.038 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.0 OUTLIER -55.38 -35.3 65.15 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.18 121.77 5.51 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.29 -50.44 73.61 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -173.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.9 mt -65.99 -43.62 92.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-O 121.585 0.707 . . . . 0.0 110.172 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -59.1 -44.12 91.91 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.295 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 33.7 t0 -62.07 -48.15 81.53 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.282 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.637 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.7 OUTLIER -53.76 -41.54 67.27 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.861 177.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.586 ' O ' HG12 ' A' ' 88' ' ' ILE . 28.0 m-80 -60.09 -43.99 95.12 Favored 'General case' 0 C--O 1.246 0.894 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.365 177.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.456 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 53.3 mm-40 -65.67 -41.91 91.93 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.3 m -61.88 -42.17 98.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.264 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.637 HG23 ' O ' ' A' ' 84' ' ' LEU . 26.1 pt -66.23 -25.12 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 120.611 -0.435 . . . . 0.0 110.335 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.18 92.28 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.121 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -80.75 -8.99 59.84 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -119.81 145.97 46.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 43.4 m -115.73 10.73 15.5 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -133.36 157.65 77.6 Favored Pre-proline 0 CA--C 1.507 -0.707 0 CA-C-N 113.927 -1.488 . . . . 0.0 110.121 -176.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -68.84 146.05 64.6 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.195 1.93 . . . . 0.0 111.557 178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -139.2 158.26 44.48 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.686 HD21 HD12 ' A' ' 154' ' ' ILE . 27.0 tp -86.27 140.62 29.93 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.928 -176.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 60.3 t -115.17 131.34 67.73 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG22 ' HA ' ' A' ' 5' ' ' ILE . 11.0 m -126.97 157.02 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 119.958 -0.697 . . . . 0.0 111.691 -178.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.462 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 36.3 t -99.71 136.5 39.54 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.411 ' OG ' ' HB ' ' A' ' 17' ' ' VAL . 74.8 p -64.54 -34.03 77.29 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -174.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -88.79 1.95 54.37 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -173.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.629 HD22 HD13 ' A' ' 175' ' ' ILE . 70.3 mt -91.26 114.11 26.55 Favored 'General case' 0 C--O 1.246 0.887 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.757 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 85.2 mt -121.88 130.29 74.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -176.91 -178.08 0.82 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.3 mt -72.97 71.7 1.09 Allowed 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.694 ' HA ' HD12 ' A' ' 109' ' ' ILE . 58.6 mtpt -79.98 -8.05 59.13 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.546 -174.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.8 t -59.75 -45.94 90.67 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -82.97 -24.26 33.03 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.797 0.808 . . . . 0.0 110.169 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.694 HD12 ' HA ' ' A' ' 106' ' ' LYS . 78.6 mt -65.63 -39.24 84.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.03 -177.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 106' ' ' LYS . 60.3 mt -57.09 -46.47 84.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.279 178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -61.66 -43.9 97.99 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.12 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.8 m -63.98 -40.77 97.14 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.738 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.693 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.01 -49.11 85.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.217 0.532 . . . . 0.0 110.373 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.507 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.7 t -62.48 -46.83 95.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.244 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -61.61 -43.81 98.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.113 -179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.433 ' CD2' ' HG3' ' A' ' 169' ' ' MET . 37.5 t80 -66.77 -42.75 85.57 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.147 0.498 . . . . 0.0 110.287 -178.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.459 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.2 t80 -57.46 -47.3 82.2 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.333 177.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.507 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 39.8 m-85 -67.95 -30.75 70.13 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.5 m -63.39 -39.79 95.48 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 74.6 mt -65.34 -42.33 93.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.409 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.922 177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.418 ' N ' ' HE3' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -57.33 -38.5 74.18 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.67 177.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.48 91.17 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.561 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -88.59 -37.39 15.69 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.921 0.391 . . . . 0.0 111.612 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 28.6 m -141.27 92.06 8.49 Favored Pre-proline 0 N--CA 1.442 -0.842 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.411 -176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -19.82 57.43 Favored 'Trans proline' 0 N--CA 1.48 0.711 0 C-N-CA 123.262 2.641 . . . . 0.0 112.295 177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -61.39 -30.47 70.57 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.463 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.544 HG22 ' HE3' ' A' ' 165' ' ' LYS . 61.9 t -67.05 127.45 28.6 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 CA-C-O 120.872 0.368 . . . . 0.0 110.087 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 158' ' ' SER . 30.1 mt-10 -102.44 -34.11 9.28 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.234 -173.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -131.45 165.6 23.17 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -174.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.459 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.4 OUTLIER -140.22 134.25 30.85 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.807 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.51 135.93 51.03 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.671 HG21 HD12 ' A' ' 113' ' ' ILE . 78.3 t -117.24 118.61 59.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 CA-C-O 121.234 0.54 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.68 41.92 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.747 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.687 HD11 ' HD1' ' A' ' 139' ' ' TYR . 34.8 pt -124.58 163.28 37.71 Favored Pre-proline 0 C--N 1.311 -1.083 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.577 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 10.7 Cg_endo -57.1 124.83 17.15 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 121.82 1.68 . . . . 0.0 110.772 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -60.76 -24.34 65.68 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.059 -175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -66.41 -39.2 88.83 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -82.94 -22.23 33.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.431 0.634 . . . . 0.0 110.432 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.687 ' HD1' HD11 ' A' ' 134' ' ' ILE . 43.9 t80 -71.54 138.12 83.47 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.357 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -54.59 -73.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.363 2.042 . . . . 0.0 112.271 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.424 ' O ' ' HE2' ' A' ' 139' ' ' TYR . 31.6 p30 -158.16 143.18 11.99 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.702 176.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.452 ' HB2' ' O ' ' A' ' 145' ' ' ASP . 35.2 Cg_exo -62.72 145.35 94.96 Favored 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.541 2.161 . . . . 0.0 111.682 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 53.7 m -73.99 101.87 3.98 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.4 mm 71.86 -38.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.593 0.757 . . . . 0.0 112.864 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 142' ' ' PRO . 8.9 t0 -61.41 133.23 55.55 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -70.86 -42.05 70.62 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -171.81 132.07 0.7 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.755 0.312 . . . . 0.0 111.325 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.86 -148.2 13.84 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.7 mp -88.35 140.92 28.98 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.4 m -117.53 118.67 35.08 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.529 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.96 144.92 48.87 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.271 1.981 . . . . 0.0 110.977 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.531 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -128.79 16.65 6.34 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 120.785 0.326 . . . . 0.0 111.525 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.18 -114.86 0.33 Allowed Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 119.357 -1.402 . . . . 0.0 112.89 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.686 HD12 HD21 ' A' ' 96' ' ' LEU . 13.0 pt -134.45 160.87 41.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.239 -0.481 . . . . 0.0 110.348 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.482 ' O ' HD12 ' A' ' 96' ' ' LEU . 1.7 t30 -118.19 155.91 29.68 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -175.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 93.8 t -124.69 130.36 73.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 C-N-CA 122.421 0.289 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.53 147.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.134 0.492 . . . . 0.0 111.13 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.523 ' HB2' ' O ' ' A' ' 128' ' ' GLU . 8.4 t -99.28 158.45 32.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 173.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.484 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 28.7 Cg_exo -62.98 93.93 0.15 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 121.373 1.382 . . . . 0.0 110.669 176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.502 ' HD2' ' HA ' ' A' ' 163' ' ' TYR . 20.6 pttp -78.01 174.83 10.68 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.843 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -124.08 -68.81 0.84 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.069 171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -113.46 47.23 1.06 Allowed Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.502 ' HA ' ' HD2' ' A' ' 160' ' ' LYS . 91.8 m-85 74.9 148.9 0.1 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.566 0.746 . . . . 0.0 110.542 -176.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.48 ' OE1' ' HB3' ' A' ' 158' ' ' SER . 26.7 pt20 -133.84 165.11 25.75 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.544 ' HE3' HG22 ' A' ' 127' ' ' VAL . 64.9 tttp -67.85 121.97 17.14 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.204 178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -123.38 126.74 47.37 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.848 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -94.37 163.05 13.58 Favored 'General case' 0 CA--C 1.469 -2.172 0 CA-C-O 121.895 0.855 . . . . 0.0 113.218 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.3 mm -114.0 129.51 69.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.006 -176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.496 ' SD ' HG23 ' A' ' 171' ' ' ILE . 15.0 tmm? -131.31 138.24 49.15 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.738 177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.22 131.09 68.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.921 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.572 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 2.2 pp -114.63 178.52 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.889 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -115.81 3.36 13.78 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.011 0.434 . . . . 0.0 112.031 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.572 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 1.8 pm0 -98.83 136.85 38.26 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.81 0.814 . . . . 0.0 111.583 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.3 mt -95.68 139.27 32.16 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.965 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.629 HD13 HD22 ' A' ' 102' ' ' LEU . 1.8 pp -101.93 155.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.189 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -98.99 107.31 19.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -92.3 124.92 36.72 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.634 HG21 HD23 ' A' ' 184' ' ' LEU . 85.5 mt -108.86 110.01 30.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.725 -177.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -124.4 -13.72 7.07 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.731 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 43.1 p -127.04 167.75 15.52 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.381 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.471 ' HA ' HD12 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -65.09 -35.18 80.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.634 177.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -58.83 -42.45 89.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.054 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.568 ' HB2' HG23 ' A' ' 178' ' ' ILE . 73.2 m-20 -62.28 -37.8 86.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.143 178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.634 HD23 HG21 ' A' ' 178' ' ' ILE . 95.5 mt -60.26 -46.79 88.6 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.765 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.545 ' O ' ' HG3' ' A' ' 189' ' ' MET . 28.9 mtpp -64.93 -38.41 90.89 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.066 -0.97 . . . . 0.0 111.368 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 67.6 tp -58.98 -50.5 73.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.154 0.502 . . . . 0.0 110.078 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.45 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -66.35 -41.92 88.85 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.435 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.503 ' CG ' ' HA ' ' A' ' 185' ' ' LYS . 0.8 OUTLIER -68.98 -30.8 69.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.545 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.4 mtp -64.61 -41.57 96.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.747 0.308 . . . . 0.0 111.684 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -77.84 -33.02 52.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.923 -176.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 190' ' ' LEU . 86.9 mt -61.28 -47.42 86.1 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.12 0.486 . . . . 0.0 111.851 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.414 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 37.4 mtmm -70.56 -40.93 73.07 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.988 -178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -68.06 -43.14 79.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.824 0.345 . . . . 0.0 111.648 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -71.76 -26.23 62.36 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.912 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -60.61 -40.56 98.07 Favored Glycine 0 C--N 1.321 -0.265 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.146 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 C--O 1.272 2.256 0 CA-C-O 117.561 -1.209 . . . . 0.0 111.12 179.258 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.637 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 36.4 ttp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.784 0.326 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -90.37 166.2 13.42 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.021 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -123.29 134.01 54.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.619 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 22.1 tp -105.66 127.28 52.96 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.148 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.619 ' HA ' HG22 ' A' ' 98' ' ' VAL . 61.4 mt -118.11 106.83 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 60.3 ttm -80.5 101.53 9.15 Favored 'General case' 0 N--CA 1.405 -2.687 0 CA-C-O 121.898 0.856 . . . . 0.0 111.021 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB2' HD13 ' A' ' 30' ' ' ILE . . . -115.54 97.72 6.31 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.35 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.33 106.26 0.55 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.984 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . 164.41 -163.13 35.94 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.087 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 72.74 105.33 0.07 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.236 1.015 . . . . 0.0 112.366 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.35 154.28 19.73 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.268 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.4 p -92.15 -16.43 26.3 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.151 0.5 . . . . 0.0 110.132 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -130.5 149.77 52.01 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.047 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -95.77 116.44 28.89 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.091 0.472 . . . . 0.0 111.382 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -115.73 134.21 11.35 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.85 -129.58 46.79 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.17 -68.88 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 116.999 0.399 . . . . 0.0 109.973 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.473 ' HA ' HD11 ' A' ' 22' ' ' ILE . 46.7 mt-10 49.69 -162.45 0.05 OUTLIER 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.215 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER 67.26 176.25 0.06 OUTLIER Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.051 175.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 19' ' ' LYS . 51.1 Cg_exo -59.16 -8.96 7.2 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.607 2.205 . . . . 0.0 113.546 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.542 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 49.7 mt -89.08 6.34 40.32 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.473 HD11 ' HA ' ' A' ' 18' ' ' GLU . 97.3 mt -63.58 114.21 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 60.4 pttt -95.6 131.77 41.45 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.583 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 188' ' ' GLU . 61.9 tp -136.13 120.97 18.57 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.322 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.6 m 58.54 24.09 11.56 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.86 -31.36 4.57 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 119.942 -1.123 . . . . 0.0 115.223 175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.722 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 95.8 mtt180 -126.39 157.54 38.25 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 118.787 1.294 . . . . 0.0 111.764 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.5 m -81.54 163.52 22.6 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.535 176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 33' ' ' VAL . 84.9 mt -58.77 -39.7 81.79 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.592 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.604 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.7 tp -56.21 -47.47 80.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.761 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.245 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.683 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.1 t70 -65.02 -42.86 94.02 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 121.168 0.508 . . . . 0.0 110.634 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.722 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 30.8 m-85 -64.07 -36.94 85.66 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.427 178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.513 ' O ' ' HD2' ' A' ' 36' ' ' PRO . 79.1 t -70.07 -41.05 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.14 0.495 . . . . 0.0 110.647 176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 30' ' ' ILE . 59.8 t -61.47 -43.27 96.52 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.445 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.899 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.447 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 65.8 m -52.76 -52.46 64.31 Favored Pre-proline 0 CA--C 1.571 1.768 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -173.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 33' ' ' VAL . 51.9 Cg_exo -60.53 -42.46 40.24 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 121.758 1.639 . . . . 0.0 111.982 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.566 HD11 HG11 ' A' ' 98' ' ' VAL . 96.1 mt -68.2 -37.23 80.68 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.722 0.772 . . . . 0.0 110.585 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 69' ' ' ASN . 59.7 tp -58.33 -45.77 87.45 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.989 175.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -89.11 -1.61 58.17 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.414 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.627 ' HB2' HG21 ' A' ' 110' ' ' ILE . 60.3 p -75.69 175.4 8.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 120.951 0.405 . . . . 0.0 110.838 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.9 ttmm -58.26 -27.01 63.62 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.493 0.717 . . . . 0.0 112.469 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG22 ' OG ' ' A' ' 40' ' ' SER . 30.7 m -59.94 154.51 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -77.16 -69.0 0.56 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.801 -1.091 . . . . 0.0 111.844 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.92 153.67 36.91 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 121.207 0.527 . . . . 0.0 111.16 -179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.8 mm -106.64 115.26 47.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.836 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 87.0 m-85 -104.91 116.09 31.39 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.719 HG21 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -94.97 116.05 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-O 121.574 0.702 . . . . 0.0 110.319 179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.66 120.74 28.29 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.439 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.9 p -125.06 158.0 34.86 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.031 0.443 . . . . 0.0 110.472 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 28.9 t -111.9 142.29 26.44 Favored Pre-proline 0 C--N 1.296 -1.742 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.169 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 75.6 Cg_exo -55.48 -25.89 51.29 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.457 2.771 . . . . 0.0 111.949 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -75.84 -9.0 58.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.792 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.1 p -140.35 67.12 31.41 Favored Pre-proline 0 N--CA 1.438 -1.026 0 CA-C-O 119.244 -0.408 . . . . 0.0 112.011 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 67.0 Cg_endo -104.68 85.26 0.02 OUTLIER 'Trans proline' 1 N--CA 1.387 -4.781 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.413 170.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 97.6 mttt -147.63 -46.78 0.17 Allowed 'General case' 1 C--N 1.214 -5.308 0 CA-C-N 109.932 -3.304 . . . . 0.0 103.721 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.472 HG21 ' HB1' ' A' ' 7' ' ' ALA . 87.9 m -61.93 -47.43 84.96 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 164.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.641 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -62.68 -49.62 74.39 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.016 176.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.1 pt-20 -59.19 -37.73 78.12 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.876 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -63.48 -50.25 70.4 Favored 'General case' 0 C--O 1.205 -1.243 0 CA-C-O 120.703 0.287 . . . . 0.0 111.301 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 47' ' ' ILE . 94.7 mt -63.47 -41.53 93.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.601 -176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.546 ' OD1' HG11 ' A' ' 72' ' ' VAL . 92.7 m-20 -57.06 -45.73 83.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.866 177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 58.3 m -71.32 -41.96 69.22 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.262 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.45 -38.91 92.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.328 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.462 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 70.3 m-85 -113.55 37.86 3.1 Favored 'General case' 0 C--O 1.204 -1.292 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.71 -176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 10.8 mmmm -62.47 -23.38 66.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.316 0.579 . . . . 0.0 110.758 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -92.55 11.28 26.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.332 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.462 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 53.0 p90 -43.25 128.6 4.73 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -175.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -101.36 -52.03 3.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.023 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.513 HD21 HD12 ' A' ' 38' ' ' LEU . 6.8 p-10 -119.48 14.31 12.77 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.71 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.52 125.86 58.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 59.3 t -125.42 133.17 69.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.957 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.546 HG11 ' OD1' ' A' ' 61' ' ' ASN . 7.2 p -104.5 134.47 45.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.505 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.2 pt -129.25 157.1 42.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.585 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -116.07 136.13 53.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 12.7 t -160.2 -172.4 3.58 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -66.73 3.81 0.95 Allowed 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 127.543 2.337 . . . . 0.0 114.592 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.98 -20.73 0.0 OUTLIER Glycine 1 N--CA 1.517 4.099 0 C-N-CA 126.51 2.005 . . . . 0.0 116.947 -173.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 76' ' ' SER . 55.8 tptt -56.55 -39.78 73.99 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.26 122.37 6.09 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.15 -50.44 73.68 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.219 0.533 . . . . 0.0 111.718 -174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.3 -45.65 95.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-O 121.71 0.766 . . . . 0.0 110.266 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 48.3 mt-10 -60.07 -42.48 94.65 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.83 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.2 t0 -58.79 -51.61 69.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.347 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.628 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.0 mm? -58.76 -43.56 90.35 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.108 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.629 ' O ' HG12 ' A' ' 88' ' ' ILE . 30.0 m-80 -61.61 -39.93 93.02 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.332 0.587 . . . . 0.0 112.4 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 54.6 mm-40 -65.91 -42.21 90.47 Favored 'General case' 0 C--N 1.313 -1.008 0 O-C-N 121.506 -0.746 . . . . 0.0 109.009 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 98.5 m -61.73 -43.21 99.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.961 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.629 HG12 ' O ' ' A' ' 85' ' ' ASN . 33.1 pt -63.64 -27.1 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.687 0.28 . . . . 0.0 110.344 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.73 -24.87 64.88 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.566 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -99.93 2.87 44.08 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -118.85 135.6 54.47 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 112.285 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.0 m -103.66 -2.35 26.7 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.491 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 42.1 mt-10 -131.55 160.83 65.58 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.1 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.637 ' O ' ' HG3' ' A' ' 1' ' ' MET . 48.7 Cg_endo -67.31 157.67 60.66 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.445 2.096 . . . . 0.0 111.411 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -144.71 159.25 43.14 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.367 0.603 . . . . 0.0 111.699 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 3' ' ' ALA . 21.9 tp -86.64 145.98 26.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.726 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.563 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 95.8 t -116.63 130.11 72.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 C-N-CA 124.07 0.948 . . . . 0.0 108.601 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.619 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.4 m -131.77 163.97 35.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 C-N-CA 119.92 -0.712 . . . . 0.0 112.26 -178.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 46.9 t -99.8 139.71 35.07 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 173.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.4 p -89.6 -1.3 57.98 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -173.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -117.01 9.54 13.71 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.699 0.999 . . . . 0.0 113.699 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.517 ' O ' HD12 ' A' ' 102' ' ' LEU . 2.8 pp -92.53 143.48 26.3 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.938 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 18.0 tt -140.26 132.41 32.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.074 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 18.9 t-20 173.28 167.61 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.163 0.985 . . . . 0.0 108.415 176.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.2 tt -80.19 88.32 5.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.581 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -101.82 3.6 39.52 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -176.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.5 p -52.76 -36.04 57.33 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.429 ' CG ' HD12 ' A' ' 109' ' ' ILE . 21.5 pttp -73.15 -28.51 62.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.254 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.751 ' O ' HG12 ' A' ' 113' ' ' ILE . 2.0 mp -61.4 -43.05 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.304 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.627 HG21 ' HB2' ' A' ' 40' ' ' SER . 5.2 mm -54.16 -49.82 59.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-O 121.821 0.819 . . . . 0.0 109.743 -177.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 62.3 m-80 -61.98 -42.93 99.69 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.216 -1.356 . . . . 0.0 110.662 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.2 m -61.81 -38.35 87.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.726 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.751 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -60.83 -49.15 85.78 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.11 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 77.7 t -62.54 -47.76 91.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.863 -176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -61.08 -46.91 88.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.731 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.662 ' CE2' HD11 ' A' ' 120' ' ' ILE . 45.2 t80 -66.53 -46.05 77.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.637 0.256 . . . . 0.0 111.483 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 62.9 t80 -58.19 -47.58 83.01 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-O 121.073 0.464 . . . . 0.0 110.694 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -62.84 -37.36 86.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.204 177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 91.7 m -63.75 -40.15 96.01 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.024 0.44 . . . . 0.0 110.568 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.662 HD11 ' CE2' ' A' ' 116' ' ' TYR . 81.2 mt -65.45 -46.02 91.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.138 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 52.8 mtmt -63.08 -37.52 87.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.218 0.533 . . . . 0.0 110.531 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.26 -42.61 91.55 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.293 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -82.2 -35.0 28.74 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.024 0.44 . . . . 0.0 111.513 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 66.4 m -137.24 97.51 10.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.447 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.04 -20.52 54.13 Favored 'Trans proline' 0 N--CA 1.485 0.982 0 C-N-CA 123.412 2.742 . . . . 0.0 113.036 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -62.77 -30.39 71.41 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.787 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.447 HG22 ' HE3' ' A' ' 165' ' ' LYS . 67.5 t -73.77 125.38 32.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.765 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.82 2.58 7.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.995 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -143.0 156.08 44.78 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.962 0.41 . . . . 0.0 111.468 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.5 OUTLIER -140.39 133.1 28.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.954 -177.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.404 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -120.37 129.98 54.19 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.86 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.722 HG21 ' CD1' ' A' ' 113' ' ' ILE . 60.8 t -115.01 121.74 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.58 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 6.5 ptm -145.89 156.8 43.79 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.661 -174.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.584 HG23 ' HB2' ' A' ' 152' ' ' ALA . 14.3 pt -128.54 156.52 77.09 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.633 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.9 131.78 48.07 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.219 1.946 . . . . 0.0 111.95 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.89 -19.7 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.521 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -65.09 -37.01 86.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.42 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -93.99 -23.6 17.97 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.705 0.764 . . . . 0.0 110.207 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -64.55 135.35 96.33 Favored Pre-proline 0 C--N 1.297 -1.678 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.652 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -49.96 -66.97 0.11 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.883 2.389 . . . . 0.0 112.952 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -156.57 133.86 6.68 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 143' ' ' SER . 50.2 Cg_exo -59.37 -41.52 57.62 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.553 2.169 . . . . 0.0 112.207 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 142' ' ' PRO . 23.3 t 171.2 -63.34 0.01 OUTLIER 'General case' 0 CA--C 1.524 -0.052 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.285 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 15.2 tt -155.6 -39.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.042 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -107.81 149.46 28.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.761 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -88.22 -179.66 6.19 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.3 t30 75.7 161.64 0.24 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.996 0.918 . . . . 0.0 111.567 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.98 179.44 35.86 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.645 HD23 ' H ' ' A' ' 149' ' ' LEU . 2.5 pt? -106.98 149.97 26.97 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 117.358 0.579 . . . . 0.0 110.434 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.31 135.49 26.94 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.086 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -72.26 153.61 56.46 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.843 2.362 . . . . 0.0 111.792 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.694 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -102.32 -7.69 21.85 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.117 0.484 . . . . 0.0 111.371 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 177.86 -88.9 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.749 -178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.668 HD11 HG13 ' A' ' 113' ' ' ILE . 16.9 pt -131.36 161.31 41.35 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-O 121.237 0.541 . . . . 0.0 112.308 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.563 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 9.9 t-20 -120.65 153.82 36.35 Favored 'General case' 0 C--O 1.207 -1.177 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.928 -177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.91 131.18 72.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 O-C-N 122.368 -0.207 . . . . 0.0 111.141 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.1 m -135.32 155.07 36.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-O 121.192 0.52 . . . . 0.0 111.141 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.445 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 72.3 m -97.51 158.79 32.51 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 84.5 Cg_endo -75.61 59.39 5.58 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.108 1.872 . . . . 0.0 112.484 -178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -117.87 138.5 52.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.31 -0.404 . . . . 0.0 109.95 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -72.54 133.71 44.89 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -173.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 84.83 -130.35 9.75 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.936 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.99 141.68 46.55 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.353 0.597 . . . . 0.0 111.635 -178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.445 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 22.9 pt20 -134.91 162.72 31.63 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.664 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.447 ' HE3' HG22 ' A' ' 127' ' ' VAL . 63.9 tttp -60.68 128.13 35.04 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.9 0.381 . . . . 0.0 111.4 -176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -124.76 131.55 53.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.466 -177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 120' ' ' ILE . 28.8 mm-40 -97.35 163.15 13.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.404 HD13 ' HB3' ' A' ' 131' ' ' ALA . 50.0 mm -115.52 131.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.718 -1.128 . . . . 0.0 112.256 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 61.6 ttp -133.42 132.67 41.41 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.967 174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.6 t -112.49 131.21 64.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 173' ' ' GLU . 50.7 pt -115.63 176.12 2.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.742 -177.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -100.52 -3.27 31.03 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.205 0.526 . . . . 0.0 110.861 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.569 ' HB2' HD12 ' A' ' 171' ' ' ILE . 56.7 mp0 -98.83 130.47 45.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.922 0.868 . . . . 0.0 112.775 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 174' ' ' LEU . 1.4 pt? -97.72 153.83 17.99 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.754 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.6 pt -112.08 149.18 14.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.429 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -105.48 115.2 29.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -103.52 150.29 24.06 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.616 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.652 HG23 ' HB2' ' A' ' 183' ' ' ASP . 88.1 mt -116.28 117.66 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 120.998 0.427 . . . . 0.0 111.28 -178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -120.73 -18.9 7.56 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.121 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.3 p -128.96 164.21 23.65 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.403 -176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -60.87 -29.5 69.58 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.262 0.553 . . . . 0.0 109.531 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -63.58 -41.35 98.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.335 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.652 ' HB2' HG23 ' A' ' 178' ' ' ILE . 72.6 m-20 -64.21 -28.4 69.71 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.703 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.486 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 96.4 mt -61.54 -45.25 94.96 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.546 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -62.09 -42.66 99.43 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.747 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.43 -49.84 76.24 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.456 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -62.76 -42.54 99.73 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.315 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.546 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 8.0 pt-20 -68.15 -33.98 75.48 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.9 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.492 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -63.67 -41.42 98.18 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 120.731 0.3 . . . . 0.0 111.35 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -77.2 -31.17 55.14 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.131 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 69.3 tp -64.42 -45.08 89.1 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-O 121.483 0.658 . . . . 0.0 110.165 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -66.1 -37.71 86.44 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.654 176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -58.1 -41.68 84.05 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -173.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -74.19 -3.59 30.79 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.382 -176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -63.16 -39.32 97.81 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 174.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.27 2.15 0 CA-C-O 117.675 -1.155 . . . . 0.0 110.871 178.581 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' HG23 ' A' ' 42' ' ' VAL . 54.2 tpp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.639 0.257 . . . . 0.0 110.74 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -113.93 166.19 11.83 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.533 ' HB1' HD13 ' A' ' 37' ' ' LEU . . . -114.6 130.86 56.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.261 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.9 tp -105.42 124.21 49.17 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.614 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -118.71 101.05 11.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.7 ptm -91.76 106.2 18.29 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 122.851 1.31 . . . . 0.0 111.984 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -115.05 103.75 11.21 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.585 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -161.59 -166.9 21.21 Favored Glycine 0 C--N 1.292 -1.865 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.65 139.01 29.52 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.958 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -85.6 80.57 8.98 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.811 0.339 . . . . 0.0 111.261 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.14 -62.61 3.34 Favored Glycine 0 CA--C 1.518 0.224 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.905 178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.0 m -101.1 125.23 47.7 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -80.73 -11.5 59.61 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.2 mtt -123.96 145.73 48.96 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.655 0.265 . . . . 0.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 147.39 173.99 18.99 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.634 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -100.34 16.77 57.7 Favored Glycine 0 C--O 1.239 0.441 0 N-CA-C 111.631 -0.588 . . . . 0.0 111.631 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.34 165.11 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.204 0.526 . . . . 0.0 111.487 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.511 ' OE2' ' HG3' ' A' ' 181' ' ' LYS . 24.5 mp0 -70.34 144.43 51.65 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.274 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 97.7 mttt -123.04 157.27 61.05 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.451 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 19' ' ' LYS . 27.5 Cg_endo -61.13 -15.72 41.42 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.174 2.583 . . . . 0.0 114.346 -176.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 59' ' ' TYR . 44.4 mt -92.69 5.87 49.5 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.723 HG21 HD21 ' A' ' 184' ' ' LEU . 77.2 mt -76.73 118.55 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 C-N-CA 119.446 -0.902 . . . . 0.0 108.93 178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 25.1 pttm -76.75 130.62 37.96 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 114.191 -1.368 . . . . 0.0 113.056 -175.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 188' ' ' GLU . 81.8 mt -127.75 125.43 39.91 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 113.544 -1.662 . . . . 0.0 109.522 177.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 79.8 m 54.31 28.88 9.9 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.61 -18.21 35.32 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 120.873 -0.68 . . . . 0.0 114.764 176.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HB3' ' HB2' ' A' ' 31' ' ' ASP . 98.8 mtt180 -129.77 153.35 48.3 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 118.181 0.99 . . . . 0.0 112.435 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 61.2 m -80.16 164.4 23.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 176.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 95.8 mt -59.32 -39.24 82.46 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 120.793 0.33 . . . . 0.0 110.87 -176.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.453 HG13 HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -62.75 -39.76 86.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.728 178.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HB2' ' HB3' ' A' ' 27' ' ' ARG . 21.2 m-20 -62.29 -40.93 97.9 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 121.153 0.501 . . . . 0.0 110.497 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 10.1 m-85 -63.04 -37.14 86.02 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.693 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 88.6 t -69.67 -42.41 80.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.175 0.512 . . . . 0.0 110.766 177.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 30' ' ' ILE . 67.7 t -63.35 -44.42 99.02 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.777 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.0 m -53.58 -51.94 71.57 Favored Pre-proline 0 CA--C 1.565 1.527 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -64.37 -38.17 35.68 Favored 'Trans proline' 0 C--N 1.364 1.364 0 C-N-CA 121.531 1.487 . . . . 0.0 112.082 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.7 HD11 HG11 ' A' ' 98' ' ' VAL . 93.1 mt -68.45 -40.04 81.23 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-O 121.401 0.619 . . . . 0.0 110.782 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 55.0 tp -58.65 -44.04 89.99 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.398 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -84.03 -14.73 49.87 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.538 ' OG ' HG12 ' A' ' 42' ' ' VAL . 85.5 p -74.37 172.35 12.06 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.973 0.416 . . . . 0.0 111.301 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.8 ttpp -65.49 -7.06 12.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.7 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG12 ' OG ' ' A' ' 40' ' ' SER . 12.2 p -71.24 144.98 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 O-C-N 122.183 -0.323 . . . . 0.0 110.771 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -82.33 -72.37 0.44 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -104.57 147.08 28.01 Favored 'General case' 0 CA--C 1.499 -0.992 0 CA-C-O 121.528 0.68 . . . . 0.0 111.656 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.2 mm -109.09 113.66 44.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.693 -1.139 . . . . 0.0 108.61 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 91.6 m-85 -103.31 115.17 30.04 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -95.21 116.46 36.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-O 121.7 0.762 . . . . 0.0 110.368 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -89.9 118.8 29.75 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 114.039 -1.437 . . . . 0.0 110.245 -177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.4 p -129.63 158.15 40.13 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.454 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 63.3 m -105.63 148.84 37.11 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.376 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 52.6 Cg_exo -58.07 -24.99 68.79 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.06 2.507 . . . . 0.0 111.085 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -77.92 -5.89 52.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.185 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -139.84 66.87 34.47 Favored Pre-proline 0 N--CA 1.436 -1.14 0 CA-C-O 119.401 -0.333 . . . . 0.0 111.879 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.666 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 96.1 Cg_endo -105.8 86.57 0.02 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.813 0 CA-C-N 120.982 1.386 . . . . 0.0 109.653 168.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 38.7 mmtm -155.61 -46.18 0.08 Allowed 'General case' 1 C--N 1.212 -5.405 0 CA-C-N 109.709 -3.405 . . . . 0.0 102.443 179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 21' ' ' LEU . 97.9 m -63.99 -49.31 72.99 Favored 'General case' 0 N--CA 1.381 -3.9 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 162.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.666 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -63.59 -51.28 66.0 Favored 'General case' 0 C--N 1.358 0.939 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.11 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.3 pt-20 -63.66 -29.4 70.64 Favored 'General case' 0 C--N 1.37 1.469 0 C-N-CA 116.639 -2.024 . . . . 0.0 112.907 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.562 ' CD2' HD22 ' A' ' 21' ' ' LEU . 55.8 t80 -64.96 -50.37 66.66 Favored 'General case' 0 CA--C 1.506 -0.75 0 CA-C-O 121.434 0.635 . . . . 0.0 110.623 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.453 HD11 HG13 ' A' ' 30' ' ' ILE . 98.0 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.0 -176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -57.63 -45.97 84.75 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.902 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 42.3 t -67.04 -42.45 84.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.547 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.03 92.85 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.166 -177.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.516 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 45.8 m-85 -115.84 37.98 3.46 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.059 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.6 mmmm -60.68 -24.21 65.44 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.162 0.506 . . . . 0.0 111.057 178.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.67 10.47 25.63 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.46 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.609 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.2 p90 -45.02 131.4 7.36 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -102.5 -48.92 4.0 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.597 174.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -118.28 16.35 13.97 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.786 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.9 mt -107.62 131.06 58.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-O 121.117 0.484 . . . . 0.0 110.512 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 74.3 t -125.17 133.05 70.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.27 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.0 p -105.43 130.46 56.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-O 121.314 0.578 . . . . 0.0 110.313 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.453 HG13 ' HA ' ' A' ' 48' ' ' ALA . 41.5 pt -127.88 156.53 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.223 0 CA-C-O 121.967 0.889 . . . . 0.0 111.37 -176.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.01 130.76 55.49 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 113.972 -1.467 . . . . 0.0 109.435 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.417 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 11.2 t -158.06 -173.24 4.25 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.734 0.778 . . . . 0.0 112.891 -178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 78' ' ' LYS . 49.2 m -71.53 2.09 5.57 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 126.472 1.909 . . . . 0.0 114.637 -173.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.607 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.67 -23.73 0.0 OUTLIER Glycine 1 N--CA 1.521 4.331 0 C-N-CA 126.462 1.982 . . . . 0.0 117.393 -173.664 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 12.1 tmtt? -56.17 -36.48 68.37 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 172.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -110.73 122.4 6.2 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 108.488 -1.845 . . . . 0.0 108.488 173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -60.27 -51.05 71.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -170.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 47.9 pt -77.68 -28.64 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 C-N-CA 119.119 -1.032 . . . . 0.0 111.802 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.91 -41.68 99.53 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.607 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 14.0 t0 -60.2 -51.48 69.4 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.049 175.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -57.71 -43.71 85.43 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.09 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.538 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.5 m-80 -60.29 -41.33 93.17 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.417 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 70.3 mm-40 -63.95 -46.95 82.39 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.121 -0.632 . . . . 0.0 109.375 177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 96.1 m -62.71 -42.99 99.93 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.351 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 85' ' ' ASN . 37.2 pt -65.46 -30.6 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 120.962 0.41 . . . . 0.0 110.431 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.44 -39.29 95.65 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.582 -0.818 . . . . 0.0 113.245 176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -82.01 -36.78 27.46 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -176.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.517 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 75.2 m-85 -71.31 146.53 48.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.19 0.519 . . . . 0.0 111.801 -177.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -102.06 -10.61 19.55 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.369 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -138.46 160.32 64.13 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.667 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.77 142.45 41.53 Favored 'Trans proline' 0 C--O 1.241 0.665 0 C-N-CA 123.27 2.647 . . . . 0.0 112.307 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -142.99 155.62 44.7 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.057 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.695 HD12 ' O ' ' A' ' 155' ' ' ASN . 42.4 tp -86.37 143.91 27.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.221 -178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 66.5 t -115.49 133.79 60.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 108.93 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.7 HG11 HD11 ' A' ' 37' ' ' LEU . 11.1 m -129.98 164.82 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-O 121.371 0.605 . . . . 0.0 112.225 -178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.58 ' HB2' ' CD1' ' A' ' 102' ' ' LEU . 50.6 m -99.21 152.79 19.51 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 171.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 84.0 p -73.61 -10.79 60.07 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.605 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 45.4 p-10 -117.23 16.55 14.87 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 -174.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.58 ' CD1' ' HB2' ' A' ' 99' ' ' SER . 11.0 mp -61.54 153.13 28.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.166 0.508 . . . . 0.0 111.798 175.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -118.89 174.1 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.686 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 105' ' ' LEU . 65.6 t30 -63.68 162.59 12.9 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.013 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 104' ' ' ASN . 51.5 tp 82.52 3.28 1.15 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.576 1.151 . . . . 0.0 110.213 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 106' ' ' LYS . 0.1 OUTLIER -94.02 -1.23 54.81 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.604 179.227 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.501 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -62.21 -24.73 67.39 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.155 0.502 . . . . 0.0 111.786 -179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.98 -20.91 61.65 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.15 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.455 HD11 ' HG3' ' A' ' 173' ' ' GLU . 28.5 mm -68.57 -41.42 82.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 107' ' ' SER . 61.7 mt -60.99 -44.46 98.25 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.204 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -62.41 -46.84 86.77 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 121.716 0.769 . . . . 0.0 109.03 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.3 m -64.15 -42.62 96.7 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.026 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.637 HG13 ' N ' ' A' ' 114' ' ' VAL . 36.0 pt -67.76 -43.35 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.637 ' N ' HG13 ' A' ' 113' ' ' ILE . 62.9 t -62.44 -49.15 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.824 -178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -62.55 -45.36 93.3 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.464 -0.494 . . . . 0.0 112.247 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.709 ' CE2' HD11 ' A' ' 120' ' ' ILE . 54.2 t80 -65.84 -46.12 79.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.623 0.249 . . . . 0.0 110.918 -177.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -58.8 -47.9 83.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.965 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.408 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 15.8 m-85 -61.81 -39.22 90.98 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.081 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 93.2 m -63.72 -40.37 96.6 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.672 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -66.85 -47.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.521 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 124' ' ' THR . 54.6 pttt -65.15 -26.26 68.1 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.418 -0.513 . . . . 0.0 111.302 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.04 99.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.918 0.39 . . . . 0.0 110.455 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 65.3 pttt -83.24 -34.04 25.93 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.125 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 50.7 m -139.52 97.42 8.34 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.663 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.53 -11.77 31.87 Favored 'Trans proline' 0 N--CA 1.476 0.495 0 C-N-CA 122.933 2.422 . . . . 0.0 112.856 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.29 -32.7 73.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.901 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.547 HG21 ' HG2' ' A' ' 167' ' ' GLU . 7.6 p -87.29 122.41 39.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.975 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.639 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 41.6 mt-10 -127.38 19.15 6.89 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.111 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -142.19 148.75 38.72 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.626 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.0 tp -139.63 148.08 41.95 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.816 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -126.8 136.18 52.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.09 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.554 HG12 ' HB3' ' A' ' 152' ' ' ALA . 99.2 t -111.12 115.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.244 0.545 . . . . 0.0 109.722 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.549 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -145.61 157.46 43.97 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.775 -176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 152' ' ' ALA . 17.0 pt -134.97 155.51 79.14 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.758 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -60.11 137.05 73.02 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.356 2.037 . . . . 0.0 110.797 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 139' ' ' TYR . 14.6 ptmm? -69.93 -16.35 63.2 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.1 -38.93 90.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -89.91 -15.03 32.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.476 0.655 . . . . 0.0 110.434 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 136' ' ' LYS . 50.7 t80 -82.77 112.94 41.58 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.986 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.42 -27.77 22.92 Favored 'Trans proline' 0 N--CA 1.479 0.649 0 C-N-CA 123.083 2.522 . . . . 0.0 115.905 -172.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -130.54 78.94 73.18 Favored Pre-proline 0 C--N 1.316 -0.871 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -175.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.61 148.26 41.81 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.301 2.668 . . . . 0.0 112.825 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.7 m -131.31 150.95 51.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.066 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 54.2 mt 69.94 114.63 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.831 0.852 . . . . 0.0 111.282 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.27 135.68 47.57 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 46.3 t80 83.31 -7.94 1.13 Allowed 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -63.08 -37.84 88.81 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.546 178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 81.76 -41.8 2.75 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.429 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 pp -107.75 154.29 21.72 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.417 HG21 ' CG ' ' A' ' 139' ' ' TYR . 30.5 m -130.0 149.21 72.52 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.414 -178.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.34 143.92 60.07 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.183 1.922 . . . . 0.0 110.456 177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.554 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -112.27 4.98 18.09 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 164.54 -97.98 0.15 Allowed Glycine 0 N--CA 1.431 -1.674 0 C-N-CA 118.759 -1.686 . . . . 0.0 114.346 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.628 HD12 HD21 ' A' ' 96' ' ' LEU . 15.0 pt -130.17 160.85 40.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -172.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.695 ' O ' HD12 ' A' ' 96' ' ' LEU . 5.0 m-20 -123.74 158.78 30.9 Favored 'General case' 0 C--O 1.207 -1.158 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.155 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 92.1 t -121.46 129.58 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -134.29 156.04 40.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.638 0.732 . . . . 0.0 112.06 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 33.3 t -98.28 146.48 31.61 Favored Pre-proline 0 C--N 1.306 -1.311 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.528 176.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.01 66.99 4.1 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.691 2.261 . . . . 0.0 112.549 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -91.37 175.81 6.79 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -104.7 -11.63 16.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.268 0.556 . . . . 0.0 109.732 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -122.45 -156.28 9.61 Favored Glycine 0 N--CA 1.44 -1.088 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.838 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -106.7 134.34 49.99 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.342 0.591 . . . . 0.0 109.987 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.431 HE21 ' H ' ' A' ' 158' ' ' SER . 20.1 pm0 -121.2 167.19 12.96 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.254 -173.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -55.18 130.08 40.71 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.321 0.581 . . . . 0.0 112.151 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -123.52 132.55 53.94 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.259 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.547 ' HG2' HG21 ' A' ' 127' ' ' VAL . 25.5 mm-40 -96.75 162.6 13.36 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 121.603 0.716 . . . . 0.0 111.967 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.019 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.0 ttp -128.74 129.94 46.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.266 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 133' ' ' MET . 89.6 t -102.23 129.3 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' A' ' 173' ' ' GLU . 50.0 pt -110.55 174.72 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.42 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -103.57 0.65 31.13 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.692 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.549 ' HB2' HD12 ' A' ' 171' ' ' ILE . 79.1 mm-40 -98.51 139.38 34.33 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.776 0.798 . . . . 0.0 112.641 -176.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -96.29 143.89 26.96 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.628 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 2.7 pp -130.6 155.6 41.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.88 111.04 19.86 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.876 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.605 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 26.5 t-20 -91.02 109.58 20.83 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 174.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.474 ' HA ' ' OD2' ' A' ' 183' ' ' ASP . 51.4 mm -66.26 123.84 20.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.431 0.634 . . . . 0.0 112.652 -172.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.45 -36.43 8.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.674 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.466 ' H ' ' HB3' ' A' ' 183' ' ' ASP . 61.5 p -137.72 165.74 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.599 0.237 . . . . 0.0 111.469 -177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.511 ' HG3' ' OE2' ' A' ' 18' ' ' GLU . 15.1 mtmm -62.03 -37.37 84.64 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.641 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -63.44 -40.62 97.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.005 0.431 . . . . 0.0 110.272 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.474 ' OD2' ' HA ' ' A' ' 178' ' ' ILE . 38.8 t70 -64.57 -38.92 92.69 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.723 HD21 HG21 ' A' ' 22' ' ' ILE . 54.2 tp -59.3 -46.89 87.33 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.275 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.568 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.9 ttpt -62.5 -40.63 97.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.338 176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 64.7 tp -59.53 -49.03 79.34 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.294 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.499 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.79 -41.23 97.46 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.775 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.675 ' HB3' HD22 ' A' ' 24' ' ' LEU . 13.6 pt-20 -72.42 -36.14 68.52 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.855 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.4 ptm -71.61 -32.53 68.1 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.37 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.6 pp -72.15 -28.66 63.38 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 120.389 -0.525 . . . . 0.0 110.761 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 85.6 mt -61.62 -44.99 95.96 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.491 0.662 . . . . 0.0 109.802 176.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -68.07 -45.3 74.21 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.758 177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.15 -44.59 96.27 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.774 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -88.98 -4.86 58.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 120.91 0.386 . . . . 0.0 111.689 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -90.23 -7.04 68.13 Favored Glycine 0 N--CA 1.436 -1.304 0 C-N-CA 120.273 -0.965 . . . . 0.0 110.742 175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.2 tt . . . . . 0 C--O 1.261 1.7 0 CA-C-O 117.385 -1.293 . . . . 0.0 110.347 -178.491 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' HG23 ' A' ' 42' ' ' VAL . 58.8 ttm . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -113.42 164.41 13.64 Favored 'General case' 0 CA--C 1.504 -0.812 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -114.25 140.47 48.56 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.097 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 28.4 tp -115.63 120.61 39.97 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.512 ' HA ' ' HB ' ' A' ' 98' ' ' VAL . 69.4 mt -111.71 108.72 26.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.528 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 60.4 ttm -80.25 104.8 11.05 Favored 'General case' 0 N--CA 1.398 -3.051 0 CA-C-O 121.643 0.735 . . . . 0.0 110.583 -178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.624 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -112.43 97.78 6.84 Favored 'General case' 0 N--CA 1.429 -1.521 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.745 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.16 174.85 43.64 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.493 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.439 ' N ' HG21 ' A' ' 53' ' ' THR . . . -82.27 147.59 25.96 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.297 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 60.47 39.22 18.59 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.79 0.436 . . . . 0.0 112.165 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' A' ' 16' ' ' GLY . . . -92.29 -143.84 13.01 Favored Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER 55.99 -144.32 0.68 Allowed 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 116.808 0.304 . . . . 0.0 110.65 177.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 12' ' ' THR . 67.6 ttt180 -136.86 142.66 42.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.1 mmt 73.41 -74.64 0.08 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.881 0.872 . . . . 0.0 111.282 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -130.08 86.42 0.31 Allowed Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.494 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 11' ' ' GLY . . . -69.19 151.64 51.36 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.127 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -80.22 127.45 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 120.865 0.364 . . . . 0.0 110.489 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.405 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 44.8 tt0 -66.13 -40.89 91.02 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.792 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 22' ' ' ILE . 17.0 tppt? -113.09 98.54 46.16 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-O 120.877 0.37 . . . . 0.0 111.832 -176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 18' ' ' GLU . 23.8 Cg_exo -68.54 -12.78 35.73 Favored 'Trans proline' 0 N--CA 1.476 0.492 0 C-N-CA 123.301 2.667 . . . . 0.0 111.664 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 56' ' ' THR . 73.3 mt -92.3 14.05 17.49 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 19' ' ' LYS . 46.4 mm -63.09 125.71 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 61.3 mttp -95.28 133.64 38.95 Favored 'General case' 0 C--N 1.268 -2.965 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.819 -172.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' O ' ' HE2' ' A' ' 32' ' ' TYR . 56.6 tp -130.08 121.5 26.5 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-N 113.316 -1.766 . . . . 0.0 108.565 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.0 t 58.04 27.04 14.29 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 121.393 0.616 . . . . 0.0 110.73 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.31 -8.87 69.62 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.012 -0.614 . . . . 0.0 114.548 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.592 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 85.9 mtt180 -117.07 155.03 29.96 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 118.169 0.985 . . . . 0.0 110.717 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.454 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 72.2 m -82.08 163.15 22.24 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.834 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.503 HD21 ' CG1' ' A' ' 178' ' ' ILE . 83.7 mt -59.22 -44.48 92.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 110.256 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.507 HD13 HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -62.75 -36.82 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.77 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -63.45 -45.23 91.82 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 121.337 0.589 . . . . 0.0 110.4 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 8.5 m-85 -65.72 -30.19 70.82 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.553 177.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.549 HG21 ' HA ' ' A' ' 100' ' ' SER . 66.6 t -70.1 -43.23 79.2 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 120.649 0.261 . . . . 0.0 111.574 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.507 HG23 HD13 ' A' ' 30' ' ' ILE . 79.8 t -65.34 -43.58 94.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.541 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 67.5 m -50.59 -53.58 44.61 Favored Pre-proline 0 CA--C 1.56 1.351 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -173.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 33.8 Cg_exo -62.4 -41.28 34.3 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 121.931 1.754 . . . . 0.0 112.286 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.87 -42.32 90.51 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -60.89 -45.37 94.87 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.757 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HG2' ' O ' ' A' ' 35' ' ' SER . 64.1 pttt -80.98 -9.31 59.86 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.58 ' OG ' HG12 ' A' ' 42' ' ' VAL . 84.2 p -77.85 175.55 9.9 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 111.514 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.16 -22.12 60.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.141 -177.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.58 HG12 ' OG ' ' A' ' 40' ' ' SER . 12.7 p -66.07 145.03 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.671 -177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -78.37 -79.0 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -173.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -102.6 152.48 21.13 Favored 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.451 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.4 mm -110.06 116.42 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.118 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' LEU . 93.8 m-85 -106.93 117.09 33.15 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.639 HG21 HD13 ' A' ' 60' ' ' ILE . 94.7 mt -98.74 118.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.527 0.68 . . . . 0.0 110.576 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.487 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -86.23 116.4 24.39 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 114.213 -1.358 . . . . 0.0 109.795 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.483 HG23 HG22 ' A' ' 47' ' ' ILE . 66.3 p -127.28 162.87 25.22 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.028 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.5 p -129.44 157.25 76.9 Favored Pre-proline 0 C--N 1.296 -1.746 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.906 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.69 -19.09 67.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.834 2.356 . . . . 0.0 110.896 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -70.92 -24.95 62.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.744 177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.439 HG21 ' N ' ' A' ' 9' ' ' GLY . 0.9 OUTLIER -141.16 67.33 26.3 Favored Pre-proline 0 N--CA 1.436 -1.144 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -179.608 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.624 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 66.6 Cg_endo -103.87 85.45 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.683 0 C-N-CA 117.172 -1.419 . . . . 0.0 109.906 169.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.632 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 36.0 mmtm -148.99 -44.98 0.14 Allowed 'General case' 1 C--N 1.215 -5.272 0 CA-C-N 109.605 -3.452 . . . . 0.0 102.638 179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.624 HG21 ' HB1' ' A' ' 7' ' ' ALA . 96.8 m -63.16 -47.77 81.26 Favored 'General case' 1 N--CA 1.379 -4.006 0 CA-C-N 112.307 -2.224 . . . . 0.0 105.773 163.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.08 -51.19 68.95 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.796 178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.632 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.7 pt-20 -64.58 -30.73 71.75 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 117.388 -1.725 . . . . 0.0 112.341 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -62.91 -50.21 71.74 Favored 'General case' 0 C--O 1.212 -0.894 0 CA-C-O 121.071 0.462 . . . . 0.0 111.18 175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.639 HD13 HG21 ' A' ' 47' ' ' ILE . 97.5 mt -62.68 -42.75 97.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.964 -176.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -58.25 -41.38 84.08 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.574 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.671 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 34.8 t -73.74 -43.31 59.48 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.157 0.503 . . . . 0.0 111.233 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.7 -38.53 90.8 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.337 0.589 . . . . 0.0 111.105 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.459 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 58.1 m-85 -114.44 42.59 2.07 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.002 -177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.671 ' HG3' ' O ' ' A' ' 62' ' ' SER . 38.1 mtmm -59.82 -26.79 66.07 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.028 0.442 . . . . 0.0 110.971 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -87.42 10.13 18.5 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.055 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.479 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 53.8 p90 -44.59 122.77 3.27 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.47 -49.44 3.7 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.36 171.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -110.26 7.74 23.26 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.095 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 4.8 mp -100.31 119.62 48.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.257 0.551 . . . . 0.0 110.028 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 78.3 t -120.55 129.81 75.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.312 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.7 p -102.9 132.51 48.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.487 HG13 ' HA ' ' A' ' 48' ' ' ALA . 38.9 pt -123.66 154.74 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-O 121.161 0.505 . . . . 0.0 109.95 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -117.08 127.82 54.53 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.3 t -155.96 -167.98 2.63 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 71.0 m -67.81 2.41 1.98 Allowed 'General case' 0 C--O 1.209 -1.075 0 C-N-CA 126.633 1.973 . . . . 0.0 114.22 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.19 -16.62 0.0 OUTLIER Glycine 0 N--CA 1.516 3.971 0 C-N-CA 126.693 2.092 . . . . 0.0 117.376 -175.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 14.2 tmtt? -58.61 -38.45 78.04 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 171.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.6 127.48 7.73 Favored Glycine 0 N--CA 1.435 -1.381 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.459 176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -59.97 -49.91 75.82 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.093 0.473 . . . . 0.0 111.987 -176.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 49.5 mm -63.83 -47.49 90.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 CA-C-O 121.547 0.689 . . . . 0.0 110.294 -178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 53.6 mt-10 -60.91 -43.28 98.79 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.446 -1.252 . . . . 0.0 110.784 -178.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.528 ' CG ' ' HE2' ' A' ' 6' ' ' MET . 7.4 t0 -60.05 -50.77 72.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.116 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -59.62 -42.87 93.66 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.169 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 88' ' ' ILE . 10.1 m120 -60.56 -42.02 95.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.257 0.551 . . . . 0.0 111.053 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 66.0 mm-40 -65.58 -45.65 82.46 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.0 m -63.57 -41.82 98.35 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.497 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 84' ' ' LEU . 38.1 pt -65.92 -29.88 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 120.97 0.414 . . . . 0.0 110.081 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.41 96.56 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.941 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -71.9 -40.12 69.06 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.472 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.1 m-85 -79.01 154.08 29.77 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.8 m -113.24 -4.52 13.72 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.997 174.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' N ' ' HG3' ' A' ' 159' ' ' PRO . 40.0 mt-10 -132.74 156.02 80.55 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.275 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -53.44 140.0 64.41 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.207 2.604 . . . . 0.0 111.649 177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -141.55 156.7 45.69 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.34 0.591 . . . . 0.0 110.748 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.558 HD11 HD12 ' A' ' 154' ' ' ILE . 24.3 tp -87.53 144.4 26.72 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.029 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 93.7 t -107.14 125.89 63.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 5' ' ' ILE . 60.8 t -130.47 141.11 47.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.5 m -96.09 142.49 28.22 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.782 174.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.549 ' HA ' HG21 ' A' ' 33' ' ' VAL . 67.9 m -89.45 0.78 56.62 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -104.93 -4.2 22.41 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.552 HD23 ' HB3' ' A' ' 177' ' ' ASN . 75.2 mt -82.6 136.63 34.76 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.278 0.49 . . . . 0.0 110.599 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.8 pt -75.67 -174.24 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-O 120.953 0.406 . . . . 0.0 111.35 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -78.53 71.18 4.98 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -176.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.39 -3.84 4.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.413 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 11.7 ptmm? -88.38 -2.24 58.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.217 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 p -60.99 -41.57 96.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -80.43 -22.44 41.16 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.895 0.855 . . . . 0.0 109.725 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' HG12 ' A' ' 113' ' ' ILE . 38.4 mm -67.7 -37.61 78.91 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.953 -174.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 106' ' ' LYS . 64.4 mt -57.26 -50.0 78.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.064 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -70.74 -39.65 73.2 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.172 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.8 m -63.36 -42.95 98.91 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.07 -177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.2 mm -64.39 -44.78 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 CA-C-O 121.094 0.473 . . . . 0.0 110.603 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 63.8 t -60.44 -46.71 94.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.273 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -60.75 -46.1 91.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.657 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CE2' HD11 ' A' ' 120' ' ' ILE . 31.8 t80 -70.19 -41.82 73.2 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.2 -177.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 71.5 t80 -59.18 -48.35 81.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.903 0.382 . . . . 0.0 110.509 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.571 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 21.3 m-85 -62.88 -35.5 80.22 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.658 178.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 52.4 t -60.8 -47.5 86.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.966 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.605 HD11 ' CE2' ' A' ' 116' ' ' TYR . 70.5 mt -66.45 -49.37 75.91 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.756 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.484 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 16.0 ptmt -65.34 -25.85 67.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.965 -178.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.87 -41.56 98.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.949 0.404 . . . . 0.0 110.27 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 120' ' ' ILE . 63.6 pttt -85.69 -36.83 19.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.309 178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.564 ' O ' HG12 ' A' ' 127' ' ' VAL . 32.0 m -130.9 96.21 23.46 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.154 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.91 -14.2 40.6 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.918 2.412 . . . . 0.0 113.197 -177.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -63.47 -32.94 74.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.889 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.587 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -75.79 120.53 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-O 121.606 0.717 . . . . 0.0 110.625 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.684 ' HB3' ' HB2' ' A' ' 158' ' ' SER . 45.8 mt-10 -123.04 15.0 9.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.872 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.71 150.07 33.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.931 177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.456 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -140.86 135.04 30.94 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.034 -177.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.33 140.84 51.65 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.727 177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 152' ' ' ALA . 14.8 p -123.22 135.95 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.235 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 75.1 mtm -134.47 158.02 44.98 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.747 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 152' ' ' ALA . 9.9 pt -130.12 154.55 81.33 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.516 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -58.21 134.91 64.84 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.62 2.213 . . . . 0.0 113.253 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -60.83 -37.57 82.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.813 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -59.67 -37.03 77.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.343 -0.844 . . . . 0.0 113.005 -173.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -99.82 -16.45 18.06 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.178 -0.609 . . . . 0.0 112.091 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.515 ' CG ' HG21 ' A' ' 150' ' ' VAL . 55.6 t80 -64.77 137.23 97.08 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.5 -70.77 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.674 2.249 . . . . 0.0 112.651 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -167.33 141.0 2.96 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.21 -21.15 27.37 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.85 2.367 . . . . 0.0 112.494 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.515 ' HA ' ' OD1' ' A' ' 179' ' ' ASN . 13.9 p -176.73 -66.85 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.196 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 85.6 mt -142.59 -66.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.269 174.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -150.87 86.52 1.38 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.282 0.563 . . . . 0.0 111.794 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.28 152.53 47.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.43 176.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -111.81 130.93 55.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.999 0.428 . . . . 0.0 111.13 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 165.55 -174.79 41.33 Favored Glycine 0 N--CA 1.441 -0.967 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.8 mp -89.72 144.68 25.78 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.223 0.512 . . . . 0.0 110.334 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.515 HG21 ' CG ' ' A' ' 139' ' ' TYR . 35.9 m -115.64 148.94 42.17 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.289 -176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.25 148.74 56.16 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.52 2.146 . . . . 0.0 111.517 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.62 ' HB3' HG13 ' A' ' 132' ' ' VAL . . . -91.75 -4.26 55.23 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.504 ' HA2' ' CD1' ' A' ' 102' ' ' LEU . . . 152.5 -75.06 0.24 Allowed Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.338 -1.411 . . . . 0.0 114.376 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.558 HD12 HD11 ' A' ' 96' ' ' LEU . 25.0 pt -128.32 161.49 36.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -173.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.629 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 11.5 t-20 -127.75 155.55 43.84 Favored 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.884 -177.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 91.9 t -120.97 130.3 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 O-C-N 122.167 -0.333 . . . . 0.0 110.691 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.45 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.2 m -133.1 154.24 39.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.656 0.741 . . . . 0.0 111.967 177.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.684 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 45.0 t -98.52 144.27 27.81 Favored Pre-proline 0 C--N 1.304 -1.373 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.115 175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.446 ' HG3' ' N ' ' A' ' 93' ' ' GLU . 72.2 Cg_endo -72.89 67.07 4.01 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.116 2.544 . . . . 0.0 113.35 -177.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 164' ' ' GLN . 69.0 mttm -99.99 -168.37 1.58 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -133.56 90.03 2.67 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.889 0.852 . . . . 0.0 109.221 172.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.41 -136.74 6.65 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -127.26 142.74 51.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.815 0.34 . . . . 0.0 110.347 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.449 ' HB3' ' HD2' ' A' ' 160' ' ' LYS . 18.6 pm0 -134.02 166.1 23.5 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.924 -177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -60.08 127.81 33.72 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.109 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -128.04 133.57 49.11 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.86 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -93.5 160.93 14.58 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-O 121.609 0.719 . . . . 0.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.6 128.87 75.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.192 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 61.7 ttp -127.35 135.21 50.19 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.677 175.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.14 126.63 71.68 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.547 HD11 ' HB1' ' A' ' 152' ' ' ALA . 50.4 pt -116.18 174.94 3.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.003 -178.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -117.66 21.5 12.93 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.143 0.496 . . . . 0.0 110.544 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' HB3' HD12 ' A' ' 171' ' ' ILE . 35.7 tp10 -98.33 133.17 43.11 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.8 mp -95.3 150.69 19.98 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.401 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 102' ' ' LEU . 5.0 pt -130.11 153.26 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.33 175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -125.69 144.48 50.59 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.552 ' HB3' HD23 ' A' ' 102' ' ' LEU . 28.4 p-10 -137.29 156.76 47.88 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.641 HD12 ' HA ' ' A' ' 184' ' ' LEU . 31.9 mm -94.97 81.09 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 121.546 0.688 . . . . 0.0 111.171 -176.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.515 ' OD1' ' HA ' ' A' ' 143' ' ' SER . 66.9 m-80 -65.96 -40.1 90.98 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.515 178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 182' ' ' ASP . 13.5 t -149.36 177.41 9.71 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.051 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -57.89 -28.35 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.932 0.493 . . . . 0.0 111.418 -178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.435 ' H ' HG23 ' A' ' 180' ' ' THR . 27.3 t70 -60.13 -46.77 88.53 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.49 0.662 . . . . 0.0 109.943 177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 44.7 m-20 -64.78 -35.67 81.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.212 178.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.641 ' HA ' HD12 ' A' ' 178' ' ' ILE . 59.8 tp -59.36 -45.32 91.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.833 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 12.9 mmtt -64.08 -38.23 90.32 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.774 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.04 -49.76 74.74 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.268 0.556 . . . . 0.0 109.524 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.534 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.1 -43.3 98.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.751 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 4.3 pt-20 -67.72 -34.12 76.23 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.461 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.431 ' N ' ' HG3' ' A' ' 188' ' ' GLU . 57.8 ttm -62.13 -45.49 93.24 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.692 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.4 pp -70.38 -37.16 74.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.366 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.58 -44.44 90.67 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.347 0.594 . . . . 0.0 110.53 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -64.86 -42.77 94.58 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.862 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.38 -39.9 94.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.766 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.77 -28.36 68.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.256 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.521 ' C ' HD13 ' A' ' 196' ' ' LEU . . . -94.13 7.56 72.77 Favored Glycine 0 C--N 1.311 -0.85 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.872 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.521 HD13 ' C ' ' A' ' 195' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.265 1.881 0 CA-C-O 117.274 -1.345 . . . . 0.0 113.935 -177.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.484 1.236 0 CA-C-O 120.751 0.31 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 37.0 m-20 -111.59 164.73 12.68 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 175.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . . . -113.8 132.03 56.01 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.881 -177.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.528 HD11 ' HB2' ' A' ' 48' ' ' ALA . 33.3 tp -106.32 125.66 51.27 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.024 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.625 ' HA ' HG22 ' A' ' 98' ' ' VAL . 69.4 mt -117.24 104.76 16.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.403 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 11.1 ptm -95.98 97.93 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.892 1.329 . . . . 0.0 112.042 -175.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.66 97.15 5.97 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.173 -1.831 . . . . 0.0 110.805 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.23 32.47 0.03 OUTLIER Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.765 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.6 142.95 16.43 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.442 -178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -133.79 147.47 51.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.2 -174.25 46.38 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.408 -0.901 . . . . 0.0 111.431 177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 48.3 p -67.75 -33.25 74.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.552 0.692 . . . . 0.0 109.999 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 5.8 tpm_? -137.18 129.12 29.11 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 67.4 mtt -67.01 137.89 56.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.952 0.406 . . . . 0.0 111.308 -175.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.52 5.96 2.78 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.602 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -103.87 -143.41 12.56 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.771 -0.728 . . . . 0.0 111.472 177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.99 86.31 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.803 0.811 . . . . 0.0 110.017 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.486 ' HG3' ' HG3' ' A' ' 19' ' ' LYS . 13.2 pt-20 -161.59 -164.64 1.15 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.731 -175.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 29.4 mtpp 61.4 72.02 0.72 Allowed Pre-proline 0 N--CA 1.473 0.685 0 CA-C-O 121.162 0.506 . . . . 0.0 111.127 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.33 -17.75 41.74 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 123.469 2.78 . . . . 0.0 113.474 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 56' ' ' THR . 41.5 mt -90.49 12.59 18.16 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 19' ' ' LYS . 93.5 mt -66.23 117.6 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 0.0 OUTLIER -82.16 134.79 35.33 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.8 -1.091 . . . . 0.0 110.675 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' A' ' 188' ' ' GLU . 46.6 tp -136.29 112.47 9.77 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.257 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.1 t 61.27 20.14 10.76 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.381 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.34 -23.2 5.8 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 119.837 -1.173 . . . . 0.0 115.422 176.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.762 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 90.5 mtt180 -131.06 158.75 39.52 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.579 1.19 . . . . 0.0 111.088 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 71.6 m -76.2 150.79 37.04 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.199 176.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 100' ' ' SER . 0.5 OUTLIER -49.22 -45.6 44.72 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 122.832 0.453 . . . . 0.0 111.298 -178.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.36 -38.0 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.233 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.685 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.7 t70 -64.03 -42.59 97.03 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.212 0.529 . . . . 0.0 109.867 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.762 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 28.2 m-85 -61.03 -38.08 84.83 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.738 177.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.0 t -65.45 -42.54 93.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.137 0.494 . . . . 0.0 110.671 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 30' ' ' ILE . 77.5 t -62.31 -43.34 97.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.566 -178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.576 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . 44.5 t -50.3 -57.94 11.32 Favored Pre-proline 0 CA--C 1.568 1.651 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 35' ' ' SER . 37.2 Cg_exo -62.07 -41.09 38.11 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 121.803 1.669 . . . . 0.0 112.359 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.697 HD11 HG11 ' A' ' 98' ' ' VAL . 90.5 mt -66.09 -42.11 89.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.184 -177.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.411 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.7 tt -63.37 -45.43 91.16 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.073 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -73.04 -15.92 61.5 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.406 ' CB ' HD13 ' A' ' 110' ' ' ILE . 71.6 p -70.57 172.51 8.44 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.246 0.546 . . . . 0.0 111.231 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -70.03 2.24 3.77 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.537 -176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 3' ' ' ALA . 9.7 p -72.67 152.89 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 O-C-N 122.182 -0.324 . . . . 0.0 111.137 -178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' C ' HD22 ' A' ' 44' ' ' ASN . 59.5 t30 -68.17 -79.62 0.05 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -121.04 163.96 17.51 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.238 0.542 . . . . 0.0 111.074 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -107.89 115.57 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.213 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.997 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -106.52 117.16 33.31 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.746 HG21 HD13 ' A' ' 60' ' ' ILE . 96.6 mt -97.58 118.09 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.745 0 CA-C-O 121.774 0.797 . . . . 0.0 110.743 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.4 122.92 33.08 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 113.931 -1.486 . . . . 0.0 109.853 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.467 HG22 ' O ' ' A' ' 7' ' ' ALA . 56.8 p -130.48 156.61 44.5 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.552 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 75' ' ' THR . 35.4 t -105.04 143.15 26.14 Favored Pre-proline 0 C--N 1.297 -1.679 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.283 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -56.79 -25.22 59.85 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 123.074 2.516 . . . . 0.0 111.033 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -80.44 -2.85 47.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.4 p -141.77 66.43 21.97 Favored Pre-proline 0 N--CA 1.44 -0.943 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.597 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.717 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 95.3 Cg_endo -105.14 86.36 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.144 0 C-N-CA 116.759 -1.694 . . . . 0.0 109.854 170.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.583 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 39.1 ttmt -148.84 -50.83 0.16 Allowed 'General case' 1 C--N 1.212 -5.386 0 CA-C-N 109.89 -3.323 . . . . 0.0 103.044 -179.724 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD11 ' A' ' 21' ' ' LEU . 86.4 m -62.07 -47.53 84.28 Favored 'General case' 0 N--CA 1.394 -3.248 0 CA-C-N 112.918 -1.946 . . . . 0.0 105.906 163.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.717 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.5 tttt -62.71 -47.96 81.34 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.949 176.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.583 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 10.4 pt-20 -57.23 -38.02 73.14 Favored 'General case' 0 C--N 1.369 1.431 0 C-N-CA 117.72 -1.592 . . . . 0.0 110.683 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -65.89 -51.62 57.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 CA-C-O 120.912 0.387 . . . . 0.0 111.714 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.746 HD13 HG21 ' A' ' 47' ' ' ILE . 97.0 mt -62.99 -46.26 96.78 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.505 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.589 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 65.1 t30 -59.25 -39.97 84.48 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.381 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 37.1 t -74.91 -47.43 29.87 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.358 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.31 87.95 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -108.82 14.83 24.01 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.635 -0.426 . . . . 0.0 112.015 -173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.0 pttt -62.9 -22.09 66.49 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -88.36 -1.19 57.89 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -102.81 128.54 49.53 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.943 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.9 OUTLIER -70.23 -41.25 73.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.834 -178.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.411 HD21 ' HG ' ' A' ' 38' ' ' LEU . 10.1 p-10 -80.17 -0.67 37.08 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 89.2 mt -108.06 122.67 62.79 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.515 0.674 . . . . 0.0 110.206 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 84.5 t -125.9 135.68 63.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.929 -175.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 p -106.95 131.03 57.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 121.061 0.458 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.6 pt -125.56 157.57 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-O 121.339 0.59 . . . . 0.0 111.814 -176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -102.32 133.32 47.43 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.389 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.641 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.2 t -161.77 -177.94 6.19 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 122.113 0.959 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.471 ' O ' ' N ' ' A' ' 78' ' ' LYS . 57.4 m -75.09 5.21 5.56 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 126.943 2.097 . . . . 0.0 113.158 -176.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.04 -19.62 0.0 OUTLIER Glycine 0 N--CA 1.513 3.793 0 C-N-CA 127.876 2.655 . . . . 0.0 118.134 -171.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 11.5 tmtt? -59.29 -38.85 81.2 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 171.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.91 127.12 8.56 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -62.2 -50.51 71.51 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 86.1 mt -65.17 -45.35 94.25 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.738 0 CA-C-O 121.872 0.844 . . . . 0.0 110.575 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -59.84 -43.57 94.55 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 113.997 -1.456 . . . . 0.0 110.378 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.2 t0 -58.4 -50.12 74.83 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.874 177.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.566 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -56.87 -41.86 78.74 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.041 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.496 ' HA ' HG12 ' A' ' 88' ' ' ILE . 23.0 m-80 -60.03 -43.72 95.13 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.641 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 62.7 mm-40 -66.74 -42.61 85.95 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.79 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 97.8 m -62.58 -42.52 99.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.49 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -67.95 -26.57 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.406 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.02 -38.64 96.95 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.929 175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -70.5 -40.06 73.79 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.01 150.66 27.5 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -172.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 46.1 m -111.75 -0.96 15.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.047 174.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 28.2 mt-10 -134.86 159.01 73.75 Favored Pre-proline 0 CA--C 1.508 -0.663 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.161 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 93' ' ' GLU . 36.5 Cg_endo -65.02 147.85 89.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.157 1.904 . . . . 0.0 111.124 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.485 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 51.2 p90 -141.69 162.13 36.23 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.588 0.709 . . . . 0.0 111.707 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.645 HD11 ' HB ' ' A' ' 154' ' ' ILE . 1.1 tm? -86.17 139.41 31.11 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.597 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.704 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 89.3 t -117.12 134.08 61.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.78 0.832 . . . . 0.0 108.857 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.697 HG11 HD11 ' A' ' 37' ' ' LEU . 8.6 m -127.79 159.88 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.246 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.6 m -100.19 135.3 41.83 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 172.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.546 ' O ' HD22 ' A' ' 29' ' ' LEU . 81.0 p -74.95 -12.03 60.25 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -102.32 3.28 37.87 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.636 HD22 HD12 ' A' ' 175' ' ' ILE . 70.0 mt -91.22 121.01 32.61 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.156 -0.617 . . . . 0.0 111.882 -177.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.577 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 86.2 mt -118.33 118.67 58.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.193 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 60.8 t30 166.87 168.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.676 0.79 . . . . 0.0 110.386 174.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 89.6 mt -77.18 93.48 3.95 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.546 0.689 . . . . 0.0 109.914 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HE3' HG13 ' A' ' 109' ' ' ILE . 31.8 mmmt -99.43 2.88 45.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.266 -176.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.618 ' HA ' HD12 ' A' ' 110' ' ' ILE . 71.9 p -53.65 -32.56 51.92 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -70.7 -27.78 64.25 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.745 0.783 . . . . 0.0 110.008 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.486 HG13 ' HE3' ' A' ' 106' ' ' LYS . 28.1 mm -71.57 -40.57 71.46 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.304 -175.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.618 HD12 ' HA ' ' A' ' 107' ' ' SER . 70.0 mt -60.4 -45.79 96.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.933 -177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -64.64 -43.37 93.89 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.436 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 41.9 t -61.9 -45.54 93.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.395 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.533 HG13 ' N ' ' A' ' 114' ' ' VAL . 42.6 pt -65.04 -41.57 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.533 ' N ' HG13 ' A' ' 113' ' ' ILE . 57.6 t -62.16 -49.13 85.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -64.98 -43.18 93.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.852 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.518 ' CE2' HD11 ' A' ' 120' ' ' ILE . 71.7 t80 -63.7 -49.48 72.93 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.054 0.454 . . . . 0.0 110.949 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.433 ' HB2' HD22 ' A' ' 130' ' ' LEU . 70.4 t80 -59.04 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.986 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.406 ' HD2' ' O ' ' A' ' 114' ' ' VAL . 28.1 m-85 -65.03 -31.83 73.25 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 50.3 t -62.02 -46.85 87.36 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.445 0.641 . . . . 0.0 109.421 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.659 HG22 HG11 ' A' ' 127' ' ' VAL . 71.6 mt -64.59 -43.54 96.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.352 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER -60.48 -41.74 94.86 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.279 -179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.44 -44.33 95.92 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.648 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -77.85 -32.42 52.1 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.999 0.428 . . . . 0.0 111.33 178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 127' ' ' VAL . 46.9 m -143.57 100.69 5.14 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.353 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -67.8 -13.75 39.55 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.8 2.333 . . . . 0.0 112.966 -177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -63.01 -32.73 74.15 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -71.37 129.56 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -128.45 4.6 5.66 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.637 -177.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.05 153.41 39.96 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.939 0.4 . . . . 0.0 111.374 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.433 HD22 ' HB2' ' A' ' 117' ' ' PHE . 23.4 tp -137.64 146.34 43.78 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.52 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.88 129.41 46.85 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.943 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 152' ' ' ALA . 63.9 t -105.06 115.11 46.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.466 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.3 ptm -145.82 157.53 43.91 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.19 -174.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 152' ' ' ALA . 14.5 pt -133.03 155.0 81.57 Favored Pre-proline 0 N--CA 1.444 -0.751 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.834 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -55.36 128.09 28.99 Favored 'Trans proline' 0 C--O 1.237 0.445 0 C-N-CA 122.361 2.04 . . . . 0.0 111.923 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' A' ' 142' ' ' PRO . 1.5 pptp? -69.38 -21.97 63.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.56 -36.46 83.84 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -87.26 -22.8 24.97 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.577 0.703 . . . . 0.0 109.92 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -63.45 133.61 95.56 Favored Pre-proline 0 C--N 1.3 -1.551 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.662 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.83 -36.65 83.5 Favored 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.569 2.846 . . . . 0.0 113.54 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -126.03 84.11 61.95 Favored Pre-proline 0 C--N 1.315 -0.928 0 CA-C-O 121.852 0.834 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.578 ' HB3' ' O ' ' A' ' 136' ' ' LYS . 74.2 Cg_endo -74.47 148.89 38.51 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.57 2.847 . . . . 0.0 113.508 -175.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.1 t -89.37 70.41 8.11 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.09 -38.47 82.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.607 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -56.54 -40.96 76.0 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.424 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -108.69 -13.05 14.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.711 0.291 . . . . 0.0 111.033 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 64.9 t30 55.73 39.28 30.81 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.928 0.87 . . . . 0.0 109.467 -176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.64 -160.4 28.87 Favored Glycine 0 N--CA 1.433 -1.546 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.073 -179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.58 152.96 21.12 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.934 0.397 . . . . 0.0 110.008 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m -117.85 124.14 29.05 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.809 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.47 136.76 77.92 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.993 1.795 . . . . 0.0 110.352 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -93.47 0.78 56.88 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.386 0.613 . . . . 0.0 110.617 -178.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.79 -91.26 0.08 OUTLIER Glycine 0 N--CA 1.419 -2.474 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.993 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.645 ' HB ' HD11 ' A' ' 96' ' ' LEU . 14.4 pt -139.66 162.12 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 CA-C-O 121.171 0.51 . . . . 0.0 112.173 -176.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.704 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 6.4 m120 -112.45 156.6 22.29 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.45 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 91.6 t -125.4 129.47 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 122.788 0.435 . . . . 0.0 109.889 176.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.2 m -137.35 155.27 31.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-O 121.048 0.451 . . . . 0.0 111.56 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.518 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 61.3 m -98.17 155.06 37.39 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.954 173.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 88' ' ' ILE . 72.4 Cg_endo -76.52 86.11 1.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.579 2.186 . . . . 0.0 111.519 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -108.54 -175.42 2.77 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.443 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -128.9 28.16 5.37 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.875 0.845 . . . . 0.0 109.627 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -167.12 -176.72 38.26 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -77.4 143.15 38.87 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 117.43 0.615 . . . . 0.0 109.545 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.518 ' OE1' ' HB2' ' A' ' 158' ' ' SER . 20.9 pt20 -130.06 161.31 31.29 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.754 -174.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -65.38 125.95 26.72 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.835 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.69 127.33 52.78 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.758 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -93.76 162.79 13.79 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-O 121.528 0.68 . . . . 0.0 111.716 177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -117.42 129.74 73.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.891 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 63.4 ttp -128.45 126.02 39.69 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.686 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.8 t -105.38 132.06 53.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 173' ' ' GLU . 43.3 pt -119.78 171.73 7.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 121.208 0.527 . . . . 0.0 111.211 -176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -109.02 13.94 24.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.451 177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.657 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.8 mm-40 -97.95 135.77 39.19 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 121.871 0.843 . . . . 0.0 111.278 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.4 mt -93.9 153.67 18.11 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.459 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.636 HD12 HD22 ' A' ' 102' ' ' LEU . 1.8 pt -132.78 151.02 33.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.386 174.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -118.12 116.94 27.86 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.474 ' HB3' HD23 ' A' ' 102' ' ' LEU . 31.0 p-10 -116.13 175.78 5.39 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.688 HD12 ' HA ' ' A' ' 184' ' ' LEU . 46.4 mm -116.3 120.13 64.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.975 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 -47.25 5.72 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.82 174.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.5 p -128.03 166.54 18.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.19 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -36.97 85.22 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.778 0.323 . . . . 0.0 110.699 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -60.35 -42.11 95.03 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.557 0.694 . . . . 0.0 109.754 174.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.58 -39.39 94.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.679 177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.688 ' HA ' HD12 ' A' ' 178' ' ' ILE . 57.8 tp -61.02 -42.36 98.31 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.486 176.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 61.4 tttp -61.56 -40.92 96.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.872 177.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 8.9 tt -60.9 -45.57 94.12 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.74 98.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.947 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 11.5 pt-20 -64.86 -37.75 88.69 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 120.374 -0.531 . . . . 0.0 110.526 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 193' ' ' LYS . 94.8 mmm -63.54 -39.65 94.97 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.979 0.418 . . . . 0.0 110.349 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 67.1 tp -62.6 -44.86 95.25 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.908 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.432 HD12 ' HG ' ' A' ' 24' ' ' LEU . 94.3 mt -64.14 -39.43 94.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.337 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 188' ' ' GLU . 99.3 mttt -61.89 -17.29 56.06 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.345 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 189' ' ' MET . 68.7 mttm -75.06 -8.01 55.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.01 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.64 -19.73 64.43 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.322 0.582 . . . . 0.0 109.804 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -101.82 -154.77 26.02 Favored Glycine 0 N--CA 1.438 -1.196 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.347 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.8 tp . . . . . 0 C--O 1.26 1.643 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.338 178.628 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 95' ' ' PHE . 59.8 tpp . . . . . 0 N--CA 1.477 0.921 0 CA-C-O 121.258 0.551 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -122.04 166.3 14.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.2 127.14 56.08 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.942 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.517 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.7 tp -101.48 126.21 48.24 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.677 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -119.08 107.97 22.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.598 ' O ' ' HB3' ' A' ' 100' ' ' SER . 60.6 ttm -80.93 98.07 7.72 Favored 'General case' 0 N--CA 1.409 -2.482 0 CA-C-O 121.513 0.673 . . . . 0.0 111.47 -178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.533 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.22 98.04 6.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.364 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 130.86 81.3 0.23 Allowed Glycine 0 C--N 1.308 -0.99 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.347 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.27 -154.24 11.46 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.171 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -101.63 -11.44 19.2 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.17 176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 69.05 -98.33 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.753 . . . . 0.0 111.904 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 14' ' ' MET . 84.9 m -64.39 139.82 58.8 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.1 mtm180 -60.51 -37.38 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.736 0.303 . . . . 0.0 111.368 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.444 ' H ' HG22 ' A' ' 12' ' ' THR . 24.3 mmt -79.49 -5.08 54.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.974 0.416 . . . . 0.0 111.05 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.61 179.47 42.11 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.131 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA3' ' OG ' ' A' ' 143' ' ' SER . . . 123.91 -122.97 5.04 Favored Glycine 0 N--CA 1.438 -1.17 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.786 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.612 HG11 ' ND2' ' A' ' 177' ' ' ASN . 12.7 p -65.41 142.45 16.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 19' ' ' LYS . 2.3 tm-20 169.49 -153.14 0.01 OUTLIER 'General case' 0 C--O 1.235 0.324 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.564 ' H ' ' CD ' ' A' ' 18' ' ' GLU . 55.9 mmtt 61.19 77.98 0.34 Allowed Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 121.488 0.661 . . . . 0.0 110.349 178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.52 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 27.4 Cg_endo -62.12 -4.75 5.43 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 123.905 3.07 . . . . 0.0 114.639 -175.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 33.0 mt -83.09 4.95 24.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.563 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 90.6 mt -71.68 126.11 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.532 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 170.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 62.9 pttt -115.11 143.18 45.6 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -172.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 184' ' ' LEU . 89.4 mt -127.47 140.25 52.27 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.263 -1.789 . . . . 0.0 109.735 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.7 m 48.42 35.43 5.8 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.74 -12.7 53.57 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 116.253 1.261 . . . . 0.0 116.253 174.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.23 161.28 38.67 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-N 119.476 1.638 . . . . 0.0 112.124 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 80.8 m -77.82 164.91 24.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.505 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 92.6 mt -58.35 -39.73 80.28 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.151 -177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.523 HG12 HG12 ' A' ' 60' ' ' ILE . 4.6 tp -58.32 -45.24 89.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.199 178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -63.77 -42.41 97.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.007 0.432 . . . . 0.0 110.12 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HE2' ' O ' ' A' ' 24' ' ' LEU . 4.2 m-85 -62.65 -36.17 81.99 Favored 'General case' 0 C--O 1.214 -0.768 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.773 176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 29' ' ' LEU . 74.7 t -72.17 -45.2 63.11 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-O 120.818 0.342 . . . . 0.0 111.04 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 30' ' ' ILE . 76.0 t -63.85 -44.98 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.581 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 74.7 m -53.0 -54.58 42.54 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -173.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 51.3 Cg_exo -60.67 -40.3 56.47 Favored 'Trans proline' 0 C--N 1.367 1.533 0 C-N-CA 122.009 1.806 . . . . 0.0 112.299 176.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.561 HD11 HG11 ' A' ' 98' ' ' VAL . 81.7 mt -67.3 -43.2 82.31 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.919 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -61.9 -46.06 91.03 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.974 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 21.6 ptmt -72.99 -15.57 61.53 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.485 ' OG ' HG12 ' A' ' 42' ' ' VAL . 79.9 p -75.41 173.71 10.57 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 121.195 0.521 . . . . 0.0 111.007 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -60.6 -18.39 52.71 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.746 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG12 ' OG ' ' A' ' 40' ' ' SER . 11.9 p -64.98 146.41 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.991 0.424 . . . . 0.0 111.108 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -79.79 -73.05 0.37 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -106.05 150.78 25.43 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.452 0.644 . . . . 0.0 111.799 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.8 mm -111.06 116.12 51.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 114.844 -1.071 . . . . 0.0 108.553 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 84.4 m-85 -106.12 117.79 34.94 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 60' ' ' ILE . 96.2 mt -98.64 118.48 45.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-O 121.645 0.736 . . . . 0.0 110.301 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.508 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -88.18 117.85 27.36 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.964 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 7' ' ' ALA . 70.0 p -125.94 157.85 36.69 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.6 p -109.27 155.65 40.72 Favored Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.116 -0.634 . . . . 0.0 110.326 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.29 -18.44 62.59 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.598 2.199 . . . . 0.0 111.002 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -83.38 -7.4 59.57 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.999 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.0 p -141.37 66.74 24.41 Favored Pre-proline 0 N--CA 1.439 -0.983 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.749 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 91.0 Cg_endo -102.09 84.22 0.03 OUTLIER 'Trans proline' 1 N--CA 1.388 -4.699 0 C-N-CA 116.469 -1.888 . . . . 0.0 108.577 168.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 53.5 mtmt -150.68 -50.34 0.13 Allowed 'General case' 1 C--N 1.216 -5.198 0 CA-C-N 109.446 -3.524 . . . . 0.0 103.184 -176.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.3 m -62.82 -46.97 85.46 Favored 'General case' 0 N--CA 1.391 -3.41 0 CA-C-N 112.692 -2.049 . . . . 0.0 106.125 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.749 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -61.5 -49.27 77.42 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.383 177.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.566 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 14.3 pt-20 -58.71 -38.48 78.38 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 118.275 -1.37 . . . . 0.0 111.03 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -63.76 -50.26 69.74 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 120.704 0.287 . . . . 0.0 111.458 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 47' ' ' ILE . 96.7 mt -63.59 -43.65 98.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.879 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -58.23 -44.36 88.18 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.346 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.439 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 75.1 m -68.74 -40.16 79.99 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.348 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.16 90.57 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.007 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.42 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 60.0 m-85 -115.96 42.19 2.4 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.549 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 30.2 mmmt -60.62 -21.39 62.66 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.143 0.497 . . . . 0.0 110.976 177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -93.24 11.69 27.14 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.631 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.465 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 48.4 p90 -43.4 122.34 2.57 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.33 -50.0 3.58 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -111.05 10.96 22.07 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.531 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 85.9 mt -105.99 124.27 61.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.295 0.569 . . . . 0.0 110.35 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 60.3 t -125.28 133.7 68.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.687 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.9 p -106.41 132.46 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.091 0.472 . . . . 0.0 109.818 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.421 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.9 pt -127.83 156.03 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.315 0 CA-C-O 121.912 0.863 . . . . 0.0 111.325 -177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -110.35 133.14 53.55 Favored 'General case' 0 N--CA 1.411 -2.398 0 CA-C-N 114.04 -1.436 . . . . 0.0 109.496 -178.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.423 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 10.1 t -162.22 -169.81 2.28 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.621 0.724 . . . . 0.0 112.911 -178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 53.8 m -69.6 1.77 3.82 Favored 'General case' 0 C--O 1.205 -1.266 0 C-N-CA 126.56 1.944 . . . . 0.0 114.438 -175.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.46 -21.53 0.0 OUTLIER Glycine 1 N--CA 1.519 4.226 0 C-N-CA 126.209 1.862 . . . . 0.0 117.019 -174.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 76' ' ' SER . 2.5 tmmt? -56.57 -34.2 66.91 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 172.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.78 126.08 6.57 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -60.26 -51.69 68.47 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -172.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.48 -45.76 91.84 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 121.727 0.775 . . . . 0.0 110.795 -176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.593 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 69.5 mm-40 -60.99 -42.69 98.9 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.859 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.503 ' HB3' ' HE1' ' A' ' 6' ' ' MET . 8.7 t0 -58.94 -50.69 73.09 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.9 176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 88' ' ' ILE . 2.3 mm? -57.5 -43.98 84.6 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.055 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.523 ' HA ' HG12 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -61.36 -40.1 93.06 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.968 178.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 70.7 mm-40 -67.17 -44.27 80.13 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.565 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 97.0 m -63.92 -41.63 97.61 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.619 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.531 HG23 ' O ' ' A' ' 84' ' ' LEU . 35.4 pt -66.73 -35.3 74.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.197 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.45 -39.33 94.06 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.345 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -62.0 -49.19 77.06 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.958 . . . . 0.0 112.969 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.565 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 75.5 m-85 -74.2 148.23 41.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.176 0.512 . . . . 0.0 112.103 -177.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.4 m -96.26 -8.41 32.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.627 ' HB2' ' HD2' ' A' ' 94' ' ' PRO . 15.5 pt-20 -151.55 173.47 4.39 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.627 ' HD2' ' HB2' ' A' ' 93' ' ' GLU . 58.1 Cg_endo -69.35 148.48 67.82 Favored 'Trans proline' 0 C--N 1.363 1.312 0 C-N-CA 122.072 1.848 . . . . 0.0 113.795 -171.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 40.6 p90 -146.18 162.39 38.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.643 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.541 HD13 HG21 ' A' ' 154' ' ' ILE . 91.2 mt -84.44 150.13 25.51 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.542 178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 87.3 t -121.84 129.57 75.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.434 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.677 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.7 m -131.65 162.96 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.088 178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 34.1 t -99.4 145.89 26.9 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 173.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.598 ' HB3' ' O ' ' A' ' 6' ' ' MET . 80.0 p -65.49 -20.5 66.37 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 177' ' ' ASN . 53.7 p-10 -105.14 12.41 32.06 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.21 115.37 11.37 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.929 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 29' ' ' LEU . 73.6 mt -122.45 117.02 50.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 33.6 t-20 173.88 169.62 0.2 Allowed 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.62 73.71 5.16 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.76 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.2 pttp -82.64 -1.84 52.23 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.57 -1.195 . . . . 0.0 113.185 -176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.623 ' HA ' HD12 ' A' ' 110' ' ' ILE . 71.2 m -58.95 -40.61 85.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.146 0.498 . . . . 0.0 111.52 -177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -71.33 -40.35 70.78 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 122.558 1.17 . . . . 0.0 109.895 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.76 HD12 ' HA ' ' A' ' 106' ' ' LYS . 66.7 mt -63.02 -39.56 85.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.12 -1.854 . . . . 0.0 111.127 -174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 107' ' ' SER . 59.8 mt -57.52 -47.61 84.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.115 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -63.9 -39.97 95.42 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.718 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.7 m -61.66 -37.44 84.06 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.184 178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -60.05 -48.38 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-O 121.323 0.582 . . . . 0.0 109.622 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.84 -44.77 98.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.162 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.55 -47.56 85.64 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.157 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.528 ' CE2' HD11 ' A' ' 120' ' ' ILE . 80.9 t80 -64.18 -49.52 71.72 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.239 -178.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.8 t80 -59.44 -47.92 83.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.783 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.588 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 4.2 m-85 -61.5 -35.46 77.73 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 48.9 t -63.15 -46.71 85.9 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 121.23 0.538 . . . . 0.0 109.733 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.528 HD11 ' CE2' ' A' ' 116' ' ' TYR . 73.0 mt -65.08 -49.92 76.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.481 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.588 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 20.4 ptmt -66.32 -27.31 67.81 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -178.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.64 -42.3 96.64 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.566 176.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 120' ' ' ILE . 20.5 pttp -83.45 -39.71 20.21 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.917 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 25.2 m -130.49 98.83 19.69 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.403 -177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.88 -9.56 26.62 Favored 'Trans proline' 0 N--CA 1.479 0.658 0 C-N-CA 122.842 2.361 . . . . 0.0 112.55 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -61.17 -32.81 72.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.856 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.517 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 10.3 p -74.72 124.99 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.227 0.537 . . . . 0.0 110.993 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.453 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 41.1 mt-10 -117.85 -2.61 11.31 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.702 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.16 153.78 41.73 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.859 0.361 . . . . 0.0 111.289 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.428 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -135.16 131.98 37.44 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -178.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' HB2' ' CD ' ' A' ' 166' ' ' GLU . . . -119.06 127.08 53.07 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.235 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.575 HG21 ' CD1' ' A' ' 113' ' ' ILE . 90.1 t -107.55 112.55 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.564 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.454 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 9.9 ptm -146.22 158.4 43.88 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.225 -176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 152' ' ' ALA . 25.7 pt -134.22 157.0 78.55 Favored Pre-proline 0 C--N 1.305 -1.36 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.147 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.96 139.86 91.87 Favored 'Trans proline' 0 C--O 1.239 0.536 0 C-N-CA 122.235 1.956 . . . . 0.0 111.878 178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.531 ' O ' ' HD3' ' A' ' 136' ' ' LYS . 14.0 tmtt? -59.92 -25.91 65.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.939 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -59.27 -38.05 79.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.201 -177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' HD3' ' HB ' ' A' ' 134' ' ' ILE . 22.8 ptmt -93.86 -21.96 18.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.999 0.428 . . . . 0.0 111.149 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.59 128.63 83.56 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.557 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.72 51.94 4.0 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 122.918 2.412 . . . . 0.0 114.002 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 59.69 107.56 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.574 ' HG3' HG12 ' A' ' 150' ' ' VAL . 72.2 Cg_endo -74.6 -20.42 17.88 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 123.128 2.552 . . . . 0.0 112.507 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.427 ' OG ' ' HA3' ' A' ' 16' ' ' GLY . 22.9 t -164.68 -175.65 3.92 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.1 -44.52 99.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -115.53 149.0 38.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.096 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.418 ' HD2' ' H ' ' A' ' 148' ' ' GLY . 43.8 p90 -84.7 158.63 20.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.058 0.456 . . . . 0.0 111.528 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -99.39 24.47 8.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.74 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.418 ' H ' ' HD2' ' A' ' 146' ' ' PHE . . . 89.25 -57.48 3.93 Favored Glycine 0 C--N 1.32 -0.353 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 pp -131.3 159.0 39.14 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 175.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.574 HG12 ' HG3' ' A' ' 142' ' ' PRO . 32.7 m -121.85 124.85 26.91 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.907 -177.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.408 ' O ' HD11 ' A' ' 175' ' ' ILE . 58.9 Cg_endo -70.58 147.89 58.57 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.395 2.063 . . . . 0.0 110.891 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -114.22 0.22 14.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 176.21 -123.72 0.93 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 119.268 -1.444 . . . . 0.0 113.648 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.541 ' HB ' HG13 ' A' ' 113' ' ' ILE . 4.1 mp -101.17 137.09 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 CA-C-O 121.679 0.752 . . . . 0.0 111.713 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.626 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 10.9 t-20 -109.6 156.7 19.87 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.48 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.531 HG22 HD23 ' A' ' 96' ' ' LEU . 94.7 t -123.62 130.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.843 0 C-N-CA 122.667 0.387 . . . . 0.0 110.243 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.429 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.9 m -133.96 150.84 31.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-O 121.379 0.609 . . . . 0.0 111.415 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.472 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 53.0 p -98.25 164.58 16.93 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.383 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 77.9 Cg_endo -75.72 76.1 3.79 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.55 2.167 . . . . 0.0 111.826 178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.82 -172.08 2.14 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.812 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -127.46 131.78 50.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.583 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.91 -114.09 3.77 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.975 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -129.33 145.34 51.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.52 166.98 21.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.517 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 2.5 tmtm? -55.81 127.66 31.25 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.152 0.501 . . . . 0.0 110.615 -179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' CD ' ' HB2' ' A' ' 131' ' ' ALA . 44.1 tt0 -137.52 134.72 36.02 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.587 -176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.428 ' HG3' HG21 ' A' ' 120' ' ' ILE . 34.5 mm-40 -94.11 162.84 13.71 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.485 0.66 . . . . 0.0 111.646 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 47.5 mm -118.01 130.08 73.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 CA-C-N 114.788 -1.097 . . . . 0.0 112.081 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.484 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.7 ttp -129.6 130.99 46.37 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.691 175.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.9 t -111.42 131.51 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 173' ' ' GLU . 42.1 pt -117.66 169.69 7.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.777 0.799 . . . . 0.0 112.482 -175.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -93.51 2.84 56.3 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.432 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' A' ' 171' ' ' ILE . 57.7 mm-40 -99.45 131.71 45.27 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 122.076 0.941 . . . . 0.0 113.149 -177.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -97.08 149.47 21.91 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 113.551 -1.659 . . . . 0.0 109.886 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.408 HD11 ' O ' ' A' ' 151' ' ' PRO . 2.2 pt -123.64 139.81 49.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.833 176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -113.53 126.44 55.3 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.612 ' ND2' HG11 ' A' ' 17' ' ' VAL . 34.1 p-10 -119.13 19.33 12.93 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.555 0.693 . . . . 0.0 111.595 -175.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 184' ' ' LEU . 23.2 mm 77.21 -93.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.879 -1.055 . . . . 0.0 113.515 173.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 143' ' ' SER . 38.1 m-80 69.91 -36.69 0.35 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.9 p -128.55 162.36 27.43 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 122.143 -0.348 . . . . 0.0 111.71 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.62 -39.12 83.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.702 177.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -60.09 -48.66 80.81 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -65.52 -36.54 84.14 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.743 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.655 ' HA ' HD12 ' A' ' 178' ' ' ILE . 47.9 tp -59.98 -50.25 74.5 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.433 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.95 -40.5 91.4 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -60.61 -43.53 97.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.977 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.477 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.79 -43.51 98.02 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.698 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.43 ' OE2' ' HA ' ' A' ' 24' ' ' LEU . 53.7 mm-40 -60.7 -45.48 94.07 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.24 0.543 . . . . 0.0 110.201 177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 98.5 mtp -63.36 -42.28 98.88 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.698 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 58.3 tp -65.4 -42.26 92.78 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 120.884 0.373 . . . . 0.0 111.279 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -60.99 -43.25 99.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.354 0.597 . . . . 0.0 110.003 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -64.22 -43.21 95.69 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.433 176.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -62.13 -43.69 98.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.736 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -93.35 -25.77 17.56 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.863 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -90.21 -13.0 60.9 Favored Glycine 0 C--N 1.314 -0.643 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.178 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.5 tp . . . . . 0 C--O 1.267 1.987 0 CA-C-O 118.049 -0.977 . . . . 0.0 111.362 -179.116 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 94' ' ' PRO . 59.2 ttm . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.951 0.405 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.524 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 38.9 m-20 -115.8 166.1 12.33 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . . . -113.81 127.4 55.99 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.09 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 40.3 tp -103.38 124.8 49.39 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.444 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.693 ' HA ' HG22 ' A' ' 98' ' ' VAL . 64.0 mt -118.3 106.38 19.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.484 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 14.1 ptm -99.69 100.36 11.32 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 122.905 1.336 . . . . 0.0 113.736 -172.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -116.54 96.8 5.68 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.128 -1.851 . . . . 0.0 109.537 176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.03 54.14 0.52 Allowed Glycine 0 C--N 1.305 -1.158 0 C-N-CA 121.042 -0.599 . . . . 0.0 113.197 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.403 ' HA2' HG13 ' A' ' 17' ' ' VAL . . . 71.71 42.87 53.09 Favored Glycine 0 C--O 1.235 0.212 0 C-N-CA 120.508 -0.853 . . . . 0.0 114.559 176.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -61.66 106.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 76.72 19.13 78.24 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.383 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -116.18 133.82 55.6 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 120.861 0.362 . . . . 0.0 111.174 -178.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -122.9 -78.84 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.18 0.514 . . . . 0.0 110.627 177.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 16.8 tpt -70.36 -38.36 74.76 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.578 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.53 172.59 42.0 Favored Glycine 0 C--N 1.319 -0.369 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.825 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.67 19.94 44.93 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 20' ' ' PRO . 4.8 t 70.4 58.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.461 0 C-N-CA 123.7 0.8 . . . . 0.0 110.561 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.8 mp0 -80.49 65.99 5.84 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.558 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' O ' HD12 ' A' ' 29' ' ' LEU . 24.9 ttmm -140.0 -63.53 0.02 OUTLIER Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.009 177.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' A' ' 19' ' ' LYS . 56.5 Cg_endo -68.53 -19.8 42.13 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 121.752 1.635 . . . . 0.0 111.712 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 59' ' ' TYR . 35.0 mt -95.43 7.32 46.58 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.334 -0.393 . . . . 0.0 112.042 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.9 mt -72.76 119.83 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 39.9 pttt -100.55 138.39 37.67 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.029 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 188' ' ' GLU . 27.0 tp -136.47 115.9 12.75 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.197 -175.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.2 m 60.53 19.66 9.47 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.85 -89.1 0.12 Allowed Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.013 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 99.0 mtt180 -103.84 170.03 8.17 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.24 0.543 . . . . 0.0 111.954 -174.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 69.7 m -76.71 163.72 26.56 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.462 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 19' ' ' LYS . 77.0 mt -58.78 -39.43 81.01 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.603 -0.272 . . . . 0.0 111.283 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 34' ' ' VAL . 5.6 tp -56.73 -46.32 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.183 178.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.538 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 11.7 t70 -67.35 -40.76 85.84 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.044 0.45 . . . . 0.0 110.947 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.604 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 13.5 m-30 -62.29 -33.99 75.72 Favored 'General case' 0 C--O 1.217 -0.623 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.36 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 78.4 t -71.55 -42.91 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.85 174.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 30' ' ' ILE . 74.2 t -63.92 -43.79 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 58.2 m -52.42 -54.55 41.03 Favored Pre-proline 0 CA--C 1.556 1.204 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.56 -39.51 16.0 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 121.565 1.51 . . . . 0.0 112.275 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.24 -42.82 92.99 Favored 'General case' 0 C--O 1.216 -0.697 0 CA-C-O 120.801 0.334 . . . . 0.0 111.534 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.4 tt -61.3 -46.52 89.96 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.708 0.29 . . . . 0.0 111.19 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -76.3 -13.15 60.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.4 p -73.82 -178.49 3.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.625 0.726 . . . . 0.0 112.126 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 23.5 ttmm -59.48 -24.95 64.01 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.941 -178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -63.56 156.02 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 CA-C-O 121.176 0.513 . . . . 0.0 112.29 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.524 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -77.74 -86.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.42 ' HB2' ' CE1' ' A' ' 46' ' ' PHE . 10.0 m120 -107.72 156.85 18.64 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.243 0.544 . . . . 0.0 111.454 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mm -107.85 115.62 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.016 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 89.7 m-85 -108.91 121.29 44.8 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.536 HG21 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -102.33 118.9 49.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 121.667 0.746 . . . . 0.0 110.715 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.484 ' HB3' ' HA ' ' A' ' 6' ' ' MET . . . -87.77 126.43 34.99 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.752 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 72.5 p -133.85 170.78 15.09 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.541 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.4 m -127.34 150.88 73.73 Favored Pre-proline 0 C--N 1.309 -1.173 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.817 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -58.45 -27.16 80.94 Favored 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 123.501 2.801 . . . . 0.0 111.986 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -87.15 5.01 40.02 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.996 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 18.5 p -140.77 66.08 26.08 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.43 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 88.4 Cg_endo -106.73 88.12 0.02 OUTLIER 'Trans proline' 1 N--CA 1.379 -5.212 0 C-N-CA 117.212 -1.392 . . . . 0.0 110.66 170.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.665 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 72.6 mmtt -151.39 -50.41 0.12 Allowed 'General case' 1 C--N 1.22 -5.04 0 CA-C-N 109.862 -3.335 . . . . 0.0 103.054 177.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.497 HG22 HD12 ' A' ' 60' ' ' ILE . 86.8 m -63.83 -48.34 77.2 Favored 'General case' 0 N--CA 1.384 -3.759 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.107 163.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.685 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 13.5 tmtt? -64.66 -52.37 57.67 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.37 177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 6.3 pt-20 -60.13 -33.07 71.63 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 116.701 -1.999 . . . . 0.0 112.781 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.569 ' CD2' HD22 ' A' ' 21' ' ' LEU . 58.0 t80 -70.34 -52.73 20.51 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.483 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.536 HD13 HG21 ' A' ' 47' ' ' ILE . 97.1 mt -63.44 -45.91 96.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.525 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -59.57 -42.26 92.07 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.264 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.1 t -71.67 -41.72 68.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.491 178.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.19 90.05 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.092 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.538 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 77.5 m-85 -106.69 32.51 4.48 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.502 -176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.4 mtmt -63.34 -18.66 63.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.474 0.654 . . . . 0.0 110.08 175.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.31 10.4 24.98 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.641 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.507 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.1 p90 -45.84 128.1 8.58 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -102.48 -51.48 3.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.846 173.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.547 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.0 p-10 -118.74 15.74 13.55 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.885 178.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -106.45 129.8 59.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.854 -177.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.7 t -127.86 131.5 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.101 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.4 p -98.52 129.39 48.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 48' ' ' ALA . 44.0 pt -125.63 157.08 35.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-O 121.473 0.654 . . . . 0.0 111.818 -176.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -108.05 134.3 51.13 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.827 -1.078 . . . . 0.0 109.844 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 9.6 t -161.18 -172.18 3.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.565 -176.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 66.1 m -77.65 4.66 10.89 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 126.921 2.088 . . . . 0.0 113.28 -176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.601 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.6 -23.66 0.0 OUTLIER Glycine 0 N--CA 1.513 3.822 0 C-N-CA 127.167 2.317 . . . . 0.0 117.623 -171.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 22.3 tptm -58.01 -37.11 73.69 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 172.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.19 122.95 6.7 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.412 ' O ' HD23 ' A' ' 84' ' ' LEU . 87.5 t80 -59.89 -51.3 70.31 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -172.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 79.8 mt -67.44 -43.98 87.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.677 0.751 . . . . 0.0 110.523 -177.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -59.89 -42.87 94.76 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.551 -179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.601 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 34.9 t0 -60.07 -50.27 74.39 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.952 176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.587 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.6 mm? -56.64 -41.76 77.73 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.583 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.455 ' O ' HG12 ' A' ' 88' ' ' ILE . 0.9 OUTLIER -61.37 -42.1 98.17 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.849 178.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 64.4 mm-40 -66.16 -44.24 84.65 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 96.4 m -63.4 -41.52 98.75 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.182 -0.917 . . . . 0.0 113.324 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.593 HD12 ' O ' ' A' ' 160' ' ' LYS . 34.4 pt -64.42 -30.16 49.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.67 96.53 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.076 -1.059 . . . . 0.0 111.331 173.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -71.55 -38.18 71.04 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.41 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 92.2 m-85 -92.55 136.8 32.91 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.3 m -100.68 -4.53 28.13 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.441 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 41.3 mt-10 -134.46 160.58 67.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.894 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.559 ' O ' ' HA ' ' A' ' 1' ' ' MET . 27.5 Cg_endo -63.06 143.54 90.86 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.082 1.855 . . . . 0.0 111.843 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -144.49 162.04 37.54 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.719 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.582 HD23 HG22 ' A' ' 156' ' ' VAL . 92.8 mt -84.73 149.82 25.51 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.914 177.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 59.7 t -122.14 125.12 72.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.54 -1.209 . . . . 0.0 108.104 176.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 5' ' ' ILE . 1.3 m -136.37 158.13 37.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.302 -179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.465 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.2 t -100.9 143.49 30.99 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.78 -1.1 . . . . 0.0 108.241 172.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 7' ' ' ALA . 49.9 m -76.73 -9.35 58.61 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 113.901 1.074 . . . . 0.0 113.901 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -106.27 11.18 31.39 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.57 HD22 HD12 ' A' ' 175' ' ' ILE . 62.5 mt -91.63 114.67 27.26 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.85 135.06 65.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.238 0.542 . . . . 0.0 112.009 -177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 178.61 -178.89 0.31 Allowed 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.7 mt -77.83 58.69 1.93 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 109' ' ' ILE . 16.6 ptmt -66.23 -8.1 22.41 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 113.9 -1.5 . . . . 0.0 113.519 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.476 ' HA ' HD12 ' A' ' 110' ' ' ILE . 60.3 m -58.72 -41.44 86.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.204 0.526 . . . . 0.0 111.404 -177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -72.82 -37.85 67.36 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.578 0.704 . . . . 0.0 110.192 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.754 ' O ' HG12 ' A' ' 113' ' ' ILE . 33.6 mm -60.78 -40.81 86.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.188 -172.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.476 HD12 ' HA ' ' A' ' 107' ' ' SER . 59.4 mt -58.33 -48.65 84.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.445 -177.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 55.0 m-80 -65.65 -39.91 91.9 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.045 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.3 m -61.55 -37.23 83.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.18 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.754 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.7 mm -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.872 179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.89 -44.66 99.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.687 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -60.03 -48.19 82.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.8 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.75 ' CE2' HD11 ' A' ' 120' ' ' ILE . 78.9 t80 -63.98 -47.21 81.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.517 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -57.4 -46.61 83.29 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.435 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 14.4 m-85 -62.13 -38.3 88.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.949 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.49 -41.51 98.86 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.159 0.504 . . . . 0.0 110.339 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.75 HD11 ' CE2' ' A' ' 116' ' ' TYR . 74.7 mt -67.9 -48.63 74.37 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.204 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.17 -25.46 68.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.543 -177.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.72 98.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.819 175.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.99 -39.52 19.58 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.082 0.468 . . . . 0.0 110.67 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.7 m -130.67 95.37 26.52 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.656 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.07 -13.14 35.85 Favored 'Trans proline' 0 N--CA 1.474 0.38 0 C-N-CA 122.738 2.292 . . . . 0.0 111.952 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -62.91 -31.01 71.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.069 -178.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 124' ' ' THR . 13.4 p -65.53 133.1 31.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 CA-C-O 121.061 0.458 . . . . 0.0 111.154 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.535 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 43.7 mt-10 -124.34 -3.28 7.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.899 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -146.26 156.8 43.63 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.801 0.334 . . . . 0.0 111.433 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.78 137.74 38.53 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -127.7 139.32 52.77 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.037 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.513 HG21 ' CD1' ' A' ' 113' ' ' ILE . 67.8 t -113.97 117.06 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.148 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.9 ptm -145.72 152.81 40.19 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.872 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 152' ' ' ALA . 36.4 pt -132.02 159.55 71.63 Favored Pre-proline 0 C--N 1.31 -1.136 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.051 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.35 134.04 61.11 Favored 'Trans proline' 0 C--O 1.238 0.477 0 C-N-CA 122.003 1.802 . . . . 0.0 110.784 177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.36 -16.34 63.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.977 0.418 . . . . 0.0 111.157 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -63.21 -39.57 95.0 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.64 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -93.27 -15.76 25.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.272 0.558 . . . . 0.0 110.78 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -65.44 128.37 93.74 Favored Pre-proline 0 C--N 1.314 -0.969 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.81 -44.37 21.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.231 1.954 . . . . 0.0 113.928 -174.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 28.5 p-10 -172.84 129.16 0.56 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-O 120.529 0.204 . . . . 0.0 111.104 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 141' ' ' ASN . 45.7 Cg_exo -60.97 137.17 70.37 Favored 'Trans proline' 0 C--O 1.239 0.543 0 C-N-CA 122.41 2.073 . . . . 0.0 111.226 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.1 t -64.23 -48.14 76.96 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.057 0.456 . . . . 0.0 109.785 178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 47.4 pt -140.17 148.14 22.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.583 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 146' ' ' PHE . 13.6 t70 54.3 -156.81 0.21 Allowed 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.593 0.558 . . . . 0.0 110.161 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.488 ' H ' ' CG ' ' A' ' 145' ' ' ASP . 98.9 m-85 -110.64 -30.37 7.63 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 176.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.1 m120 64.2 138.48 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 115.01 -0.995 . . . . 0.0 112.927 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.23 -39.64 97.95 Favored Glycine 0 C--N 1.331 0.263 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.3 pp -139.3 149.8 44.68 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.37 121.31 31.22 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-O 121.069 0.461 . . . . 0.0 111.851 -177.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 132' ' ' VAL . 59.1 Cg_endo -71.0 144.29 47.03 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.709 2.273 . . . . 0.0 112.102 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -118.39 -6.03 10.79 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -146.34 -120.35 1.26 Allowed Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.727 -1.225 . . . . 0.0 112.934 -177.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.619 ' CG1' HG13 ' A' ' 113' ' ' ILE . 40.5 pt -121.21 158.53 23.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-O 120.903 0.382 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.682 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.1 t-20 -116.5 152.23 34.49 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.409 -177.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.582 HG22 HD23 ' A' ' 96' ' ' LEU . 93.6 t -121.41 129.46 75.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 122.51 0.324 . . . . 0.0 110.409 178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 155' ' ' ASN . 31.6 m -135.3 149.01 28.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-O 121.143 0.497 . . . . 0.0 111.391 176.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 77.1 p -98.79 163.7 18.35 Favored Pre-proline 0 C--N 1.309 -1.182 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.543 175.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 62.4 Cg_endo -73.4 74.65 3.1 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 122.258 1.972 . . . . 0.0 112.079 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.593 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.3 mmmt -115.33 137.68 51.78 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.748 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -93.18 107.05 18.93 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.336 0.589 . . . . 0.0 110.23 176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 127.02 -128.95 6.37 Favored Glycine 0 N--CA 1.434 -1.439 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -136.29 129.27 31.19 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -117.53 166.5 12.29 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.607 -175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.0 120.37 9.53 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.301 0.572 . . . . 0.0 110.914 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -121.02 130.1 53.65 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.801 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.482 ' HG3' HG21 ' A' ' 120' ' ' ILE . 42.8 mm-40 -92.8 161.9 14.33 Favored 'General case' 0 CA--C 1.471 -2.085 0 CA-C-O 121.731 0.777 . . . . 0.0 112.196 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.2 mm -117.89 127.05 75.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.652 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.56 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 53.3 ttp -124.77 128.71 49.17 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.92 174.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 133' ' ' MET . 58.3 t -107.97 128.75 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.492 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.671 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.6 pt -115.51 175.72 2.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.019 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -121.69 23.07 10.34 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.769 0.795 . . . . 0.0 109.889 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.671 ' HB2' HD12 ' A' ' 171' ' ' ILE . 20.0 mp0 -98.7 130.78 45.2 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.988 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.7 mt -97.03 143.03 28.27 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.287 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.57 HD12 HD22 ' A' ' 102' ' ' LEU . 10.1 pt -121.6 154.06 25.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.409 178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -114.38 106.1 13.91 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.672 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -68.05 -35.79 78.82 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.088 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 183' ' ' ASP . 98.7 mt 66.32 109.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.045 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -120.93 -15.26 8.33 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.217 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 51.8 p -127.54 166.34 18.19 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.414 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -63.51 -36.91 85.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.04 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -59.54 -40.6 87.78 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.826 178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.566 ' HB2' HG23 ' A' ' 178' ' ' ILE . 77.0 m-20 -61.27 -41.71 97.4 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.491 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 178' ' ' ILE . 89.9 mt -61.94 -47.63 84.02 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.312 0.577 . . . . 0.0 109.949 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.601 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 88.0 tttt -61.92 -42.68 99.38 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.623 -178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 186' ' ' LEU . 8.6 tt -60.47 -47.97 83.8 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.937 179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -64.91 -42.11 95.0 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.202 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.601 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.8 pt-20 -69.5 -31.65 70.04 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 96.5 mtp -62.73 -40.96 98.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.646 0.26 . . . . 0.0 111.537 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.6 -36.27 60.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.189 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 190' ' ' LEU . 92.3 mt -62.95 -45.77 90.89 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.443 0.64 . . . . 0.0 110.525 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -63.96 -46.03 86.46 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.994 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -63.5 -42.5 98.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.617 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.89 -29.48 66.68 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.156 0.503 . . . . 0.0 110.246 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.07 -40.65 95.2 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.084 177.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.263 1.764 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.811 -178.822 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.4 ttm . . . . . 0 N--CA 1.482 1.175 0 CA-C-O 120.957 0.408 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 33.5 m-20 -100.12 166.17 11.15 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -115.58 130.77 56.99 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.924 0.392 . . . . 0.0 111.101 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.8 tp -106.06 125.07 50.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.181 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.693 ' HA ' HG22 ' A' ' 98' ' ' VAL . 71.9 mt -117.68 102.22 13.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.438 ' O ' ' HB3' ' A' ' 100' ' ' SER . 12.1 ptm -96.22 98.52 10.38 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.987 1.375 . . . . 0.0 112.093 -175.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.44 98.23 6.78 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 113.196 -1.82 . . . . 0.0 110.332 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.24 14.58 0.02 OUTLIER Glycine 0 C--N 1.302 -1.331 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.843 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -116.68 100.62 0.92 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.179 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -146.73 22.83 1.26 Allowed 'General case' 0 C--O 1.237 0.419 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.99 32.04 66.4 Favored Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.3 p -96.66 141.67 29.63 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.821 0.343 . . . . 0.0 111.109 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -121.49 -27.62 4.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 60.1 mtt -103.37 -57.03 2.11 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.853 0.359 . . . . 0.0 111.29 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.4 143.8 14.4 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.365 -0.922 . . . . 0.0 111.513 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.66 145.2 36.64 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.76 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG12 ' HG3' ' A' ' 19' ' ' LYS . 64.8 t -84.83 135.73 24.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.6 mp0 -75.3 22.18 0.12 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 97.3 mttt -56.82 -48.5 97.21 Favored Pre-proline 0 N--CA 1.475 0.794 0 CA-C-N 118.298 0.499 . . . . 0.0 112.064 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 19' ' ' LYS . 42.9 Cg_endo -68.15 -14.51 40.86 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 121.767 1.645 . . . . 0.0 111.77 176.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 59' ' ' TYR . 57.8 mt -102.59 7.61 39.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 18' ' ' GLU . 95.7 mt -69.41 118.37 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 CA-C-O 121.592 0.711 . . . . 0.0 109.129 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 48.8 pttt -87.68 125.92 34.67 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.999 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 188' ' ' GLU . 60.3 tp -131.71 119.69 21.69 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.003 -173.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.1 m 57.29 28.72 15.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.517 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.25 -76.02 0.39 Allowed Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.019 -1.086 . . . . 0.0 114.48 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.713 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 44.3 mtt180 -101.73 166.42 10.69 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 121.164 0.507 . . . . 0.0 112.36 -172.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 75.7 m -76.15 151.79 36.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.674 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 33' ' ' VAL . 3.1 tt -48.91 -47.93 42.95 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.26 0.624 . . . . 0.0 111.711 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 60' ' ' ILE . 5.7 tp -57.61 -42.49 81.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.766 0.317 . . . . 0.0 111.811 179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.713 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 15.0 t70 -65.24 -39.73 93.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.142 0.496 . . . . 0.0 109.933 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -63.73 -37.34 86.99 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.969 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 29' ' ' LEU . 72.3 t -65.27 -43.43 95.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.398 0.618 . . . . 0.0 110.239 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -63.61 -43.0 98.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.583 -178.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.6 t -49.99 -57.01 13.85 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -174.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 40' ' ' SER . 41.8 Cg_endo -67.83 -37.99 14.52 Favored 'Trans proline' 0 C--N 1.365 1.414 0 C-N-CA 121.57 1.514 . . . . 0.0 112.462 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.528 HD11 HG11 ' A' ' 98' ' ' VAL . 83.3 mt -65.09 -41.22 95.19 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.879 0.371 . . . . 0.0 111.67 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.488 ' HG ' HD21 ' A' ' 69' ' ' ASN . 5.7 tt -59.97 -46.58 88.98 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.035 177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -83.31 -5.87 59.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 57.4 p -75.79 -178.38 4.22 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 121.518 0.675 . . . . 0.0 111.585 -178.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.401 ' HE2' ' OD1' ' A' ' 111' ' ' ASN . 24.5 ttmm -57.44 -24.8 57.8 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.59 -1.186 . . . . 0.0 112.719 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 3' ' ' ALA . 22.7 m -67.38 161.8 3.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -174.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.517 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 60.1 t30 -80.43 -76.83 0.21 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.669 -1.151 . . . . 0.0 112.544 -177.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -117.56 159.77 22.34 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 120.909 0.385 . . . . 0.0 110.767 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.4 mm -107.67 114.06 45.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.304 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.3 m-85 -107.88 116.75 32.53 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.567 HG21 HD13 ' A' ' 60' ' ' ILE . 96.1 mt -97.98 116.15 39.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 121.558 0.694 . . . . 0.0 110.543 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.51 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.81 125.35 34.4 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-N 114.243 -1.344 . . . . 0.0 109.705 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -129.34 158.94 37.7 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.014 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 38.0 m -103.93 149.76 37.53 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.575 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.9 -20.63 57.99 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.745 2.297 . . . . 0.0 111.309 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -89.04 1.66 55.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.397 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 20.3 p -138.08 67.51 48.07 Favored Pre-proline 0 N--CA 1.437 -1.122 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.653 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 90.8 Cg_endo -100.99 87.59 0.04 OUTLIER 'Trans proline' 1 N--CA 1.384 -4.939 0 C-N-CA 117.303 -1.331 . . . . 0.0 109.17 169.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.7 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.5 mmtm -156.94 -52.7 0.08 Allowed 'General case' 1 C--N 1.215 -5.268 0 CA-C-N 110.183 -3.19 . . . . 0.0 103.057 179.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.518 HG22 HD12 ' A' ' 60' ' ' ILE . 93.3 m -63.77 -50.03 70.62 Favored 'General case' 0 N--CA 1.379 -3.991 0 N-CA-C 105.696 -1.965 . . . . 0.0 105.696 165.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.684 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -65.25 -49.25 70.35 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 176.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.7 pt-20 -60.83 -31.36 70.78 Favored 'General case' 0 C--N 1.374 1.664 0 C-N-CA 116.16 -2.216 . . . . 0.0 112.17 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.518 ' CD2' HD22 ' A' ' 21' ' ' LEU . 52.9 t80 -72.2 -51.22 22.1 Favored 'General case' 0 C--O 1.208 -1.115 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.582 177.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.567 HD13 HG21 ' A' ' 47' ' ' ILE . 97.8 mt -62.35 -44.92 99.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.689 -174.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.71 -44.01 90.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.499 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.424 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 73.1 m -68.8 -41.21 79.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.384 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.72 -37.58 88.08 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.45 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.59 ' OH ' ' HA ' ' A' ' 31' ' ' ASP . 66.5 m-85 -110.54 31.82 5.67 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.409 -175.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.3 mmmm -61.77 -24.19 66.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.16 0.505 . . . . 0.0 110.739 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -91.27 10.97 25.09 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.017 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.495 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 54.4 p90 -45.44 134.26 6.97 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 -175.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.06 -49.53 3.74 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.488 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.2 p-10 -119.25 11.65 12.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.563 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 80.8 mt -106.2 127.29 61.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-O 121.27 0.557 . . . . 0.0 110.697 -176.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 76.9 t -126.45 132.23 70.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.732 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -102.85 130.58 52.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.51 HG13 ' HA ' ' A' ' 48' ' ' ALA . 37.7 pt -124.07 155.73 31.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.391 0.615 . . . . 0.0 110.396 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -117.72 132.35 56.49 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.122 -0.945 . . . . 0.0 108.865 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.535 ' OG1' ' HG2' ' A' ' 86' ' ' GLU . 14.2 t -163.66 -167.42 1.4 Allowed 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.5 m -66.04 1.0 1.61 Allowed 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 127.017 2.127 . . . . 0.0 114.349 -176.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.56 -22.39 0.0 OUTLIER Glycine 0 N--CA 1.514 3.875 0 C-N-CA 126.026 1.774 . . . . 0.0 116.67 -175.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 76' ' ' SER . 13.9 tmtt? -57.39 -36.6 71.49 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.38 122.84 6.23 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 174.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -59.58 -50.47 73.76 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -172.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 48.8 pt -71.49 -32.16 45.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.097 -177.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -65.53 -43.46 89.9 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.467 0.651 . . . . 0.0 109.891 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.608 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.1 t0 -61.3 -50.5 72.74 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.859 177.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.562 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.4 mm? -57.44 -45.09 85.1 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.035 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.6 m-80 -60.69 -42.63 97.53 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.535 ' HG2' ' OG1' ' A' ' 75' ' ' THR . 16.8 tp10 -65.37 -46.43 80.15 Favored 'General case' 0 N--CA 1.385 -3.676 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.534 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 99.0 m -63.78 -41.01 98.03 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.403 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.2 pt -65.18 -36.82 78.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.393 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.63 -38.97 95.16 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.4 174.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -63.35 -49.22 74.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.64 0.776 . . . . 0.0 112.814 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.534 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 83.3 m-85 -75.76 149.83 37.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.4 m -103.06 -5.29 23.48 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.386 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -135.78 158.33 74.31 Favored Pre-proline 0 CA--C 1.505 -0.787 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.152 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.94 141.62 77.83 Favored 'Trans proline' 0 C--O 1.24 0.594 0 C-N-CA 122.858 2.372 . . . . 0.0 110.534 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 45.5 p90 -141.84 156.81 45.53 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.543 0.687 . . . . 0.0 111.923 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.534 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.42 138.5 31.73 Favored 'General case' 0 C--O 1.199 -1.585 0 CA-C-N 114.302 -1.317 . . . . 0.0 109.931 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.605 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 64.3 t -116.94 131.67 68.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 123.311 0.644 . . . . 0.0 109.291 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' A' ' 5' ' ' ILE . 17.7 m -126.72 164.04 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.316 0.579 . . . . 0.0 112.02 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.443 ' O ' HD22 ' A' ' 102' ' ' LEU . 47.6 t -82.54 159.95 22.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.009 175.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 6' ' ' MET . 81.1 p -86.1 -26.07 25.46 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -120.6 28.77 7.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.866 1.062 . . . . 0.0 113.866 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.443 HD22 ' O ' ' A' ' 99' ' ' SER . 1.5 pt? -86.55 156.88 19.89 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.694 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 49.7 pt -96.74 174.09 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 105' ' ' LEU . 96.2 m-20 -69.19 -170.29 0.25 Allowed 'General case' 0 C--O 1.247 0.932 0 CA-C-N 115.253 -0.885 . . . . 0.0 113.041 -177.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 104' ' ' ASN . 4.2 mm? 75.03 14.74 3.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.311 1.044 . . . . 0.0 109.97 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HA ' HG12 ' A' ' 109' ' ' ILE . 47.9 mmtm -99.52 -0.81 39.84 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.032 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' HD12 ' A' ' 110' ' ' ILE . 75.4 p -59.31 -37.1 76.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -73.97 -24.77 59.66 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.87 0.843 . . . . 0.0 109.747 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.777 ' O ' HG12 ' A' ' 113' ' ' ILE . 41.2 mm -67.17 -39.77 83.78 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 114.413 -1.267 . . . . 0.0 109.27 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 107' ' ' SER . 66.3 mt -57.24 -49.07 81.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.13 -175.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 52.7 m-80 -66.12 -40.41 90.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.195 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.8 m -62.77 -41.09 99.08 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.97 178.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.777 HG12 ' O ' ' A' ' 109' ' ' ILE . 47.7 mm -62.12 -48.69 87.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.706 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.044 -178.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.47 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.1 t -61.98 -48.77 87.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.428 -177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -63.57 -41.99 98.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.057 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -68.82 -41.65 78.32 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.927 0.394 . . . . 0.0 110.354 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -58.75 -46.68 86.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.93 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.47 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 17.2 m-85 -60.05 -37.01 78.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.492 176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 99.0 m -62.05 -41.14 97.82 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.265 0.555 . . . . 0.0 109.563 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 79.1 mt -68.55 -41.36 82.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.566 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.298 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.448 ' HD2' ' O ' ' A' ' 127' ' ' VAL . 17.7 mmmt -59.94 -43.11 95.19 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.478 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.56 93.51 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.724 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -81.29 -34.73 31.78 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.519 179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 45.3 m -140.31 95.43 8.25 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-O 120.76 0.314 . . . . 0.0 110.672 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.31 -25.12 77.24 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.207 2.605 . . . . 0.0 112.688 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -62.66 -31.75 72.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.511 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.448 ' O ' ' HD2' ' A' ' 121' ' ' LYS . 63.3 t -69.26 122.6 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.731 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 33.8 mt-10 -130.93 18.83 5.04 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.041 0.448 . . . . 0.0 112.067 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 156' ' ' VAL . . . -151.0 151.55 32.23 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.043 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.454 HD23 HG23 ' A' ' 113' ' ' ILE . 18.7 tp -138.89 143.29 38.64 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.905 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -128.55 138.56 52.3 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.111 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.472 HG21 ' CD1' ' A' ' 113' ' ' ILE . 60.0 t -117.5 117.03 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.239 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.421 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 4.3 ptm -146.01 161.77 39.37 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.53 -176.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.457 HD11 ' HD2' ' A' ' 139' ' ' TYR . 22.7 pt -132.66 154.58 81.54 Favored Pre-proline 0 C--N 1.307 -1.245 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.558 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.519 ' O ' ' HG2' ' A' ' 138' ' ' LYS . 65.1 Cg_exo -56.77 131.29 44.65 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.971 1.78 . . . . 0.0 110.1 176.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 142' ' ' PRO . 65.6 pttt -64.42 -21.98 66.81 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.863 0.363 . . . . 0.0 111.532 -177.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.49 -37.57 88.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.474 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.519 ' HG2' ' O ' ' A' ' 135' ' ' PRO . 13.7 ptmm? -83.35 -21.52 33.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.226 0.536 . . . . 0.0 110.829 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.457 ' HD2' HD11 ' A' ' 134' ' ' ILE . 35.0 t80 -78.03 120.55 81.68 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.472 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.0 126.75 18.67 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.409 2.072 . . . . 0.0 111.937 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 66.3 t30 56.99 59.77 7.59 Favored Pre-proline 0 N--CA 1.483 1.195 0 CA-C-O 121.598 0.713 . . . . 0.0 111.421 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' A' ' 136' ' ' LYS . 63.5 Cg_endo -72.89 -27.03 14.9 Favored 'Trans proline' 0 C--N 1.327 -0.586 0 C-N-CA 123.533 2.822 . . . . 0.0 113.747 -177.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.0 m 65.21 178.94 0.19 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.522 0.513 . . . . 0.0 110.464 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.6 mm 51.2 85.63 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 121.427 0.632 . . . . 0.0 111.787 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -63.26 -40.55 97.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.328 -178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -102.3 119.1 38.24 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.483 -176.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 65.5 t30 62.0 -174.26 0.14 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.127 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.04 157.96 34.09 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.068 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 pp -140.53 158.98 43.18 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 35.9 m -121.74 121.94 28.03 Favored Pre-proline 0 C--N 1.312 -1.055 0 CA-C-O 121.149 0.5 . . . . 0.0 111.912 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.01 151.2 55.78 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.501 2.134 . . . . 0.0 110.432 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.425 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -131.98 -28.3 1.77 Allowed 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.895 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -112.57 -136.63 6.75 Favored Glycine 0 N--CA 1.429 -1.822 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.977 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 96' ' ' LEU . 20.6 pt -123.66 161.02 26.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.103 -0.548 . . . . 0.0 110.735 -177.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.605 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.7 t-20 -112.13 152.52 28.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.449 -174.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 129' ' ' ALA . 71.6 t -124.59 130.86 73.36 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.201 175.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' A' ' 155' ' ' ASN . 20.1 m -133.75 149.03 30.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-O 121.513 0.673 . . . . 0.0 111.396 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.594 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 23.3 t -97.83 151.66 37.7 Favored Pre-proline 0 C--N 1.301 -1.529 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.411 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 43.2 Cg_endo -67.32 77.73 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.589 2.193 . . . . 0.0 111.61 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -108.71 -175.67 2.83 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.057 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -133.13 115.9 15.63 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 108.71 -123.78 7.12 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.275 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -129.91 140.7 50.91 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pm0 -134.12 164.14 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.649 0.261 . . . . 0.0 111.653 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.435 ' CG ' HG22 ' A' ' 127' ' ' VAL . 49.4 tptt -57.08 127.98 34.7 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 121.506 0.67 . . . . 0.0 112.22 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -128.63 137.26 51.57 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.538 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -99.1 163.19 12.67 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.53 130.97 69.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.597 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 41.7 ttm -122.63 141.76 51.38 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.026 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 133' ' ' MET . 57.9 t -117.06 131.41 69.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.693 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.4 pt -120.76 175.1 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.371 0.605 . . . . 0.0 112.099 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.12 5.5 30.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.328 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.693 ' HB2' HD12 ' A' ' 171' ' ' ILE . 26.4 mp0 -96.84 130.24 44.15 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 122.195 0.998 . . . . 0.0 111.917 -176.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.2 mt -97.05 152.22 18.96 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.115 -178.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.61 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.833 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.1 119.34 28.34 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -82.26 118.91 23.48 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.7 mm -79.84 105.68 9.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-O 121.107 0.479 . . . . 0.0 110.402 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -113.1 -19.18 11.96 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.163 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -147.64 165.92 28.96 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.12 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 17.8 mmtp -58.26 -31.91 67.87 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.844 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.51 -43.01 99.62 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.863 0.363 . . . . 0.0 110.414 176.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -61.1 -42.32 98.3 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.459 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.446 ' CD1' HD13 ' A' ' 24' ' ' LEU . 58.9 tp -62.08 -46.67 88.07 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.669 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 63.5 tttm -64.24 -42.13 96.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.989 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.0 tt -60.15 -45.38 93.26 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.13 -40.89 98.9 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.173 -0.922 . . . . 0.0 111.996 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 8.7 pt-20 -67.42 -36.28 80.93 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.872 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 98.0 mtp -62.59 -39.08 92.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.75 -176.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -75.33 -34.96 61.26 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.3 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.47 -46.06 64.53 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.066 0.46 . . . . 0.0 112.157 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 14.5 ptmt -67.89 -28.44 67.51 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.214 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -64.85 -41.4 95.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.092 0.472 . . . . 0.0 110.238 176.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -68.36 -28.01 66.75 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.847 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -81.06 -60.53 2.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.978 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.8 tp . . . . . 0 C--O 1.263 1.803 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.109 179.75 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 94' ' ' PRO . 23.5 ptp . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 22.7 m-20 -95.33 163.36 13.29 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.428 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -121.09 128.51 52.66 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 40.9 tp -103.75 127.45 51.22 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.727 ' HA ' HG22 ' A' ' 98' ' ' VAL . 63.6 mt -117.63 103.48 14.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.51 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 14.7 ptm -98.25 115.94 29.44 Favored 'General case' 0 CA--C 1.475 -1.91 0 CA-C-O 123.474 1.607 . . . . 0.0 112.07 -176.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.91 -173.22 2.24 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-N 111.226 -2.716 . . . . 0.0 109.819 -178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.03 -73.48 0.2 Allowed Glycine 0 C--N 1.267 -3.271 0 CA-C-N 114.12 -1.4 . . . . 0.0 111.283 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -166.62 167.95 39.85 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.605 ' O ' ' HA3' ' A' ' 15' ' ' GLY . 75.1 mmtt -122.4 143.41 49.68 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 117.07 0.435 . . . . 0.0 110.169 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.43 137.02 5.16 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.655 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.428 HG22 ' HA2' ' A' ' 79' ' ' GLY . 12.8 p -80.95 -77.44 0.2 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.014 0.435 . . . . 0.0 111.031 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.6 mtm105 -65.29 -41.94 93.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.298 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.9 mmt -139.7 148.9 43.0 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.953 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 10' ' ' LYS . . . -161.5 131.26 2.53 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.195 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.81 -0.42 68.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 121.0 -0.619 . . . . 0.0 113.052 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.8 t -122.33 123.2 68.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.053 0.454 . . . . 0.0 111.088 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -163.41 178.53 8.01 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.97 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 22' ' ' ILE . 23.4 tptp 60.34 67.8 1.54 Allowed Pre-proline 0 CA--C 1.542 0.648 0 O-C-N 123.568 0.542 . . . . 0.0 110.147 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -60.75 -7.54 7.66 Favored 'Trans proline' 0 N--CA 1.482 0.819 0 C-N-CA 123.76 2.973 . . . . 0.0 113.517 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.536 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 64.3 mt -88.11 10.76 18.16 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 19' ' ' LYS . 97.8 mt -63.87 126.81 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 173.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 62.6 mttp -102.32 141.15 35.62 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 122.264 1.03 . . . . 0.0 113.705 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.612 HD21 HD12 ' A' ' 184' ' ' LEU . 86.4 mt -125.41 110.25 13.72 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.222 175.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.8 m 61.38 33.44 18.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.047 0.451 . . . . 0.0 111.657 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.09 -20.01 39.19 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 115.904 1.121 . . . . 0.0 115.904 174.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.678 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . 89.6 mtt180 -117.71 152.31 35.5 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-N 119.235 1.518 . . . . 0.0 112.327 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.536 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 81.7 m -75.27 162.45 28.43 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.779 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 100' ' ' SER . 88.6 mt -59.86 -40.67 89.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.051 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.668 HG12 HD11 ' A' ' 60' ' ' ILE . 3.8 tp -59.77 -43.08 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.117 177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.638 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 9.9 t70 -62.86 -44.08 97.07 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.292 0.568 . . . . 0.0 110.029 -178.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CE1' ' HB2' ' A' ' 27' ' ' ARG . 23.9 m-85 -65.11 -33.3 75.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.646 177.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.627 ' HA ' ' NZ ' ' A' ' 106' ' ' LYS . 69.7 t -71.9 -44.61 67.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.606 176.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 30' ' ' ILE . 72.2 t -64.57 -43.76 96.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.549 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 73.4 m -52.22 -54.61 39.71 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -173.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 42.4 Cg_exo -62.41 -41.91 30.66 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.11 1.874 . . . . 0.0 112.479 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.565 HD11 HG11 ' A' ' 98' ' ' VAL . 87.2 mt -67.11 -40.28 86.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.087 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.473 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.2 tt -62.28 -46.3 89.43 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.0 0.429 . . . . 0.0 109.891 179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -74.61 -17.15 60.75 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.404 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.429 ' CB ' HG21 ' A' ' 110' ' ' ILE . 78.7 p -70.69 170.05 13.16 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.185 0.517 . . . . 0.0 111.757 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -71.85 24.77 0.05 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 CA-C-N 115.366 -0.834 . . . . 0.0 113.1 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.0 m -91.92 162.38 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.828 -0.545 . . . . 0.0 110.767 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 64.5 t30 -72.27 -76.68 0.11 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.619 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -125.9 160.19 30.57 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 120.952 0.406 . . . . 0.0 110.438 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 3' ' ' ALA . 49.0 mm -108.4 116.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.152 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 90.7 m-85 -109.72 116.97 32.69 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.581 HG21 HD13 ' A' ' 60' ' ' ILE . 95.8 mt -98.15 119.85 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.448 0 CA-C-O 121.562 0.696 . . . . 0.0 111.039 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.479 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -95.19 119.8 34.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.984 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.3 p -125.95 150.99 47.58 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.419 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 75' ' ' THR . 54.8 m -83.77 152.2 62.58 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.009 -177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.32 -18.43 63.16 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.152 2.568 . . . . 0.0 111.4 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -89.95 -0.63 57.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.6 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -141.32 68.17 26.3 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 97.5 Cg_endo -104.65 85.67 0.02 OUTLIER 'Trans proline' 1 N--CA 1.382 -5.056 0 C-N-CA 116.845 -1.637 . . . . 0.0 108.889 167.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.685 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 35.1 mmtp -144.94 -50.14 0.26 Allowed 'General case' 1 C--N 1.224 -4.857 0 CA-C-N 110.299 -3.137 . . . . 0.0 103.78 -179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.517 ' HA ' HD21 ' A' ' 21' ' ' LEU . 68.4 m -62.41 -45.8 91.46 Favored 'General case' 0 N--CA 1.395 -3.194 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 163.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.2 tttt -61.95 -50.86 70.42 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.896 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.685 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 9.3 pt-20 -63.12 -32.19 73.51 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 117.432 -1.707 . . . . 0.0 112.039 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -62.59 -50.5 71.04 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 120.91 0.386 . . . . 0.0 111.466 176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.668 HD11 HG12 ' A' ' 30' ' ' ILE . 92.1 mt -63.29 -43.75 98.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.104 -176.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.4 t-20 -57.65 -43.71 85.12 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.5 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.656 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 31.8 t -71.82 -43.07 66.23 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.347 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.8 -39.48 93.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.347 0.594 . . . . 0.0 110.891 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 90.2 m-85 -111.6 41.65 1.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.006 -176.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.656 ' HG3' ' O ' ' A' ' 62' ' ' SER . 58.5 mtmt -61.3 -21.79 64.28 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.261 0.553 . . . . 0.0 110.423 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -91.2 10.59 26.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.4 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.434 ' HD2' ' O ' ' A' ' 64' ' ' TYR . 35.3 p90 -35.62 113.79 0.22 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -174.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.51 ' C ' ' HD3' ' A' ' 68' ' ' LYS . 4.6 tmtm? -93.16 -51.93 4.8 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.066 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.473 HD21 ' HG ' ' A' ' 38' ' ' LEU . 27.2 p-10 -118.74 13.92 13.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.767 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.19 126.48 56.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.403 0.62 . . . . 0.0 111.527 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 66.8 t -126.06 133.1 69.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 114.99 -1.004 . . . . 0.0 108.577 176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -107.56 132.71 54.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.386 0.612 . . . . 0.0 110.564 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.479 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.8 pt -127.34 155.28 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.426 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -118.11 131.18 56.44 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.222 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.597 ' O ' ' HA ' ' A' ' 50' ' ' SER . 13.0 t -165.41 -173.66 2.89 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 122.137 0.97 . . . . 0.0 113.582 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 78' ' ' LYS . 48.9 m -64.67 3.48 0.51 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.404 2.282 . . . . 0.0 115.497 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -28.14 -29.36 0.01 OUTLIER Glycine 1 N--CA 1.519 4.186 0 C-N-CA 126.434 1.969 . . . . 0.0 117.602 -169.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 76' ' ' SER . 53.6 tptt -58.08 -38.91 77.26 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.428 ' HA2' HG22 ' A' ' 12' ' ' THR . . . -100.46 114.58 5.05 Favored Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -59.74 -47.77 84.33 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -173.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.63 -49.01 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.629 0.728 . . . . 0.0 109.797 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.7 -47.16 86.74 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.631 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.591 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 6.4 t0 -61.12 -51.9 67.15 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.733 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.5 mm? -58.29 -44.99 88.74 Favored 'General case' 0 C--O 1.197 -1.658 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.805 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.415 ' HA ' HG12 ' A' ' 88' ' ' ILE . 4.4 m120 -58.29 -46.49 85.99 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.083 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -63.91 -46.97 82.42 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.176 177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 96.4 m -63.6 -43.47 96.81 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.194 -177.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 84' ' ' LEU . 35.8 pt -65.73 -30.86 51.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 CA-C-O 120.855 0.36 . . . . 0.0 110.27 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.94 -39.67 97.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.983 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -74.99 -34.75 62.0 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.579 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 74.6 m-85 -76.16 142.65 41.51 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -176.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.9 m -103.69 1.14 31.49 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.981 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 36.5 mt-10 -138.39 160.86 62.07 Favored Pre-proline 0 CA--C 1.503 -0.847 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.464 -176.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.608 ' O ' ' HB2' ' A' ' 1' ' ' MET . 42.9 Cg_endo -68.19 145.4 66.37 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.808 1.672 . . . . 0.0 109.792 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -145.21 161.91 38.38 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.201 0.524 . . . . 0.0 112.192 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.599 HD23 HG22 ' A' ' 156' ' ' VAL . 93.3 mt -85.63 149.74 25.11 Favored 'General case' 0 C--O 1.203 -1.353 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.693 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.639 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 90.9 t -120.77 125.47 74.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 5' ' ' ILE . 6.1 m -131.44 162.4 39.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 119.731 -0.788 . . . . 0.0 112.325 -177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.517 ' HB3' ' OD1' ' A' ' 101' ' ' ASP . 49.0 m -99.45 143.3 29.86 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.16 175.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 78.2 p -73.15 -10.01 59.32 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.299 0.571 . . . . 0.0 111.605 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.517 ' OD1' ' HB3' ' A' ' 99' ' ' SER . 4.7 p-10 -101.41 16.78 24.51 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.251 -176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.1 mt -90.45 117.17 28.94 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 122.007 -0.433 . . . . 0.0 110.619 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 47.4 pt -69.93 -172.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.782 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -75.44 -175.42 2.79 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 31.1 tp 80.73 24.32 0.32 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 110.023 -178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.627 ' NZ ' ' HA ' ' A' ' 33' ' ' VAL . 50.0 mtmt -98.79 -1.86 39.36 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.829 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.0 m -58.07 -43.75 87.17 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -170.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.8 pttm -86.82 -20.64 27.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG12 ' A' ' 113' ' ' ILE . 43.2 mm -63.73 -45.73 96.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.961 -175.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.429 HG21 ' CB ' ' A' ' 40' ' ' SER . 58.3 mt -59.52 -48.58 86.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.556 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -63.92 -39.67 94.71 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.084 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 73.2 m -62.45 -38.04 88.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.855 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.734 HG12 ' O ' ' A' ' 109' ' ' ILE . 46.6 mm -59.61 -48.23 88.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 121.219 0.533 . . . . 0.0 109.932 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.53 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 78.7 t -62.71 -49.51 83.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.495 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -63.02 -41.97 99.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.287 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.518 ' CE2' HD11 ' A' ' 120' ' ' ILE . 46.0 t80 -63.92 -46.68 83.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.148 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -59.46 -47.69 84.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.989 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.53 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 27.2 m-85 -61.02 -36.88 80.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.169 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.8 t -62.21 -45.37 93.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.455 0.645 . . . . 0.0 109.71 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.576 HG21 ' HG3' ' A' ' 167' ' ' GLU . 84.7 mt -63.38 -49.22 83.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.497 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -64.64 -25.0 67.77 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -179.271 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -42.59 99.38 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.552 176.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -83.83 -34.33 24.7 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.528 -0.469 . . . . 0.0 110.65 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 54.4 m -137.73 97.23 10.26 Favored Pre-proline 0 N--CA 1.441 -0.918 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.33 -13.4 39.27 Favored 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.049 2.499 . . . . 0.0 111.831 -178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -61.69 -29.64 70.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.425 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.553 ' HA ' ' HD2' ' A' ' 165' ' ' LYS . 85.7 t -67.21 126.48 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.214 0.531 . . . . 0.0 110.681 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.509 ' HB3' ' OG ' ' A' ' 158' ' ' SER . 39.8 mt-10 -108.25 -25.22 11.15 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.798 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -138.69 160.7 38.99 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.115 0.483 . . . . 0.0 112.111 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -135.96 132.21 36.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.174 -178.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -122.28 135.41 54.73 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 113' ' ' ILE . 59.0 t -113.72 119.19 60.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 177.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -146.22 157.88 43.85 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.563 -177.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.649 HG12 ' HB2' ' A' ' 152' ' ' ALA . 37.8 pt -134.07 157.83 76.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.595 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.97 139.08 89.13 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.446 2.098 . . . . 0.0 112.054 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.641 ' O ' ' HD2' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -62.66 -21.15 65.5 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.83 179.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -59.33 -38.76 81.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.589 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -99.12 -20.26 16.76 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-O 120.984 0.421 . . . . 0.0 110.974 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -63.23 133.18 95.36 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.35 -63.14 0.29 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.684 2.256 . . . . 0.0 112.883 -175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -161.61 154.52 17.35 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.2 71.28 2.29 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.699 2.266 . . . . 0.0 111.481 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 179' ' ' ASN . 70.1 m -60.02 -36.52 77.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.255 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 50.7 mm -58.7 -27.82 35.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.134 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.2 t70 73.14 26.77 2.09 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.147 0.979 . . . . 0.0 110.188 -178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.72 124.51 44.42 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.6 -1.182 . . . . 0.0 107.848 176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -82.59 177.31 8.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.097 0.475 . . . . 0.0 112.14 -175.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 95.39 -134.33 11.88 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 mp -89.88 146.5 24.37 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.843 0.354 . . . . 0.0 110.097 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' MET . 27.6 m -118.32 138.54 25.77 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.348 -176.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.65 144.18 53.81 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.496 2.13 . . . . 0.0 111.501 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.649 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -116.49 -2.67 11.96 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -174.71 -127.29 1.0 Allowed Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 118.724 -1.703 . . . . 0.0 114.163 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.59 HG21 HD13 ' A' ' 96' ' ' LEU . 4.0 mp -101.63 140.43 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.271 0 CA-C-O 121.591 0.71 . . . . 0.0 111.918 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.639 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.4 t-20 -109.13 155.49 20.95 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.397 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.599 HG22 HD23 ' A' ' 96' ' ' LEU . 87.9 t -124.58 135.74 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 122.905 0.482 . . . . 0.0 110.467 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.16 151.41 30.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-O 120.79 0.328 . . . . 0.0 110.566 174.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 128' ' ' GLU . 82.9 p -90.8 163.18 31.01 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.037 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 71.9 Cg_endo -75.75 63.25 6.59 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.385 2.057 . . . . 0.0 112.426 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.421 ' HG3' ' OE2' ' A' ' 128' ' ' GLU . 33.6 mmtp -110.89 -172.77 2.1 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.674 178.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -143.03 120.23 11.49 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 173.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.35 -125.49 5.79 Favored Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.242 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -112.99 142.41 45.71 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.03 152.3 47.45 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.852 -172.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.553 ' HD2' ' HA ' ' A' ' 127' ' ' VAL . 9.1 tmtm? -76.75 125.98 30.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -123.67 136.48 54.5 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.987 -174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.576 ' HG3' HG21 ' A' ' 120' ' ' ILE . 24.8 mm-40 -95.77 164.01 12.93 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 121.328 0.585 . . . . 0.0 112.058 177.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -114.71 131.04 68.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.427 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.461 ' HB3' HG22 ' A' ' 132' ' ' VAL . 44.1 ttm -116.75 135.49 53.72 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.645 175.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.2 t -112.31 126.45 69.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.645 HD12 ' HG2' ' A' ' 173' ' ' GLU . 42.7 pt -119.28 175.48 3.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.407 -178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -122.13 3.3 9.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.132 0.491 . . . . 0.0 111.496 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.645 ' HG2' HD12 ' A' ' 171' ' ' ILE . 1.8 pm0 -98.78 137.03 37.97 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.621 0.724 . . . . 0.0 111.262 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.2 mt -95.86 150.59 20.25 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.599 -1.182 . . . . 0.0 112.831 -176.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 11.0 pt -127.18 153.94 36.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.512 176.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -119.67 107.61 13.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.534 ' HB2' ' CB ' ' A' ' 143' ' ' SER . 7.3 m120 -74.51 -35.3 63.19 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.606 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.508 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 86.1 mt 79.98 96.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.772 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 143' ' ' SER . 27.3 t-20 -110.28 -19.38 13.01 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.933 -1.03 . . . . 0.0 108.697 175.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 50.2 p -126.33 162.24 25.97 Favored 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.096 -174.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.71 -35.07 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.956 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -62.07 -41.78 98.52 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.568 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 73.3 m-20 -63.96 -41.73 97.49 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 121.249 0.547 . . . . 0.0 109.571 178.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.612 HD12 HD21 ' A' ' 24' ' ' LEU . 60.0 tp -61.51 -48.35 81.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.194 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.523 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 62.9 tttm -63.4 -44.33 94.97 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.138 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.3 tt -61.66 -44.65 96.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.948 0.404 . . . . 0.0 110.02 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -61.81 -42.47 99.06 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.705 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.523 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.3 pt-20 -70.97 -36.11 72.4 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 120.402 -0.519 . . . . 0.0 111.035 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 95.0 mtp -63.99 -42.37 97.21 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.5 pp -65.19 -36.02 82.89 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.955 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.437 ' N ' HD12 ' A' ' 190' ' ' LEU . 95.0 mt -63.48 -46.14 87.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -70.61 -43.52 69.15 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.71 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -63.89 -39.51 94.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 111.763 0.283 . . . . 0.0 111.763 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -67.28 -26.55 66.61 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.166 0.508 . . . . 0.0 111.096 -178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -86.43 -11.94 70.91 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.921 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.7 pp . . . . . 0 C--O 1.271 2.21 0 CA-C-O 117.63 -1.176 . . . . 0.0 112.601 -179.241 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 ttm . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 42.6 m-20 -96.52 165.91 11.94 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.81 137.87 51.75 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.677 -0.809 . . . . 0.0 112.7 -177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 98' ' ' VAL . 8.5 mt -96.58 135.78 38.01 Favored 'General case' 0 CA--C 1.479 -1.765 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.785 174.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.586 ' HA ' HG22 ' A' ' 98' ' ' VAL . 75.7 mt -127.59 100.03 5.82 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 7.4 ptm -95.5 99.08 11.02 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 123.269 1.509 . . . . 0.0 112.248 -174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -114.0 110.53 20.2 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 112.378 -2.192 . . . . 0.0 109.615 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.23 -2.36 5.44 Favored Glycine 0 C--N 1.291 -1.966 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.722 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.66 73.26 1.67 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.322 -0.466 . . . . 0.0 113.134 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -139.95 123.12 16.85 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.15 -13.94 59.69 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.175 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -83.9 169.87 14.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.695 0.283 . . . . 0.0 111.196 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -86.39 -148.35 0.13 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 0.0 111.081 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 9.7 tpt -69.25 76.47 0.36 Allowed 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.606 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.94 176.26 42.57 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.22 -121.7 27.49 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -77.5 93.94 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 172.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 36.8 tt0 -60.42 -50.14 74.78 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.983 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.524 ' O ' HG13 ' A' ' 22' ' ' ILE . 99.0 mttt -143.42 129.8 10.35 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 25.4 Cg_exo -68.71 -11.22 31.3 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.406 2.071 . . . . 0.0 109.08 168.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.588 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 73.4 mt -95.93 18.27 13.64 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.471 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 19' ' ' LYS . 95.1 mt -62.83 118.81 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 CA-C-O 121.883 0.849 . . . . 0.0 109.296 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 58.4 pttt -86.14 131.2 34.3 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.789 -1.55 . . . . 0.0 112.991 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.1 mt -132.57 125.46 30.55 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.573 -1.648 . . . . 0.0 108.737 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 52.28 30.0 7.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 100.45 -9.19 58.96 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.509 -0.853 . . . . 0.0 115.063 176.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.702 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.7 mtt180 -127.01 153.84 45.4 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 118.826 1.313 . . . . 0.0 111.846 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 77.3 m -80.26 164.09 23.49 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.878 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 33' ' ' VAL . 77.6 mt -59.05 -43.99 91.75 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.919 0.39 . . . . 0.0 110.075 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -61.58 -39.88 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.874 178.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.702 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 12.3 t70 -64.55 -43.61 93.4 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.276 0.56 . . . . 0.0 110.193 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' HB2' ' A' ' 27' ' ' ARG . 7.5 m-85 -63.24 -34.17 77.08 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.622 177.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.8 t -69.34 -42.12 81.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 120.915 0.388 . . . . 0.0 110.543 176.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 30' ' ' ILE . 66.2 t -62.45 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.793 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.553 ' O ' ' HG2' ' A' ' 39' ' ' LYS . 67.8 m -53.47 -52.29 68.05 Favored Pre-proline 0 CA--C 1.561 1.368 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -172.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 35' ' ' SER . 53.2 Cg_exo -60.33 -43.1 36.57 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 121.789 1.66 . . . . 0.0 112.484 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.586 HD11 HG11 ' A' ' 98' ' ' VAL . 93.2 mt -66.68 -38.31 86.52 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 110.563 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.613 HD12 HD21 ' A' ' 69' ' ' ASN . 62.1 tp -59.33 -44.7 92.58 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.385 178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.553 ' HG2' ' O ' ' A' ' 35' ' ' SER . 61.1 pttt -91.18 -4.39 56.14 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 80.8 p -82.46 -176.55 6.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.177 0.513 . . . . 0.0 111.071 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -54.22 -22.45 11.59 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.642 1.177 . . . . 0.0 112.23 178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.5 t -54.49 137.59 15.32 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -175.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.512 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -72.0 -79.44 0.07 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.242 -1.345 . . . . 0.0 111.153 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.466 HD22 ' C ' ' A' ' 43' ' ' ASN . 0.9 OUTLIER -115.58 155.76 27.02 Favored 'General case' 0 CA--C 1.506 -0.739 0 CA-C-O 121.258 0.552 . . . . 0.0 110.567 176.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.9 mm -107.05 116.05 49.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.046 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 116.54 32.14 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.796 HG21 HD13 ' A' ' 60' ' ' ILE . 82.1 mt -98.96 116.69 42.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 -177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.497 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.38 123.99 32.92 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 114.149 -1.387 . . . . 0.0 110.17 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 54.5 p -129.26 161.9 29.14 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.664 179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.7 m -117.12 151.4 47.62 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.895 -178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.82 -19.08 53.22 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.867 2.378 . . . . 0.0 111.245 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -80.15 -10.86 59.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.5 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -140.76 66.7 27.69 Favored Pre-proline 0 N--CA 1.435 -1.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.558 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 98.2 Cg_endo -102.64 88.8 0.03 OUTLIER 'Trans proline' 1 N--CA 1.376 -5.41 0 C-N-CA 117.197 -1.402 . . . . 0.0 110.345 171.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -150.9 -47.35 0.12 Allowed 'General case' 1 C--N 1.205 -5.699 0 CA-C-N 110.368 -3.106 . . . . 0.0 102.865 176.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.416 ' HA ' HD21 ' A' ' 21' ' ' LEU . 99.4 m -63.38 -48.27 78.58 Favored 'General case' 0 N--CA 1.386 -3.64 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.679 164.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 87.9 tttt -62.91 -45.12 94.02 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.522 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 54' ' ' PRO . 32.0 mm-40 -57.3 -43.52 83.3 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.182 -1.407 . . . . 0.0 110.975 176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -60.98 -51.59 68.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.845 0.355 . . . . 0.0 111.89 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.796 HD13 HG21 ' A' ' 47' ' ' ILE . 87.2 mt -63.98 -45.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.736 -176.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 65' ' ' LYS . 54.9 t-20 -58.8 -39.38 80.97 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.306 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.1 t -86.74 -31.1 21.14 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.831 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.17 -34.67 20.47 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -175.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.408 ' CD2' HG23 ' A' ' 60' ' ' ILE . 91.8 m-85 -103.6 6.82 37.46 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.892 -175.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 61' ' ' ASN . 65.4 pttt -61.32 -23.7 65.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.374 0.607 . . . . 0.0 110.835 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -70.46 -33.58 71.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.536 177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -80.15 140.81 36.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.334 0.588 . . . . 0.0 112.38 -173.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -86.9 -43.53 12.36 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.606 -179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.613 HD21 HD12 ' A' ' 38' ' ' LEU . 15.9 p-10 -82.14 -0.77 46.37 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.677 -0.409 . . . . 0.0 111.949 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.8 mt -106.37 121.25 58.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 73.2 t -123.28 130.68 74.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.248 -175.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.2 p -98.38 131.59 45.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.497 HG13 ' HA ' ' A' ' 48' ' ' ALA . 40.6 pt -126.89 156.71 38.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 CA-C-O 121.267 0.556 . . . . 0.0 110.573 -178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -117.08 134.22 55.03 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 8.9 t -158.42 -171.16 3.35 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 78' ' ' LYS . 70.1 m -66.69 1.86 1.61 Allowed 'General case' 0 C--O 1.202 -1.447 0 C-N-CA 126.696 1.999 . . . . 0.0 114.774 -174.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.594 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.37 -24.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.056 0 C-N-CA 125.877 1.703 . . . . 0.0 116.841 -174.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 76' ' ' SER . 12.0 tmtt? -53.31 -33.83 54.94 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -118.06 120.23 4.66 Favored Glycine 0 N--CA 1.44 -1.074 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 173.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -59.22 -50.55 73.57 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -173.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 50.9 mm -64.08 -44.8 97.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.94 0.876 . . . . 0.0 109.823 -178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -60.96 -42.02 97.47 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.879 -1.509 . . . . 0.0 110.71 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.594 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 8.0 t0 -58.68 -50.94 72.01 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.17 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.563 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.6 mm? -58.78 -42.59 89.34 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.998 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.532 ' HA ' HG12 ' A' ' 88' ' ' ILE . 17.8 m-80 -59.98 -41.27 91.66 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 67.0 mm-40 -64.52 -44.84 89.6 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.271 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 92.3 m -63.47 -44.75 93.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.418 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 160' ' ' LYS . 24.6 pt -65.06 -28.42 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.946 0.403 . . . . 0.0 110.79 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.61 -37.77 94.75 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.455 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -97.56 -2.23 42.18 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -97.51 156.74 16.36 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.752 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.7 m -118.58 1.25 11.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.33 0.586 . . . . 0.0 110.635 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -134.09 155.22 80.27 Favored Pre-proline 0 CA--C 1.502 -0.878 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.249 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -56.65 141.92 91.21 Favored 'Trans proline' 0 C--O 1.24 0.614 0 C-N-CA 122.868 2.379 . . . . 0.0 110.509 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.499 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 42.2 p90 -141.83 158.4 43.84 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.372 0.606 . . . . 0.0 111.755 -178.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.555 HD13 ' N ' ' A' ' 97' ' ' VAL . 0.9 OUTLIER -86.03 143.84 27.9 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.118 -175.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 75.6 t -120.32 130.73 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.935 0.894 . . . . 0.0 109.765 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.586 HG22 ' HA ' ' A' ' 5' ' ' ILE . 18.7 m -131.34 159.64 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.514 0.674 . . . . 0.0 112.774 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.553 ' HB3' ' CD2' ' A' ' 102' ' ' LEU . 42.3 t -99.97 153.72 18.96 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' HG21 ' A' ' 33' ' ' VAL . 80.5 p -88.58 -0.19 57.0 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 -173.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 24.7 p-10 -108.82 -3.59 17.57 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 114.949 1.462 . . . . 0.0 114.949 -174.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.553 ' CD2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER -87.98 115.28 25.34 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.181 177.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.3 pt -96.27 8.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.72 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.536 ' CB ' HG22 ' A' ' 175' ' ' ILE . 21.9 t-20 -55.93 143.88 30.32 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.126 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 105' ' ' LEU . 4.4 mm? -69.61 80.0 0.42 Allowed 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 122.169 0.985 . . . . 0.0 109.257 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -74.38 -1.08 19.38 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.574 -1.648 . . . . 0.0 113.724 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.7 t -57.31 -45.34 84.31 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -76.95 -26.33 53.87 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.588 0.708 . . . . 0.0 109.841 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 113' ' ' ILE . 37.6 mm -69.73 -43.0 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.646 -174.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.425 ' HA ' HD11 ' A' ' 154' ' ' ILE . 63.5 mt -58.62 -48.54 85.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.381 -177.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -64.6 -41.23 96.37 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.252 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 68.0 m -62.9 -39.38 94.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.086 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.769 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.5 mm -61.01 -47.87 91.67 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.191 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 76.9 t -61.99 -47.57 92.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.433 -178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -61.91 -43.7 98.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.081 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.571 ' CD2' ' HE2' ' A' ' 169' ' ' MET . 83.2 t80 -63.86 -49.02 74.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.9 0.381 . . . . 0.0 111.04 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -59.57 -47.8 84.14 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.89 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.663 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 31.8 m-85 -65.83 -31.4 72.33 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.028 178.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 42.6 t -62.93 -45.07 94.21 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.478 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.9 mt -63.22 -49.44 83.12 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.166 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.329 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.663 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 14.8 ptmt -63.64 -23.43 67.37 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.938 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.34 -41.86 97.75 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.53 176.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -92.11 -41.3 10.56 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.203 0.525 . . . . 0.0 111.23 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 29.6 m -127.47 91.99 44.48 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.54 -12.0 32.35 Favored 'Trans proline' 0 C--N 1.332 -0.335 0 C-N-CA 122.595 2.197 . . . . 0.0 112.508 -176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.451 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 23.3 t70 -64.86 -28.84 69.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.123 -178.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 124' ' ' THR . 7.7 p -54.13 130.06 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.19 0.519 . . . . 0.0 111.32 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.6 ' HB3' ' OE1' ' A' ' 164' ' ' GLN . 47.1 mt-10 -115.01 -12.52 11.98 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.057 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -155.2 163.34 40.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 120.939 0.4 . . . . 0.0 111.612 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 130' ' ' LEU . 0.4 OUTLIER -138.89 133.3 31.74 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.752 -178.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -123.6 139.13 54.31 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.808 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 113' ' ' ILE . 58.4 t -118.22 122.67 70.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.115 0.484 . . . . 0.0 110.505 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -145.0 166.67 24.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.695 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.444 ' HB ' ' HD2' ' A' ' 135' ' ' PRO . 9.1 pt -124.39 158.53 61.11 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.645 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 32.3 Cg_endo -64.97 129.47 23.25 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 121.885 1.723 . . . . 0.0 112.119 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -61.09 -35.74 77.79 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.453 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -59.75 -37.37 78.81 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.839 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -88.57 -22.65 23.43 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.217 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -79.71 118.86 74.63 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.518 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -78.98 53.28 4.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.81 2.34 . . . . 0.0 113.418 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 64.93 140.85 0.06 OUTLIER Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 123.253 0.621 . . . . 0.0 112.103 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -75.81 -78.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.735 1.624 . . . . 0.0 113.282 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.466 ' HB3' ' OD1' ' A' ' 179' ' ' ASN . 57.1 p -131.8 20.75 4.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.276 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 75.7 mt 67.53 82.78 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -147.15 -166.11 2.42 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -63.91 137.33 57.97 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.513 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -92.56 134.21 35.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.204 0.526 . . . . 0.0 111.444 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -170.4 -131.16 1.29 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.01 143.04 27.13 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.319 0.559 . . . . 0.0 109.577 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.33 98.42 50.43 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-O 121.351 0.596 . . . . 0.0 112.475 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -61.09 142.03 95.79 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.713 2.275 . . . . 0.0 110.595 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.445 ' HB3' HD11 ' A' ' 171' ' ' ILE . . . -126.91 -47.36 1.52 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.111 0.482 . . . . 0.0 111.29 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -88.33 -153.49 26.42 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.457 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.552 ' HB ' HD11 ' A' ' 96' ' ' LEU . 20.2 pt -107.91 160.19 7.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 CA-C-N 115.217 -0.491 . . . . 0.0 110.296 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.8 t-20 -109.9 151.83 26.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.864 -172.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.4 t -123.35 131.75 72.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 122.963 0.505 . . . . 0.0 110.097 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.465 HG13 ' OD1' ' A' ' 155' ' ' ASN . 23.5 m -131.83 150.98 34.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.186 0.517 . . . . 0.0 111.238 177.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.576 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 59.7 m -97.55 160.78 27.91 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.613 174.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 158' ' ' SER . 74.1 Cg_endo -74.06 52.5 2.68 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.672 2.248 . . . . 0.0 111.963 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.64 ' O ' HD12 ' A' ' 88' ' ' ILE . 30.1 mmmt -112.61 109.41 18.93 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -61.99 146.37 50.29 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.281 0.363 . . . . 0.0 111.284 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 88.13 -146.05 19.49 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -104.58 141.59 36.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 120.917 0.389 . . . . 0.0 110.002 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.6 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 27.5 pt20 -133.84 160.8 36.54 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.82 -176.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -59.37 118.69 6.28 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.019 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -120.9 126.28 49.62 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.134 -177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -94.52 164.14 13.11 Favored 'General case' 0 CA--C 1.472 -2.021 0 CA-C-O 121.773 0.797 . . . . 0.0 112.509 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -112.96 130.2 67.23 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 114.231 -1.349 . . . . 0.0 112.745 -173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.571 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 46.6 ttm -114.14 130.21 56.6 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.046 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.1 t -109.53 123.11 65.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.53 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 42.4 pt -112.45 173.22 2.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.768 -177.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -121.96 1.72 9.86 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.605 0.717 . . . . 0.0 110.288 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.53 ' OE2' ' HB ' ' A' ' 171' ' ' ILE . 2.2 pm0 -98.73 134.18 42.0 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.049 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.77 149.61 21.06 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.561 -178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.536 HG22 ' CB ' ' A' ' 104' ' ' ASN . 1.9 pp -104.08 154.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.559 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -108.16 113.55 26.77 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 101' ' ' ASP . 97.6 m-20 -113.43 153.44 28.62 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.002 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 47.7 mm -91.67 109.88 21.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 143' ' ' SER . 45.1 m-80 -104.63 -34.63 8.1 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.492 0.663 . . . . 0.0 109.67 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.6 t -149.47 -178.5 6.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.54 -177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.486 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -62.58 -36.81 83.87 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 122.826 0.45 . . . . 0.0 111.973 -177.401 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 185' ' ' LYS . 29.9 m-20 -60.37 -36.02 77.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.169 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 179' ' ' ASN . 58.6 m-20 -61.69 -33.94 74.88 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.936 178.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.629 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 97.7 mt -61.29 -42.36 98.52 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.47 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -61.85 -41.85 98.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.831 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.08 -47.87 84.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.201 175.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.418 ' O ' ' HG ' ' A' ' 191' ' ' LEU . . . -60.91 -46.19 91.64 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.914 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 184' ' ' LEU . 9.0 pt-20 -68.9 -31.01 69.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.99 0.424 . . . . 0.0 110.998 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.9 ttm -61.58 -46.07 91.45 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.298 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.6 pp -72.89 -30.64 64.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.335 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 94.8 mt -64.43 -41.93 96.31 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.508 0.671 . . . . 0.0 109.624 176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . 0.425 ' C ' ' HD3' ' A' ' 192' ' ' LYS . 7.8 tmtm? -63.82 -39.6 94.62 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.104 175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -35.11 74.38 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.86 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.47 -26.94 68.16 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.4 0.619 . . . . 0.0 109.778 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -96.08 57.13 1.51 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.262 1.751 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.713 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.588 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.8 ptm . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.484 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 45.3 m-20 -104.83 165.71 10.88 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 120.614 0.245 . . . . 0.0 110.801 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.46 134.45 55.21 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.896 0.379 . . . . 0.0 111.181 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.37 126.25 51.9 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.603 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.666 ' HA ' HG22 ' A' ' 98' ' ' VAL . 70.4 mt -117.55 102.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.476 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 10.2 ptm -92.34 99.06 11.89 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.964 1.364 . . . . 0.0 111.3 -176.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' HG21 ' A' ' 56' ' ' THR . . . -114.87 96.7 5.84 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.895 -178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -155.57 33.15 0.63 Allowed Glycine 0 C--N 1.294 -1.799 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.6 173.04 45.66 Favored Glycine 0 N--CA 1.432 -1.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.41 86.88 7.28 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.359 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.37 -8.74 59.85 Favored Glycine 0 C--O 1.229 -0.168 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.045 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.1 t -60.46 -18.02 48.67 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -138.72 -76.11 0.37 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.15 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 25.4 mmt -113.84 -55.39 2.51 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.036 0.446 . . . . 0.0 111.202 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.42 168.96 44.63 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.435 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.27 -63.5 4.13 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.437 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.53 -39.72 82.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.977 0.418 . . . . 0.0 111.698 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -108.12 123.33 48.55 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -139.94 155.9 70.78 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.681 -175.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 60.3 Cg_endo -72.23 -4.18 14.72 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 123.224 2.616 . . . . 0.0 113.583 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 56' ' ' THR . 35.8 mt -82.22 16.85 1.83 Allowed 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.29 121.18 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.146 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -81.07 125.56 30.35 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 113.893 -1.503 . . . . 0.0 109.041 -177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 188' ' ' GLU . 31.3 tp -144.92 117.18 8.43 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.283 -175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.4 m 54.17 39.66 30.94 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.19 -27.12 10.44 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 115.339 0.895 . . . . 0.0 115.339 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.738 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 25.8 ptt180 -146.18 171.8 14.39 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.835 1.318 . . . . 0.0 111.941 -178.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.3 m -82.36 153.57 25.69 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.021 -178.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 33' ' ' VAL . 1.5 tt -53.51 -38.9 64.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.092 -178.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 14.0 tt -62.85 -39.67 85.85 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 C-N-CA 120.196 -0.601 . . . . 0.0 111.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.68 -39.55 94.3 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.738 ' CE2' ' HG3' ' A' ' 27' ' ' ARG . 27.5 m-85 -61.08 -35.41 76.92 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.493 174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 29' ' ' LEU . 76.5 t -71.3 -45.89 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.799 0.333 . . . . 0.0 111.41 176.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.88 -42.55 96.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.534 -177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -51.36 -55.43 28.97 Favored Pre-proline 0 CA--C 1.555 1.135 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 41.2 Cg_endo -67.86 -37.05 16.53 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.314 1.343 . . . . 0.0 112.584 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.659 HD11 HG11 ' A' ' 98' ' ' VAL . 78.9 mt -65.49 -42.18 92.44 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.414 ' HG ' HD21 ' A' ' 69' ' ' ASN . 8.4 tt -63.36 -45.03 93.06 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.965 0.412 . . . . 0.0 110.987 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 19.0 ptmt -79.04 -7.84 58.45 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -74.96 179.7 4.78 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.085 0.469 . . . . 0.0 111.047 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -59.32 -22.7 61.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 123.615 0.766 . . . . 0.0 112.934 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 m -62.0 160.75 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 113.313 0.857 . . . . 0.0 113.313 -174.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.484 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.5 t30 -83.09 -73.24 0.41 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.578 -176.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -116.69 156.71 26.65 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.037 0.446 . . . . 0.0 110.645 -178.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.86 115.4 49.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -106.79 117.9 35.26 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 60' ' ' ILE . 88.6 mt -100.05 118.92 47.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.609 0.718 . . . . 0.0 110.524 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.22 121.98 31.23 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.399 -178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 7' ' ' ALA . 73.0 p -129.83 166.76 19.29 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.738 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -130.92 158.12 75.97 Favored Pre-proline 0 C--N 1.298 -1.634 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.884 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.17 -21.06 72.26 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.633 2.222 . . . . 0.0 110.902 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -70.45 -23.17 62.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.817 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 p -138.17 68.36 48.16 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.715 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 69.9 Cg_endo -99.35 84.08 0.05 OUTLIER 'Trans proline' 1 N--CA 1.392 -4.492 0 C-N-CA 116.659 -1.761 . . . . 0.0 108.688 169.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.658 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 99.7 mttt -146.1 -52.18 0.24 Allowed 'General case' 1 C--N 1.222 -4.945 0 CA-C-N 109.568 -3.469 . . . . 0.0 102.799 -177.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.523 ' HA ' HD11 ' A' ' 21' ' ' LEU . 96.0 m -63.71 -47.37 81.42 Favored 'General case' 0 N--CA 1.385 -3.708 0 CA-C-N 112.487 -2.142 . . . . 0.0 106.493 164.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.715 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -62.39 -49.36 75.82 Favored 'General case' 0 C--N 1.347 0.5 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.148 178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.658 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 4.8 pt-20 -58.09 -36.58 73.07 Favored 'General case' 0 C--N 1.371 1.521 0 C-N-CA 117.564 -1.654 . . . . 0.0 111.526 176.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -63.68 -51.22 66.06 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-O 120.986 0.422 . . . . 0.0 111.63 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.839 HD13 HG21 ' A' ' 47' ' ' ILE . 89.6 mt -61.85 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.192 -174.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.725 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 54.6 t-20 -57.85 -45.3 86.47 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.694 -178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.2 t -73.49 -44.92 56.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.396 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.22 90.26 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.327 0.584 . . . . 0.0 111.349 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 68.2 m-85 -109.94 33.56 4.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.253 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.725 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 2.7 mmpt? -60.75 -25.49 66.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.997 0.427 . . . . 0.0 111.242 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -90.95 11.53 22.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.906 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 55.0 p90 -43.71 133.96 4.46 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -176.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.02 -48.97 3.89 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.414 HD21 ' HG ' ' A' ' 38' ' ' LEU . 26.7 p-10 -118.92 10.11 12.14 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.013 -177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 86.4 mt -100.66 122.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.606 0.717 . . . . 0.0 111.312 -177.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 86.5 t -121.78 130.68 74.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.802 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -101.06 131.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-O 121.198 0.523 . . . . 0.0 109.696 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.53 HG13 ' HA ' ' A' ' 48' ' ' ALA . 39.3 pt -125.78 155.81 35.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.086 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -118.65 131.3 56.17 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.196 -178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.7 t -160.12 -167.94 2.07 Favored 'General case' 0 C--N 1.283 -2.3 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 78' ' ' LYS . 51.6 m -64.03 1.96 0.61 Allowed 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 127.126 2.17 . . . . 0.0 114.556 -176.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -31.03 -18.76 0.0 OUTLIER Glycine 0 N--CA 1.514 3.851 0 C-N-CA 126.484 1.993 . . . . 0.0 117.265 -175.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' O ' ' HD2' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -58.23 -38.24 76.45 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 172.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -112.33 129.76 9.21 Favored Glycine 0 N--CA 1.451 -0.35 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -61.34 -51.25 69.64 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 46.9 pt -74.14 -30.32 26.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.004 -0.679 . . . . 0.0 111.746 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.07 -43.13 88.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.531 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.8 t0 -61.52 -50.83 71.11 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.947 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.519 ' O ' HG23 ' A' ' 88' ' ' ILE . 1.7 mm? -55.69 -47.83 76.12 Favored 'General case' 0 C--O 1.21 -0.988 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.925 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' HA ' HG12 ' A' ' 88' ' ' ILE . 15.0 m-80 -60.14 -42.86 95.77 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -65.56 -44.42 86.83 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.362 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 99.0 m -63.91 -42.0 97.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.225 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' A' ' 85' ' ' ASN . 22.3 pt -68.56 -23.67 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 110.374 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -74.02 -14.09 80.54 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.456 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -98.93 -0.52 42.05 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 159' ' ' PRO . 99.3 m-85 -126.5 150.08 48.97 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.658 -178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 55.0 m -109.9 3.48 20.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.599 0.714 . . . . 0.0 109.626 175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -128.92 153.34 80.1 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.498 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.92 148.75 76.95 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.679 2.253 . . . . 0.0 112.058 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.516 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 50.6 p90 -144.24 163.17 34.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.26 0.553 . . . . 0.0 111.79 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.556 HD21 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -85.63 140.92 30.17 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.735 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 79.6 t -117.29 133.41 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.174 0.99 . . . . 0.0 108.824 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 5' ' ' ILE . 14.1 m -128.39 162.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.88 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HB3' ' HG ' ' A' ' 102' ' ' LEU . 44.5 t -98.6 142.58 30.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 173.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 87.3 p -70.95 -13.26 61.95 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.9 p-10 -110.84 12.32 22.36 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' A' ' 99' ' ' SER . 70.4 mt -77.21 113.2 14.71 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.205 178.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 104' ' ' ASN . 19.0 tt -129.49 122.04 54.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.719 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 103' ' ' ILE . 63.4 t30 162.02 178.93 0.01 OUTLIER 'General case' 0 C--O 1.248 0.985 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.4 103.51 4.8 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.576 ' HA ' HD12 ' A' ' 109' ' ' ILE . 37.6 mtmm -99.79 -1.11 38.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.404 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -56.64 -41.11 76.62 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -169.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -85.07 -25.83 27.35 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.984 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.576 HD12 ' HA ' ' A' ' 106' ' ' LYS . 84.4 mt -65.62 -42.75 93.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.536 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.551 ' HA ' HD11 ' A' ' 154' ' ' ILE . 58.5 mt -59.71 -49.54 83.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 114.793 -1.094 . . . . 0.0 110.066 -178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -64.21 -38.85 92.51 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.157 -0.928 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.8 m -62.64 -42.39 99.57 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.55 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.0 mm -63.96 -48.31 86.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.097 0.475 . . . . 0.0 110.793 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.588 HG22 ' SD ' ' A' ' 1' ' ' MET . 79.2 t -60.75 -48.0 90.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.534 -178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -61.85 -47.5 84.78 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.301 -178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.513 ' CE2' HD11 ' A' ' 120' ' ' ILE . 44.7 t80 -64.42 -45.07 89.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -177.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 77.1 t80 -58.33 -48.62 79.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.229 177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.426 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 20.0 m-85 -60.68 -37.05 80.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.437 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.65 -44.72 96.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.279 0.561 . . . . 0.0 109.55 178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.552 ' CG2' HG21 ' A' ' 127' ' ' VAL . 74.8 mt -62.99 -43.5 99.11 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.801 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -60.1 -42.59 95.0 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.615 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.24 -43.53 96.01 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.457 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -83.03 -36.85 24.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.009 0.433 . . . . 0.0 111.797 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 59.7 m -133.66 89.36 31.07 Favored Pre-proline 0 C--N 1.314 -0.957 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 -177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -60.28 -15.51 35.35 Favored 'Trans proline' 0 N--CA 1.478 0.605 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.95 -31.96 70.35 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.206 0.603 . . . . 0.0 111.533 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.583 HG22 ' HE2' ' A' ' 165' ' ' LYS . 87.9 t -69.45 126.51 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.406 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -120.62 5.37 10.58 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.585 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.92 160.37 24.8 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.687 0.28 . . . . 0.0 111.205 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.544 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -137.46 129.5 29.07 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -129.05 142.08 51.02 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.347 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 152' ' ' ALA . 18.9 m -121.24 144.75 29.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-O 120.891 0.377 . . . . 0.0 110.439 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.455 ' C ' ' HB2' ' A' ' 152' ' ' ALA . 63.3 mtm -134.99 153.84 51.94 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.847 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 171' ' ' ILE . 9.3 pt -131.84 145.53 57.87 Favored Pre-proline 0 C--N 1.31 -1.132 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.026 174.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 51.4 Cg_exo -57.7 137.67 82.35 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.425 2.083 . . . . 0.0 113.12 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.456 ' HE3' ' OD1' ' A' ' 145' ' ' ASP . 25.0 ttmm -59.49 -39.44 83.79 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.794 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -62.27 -37.54 85.84 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -84.83 -23.09 29.23 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.389 -0.525 . . . . 0.0 111.311 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.09 125.03 91.81 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.648 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.82 126.44 13.94 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.971 1.781 . . . . 0.0 110.471 176.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 52.3 t-20 66.48 77.06 0.27 Allowed Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 122.174 0.988 . . . . 0.0 109.829 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -76.88 -1.69 11.86 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 C-N-CA 123.736 2.958 . . . . 0.0 112.336 -177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.8 t 60.1 40.79 18.01 Favored 'General case' 0 C--N 1.346 0.433 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 81.1 mt 65.26 -84.09 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.721 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.456 ' OD1' ' HE3' ' A' ' 136' ' ' LYS . 29.8 t70 -171.63 -77.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.011 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 58.65 26.16 14.17 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 0.0 111.933 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 61.89 19.27 10.53 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.194 0.598 . . . . 0.0 111.236 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.81 143.89 16.31 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.102 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.2 pp -90.54 160.1 16.14 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.9 m -108.7 137.36 20.01 Favored Pre-proline 0 C--N 1.311 -1.071 0 C-N-CA 120.925 -0.31 . . . . 0.0 110.5 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.45 146.76 56.82 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.264 1.976 . . . . 0.0 111.715 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.525 ' HB3' HG23 ' A' ' 132' ' ' VAL . . . -88.95 -10.22 48.55 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.782 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 161.48 -99.0 0.17 Allowed Glycine 0 N--CA 1.429 -1.772 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.748 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.556 HD12 HD21 ' A' ' 96' ' ' LEU . 30.6 pt -118.79 161.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-O 121.237 0.541 . . . . 0.0 112.23 -174.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.516 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 13.3 t-20 -119.54 156.59 30.0 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.476 -176.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.433 HG11 ' CD2' ' A' ' 117' ' ' PHE . 94.0 t -124.84 133.54 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 C-N-CA 122.334 0.253 . . . . 0.0 110.609 175.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.42 HG13 ' OD1' ' A' ' 155' ' ' ASN . 32.3 m -131.12 150.33 34.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.367 0.603 . . . . 0.0 111.988 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 69.3 m -98.92 159.13 31.03 Favored Pre-proline 0 C--N 1.312 -1.061 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.095 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.535 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 17.3 Cg_exo -68.15 91.28 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.335 0 C-N-CA 122.362 2.041 . . . . 0.0 112.037 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -125.19 -165.85 1.46 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.073 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -140.74 147.4 39.1 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 171.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.73 -116.82 5.84 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.033 -1.079 . . . . 0.0 111.261 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -129.87 145.27 51.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -134.36 163.89 28.65 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 127' ' ' VAL . 1.6 tmtp? -61.03 128.01 34.34 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.963 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -128.09 139.28 52.6 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.095 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -92.68 160.78 14.83 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-O 121.727 0.775 . . . . 0.0 111.996 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.83 129.2 75.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.394 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 14.7 tmm? -137.27 136.04 37.7 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.15 178.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.8 t -109.7 129.93 63.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.062 0.458 . . . . 0.0 110.769 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.4 pt -120.52 176.14 4.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.426 -177.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -127.55 69.54 1.31 Allowed 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.664 0.745 . . . . 0.0 109.128 175.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.525 ' HB2' HD12 ' A' ' 171' ' ' ILE . 77.5 mm-40 -128.59 143.59 50.99 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.205 -179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.95 140.63 31.2 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-O 121.985 0.898 . . . . 0.0 113.082 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.9 pt -139.55 151.44 22.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 113.833 -1.531 . . . . 0.0 107.435 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 103' ' ' ILE . 93.0 m-85 -120.55 107.93 13.44 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.176 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.457 ' OD1' HD23 ' A' ' 102' ' ' LEU . 98.0 m-20 -93.96 110.8 22.46 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.704 HG23 ' HB2' ' A' ' 183' ' ' ASP . 98.2 mt -81.32 114.44 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.354 0.597 . . . . 0.0 111.337 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -113.75 -20.97 10.94 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.944 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 73.1 p -131.59 164.9 24.83 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.269 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.752 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 0.5 OUTLIER -60.87 -27.63 68.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.104 176.311 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -68.58 -39.24 81.05 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.44 0.638 . . . . 0.0 109.95 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.704 ' HB2' HG23 ' A' ' 178' ' ' ILE . 71.9 m-20 -61.52 -33.57 74.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.514 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 178' ' ' ILE . 96.1 mt -59.95 -44.77 94.2 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-O 121.224 0.535 . . . . 0.0 109.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 7.8 tmtm? -67.5 -42.46 82.84 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.759 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 9.8 tt -62.09 -46.93 86.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.944 0.402 . . . . 0.0 110.102 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.5 -41.24 98.55 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.757 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 2.9 pp20? -68.02 -30.91 70.26 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.651 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 94.1 mmm -61.51 -43.8 98.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 3.4 pp -74.85 -39.74 61.41 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.127 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.3 -40.59 96.24 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.44 0.638 . . . . 0.0 110.275 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -61.99 -42.13 98.8 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.575 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 189' ' ' MET . 35.2 mmtp -66.18 -41.4 90.31 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 111.181 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -83.67 -26.21 30.04 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.196 0.522 . . . . 0.0 112.052 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -92.3 -1.82 68.89 Favored Glycine 0 C--N 1.31 -0.894 0 CA-C-N 115.886 -0.597 . . . . 0.0 114.307 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 61.3 tp . . . . . 0 C--O 1.269 2.084 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.786 -179.658 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 114' ' ' VAL . 8.1 ptm . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -113.53 165.11 12.82 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.433 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.565 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -117.29 142.69 46.76 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.298 -176.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 48' ' ' ALA . 30.2 tp -120.35 127.51 52.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.275 177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.683 ' HA ' HG22 ' A' ' 98' ' ' VAL . 64.5 mt -117.69 108.27 24.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.016 178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.412 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 60.4 ttm -82.31 92.71 7.01 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-O 121.84 0.829 . . . . 0.0 111.545 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.478 ' O ' HG22 ' A' ' 49' ' ' THR . . . -117.62 97.53 5.91 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.406 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.21 89.96 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.968 -1.11 . . . . 0.0 113.129 177.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.37 18.95 67.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.177 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -114.2 126.74 55.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.787 0.327 . . . . 0.0 111.203 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.4 119.51 0.92 Allowed Glycine 0 N--CA 1.44 -1.049 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 176.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m 65.92 91.1 0.09 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.226 0.536 . . . . 0.0 111.511 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 85.1 mtm180 66.46 -93.3 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 79.3 mtm -132.39 153.5 50.74 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.7 -161.76 44.56 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.14 149.35 7.82 Favored Glycine 0 C--N 1.31 -0.898 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.421 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.4 m -119.15 -7.01 11.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -110.54 143.65 40.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.556 0.694 . . . . 0.0 112.423 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -75.18 154.68 86.35 Favored Pre-proline 0 C--N 1.318 -0.788 0 CA-C-N 114.64 -1.164 . . . . 0.0 112.655 -176.293 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.518 ' HB2' ' HB ' ' A' ' 30' ' ' ILE . 24.4 Cg_exo -69.97 -5.7 16.95 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.119 3.213 . . . . 0.0 112.263 174.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.501 HD21 ' CB ' ' A' ' 59' ' ' TYR . 8.8 mp -77.23 26.87 0.15 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.3 mt -77.6 119.44 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -87.81 136.65 32.87 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-O 122.011 0.91 . . . . 0.0 113.048 -174.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 184' ' ' LEU . 80.2 mt -136.83 124.69 22.62 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.659 -1.609 . . . . 0.0 110.291 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 191' ' ' LEU . 74.3 m 53.95 30.54 11.83 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 176.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.01 -16.39 20.54 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 119.913 -1.136 . . . . 0.0 115.794 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 31' ' ' ASP . 34.7 ptt180 -146.22 166.35 26.47 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-N 119.085 1.443 . . . . 0.0 112.434 178.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 73.3 m -73.29 156.58 38.31 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.222 -176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.506 ' HB3' ' O ' ' A' ' 20' ' ' PRO . 5.1 tt -57.53 -44.69 85.31 Favored 'General case' 0 N--CA 1.42 -1.959 0 C-N-CA 124.395 1.078 . . . . 0.0 110.475 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.518 ' HB ' ' HB2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -60.2 -39.94 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.434 178.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' OD1' ' HD2' ' A' ' 27' ' ' ARG . 13.8 t70 -63.95 -41.69 97.51 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.249 0.547 . . . . 0.0 109.569 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' CD2' ' HG3' ' A' ' 27' ' ' ARG . 5.7 m-85 -61.06 -36.57 79.93 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.158 175.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 29' ' ' LEU . 69.1 t -66.87 -42.99 89.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.932 0.396 . . . . 0.0 110.811 177.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.6 t -62.85 -45.02 99.91 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.97 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.576 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 41.3 t -50.91 -53.61 45.85 Favored Pre-proline 0 CA--C 1.57 1.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -172.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 28.8 Cg_endo -63.94 -39.42 32.83 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 121.518 1.479 . . . . 0.0 112.387 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.585 HD11 HG11 ' A' ' 98' ' ' VAL . 83.3 mt -67.13 -39.68 86.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.609 0.719 . . . . 0.0 110.018 177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.2 tp -59.31 -45.67 90.68 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.515 177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 22.2 ptmt -84.99 -8.71 58.62 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.493 ' OG ' HG12 ' A' ' 42' ' ' VAL . 77.9 p -74.58 174.74 8.6 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.213 0.53 . . . . 0.0 111.668 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -60.32 -18.51 50.19 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.056 0.942 . . . . 0.0 112.603 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 3' ' ' ALA . 11.4 p -63.64 150.76 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-O 120.909 0.385 . . . . 0.0 111.999 -176.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -76.7 -75.91 0.18 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -110.43 152.13 26.67 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.057 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.0 mm -107.47 110.99 33.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 95.1 m-85 -104.16 117.86 35.26 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.605 HG21 HD13 ' A' ' 60' ' ' ILE . 95.6 mt -97.88 119.19 45.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 121.602 0.715 . . . . 0.0 110.568 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.489 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -89.37 122.13 32.3 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.811 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 7' ' ' ALA . 41.9 p -126.59 155.0 43.17 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.474 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 50.1 m -98.79 145.1 29.35 Favored Pre-proline 0 C--N 1.304 -1.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.871 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' A' ' 75' ' ' THR . 51.8 Cg_exo -59.27 -28.78 88.58 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 123.197 2.598 . . . . 0.0 111.348 178.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 -6.89 58.98 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.963 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 7.7 p -134.63 66.47 69.59 Favored Pre-proline 0 N--CA 1.436 -1.163 0 CA-C-O 119.365 -0.35 . . . . 0.0 111.414 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.699 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 83.0 Cg_endo -103.73 85.62 0.03 OUTLIER 'Trans proline' 1 N--CA 1.377 -5.332 0 C-N-CA 116.764 -1.691 . . . . 0.0 109.246 169.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.541 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 34.4 mmtp -145.45 -52.04 0.26 Allowed 'General case' 1 C--N 1.214 -5.318 0 N-CA-C 101.576 -3.49 . . . . 0.0 101.576 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.45 ' HA ' ' CD1' ' A' ' 21' ' ' LEU . 99.0 m -63.48 -48.39 77.86 Favored 'General case' 0 N--CA 1.388 -3.546 0 CA-C-N 111.958 -2.383 . . . . 0.0 106.363 165.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.699 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.0 tttt -63.1 -48.18 79.68 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.913 177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.541 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 8.8 pt-20 -58.64 -34.97 71.79 Favored 'General case' 0 C--N 1.365 1.266 0 C-N-CA 117.481 -1.687 . . . . 0.0 110.335 179.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.501 ' CB ' HD21 ' A' ' 21' ' ' LEU . 48.8 t80 -67.57 -52.25 40.9 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 120.86 0.362 . . . . 0.0 111.828 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 47' ' ' ILE . 96.8 mt -63.62 -46.54 94.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.837 -175.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.1 t30 -58.92 -44.0 91.23 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.756 -178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.404 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 34.5 t -69.72 -44.62 69.96 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.856 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.65 -38.18 90.14 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.305 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.434 ' HD2' HG23 ' A' ' 60' ' ' ILE . 78.7 m-85 -105.83 25.69 10.55 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.194 -176.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 61' ' ' ASN . 9.9 mmmm -62.22 -21.39 65.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.063 0.459 . . . . 0.0 110.857 175.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -89.26 10.57 21.73 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.374 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 54.3 p90 -44.18 138.04 3.18 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -176.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.596 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.6 OUTLIER -101.62 -52.55 3.18 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.913 0.863 . . . . 0.0 109.361 172.59 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -121.45 12.67 10.87 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 114.163 -1.381 . . . . 0.0 111.467 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 82.6 mt -99.1 128.44 50.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.291 0.567 . . . . 0.0 111.053 -175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 67.3 t -128.04 132.31 68.69 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.032 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 p -102.18 132.15 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.46 HD11 HD11 ' A' ' 4' ' ' LEU . 40.1 pt -126.96 156.89 38.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.624 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' OD1' ' HG3' ' A' ' 51' ' ' PRO . 10.5 t70 -114.74 131.96 56.6 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.201 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.496 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 12.9 t -161.95 -171.87 3.04 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.95 0.881 . . . . 0.0 113.218 -176.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.1 m -74.18 3.58 6.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 126.602 1.961 . . . . 0.0 114.605 -174.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.615 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.94 -21.82 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 C-N-CA 126.638 2.066 . . . . 0.0 117.605 -173.126 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 76' ' ' SER . 58.4 tptt -58.53 -37.88 76.58 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.88 123.11 6.26 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 174.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.478 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.8 t80 -59.45 -50.4 74.07 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.14 -47.44 92.43 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-O 121.574 0.702 . . . . 0.0 110.635 -177.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.463 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 55.1 mt-10 -59.83 -44.94 93.8 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.798 -177.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.615 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 5.5 t0 -59.29 -51.39 70.15 Favored 'General case' 0 CA--C 1.491 -1.293 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.437 178.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.59 ' O ' HG23 ' A' ' 88' ' ' ILE . 4.2 mm? -59.98 -41.74 92.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.962 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.418 ' HA ' HG12 ' A' ' 88' ' ' ILE . 9.2 m120 -60.42 -43.19 97.0 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 178.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.483 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 72.4 mm-40 -65.72 -44.42 86.1 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.57 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.8 m -62.31 -43.16 99.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.114 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.59 HG23 ' O ' ' A' ' 84' ' ' LEU . 33.9 pt -66.08 -24.64 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.847 0.356 . . . . 0.0 110.351 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.27 -22.28 77.47 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.411 176.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -104.75 -21.47 13.36 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.57 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 82.2 m-85 -89.1 140.92 28.96 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.986 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 51.1 m -104.42 -6.32 20.84 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.417 0.627 . . . . 0.0 109.817 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -132.24 152.49 80.22 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.443 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.94 142.03 54.27 Favored 'Trans proline' 0 CA--C 1.514 -0.495 0 C-N-CA 123.515 2.81 . . . . 0.0 112.223 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -139.64 154.12 47.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-O 121.503 0.668 . . . . 0.0 111.595 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.71 HD11 HD12 ' A' ' 154' ' ' ILE . 2.1 tm? -87.05 132.81 33.7 Favored 'General case' 0 C--O 1.193 -1.889 0 CA-C-N 114.535 -1.211 . . . . 0.0 109.726 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 68.4 t -108.37 127.87 64.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 123.225 0.61 . . . . 0.0 109.559 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.683 HG22 ' HA ' ' A' ' 5' ' ' ILE . 8.4 m -126.53 156.62 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.759 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.47 ' HB2' ' CD2' ' A' ' 102' ' ' LEU . 67.7 m -101.03 132.92 46.23 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 170.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.48 ' O ' HD21 ' A' ' 29' ' ' LEU . 69.3 m -67.46 -37.39 82.87 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.499 0.666 . . . . 0.0 111.532 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -79.37 -0.85 34.42 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -170.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 102' ' ' LEU . 1.4 pp -91.63 116.26 28.73 Favored 'General case' 0 C--O 1.245 0.834 0 C-N-CA 119.523 -0.871 . . . . 0.0 111.15 175.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.4 mt -103.1 119.6 51.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.036 -177.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.439 HD21 ' HB2' ' A' ' 173' ' ' GLU . 64.9 t30 178.38 163.5 0.71 Allowed 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.145 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 11.2 mp -72.54 98.6 2.34 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.636 ' HA ' HD12 ' A' ' 109' ' ' ILE . 15.6 ptpt -97.8 -2.28 41.38 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.908 -173.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.562 ' HA ' HD12 ' A' ' 110' ' ' ILE . 77.9 p -60.26 -38.94 85.03 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -173.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -80.61 -27.17 37.4 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.432 1.111 . . . . 0.0 109.36 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.726 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -70.08 -39.52 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.759 -175.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 107' ' ' SER . 65.3 mt -56.92 -49.21 79.84 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.944 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -65.07 -40.86 95.29 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.195 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.7 m -63.32 -40.67 97.97 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.548 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.726 HG12 ' O ' ' A' ' 109' ' ' ILE . 45.6 mm -62.26 -48.33 88.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.209 0.528 . . . . 0.0 110.674 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.658 HG22 ' SD ' ' A' ' 1' ' ' MET . 69.4 t -61.43 -48.21 89.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.93 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.67 -43.79 97.92 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.966 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.751 ' CE2' HD11 ' A' ' 120' ' ' ILE . 73.1 t80 -63.83 -46.58 84.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.82 0.343 . . . . 0.0 110.973 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -58.11 -48.19 80.96 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.891 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.502 ' O ' ' HG3' ' A' ' 121' ' ' LYS . 30.0 m-85 -62.03 -36.19 80.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.299 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 46.9 t -61.53 -46.66 88.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.257 0.551 . . . . 0.0 109.997 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.751 HD11 ' CE2' ' A' ' 116' ' ' TYR . 67.3 mt -66.03 -47.06 86.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.854 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 118' ' ' TYR . 0.0 OUTLIER -64.03 -25.09 67.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.997 -178.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.55 99.75 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.788 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -83.91 -39.05 20.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 121.038 0.447 . . . . 0.0 110.96 178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.621 ' O ' HG12 ' A' ' 127' ' ' VAL . 90.2 m -132.65 92.51 26.89 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.458 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -59.31 -19.04 48.59 Favored 'Trans proline' 0 N--CA 1.479 0.67 0 C-N-CA 123.263 2.642 . . . . 0.0 113.069 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.448 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 39.0 t70 -62.01 -32.31 72.78 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.624 HG11 HG22 ' A' ' 120' ' ' ILE . 10.7 p -70.61 118.43 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 121.596 0.712 . . . . 0.0 109.829 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.3 mt-10 -122.43 13.11 10.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.402 -176.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.3 155.01 37.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.18 133.25 27.78 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.442 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -122.79 139.61 53.82 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.373 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.614 HG21 ' CD1' ' A' ' 113' ' ' ILE . 95.8 t -121.18 123.39 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 CA-C-O 121.54 0.686 . . . . 0.0 111.179 178.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.491 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 3.1 ptm -145.48 162.5 37.22 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.551 -178.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.478 HG13 HG23 ' A' ' 150' ' ' VAL . 22.6 pt -123.15 158.07 59.05 Favored Pre-proline 0 C--N 1.312 -1.064 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -60.31 132.5 44.21 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 121.816 1.677 . . . . 0.0 110.675 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -64.7 -21.8 66.83 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.105 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -65.52 -37.55 87.07 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.354 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.22 -25.27 42.68 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-O 121.482 0.658 . . . . 0.0 110.649 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -75.37 132.51 75.85 Favored Pre-proline 0 C--N 1.294 -1.84 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.257 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -54.96 -62.35 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.883 2.389 . . . . 0.0 113.607 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -129.09 96.67 28.15 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.19 -30.98 15.24 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 123.233 2.622 . . . . 0.0 113.546 -176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 147' ' ' ASN . 36.5 t -177.18 152.54 0.89 Allowed 'General case' 0 C--O 1.24 0.571 0 CA-C-O 120.784 0.325 . . . . 0.0 110.532 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 19.8 tt -71.92 -28.95 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.345 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -127.78 -73.48 0.6 Allowed 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.46 133.4 32.69 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 143' ' ' SER . 64.2 t30 -162.65 104.27 1.06 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.809 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.11 -40.25 98.96 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.86 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 149' ' ' LEU . 2.6 pt? -135.49 150.96 49.93 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.123 0.487 . . . . 0.0 111.072 -177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 134' ' ' ILE . 29.6 m -119.5 98.91 50.14 Favored Pre-proline 0 C--N 1.304 -1.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.086 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.36 139.02 87.84 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.504 2.136 . . . . 0.0 110.676 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.669 ' HA ' HD13 ' A' ' 175' ' ' ILE . . . -132.62 -36.84 1.07 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.264 0.554 . . . . 0.0 111.337 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -95.81 -149.55 25.8 Favored Glycine 0 N--CA 1.422 -2.298 0 C-N-CA 120.132 -1.032 . . . . 0.0 112.521 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.71 HD12 HD11 ' A' ' 96' ' ' LEU . 17.2 pt -119.44 161.09 19.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 CA-C-N 115.045 -0.577 . . . . 0.0 110.46 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.571 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 14.6 t-20 -110.27 152.12 26.53 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.475 -172.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.87 131.6 72.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.321 175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.51 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.7 m -134.45 149.36 29.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.399 0.619 . . . . 0.0 111.243 175.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 58.5 m -98.51 153.63 37.89 Favored Pre-proline 0 C--N 1.302 -1.476 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.443 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 14.8 Cg_exo -69.79 89.81 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.951 1.768 . . . . 0.0 110.99 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -116.72 -160.14 0.75 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.7 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -136.97 149.47 47.56 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 62.93 -124.17 31.96 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.1 -1.048 . . . . 0.0 110.657 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -128.02 149.22 50.46 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -131.62 163.99 26.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.008 -178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -57.77 128.5 37.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.027 0.441 . . . . 0.0 111.873 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -125.53 129.4 49.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.67 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -94.56 161.96 14.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 121.593 0.711 . . . . 0.0 112.212 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.442 HD13 ' HB3' ' A' ' 131' ' ' ALA . 46.8 mm -115.69 130.84 69.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.303 -175.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.8 ttp -131.17 138.75 49.58 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.681 176.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 133' ' ' MET . 76.0 t -108.12 129.64 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.79 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.541 ' HB ' ' OE2' ' A' ' 173' ' ' GLU . 36.7 pt -101.3 174.51 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 120.986 0.422 . . . . 0.0 111.321 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -99.77 -21.18 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.662 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HG3' HD11 ' A' ' 109' ' ' ILE . 1.6 pm0 -99.08 138.32 36.36 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.811 0.815 . . . . 0.0 112.568 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.8 mp -95.02 151.92 18.76 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.458 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.669 HD13 ' HA ' ' A' ' 152' ' ' ALA . 23.6 pt -107.41 155.04 8.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.098 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -102.98 106.91 17.54 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 121.112 0.482 . . . . 0.0 110.824 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.85 121.47 37.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 184' ' ' LEU . 40.9 mm -71.19 85.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-O 121.339 0.59 . . . . 0.0 112.396 -173.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -70.65 -38.8 73.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.323 175.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 81.0 p -129.57 162.92 27.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.104 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.464 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 0.0 OUTLIER -63.13 -32.67 74.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.522 178.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -61.45 -36.29 79.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.108 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -62.43 -40.38 96.36 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.482 ' CD1' HD21 ' A' ' 24' ' ' LEU . 51.6 tp -62.64 -42.71 99.75 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.059 178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.533 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 39.8 ttmt -61.0 -42.54 98.64 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.67 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -61.93 -43.21 99.32 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -60.9 -43.01 99.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.022 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.533 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 14.7 pt-20 -71.05 -36.02 72.15 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.887 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 35.2 mmt -64.4 -39.99 94.92 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 120.776 0.322 . . . . 0.0 110.876 178.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.28 -47.47 84.19 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.403 177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.46 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 95.5 mt -63.9 -43.2 96.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.902 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -61.74 -49.49 76.21 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.147 -0.933 . . . . 0.0 112.044 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -71.78 -42.67 66.86 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -92.92 -25.02 18.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 -173.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.24 -43.37 99.19 Favored Glycine 0 C--N 1.314 -0.651 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.733 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 C--O 1.263 1.776 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.146 179.658 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.712 ' HG3' ' O ' ' A' ' 94' ' ' PRO . 42.9 ttp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.592 0.234 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 61.8 m-20 -98.88 166.97 11.04 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.934 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.548 ' HB2' HG21 ' A' ' 42' ' ' VAL . . . -114.34 130.98 56.69 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.486 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.453 ' O ' HG22 ' A' ' 98' ' ' VAL . 38.4 tp -106.69 125.46 51.04 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.521 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.681 ' HA ' HG22 ' A' ' 98' ' ' VAL . 60.4 mt -116.65 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.533 ' HA ' ' HB3' ' A' ' 48' ' ' ALA . 12.7 ptm -95.92 92.11 6.34 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.941 1.353 . . . . 0.0 112.908 -173.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.597 ' CB ' HD12 ' A' ' 30' ' ' ILE . . . -116.82 97.79 6.16 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 113.101 -1.863 . . . . 0.0 109.936 177.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.84 32.61 0.03 OUTLIER Glycine 0 C--N 1.287 -2.149 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -99.76 177.16 29.08 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.444 -0.884 . . . . 0.0 111.331 179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -150.57 147.77 27.86 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.55 152.69 23.03 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.8 t -168.51 150.22 4.98 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.561 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 tpm_? -118.38 74.09 0.94 Allowed 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 15.5 tpt 71.86 -49.99 0.69 Allowed 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.459 -175.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.56 165.85 21.29 Favored Glycine 0 N--CA 1.439 -1.137 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.0 162.55 38.44 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.634 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.9 p -136.81 145.01 30.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 120.846 0.355 . . . . 0.0 110.583 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -121.07 124.06 43.88 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.964 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -157.67 148.18 16.0 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-O 120.753 0.311 . . . . 0.0 111.411 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -76.03 -5.75 16.64 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.486 2.791 . . . . 0.0 113.052 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 69.1 mt -88.83 11.34 18.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 92.0 mt -69.87 115.73 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.685 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -82.11 140.88 33.56 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.663 -176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.404 HD13 ' CD1' ' A' ' 184' ' ' LEU . 62.8 tp -130.97 107.59 9.21 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.227 -1.351 . . . . 0.0 110.698 -178.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 86.1 m 58.25 20.94 7.62 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.218 178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 -80.87 0.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.009 -1.091 . . . . 0.0 113.926 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.549 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 92.5 mtt180 -93.7 172.2 8.4 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.422 0.629 . . . . 0.0 112.107 -175.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 78.1 m -79.25 162.75 25.47 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.37 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.5 mt -59.08 -45.52 90.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.218 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.597 HD12 ' CB ' ' A' ' 7' ' ' ALA . 11.8 tt -65.49 -37.91 81.19 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.914 0 C-N-CA 119.942 -0.703 . . . . 0.0 112.168 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 6.9 t0 -60.59 -43.13 97.73 Favored 'General case' 0 C--O 1.252 1.226 0 CA-C-O 121.636 0.731 . . . . 0.0 109.075 -177.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -65.86 -36.53 83.71 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.595 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 29' ' ' LEU . 58.6 t -66.11 -43.29 92.29 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 177.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 30' ' ' ILE . 73.8 t -63.49 -45.35 98.05 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.986 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.075 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 67.3 m -49.75 -52.59 49.94 Favored Pre-proline 0 CA--C 1.571 1.778 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.06 -36.51 29.45 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.412 1.408 . . . . 0.0 112.44 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.533 HD11 HG11 ' A' ' 98' ' ' VAL . 83.7 mt -68.48 -37.57 80.26 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.576 0.703 . . . . 0.0 110.553 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 65.1 tp -59.11 -43.93 91.95 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.38 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -89.3 -7.19 55.88 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.91 -0.587 . . . . 0.0 112.523 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.49 ' OG ' HG12 ' A' ' 42' ' ' VAL . 83.3 p -72.52 172.0 11.33 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.206 0.527 . . . . 0.0 111.605 -178.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -71.82 5.08 2.77 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.783 -175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG21 ' HB2' ' A' ' 3' ' ' ALA . 11.2 p -77.96 152.53 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 O-C-N 121.821 -0.549 . . . . 0.0 111.2 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.447 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 65.6 t30 -69.23 -77.98 0.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.32 -177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -117.69 156.46 28.18 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.137 0.494 . . . . 0.0 111.021 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.3 114.61 47.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -106.86 119.79 40.3 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.626 HG21 HD13 ' A' ' 60' ' ' ILE . 95.9 mt -99.91 119.66 48.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.565 0.698 . . . . 0.0 110.862 -179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 6' ' ' MET . . . -89.42 121.82 32.03 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.293 -178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 7' ' ' ALA . 68.3 p -131.7 169.53 16.05 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.031 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.3 p -131.29 158.83 74.13 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.412 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.21 -19.24 68.14 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.576 2.184 . . . . 0.0 110.782 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 61.4 m-80 -70.3 -25.39 63.3 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.595 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.9 p -135.76 66.65 63.38 Favored Pre-proline 0 N--CA 1.431 -1.414 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -175.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.676 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.8 Cg_endo -101.26 85.32 0.04 OUTLIER 'Trans proline' 1 N--CA 1.386 -4.814 0 C-N-CA 116.869 -1.62 . . . . 0.0 109.087 169.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.66 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 32.1 mmtm -155.29 -46.82 0.08 Allowed 'General case' 1 C--N 1.209 -5.511 0 CA-C-N 109.182 -3.644 . . . . 0.0 102.462 -179.072 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.458 ' HA ' HD21 ' A' ' 21' ' ' LEU . 97.8 m -64.05 -49.07 73.79 Favored 'General case' 0 N--CA 1.382 -3.842 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 163.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.676 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.3 tttt -62.85 -50.36 71.24 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.1 177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.6 pt-20 -64.35 -30.05 71.11 Favored 'General case' 0 C--N 1.369 1.42 0 C-N-CA 116.722 -1.991 . . . . 0.0 112.759 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -64.07 -50.94 66.38 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.327 0.584 . . . . 0.0 111.208 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.626 HD13 HG21 ' A' ' 47' ' ' ILE . 93.3 mt -63.13 -45.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.426 -175.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -57.87 -44.04 86.37 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.576 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 27.7 t -69.64 -40.89 76.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.804 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.51 93.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.958 -178.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.531 ' O ' ' HD2' ' A' ' 67' ' ' TYR . 57.0 m-85 -116.41 42.31 2.45 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.109 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 62' ' ' SER . 56.4 mtmt -58.93 -35.46 73.15 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.218 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -88.47 12.37 14.54 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.15 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' ' 70' ' ' ILE . 53.6 p90 -39.64 131.87 1.7 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 -48.22 4.26 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -116.82 13.17 14.99 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.147 -177.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 67' ' ' TYR . 84.6 mt -104.99 124.46 59.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.267 0.556 . . . . 0.0 110.426 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 95.2 t -123.29 133.51 68.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.95 -177.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.0 p -103.57 130.68 53.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.276 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 48' ' ' ALA . 43.1 pt -128.48 157.1 41.07 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.105 0 CA-C-O 121.749 0.785 . . . . 0.0 111.347 -177.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -107.82 136.52 47.41 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.703 -177.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.658 ' OG1' ' HB2' ' A' ' 86' ' ' GLU . 7.8 t -159.96 -173.84 4.27 Favored 'General case' 0 CA--C 1.556 1.205 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 78' ' ' LYS . 69.0 m -74.34 5.09 4.9 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 127.328 2.251 . . . . 0.0 114.19 -175.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -29.21 -13.81 0.0 OUTLIER Glycine 1 N--CA 1.525 4.632 0 C-N-CA 127.184 2.326 . . . . 0.0 117.646 -174.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -57.39 -39.56 76.34 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 168.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.531 ' HA3' ' OE1' ' A' ' 82' ' ' GLU . . . -116.32 132.8 10.38 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.443 ' O ' HD23 ' A' ' 84' ' ' LEU . 85.4 t80 -61.29 -52.81 63.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -174.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 70.5 mt -70.6 -39.81 76.41 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 CA-C-O 121.755 0.788 . . . . 0.0 110.071 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' OE1' ' HA3' ' A' ' 79' ' ' GLY . 48.7 mt-10 -57.93 -43.49 86.32 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.548 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.56 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 9.5 t0 -60.59 -49.89 75.74 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.671 176.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.7 mm? -57.14 -40.44 77.16 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.772 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.453 ' HA ' HG12 ' A' ' 88' ' ' ILE . 11.3 m120 -60.05 -42.96 95.6 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.626 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.658 ' HB2' ' OG1' ' A' ' 75' ' ' THR . 46.0 mm-40 -66.86 -43.38 83.76 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.15 178.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.522 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 97.1 m -62.18 -45.01 95.3 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.277 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.711 HD12 ' O ' ' A' ' 160' ' ' LYS . 30.3 pt -64.92 -27.44 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.494 0 CA-C-O 120.789 0.328 . . . . 0.0 110.911 -178.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.45 -22.1 69.22 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.453 -0.879 . . . . 0.0 113.419 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -111.87 7.25 19.99 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.522 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 76.9 m-85 -109.86 143.17 40.14 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 122.05 -0.406 . . . . 0.0 111.274 176.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.6 m -100.67 -11.63 19.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.337 0.589 . . . . 0.0 110.382 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 38.6 mt-10 -133.19 162.46 57.52 Favored Pre-proline 0 C--N 1.313 -0.985 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.327 -178.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.712 ' O ' ' HG3' ' A' ' 1' ' ' MET . 38.1 Cg_endo -64.65 156.73 59.53 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.109 1.872 . . . . 0.0 111.466 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.497 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 46.6 p90 -143.94 156.6 44.49 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.526 0.679 . . . . 0.0 111.663 -178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 154' ' ' ILE . 1.6 tm? -86.33 135.45 33.52 Favored 'General case' 0 C--O 1.199 -1.568 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.616 -179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 63.6 t -110.85 130.21 64.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 C-N-CA 123.5 0.72 . . . . 0.0 109.146 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.681 HG22 ' HA ' ' A' ' 5' ' ' ILE . 4.9 m -128.34 163.35 32.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 C-N-CA 119.977 -0.689 . . . . 0.0 112.272 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.435 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 69.8 m -98.7 141.92 30.92 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.2 p -88.21 -3.41 58.87 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.257 0.465 . . . . 0.0 112.257 -176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.552 ' OD2' ' HB2' ' A' ' 177' ' ' ASN . 10.9 p-10 -108.95 3.98 22.83 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 175' ' ' ILE . 75.0 mt -91.11 132.98 35.71 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.29 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -68.3 171.24 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.123 0.487 . . . . 0.0 111.717 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -81.72 78.53 8.44 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -122.42 -6.27 8.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 171.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.677 ' HA ' HD12 ' A' ' 109' ' ' ILE . 23.4 pttp -84.41 0.16 50.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 113.85 -1.523 . . . . 0.0 113.83 -175.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.456 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.3 p -53.86 -42.9 69.07 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -173.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -86.59 -26.8 24.26 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 122.071 0.939 . . . . 0.0 109.852 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.695 ' O ' HG12 ' A' ' 113' ' ' ILE . 78.4 mt -64.57 -37.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 113.868 -1.515 . . . . 0.0 110.405 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 106' ' ' LYS . 61.6 mt -54.77 -49.18 70.92 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.584 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -67.55 -39.04 84.98 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.507 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 63.9 m -60.63 -42.22 96.49 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.771 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.695 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -63.54 -47.77 89.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.165 -178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.465 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 77.4 t -61.56 -48.76 87.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.328 -177.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -63.39 -42.57 98.82 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.988 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CE2' HD11 ' A' ' 120' ' ' ILE . 58.0 t80 -64.55 -47.33 79.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.954 0.407 . . . . 0.0 110.734 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.403 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 72.3 t80 -59.04 -48.26 82.24 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.015 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.545 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 25.1 m-85 -61.78 -36.47 81.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.521 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 47.7 t -61.69 -47.08 86.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.108 0.48 . . . . 0.0 110.147 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.667 HG22 HG11 ' A' ' 127' ' ' VAL . 68.4 mt -65.04 -48.83 82.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.886 -178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.545 ' HG2' ' HA ' ' A' ' 118' ' ' TYR . 19.8 ptmt -66.03 -26.6 67.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.58 -43.95 97.92 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.598 175.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -81.57 -38.05 26.74 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.118 0.485 . . . . 0.0 110.874 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.546 ' O ' HG12 ' A' ' 127' ' ' VAL . 45.7 m -132.1 96.49 19.78 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.694 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.2 -14.14 42.07 Favored 'Trans proline' 0 N--CA 1.472 0.229 0 C-N-CA 122.772 2.315 . . . . 0.0 113.273 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 35.4 t70 -66.03 -31.44 72.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.667 HG11 HG22 ' A' ' 120' ' ' ILE . 9.1 p -71.33 120.59 19.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.376 0.607 . . . . 0.0 110.069 178.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 41.4 mt-10 -127.64 19.2 6.75 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.782 -175.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -152.27 150.15 29.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.485 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 167' ' ' GLU . 0.4 OUTLIER -137.81 130.75 30.14 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.28 136.7 54.93 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.715 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.848 HG12 ' HB3' ' A' ' 152' ' ' ALA . 47.4 t -116.95 122.46 70.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 ptm -144.69 158.26 43.85 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.6 -177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' A' ' 152' ' ' ALA . 6.6 pt -130.77 165.6 33.51 Favored Pre-proline 0 C--N 1.313 -1.014 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.107 -178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.99 136.25 73.88 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.536 2.157 . . . . 0.0 112.378 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' HE2' ' O ' ' A' ' 148' ' ' GLY . 99.5 mttt -61.16 -39.93 91.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.213 -178.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -64.06 -37.14 86.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -82.35 -13.43 56.9 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 121.395 0.617 . . . . 0.0 110.832 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -84.92 114.62 56.81 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.24 -36.24 47.4 Favored 'Trans proline' 0 N--CA 1.474 0.351 0 C-N-CA 122.569 2.179 . . . . 0.0 114.866 -172.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -160.82 95.15 1.45 Allowed Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.612 ' HB3' HG12 ' A' ' 150' ' ' VAL . 32.0 Cg_endo -81.67 -67.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 121.781 1.654 . . . . 0.0 110.228 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.9 p -160.88 153.41 20.65 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 145' ' ' ASP . 3.4 mp -111.83 80.44 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 144' ' ' ILE . 34.8 t70 173.04 -86.09 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.417 -177.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -64.15 -47.37 80.14 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.398 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 15.7 m120 63.12 -104.83 0.14 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.681 -177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.543 ' O ' ' HE2' ' A' ' 136' ' ' LYS . . . 71.31 -152.49 49.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.983 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.2 151.47 22.14 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.612 HG12 ' HB3' ' A' ' 142' ' ' PRO . 31.7 m -106.23 118.97 53.51 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -174.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -59.83 139.6 89.08 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.75 2.3 . . . . 0.0 110.931 176.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.848 ' HB3' HG12 ' A' ' 132' ' ' VAL . . . -103.13 2.88 35.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 166.87 -100.66 0.17 Allowed Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 118.937 -1.602 . . . . 0.0 113.503 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.515 ' CG1' HG13 ' A' ' 113' ' ' ILE . 28.2 pt -124.77 161.48 28.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 CA-C-O 121.119 0.485 . . . . 0.0 111.75 -175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.544 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 7.7 t-20 -120.17 155.11 33.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.861 -176.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.72 130.5 73.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 122.383 0.273 . . . . 0.0 110.612 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.526 HG13 ' OD1' ' A' ' 155' ' ' ASN . 27.9 m -136.68 152.0 28.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-O 121.41 0.624 . . . . 0.0 112.001 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.1 t -97.33 145.11 29.08 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 173.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 94' ' ' PRO . 64.9 Cg_endo -70.85 74.66 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.52 2.147 . . . . 0.0 112.267 -178.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.711 ' O ' HD12 ' A' ' 88' ' ' ILE . 75.8 mmtt -105.0 132.0 51.8 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.582 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -81.87 74.0 8.88 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 156.05 -146.25 13.71 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -118.74 144.19 46.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 117.048 0.424 . . . . 0.0 109.992 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -134.28 166.38 22.94 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -175.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -59.29 129.8 43.84 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.006 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -125.07 126.89 46.07 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.57 -176.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.422 ' HB2' HD22 ' A' ' 130' ' ' LEU . 28.7 mm-40 -93.96 162.36 13.92 Favored 'General case' 0 CA--C 1.486 -1.519 0 CA-C-O 121.558 0.694 . . . . 0.0 111.582 176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.0 mm -117.31 129.57 73.59 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.977 -175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.463 ' HE2' ' CD2' ' A' ' 116' ' ' TYR . 49.8 ttm -116.16 131.53 56.92 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.623 176.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 133' ' ' MET . 7.4 p -119.68 128.21 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 174.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.543 HD11 ' HB1' ' A' ' 152' ' ' ALA . 33.6 pt -119.95 172.41 7.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.541 -176.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -109.33 -2.33 17.91 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.335 0.588 . . . . 0.0 110.358 -178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.458 ' CG ' HD12 ' A' ' 171' ' ' ILE . 4.1 pt-20 -97.99 131.13 44.69 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.666 0.746 . . . . 0.0 110.401 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.4 mt -95.19 149.38 21.37 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.937 -174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.543 HD13 HD22 ' A' ' 102' ' ' LEU . 1.7 pp -123.84 154.8 30.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.638 -1.164 . . . . 0.0 108.218 171.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -114.85 137.38 52.03 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.552 ' HB2' ' OD2' ' A' ' 101' ' ' ASP . 9.3 p30 -110.39 127.73 55.23 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.08 -176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.535 HD13 ' OD2' ' A' ' 183' ' ' ASP . 16.9 mm -88.59 61.47 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.77 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -93.3 -0.37 56.71 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.313 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.8 t -148.11 151.39 35.54 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.655 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.658 ' HD2' ' H ' ' A' ' 181' ' ' LYS . 0.2 OUTLIER -62.09 -37.14 83.94 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.302 -177.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -61.56 -41.72 97.79 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.417 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.535 ' OD2' HD13 ' A' ' 178' ' ' ILE . 11.6 t70 -63.6 -36.05 82.54 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 178' ' ' ILE . 59.4 tp -58.52 -43.44 89.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.521 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.625 ' O ' ' HG2' ' A' ' 188' ' ' GLU . 60.7 tttm -62.21 -43.72 98.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.718 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.7 tt -61.39 -45.05 95.98 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.12 -42.04 98.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.013 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.625 ' HG2' ' O ' ' A' ' 185' ' ' LYS . 12.5 pt-20 -66.34 -33.43 75.72 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.945 0.402 . . . . 0.0 110.185 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.3 mtp -64.89 -40.25 94.81 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.643 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 88.2 mt -64.83 -43.19 93.86 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-O 121.362 0.601 . . . . 0.0 110.09 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.26 -40.76 97.27 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.584 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -62.0 -44.42 96.77 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.518 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 189' ' ' MET . 31.4 mmmt -85.07 -42.33 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -88.65 -25.82 22.2 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -95.1 -50.95 1.98 Allowed Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.603 -176.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 67.5 tp . . . . . 0 C--O 1.269 2.132 0 CA-C-O 118.059 -0.972 . . . . 0.0 111.233 -178.754 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 59.5 ttm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.5 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 19.3 m-20 -97.93 165.9 11.7 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.454 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -114.69 130.48 56.82 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.279 0.562 . . . . 0.0 111.533 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -107.0 122.15 45.87 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.704 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.5 mt -117.98 116.23 50.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.238 -178.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.501 ' CE ' HD22 ' A' ' 84' ' ' LEU . 38.3 mtt -89.05 96.57 10.78 Favored 'General case' 0 CA--C 1.49 -1.344 0 CA-C-O 122.32 1.057 . . . . 0.0 113.638 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' HG22 ' A' ' 49' ' ' THR . . . -116.11 97.43 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.284 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 169.64 -118.94 0.79 Allowed Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.446 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.15 140.33 32.39 Favored Glycine 0 N--CA 1.435 -1.404 0 C-N-CA 120.514 -0.851 . . . . 0.0 111.89 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -108.85 14.29 24.33 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.388 0.613 . . . . 0.0 109.757 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.54 -150.28 18.6 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.175 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 37.8 p -88.57 -3.08 58.88 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.189 0.519 . . . . 0.0 110.948 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 mmm180 -92.3 113.7 26.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.293 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 66.2 mtt -119.66 112.65 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.946 179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.05 -158.5 28.65 Favored Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.839 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 -179.26 47.39 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.971 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.1 m -105.85 -0.32 10.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.149 0.5 . . . . 0.0 110.295 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -97.42 119.66 36.37 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.663 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.536 ' O ' HD12 ' A' ' 29' ' ' LEU . 61.5 mtpt -136.84 142.03 37.22 Favored Pre-proline 0 C--N 1.315 -0.911 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 176.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -61.13 -20.24 66.94 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.973 2.449 . . . . 0.0 114.523 -174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 39.6 mt -97.75 4.69 49.85 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.6 mt -78.31 123.78 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -94.93 139.38 31.41 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 114.856 -1.065 . . . . 0.0 111.818 -177.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.55 108.16 12.82 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.299 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 76.9 m 54.5 26.24 7.0 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.135 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.91 -101.58 0.2 Allowed Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.915 -1.136 . . . . 0.0 113.668 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.563 ' HD3' ' OD2' ' A' ' 31' ' ' ASP . 75.3 mtt-85 -88.03 168.36 12.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.105 0.479 . . . . 0.0 111.969 -173.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.494 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 74.9 m -79.5 163.81 24.42 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.605 ' O ' HG23 ' A' ' 33' ' ' VAL . 67.1 mt -57.89 -45.28 86.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -39.5 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.785 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.563 ' OD2' ' HD3' ' A' ' 27' ' ' ARG . 18.8 t70 -65.74 -39.58 91.26 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.075 0.464 . . . . 0.0 110.038 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -63.69 -34.62 78.26 Favored 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.605 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 100' ' ' SER . 75.8 t -66.4 -45.36 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.961 0.41 . . . . 0.0 110.918 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.6 t -66.3 -41.04 88.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.592 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.1 m -50.88 -54.52 36.07 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -173.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 40' ' ' SER . 56.5 Cg_endo -71.36 -36.47 6.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.585 1.523 . . . . 0.0 112.249 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.453 HD11 HG11 ' A' ' 98' ' ' VAL . 84.8 mt -64.97 -41.8 95.12 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tt -59.95 -46.32 89.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.872 0.368 . . . . 0.0 110.87 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -82.03 -9.07 59.67 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 36' ' ' PRO . 59.3 p -74.28 -177.94 3.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.539 0.685 . . . . 0.0 112.202 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' HD2' HG11 ' A' ' 114' ' ' VAL . 23.8 ttmm -56.26 -26.32 51.2 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.253 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.69 161.91 2.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 121.677 0.751 . . . . 0.0 112.989 -174.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.0 t30 -81.07 -78.42 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.19 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -117.99 161.95 18.97 Favored 'General case' 0 CA--C 1.503 -0.842 0 CA-C-O 121.027 0.441 . . . . 0.0 111.128 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.454 HD13 ' HB3' ' A' ' 3' ' ' ALA . 48.9 mm -109.34 116.53 52.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.488 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -109.72 114.81 28.71 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.526 HG21 HD13 ' A' ' 60' ' ' ILE . 94.3 mt -97.24 117.82 42.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.569 0.7 . . . . 0.0 110.66 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.85 119.29 28.04 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.381 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 7' ' ' ALA . 69.8 p -121.42 155.92 33.82 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.57 ' HB2' ' OG1' ' A' ' 53' ' ' THR . 35.8 m -105.45 145.66 31.24 Favored Pre-proline 0 C--N 1.299 -1.612 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.733 -177.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 50' ' ' SER . 53.6 Cg_exo -57.96 -29.83 87.86 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.449 2.766 . . . . 0.0 112.01 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -83.16 -2.84 56.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.214 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.57 ' OG1' ' HB2' ' A' ' 50' ' ' SER . 2.1 p -139.03 67.07 40.47 Favored Pre-proline 0 CA--C 1.498 -1.049 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.968 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 92.4 Cg_endo -106.99 86.59 0.02 OUTLIER 'Trans proline' 1 N--CA 1.381 -5.11 0 C-N-CA 117.115 -1.456 . . . . 0.0 110.486 169.206 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.586 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 29.5 mtmm -144.06 -48.1 0.28 Allowed 'General case' 1 C--N 1.219 -5.081 0 CA-C-N 109.973 -3.285 . . . . 0.0 103.424 177.743 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.419 HG21 ' HB1' ' A' ' 7' ' ' ALA . 96.7 m -61.8 -48.9 78.53 Favored 'General case' 0 N--CA 1.393 -3.289 0 CA-C-N 112.549 -2.114 . . . . 0.0 106.054 164.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.69 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.1 tttt -62.13 -49.66 75.01 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.963 177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.586 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.2 pt-20 -59.78 -34.52 73.11 Favored 'General case' 0 C--N 1.366 1.305 0 C-N-CA 117.938 -1.505 . . . . 0.0 110.698 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -64.14 -50.8 66.76 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.103 0.477 . . . . 0.0 111.088 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.526 HD13 HG21 ' A' ' 47' ' ' ILE . 97.3 mt -64.0 -41.59 92.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.884 -176.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 57' ' ' LYS . 87.9 m-20 -57.74 -40.99 80.94 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.264 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 4.5 t -82.04 -39.12 23.96 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.895 0.378 . . . . 0.0 110.575 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.09 93.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.363 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 60' ' ' ILE . 81.0 m-85 -110.19 34.59 3.81 Favored 'General case' 0 C--O 1.206 -1.191 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.757 -176.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 10.9 mmmm -61.51 -25.04 67.02 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.09 0.471 . . . . 0.0 111.035 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -89.38 11.08 20.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.299 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 53.8 p90 -43.32 127.4 4.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.622 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -103.0 -49.05 3.87 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.945 0.878 . . . . 0.0 109.661 172.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -117.97 11.87 13.54 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.935 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 mp -102.96 125.21 57.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.27 0.557 . . . . 0.0 110.302 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.45 131.76 71.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.378 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.4 p -106.5 132.63 53.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-O 121.138 0.494 . . . . 0.0 109.67 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.6 pt -125.98 152.16 32.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.288 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -119.83 130.49 54.92 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.452 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.47 HG23 ' CG ' ' A' ' 83' ' ' ASP . 11.6 t -165.26 -167.42 1.17 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 78' ' ' LYS . 73.7 m -59.42 0.59 0.11 Allowed 'General case' 0 C--O 1.198 -1.61 0 C-N-CA 127.383 2.273 . . . . 0.0 116.082 -173.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.464 ' N ' ' HB2' ' A' ' 83' ' ' ASP . . . -31.61 -22.36 0.0 OUTLIER Glycine 0 N--CA 1.516 3.998 0 C-N-CA 125.805 1.669 . . . . 0.0 116.972 -174.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 76' ' ' SER . 1.2 tmmt? -56.84 -35.51 68.91 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.83 113.62 3.81 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -59.31 -49.08 79.19 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 89.6 mt -61.96 -48.21 89.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.713 0.768 . . . . 0.0 110.4 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -61.53 -45.91 92.18 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.305 -1.316 . . . . 0.0 112.271 -176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' CG ' HG23 ' A' ' 75' ' ' THR . 28.6 t0 -63.09 -50.03 72.12 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.385 176.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.1 OUTLIER -53.61 -47.39 70.27 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.237 0.542 . . . . 0.0 109.61 179.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.556 ' HA ' HG12 ' A' ' 88' ' ' ILE . 18.2 m-80 -61.98 -40.44 95.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.032 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -66.84 -42.99 84.87 Favored 'General case' 1 N--CA 1.374 -4.235 0 O-C-N 122.092 -0.38 . . . . 0.0 110.632 177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 91.3 m -62.98 -42.07 99.73 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.774 177.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 95' ' ' PHE . 26.3 pt -67.01 -28.13 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.585 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -63.29 -38.24 96.14 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.976 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -84.0 -12.09 55.78 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.483 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 81.2 m-85 -96.06 145.26 25.61 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.887 178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 63.7 p -105.67 -2.74 23.01 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.806 0.813 . . . . 0.0 109.208 175.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -128.82 157.1 76.55 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.032 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -68.37 148.61 74.04 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.357 2.038 . . . . 0.0 111.626 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.594 ' CZ ' HG22 ' A' ' 88' ' ' ILE . 40.7 p90 -143.28 159.33 42.54 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.279 0.561 . . . . 0.0 111.394 -177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.699 HD21 HD12 ' A' ' 154' ' ' ILE . 30.7 tp -86.41 143.05 28.0 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.532 -178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 155' ' ' ASN . 92.2 t -115.2 126.32 72.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.6 m -130.85 157.22 43.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.355 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.473 ' HB3' ' CD1' ' A' ' 102' ' ' LEU . 33.8 t -100.23 150.93 22.04 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 171.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.623 ' HA ' HG21 ' A' ' 33' ' ' VAL . 68.3 m -88.39 1.33 54.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.75 1.019 . . . . 0.0 113.75 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' OD1' HD12 ' A' ' 102' ' ' LEU . 40.5 p-10 -104.14 4.18 33.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -176.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 99' ' ' SER . 7.2 mp -88.57 140.53 29.36 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.099 -0.376 . . . . 0.0 111.106 177.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.535 ' O ' ' HE2' ' A' ' 106' ' ' LYS . 41.7 pt -64.36 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.555 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -82.24 4.31 24.07 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 35.8 tp -76.03 11.84 1.33 Allowed 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.689 0.757 . . . . 0.0 110.612 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HE2' ' O ' ' A' ' 103' ' ' ILE . 57.9 mtmt -83.86 -1.4 54.35 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.278 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.6 t -57.31 -46.39 83.26 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 64.3 pttt -78.59 -23.8 45.79 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.716 0.77 . . . . 0.0 109.463 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.74 ' O ' HG12 ' A' ' 113' ' ' ILE . 39.2 mm -67.12 -41.52 87.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.74 0 CA-C-N 114.581 -1.191 . . . . 0.0 110.117 -174.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 106' ' ' LYS . 59.6 mt -58.28 -48.89 83.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.83 -177.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.414 ' OD1' ' HE2' ' A' ' 41' ' ' LYS . 59.5 m-80 -65.9 -39.85 90.99 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 70.1 m -61.76 -40.2 94.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.849 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.74 HG12 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -62.84 -47.54 92.37 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.471 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 72.6 t -61.85 -48.83 86.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.556 -177.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -62.03 -43.46 98.78 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.463 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.519 ' CE2' HD11 ' A' ' 120' ' ' ILE . 68.8 t80 -64.84 -49.86 68.91 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.887 0.375 . . . . 0.0 110.994 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 82.1 t80 -59.37 -48.63 80.89 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.278 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 36.4 m-85 -65.85 -30.7 71.35 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.334 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.26 -45.51 92.97 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 177.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.519 HD11 ' CE2' ' A' ' 116' ' ' TYR . 75.0 mt -64.63 -42.97 96.6 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.584 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HD2' HG13 ' A' ' 127' ' ' VAL . 17.1 mmmt -59.93 -42.38 93.83 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.269 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.07 85.48 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.794 -1.094 . . . . 0.0 112.064 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.41 -34.07 15.78 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.098 0.475 . . . . 0.0 111.076 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 26.0 m -133.23 98.39 15.55 Favored Pre-proline 0 N--CA 1.443 -0.789 0 C-N-CA 123.184 0.594 . . . . 0.0 109.717 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.93 -15.32 36.42 Favored 'Trans proline' 0 C--N 1.333 -0.237 0 C-N-CA 122.394 2.063 . . . . 0.0 112.327 -177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 128' ' ' GLU . 40.1 m-20 -63.28 -31.23 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -176.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.571 HG13 ' HD2' ' A' ' 121' ' ' LYS . 9.8 p -66.31 127.23 27.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.711 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 42.8 mt-10 -119.52 6.27 11.08 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.606 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.31 159.25 25.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.859 0.361 . . . . 0.0 111.622 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -138.33 135.03 35.0 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -178.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.4 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -124.24 137.66 54.49 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.722 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' CD1' ' A' ' 113' ' ' ILE . 72.1 t -115.39 117.02 54.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 121.257 0.551 . . . . 0.0 109.666 177.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 6.8 ptm -146.48 159.07 43.88 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.2 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.65 HG12 ' HB2' ' A' ' 152' ' ' ALA . 18.1 pt -132.6 158.37 75.88 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.792 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 134' ' ' ILE . 30.9 Cg_endo -64.58 130.91 27.83 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.451 1.434 . . . . 0.0 111.722 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 139' ' ' TYR . 65.6 pttt -62.65 -16.42 56.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.554 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -63.43 -37.55 87.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.106 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -96.71 -21.93 17.29 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.495 0.664 . . . . 0.0 110.022 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 136' ' ' LYS . 31.4 t80 -67.53 124.43 89.18 Favored Pre-proline 0 C--N 1.305 -1.342 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.716 178.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -59.1 -72.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.236 1.958 . . . . 0.0 113.128 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.509 ' OD1' ' HD2' ' A' ' 142' ' ' PRO . 60.0 t30 -163.62 127.6 1.86 Allowed Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.509 ' HD2' ' OD1' ' A' ' 141' ' ' ASN . 72.5 Cg_endo -75.9 148.41 31.88 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.654 2.236 . . . . 0.0 112.654 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 77.6 p -63.91 -38.92 92.87 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.241 0.543 . . . . 0.0 110.765 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 46.5 pt -80.89 138.29 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.995 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.708 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -84.22 85.5 7.36 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.234 0.54 . . . . 0.0 110.455 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -160.38 126.52 4.12 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.318 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -96.63 108.55 21.18 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.316 0.579 . . . . 0.0 110.663 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.93 -108.41 0.21 Allowed Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.5 mt -109.52 140.96 42.65 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-O 121.351 0.596 . . . . 0.0 110.385 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 30.2 m -109.88 120.88 43.56 Favored Pre-proline 0 C--N 1.289 -2.037 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.875 -177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.06 142.99 48.02 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.331 2.021 . . . . 0.0 111.389 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.65 ' HB2' HG12 ' A' ' 134' ' ' ILE . . . -109.09 -13.03 14.76 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.732 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -162.28 -117.74 0.44 Allowed Glycine 0 N--CA 1.432 -1.584 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.309 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.699 HD12 HD21 ' A' ' 96' ' ' LEU . 17.8 pt -122.98 160.93 25.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 122.656 0.382 . . . . 0.0 111.443 -175.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.596 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 15.7 t-20 -116.61 153.71 31.79 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.906 -174.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 85.9 t -123.51 132.9 70.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.423 0.289 . . . . 0.0 110.378 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' OD1' ' A' ' 155' ' ' ASN . 28.4 m -130.79 149.79 33.92 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.412 0.625 . . . . 0.0 112.1 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.413 ' OG ' ' HD2' ' A' ' 159' ' ' PRO . 23.1 t -98.19 151.62 37.61 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 91' ' ' PHE . 29.1 Cg_endo -63.11 82.17 0.12 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.844 2.363 . . . . 0.0 112.582 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.96 -172.64 2.16 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.034 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -137.2 92.24 2.7 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 173.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.96 -137.09 10.95 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -107.96 139.87 41.95 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.136 0.494 . . . . 0.0 110.746 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -134.91 166.59 22.64 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.063 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -54.31 121.62 8.64 Favored 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 123.416 0.447 . . . . 0.0 110.859 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -129.78 129.42 44.06 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.545 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -93.84 162.95 13.71 Favored 'General case' 0 CA--C 1.471 -2.071 0 CA-C-O 121.936 0.874 . . . . 0.0 112.716 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.4 HD13 ' HB3' ' A' ' 131' ' ' ALA . 49.6 mm -116.12 128.08 73.53 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 CA-C-N 113.821 -1.536 . . . . 0.0 111.579 -175.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 55.4 ttp -125.79 129.99 50.54 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.419 175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 133' ' ' MET . 60.0 t -106.63 129.94 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.015 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 173' ' ' GLU . 49.3 pt -115.87 175.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.492 -176.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -113.4 11.44 18.51 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.238 0.542 . . . . 0.0 110.23 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.657 ' HB2' HD12 ' A' ' 171' ' ' ILE . 29.2 mp0 -97.41 131.45 44.05 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.791 0.805 . . . . 0.0 110.882 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.7 139.63 32.49 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.667 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 175' ' ' ILE . 2.0 pp -120.84 148.85 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 116.338 -0.392 . . . . 0.0 109.946 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -114.48 117.34 30.71 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.892 0.377 . . . . 0.0 110.018 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -105.26 13.99 29.67 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.257 -177.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 184' ' ' LEU . 11.7 mm 55.46 71.84 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 174.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -67.62 -41.99 83.09 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.429 0.633 . . . . 0.0 110.277 175.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -145.88 -175.34 4.71 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.336 -173.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.558 ' H ' ' HD3' ' A' ' 181' ' ' LYS . 1.3 mptp? -59.48 -36.49 76.12 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.222 0.609 . . . . 0.0 111.328 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -58.23 -43.3 87.66 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.473 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 63.9 m-20 -70.7 -39.52 73.4 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.303 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 178' ' ' ILE . 64.3 tp -59.45 -50.49 73.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.2 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 188' ' ' GLU . 87.5 tttt -64.36 -43.26 95.12 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.93 178.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 9.8 tt -61.03 -49.01 79.11 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.737 -178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.04 96.95 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 185' ' ' LYS . 11.0 pt-20 -66.26 -37.45 85.51 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.049 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 97.0 mtp -66.69 -37.56 84.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.715 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 89.5 mt -62.46 -44.39 96.53 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.452 0.644 . . . . 0.0 109.323 178.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.49 -42.97 98.53 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.467 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.35 -45.7 92.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.572 -1.195 . . . . 0.0 111.077 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -68.39 -41.43 80.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.155 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -67.87 -27.15 66.43 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.302 0.572 . . . . 0.0 110.722 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -96.84 29.96 9.7 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.784 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 55.0 tp . . . . . 0 C--O 1.267 1.983 0 C-N-CA 124.72 1.208 . . . . 0.0 111.323 -179.481 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HG3' ' HA ' ' A' ' 95' ' ' PHE . 60.1 ttm . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 120.813 0.34 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.572 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 75.9 m-20 -105.38 166.27 10.54 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -113.46 127.39 56.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.161 0.505 . . . . 0.0 110.468 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -103.26 119.68 39.32 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.782 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.644 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.6 mt -118.88 104.16 15.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.552 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.46 ' HE3' ' CG ' ' A' ' 83' ' ' ASP . 8.0 ptm -92.83 102.19 14.57 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.008 1.385 . . . . 0.0 112.047 -176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' HB1' ' HG2' ' A' ' 20' ' ' PRO . . . -115.12 98.29 6.7 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 112.795 -2.002 . . . . 0.0 111.139 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.75 107.36 1.11 Allowed Glycine 0 C--N 1.302 -1.31 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.775 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.1 -13.38 67.16 Favored Glycine 0 N--CA 1.465 0.611 0 C-N-CA 121.602 -0.332 . . . . 0.0 112.57 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 18' ' ' GLU . 3.9 tmtt? -77.71 148.06 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 120.76 0.314 . . . . 0.0 111.034 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -142.43 150.18 21.92 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 176.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 p -68.69 -38.91 80.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 117.287 0.543 . . . . 0.0 111.01 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.492 ' HB3' ' HA ' ' A' ' 145' ' ' ASP . 7.0 ptm180 -71.73 -31.82 67.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.343 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 13' ' ' ARG . 27.4 ptm 169.81 -36.76 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.8 0.84 . . . . 0.0 110.114 177.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.11 -177.49 47.65 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.61 -163.26 27.26 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.798 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.8 t -82.29 107.34 14.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 38.7 tp10 -101.38 127.29 48.08 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.525 -178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -125.93 85.01 60.08 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 121.362 0.601 . . . . 0.0 110.29 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.474 ' HG2' ' HB1' ' A' ' 7' ' ' ALA . 20.7 Cg_exo -69.34 -5.26 15.51 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.608 2.872 . . . . 0.0 111.579 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.514 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 21.7 mt -87.05 6.07 34.38 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 87.6 mt -74.13 110.56 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 24.7 pttm -81.67 131.39 35.27 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.685 -178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.48 HD13 ' CD1' ' A' ' 184' ' ' LEU . 57.6 tp -122.71 112.07 17.49 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 113.687 -1.597 . . . . 0.0 110.155 -176.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.6 m 58.2 17.95 4.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 153.87 -95.48 0.15 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.146 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HG2' ' CD2' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -87.29 172.41 9.89 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.141 0.496 . . . . 0.0 111.34 -176.144 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.514 ' HB3' ' HA ' ' A' ' 21' ' ' LEU . 76.6 m -76.07 163.42 27.14 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.067 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 98.9 mt -59.61 -39.18 83.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.631 -177.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.8 tp -57.68 -45.18 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.035 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' HA ' ' OH ' ' A' ' 64' ' ' TYR . 17.7 t70 -64.56 -40.34 95.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.493 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CD2' ' HG2' ' A' ' 27' ' ' ARG . 11.2 m-85 -61.26 -37.99 85.12 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.274 175.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.15 -44.34 74.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.958 0.409 . . . . 0.0 111.148 178.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' ILE . 78.1 t -64.14 -41.97 94.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.3 m -51.67 -55.67 27.75 Favored Pre-proline 0 CA--C 1.562 1.436 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -68.23 -37.27 14.46 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 121.512 1.475 . . . . 0.0 112.409 178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.663 HD11 HG11 ' A' ' 98' ' ' VAL . 82.1 mt -66.26 -41.53 89.78 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.845 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.0 tt -61.33 -46.26 91.02 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.875 0.369 . . . . 0.0 110.684 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -79.16 -9.29 59.52 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.409 ' OG ' HG22 ' A' ' 42' ' ' VAL . 54.7 p -72.08 -177.7 2.15 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.358 0.599 . . . . 0.0 111.934 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -73.34 2.54 7.36 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.811 -177.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG22 ' OG ' ' A' ' 40' ' ' SER . 34.2 m -80.42 162.03 3.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.342 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 63.6 t30 -81.63 -71.78 0.46 Allowed 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.947 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -120.52 160.14 23.77 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.256 0.55 . . . . 0.0 111.396 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.1 mm -109.8 117.54 54.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.271 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 83.7 m-85 -109.46 116.86 32.59 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 177.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.457 HG21 HD13 ' A' ' 60' ' ' ILE . 96.0 mt -97.39 116.22 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 121.715 0.769 . . . . 0.0 110.467 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -87.18 120.53 28.55 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.65 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 7' ' ' ALA . 45.1 p -127.93 154.72 45.23 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.579 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.6 m -100.58 149.36 36.06 Favored Pre-proline 0 C--N 1.293 -1.854 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.266 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.56 -17.58 53.23 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.714 2.276 . . . . 0.0 110.169 176.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -78.07 -11.1 59.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.821 -1.081 . . . . 0.0 109.599 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.3 p -140.17 67.55 33.07 Favored Pre-proline 0 N--CA 1.44 -0.971 0 CA-C-O 119.209 -0.424 . . . . 0.0 112.117 -177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 77.3 Cg_endo -102.46 85.76 0.03 OUTLIER 'Trans proline' 1 N--CA 1.389 -4.629 0 C-N-CA 116.793 -1.671 . . . . 0.0 110.107 170.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.651 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 37.7 mmtm -149.8 -48.45 0.13 Allowed 'General case' 1 C--N 1.22 -5.049 0 CA-C-N 109.845 -3.343 . . . . 0.0 103.074 178.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.436 ' HA ' HD21 ' A' ' 21' ' ' LEU . 99.3 m -62.81 -48.63 78.26 Favored 'General case' 0 N--CA 1.386 -3.659 0 CA-C-N 113.104 -1.862 . . . . 0.0 105.987 163.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.674 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.32 -50.42 70.08 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.341 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.651 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 7.8 pt-20 -62.6 -34.14 76.42 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 117.159 -1.817 . . . . 0.0 112.138 177.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CD2' HD22 ' A' ' 21' ' ' LEU . 51.0 t80 -64.55 -51.09 64.63 Favored 'General case' 0 C--O 1.211 -0.972 0 O-C-N 122.089 -0.382 . . . . 0.0 111.728 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 47' ' ' ILE . 95.5 mt -62.59 -41.25 91.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.297 -175.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.1 -46.02 79.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.065 177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.694 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 23.2 t -73.06 -40.26 65.23 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.38 0.61 . . . . 0.0 110.848 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.97 -37.78 86.07 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.908 -177.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.432 ' O ' ' HD1' ' A' ' 67' ' ' TYR . 89.5 m-85 -114.75 42.29 2.18 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.544 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.694 ' HG3' ' O ' ' A' ' 62' ' ' SER . 39.2 mtmm -60.55 -22.21 63.41 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.221 0.534 . . . . 0.0 110.25 176.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.98 10.64 18.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.235 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 64' ' ' TYR . 55.4 p90 -44.33 117.27 1.2 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -176.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 68' ' ' LYS . 3.9 mmpt? -103.06 -49.35 3.78 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.444 1.116 . . . . 0.0 109.088 171.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -113.42 9.92 18.21 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.577 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.4 mp -103.48 123.87 57.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.083 0.468 . . . . 0.0 110.124 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 46' ' ' PHE . 65.5 t -124.02 131.9 72.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.347 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.2 131.89 53.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.112 0.482 . . . . 0.0 109.83 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 48' ' ' ALA . 34.3 pt -125.89 156.53 35.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.307 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -117.36 129.59 55.97 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 7.5 t -158.74 -170.19 2.97 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' LYS . 50.5 m -66.18 2.36 1.2 Allowed 'General case' 0 C--O 1.208 -1.099 0 C-N-CA 127.268 2.227 . . . . 0.0 115.011 -175.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.621 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -30.17 -22.61 0.0 OUTLIER Glycine 1 N--CA 1.52 4.262 0 C-N-CA 126.187 1.851 . . . . 0.0 117.02 -174.46 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -55.65 -39.87 71.48 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 172.482 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.14 122.64 6.98 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -59.82 -50.56 73.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 117.218 0.509 . . . . 0.0 111.454 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 42.9 pt -72.88 -30.81 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.774 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.87 -43.34 93.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.419 0.628 . . . . 0.0 109.353 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.621 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 7.5 t0 -61.45 -51.09 70.13 Favored 'General case' 0 CA--C 1.495 -1.173 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.15 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 88' ' ' ILE . 3.3 mm? -57.61 -43.2 84.56 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.499 ' HA ' HG12 ' A' ' 88' ' ' ILE . 14.9 m-80 -60.39 -42.62 96.29 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 178.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -63.84 -45.71 88.29 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.286 175.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.496 ' O ' ' HD2' ' A' ' 91' ' ' PHE . 98.9 m -62.56 -41.95 99.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.158 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 84' ' ' LEU . 29.5 pt -66.0 -29.51 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.24 -39.59 96.14 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.637 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -71.38 -40.97 70.25 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.496 ' HD2' ' O ' ' A' ' 87' ' ' CYS . 86.8 m-85 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.943 0.402 . . . . 0.0 111.916 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.6 m -105.16 -2.36 24.32 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -134.67 157.02 78.17 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.975 -178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -53.39 141.94 59.59 Favored 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 123.486 2.791 . . . . 0.0 112.237 177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 1' ' ' MET . 32.4 p90 -141.66 156.4 45.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.354 0.597 . . . . 0.0 111.543 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.601 HD11 HD12 ' A' ' 154' ' ' ILE . 1.2 tm? -86.34 138.78 31.55 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.178 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.62 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 63.5 t -113.96 129.99 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.663 HG11 HD11 ' A' ' 37' ' ' LEU . 7.3 m -129.47 160.17 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.484 0.659 . . . . 0.0 112.505 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.452 ' HB2' ' HG ' ' A' ' 102' ' ' LEU . 62.4 m -100.44 138.26 37.74 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.772 172.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 71.7 p -64.79 -21.46 66.78 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.537 ' CG ' ' HZ1' ' A' ' 10' ' ' LYS . 39.9 p-10 -112.27 22.76 14.39 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -175.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' A' ' 99' ' ' SER . 95.9 mt -68.81 138.4 54.75 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 120.547 -0.461 . . . . 0.0 109.915 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.0 mm -92.99 142.81 12.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 79.37 171.65 0.16 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.527 1.131 . . . . 0.0 112.799 174.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.0 mt -70.75 134.33 47.34 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.212 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -101.81 -1.65 31.8 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.431 -172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.568 ' HA ' HD12 ' A' ' 110' ' ' ILE . 69.6 m -57.19 -40.73 77.97 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -170.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.507 ' HG3' HG13 ' A' ' 109' ' ' ILE . 17.2 ptmt -74.34 -38.22 63.31 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.065 0.936 . . . . 0.0 110.304 -177.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.783 ' O ' HG12 ' A' ' 113' ' ' ILE . 58.8 mt -66.49 -40.43 86.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.23 -175.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 107' ' ' SER . 62.6 mt -58.42 -45.8 89.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.913 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.455 HD22 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -60.95 -45.14 95.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.986 179.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -62.99 -39.85 96.01 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.624 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.783 HG12 ' O ' ' A' ' 109' ' ' ILE . 48.9 mm -61.69 -48.66 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-O 121.205 0.526 . . . . 0.0 110.331 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 69.3 t -62.04 -48.19 89.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.687 -177.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -62.26 -45.68 92.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.694 ' CE2' HD11 ' A' ' 120' ' ' ILE . 80.1 t80 -64.08 -47.79 78.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 79.6 t80 -58.37 -46.02 87.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.453 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -60.4 -37.15 79.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 98.9 m -62.96 -42.72 99.91 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.913 0.387 . . . . 0.0 110.528 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.694 HD11 ' CE2' ' A' ' 116' ' ' TYR . 71.2 mt -68.26 -44.19 84.12 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.711 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -66.73 -37.0 83.78 Favored 'General case' 0 N--CA 1.406 -2.655 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.585 -178.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.422 ' N ' ' HD3' ' A' ' 121' ' ' LYS . . . -62.01 -42.71 99.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.783 0.325 . . . . 0.0 111.16 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -80.14 -39.42 29.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.073 0.464 . . . . 0.0 111.034 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 126' ' ' ASP . 35.8 m -132.36 99.97 15.61 Favored Pre-proline 0 N--CA 1.435 -1.185 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 -176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -67.12 -11.9 34.0 Favored 'Trans proline' 0 N--CA 1.475 0.387 0 C-N-CA 123.002 2.468 . . . . 0.0 112.231 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 124' ' ' THR . 25.4 t70 -61.49 -32.63 72.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.208 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.428 HG22 ' HE2' ' A' ' 165' ' ' LYS . 60.4 t -81.3 119.24 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.282 0.563 . . . . 0.0 111.011 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.597 ' HB3' ' CB ' ' A' ' 158' ' ' SER . 39.5 mt-10 -122.55 7.12 9.49 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.658 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -147.59 153.75 39.81 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.004 0.43 . . . . 0.0 111.506 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -139.37 139.0 37.06 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.191 -177.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB3' HD13 ' A' ' 168' ' ' ILE . . . -128.14 139.0 52.73 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.191 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.566 HG21 ' CD1' ' A' ' 113' ' ' ILE . 98.4 t -115.32 117.51 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-O 121.74 0.781 . . . . 0.0 110.683 177.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.463 ' SD ' HD23 ' A' ' 149' ' ' LEU . 5.2 ptm -146.5 161.87 39.52 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.113 -177.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 24.9 pt -128.77 159.59 67.49 Favored Pre-proline 0 C--N 1.304 -1.391 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.351 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.96 144.65 99.06 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.261 1.974 . . . . 0.0 111.298 178.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -57.76 -39.89 78.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.805 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -64.83 -37.13 86.6 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.115 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -76.31 -27.27 56.49 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-O 121.534 0.683 . . . . 0.0 110.075 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.406 ' HB2' HG21 ' A' ' 150' ' ' VAL . 46.2 t80 -68.31 139.2 92.09 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.268 176.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.44 55.85 2.08 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.669 2.246 . . . . 0.0 112.813 -178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 18.0 m120 67.3 119.55 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.554 0 C-N-CA 124.061 0.944 . . . . 0.0 112.556 178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.64 140.18 92.64 Favored 'Trans proline' 0 C--O 1.236 0.388 0 C-N-CA 122.695 2.263 . . . . 0.0 110.395 177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.0 m -113.49 88.5 2.85 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.448 -175.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 144' ' ' ILE . 26.4 mm 66.38 1.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.093 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.492 ' HA ' ' HB3' ' A' ' 13' ' ' ARG . 29.9 m-20 -63.58 -51.15 66.59 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.598 -178.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 46.88 29.09 0.94 Allowed 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -98.27 -1.23 42.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.288 0.566 . . . . 0.0 111.236 -177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 84.49 -59.1 4.96 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.142 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.463 HD23 ' SD ' ' A' ' 133' ' ' MET . 4.0 mp -90.4 148.07 23.04 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 139' ' ' TYR . 29.0 m -126.72 116.06 22.58 Favored Pre-proline 0 C--N 1.301 -1.529 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.242 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.497 ' O ' HD11 ' A' ' 175' ' ' ILE . 61.8 Cg_endo -71.73 149.94 55.44 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.483 2.122 . . . . 0.0 111.218 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 175' ' ' ILE . . . -132.4 -31.82 1.38 Allowed 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.974 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -117.03 -134.16 5.21 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.993 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.601 HD12 HD11 ' A' ' 96' ' ' LEU . 22.6 pt -126.08 160.36 33.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.223 -0.489 . . . . 0.0 110.399 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.62 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.5 m-20 -111.78 158.03 19.85 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.1 132.31 71.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.785 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.9 153.72 38.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.379 0.609 . . . . 0.0 111.808 178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.597 ' CB ' ' HB3' ' A' ' 128' ' ' GLU . 34.3 t -97.99 151.19 37.43 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.893 176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.461 ' HD2' ' OG ' ' A' ' 158' ' ' SER . 61.3 Cg_endo -70.28 59.18 1.87 Allowed 'Trans proline' 0 N--CA 1.479 0.627 0 C-N-CA 123.281 2.654 . . . . 0.0 112.684 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -88.72 -172.33 3.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.259 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -134.31 94.86 3.29 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 122.92 -119.99 4.1 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.778 -0.725 . . . . 0.0 111.689 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -127.82 140.99 51.7 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.968 0.413 . . . . 0.0 110.402 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -135.37 167.0 21.84 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.846 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.428 ' HE2' HG22 ' A' ' 127' ' ' VAL . 20.3 tptm -55.25 128.33 33.5 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.137 177.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -132.58 130.59 40.49 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.298 -176.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -98.94 162.34 13.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-O 121.701 0.762 . . . . 0.0 112.996 178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.413 HD13 ' HB3' ' A' ' 131' ' ' ALA . 50.0 mm -118.09 130.16 73.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.696 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 60.6 ttp -127.9 137.97 52.5 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.399 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 133' ' ' MET . 62.6 t -110.1 130.39 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.073 -178.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 173' ' ' GLU . 48.5 pt -113.74 172.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.018 0.437 . . . . 0.0 110.503 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -106.7 9.98 31.05 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.311 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.426 ' HB2' HD12 ' A' ' 171' ' ' ILE . 35.6 mt-10 -101.65 129.04 47.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.804 0.811 . . . . 0.0 111.247 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.75 150.76 20.34 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.168 -1.378 . . . . 0.0 113.508 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.497 HD11 ' O ' ' A' ' 151' ' ' PRO . 23.3 pt -133.79 155.4 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.952 176.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.08 127.32 54.77 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.635 0.255 . . . . 0.0 110.483 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -84.41 109.36 17.81 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.605 HG23 ' HB2' ' A' ' 183' ' ' ASP . 94.5 mt -85.63 115.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.537 -176.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -119.73 -18.72 8.25 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.319 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 68.6 p -128.38 167.21 17.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.33 -176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -59.72 -38.9 82.94 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.847 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -61.54 -39.96 92.94 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.737 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.605 ' HB2' HG23 ' A' ' 178' ' ' ILE . 71.7 m-20 -62.44 -42.0 99.14 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.296 0.569 . . . . 0.0 109.871 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.48 ' CD1' HD13 ' A' ' 24' ' ' LEU . 55.2 tp -62.12 -43.96 97.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.291 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.585 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 6.1 tmtt? -62.07 -39.2 91.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.24 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 190' ' ' LEU . 10.1 tt -62.46 -46.09 90.11 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.88 -41.58 99.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.759 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.0 OUTLIER -67.74 -31.88 72.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 120.884 0.373 . . . . 0.0 110.533 -179.092 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 58.3 ttm -64.32 -39.74 94.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.642 177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 186' ' ' LEU . 87.4 mt -63.77 -43.68 95.69 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.625 0.726 . . . . 0.0 109.624 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.78 -39.28 93.34 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.418 178.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -60.82 -45.66 93.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.316 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -62.41 -41.84 98.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.824 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.28 11.52 18.69 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.273 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.87 8.38 79.93 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 68.7 tp . . . . . 0 C--O 1.265 1.914 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.896 179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttm . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.856 0.36 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 43' ' ' ASN . 35.5 m-20 -106.28 166.12 10.75 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.26 129.83 55.7 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.94 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' O ' HG22 ' A' ' 98' ' ' VAL . 25.5 tp -105.31 125.23 50.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.682 ' HA ' HG22 ' A' ' 98' ' ' VAL . 65.0 mt -117.1 103.41 14.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.512 ' HE2' ' CG ' ' A' ' 83' ' ' ASP . 58.2 ttm -83.04 96.84 8.48 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-O 121.711 0.767 . . . . 0.0 110.887 -178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 49' ' ' THR . . . -115.96 97.69 6.23 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.535 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -98.41 0.12 Allowed Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.662 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.08 168.25 51.86 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.703 -176.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -168.32 -36.07 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.52 179.73 51.5 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.2 p -90.58 130.54 36.6 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 117.394 0.597 . . . . 0.0 112.415 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 58.68 -91.01 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 96.7 mtp -108.72 151.79 25.71 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.106 0.479 . . . . 0.0 112.032 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.65 89.85 1.5 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.03 61.18 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.961 -176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.446 ' O ' ' HD3' ' A' ' 19' ' ' LYS . 39.2 t 56.32 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 123.732 0.813 . . . . 0.0 112.51 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.01 93.3 3.25 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.86 -0.525 . . . . 0.0 111.864 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.625 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 2.5 mppt? -105.81 -60.11 0.05 OUTLIER Pre-proline 0 C--O 1.219 -0.518 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.284 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 19' ' ' LYS . 24.2 Cg_exo -65.4 -24.12 57.57 Favored 'Trans proline' 0 C--N 1.372 1.8 0 C-N-CA 122.318 2.012 . . . . 0.0 112.869 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.477 ' HA ' ' HB3' ' A' ' 28' ' ' CYS . 42.8 mt -97.02 14.87 24.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 87.0 mt -75.3 114.12 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 8.6 ptmm? -85.45 125.04 32.71 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.82 -178.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 188' ' ' GLU . 62.4 tp -126.38 115.68 20.01 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.94 -174.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 32.9 t 58.84 19.19 6.75 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.975 178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.3 -62.92 0.54 Allowed Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.253 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.704 ' HD3' ' OD1' ' A' ' 31' ' ' ASP . 96.2 mtt180 -104.85 167.47 9.69 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 117.508 0.654 . . . . 0.0 111.476 -175.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 76.1 m -82.15 160.84 23.0 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.704 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 19' ' ' LYS . 90.1 mt -59.41 -39.65 84.13 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.949 0.155 . . . . 0.0 111.246 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.522 ' O ' HG23 ' A' ' 34' ' ' VAL . 3.7 tp -57.04 -46.1 84.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.704 ' OD1' ' HD3' ' A' ' 27' ' ' ARG . 11.4 t70 -64.87 -41.64 95.49 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.138 0.494 . . . . 0.0 110.403 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 27' ' ' ARG . 18.8 m-85 -64.4 -34.34 77.95 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.809 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' LEU . 77.0 t -66.99 -43.87 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-O 121.327 0.584 . . . . 0.0 110.206 175.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 30' ' ' ILE . 79.0 t -63.35 -41.65 93.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.38 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.7 m -51.28 -55.93 24.57 Favored Pre-proline 0 CA--C 1.565 1.547 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.498 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 45.8 Cg_endo -69.23 -36.1 12.88 Favored 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 121.573 1.516 . . . . 0.0 112.491 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.634 HD11 HG11 ' A' ' 98' ' ' VAL . 99.4 mt -67.46 -41.79 84.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.642 -178.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.48 ' HG ' HD21 ' A' ' 69' ' ' ASN . 7.8 tt -63.0 -44.54 95.73 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.049 0.452 . . . . 0.0 110.886 177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 36' ' ' PRO . 22.1 ptmt -75.26 -12.31 60.25 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.0 p -71.24 -178.9 2.19 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.144 0.497 . . . . 0.0 110.588 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -76.51 0.32 20.34 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.67 159.38 5.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-O 121.333 0.587 . . . . 0.0 111.839 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.453 ' HB3' ' OD1' ' A' ' 2' ' ' ASP . 61.2 t30 -77.35 -73.18 0.31 Allowed 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.755 -178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -121.17 159.46 25.8 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.171 0.51 . . . . 0.0 111.132 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.6 mm -107.16 116.31 50.53 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.11 114.95 29.11 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.637 HG21 HD13 ' A' ' 60' ' ' ILE . 96.5 mt -95.03 117.8 39.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-O 121.501 0.667 . . . . 0.0 110.182 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' HA ' HG13 ' A' ' 73' ' ' ILE . . . -88.1 119.68 28.72 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.219 -178.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.519 HG22 ' O ' ' A' ' 7' ' ' ALA . 77.6 p -129.88 166.86 19.13 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.565 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 80.5 p -131.3 158.84 74.12 Favored Pre-proline 0 C--N 1.298 -1.65 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.856 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.23 -19.79 65.27 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.809 2.339 . . . . 0.0 111.435 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.63 -13.9 59.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.881 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.2 p -142.09 67.16 21.63 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HA ' ' HB3' ' A' ' 57' ' ' LYS . 85.6 Cg_endo -104.29 86.58 0.03 OUTLIER 'Trans proline' 1 N--CA 1.385 -4.863 0 C-N-CA 116.827 -1.649 . . . . 0.0 110.108 169.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 58' ' ' GLU . 73.6 mmtt -146.96 -47.51 0.18 Allowed 'General case' 1 C--N 1.222 -4.964 0 CA-C-N 110.08 -3.236 . . . . 0.0 103.405 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.445 HG21 ' HB1' ' A' ' 7' ' ' ALA . 99.8 m -61.93 -48.59 79.73 Favored 'General case' 0 N--CA 1.379 -3.996 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 164.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 54' ' ' PRO . 88.4 tttt -63.16 -50.68 69.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.558 177.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 55' ' ' LYS . 11.3 pt-20 -64.36 -26.39 68.45 Favored 'General case' 0 C--N 1.368 1.39 0 C-N-CA 117.098 -1.841 . . . . 0.0 112.879 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -70.52 -51.23 30.21 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.277 0.561 . . . . 0.0 111.483 176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.637 HD13 HG21 ' A' ' 47' ' ' ILE . 94.5 mt -63.55 -43.62 98.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.493 -175.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -56.73 -45.01 82.2 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.495 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.421 ' HA ' ' HG2' ' A' ' 65' ' ' LYS . 33.0 t -69.18 -42.28 76.07 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.631 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.05 93.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.199 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.478 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 70.9 m-85 -114.61 41.61 2.3 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.39 -176.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 62' ' ' SER . 12.0 mmmm -58.93 -37.01 75.71 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.131 0.491 . . . . 0.0 110.951 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -83.52 11.9 6.42 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.15 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.478 ' HB3' ' O ' ' A' ' 64' ' ' TYR . 49.8 p90 -44.46 130.65 6.63 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.417 ' HD2' ' C ' ' A' ' 68' ' ' LYS . 3.6 tmmm? -102.55 -48.28 4.19 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.21 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.48 HD21 ' HG ' ' A' ' 38' ' ' LEU . 24.1 p-10 -118.12 7.89 12.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.251 -178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.1 mp -100.09 116.34 43.21 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 85.1 t -117.7 130.74 72.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.77 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.2 p -104.09 127.69 58.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.5 HG13 ' HA ' ' A' ' 48' ' ' ALA . 36.1 pt -120.85 153.3 24.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.331 0.586 . . . . 0.0 110.959 -177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -118.08 131.21 56.46 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.841 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.4 t -166.67 -166.22 0.83 Allowed 'General case' 0 C--N 1.281 -2.391 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.469 ' O ' ' N ' ' A' ' 78' ' ' LYS . 67.5 m -57.58 1.5 0.04 OUTLIER 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 126.965 2.106 . . . . 0.0 115.344 -177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.545 ' HA2' ' HB2' ' A' ' 83' ' ' ASP . . . -33.07 -12.5 0.0 OUTLIER Glycine 1 N--CA 1.517 4.069 0 C-N-CA 126.048 1.785 . . . . 0.0 116.587 -179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 76' ' ' SER . 0.8 OUTLIER -58.13 -38.96 77.52 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.419 ' HA3' ' OE2' ' A' ' 82' ' ' GLU . . . -114.92 131.83 10.02 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -61.08 -51.33 69.58 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 117.067 0.433 . . . . 0.0 111.957 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.6 pt -79.45 -25.99 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 111.199 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 86' ' ' GLU . 47.1 mt-10 -62.18 -44.73 95.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.545 ' HB2' ' HA2' ' A' ' 77' ' ' GLY . 10.6 t0 -63.45 -48.57 77.15 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.18 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -54.82 -46.96 74.62 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.792 178.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.469 ' HA ' HG12 ' A' ' 88' ' ' ILE . 29.1 m-80 -61.43 -40.5 94.68 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.861 178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 76.8 mm-40 -63.36 -45.66 90.14 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.135 0.493 . . . . 0.0 109.744 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.572 ' O ' ' HD1' ' A' ' 91' ' ' PHE . 98.0 m -63.07 -42.2 99.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.526 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 84' ' ' LEU . 36.4 pt -64.83 -28.73 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.785 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.37 -20.24 75.09 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.543 -0.753 . . . . 0.0 113.302 177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -103.78 -28.25 11.75 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 117.563 0.682 . . . . 0.0 112.786 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.572 ' HD1' ' O ' ' A' ' 87' ' ' CYS . 71.8 m-85 -77.24 141.28 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.878 0.37 . . . . 0.0 111.427 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -105.87 -1.95 23.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.507 0.67 . . . . 0.0 109.868 176.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 94' ' ' PRO . 40.4 mt-10 -132.99 160.0 70.44 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.28 -178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 158' ' ' SER . 41.6 Cg_endo -67.65 145.46 69.94 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 121.729 1.619 . . . . 0.0 110.761 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.1 157.98 44.55 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.61 0.719 . . . . 0.0 111.488 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 154' ' ' ILE . 26.6 tp -87.43 141.46 28.61 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.457 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.63 ' HB ' ' HB2' ' A' ' 155' ' ' ASN . 94.0 t -112.87 130.92 65.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' HA ' ' A' ' 5' ' ' ILE . 5.1 m -128.82 168.38 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 120.146 -0.622 . . . . 0.0 112.283 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.2 m -98.45 144.61 27.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.013 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 6' ' ' MET . 88.0 p -73.16 -12.51 60.91 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -174.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.437 ' OD2' ' HA ' ' A' ' 177' ' ' ASN . 7.9 p-10 -116.9 11.67 14.47 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -175.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.38 157.2 30.73 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.74 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.2 pt -116.64 174.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.003 0.43 . . . . 0.0 111.911 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -62.31 178.42 0.4 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.829 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.3 mt 81.47 5.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.576 1.15 . . . . 0.0 109.893 -176.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 109' ' ' ILE . 48.5 mmtm -98.69 1.88 46.59 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.288 178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.736 ' HA ' HD12 ' A' ' 110' ' ' ILE . 78.2 p -58.01 -35.29 71.05 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -73.92 -29.69 62.17 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 122.169 0.985 . . . . 0.0 108.944 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.613 ' O ' HG12 ' A' ' 113' ' ' ILE . 25.7 mm -64.59 -38.69 83.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 113.632 -1.622 . . . . 0.0 108.802 -176.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' A' ' 107' ' ' SER . 73.8 mt -59.31 -45.31 93.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.348 -1.297 . . . . 0.0 108.307 177.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -61.31 -43.62 98.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.96 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 69.0 m -64.73 -41.68 95.77 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.591 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 109' ' ' ILE . 44.9 mm -62.86 -45.51 98.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 121.27 0.557 . . . . 0.0 109.873 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.432 ' O ' ' HD1' ' A' ' 118' ' ' TYR . 53.8 t -60.44 -47.34 92.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.355 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -60.9 -47.61 85.59 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.03 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.613 ' CE2' HD11 ' A' ' 120' ' ' ILE . 54.3 t80 -64.56 -45.76 85.7 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.88 0.372 . . . . 0.0 110.554 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -59.27 -48.8 80.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.106 178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.432 ' HD1' ' O ' ' A' ' 114' ' ' VAL . 23.3 m-85 -62.81 -36.24 82.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.897 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.78 -41.59 97.92 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 120.984 0.421 . . . . 0.0 110.615 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.613 HD11 ' CE2' ' A' ' 116' ' ' TYR . 76.3 mt -68.96 -46.94 78.19 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.004 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER -68.22 -27.68 66.58 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.062 -177.575 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.23 99.34 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.039 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -83.92 -38.24 21.32 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.097 0.475 . . . . 0.0 110.387 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' LYS . 24.1 m -126.65 96.45 35.47 Favored Pre-proline 0 N--CA 1.439 -1.001 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.643 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.66 -15.61 48.03 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 122.804 2.336 . . . . 0.0 112.349 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.67 -32.08 73.58 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.814 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 116.45 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.835 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.555 ' HB2' ' OE1' ' A' ' 164' ' ' GLN . 38.7 mt-10 -126.72 14.07 7.49 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.113 -178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -145.09 145.91 31.62 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.404 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.5 tp -140.83 143.27 34.7 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.178 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -130.18 143.21 50.65 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.279 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 154' ' ' ILE . 12.1 p -123.24 133.27 69.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-O 121.159 0.504 . . . . 0.0 110.163 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' MET . . . . . 0.455 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 71.5 mtm -134.01 157.04 47.11 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.361 -177.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 171' ' ' ILE . 7.7 pt -127.8 151.81 76.1 Favored Pre-proline 0 C--N 1.314 -0.942 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.788 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_exo -60.64 141.54 95.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.55 2.167 . . . . 0.0 112.448 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -59.06 -38.76 80.16 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.02 177.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -62.03 -37.63 85.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.929 -1.032 . . . . 0.0 112.726 -175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -83.05 -22.63 33.46 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.414 0.626 . . . . 0.0 111.322 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -59.57 134.66 89.02 Favored Pre-proline 0 C--N 1.291 -1.977 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.607 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.01 -32.7 98.05 Favored 'Trans proline' 0 C--N 1.359 1.094 0 C-N-CA 122.871 2.381 . . . . 0.0 113.001 -175.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -144.54 90.44 6.51 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.37 144.18 45.07 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 C-N-CA 123.23 2.62 . . . . 0.0 112.608 -175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 20.2 m -82.79 90.53 6.92 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.003 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.3 pt -81.37 87.23 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-O 121.887 0.851 . . . . 0.0 110.307 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -153.65 -58.26 0.12 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.929 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -126.95 6.5 6.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.878 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 55.69 -115.49 0.94 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.784 -177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.86 -152.96 52.78 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.021 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.9 mp -121.4 147.72 45.35 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.85 150.94 42.03 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.26 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.487 ' O ' HD11 ' A' ' 175' ' ' ILE . 52.6 Cg_exo -58.82 144.56 98.4 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.003 2.469 . . . . 0.0 111.725 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.515 ' CB ' HG23 ' A' ' 134' ' ' ILE . . . -103.69 -15.42 15.77 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 170.11 -89.14 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.384 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.39 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 96' ' ' LEU . 22.3 pt -133.85 159.83 42.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.113 0.483 . . . . 0.0 111.722 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.63 ' HB2' ' HB ' ' A' ' 97' ' ' VAL . 5.4 m-20 -122.57 157.77 31.38 Favored 'General case' 0 C--O 1.208 -1.13 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.51 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.12 127.95 72.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 O-C-N 122.322 -0.236 . . . . 0.0 110.745 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.68 151.23 25.78 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-O 121.245 0.545 . . . . 0.0 111.795 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.522 ' HB2' ' HD2' ' A' ' 159' ' ' PRO . 88.8 p -97.29 169.78 8.16 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 173.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 158' ' ' SER . 37.4 Cg_endo -67.88 67.69 0.88 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.906 1.738 . . . . 0.0 110.978 174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.541 ' HB3' ' NE2' ' A' ' 164' ' ' GLN . 61.0 pttt -67.15 123.42 20.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.016 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -62.44 -43.03 99.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.547 0.689 . . . . 0.0 109.197 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 160' ' ' LYS . . . -128.77 -177.31 14.81 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 175.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -72.31 128.46 35.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 118.066 0.933 . . . . 0.0 108.629 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.555 ' OE1' ' HB2' ' A' ' 128' ' ' GLU . 29.9 pt20 -117.8 168.09 10.79 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.586 -169.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -56.91 121.0 8.88 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 121.569 0.699 . . . . 0.0 110.086 177.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -123.62 130.65 52.98 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.323 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -92.9 161.64 14.4 Favored 'General case' 0 CA--C 1.471 -2.07 0 CA-C-O 121.976 0.893 . . . . 0.0 112.954 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 50.6 mm -118.44 129.6 74.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 113.713 -1.585 . . . . 0.0 111.583 -175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.431 ' O ' ' HA ' ' A' ' 132' ' ' VAL . 62.0 ttp -129.72 134.14 47.45 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.332 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 133' ' ' MET . 49.8 t -112.14 126.47 69.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.692 HD12 ' HB2' ' A' ' 173' ' ' GLU . 47.8 pt -113.47 175.82 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-O 121.056 0.455 . . . . 0.0 111.052 -176.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -111.18 16.07 21.21 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.32 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.692 ' HB2' HD12 ' A' ' 171' ' ' ILE . 75.0 mm-40 -98.76 133.28 43.3 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.672 0.749 . . . . 0.0 111.109 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 83.0 mt -97.09 149.5 21.89 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 114.298 -1.319 . . . . 0.0 113.514 -175.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 151' ' ' PRO . 12.9 pt -127.73 155.83 39.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.863 175.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -110.6 112.3 24.1 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.541 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.437 ' HA ' ' OD2' ' A' ' 101' ' ' ASP . 7.8 t-20 -95.13 103.67 15.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.015 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.475 ' HA ' ' CB ' ' A' ' 183' ' ' ASP . 1.9 mp -81.92 113.85 21.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 120.093 -0.643 . . . . 0.0 110.521 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -117.91 -22.48 7.89 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 64.9 p -130.37 165.87 21.63 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 114.801 -1.091 . . . . 0.0 110.163 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 181' ' ' LYS . 3.8 mppt? -65.98 -28.39 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.105 0.479 . . . . 0.0 109.777 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -61.46 -42.35 98.64 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.227 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.475 ' CB ' ' HA ' ' A' ' 178' ' ' ILE . 49.3 m-20 -61.3 -41.03 96.29 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.371 0.605 . . . . 0.0 109.535 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.403 ' CD1' HD13 ' A' ' 24' ' ' LEU . 59.2 tp -61.62 -45.05 95.72 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.063 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.485 ' O ' ' HG3' ' A' ' 188' ' ' GLU . 30.4 mmmt -62.47 -39.87 94.83 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.501 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -63.01 -45.99 89.76 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.596 ' O ' ' HG ' ' A' ' 190' ' ' LEU . . . -63.83 -42.78 97.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.472 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 185' ' ' LYS . 0.9 OUTLIER -70.59 -34.68 72.42 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.757 0.313 . . . . 0.0 111.674 -178.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 57.5 ttm -62.35 -43.38 98.96 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.301 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 187' ' ' ALA . 4.1 pp -69.72 -37.94 76.71 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.717 -0.393 . . . . 0.0 111.178 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.87 -42.72 97.44 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.315 0.578 . . . . 0.0 110.385 178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.74 -40.98 98.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.763 178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.6 -42.02 91.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.614 -175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -84.63 -9.59 58.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.895 0.379 . . . . 0.0 111.071 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.33 -39.79 97.73 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.359 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.269 2.11 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.445 179.2 . . . . . . . . 0 0 . 1 stop_ save_